,condition,date_processed,enrollment,id,intervention,location_countries,overall_status,sponsors,start_date,study_type,title,study_topic
0,"SOLID TUMOR, ADULT","February 08, 2021",1000,NCT00571389,,UNITED STATES,Recruiting,"BioCytics, Inc.",November 2007,Observational,"A Study to Facilitate Development of an Ex-Vivo Device Platform for Circulating Tumor Cell and Immune Cell Harvesting, Banking, and Apoptosis-Viability Assay",Unrelated
1,HAIRY CELL LEUKEMIA (HCL),"February 08, 2021",1263,NCT01087333,,UNITED STATES,Recruiting,National Cancer Institute (NCI),"March 2, 2010",Observational,Collection of Human Samples to Study Hairy Cell and Other Leukemias and to Develop Recombinant Immunotoxins for Cancer Treatment,Unrelated
2,BREAST CANCER,"February 08, 2021",935,NCT01134172,SURVEY WEB-BASED OR TELEPHONE INTERVIEW,UNITED STATES,"Active, not recruiting",Memorial Sloan Kettering Cancer Center,May 2010,Observational,"Breast Cancer and the Workforce: Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life (BCW)",Unrelated
3,ANOGENITAL HERPES,"February 08, 2021",1000,NCT01306084,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"March 15, 2011",Observational,Viral Infections in Healthy and Immunocompromised Hosts,Unrelated
4,HIV-1 INFECTION,"February 08, 2021",334,NCT01435018,ETOPOSIDE (ET),BRAZIL,Completed,AIDS Clinical Trials Group,"October 1, 2013",Interventional,A Randomized Comparison of Three Regimens of Chemotherapy With Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings,Unrelated
5,CANCER PATIENTS,"February 08, 2021",668,NCT01603316,SURVEYS,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"May 8, 2012",Interventional,Food: A Three-Arm Randomized Controlled Study Examining Food Insecurity Interventions,Unrelated
6,COMPLICATIONS; CESAREAN SECTION,"February 08, 2021",608,NCT02495753,VAGINAL CLEANSING,UNITED STATES,Recruiting,Washington University School of Medicine,August 2015,Interventional,Vaginal Cleansing Before Cesarean Delivery to Reduce Infection: A Randomized Trial,Unrelated
7,COMMUNITY ACQUIRED PNEUMONIA,"February 08, 2021",1200,NCT02517489,HYDROCORTISONE,FRANCE,Recruiting,"University Hospital, Tours","October 28, 2015",Interventional,Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia,Respiratory
8,HYPERTROPHIC CARDIOMYOPATHY,"February 08, 2021",4299,NCT02549664,,AUSTRALIA,"Active, not recruiting",Yale University,May 2015,Observational [Patient Registry],"Exercise in Genetic Cardiovascular Conditions (Lifestyle and Exercise in Hypertrophic Cardiomyopathy ""LIVE-HCM""/Lifestyle and Exercise in the Long QT Syndrome ""LIVE-LQTS""",Unrelated
9,UVEITIS,"February 08, 2021",650,NCT02656381,,UNITED STATES,Recruiting,National Eye Institute (NEI),"July 26, 2016",Observational,Uveitis/Intraocular Inflammatory Disease Biobank (iBank),Unrelated
10,TRANSIENT ISCHEMIC ATTACK,"February 08, 2021",88,NCT02669394,RESISTANCE EXERCISE TRAINING,CANADA,Recruiting,University of British Columbia,January 2016,Interventional,Reshaping the Path of Vascular Cognitive Impairment With Resistance Training,Unrelated
11,"COMMUNITY-ACQUIRED PNEUMONIA, INFLUENZA, COVID","February 08, 2021",7100,NCT02735707,FIXED-DURATION HYDROCORTISONE,AUSTRALIA,Recruiting,MJM Bonten,"April 11, 2016",Interventional,"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia",COVID
12,MILD COGNITIVE IMPAIRMENT,"February 08, 2021",216,NCT02737878,AEROBIC TRAINING,CANADA,Recruiting,University of British Columbia,April 2016,Interventional,Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription: Understanding Training Type and Exploring Mechanisms,Unrelated
13,"SEPSIS, SEVERE","February 08, 2021",20,NCT02765191,PLASMA EXPANSION WITH RINGER'S ACETATE,SWEDEN,Recruiting,Uppsala University,April 2016,Interventional,MR-Evaluation of Renal Function In Septic Patients,Unrelated
14,OBESITY,"February 08, 2021",2000000,NCT02788903,WEIGHT COUNSELING,,"Active, not recruiting",Milton S. Hershey Medical Center,March 2016,Observational,A Patient-Centered PaTH to Addressing Diabetes: Impact of State Health Policies on Diabetes Outcomes and Disparities,Unrelated
15,BREAST CANCER,"February 08, 2021",182,NCT02793921,MODERATE-INTENSITY AEROBIC EXERCISE INTERVENTION,UNITED STATES,Recruiting,University of Pittsburgh,April 2016,Interventional,Influence of Exercise on Neurocognitive Function in Breast Cancer,Unrelated
16,ARTHRITIS,"February 08, 2021",4025,NCT02868983,INTEGRATION,UNITED STATES,"Active, not recruiting",University of Vermont,April 2016,Interventional,Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems,Unrelated
17,HEALTHY,"February 08, 2021",639,NCT02875301,150 MINUTES WEEK,UNITED STATES,Recruiting,University of Pittsburgh,"September 6, 2017",Interventional,Investigating Gains in Neurocognition in an Intervention Trial of Exercise,Unrelated
18,LUNG CANCER SCREENING,"February 08, 2021",200,NCT02899754,LUNG CANCER SCREENING DECISION TOOL,UNITED STATES,Recruiting,VA Office of Research and Development,"January 28, 2019",Interventional,Incorporating Veterans Preferences Into Lung Cancer Screening Decisions,Unrelated
19,ALCOHOL DEPENDENCE,"February 08, 2021",100,NCT02901041,ZONISAMIDE,UNITED STATES,"Active, not recruiting",Boston University Charles River Campus,"September 21, 2017",Interventional,Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism,Unrelated
20,PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA,"February 08, 2021",2000,NCT03013998,SAMALIZUMAB (BAML-16-001-S1),UNITED STATES,Recruiting,"Beat AML, LLC",November 2016,Interventional,A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial),Unrelated
21,OBESITY,"February 08, 2021",164,NCT03029507,ACT ENHANCED SHIPSHAPE,UNITED STATES,Recruiting,Veterans Medical Research Foundation,"December 8, 2017",Interventional,An Acceptance and Commitment Therapy (ACT)-Enhanced Weight Management and Fitness Program for Navy Personnel,Unrelated
22,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",75,NCT03042143,HUMAN UMBILICAL CORD DERIVED CD362 ENRICHED MSCS,UNITED KINGDOM,Recruiting,Belfast Health and Social Care Trust,"January 7, 2019",Interventional,"Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST): An Open Label Dose Escalation Phase 1 Trial Followed by a Randomized, Double-blind, Placebo-controlled Phase 2 Trial (COVID-19)",Respiratory
23,RESPIRATORY SYNCYTIAL VIRUS INFECTIONS,"February 08, 2021",32,NCT03102034,D46/NS2/N/ΔM2-2-HINDIII,UNITED STATES,Completed,National Institute of Allergy and Infectious Diseases (NIAID),"April 6, 2017",Interventional,"Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, D46/NS2/N/ΔM2-2-HindIII, Lot RSV#011B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age",Respiratory
24,CROHN'S DISEASE,"February 08, 2021",1250,NCT03105102,PLACEBO FOR RISANKIZUMAB SC,ARGENTINA,Enrolling by invitation,AbbVie,"April 9, 2018",Interventional,"A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease",Unrelated
25,CHRONIC LOW BACK PAIN,"February 08, 2021",766,NCT03115359,MINDFULNESS MEDITATION,UNITED STATES,Recruiting,"University of Wisconsin, Madison","June 30, 2017",Interventional,A Comparative Effectiveness Randomized Controlled Trial of Mindfulness Meditation Versus Cognitive Behavioral Therapy for Opioid-Treated Chronic Low Back Pain,Unrelated
26,MULTIPLE SCLEROSIS,"February 08, 2021",833,NCT03117881,DIRECTCAM,UNITED STATES,Recruiting,University of Alabama at Birmingham,"January 8, 2018",Interventional,Comparative Effectiveness Trial Between a Clinic- and Home-Based Complementary and Alternative Medicine Telerehabilitation Intervention for Adults With Multiple Sclerosis (MS),Unrelated
27,"DIABETES MELLITUS, TYPE 2","February 08, 2021",22242,NCT03136471,,UNITED STATES,"Active, not recruiting",Tulane University,January 2017,Observational,Natural Experiments of the Impact of Population-Targeted Health Policies to Prevent Diabetes and Its Complications,Unrelated
28,INFANT MENTAL HEALTH,"February 08, 2021",148,NCT03175796,INFANT MENTAL HEALTH-HOME VISITING,UNITED STATES,Completed,University of Michigan,"October 12, 2017",Interventional,Infant Mental Health-Home Visiting Randomized Controlled Trial,Unrelated
29,IDIOPATHIC PULMONARY FIBROSIS,"February 08, 2021",30,NCT03183570,[18F]FP-R01-MG-F2,UNITED STATES,Recruiting,Stanford University,"November 8, 2017",Interventional,"Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 With [18F]FP-R01-MG-F2 With PET/CT",Unrelated
30,TYPE2 DIABETES,"February 08, 2021",300,NCT03184662,HIPA,BELGIUM,Recruiting,Poitiers University Hospital,"February 12, 2018",Interventional,Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes,Unrelated
31,CRITICAL ILLNESS,"February 08, 2021",2400,NCT03188796,CHOLECALCIFEROL,AUSTRIA,Recruiting,Medical University of Graz,"October 10, 2017",Interventional,"The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients With Severe Vitamin D Deficiency: a Multicenter, Placebo-controlled Double-blind Phase III Randomized Controlled Trial (RCT)",Unrelated
32,RELAPSING-REMITTING MULTIPLE SCLEROSIS,"February 08, 2021",3526,NCT03193866,RITUXIMAB,SWEDEN,"Active, not recruiting",Karolinska Institutet,"February 1, 2017",Observational [Patient Registry],"COMparison Between All immunoTherapies for Multiple Sclerosis. An Observational Long-term Prospective Cohort Study of Safety, Efficacy and Patient's Satisfaction of MS Disease Modulatory Treatments in Relapsing-remitting Multiple Sclerosis",Unrelated
33,PARENTS,"February 08, 2021",800,NCT03209713,HPV VACCINE EDUCATION,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"June 28, 2017",Interventional,Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination,Unrelated
34,RENAL CELL CARCINOMA,"February 08, 2021",360,NCT03226886,,UNITED KINGDOM,Recruiting,Royal Marsden NHS Foundation Trust,"February 5, 2012",Observational,TRACERx Renal (TRAcking Renal Cell Carcinoma Evolution Through Therapy (Rx)) CAPTURE: COVID-19 Antiviral Response in a Pan-tumour Immune Study,Unrelated
35,OBESITY,"February 08, 2021",500,NCT03260140,BEHAVIORAL LIFESTYLE INTERVENTION,UNITED STATES,"Active, not recruiting",VA Office of Research and Development,"February 15, 2018",Interventional,DVD Lifestyle Intervention (D-ELITE),Unrelated
36,EATING DISORDER,"February 08, 2021",180,NCT03261050,COUNTER ATTITUDINAL THERAPY,UNITED STATES,Recruiting,Oregon Research Institute,"July 10, 2017",Observational,Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders,Unrelated
37,CRITICAL ILLNESS,"February 08, 2021",155,NCT03276559,EMPOWER,UNITED STATES,Recruiting,Weill Medical College of Cornell University,"July 12, 2017",Interventional,Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients,Unrelated
38,ANXIETY,"February 08, 2021",240,NCT03301922,METACOGNITIVE THERAPY AND WORK-FOCUSED INTERVENTIONS,NORWAY,Recruiting,Norwegian University of Science and Technology,"October 31, 2017",Interventional,Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental Disorders: A Randomized Waiting List Controlled Trial,Unrelated
39,COVID,"February 08, 2021",20,NCT03305341,COVID-19 THERAPEUTIC BIOLOGICS - SPIKE-GM-CSF PROTEIN LACTATED RINGER'S INJECTION,UNITED STATES,"Active, not recruiting","Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair","July 18, 2020",Interventional,"Conducting an Initial Small, Controlled Clinical Pharmacology Trial to Assess for Therapeutic Biologics Activity (Proof-of-Concept) That Suggests the Potential for Clinical Benefits of COVID-19 Patients.",COVID
40,HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA,"February 08, 2021",300,NCT03323463,F-FMISO PET/CT SCAN,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"October 16, 2017",Interventional,A Prospective Single Arm Non-inferiority Trial of Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma (Major De-escalation to 30Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma),Unrelated
41,BORDERLINE PERSONALITY DISORDER,"February 08, 2021",45,NCT03329677,TRANSFERENCE-FOCUSED PSYCHOTHERAPY (TFP),UNITED STATES,Recruiting,Weill Medical College of Cornell University,"January 1, 2016",Interventional,An 18-Month Psychotherapy of Borderline Personality Disorder,Unrelated
42,RESPIRATORY TRACT INFECTIONS,"February 08, 2021",20,NCT03331445,NITRIC OXIDE 0.5 % / NITROGEN 99.5 % GAS FOR INHALATION,CANADA,Recruiting,Chris Miller,"October 24, 2017",Interventional,"An Open Label Safety Study of Inhaled Gaseous Nitric Oxide (gNO) for Adults & Adolescents With Non-Tuberculous Mycobacteria, Burkholderia Spp, Aspergillus Spp and Corona-like Viral (Sub-Study) Infections",Respiratory
43,LONELINESS,"February 08, 2021",300,NCT03343483,VOLUNTEERING,UNITED STATES,Recruiting,University of Rochester,"December 1, 2017",Interventional,The Getting Active Project (GAP): A Randomized Trial of Volunteering to Reduce Loneliness in Later Life,Unrelated
44,COVID,"February 08, 2021",20,NCT03348670,COVID-19 THERAPEUTIC BIOLOGICS - SPIKE-GM-CSF PROTEIN LACTATED RINGER'S INJECTION,UNITED STATES,"Active, not recruiting","Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair","July 20, 2020",Interventional,"Conducting an Initial Small, Controlled Clinical Trial to Assess for COVID-19 Therapeutic Biologics Activity (Proof-of-concept) That Suggests the Potential for Clinical Benefits of COVID-19 Patients.",COVID
45,"BEHAVIOR, INFANT","February 08, 2021",1200,NCT03367845,CONTROL,UNITED STATES,Recruiting,University of Notre Dame,"January 11, 2017",Interventional,Efficacy of Family Programs for Improving Child and Family Health and Development,Unrelated
46,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",20,NCT03376854,HYPOTHERMIA,UNITED STATES,Recruiting,"University of Maryland, Baltimore","May 1, 2018",Interventional,Pilot Randomized Clinical Trial of Therapeutic Hypothermia Plus Neuromuscular Blockade vs. Standard of Care in COVID-19 Patients With Moderate to Severe ARDS - the Cooling to Help Injured Lungs (CHILL) Pilot Study,Respiratory
47,DEPRESSION,"February 08, 2021",3091,NCT03392883,LADDR,COLOMBIA,"Active, not recruiting",Dartmouth-Hitchcock Medical Center,"February 13, 2018",Interventional,Scaling Up Science-based Mental Health Interventions in Latin America,Unrelated
48,CROHN'S DISEASE,"February 08, 2021",160,NCT03397108,,CANADA,Recruiting,The Hospital for Sick Children,"July 4, 2017",Observational,Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease,Unrelated
49,ULCERATIVE COLITIS (UC),"February 08, 2021",760,NCT03398135,RISANKIZUMAB,ARGENTINA,Enrolling by invitation,AbbVie,"August 28, 2018",Interventional,"A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis",Unrelated
50,CROHN DISEASE,"February 08, 2021",600,NCT03440372,OZANIMOD,ARGENTINA,Recruiting,Celgene,"February 27, 2018",Interventional,"Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease",Unrelated
51,CROHN DISEASE,"February 08, 2021",600,NCT03440385,OZANIMOD,AUSTRALIA,Recruiting,Celgene,"March 7, 2018",Interventional,"Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease",Unrelated
52,"CANCER, METASTATIC","February 08, 2021",1500,NCT03452774,CLINICAL TRIAL MATCHING,UNITED STATES,Recruiting,"Massive Bio, Inc.","January 1, 2018",Observational [Patient Registry],SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,Unrelated
53,CROHN DISEASE,"February 08, 2021",485,NCT03464097,OZANIMOD,ARGENTINA,Recruiting,Celgene,"June 27, 2018",Interventional,"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease",Unrelated
54,RECURRENT RESPIRATORY PAPILLOMATOSIS,"February 08, 2021",400,NCT03465280,MICRODEBRIDER,UNITED KINGDOM,Recruiting,Newcastle-upon-Tyne Hospitals NHS Trust,"April 1, 2018",Observational [Patient Registry],Airway Intervention Registry (AIR) Extension: Recurrent Respiratory Papillomatosis,Respiratory
55,SICKLE CELL DISEASE (SCD),"February 08, 2021",100,NCT03474965,CRIZANLIZUMAB,BELGIUM,Recruiting,Novartis Pharmaceuticals,"October 1, 2018",Interventional,"A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive Crisis",Unrelated
56,"MULTIPLE SCLEROSIS, RELAPSING-REMITTING","February 08, 2021",900,NCT03500328,EARLY AGGRESSIVE THERAPY OR TRADITIONAL THERAPY,UNITED STATES,Recruiting,Johns Hopkins University,"May 2, 2018",Interventional,"A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis",Unrelated
57,RESPIRATORY INFECTION,"February 08, 2021",406,NCT03540706,CARE WITH C-REACTIVE PROTEIN ASSAY IN MICRO METHOD,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 1, 2018",Interventional,Impact of the Use of C-reactive Protein in a Micro-method on the Prescription of Antibiotics in General Practitioners Consulting in the Office,Respiratory
58,CONGENITAL HEART DISEASE,"February 08, 2021",200,NCT03576534,USE OF PREBYPASS ULTRAFILTRATION (PBUF),UNITED STATES,Recruiting,Boston Children's Hospital,"October 3, 2019",Interventional,"Pre Bypass Ultrafiltration (PBUF) Improves Intraoperative Glucose, Sodium, Potassium and Lactate Levels in Children Requiring Cardiopulmonary Bypass",Unrelated
59,ACUTE PAIN,"February 08, 2021",1180,NCT03581123,SUPPORTED-SELF MANAGEMENT (SSM),UNITED STATES,Recruiting,University of Minnesota,"October 25, 2018",Interventional,Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back,Unrelated
60,TRAUMATIC BRAIN INJURY,"February 08, 2021",57,NCT03594734,GROUP LIFESTYLE BALANCE™,UNITED STATES,"Active, not recruiting",Baylor Research Institute,"January 8, 2019",Interventional,Efficacy of an Evidence-based Weight-loss Intervention Post Traumatic Brain Injury,Unrelated
61,SEPSIS,"February 08, 2021",290,NCT03620409,,GERMANY,Recruiting,Jena University Hospital,"May 9, 2018",Observational,Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis,Unrelated
62,NEOPLASMS,"February 08, 2021",242,NCT03648372,TAK-981,UNITED STATES,Recruiting,"Millennium Pharmaceuticals, Inc.","October 1, 2018",Interventional,"An Open Label, Dose-Escalation, Phase I Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of TAK-981 in Adult Patients With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019",Unrelated
63,"DIABETES MELLITUS, TYPE 1","February 08, 2021",69,NCT03651622,"HYPOCALORIC, LOW CARBOHYDRATE DIET",UNITED STATES,"Active, not recruiting","University of North Carolina, Chapel Hill","November 12, 2018",Interventional,Accelerating Solutions to Optimize Glycemic Control and Weight Management In Young Adults With Type 1 Diabetes,Unrelated
64,SEPSIS,"February 08, 2021",800,NCT03680274,VITAMIN C,CANADA,Recruiting,Université de Sherbrooke,"November 8, 2018",Interventional,Lessening Organ Dysfunction With VITamin C (LOVIT),Unrelated
65,"LOW BACK PAIN, RECURRENT","February 08, 2021",250,NCT03680287,WITHIN-SUBJECT TEST OF BLINDED STUDY MEDICATION,UNITED STATES,Recruiting,Johns Hopkins University,"October 7, 2019",Interventional,Effects of Sleep Disruption on Drug Response,Unrelated
66,SUBSTANCE USE DISORDER,"February 08, 2021",24,NCT03681288,MINDFUL SELF-COMPASSION,UNITED STATES,"Active, not recruiting",VA Office of Research and Development,"May 21, 2019",Interventional,Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD,Unrelated
67,DEMENTIA,"February 08, 2021",172,NCT03683394,SMARRT INTERVENTION,UNITED STATES,"Active, not recruiting",Kaiser Permanente,"August 30, 2018",Interventional,Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot,Unrelated
68,CENTRAL NERVOUS SYSTEM LYMPHOMA,"February 08, 2021",44,NCT03684980,VORAXAZE,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"November 14, 2018",Interventional,LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma,Unrelated
69,SYSTEMIC SCLEROSIS,"February 08, 2021",72,NCT03708718,PREDNISOLONE 5 MG,UNITED KINGDOM,Recruiting,Prof. Ariane herrick,"December 21, 2017",Interventional,"A Phase II Randomised Study of Oral Prednisolone in Early Diffuse Cutaneous Systemic Sclerosis (Initially Double-blind, Then Switched to Open-label Because of Covid-19)",Unrelated
70,OVERWEIGHT AND OBESITY,"February 08, 2021",450,NCT03710746,PROJECT HEALTH,UNITED STATES,Recruiting,Oregon Research Institute,"October 8, 2018",Interventional,Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program,Unrelated
71,MAJOR DEPRESSIVE DISORDER,"February 08, 2021",12506,NCT03716869,UNIVERSAL SCREENING ARM,UNITED STATES,"Active, not recruiting",Milton S. Hershey Medical Center,"July 1, 2018",Interventional,Randomized Controlled Trial of Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder,Unrelated
72,NUTRITIONAL DEFICIENCY,"February 08, 2021",50,NCT03724045,BACK SIDE OF THE MOON,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"January 1, 2019",Interventional,Back Side of the Moon Study: What is the Efficiency of Nutritional Therapy (Calories and Nitrogen) in ICU and on the Ward and What is the Metabolic Profile of Patients After ICU? Could Supplemental Nutrition Fill the Gap?,Unrelated
73,EXERCISE,"February 08, 2021",112,NCT03728257,LTGO-HOME BASED EXERCISE,UNITED STATES,Recruiting,University of Pittsburgh,"March 25, 2019",Interventional,Lung Transplant G0 (LTGO): Improving Self-Management of Exercise After Lung Transplantation,Unrelated
74,INFLUENZA,"February 08, 2021",15000,NCT03734237,EGG BASED INFLUENZA VACCINES,UNITED STATES,Recruiting,Henry M. Jackson Foundation for the Advancement of Military Medicine,"November 6, 2018",Interventional,A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD,Respiratory
75,POST INTENSIVE CARE SYNDROME,"February 08, 2021",200,NCT03738774,,UNITED STATES,Recruiting,Vanderbilt University Medical Center,"January 2, 2019",Observational,Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID),Unrelated
76,OVERACTIVE BLADDER SYNDROME,"February 08, 2021",140,NCT03758235,INCOBOTULINUMTOXINA 100 UNT INJECTION [XEOMIN],ITALY,"Active, not recruiting",University Of Perugia,"September 1, 2018",Interventional,Incobotulinumtoxin Versus Onabotulinumtoxin in the Treatment of Patients With Overactive Bladder Syndrome,Unrelated
77,GENERALIZED ANXIETY DISORDER,"February 08, 2021",130,NCT03768544,SELF-HELP GUIDED BY A LAY PROVIDER,CANADA,Recruiting,Laval University,"March 11, 2019",Interventional,Generalized Anxiety Disorder in Older Adults : Efficacy of a Self-help Treatment Guided by Trained Lay Providers,Unrelated
78,DECISION MAKING,"February 08, 2021",150,NCT03786315,,UNITED KINGDOM,Recruiting,University of Exeter,"January 4, 2021",Observational,Exploring 'VOLITION' in Context - a Study to Inform the Implementation of a New Intervention,Unrelated
79,TYPE 1 DIABETES MELLITUS,"February 08, 2021",80,NCT03793673,COYOT1 CARE,UNITED STATES,"Active, not recruiting",Children's Hospital Los Angeles,"January 20, 2019",Interventional,CoYoT1 to California - Telemedicine to Engage Young Adults With Diabetes,Unrelated
80,SPINAL CORD INJURIES,"February 08, 2021",108,NCT03797378,EM2M,UNITED STATES,Recruiting,University of Alabama at Birmingham,"August 9, 2019",Interventional,"The M2M LEADERS Project: Lakeshore Examination of Activity, Disability, and Exercise Response Study (LEADERS)",Unrelated
81,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",35,NCT03807804,HLCM051,JAPAN,Recruiting,Healios K.K.,"January 1, 2019",Interventional,"An Open-label, Standard Therapy as a Controlled, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of HLCM051(MultiStem) in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by Pneumonitis",Respiratory
82,LOWER RESPIRATORY TRACT INFECTION,"February 08, 2021",250,NCT03808922,DAS181,AUSTRALIA,Recruiting,"Ansun Biopharma, Inc.","May 23, 2019",Interventional,A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects,Respiratory
83,UPPER LIMB SPASTICITY,"February 08, 2021",83,NCT03821402,DAXI FOR INJECTION DOSE LOW DOSE,UNITED STATES,Completed,"Revance Therapeutics, Inc.","December 12, 2018",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging, Multi-Center Trial to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Upper Limb Spasticity in Adults After Stroke or Traumatic Brain Injury",Unrelated
84,OVERWEIGHT,"February 08, 2021",78,NCT03823469,CCTP,ISRAEL,Recruiting,Spaulding Rehabilitation Hospital,"May 20, 2019",Interventional,Evaluating the Impact of a Culinary Coaching Telemedicine Program on Body Weight and Metabolic Outcomes - A Randomized Controlled Trial,Unrelated
85,POSTTRAUMATIC STRESS DISORDER,"February 08, 2021",108,NCT03827057,RECONSOLIDATION OF TRAUMATIC MEMORIES (RTM),UNITED STATES,Recruiting,Uniformed Services University of the Health Sciences,"June 12, 2019",Interventional,RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD),Unrelated
86,PEDIATRIC CROHNS DISEASE,"February 08, 2021",300,NCT03827109,GROUP EDUCATIONAL ACTIVITIES,UNITED STATES,Recruiting,Laura Mackner,"June 12, 2019",Interventional,Peer Mentoring to Improve Self-management in Youth With IBD,Unrelated
87,PNEUMONIA,"February 08, 2021",90,NCT03852537,METHYLPREDNISOLONE,UNITED STATES,Recruiting,Mayo Clinic,"December 2, 2019",Interventional,SMART Trial: Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia,Respiratory
88,MATERNAL DEATH,"February 08, 2021",34000,NCT03871491,AZITHROMYCIN,BANGLADESH,Recruiting,NICHD Global Network for Women's and Children's Health,"September 1, 2020",Interventional,Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial,Unrelated
89,STROKE,"February 08, 2021",65,NCT03873467,GROUP LIFESTYLE BALANCE,UNITED STATES,"Active, not recruiting",Baylor Research Institute,"July 8, 2019",Interventional,Efficacy of an Evidence-based Healthy Lifestyle Intervention for People Following CVA,Unrelated
90,TUBERCULOSIS,"February 08, 2021",300,NCT03881228,INCREASING THE COMPLETION OF IPT,PERU,Recruiting,Universidad Peruana Cayetano Heredia,"December 1, 2019",Interventional,Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old Who Are Household Contacts of Persons With Tuberculosis,Unrelated
91,PREVENTIVE HEALTH SERVICES (PREV HEALTH SERV),"February 08, 2021",1000,NCT03885232,EXPERIMENTAL: PIVOT WITH MI,UNITED STATES,Enrolling by invitation,"University of Colorado, Denver","September 1, 2019",Interventional,Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI),Unrelated
92,COVID,"February 08, 2021",132,NCT03891420,GALIDESIVIR,BRAZIL,Recruiting,BioCryst Pharmaceuticals,"April 9, 2020",Interventional,"A Phase 1b Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Pharmacokinetics, and Anti-viral Effects of Galidesivir Administered Via Intravenous Infusion to Subjects With Yellow Fever or COVID-19",COVID
93,ISCHEMIC HEART DISEASE,"February 08, 2021",225,NCT03907891,MOTIVATIONAL SOCIAL SUPPORT FROM NURSE,UNITED STATES,Recruiting,University of Illinois at Chicago,"August 1, 2019",Interventional,A Randomized Controlled Trial to Reduce Hopelessness Through Enhanced Physical Activity in Adults With Ischemic Heart Disease,Unrelated
94,BRAIN CONCUSSION,"February 08, 2021",40,NCT03917290,NEUROMUSCULAR TRAINING,UNITED STATES,Recruiting,"University of Colorado, Denver","April 2, 2019",Interventional,A Sports Injury Prevention Program to Reduce Subsequent Injuries After Concussion,Unrelated
95,POSTPARTUM HEALTH,"February 08, 2021",400,NCT03922334,PATIENT NAVIGATION PROGRAM,UNITED STATES,Recruiting,Northwestern University,"January 21, 2020",Interventional,Navigating New Motherhood 2: Patient Navigation to Improve Outcomes Among Low-income Women in the Postpartum Period,Unrelated
96,HODGKIN LYMPHOMA,"February 08, 2021",18,NCT03923504,PHYSICAL ACTIVITY INTERVENTION (PAI),UNITED STATES,Recruiting,Virginia Commonwealth University,"May 10, 2019",Interventional,Improving Exercise Capacity With a Tailored Physical Activity Intervention in Lymphoma and Breast Cancer Patients Undergoing Treatment,Unrelated
97,CHRONIC PAIN,"February 08, 2021",200000,NCT03944447,"CANNABIS, MEDICAL",UNITED STATES,Recruiting,"OMNI Medical Services, LLC","December 1, 2018",Interventional,Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19,Unrelated
98,CANCER SURVIVORSHIP,"February 08, 2021",156,NCT03951454,CONEXIONES,UNITED STATES,Enrolling by invitation,New Mexico State University,"April 16, 2019",Interventional,Taking Time to Connect: A Randomized Clinical Trial for Hispanic Mothers Diagnosed With Cancer,Unrelated
99,"OSTEOPENIA, OSTEOPOROSIS","February 08, 2021",27,NCT03959995,HIGH INTENSITY RESISTANCE (HIT-RT) AND ENDURANCE EXERCISE (HIIT),GERMANY,Completed,University of Erlangen-Nürnberg Medical School,"January 15, 2019",Interventional,Effects of an Optimized 13-month Physical Exercise on (Early)-Postmenopausal Risk Factors in Women With Osteopenia and Osteoporosis (Actlife),Unrelated
100,ARDS,"February 08, 2021",740,NCT03963622,RESPIRATORY MECHANICS,CANADA,Recruiting,Unity Health Toronto,"November 23, 2020",Interventional,Careful Ventilation in Acute Respiratory Distress Syndrome,Unrelated
101,CARDIOTOXICITY,"February 08, 2021",340,NCT03964142,CARDIAC REHABILITATION,SPAIN,Recruiting,Hospital Clinico Universitario de Santiago,"August 1, 2018",Interventional,Randomized Controlled Trial on Comprehensive Exercise-based Cardiac Rehabilitation Programs for the Prevention of Anthracyclines and/or Anti-HER2 Antibodies-induced Cardiotoxicity in Breast Cancer,Unrelated
102,MENTAL ILLNESS,"February 08, 2021",600,NCT03966872,INTEGRATED ILLNESS MANAGEMENT AND RECOVERY,UNITED STATES,"Active, not recruiting",Dartmouth-Hitchcock Medical Center,"September 2, 2019",Interventional,Comparative Effectiveness of Integrated Illness Management and Recovery Versus the Chronic Disease Self-Management Program,Unrelated
103,DIABETES,"February 08, 2021",1139,NCT03983733,DIETARY INTERVENTION,UNITED STATES,Completed,Zoe Global Limited,"June 10, 2019",Interventional,PREDICT 2: Personalized Responses to Dietary Composition Trial 2,Unrelated
104,TEMPOROMANDIBULAR DISORDERS,"February 08, 2021",100,NCT03990662,PHYSIOTHERAPY - MANUAL THERAPY,ITALY,Recruiting,Istituto Stomatologico Italiano,"June 14, 2019",Observational,Predictors of Pain Reduction Following Manual Therapy in Patients With Temporomandibular Disorders: a Prospective Observational Study,Unrelated
105,MUSCULOSKELETAL PAIN,"February 08, 2021",1000,NCT04000035,HEALTH AND WORK ENVIRONMENT INFORMATION AND PROCESSES,NORWAY,Recruiting,University Hospital of North Norway,"March 1, 2019",Interventional,HealthAtWork - a Measure for Increased Coping and Work Inclusion - An Analysis of Effect of Preventive Information Given at the Workplace - Part 1: Quantitative Data Collection,Unrelated
106,EPILEPSY IN CHILDREN,"February 08, 2021",100,NCT04020484,MAKING MINDFULNESS MATTER© (M3),CANADA,Recruiting,Lawson Health Research Institute,"December 2, 2019",Interventional,A Live-Online Mindfulness-based Intervention for Families of Children With Epilepsy: Making Mindfulness Matter© Randomized Control Trial,Unrelated
107,ALCOHOL MISUSE,"February 08, 2021",770,NCT04025151,ALCOHOL BRIEF INTERVENTION,HONG KONG,Not yet recruiting,The University of Hong Kong,"September 30, 2020",Interventional,Nurse-led Alcohol Brief Intervention Plus Mobile Personalized Chat-based Support on Reducing Alcohol Use in University Students: a Pragmatic Randomized Controlled Trial,Unrelated
108,HEALTHY VOLUNTEER,"February 08, 2021",300,NCT04025580,FLUCELVAX,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"October 2, 2019",Interventional,Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine,Unrelated
109,ANXIETY DISORDERS,"February 08, 2021",59,NCT04026152,RESISTANCE TRAINING,CANADA,Completed,University of Regina,"July 14, 2019",Interventional,Using the Unified Protocol to Reduce Exercise Anxiety and Improve Adherence to a Resistance Training Program for People With Anxiety-Related Disorders: A Randomized Controlled Trial,Unrelated
110,AGING,"February 08, 2021",1459,NCT04029194,ASSISTANCE WITH OLD AGE PENSION APPLICATION,INDIA,"Active, not recruiting","National Bureau of Economic Research, Inc.","February 4, 2019",Interventional,The Causal Effects of Old Age Pensions,Unrelated
111,METABOLIC SYNDROME,"February 08, 2021",64,NCT04039165,PP-MI INTERVENTION,UNITED STATES,Recruiting,Massachusetts General Hospital,"July 25, 2019",Interventional,Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: A Randomized Controlled Pilot Trial,Unrelated
112,ANXIETY DISORDER OF CHILDHOOD,"February 08, 2021",90,NCT04039243,BEING BRAVE,UNITED STATES,Recruiting,Massachusetts General Hospital,"September 27, 2019",Interventional,Addressing Anxiety in 2-Year-Olds: A Pilot Screening and Intervention Study,Unrelated
113,TRICHURIS INFECTION,"February 08, 2021",176,NCT04041453,IVERMECTIN,ARGENTINA,Completed,Alejandro Krolewiecki,"October 9, 2019",Interventional,"Prospective, Parallel-group, Open-label Randomized Controlled Trial of Four Treatment Regimes for Trichuriasis in Pediatric Patients",Unrelated
114,DEMENTIA,"February 08, 2021",312,NCT04043364,LIVE,NORWAY,Recruiting,University of Bergen,"August 1, 2019",Interventional,"LIVE@Home.Path: a Mixed Method, Stepped Wedge and Randomized Controlled Trial Innovating the Clinical Pathway for Home-dwelling Persons With Dementia and Their Families",Unrelated
115,ALZHEIMER DISEASE,"February 08, 2021",15,NCT04055376,GENUS DEVICE (ACTIVE SETTINGS),UNITED STATES,"Active, not recruiting",Massachusetts Institute of Technology,"August 14, 2019",Interventional,Chronic Treatment of Alzheimer's Disease With Gamma Frequency Stimulation,Unrelated
116,CANCER,"February 08, 2021",180,NCT04055948,ONE-ON-ONE TEACHING SESSIONS,UNITED STATES,Recruiting,Case Comprehensive Cancer Center,"December 1, 2019",Interventional,Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Patients With Cancer,Unrelated
117,SEROGROUP C MENINGOCOCCAL MENINGITIS,"February 08, 2021",3800,NCT04061382,VENEPUNCTURE,UNITED KINGDOM,Recruiting,University of Oxford,"October 15, 2019",Observational,Serum Testing of Representative Youngsters: Sero- Epidemiological Survey of England in 2019/2020,Unrelated
118,AGING PROBLEMS,"February 08, 2021",200,NCT04061785,JUDO4BALANCE - 12 WEEK JUDO INSPIRED EXERCISE PROGRAM,SWEDEN,Recruiting,Dalarna University,"September 30, 2019",Interventional,Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women,Unrelated
119,AGING,"February 08, 2021",60,NCT04068922,RESILIENCE INTERVENTION,UNITED STATES,Recruiting,University of Florida,"January 21, 2020",Interventional,Adaptability and Resilience in Aging Adults-2,Unrelated
120,CHRONIC PAIN,"February 08, 2021",64,NCT04091893,USUAL CARE/WAIT LIST,UNITED STATES,"Active, not recruiting","University of California, Davis","October 12, 2019",Interventional,The Analgesic Museum: The Development and Effectiveness of Museum-Based Experiences to Reduce Social Isolation and Pain Among Individuals With Chronic Pain,Unrelated
121,SEPTIC SHOCK,"February 08, 2021",150,NCT04107402,"ASSESSMENT OF COAGULOPATHY, PLATELETS ACTIVATION AND PLATELETS-NEUTROPHILS INTERPLAY",BELGIUM,Recruiting,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"March 15, 2019",Interventional,Prospective Evaluation of PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock Patients. Impact of Platelets Metabolism to Inflammatory Response.,Unrelated
122,INPATIENTS,"February 08, 2021",2000,NCT04114110,RTLS DATA,UNITED KINGDOM,"Active, not recruiting",The Royal Wolverhampton Hospitals NHS Trust,"January 6, 2020",Observational,"A Retrospective, Observational Analysis Using Real Time Location Systems (RTLS) Technology to Explore the Effects of Clinical Staffing on Hospital Productivity and Patient Health Outcomes",Unrelated
123,CANCER,"February 08, 2021",466,NCT04136340,IN-PERSON IN CLINIC FOLLOW-UP VISIT,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"October 24, 2019",Interventional,Virtual Visits by Supportive Care Specialists to Cancer Patients at Home: A Randomized Controlled Pilot Noninferiority Trial of Video Telemedicine,Unrelated
124,INSOMNIA,"February 08, 2021",120,NCT04144231,ICBT-I,FINLAND,Recruiting,Helsinki University Central Hospital,"December 19, 2019",Interventional,Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia - A Randomized Controlled Clinical Trial (SLEEPINS),Unrelated
125,B CELL ALL,"February 08, 2021",90,NCT04148430,ANAKINRA,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"October 30, 2019",Interventional,A Phase II Study of IL-1 Receptor Antagonist Anakinra to Prevent Severe Neurotoxicity and Cytokine Release Syndrome in Patients Receiving CD19-Specific Chimeric Antigen Receptor (CAR) T Cells And to Treat Systemic Inflammation Associated With COVID-19,Unrelated
126,PERINATAL DEPRESSION,"February 08, 2021",1368,NCT04153864,BRIEF BEHAVIORAL ACTIVATION TREATMENT,CANADA,Recruiting,"Mount Sinai Hospital, Canada","January 6, 2020",Interventional,Scaling Up Maternal Mental Health Care by Increasing Access to Treatment (SUMMIT): A Study Protocol for Perinatal Depression and Anxiety,Unrelated
127,EXPOSURE TO HERBICIDES,"February 08, 2021",40,NCT04155463,ORGANIC DIET,,Not yet recruiting,Boise State University,January 2021,Interventional,Measurement of Agricultural and Dietary Glyphosate Exposure Among Pregnant Women,Unrelated
128,ANXIETY DISORDERS,"February 08, 2021",54,NCT04157296,COGNITIVE BEHAVIORAL THERAPY (CBT),UNITED STATES,Recruiting,University of Michigan,"February 4, 2020",Interventional,Neurally Targeted Cognitive Training to Augment Cognitive Behavioral Therapy (CBT) Outcomes in Pediatric Anxiety,Unrelated
129,"FLU, HUMAN","February 08, 2021",3350,NCT04160975,VIDEO ABOUT SAFETY AND EFFECTIVENESS OF ADULT SEASONAL FLU VACCINATION,UNITED STATES,Enrolling by invitation,Harvard University,"December 20, 2019",Interventional,Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects,Respiratory
130,MALNUTRITION,"February 08, 2021",586,NCT04168814,OBSERVATIONAL TEST,SPAIN,Completed,Universidad Pontificia Comillas,"June 10, 2020",Observational,An Observational Study of the Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients While Receiving Immunotherapy in Spain: the NutriOncoSearch (NOS) Study,Unrelated
131,BREAST DUCTAL CARCINOMA IN SITU,"February 08, 2021",600,NCT04169542,QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"May 21, 2019",Observational,"Potential Impact of the COVID -19 Pandemic on Financial Toxicity in Breast Cancer Surgical Patients: The Impact on Out of Pocket Costs, Lost Wages and Economic Strain",Unrelated
132,AUTISM SPECTRUM DISORDER,"February 08, 2021",180,NCT04173663,ASSIST,UNITED STATES,"Active, not recruiting",Vanderbilt University Medical Center,"January 3, 2020",Interventional,Project ASSIST: Advocating for Supports to Improve Service Transitions,Unrelated
133,PSYCHOTIC DISORDERS,"February 08, 2021",44,NCT04180709,SLEEPIO,UNITED KINGDOM,Recruiting,University of Cambridge,"October 30, 2020",Interventional,Randomised Study of Web-based CBT Intervention (Sleepio) to Reduce Insomnia and Improve Social Recovery in Early Psychosis (CRISP),Unrelated
134,ABORTION,"February 08, 2021",100,NCT04181021,VALUES CLARIFICATION AND ATTITUDES TRANSFORMATION (VCAT) WORKSHOP,ETHIOPIA,Enrolling by invitation,Ibis Reproductive Health,"November 25, 2019",Interventional,Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience in Socially Franchised Facilities in Ethiopia: A Cluster Randomized Study,Unrelated
135,ALLERGIC TO HOUSE DUST MITES,"February 08, 2021",28,NCT04184895,ASP2390,GERMANY,Recruiting,"Astellas Pharma Global Development, Inc.","October 7, 2020",Interventional,"A Phase 1 Multiple Ascending Intradermal Dose Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites",Unrelated
136,UVEITIS,"February 08, 2021",300,NCT04193020,SURVEILLANCE CARD,POLAND,Recruiting,Wroclaw Medical University,"January 1, 2020",Observational [Patient Registry],Impact of Lifestyle and Treatment on the Recurrency and Severity of Acute and Chronic Inflamatory Eye Diseases: Protocol on Prospective Cohort Study,Unrelated
137,NIPAH VIRUS INFECTION,"February 08, 2021",274,NCT04199169,HEV-SG-V,UNITED STATES,Recruiting,Auro Vaccines LLC,"February 18, 2020",Interventional,"A Phase 1 Randomized, Placebo-controlled, Observer-blind Trial to Assess the Safety and Immunogenicity of a Nipah Vaccine, HeV-sG-V (Hendra Virus Soluble Glycoprotein Vaccine), in Healthy Adults",Unrelated
138,CRITICAL LIMB ISCHEMIA,"February 08, 2021",300,NCT04209998,TRANSCUTANEOUS OXIMETRY,FRANCE,Recruiting,"University Hospital, Angers","January 16, 2020",Observational,"New Oxymetry Indices in Critical Limb Ischemia (French Original Title is ""Nouveaux Indices Oxymétriques Chez Les Patients Vus Pour Suspicion d'Ischémie Critique du membrE inférieur"")",Unrelated
139,PHYSICAL DISABILITY,"February 08, 2021",70,NCT04212442,INDEPENDENT LIVING PROGRAM FOR AFFORDABLE HOUSING.,UNITED STATES,Recruiting,University of Pennsylvania,"January 13, 2020",Interventional,Improving Aging in Place for Older Adults in Subsidized Housing,Unrelated
140,ACUTE CORONARY SYNDROME,"February 08, 2021",20,NCT04231097,MBCT INTERVENTION FOR ACS PATIENTS,UNITED STATES,Recruiting,Massachusetts General Hospital,"April 24, 2020",Interventional,Mindfulness-Based Cognitive Therapy Delivered Via Group Videoconferencing for Acute Coronary Syndrome Patients With Depressive Symptoms,Unrelated
141,LOWER RESPIRATORY TRACT INFECTION,"February 08, 2021",250,NCT04233268,RAPID PATHOGEN DETECTION,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"April 6, 2020",Observational,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study,Respiratory
142,PSYCHOSOCIAL PROBLEM,"February 08, 2021",1387,NCT04234815,CETA SHORT SESSION (CSS),UKRAINE,Recruiting,Johns Hopkins Bloomberg School of Public Health,"February 28, 2020",Interventional,Evaluating Impacts of a Brief Psychosocial Workshop for Veterans and Their Families in Ukraine,Unrelated
143,BEHAVIORAL ECONOMICS,"February 08, 2021",225,NCT04237883,STANDARD COMMUNICATION EMAIL,UNITED STATES,Completed,"University of California, Los Angeles","November 1, 2019",Interventional,Effects of Social Comparison Performance Feedback on Primary Care Quality,Unrelated
144,INVASIVE FUNGAL INFECTIONS,"February 08, 2021",50,NCT04240886,FOSMANOGEPIX,BELGIUM,Recruiting,Amplyx Pharmaceuticals,"January 4, 2020",Interventional,"A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of APX001 in the Treatment of Patients With Invasive Mold Infections Caused by Aspergillus Species or Rare Molds",Unrelated
145,COVID INFECTIONS,"February 08, 2021",80,NCT04244591,METHYLPREDNISOLONE THERAPY,CHINA,Completed,Peking Union Medical College Hospital,"January 26, 2020",Interventional,"Glucocorticoid Therapy for Critically Ill Patients With Severe Acute Respiratory Infections Caused by COVID-19: a Prospective, Randomized Controlled Trial",COVID
146,NEW CORONAVIRUS,"February 08, 2021",50,NCT04245631,RECOMBINASE AIDED AMPLIFICATION (RAA) ASSAY,CHINA,Recruiting,Beijing Ditan Hospital,"January 1, 2020",Observational,"Development of a Simple, Fast and Portable Recombinase Aided Amplification (RAA) Assay for 2019-nCoV",COVID
147,TYPE 1 DIABETES,"February 08, 2021",186,NCT04247620,DIABETTER TOGETHER,UNITED STATES,Enrolling by invitation,Baylor College of Medicine,"December 15, 2020",Interventional,"DiaBetter Together: A Strengths-based, Peer Mentor Transition RCT for Young Adults With Type 1 Diabetes",Unrelated
148,COVID COMPLICATED WITH REFRACTORY INTESTINAL INFECTIONS,"February 08, 2021",0,NCT04251767,WASHED MICROBIOTA TRANSPLANTATION,CHINA,Withdrawn,The Second Hospital of Nanjing Medical University,"February 5, 2020",Interventional,"Washed Microbiota Transplantation for Patients With 2019-nCoV Infection: a Randomized, Double-blind, Placebo-controlled Study",COVID
149,PNEUMONIA CAUSED BY HUMAN CORONAVIRUS (DISORDER),"February 08, 2021",150,NCT04251871,"CONVENTIONAL MEDICINES (OXYGEN THERAPY, ALFA INTERFERON VIA AEROSOL INHALATION, AND LOPINAVIR/RITONAVIR) AND TRADITIONAL CHINESE MEDICINES (TCMS) GRANULES",CHINA,Recruiting,Beijing 302 Hospital,"January 22, 2020",Interventional,"Effects of Traditional Chinese Medicines (TCMs) on Patients With COVID-19 Infection: A Perspective, Open-labeled, Randomized, Controlled Trial",COVID
150,COVID,"February 08, 2021",20,NCT04252118,MSCS,CHINA,Recruiting,Beijing 302 Hospital,"January 27, 2020",Interventional,Safety and Efficiency of Mesenchymal Stem Cell in Treating Pneumonia Patients Infected With COVID-19,COVID
151,"PNEUMONIA, PNEUMOCYSTIS","February 08, 2021",30,NCT04252274,DARUNAVIR AND COBICISTAT,CHINA,Recruiting,Shanghai Public Health Clinical Center,"January 30, 2020",Interventional,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Respiratory
152,COVID,"February 08, 2021",308,NCT04252664,REMDESIVIR,CHINA,Suspended,Capital Medical University,"February 12, 2020",Interventional,"A Phase 3 Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir in Hospitalized Adult Patients With Mild and Moderate COVID-19.",COVID
153,2019-NCOV,"February 08, 2021",100,NCT04254874,ABIDOL HYDROCHLORIDE,CHINA,Recruiting,Tongji Hospital,"February 1, 2020",Interventional,"An Open, Prospective/Retrospective, Randomized Controlled Cohort Study to Compare the Efficacy of Two Therapeutic Schemes(Abidol Hydrochloride,Abidol Hydrochloride Combined With Interferon Atomization)in the Treatment of 2019-nCoV Pneumonia.",COVID
154,2019-NCOV,"February 08, 2021",400,NCT04255017,ABIDOL HYDROCHLORIDE,CHINA,Recruiting,Tongji Hospital,"February 1, 2020",Interventional,"An Open, Prospective/Retrospective, Randomized Controlled Cohort Study to Compare the Efficacy of Three Antiviral Drugs(Abidol Hydrochloride, Oseltamivir and Lopinavir/Ritonavir) in the Treatment of 2019-nCoV Pneumonia.",COVID
155,CARDIOVASCULAR DEATH; MAJOR ADVERSE CARDIOVASCULAR EVENTS,"February 08, 2021",12000,NCT04255940,,CHINA,Recruiting,Qilu Hospital of Shandong University,"January 20, 2020",Observational,Impact of a Novel Coronavirus (2019-nCoV) Outbreak on Public Anxiety and Cardiovascular Disease Risk in China,Unrelated
156,SUSCEPTIBILITY TO VIRAL AND MYCOBACTERIAL INFECTION,"February 08, 2021",102456,NCT04256395,MOBILE INTERNET SURVEY ON SELF-TEST,CHINA,Completed,Beijing Tsinghua Chang Gung Hospital,"February 1, 2020",Observational,Registry Study on the Efficacy of a Self-test and Self-alert Applet in Detecting Susceptible Infection of COVID-19 --a Population Based Mobile Internet Survey,Unrelated
157,COVID,"February 08, 2021",237,NCT04257656,REMDESIVIR,CHINA,Terminated,Capital Medical University,"February 6, 2020",Interventional,"A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir in Hospitalized Adult Patients With Severe COVID-19.",COVID
158,CORONAVIRUS,"February 08, 2021",345,NCT04259892,2019-NCOV PCR,FRANCE,Recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","February 4, 2020",Observational,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,COVID
159,VIRUS; PNEUMONIA,"February 08, 2021",30000,NCT04260308,,CHINA,Recruiting,Huazhong University of Science and Technology,"February 3, 2020",Observational,"A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia in Wuhan, China",Respiratory
160,2019-NCOV,"February 08, 2021",380,NCT04260594,ARBIDOL,,Not yet recruiting,Jieming QU,"February 7, 2020",Interventional,"Randomized, Open, Multicenter Study on the Efficacy and Safety of Arbidol Hydrochloride Tablets in Treating Pneumonia in Patients Infected With Novel Coronavirus (2019-ncov).",COVID
161,2019-NCOV PNEUMONIA,"February 08, 2021",60,NCT04261270,ASC09F+OSELTAMIVIR,CHINA,Recruiting,Tongji Hospital,"February 1, 2020",Interventional,"A Randomized,Open,Controlled Small Sample Clinical Study to Evaluate the Efficacy and Safety of ASC09/Ritonavir Compound Tablets and Ritonavir for 2019-nCoV Pneumonia",COVID
162,2019-NCOV,"February 08, 2021",80,NCT04261426,INTRAVENOUS IMMUNOGLOBULIN,,Not yet recruiting,Peking Union Medical College Hospital,"February 10, 2020",Interventional,"A Randomized, Open-label, Controlled, Single-center Study to Evaluate the Efficacy of Intravenous Immunoglobulin Therapy in Patients With Severe 2019- nCoV Pneumonia",COVID
163,"PNEUMONIA, PNEUMOCYSTIS","February 08, 2021",30,NCT04261517,HYDROXYCHLOROQUINE,CHINA,Completed,Shanghai Public Health Clinical Center,"February 6, 2020",Interventional,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Respiratory
164,2019-NCOV,"February 08, 2021",160,NCT04261907,ASC09/RITONAVIR GROUP,,Not yet recruiting,First Affiliated Hospital of Zhejiang University,"February 7, 2020",Interventional,"A Randomized, Open-label, Multi-centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Pneumonia Caused by Novel Coronavirus Infection",COVID
165,CORONAVIRUS INFECTION,"February 08, 2021",5000,NCT04262921,,FRANCE,Recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","February 8, 2020",Observational,Clinical Characterisation Protocol for Severe Emerging Infections,COVID
166,2019-NCOV SEVERE PNEUMONIA,"February 08, 2021",100,NCT04263402,METHYLPREDNISOLONE,CHINA,Recruiting,Tongji Hospital,"February 1, 2020",Interventional,"An Open, Prospective/Retrospective, Randomized Controlled Cohort Study to Compare the Efficacy of Different Hormone Doses in the Treatment of 2019-nCoV Severe Pneumonia",COVID
167,VITAMIN C,"February 08, 2021",56,NCT04264533,VC,CHINA,Terminated,ZhiYong Peng,"February 14, 2020",Interventional,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia: a Prospective Randomized Clinical Trial,Unrelated
168,2019-NCOV,"February 08, 2021",10,NCT04264858,IMMUNOGLOBULIN OF CURED PATIENTS,CHINA,Not yet recruiting,"Wuhan Union Hospital, China","March 17, 2020",Interventional,An Exploratory Clinical Study on the Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured 2019-nCoV Pneumonia Patients,COVID
169,"2019 NCOV, PD-1","February 08, 2021",120,NCT04268537,PD-1 BLOCKING ANTIBODY+STANDARD TREATMENT,,Not yet recruiting,"Southeast University, China","February 10, 2020",Interventional,Immunoregulatory Therapy for 2019-nCoV-induced Severe Pneumonia Patients,COVID
170,"PNEUMONIA, VIRAL","February 08, 2021",16,NCT04269525,UC-MSCS,CHINA,Recruiting,ZhiYong Peng,"February 6, 2020",Interventional,Clinical Research Regarding the Availability and Safety of UC-MSCs Treatment for Serious Pneumonia and Critical Pneumonia Caused by the 2019-nCOV Infection,Respiratory
171,2019-NCOV,"February 08, 2021",500,NCT04270383,,CHINA,Not yet recruiting,Beijing Children's Hospital,"February 15, 2020",Observational,A Multicenter Observational Study About the Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,COVID
172,2019-NCOV,"February 08, 2021",0,NCT04272710,,CHINA,Withdrawn,Chongqing Medical University,"January 25, 2020",Observational,Prognostic Characteristics Difference Between the Hypertension Patients With and Without ACEI Treatment When Suffered With 2019-nCoV Infection in China,COVID
173,COVID,"February 08, 2021",86,NCT04273321,METHYLPREDNISOLONE,CHINA,Completed,Beijing Chao Yang Hospital,"February 14, 2020",Interventional,Efficacy and Safety of Corticosteroids in COVID-19: A Prospective Randomized Controlled Trails,COVID
174,COVID THALIDOMIDE,"February 08, 2021",100,NCT04273529,THALIDOMIDE,,Not yet recruiting,First Affiliated Hospital of Wenzhou Medical University,"February 20, 2020",Interventional,"The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia: a Prospective, Multicenter, Randomized, Double-blind, Placebo, Parallel Controlled Clinical Study",COVID
175,COVID THALIDOMIDE,"February 08, 2021",40,NCT04273581,PLACEBO,,Not yet recruiting,First Affiliated Hospital of Wenzhou Medical University,"February 18, 2020",Interventional,"The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe New Coronavirus (COVID-19) Pneumonia: a Prospective, Multicenter, Randomized, Double-blind, Placebo, Parallel Controlled Clinical Study",COVID
176,2019 NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",48,NCT04273646,UC-MSCS,CHINA,Not yet recruiting,"Wuhan Union Hospital, China","April 20, 2020",Interventional,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,COVID
177,NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",18,NCT04273763,BROMHEXINE HYDROCHLORIDE TABLETS,CHINA,"Active, not recruiting",Second Affiliated Hospital of Wenzhou Medical University,"February 16, 2020",Interventional,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),COVID
178,CRITICALLY ILL,"February 08, 2021",117,NCT04274322,NUTRITION SUPPORT,CHINA,"Active, not recruiting",Peking University Third Hospital,"February 19, 2020",Observational,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool (COV_NUTRIC),Unrelated
179,NON-CONTACT INFRARED THERMOMETER; RAPID SCREENING,"February 08, 2021",572,NCT04274621,,CHINA,Completed,Ningbo No. 1 Hospital,"February 14, 2020",Observational,"The Application Value of Non-contact Infrared Thermometers in Temperature Screening in the General Population: a Real-world, Prospective, Observational Study",Unrelated
180,2019-NCOVS INFECTION PNEUMONIA,"February 08, 2021",20,NCT04275245,MEPLAZUMAB FOR INJECTION,CHINA,Recruiting,Tang-Du Hospital,"February 3, 2020",Interventional,"Single Center, Single Arm, Open Clinical Study to Access Safety and Initial Efficacy of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia",COVID
181,2019 NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",426,NCT04275388,XIYANPING INJECTION,,Not yet recruiting,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,"May 15, 2020",Observational,Retrospective Cohort to Evaluate the Effectiveness and Safety of Xiyanping Injection Combined With Conventional Treatment for New Coronavirus Infection Pneumonia (Common Type),COVID
182,CORONAVIRUS INFECTION,"February 08, 2021",27,NCT04275414,BEVACIZUMAB INJECTION,CHINA,Completed,Qilu Hospital of Shandong University,"February 15, 2020",Interventional,Effecacy and Safety of Bevacizumab in Severe Patients With Covid-19: a Pilot Study (BEST-CP),COVID
183,COVID,"February 08, 2021",450,NCT04275947,"NCAPP, A CELL PHONE-BASED AUTO-DIAGNOSIS SYSTEM",CHINA,Recruiting,Chinese Alliance Against Lung Cancer,"February 14, 2020",Observational,"The COVID-19 Mobile Health Study, a Large-scale Clinical Observational Study Using nCapp",COVID
184,NOVEL CORONAVIRUS INFECTION,"February 08, 2021",127,NCT04276688,LOPINAVIR/RITONAVIR,HONG KONG,Completed,The University of Hong Kong,"February 10, 2020",Interventional,"An Open-label Randomized Controlled Trial on Lopinavir/ Ritonavir, Ribavirin and Interferon Beta 1b Combination Versus Lopinavir/ Ritonavir Alone, as Treatment for 2019 Novel Coronavirus Infection",COVID
185,PATHOGEN INFECTION COVID INFECTION,"February 08, 2021",100,NCT04276896,INJECTION AND INFUSION OF LV-SMENP-DC VACCINE AND ANTIGEN-SPECIFIC CTLS,CHINA,Recruiting,Shenzhen Geno-Immune Medical Institute,"March 24, 2020",Interventional,Phase I/II Multicenter Trial of Lentiviral Minigene Vaccine (LV-SMENP) of Covid-19 Coronavirus,COVID
186,CORONAVIRUS,"February 08, 2021",24,NCT04276987,MSCS-DERIVED EXOSOMES,CHINA,Completed,Ruijin Hospital,"February 15, 2020",Interventional,A Pilot Clinical Study on Aerosol Inhalation of the Exosomes Derived From Allogenic Adipose Mesenchymal Stem Cells in the Treatment of Severe Patients With Novel Coronavirus Pneumonia,COVID
187,CORONAVIRUS INFECTION (COVID),"February 08, 2021",5000,NCT04278404,"THE POP02 STUDY IS COLLECTING BODILY FLUID SAMPLES (I.E., WHOLE BLOOD, EFFLUENT SAMPLES) OF CHILDREN PRESCRIBED THE FOLLOWING DRUGS OF INTEREST PER STANDARD OF CARE:",CANADA,Recruiting,Duke University,"March 5, 2020",Observational,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs",COVID
188,COVID,"February 08, 2021",300,NCT04278963,YINHU QINGWEN DECOCTION,CHINA,Suspended,China Academy of Chinese Medical Sciences,"February 27, 2020",Interventional,"Adaptive, Randomized, Single-blind, Three-arm Parallel Controlled Clinical Trial of Yinhu Qingwen Decoction in the Treatment of Mild / Common CoVID-19",COVID
189,PULMONARY FIBROSIS DUE TO COVID,"February 08, 2021",160,NCT04279197,FUZHENG HUAYU TABLET,CHINA,Recruiting,ShuGuang Hospital,"April 23, 2020",Interventional,The Efficacy of Treating Pulmonary Fibrosis and Pulmonary Function Injury in COVID-19 With the Fuzheng Huayu Tablets: a Multicenter Randomized Controlled Trial,COVID
190,CORONAVIRUS,"February 08, 2021",100,NCT04279782,COMPREHENSIVE TREATMENT,CHINA,Recruiting,"Third Affiliated Hospital, Sun Yat-Sen University","January 20, 2020",Observational,Investigation on Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection in Isolation Unit,COVID
191,CORONAVIRUS,"February 08, 2021",20,NCT04279795,,CHINA,Recruiting,"Third Affiliated Hospital, Sun Yat-Sen University","January 20, 2020",Observational,Study on Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations in Patients,COVID
192,NEONATAL INFECTION,"February 08, 2021",100,NCT04279899,,CHINA,Recruiting,Children's Hospital of Fudan University,"February 1, 2020",Observational,A Multicenter Observational Study of the Perinatal-neonatal Population With or With Risk of COVID-19 in China,Unrelated
193,NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",30,NCT04280224,NK CELLS,CHINA,Recruiting,Xinxiang medical university,"February 15, 2020",Interventional,Clinical Investigation of Natural Killer Cells Treatment in Pneumonia Patients Infected With 2019 Novel Coronavirus,COVID
194,CORONAVIRUS DISEASE (COVID),"February 08, 2021",0,NCT04280588,FINGOLIMOD 0.5 MG,CHINA,Withdrawn,First Affiliated Hospital of Fujian Medical University,"February 22, 2020",Interventional,Efficacy of Fingolimod in the Treatment of New Coronavirus Pneumonia (COVID-19),COVID
195,COVID,"February 08, 2021",1062,NCT04280705,PLACEBO,DENMARK,Completed,National Institute of Allergy and Infectious Diseases (NIAID),"February 21, 2020",Interventional,"A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",COVID
196,CORONAVIRUS DISEASE 2019,"February 08, 2021",0,NCT04280913,RETROSPECTIVE ANALYSIS,CHINA,Withdrawn,Guangzhou Institute of Respiratory Disease,"February 22, 2020",Observational,Clinical Outcomes of Hospitalized Patients With Coronavirus Disease 2019,COVID
197,NOVEL CORONAVIRUS INFECTION PNEUMONIA,"February 08, 2021",230,NCT04281693,STANDARD SCREENING STRATEGY,CHINA,Not yet recruiting,Affiliated Hospital to Academy of Military Medical Sciences,February 2020,Interventional,Identification of a New Screening Strategy for 2019 Novel Coronavirus Infection,COVID
198,INFLUENZA,"February 08, 2021",76,NCT04282135,MCC IMS,GERMANY,Completed,Klinikum Bayreuth GmbH,"February 15, 2020",Observational,Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling,Respiratory
199,COVID,"February 08, 2021",120,NCT04283461,MRNA-1273,UNITED STATES,"Active, not recruiting",National Institute of Allergy and Infectious Diseases (NIAID),"March 16, 2020",Interventional,"Phase I, Open-Label, Dose-Ranging Study of the Safety and Immunogenicity of 2019-nCoV Vaccine (mRNA-1273) in Healthy Adults",COVID
200,CORONAVIRUS DISEASE 2019,"February 08, 2021",0,NCT04283825,PSYCHOLOGICAL AND PHYSICAL REHABILITATION BASED HUMANISTIC CARE,,Withdrawn,Second Affiliated Hospital of Xi'an Jiaotong University,"February 22, 2020",Interventional,The Therapeutic Efficacy of Psychological and Physical Rehabilitation Based Humanistic Care in Patients With Coronavirus Disease 2019,COVID
201,CORONAVIRUS DISEASE 2019,"February 08, 2021",0,NCT04283838,HUMANISTIC CARE,,Withdrawn,Second Affiliated Hospital of Xi'an Jiaotong University,"February 22, 2020",Interventional,The Effect of Humanistic Care in Healthcare Workers Participated in the Treatment of Coronavirus Disease 2019,COVID
202,CT SCORES PREDICT MORTALITY IN 2019-NCOV PNEUMONIA,"February 08, 2021",39,NCT04284046,CT SCORE,CHINA,Completed,"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","January 31, 2020",Observational,CT Scores Predict Mortality in 2019-nCoV Pneumonia,COVID
203,CORONAVIRUS DISEASE 2019,"February 08, 2021",0,NCT04285190,T89,,Withdrawn,"Tasly Pharmaceuticals, Inc.","February 26, 2020",Interventional,A Clinical Study to Investigate the Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With Coronavirus Disease 2019 (COVID-19),COVID
204,COVID,"February 08, 2021",8,NCT04285801,,HONG KONG,Completed,Chinese University of Hong Kong,"February 14, 2020",Observational,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,COVID
205,NOVEL CORONAVIRUS INFECTIOUS DISEASE (COVID),"February 08, 2021",520,NCT04286503,CARRIMYCIN,,Not yet recruiting,Beijing YouAn Hospital,"February 23, 2020",Interventional,"The Efficacy and Safety of Carrimycin Treatment in Patients With Novel Coronavirus Infectious Disease (COVID-19) : A Multicenter, Randomized, Open-controlled Study",COVID
206,COVID,"February 08, 2021",0,NCT04287686,RECOMBINANT HUMAN ANGIOTENSIN-CONVERTING ENZYME 2 (RHACE2),CHINA,Withdrawn,The First Affiliated Hospital of Guangzhou Medical University,February 2020,Interventional,"A Randomized, Open Label, Controlled Clinical Study to Evaluate the Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) in Adult Patients With COVID-19",COVID
207,CORONA VIRUS DISEASE 2019(COVID),"February 08, 2021",100,NCT04288102,UC-MSCS,CHINA,Completed,Beijing 302 Hospital,"March 5, 2020",Interventional,"A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients",COVID
208,CORONAVIRUS,"February 08, 2021",,NCT04288713,ECULIZUMAB,,Available,Hudson Medical,,Expanded Access,Soliris to Stop Immune Mediated Death In Covid 19 Infected Patients. A Trial of Distal Complement Inhibition.,COVID
209,INFECTION VIRAL,"February 08, 2021",300,NCT04290780,NOSOCOMIAL INFECTION/HOSPITAL ACQUIRED INFECTION,FRANCE,Recruiting,Hospices Civils de Lyon,"March 9, 2020",Observational,Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Unrelated
210,CORONAVIRUS INFECTION,"February 08, 2021",0,NCT04290858,NITRIC OXIDE,,Withdrawn,Xijing Hospital,"March 1, 2020",Interventional,Nitric Oxide Gas Inhalation Therapy in Spontaneous Breathing Patients With Mild/Moderate COVID19 Infection: a Randomized Clinical Trial,COVID
211,CORONAVIRUS,"February 08, 2021",0,NCT04290871,NITRIC OXIDE GAS,,Withdrawn,Xijing Hospital,"March 23, 2020",Interventional,Nitric Oxide Gas Inhalation Therapy for Severe Acute Respiratory Syndrome Due to COVID-19.,COVID
212,COVID,"February 08, 2021",550,NCT04291053,HUAIER GRANULE,,Not yet recruiting,Tongji Hospital,"April 1, 2020",Interventional,"The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19: a Prospective, Multicenter, Randomized, Parallel Controlled Clinical Study",COVID
213,HEALTH SERVICES RESEARCH,"February 08, 2021",1800,NCT04291534,,FRANCE,Recruiting,University Paris 7 - Denis Diderot,"June 15, 2020",Observational,Quality of Life and Addiction Among Hospital Night Workers - Descriptive Study of APHP Workers in Paris,Unrelated
214,SELECTIVE MUTISM,"February 08, 2021",11,NCT04291638,REMOTE CAREGIVER TRAINING,UNITED STATES,Completed,Florida International University,"March 6, 2020",Interventional,Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism,Unrelated
215,COVID,"February 08, 2021",11,NCT04291729,GANOVO+RITONAVIR+/-INTERFERON NEBULIZATION,CHINA,Completed,The Ninth Hospital of Nanchang,"February 17, 2020",Interventional,An Open Clinical Trial to Evaluate Ganovo（Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,COVID
216,PNEUMONIA CAUSED BY HUMAN CORONAVIRUS,"February 08, 2021",400,NCT04292327,,CHINA,"Active, not recruiting",Fujian Provincial Hospital,"January 1, 2020",Observational,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus(2019-nCoV),COVID
217,CORONAVIRUS,"February 08, 2021",15,NCT04292340,,CHINA,Recruiting,Shanghai Public Health Clinical Center,"February 1, 2020",Observational,The Efficacy and Safety of Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of Novel Coronavirus Pneumonia Patient (COVID-19) : An Observational Study,COVID
218,COVID,"February 08, 2021",1113,NCT04292730,REMDESIVIR,CHINA,Completed,Gilead Sciences,"March 15, 2020",Interventional,A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate COVID-19 Compared to Standard of Care Treatment,COVID
219,COVID,"February 08, 2021",4891,NCT04292899,REMDESIVIR,CHINA,Completed,Gilead Sciences,"March 6, 2020",Interventional,A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe COVID-19,COVID
220,SARS-CoV2,"February 08, 2021",201,NCT04292964,,CHINA,Completed,Chongqing Medical University,"March 1, 2020",Observational,Prognostic Factors of Patients With COVID-19,COVID
221,COVID,"February 08, 2021",0,NCT04293692,UC-MSCS,CHINA,Withdrawn,Puren Hospital Affiliated to Wuhan University of Science and Technology,"February 24, 2020",Interventional,Human Umbilical Cord Mesenchymal Stem Cells Treatment for Pneumonia Patients Infected by 2019 Novel Coronavirus,COVID
222,COVID,"February 08, 2021",328,NCT04293887,RECOMBINANT HUMAN INTERFERON Α1Β,,Not yet recruiting,Tongji Hospital,"March 1, 2020",Interventional,"Randomized, Open, Blank Control Study on the Efficacy and Safety of Recombinant Human Interferon α1β in the Treatment of Patients With New Type of Coronavirus Infection in Wuhan",COVID
223,COVID,"February 08, 2021",80,NCT04295551,LOPINAVIR / RITONAVIR TABLETS COMBINED WITH XIYANPING INJECTION,,Not yet recruiting,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,"March 14, 2020",Interventional,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),COVID
224,CORONAVIRUS,"February 08, 2021",576,NCT04296643,MEDICAL MASK,CANADA,Recruiting,McMaster University,"April 1, 2020",Interventional,Medical Masks Versus N95 Respirators to Prevent 2019 Novel Coronavirus Disease (COVID-19) in Healthcare Workers: A Randomized Trial,COVID
225,URINARY INCONTINENCE IN OLD AGE,"February 08, 2021",458,NCT04297904,SEDENTARY BEHAVIOUR,SPAIN,Recruiting,University of Vic - Central University of Catalonia,"February 20, 2020",Observational,"Associations Between Urinary Incontinence, Sedentary Behaviour and Other Health-related Outcomes in Nursing Homes in Catalonia: the OsoNaH Project",Unrelated
226,INFLUENZA INFECTION,"February 08, 2021",280,NCT04298060,DAS181,CHINA,Not yet recruiting,"Ansun Biopharma, Inc.",July 2020,Interventional,A Phase IIb Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Severe Influenza Infection,Respiratory
227,COVID,"February 08, 2021",0,NCT04298814,SEVERE COVID-19 PNEUMONIA WITH ET,CHINA,Withdrawn,Tongji Hospital,"August 7, 2020",Observational,Analysis of Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,COVID
228,SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA,"February 08, 2021",20,NCT04299152,STEM CELL EDUCATOR-TREATED MONONUCLEAR CELLS APHERESIS,,Not yet recruiting,Tianhe Stem Cell Biotechnologies Inc.,"November 10, 2020",Interventional,Clinical Application of Stem Cell Educator Therapy for the Treatment of Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Respiratory
229,MENTAL DISORDER,"February 08, 2021",3428,NCT04299711,EXPOSED TO THE NOVEL CORONAVIRUS DISEASE 2019,,Not yet recruiting,University of Macau,"October 15, 2020",Observational,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019: A Longitudinal Study Protocol,Unrelated
230,TREAT AND PREVENT COVID INFECTION,"February 08, 2021",100,NCT04299724,PATHOGEN-SPECIFIC AAPC,CHINA,Recruiting,Shenzhen Geno-Immune Medical Institute,"February 15, 2020",Interventional,Safety and Immunity Evaluation of A Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine,COVID
231,PRETERM LABOR,"February 08, 2021",6500,NCT04301518,MULTIMODAL INTERVENTION STRATEGY,UNITED STATES,Recruiting,"Sera Prognostics, Inc.","November 6, 2020",Interventional,Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs,Unrelated
232,COVID,"February 08, 2021",24,NCT04302519,DENTAL PULP MESENCHYMAL STEM CELLS,,Not yet recruiting,"CAR-T (Shanghai) Biotechnology Co., Ltd.","March 5, 2020",Interventional,Clinical Study of Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,COVID
233,PNEUMONITIS,"February 08, 2021",669,NCT04302688,,CHINA,Completed,Renmin Hospital of Wuhan University,"December 10, 2019",Observational,Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram,Unrelated
234,CORONAVIRUS DISEASE 2019,"February 08, 2021",,NCT04302766,REMDESIVIR,,Available,U.S. Army Medical Research and Development Command,,Expanded Access,Intermediate-Size Patient Population Expanded Access Treatment Protocol for Coronavirus Disease 2019 (COVID-19) Remdesivir (RDV; GS-5734™),COVID
235,BONE STRENGTH,"February 08, 2021",832,NCT04302987,,FINLAND,Recruiting,University of Helsinki,"November 1, 2019",Observational,VITAMIN D INTERVENTION IN INFANTS: Effects of Early Vitamin D Exposure on Childhood Health at 6 Years - a Follow-up Study,Unrelated
236,SARS-CoV2 INFECTIONS,"February 08, 2021",320,NCT04303299,ORAL,THAILAND,Recruiting,Rajavithi Hospital,"August 19, 2020",Interventional,"A 6 Week Prospective, Open Label, Randomized, in Multicenter Study of, Oseltamivir Plus Hydroxychloroquine Versus Lopipinavir/ Ritonavir Plus Oseltamivir Versus Darunavir/ Ritonavir Plus Oseltamivir Plus Hydroxychloroquine in Mild COVID-19 AND Lopipinavir/ Ritonavir Plus Oseltamivir Versus Favipiravir Plus Lopipinavir / Ritonavir Versus Darunavir/ Ritonavir Plus Oseltamivir Plus Hydroxychloroquine Versus Favipiravir Plus Darunavir and Ritonavir Plus Hydroxychloroquine in Moderate to Critically Ill COVID-19",COVID
237,COVID,"February 08, 2021",40000,NCT04303507,CHLOROQUINE OR HYDROXYCHLOROQUINE,INDONESIA,Recruiting,University of Oxford,"April 29, 2020",Interventional,"Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting; a Randomised, Placebo-controlled Prophylaxis Study (COPCOV)",COVID
238,COVID,"February 08, 2021",2300,NCT04304053,TREATMENT AND PROPHYLAXIS,SPAIN,Completed,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","March 18, 2020",Interventional,Treatment of Non-severe Confirmed Cases of COVID-19 and Chemoprophylaxis of Their Contacts as Prevention Strategy: a Cluster Randomized Clinical Trial (PEP CoV-2 Study),COVID
239,COVID,"February 08, 2021",10,NCT04304313,SILDENAFIL CITRATE TABLETS,CHINA,Recruiting,Tongji Hospital,"February 9, 2020",Interventional,A Pilot Study of Sildenafi in the Treatment of COVID-19,COVID
240,SARS-CoV2,"February 08, 2021",1000,NCT04304690,BLOOD SAMPLE,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 16, 2020",Interventional,"COVID-19 Seroconversion Among Medical and Paramedical Staff in Emergency, ICU and Infectious Disease Services During the 2020 Epidemic",COVID
241,COVID PNEUMONIA,"February 08, 2021",140,NCT04305106,BEVACIZUMAB,CHINA,Recruiting,Qilu Hospital of Shandong University,"March 17, 2020",Interventional,The Efficacy and Safety of Bevacizumab in Severe or Critical Patients With COVID-19--a Multicenter Randomized Controlled Clinical Trial,COVID
242,CORONAVIRUS INFECTION,"February 08, 2021",70,NCT04305457,NITRIC OXIDE,UNITED STATES,"Active, not recruiting",Massachusetts General Hospital,"March 21, 2020",Interventional,Nitric Oxide Gas Inhalation Therapy in Spontaneous Breathing Patients With Mild/Moderate COVID-19: a Randomized Clinical Trial,COVID
243,CORONAVIRUS,"February 08, 2021",1145,NCT04305574,USE OF SOCIAL MEDIA DURING COVID-19,SINGAPORE,Completed,Jean Liu,"March 7, 2020",Observational,Getting it Right: Towards Responsible Social Media Use During a Pandemic,COVID
244,BLOOD DONATION,"February 08, 2021",19491,NCT04306055,QUESTIONNAIRE WITH PRECAUTION INFORMATION,CHINA,Completed,Guangzhou Blood Center,"March 13, 2020",Interventional,"Blood Donor Recruitment During Epidemic of COVID-19 in Guangzhou, China",Unrelated
245,SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",200,NCT04306393,NITRIC OXIDE GAS,UNITED STATES,Recruiting,Massachusetts General Hospital,"March 21, 2020",Interventional,Nitric Oxide Gas Inhalation Therapy for Mechanically Ventilated Patients With Severe Acute Respiratory Syndrome Caused by SARS-CoV2: a Randomized Clinical Trial.,Respiratory
246,COVID,"February 08, 2021",340,NCT04306497,TCM PRESCRIPTIONS,CHINA,Completed,"Jiangsu Famous Medical Technology Co., Ltd.","January 22, 2020",Observational,Clinical Trial of TCM Differentiation and Treatment Protocol of COVID-19 in Jiangsu Province,COVID
247,COVID,"February 08, 2021",120,NCT04306705,TOCILIZUMAB,CHINA,Recruiting,Tongji Hospital,"February 20, 2020",Observational,A Retrospective Study of Evaluating Safety and Efficacy of Tocilizumab Compared to Continuous Renal Replacement Therapy in Controlling CRS Triggered by COVID-19,COVID
248,CORONAVIRUS INFECTION,"February 08, 2021",50,NCT04307459,STANDARD OPERATING PROCEDURES,ITALY,Recruiting,University of Milan,"March 19, 2020",Observational,Acute Respiratory Failure and Continuous Positive Airway Pressure Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: a Real Life Evaluation,COVID
249,COVID,"February 08, 2021",65,NCT04307693,LOPINAVIR/RITONAVIR,"KOREA, REPUBLIC OF",Terminated,Asan Medical Center,"March 11, 2020",Interventional,Randomized Controlled Clinical Trials of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),COVID
250,"STRESS, PSYCHOLOGICAL","February 08, 2021",50000,NCT04308187,,FRANCE,Not yet recruiting,"University Hospital, Clermont-Ferrand","March 11, 2020",Observational [Patient Registry],The COVISTRESS Study: Influence of the COvid-19 Epidemic on STRESS,Unrelated
251,"CORONA VIRUS DISEASE 2019,COVID","February 08, 2021",60,NCT04308317,TETRANDRINE,CHINA,Enrolling by invitation,Henan Provincial People's Hospital,"March 5, 2020",Interventional,Clinical Study of Tetrandrine Tablets Adjuvant Treatment With COVID-19,COVID
252,CORONAVIRUS INFECTION,"February 08, 2021",1309,NCT04308668,HYDROXYCHLOROQUINE,CANADA,Completed,University of Minnesota,"March 17, 2020",Interventional,Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial,COVID
253,COVID,"February 08, 2021",150,NCT04310228,FAVIPIRAVIR COMBINED WITH TOCILIZUMAB,CHINA,Recruiting,Peking University First Hospital,"March 8, 2020",Interventional,"Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019-A Multicenter, Randomized and Controlled Clinical Trial Study",COVID
254,COVID,"February 08, 2021",116,NCT04310865,YINHU QINGWEN GRANULA,CHINA,Suspended,Zhong Wang,November 2020,Interventional,"An Adaptive, Randomized, Double-blind, Parallel-controlled Clinical Trial of Yinhu Qingwen Granula for the Treatment of Severe CoVID-19",COVID
255,CORONAVIRUS INFECTION,"February 08, 2021",580,NCT04311177,LOSARTAN,UNITED STATES,"Active, not recruiting",University of Minnesota,"April 9, 2020",Interventional,Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization,COVID
256,COVID,"February 08, 2021",100,NCT04311398,NEW QIASTAT-DX FULLY AUTOMATIC MULTIPLE PCR DETECTION PLATFORM,CHINA,Not yet recruiting,Huashan Hospital,"May 13, 2020",Observational,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,COVID
257,CRITICAL COVID WITH RESPIRATORY FAILURE,"February 08, 2021",196,NCT04311697,AVIPTADIL BY INTRAVENOUS INFUSION + STANDARD OF CARE,UNITED STATES,"Active, not recruiting","NeuroRx, Inc.","May 15, 2020",Interventional,ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory Failure,COVID
258,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04312009,LOSARTAN,UNITED STATES,Recruiting,University of Minnesota,"April 13, 2020",Interventional,Randomized Controlled Trial of Losartan for Patients With COVID-19 Requiring Hospitalization,COVID
259,CORONAVIRUS DISEASE-2019,"February 08, 2021",30,NCT04312100,OXYGEN TREATMENT,CHINA,Recruiting,Henan Provincial People's Hospital,"February 1, 2020",Observational,Sequential Oxygen Therapy Strategy for Patients With COVID-19,COVID
260,CORONAVIRUS INFECTION,"February 08, 2021",470,NCT04312243,INHALED NITRIC OXIDE GAS,UNITED STATES,Recruiting,Massachusetts General Hospital,"April 7, 2020",Interventional,Nitric Oxide Gas Inhalation for Prevention of COVID-19 in Healthcare Providers,COVID
261,COVID,"February 08, 2021",500,NCT04312464,NON,CHINA,Enrolling by invitation,"Wuhan Union Hospital, China","January 1, 2020",Observational,Retrospective Study of Myocardial Damage in COVID-19,COVID
262,COVID,"February 08, 2021",100,NCT04312997,PUL-042 INHALATION SOLUTION,UNITED STATES,Recruiting,"Pulmotect, Inc.","June 16, 2020",Interventional,A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,COVID
263,COVID,"February 08, 2021",200,NCT04313023,PUL-042 INHALATION SOLUTION,UNITED STATES,Recruiting,"Pulmotect, Inc.","June 9, 2020",Interventional,A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,COVID
264,COVID,"February 08, 2021",108,NCT04313127,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR),CHINA,"Active, not recruiting",CanSino Biologics Inc.,"March 16, 2020",Interventional,"A Single-center,Open-label，Dose-escalating Phase I Clinical Trial to Evaluate Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Healthy Adults Aged 18-60 Years Old",COVID
265,USE OF STEM CELLS FOR COVID TREATMENT,"February 08, 2021",5,NCT04313322,WJ-MSCS,JORDAN,Recruiting,Stem Cells Arabia,"March 16, 2020",Interventional,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,COVID
266,COVID,"February 08, 2021",200,NCT04313946,SCANNING CHEST X-RAYS AND PERFORMING AI ALGORITHMS ON IMAGES,ITALY,Recruiting,Professor Adrian Covic,"March 18, 2020",Observational,The Benefits of Artificial Intelligence Algorithms (CNNs) for Discriminating Between COVID-19 and Influenza Pneumonitis in an Emergency Department Using Chest X-Ray Examinations,COVID
267,COVID,"February 08, 2021",200,NCT04314232,,NORWAY,Recruiting,"University Hospital, Akershus","March 18, 2020",Observational,"Changes in Organ Specific Biomarkers, Virus Expression and Prognosis of Covid-19",COVID
268,CORONAVIRUS,"February 08, 2021",1000,NCT04314817,ANY DRUG USED TO TREAT COVID-19,FRANCE,Recruiting,Groupe Hospitalier Pitie-Salpetriere,"March 17, 2020",Observational,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,COVID
269,COVID,"February 08, 2021",1912,NCT04315298,SARILUMAB,UNITED STATES,Completed,Regeneron Pharmaceuticals,"March 18, 2020",Interventional,"An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19",COVID
270,SARS PNEUMONIA,"February 08, 2021",38,NCT04315480,TOCILIZUMAB,ITALY,"Active, not recruiting",Università Politecnica delle Marche,"March 12, 2020",Interventional,Tocilizumab (RoActemra) as Early Treatment of Patients Affected by SARS-CoV2 (COVID-19) Infection With Severe Multifocal Interstitial Pneumonia,Respiratory
271,INFECTION VIRAL,"February 08, 2021",20,NCT04315870,PREGNANT WOMEN WITH LABORATORY-CONFIRMED 2019-N-COV,ITALY,Recruiting,Federico II University,"January 1, 2020",Observational [Patient Registry],Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy,Unrelated
272,COVID,"February 08, 2021",500,NCT04315896,HYDROXYCHLOROQUINE,MEXICO,"Active, not recruiting","National Institute of Respiratory Diseases, Mexico","April 14, 2020",Interventional,Hydroxychloroquine Treatment for Severe COVID-19 Respiratory Disease: Randomised Clinical Trial (HYDRA Trial),COVID
273,CORONAVIRUS INFECTION,"February 08, 2021",3100,NCT04315948,REMDESIVIR,AUSTRIA,"Active, not recruiting","Institut National de la Santé Et de la Recherche Médicale, France","March 22, 2020",Interventional,"Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults",COVID
274,COVID PNEUMONIA,"February 08, 2021",90,NCT04315987,NESTACELL®,BRAZIL,Not yet recruiting,Azidus Brasil,June 2020,Interventional,Exploratory Clinical Study to Assess the Efficacy of NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,COVID
275,COVID,"February 08, 2021",287,NCT04316299,,CHINA,Completed,Zhenhua Zen,"February 26, 2020",Observational,"Acute Kidney Injury in Patients Hospitalized With COVID-19 in Wuhan, China: a Single-center Retrospective Observational Study",COVID
276,CORONAVIRUS INFECTION,"February 08, 2021",53,NCT04316377,HYDROXYCHLOROQUINE SULFATE,NORWAY,"Active, not recruiting","University Hospital, Akershus","March 25, 2020",Interventional,Norwegian Coronavirus Disease 2019 Study: An Open Labeled Randomized Controlled Pragmatic Trial to Evaluate the Antiviral Effect of Chloroquine in Adult Patients With SARS-CoV-2 Infection,COVID
277,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04316728,VIVADIAG™ COVID-19 LGM/IGG RAPID TEST,ITALY,Not yet recruiting,"Centro Studi Internazionali, Italy",March 2020,Interventional,Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in a Cohort of Negative Patients for Coronavirus Infection for the Early Detection of Positive Antibodies for COVID-19,COVID
278,COVID,"February 08, 2021",100,NCT04316884,,SWEDEN,Recruiting,Uppsala University,"March 12, 2020",Observational,Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19,COVID
279,SARS-CoV2 PNEUMONIA,"February 08, 2021",350,NCT04316949,,ITALY,Recruiting,University of Bologna,"March 20, 2020",Observational,Predictors of Respiratory Failure Requiring ICU Admission Among Hospitalized Patients With SARS-Cov-2 Infection,COVID
280,COVID,"February 08, 2021",243,NCT04317040,CD24FC,UNITED STATES,"Active, not recruiting","OncoImmune, Inc.","April 8, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Multi-site, Phase III Study to Evaluate the Safety and Efficacy of CD24Fc in COVID-19 Treatment",COVID
281,COVID PNEUMONIA,"February 08, 2021",400,NCT04317092,TOCILIZUMAB INJECTION,ITALY,"Active, not recruiting","National Cancer Institute, Naples","March 19, 2020",Interventional,Multicenter Study on the Efficacy and Tolerability of Tocilizumab in the Treatment of Patients With COVID-19 Pneumonia,COVID
282,RESPIRATORY TRACT INFECTIONS,"February 08, 2021",200,NCT04317365,WOMEN RECEIVING EXTRA REMEMBERING BY HEALTHCARE,EGYPT,Completed,Aljazeera Hospital,"March 24, 2020",Interventional,Effect of Counseling Between Pregnant Women During Corona Infection,Respiratory
283,COVID,"February 08, 2021",400,NCT04318015,HYDROXYCHLOROQUINE,MEXICO,Recruiting,"National Institute of Respiratory Diseases, Mexico","April 14, 2020",Interventional,Chemoprophylaxis With Hydroxychloroquine in Healthcare Personnel in Contact With COVID-19 Patients: A Randomized Controlled Trial (PHYDRA Trial),COVID
284,COVID,"February 08, 2021",275,NCT04318301,,CHINA,Completed,Zhenhua Zen,"March 21, 2020",Observational,"Hypertension in Patients Hospitalized With COVID-19 in Wuhan, China: A Single-center Retrospective Observational Study",COVID
285,HEALTH CARE WORKER PATIENT TRANSMISSION,"February 08, 2021",400,NCT04318314,COPAN SWABBING AND BLOOD SAMPLE COLLECTION,UNITED KINGDOM,Recruiting,"University College, London","March 18, 2020",Observational [Patient Registry],COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Unrelated
286,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04318366,OBSERVATIONAL STUDY,ITALY,Recruiting,Università Vita-Salute San Raffaele,"March 19, 2020",Observational,"Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response",COVID
287,COVID,"February 08, 2021",3400,NCT04318418,,ITALY,Completed,Neuromed IRCCS,"March 23, 2020",Observational,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",COVID
288,COVID,"February 08, 2021",605,NCT04318431,DATA COLLECTION AND RHINOPHARYNGEAL SWAB,FRANCE,Completed,Centre Hospitalier Intercommunal Creteil,"April 14, 2020",Interventional,"Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children, a Cross-sectional, Prospective, Multicentre, Observational Study in Primary Care.",COVID
289,COVID,"February 08, 2021",1600,NCT04318444,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,Columbia University,"March 29, 2020",Interventional,Hydroxychloroquine Post Exposure Prophylaxis (PEP) for Household Contacts of COVID-19 Patients: A NYC Community-Based Randomized Clinical Trial,COVID
290,INFECTION VIRAL,"February 08, 2021",200,NCT04319016,PREGNANT WOMEN WITH LABORATORY-CONFIRMED 2019-N-COV,ITALY,Recruiting,Federico II University,"January 1, 2020",Observational [Patient Registry],Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Unrelated
291,TRANSPLANT RECIPIENT,"February 08, 2021",50,NCT04319172,,SPAIN,Recruiting,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,"March 12, 2020",Observational,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,Unrelated
292,HEALTHY PEOPLE,"February 08, 2021",200,NCT04319211,"DETERMINATION OF PHYSICAL ACTIVITY, QUALITY OF LIFE, STRESS LEVELS OF ISOLATED PEOPLE AT HOME WITH THE DANGER OF CORONAVIRUS.",TURKEY,Not yet recruiting,Istanbul University-Cerrahpasa,"March 25, 2020",Observational,"Investigation of Physical Activity, Quality of Life and Stress Levels of Individuals Who Live in Their Homes Isolated Because of Coronavirus (COVID-19) Disease",Unrelated
293,COVID,"February 08, 2021",400,NCT04319315,SURVEY,EGYPT,Recruiting,Assiut University,"March 11, 2020",Observational,Impact of Social Media on Knowledge Dissemination Between Physicians During COVID-19 Virus Outbreak,COVID
294,MIGRAINE DISORDERS,"February 08, 2021",233,NCT04319445,MINDFULNESS SESSION(S),UNITED STATES,"Active, not recruiting",Wake Forest University Health Sciences,"March 22, 2020",Interventional,Mindfulness During COVID-19 - Remote Mindfulness Sessions,Unrelated
295,SARS COV-2 INFECTION,"February 08, 2021",10,NCT04319731,HUMAN AMNIOTIC FLUID,UNITED STATES,Recruiting,University of Utah,"March 20, 2020",Interventional,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,Respiratory
296,COVID,"February 08, 2021",500,NCT04320017,"ELECTROCARDIOGRAM, TRANSTHORACIC ECHOCARDIOGRAPHY AND CLINICO-BIOLOGICAL PARAMETERS IN ROUTINE CARE",FRANCE,Recruiting,Groupe Hospitalier Pitie-Salpetriere,"March 20, 2020",Observational,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,COVID
297,CORONAVIRUS,"February 08, 2021",216,NCT04320056,STANDARD ADMINISTRATION OF OXYGEN FLOW,CANADA,Recruiting,Laval University,"April 20, 2020",Interventional,Automated Oxygen Titration - Monitoring and Weaning in Patients With Infectious Pneumonia Requiring Oxygen - Impact on the Number of Interventions for Healthcare Workers. An Innovative Device to Manage Patients With COVID-19 Pneumonia COVID Study (Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decreaseduring Pneumonia),COVID
298,2019 NOVEL CORONAVIRUS INFECTION,"February 08, 2021",2944,NCT04320238,RECOMBINANT HUMAN INTERFERON ALPHA-1B,CHINA,Recruiting,Shanghai Jiao Tong University School of Medicine,"January 21, 2020",Interventional,An Clinic Trial of Recombinant Human Interferon Alpha Nasal Drops to Prevent Coronavirus Disease 2019 in Medical Staff in Epidemic Area,COVID
299,PHARMACOLOGICAL ACTION,"February 08, 2021",200,NCT04320277,BARICITINIB,ITALY,Not yet recruiting,Hospital of Prato,"May 16, 2020",Interventional,"Baricitinib Combined With Antiviral Therapy in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study",Unrelated
300,COVID,"February 08, 2021",250,NCT04320472,FOLLOW UP,BRAZIL,"Active, not recruiting",Ictal Group,"March 23, 2020",Observational [Patient Registry],Outcomes in Patients With Acute Encephalopathy and SARS-Cov-2 Infection,COVID
301,SARS-CoV2,"February 08, 2021",25,NCT04320511,CT-V,UNITED STATES,Recruiting,William Beaumont Hospitals,"June 24, 2020",Observational,"COVID CT, Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2",COVID
302,COVID PNEUMONIA,"February 08, 2021",450,NCT04320615,TOCILIZUMAB (TCZ),CANADA,Completed,Hoffmann-La Roche,"April 3, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia",COVID
303,CORONAVIRUS,"February 08, 2021",250000,NCT04320732,OBSERVATION OF BEHAVIOR AND COVID-19 INFECTION WILL BE CONDUCTED.,NORWAY,Recruiting,Oslo University Hospital,"March 27, 2020",Observational,Risk Factors for Community- and Workplace Transmission of COVID-19,COVID
304,COVID,"February 08, 2021",200000,NCT04320862,,UNITED STATES,Recruiting,Duke University,"April 3, 2020",Observational,Pandemic Response Network: Duke Community Health Watch,COVID
305,GASTROINTESTINAL DISEASE,"February 08, 2021",5,NCT04320953,NON-CONTACT MCE SYSTEM,CHINA,Completed,Changhai Hospital,"March 16, 2020",Interventional,Non-contact Endoscopy at Covid-19 Outbreak,Unrelated
306,CORONAVIRUS INFECTION,"February 08, 2021",580,NCT04321096,CAMOSTAT MESILATE,DENMARK,"Active, not recruiting",University of Aarhus,"April 4, 2020",Interventional,"The Impact of Camostat Mesilate on COVID-19 Infection: An Investigator-initiated Randomized, Placebo-controlled, Phase IIa Trial",COVID
307,CORONAVIRUS INFECTION,"February 08, 2021",1220,NCT04321174,LOPINAVIR/RITONAVIR,CANADA,Recruiting,Darrell Tan,"April 17, 2020",Interventional,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,COVID
308,COVID,"February 08, 2021",4000,NCT04321265,,DENMARK,Recruiting,"Heinrich-Heine University, Duesseldorf","March 19, 2020",Observational,Outcomes and Prognostic Factors in Coronavirus Disease (COVID-19) in Very Old Intensive Care Patients,COVID
309,CORONAVIRUS INFECTION,"February 08, 2021",440,NCT04321278,HYDROXYCHLOROQUINE + AZITHROMYCIN,BRAZIL,Completed,Hospital Israelita Albert Einstein,"March 28, 2020",Interventional,Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients,COVID
310,"INFECTIONS, RESPIRATORY","February 08, 2021",533,NCT04321369,TESTING SENSITIVITY FOR SARS-COV-2 VIRUS IN SYMPTOMATIC INDIVIDUALS,UNITED STATES,Completed,Dr. Deneen Vojta,"March 9, 2020",Observational,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Respiratory
311,COVID,"February 08, 2021",49,NCT04321421,HYPERIMMUNE PLASMA,ITALY,Completed,Foundation IRCCS San Matteo Hospital,"March 17, 2020",Interventional,Plasma From Donors Recovered From New Coronavirus 2019 As Therapy For Critical Patients With Covid-19,COVID
312,SARS-COV INFECTION,"February 08, 2021",700,NCT04321616,HYDROXYCHLOROQUINE,NORWAY,Recruiting,Oslo University Hospital,"March 28, 2020",Interventional,The (Norwegian) NOR Solidarity Multicenter Trial on the Efficacy of Different Anti-viral Drugs in SARS-CoV-2 Infected Patients,Respiratory
313,CORONAVIRUS,"February 08, 2021",100000,NCT04321811,"OBSERVATION OF PATIENTS WITH KNOWN, SUSPECTED, OR AT RISK FOR COVID-19 INFECTION",UNITED STATES,Recruiting,xCures,"March 21, 2020",Observational [Patient Registry],A PATIENT-CENTRIC OUTCOMES REGISTRY OF PATIENTS WITH KNOWN OR SUSPECTED NOVEL CORONAVIRUS INFECTION SARS-COV-2 (COVID-19),COVID
314,SARS-CoV2,"February 08, 2021",7576,NCT04321928,PERSONALIZED HEALTH EDUCATION,HUNGARY,Recruiting,University of Pecs,"April 1, 2020",Interventional,Personalized Health Education Against the Health Damage of COVID-19 Epidemic in Hungary (PROACTIVE-19),COVID
315,COVID,"February 08, 2021",800,NCT04321993,BARICITINIB (JANUS KINASE INHIBITOR),CANADA,Recruiting,Lisa Barrett,"April 17, 2020",Interventional,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,COVID
316,CORONAVIRUS INFECTION,"February 08, 2021",630,NCT04322123,HYDROXYCHLOROQUINE ORAL PRODUCT,BRAZIL,"Active, not recruiting",Hospital do Coracao,"April 1, 2020",Interventional,"An Open-label, Randomized Controlled Trial of Hydroxychloroquine and Azithromycin for COVID-19 Infection on Hospitalized, Noncritical Patients",COVID
317,SEVERE ACUTE RESPIRATORY SYNDROME (ARDS) SECONDARY TO SARS-CoV2 INFECTION,"February 08, 2021",220,NCT04322188,,ITALY,Completed,A.O. Ospedale Papa Giovanni XXIII,"March 19, 2020",Observational,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,COVID
318,CORONAVIRUS,"February 08, 2021",300,NCT04322279,SEROLOGY,FRANCE,Recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","March 9, 2020",Observational,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. (CoV-CONTACT-SERO),COVID
319,CORONAVIRUS INFECTION,"February 08, 2021",120,NCT04322344,ESCIN,ITALY,Recruiting,University of Catanzaro,"March 23, 2020",Interventional,Efficacy and Safety of Escin as add-on Treatment in Covid-19 Infected Patients,COVID
320,VIRUS DISEASES,"February 08, 2021",226,NCT04322396,AZITHROMYCIN,DENMARK,Recruiting,"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","April 6, 2020",Interventional,"Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID: A Randomized, Placebo-controlled Double-blinded Trial Evaluating Treatment With Azithromycin and Hydroxychloroquine to Patients With COVID-19",Unrelated
321,CORONAVIRUS,"February 08, 2021",100,NCT04322487,LUNG ULTRASOUND,ITALY,Recruiting,Catholic University of the Sacred Heart,"April 8, 2020",Observational,"Proposal for International Standardization of the Use of Lung Ultrasound for COVID-19 Patients; a Simple, Quantitative, Reproducible Method",COVID
322,CORONAVIRUS,"February 08, 2021",110,NCT04322513,BIOMARKERS EXPRESSION,ITALY,Recruiting,University of Catanzaro,"March 24, 2020",Observational,Biomarkers Identification for Diagnosis and Treatment of SARS-COV-2 Infection,COVID
323,CORONAVIRUS INFECTION,"February 08, 2021",310,NCT04322565,COLCHICINE,ITALY,Recruiting,Azienda Ospedaliero-Universitaria di Parma,"April 20, 2020",Interventional,Colchicine to Counteract Inflammatory Response in COVID-19 Pneumonia,COVID
324,CORONAVIRUS INFECTION,"February 08, 2021",4506,NCT04322682,COLCHICINE,BRAZIL,Completed,Montreal Heart Institute,"March 23, 2020",Interventional,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),COVID
325,CORONA VIRUS DISEASE,"February 08, 2021",20,NCT04322773,ROACTEMRA IV,DENMARK,Terminated,Marius Henriksen,"April 5, 2020",Interventional,"Effectiveness of Interleukin-6 Receptor Inhibitors in the Management of Patients With Severe SARS-CoV-2 Pneumonia: An Open-Label, Multicenter Sequential and Cluster Randomized Trial",Unrelated
326,"COVID, CORONAVIRUS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, INFLUENZA, ELECTRONIC HEALTH RECORDS, EPIDEMIOLOGY, COMORBIDITY, INCIDENCE, UNITED KINGDOM","February 08, 2021",1302508,NCT04322786,ACE INHIBITOR,,"Active, not recruiting","University College, London","January 1, 1998",Observational,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective? An Analysis Using UK Based Electronic Health Records of 5.6 Million Individuals.",COVID
327,AGING,"February 08, 2021",168,NCT04323163,PHYSICAL ACTIVITY,UNITED STATES,Recruiting,University of Illinois at Urbana-Champaign,"January 1, 2021",Interventional,"Yoga, Aerobic and Stretching Exercise Effects on Neurocognitive Performance: A Randomized Controlled Trial",Unrelated
328,COVID,"February 08, 2021",40,NCT04323228,ORAL SUPPLEMENT ENRICHED IN ANTIOXIDANTS,SAUDI ARABIA,Recruiting,King Saud University,"September 1, 2020",Interventional,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation on the Cytokine Storm and Progression of COVID-19: A Randomized Controlled Trial,COVID
329,COVID,"February 08, 2021",50,NCT04323332,TRADITIONAL CHINESE MEDICINE PRESCRIPTION,CHINA,Not yet recruiting,Xiyuan Hospital of China Academy of Chinese Medical Sciences,March 2020,Interventional,A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Traditional Chinese Medicine as an Adjuvant Treatment for Patients With Severe COVID-19,COVID
330,COVID,"February 08, 2021",1000,NCT04323345,NATURAL HONEY,EGYPT,Recruiting,Misr University for Science and Technology,"April 15, 2020",Interventional,"The Efficacy of Natural Honey in Patients Infected With Novel Coronavirus (COVID-19) : A Randomized, Controlled ,Single Masked , Investigator Initiated, Multi-center Trial",COVID
331,HOSPITALIZED PATIENTS WITH COVID PNEUMONIA,"February 08, 2021",500,NCT04323514,VITAMIN C,ITALY,Recruiting,University of Palermo,"March 13, 2020",Interventional,Use of Ascorbic Acid in Patients With COVID 19,COVID
332,SARS-COV INFECTION,"February 08, 2021",278,NCT04323527,CHLOROQUINE DIPHOSPHATE,BRAZIL,Completed,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,"March 23, 2020",Interventional,"Efficacy and Safety of Chloroquine Diphosphate for the Treatment of Hospitalized Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV2: a Phase IIb, Double-blind, Randomized Adaptive Clinical Trial",Respiratory
333,SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA,"February 08, 2021",173,NCT04323592,METHYLPREDNISOLONE,ITALY,Completed,University of Trieste,"March 23, 2020",Observational [Patient Registry],Prolonged Low Doses of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Respiratory
334,COVID,"February 08, 2021",0,NCT04323631,HYDROXYCHLOROQUINE,,Withdrawn,Rambam Health Care Campus,"April 30, 2020",Interventional,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,COVID
335,COVID,"February 08, 2021",1000,NCT04323644,SURGERY,SPAIN,Recruiting,University of Birmingham,"January 1, 2020",Observational,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),COVID
336,SARS-CoV2 INFECTION,"February 08, 2021",,NCT04323761,REMDESIVIR,AUSTRALIA,Approved for marketing,Gilead Sciences,,Expanded Access,Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection,COVID
337,CORONAVIRUS,"February 08, 2021",50000,NCT04323787,OBSERVATIONAL,UNITED STATES,Recruiting,Mayo Clinic,"March 30, 2020",Observational,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary),COVID
338,CORONAVIRUS,"February 08, 2021",500,NCT04323800,ANTI- SARS-COV-2 PLASMA,UNITED STATES,Recruiting,Johns Hopkins University,"June 10, 2020",Interventional,"Convalescent Plasma to Stem Coronavirus: A Randomized, Blinded Phase 2 Study Comparing the Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19",COVID
339,PREGNANCY,"February 08, 2021",2000,NCT04323839,PREGNANT WOMEN UNDER INVESTIGATION FOR CORONAVIRUS OR DIAGNOSED WITH COVID-19,UNITED STATES,Enrolling by invitation,"University of California, San Francisco","March 20, 2020",Observational [Patient Registry],PRIORITY (Pregnancy Coronavirus Outcomes Registry),Unrelated
340,EARLY CPAP VENTILATION IN COVID PATIENTS,"February 08, 2021",3000,NCT04323878,,ITALY,Recruiting,Mario Negri Institute for Pharmacological Research,"June 1, 2020",Observational,EC-COVID-PCS - Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.,COVID
341,SARS-CoV2,"February 08, 2021",16,NCT04324021,EMAPALUMAB,ITALY,Terminated,Swedish Orphan Biovitrum,"April 2, 2020",Interventional,"A Phase 2/3, Randomized, Open-label, Parallel Group, 3-arm, Multicenter Study Investigating the Efficacy and Safety of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and Anakinra, an Interleukin-1(IL-1) Receptor Antagonist, Versus Standard of Care, in Reducing Hyper-inflammation and Respiratory Distress in Patients With SARS-CoV-2 Infection.",COVID
342,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04324047,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"March 27, 2020",Observational,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,COVID
343,CORONAVIRUS INFECTION,"February 08, 2021",239,NCT04324073,SARILUMAB,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 27, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,COVID
344,COVID,"February 08, 2021",600,NCT04324190,GUIDED ONLINE SUPPORT PROGRAM,GERMANY,Recruiting,Gunther Meinlschmidt,"April 8, 2020",Interventional,Online Support for Psychosocial Stress in the Context of the COVID-19 Pandemic,COVID
345,CORONAVIRUS,"February 08, 2021",4000,NCT04324463,COLCHICINE,BRAZIL,Recruiting,Population Health Research Institute,"April 21, 2020",Interventional,"Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial",COVID
346,COVID,"February 08, 2021",4,NCT04324489,DAS181,CHINA,Completed,Renmin Hospital of Wuhan University,"March 6, 2020",Interventional,DAS181 for Severe COVID-19: Compassionate Use,COVID
347,CORONAVIRUS,"February 08, 2021",30,NCT04324528,VV-ECMO + CYTOKINE ADSORPTION (CYTOSORB ADSORBER),GERMANY,Recruiting,Dr. Alexander Supady,"March 27, 2020",Interventional,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,COVID
348,CORONAVIRUS,"February 08, 2021",1090,NCT04324606,CHADOX1 NCOV-19,UNITED KINGDOM,"Active, not recruiting",University of Oxford,"April 23, 2020",Interventional,"A Phase I/II Study to Determine Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 in UK Healthy Adult Volunteers",COVID
349,"PNEUMONIA, VIRAL","February 08, 2021",198,NCT04324684,,ITALY,Completed,Catholic University of the Sacred Heart,"March 31, 2020",Observational,Time of Recovery and Prognostic Factors of COVID-19 Pneumonia,Respiratory
350,CORONAVIRUS,"February 08, 2021",5309,NCT04324736,NO INTERVENTIONAL STUDY,FRANCE,"Active, not recruiting",Nantes University Hospital,"March 10, 2020",Observational,"""Coronavirus SARS-CoV2 and Diabetes Outcomes"" : CORONADO",COVID
351,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04324866,NASOPHARYNGEAL SWAB,,Not yet recruiting,Universita di Verona,"April 1, 2020",Observational,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,COVID
352,COVID,"February 08, 2021",90,NCT04324996,"NK CELLS,IL15-NK CELLS,NKG2D CAR-NK CELLS,ACE2 CAR-NK CELLS,NKG2D-ACE2 CAR-NK CELLS",CHINA,Recruiting,Chongqing Public Health Medical Center,"February 21, 2020",Interventional,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells Secreting IL15 Superagonist and GM-CSF-neutralizing scFv for Therapy of COVID-19,COVID
353,CORONAVIRUS INFECTION,"February 08, 2021",5000,NCT04325048,CORDIO APP,,Not yet recruiting,Cordio Medical,April 2020,Observational [Patient Registry],Single-Arm Observational Study Designed to Clinically Evaluate Cordio Application in Adult Patients Positive to COVID-19,COVID
354,ACUTE RESPIRATORY DISTRESS SYNDROME CAUSED BY COVID,"February 08, 2021",19,NCT04325061,DEXAMETHASONE,SPAIN,Terminated,Dr. Negrin University Hospital,"April 3, 2020",Interventional,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,COVID
355,COVID; CARDIOVASCULAR DISEASES,"February 08, 2021",1000,NCT04325412,,NETHERLANDS,Recruiting,UMC Utrecht,"March 23, 2020",Observational [Patient Registry],Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,COVID
356,COVID,"February 08, 2021",584,NCT04325633,1: NAPROXEN,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 13, 2020",Interventional,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,COVID
357,SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",2000,NCT04325646,HUMAN BIOLOGICAL SAMPLES,FRANCE,Recruiting,Institut Pasteur,"March 13, 2020",Observational,Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples,Respiratory
358,CORONAVIRUS,"February 08, 2021",0,NCT04325672,CONVALESCENT PLASMA,,Withdrawn,Mayo Clinic,"April 1, 2020",Interventional,"Convalescent Plasma to Limit Coronavirus Associated Complications: An Open Label, Phase 2A Study of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19",COVID
359,ANGINA PECTORIS,"February 08, 2021",200,NCT04325867,TELE-MEDICINE PLATFORM,ROMANIA,Recruiting,Professor Adrian Covic,"March 31, 2020",Interventional,"Integrated Distance Management Strategy for Patients With Cardiovascular Disease (Ischaemic Coronary Artery Disease, High Blood Pressure, Heart Failure) in the Context of the COVID-19 Pandemic",Unrelated
360,CORONAVIRUS,"February 08, 2021",259,NCT04325893,HYDROXYCHLOROQUINE,FRANCE,Terminated,"University Hospital, Angers","April 1, 2020",Interventional,"Hydroxychloroquine Versus Placebo in Patients Presenting COVID-19 Infection and at Risk of Secondary Complication: a Prospective, Multicentre, Randomised, Double-blind Study",COVID
361,PRONE POSITIONING,"February 08, 2021",346,NCT04325906,HIGH FLOW NASAL CANNULA (HFNC),UNITED STATES,Recruiting,Rush University Medical Center,"April 2, 2020",Interventional,Early Prone Positioning Combined With High-Flow Nasal Cannula Versus High-Flow Nasal Cannula in COVID-19 Induced Moderate to Severe ARDS,Unrelated
362,CORONAVIRUS INFECTION,"February 08, 2021",170,NCT04325919,NO INTERVENTION,HONG KONG,Recruiting,Chinese University of Hong Kong,"February 24, 2020",Observational,"Comprehensive Clinical, Virological, Microbiological, Immunological and Laboratory Monitoring of Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)",COVID
363,PULMONARY ALVEOLAR PROTEINOSIS,"February 08, 2021",10,NCT04326036,MICROCANNULA HARVEST ADIPOSE DERIVED TISSUE STROMAL VASCULAR FRACTION (TSVF),UNITED STATES,Recruiting,"Black Tie Medical, Inc.","March 25, 2020",Interventional,Use of cSVF For Residual Lung Damage (COPD/Fibrotic Lung Disease After Symptomatic COVID-19 Infection For Residual Pulmonary Injury or Post-Adult Respiratory Distress Syndrome Following Viral (SARS-Co-2) Infection,Unrelated
364,CPAP VENTILATION,"February 08, 2021",900,NCT04326075,CPAP TREATMENT,ITALY,Recruiting,Mario Negri Institute for Pharmacological Research,"December 1, 2020",Interventional,EC-COVID-RCT. Early CPAP in COVID Patients With Respiratory Failure. A Randomized Clinical Trial,Unrelated
365,"DISEASE, INFECTIOUS","February 08, 2021",240,NCT04326114,INSPIRATORY TRAINING DEVICE,,Not yet recruiting,Universidad Complutense de Madrid,"July 26, 2020",Interventional,Effectiveness and Safety of Respiratory Training Devices in the Prevention and Severity of COVID-19: A Randomized Controlled Clinical Trial,Unrelated
366,COVID,"February 08, 2021",1000,NCT04326309,,UNITED STATES,Recruiting,HealthMode Inc.,"March 25, 2020",Observational,Audio Data Collection for Identification and Classification of Coughing,COVID
367,ACUTE DISEASE,"February 08, 2021",200,NCT04326387,SAMBA II (DIAGNOSTIC FOR THE REAL WORLD),UNITED KINGDOM,Recruiting,CCTU- Cancer Theme,"April 6, 2020",Observational,Evaluation of Novel Diagnostic Tests for 2019-nCOV,Unrelated
368,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04326400,,SPAIN,Recruiting,"Fundación Teófilo Hernando, Spain","March 23, 2020",Observational,Active Monitoring And Determinants of Incidence Infection of COVDI-19 in a Hospital Population (AMADIICH) Study Protocol,COVID
369,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04326426,TRADIPITANT,UNITED STATES,Enrolling by invitation,Vanda Pharmaceuticals,"April 13, 2020",Interventional,"ODYSSEY: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Treating Inflammatory Lung Injury and Improving Clinical Outcomes Associated With Severe or Critical COVID-19 Infection",COVID
370,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04326452,BIDIRECTIONAL OXYGENATION MOUTHPIECE,UNITED STATES,Recruiting,TMC HealthCare,"March 27, 2020",Interventional,The Use of a Bidirectional Oxygenation Valve in the Management of Respiratory Failure Due to COVID-19 Infection,COVID
371,PNEUMONITIS,"February 08, 2021",80,NCT04326725,PLAQUENIL 200MG TABLET,TURKEY,"Active, not recruiting",Istinye University,"March 20, 2020",Observational,"Proflaxis for Healthcare Professionals Using Hydroxychloroquine Plus Vitamin Combining Vitamins C, D and Zinc During COVID-19 Pandemia: An Observational Study",Unrelated
372,CORONA VIRUS DISEASE 19 (COVID),"February 08, 2021",180,NCT04326790,COLCHICINE,GIBRALTAR,Recruiting,National and Kapodistrian University of Athens,"April 3, 2020",Interventional,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,COVID
373,COVID,"February 08, 2021",80,NCT04326920,SARGRAMOSTIM,BELGIUM,"Active, not recruiting","University Hospital, Ghent","March 24, 2020",Interventional,"A Prospective, Randomized, Open-label, Interventional Study to Investigate the Efficacy of Sargramostim (Leukine®) in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 (Corona Virus Disease) Patients With Acute Hypoxic Respiratory Failure.",COVID
374,INFECTION VIRAL,"February 08, 2021",500,NCT04327180,,FRANCE,Recruiting,"University Hospital, Lille","March 30, 2020",Observational,PCR-COVID-19 Predictors of Positivity in Patients Admitted to ICU for Respiratory Infection: A Prospective Observational Cohort Study,Unrelated
375,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",10078,NCT04327206,BCG VACCINE,AUSTRALIA,Recruiting,Murdoch Childrens Research Institute,"March 30, 2020",Interventional,BCG Vaccination to Reduce the Impact of COVID-19 in Healthcare Workers (BRACE) Trial,COVID
376,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04327349,CONVALESCENT PLASMA,"IRAN, ISLAMIC REPUBLIC OF",Enrolling by invitation,Mazandaran University of Medical Sciences,"March 28, 2020",Interventional,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,COVID
377,CORONAVIRUS INFECTION,"February 08, 2021",420,NCT04327388,SARILUMAB SAR153191,ARGENTINA,Completed,Sanofi,"March 28, 2020",Interventional,"An Adaptive Phase 3, Randomized, Double-blind, Placebo-controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID19",COVID
378,CORONAVIRUS INFECTION,"February 08, 2021",299,NCT04327401,DEXAMETHASONE,BRAZIL,Terminated,Hospital Sirio-Libanes,"April 13, 2020",Interventional,"COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)",COVID
379,CARDIOVASCULAR DISEASES,"February 08, 2021",728,NCT04327479,ASSESSMENT OF CARDIOVASCULAR DISEASES AND CARDIOVASCULAR RISK FACTORS,GERMANY,Recruiting,"University Hospital, Essen","March 26, 2020",Observational [Patient Registry],Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Unrelated
380,SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",200,NCT04327505,HYPERBARIC OXYGEN,GERMANY,Recruiting,Karolinska Institutet,"June 3, 2020",Interventional,"A Randomized, Controlled, Open Label, Multicentre Clinical Trial to Explore Safety and Efficacy of Hyperbaric Oxygen for Preventing ICU Admission, Morbidity and Mortality in Adult Patients With COVID-19",Respiratory
381,COVID,"February 08, 2021",200,NCT04327531,TURKISH PHYSICIANS,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 26, 2020",Observational,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",COVID
382,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04327570,PATIENT SAMPLING,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"March 27, 2020",Observational [Patient Registry],In-depth Characterisation of the Dynamic Host Immune Response to Coronavirus SARS-CoV-2,COVID
383,COVID,"February 08, 2021",375,NCT04327674,,DENMARK,Recruiting,University of Aarhus,"March 14, 2020",Observational [Patient Registry],The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,COVID
384,SARS-COV INFECTION,"February 08, 2021",120,NCT04327804,ODD/EVEN BIRTH YEAR INTERVENTION GROUPS,UNITED STATES,Recruiting,Dr. Deneen Vojta,"March 25, 2020",Observational,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Respiratory
385,SARS-CoV2 INFECTION,"February 08, 2021",4000,NCT04328012,LOPINAVIR/RITONAVIR,UNITED STATES,Recruiting,Bassett Healthcare,"April 6, 2020",Interventional,Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial),COVID
386,CORONAVIRUS INFECTION,"February 08, 2021",1300,NCT04328129,HUMAN BIOLOGICAL SAMPLES,FRENCH GUIANA,Recruiting,Institut Pasteur,"March 23, 2020",Interventional,Household Transmission Investigation Study for Coronavirus Disease 2019 (COVID-19) in Tropical Regions,COVID
387,COVID,"February 08, 2021",75,NCT04328272,HYDROXYCHLOROQUINE 200 MG ORAL TABLET,PAKISTAN,Not yet recruiting,Prof. Dr. Umar Farooq,"March 28, 2020",Interventional,Effectiveness of Hydroxychloroquine in Covid-19 Patients: A Single Centred Single-blind RCT Study,COVID
388,COVID,"February 08, 2021",1200,NCT04328285,HYDROXYCHLOROQUINE,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire de Saint Etienne,"April 14, 2020",Interventional,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers : A Randomized Double-blind Placebo-controlled Clinical Trial,COVID
389,COVID,"February 08, 2021",1500,NCT04328441,BCG VACCINE,NETHERLANDS,"Active, not recruiting",UMC Utrecht,"March 25, 2020",Interventional,"Reducing Health Care Workers Absenteeism in COVID-19 Pandemic by Enhanced Trained Immune Responses Through Bacillus Calmette-Guérin Vaccination, a Randomized Controlled Trial.",COVID
390,CORONAVIRUS,"February 08, 2021",120,NCT04328454,RETROSPECTIVE ANALYSIS,CHINA,Recruiting,Shanghai 10th People's Hospital,"January 30, 2020",Observational,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 in Chibi Hospital of Hubei Province,COVID
391,COVID,"February 08, 2021",1500,NCT04328467,HYDROXYCHLOROQUINE,UNITED STATES,"Active, not recruiting",University of Minnesota,"April 6, 2020",Interventional,Pre-exposure Prophylaxis for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial,COVID
392,COVID,"February 08, 2021",1200,NCT04328480,COLCHICINE,ARGENTINA,Recruiting,Estudios Clínicos Latino América,"April 17, 2020",Interventional,The ECLA PHRI COLCOVID Trial,COVID
393,SARS-CoV2 INFECTION,"February 08, 2021",250,NCT04328493,CHLOROQUINE PHOSPHATE,VIETNAM,Recruiting,"Oxford University Clinical Research Unit, Vietnam","April 7, 2020",Interventional,A Multi Center Randomized Open Label Trial on the Safety and Efficacy of Chloroquine for the Treatment of Hospitalized Adults With Laboratory Confirmed SARS-CoV-2 Infection in Vietnam,COVID
394,COVID,"February 08, 2021",829,NCT04328961,HYDROXYCHLOROQUINE SULFATE,UNITED STATES,Completed,University of Washington,"March 31, 2020",Interventional,"Efficacy of Hydroxychloroquine for Post-exposure Prophylaxis (PEP) to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Adults Exposed to Coronavirus Disease (COVID-19): a Blinded, Randomized Study",COVID
395,HISTORY OF CARDIOVASCULAR DISEASE TREATED WITH RAS BLOCKERS AND WITH SARS-CoV2 INFECTION,"February 08, 2021",554,NCT04329195,1: DISCONTINUATION OF RAS BLOCKER THERAPY,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 9, 2020",Interventional,ACE Inhibitors or ARBs Discontinuation for Clinical Outcome Risk Reduction in Patients Hospitalized for the Endemic Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) Infection: the Randomized ACORES-2 Study,COVID
396,COVID,"February 08, 2021",200,NCT04329507,BREATH TEST,UNITED KINGDOM,Recruiting,NHS Lothian,"March 25, 2020",Observational,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),COVID
397,PERCEIVED STRESS,"February 08, 2021",101,NCT04329533,"""CALM"" IS A MINDFULNESS MEDITATION MOBILE APP",UNITED STATES,Completed,University of Arizona,"April 13, 2020",Interventional,Effects of a Mobile Meditation App on Stress During COVID-19 Pandemic in Outpatient Obstetrics and Gynecology Patients; a Randomized Controlled Trial,Unrelated
398,SARS-CoV2 VIRAL KINETICS AND HOST IMMUNE RESPONSES,"February 08, 2021",250,NCT04329546,NA (NO INTERVENTION),SWITZERLAND,Recruiting,"University Hospital, Geneva","March 27, 2020",Observational,How Immune Responses Shape Virological and Clinical Characteristics of COVID-19: a Prospective Cohort Study,COVID
399,COVID,"February 08, 2021",50,NCT04329559,,CHINA,Recruiting,Hepatopancreatobiliary Surgery Institute of Gansu Province,"March 30, 2020",Observational [Patient Registry],Clinical Characteristics of COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,COVID
400,COVID,"February 08, 2021",400,NCT04329572,HYDROXYCHLOROQUINE SULFATE,BRAZIL,Suspended,Azidus Brasil,"April 23, 2020",Interventional,"Open, Multicentric, Non Randomized, Exploratory Clinical Trial to Assess the Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Acute Respiratory Syndrome (COVID-19) Caused by SARS-CoV-2 Virus",COVID
401,COVID,"February 08, 2021",148,NCT04329611,HYDROXYCHLOROQUINE,CANADA,Terminated,Dr. Michael Hill,"April 13, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Oral Hydroxychloroquine for the Treatment of SARS-CoV-2 Positive Patients for the Prevention of Severe COVID-19 Disease.",COVID
402,COVID,"February 08, 2021",200,NCT04329650,SILTUXIMAB,SPAIN,Recruiting,Judit Pich Martínez,"April 15, 2020",Interventional,"Phase 2, Randomized, Open-label Study to Compare Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia",COVID
403,COVID,"February 08, 2021",85,NCT04329832,HYDROXYCHLOROQUINE,UNITED STATES,"Active, not recruiting","Intermountain Health Care, Inc.","March 30, 2020",Interventional,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 (HAHPS): A Prospective Pragmatic Trial,COVID
404,HIP OSTEOARTHRITIS,"February 08, 2021",90,NCT04329897,SOFTWARE MESSAGING,UNITED STATES,Completed,University of Iowa,"April 5, 2020",Interventional,Acceptance and Commitment Therapy Delivered by Automated Software Messaging,Unrelated
405,COVID,"February 08, 2021",173,NCT04329923,HYDROXYCHLOROQUINE SULFATE 400 MG TWICE A DAY,UNITED STATES,Terminated,"Ravi Amaravadi, MD","April 9, 2020",Interventional,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),COVID
406,CONTACT PERSON FROM COVID CONFIRMED PATIENT,"February 08, 2021",2486,NCT04330144,HYDROXYCHLOROQUINE AS POST EXPOSURE PROPHYLAXIS,,Not yet recruiting,Gangnam Severance Hospital,"April 1, 2020",Interventional,A Study of Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),COVID
407,COVID,"February 08, 2021",12500,NCT04330261,EXPOSURE (NOT INTERVENTION) - SARS-COV-2 INFECTION,CANADA,Recruiting,University of Calgary,"March 18, 2020",Observational,Clinical Characteristics and Outcomes of Children Potentially Infected by Severe Acute Respiratory Distress Syndrome (SARS)-CoV-2 Presenting to Pediatric Emergency Departments,COVID
408,HYPERTENSION,"February 08, 2021",2414,NCT04330300,THIAZIDE OR THIAZIDE-LIKE DIURETICS,IRELAND,Suspended,"National University of Ireland, Galway, Ireland","April 30, 2020",Interventional,The CORONAvirus Disease 2019 Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker InvestigatiON (CORONACION) Randomized Clinical Trial,Unrelated
409,FACE-TOUCHING BEHAVIOR,"February 08, 2021",1094,NCT04330352,"MINDFULNESS-BASED ""STOP TOUCHING YOUR FACE"" PRACTICE",CHINA,Completed,Sir Run Run Shaw Hospital,"April 2, 2020",Interventional,"""STOP Touching Your Face"": a Randomized Controlled Trial of Brief Mindfulness-based Intervention",Unrelated
410,COVID,"February 08, 2021",800,NCT04330495,HIDROXICLOROQUINA,,Not yet recruiting,Instituto de Investigación Marqués de Valdecilla,"April 6, 2020",Interventional,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",COVID
411,CANCER,"February 08, 2021",50,NCT04330521,,UNITED STATES,Recruiting,Stanford University,"April 8, 2020",Observational,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Unrelated
412,COVID,"February 08, 2021",66,NCT04330586,CICLESONIDE METERED DOSE INHALER [ALVESCO],"KOREA, REPUBLIC OF",Recruiting,Korea University Guro Hospital,"April 1, 2020",Interventional,A Trial of Ciclesonide to Assess The Antiviral Effect for Adults With Mild-to-moderate COVID-19,COVID
413,COVID,"February 08, 2021",12000,NCT04330599,,UNITED KINGDOM,Recruiting,Queen Mary University of London,"May 1, 2020",Observational,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,COVID
414,COVID,"February 08, 2021",342,NCT04330638,USUAL CARE,BELGIUM,"Active, not recruiting","University Hospital, Ghent","April 3, 2020",Interventional,"A Prospective, Randomized, Factorial Design, Interventional Study to Compare the Safety and Efficacy of Combinations of Blockade of Interleukin-6 Pathway and Interleukin-1 Pathway to Best Standard of Care in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure and Systemic Cytokine Release Syndrome",COVID
415,COVID,"February 08, 2021",2900,NCT04330690,INTERFERON BETA-1A,CANADA,Recruiting,Sunnybrook Health Sciences Centre,"March 18, 2020",Interventional,"A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)",COVID
416,COVID INFECTION,"February 08, 2021",436,NCT04331054,2: USUAL PRACTICE + SYMBICORT RAPIHALER,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 13, 2020",Interventional,Protective Role of Inhaled Steroids for Covid-19 Infection,COVID
417,ANXIETY RELATED TO THE COVID PANDEMIC,"February 08, 2021",7500,NCT04331106,ONLINE QUESTIONNAIRE,GERMANY,Recruiting,"Charite University, Berlin, Germany","March 27, 2020",Observational,Online-based Survey of the Anxiety Associated With the COVID-19 Pandemic in the General Population in Germany,COVID
418,COVID,"February 08, 2021",12000000,NCT04331171,WEB APPLICATION USERS,FRANCE,Recruiting,Weprom,"March 17, 2020",Observational [Patient Registry],Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,COVID
419,COVID,"February 08, 2021",2,NCT04331366,GO2 PEEP MOUTHPIECE,UNITED STATES,Completed,Emory University,"April 8, 2020",Interventional,GO2 PEEP Study: The Use of a Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,COVID
420,COVID,"February 08, 2021",30,NCT04331470,LEVAMISOLE PILL + BUDESONIDE+FORMOTEROL INHALER,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Fasa University of Medical Sciences,"April 4, 2020",Interventional,Evaluation of Efficacy of Pharmacotherapy Treatment of COVID- 19 Infection Using Oral Levamisole and Formoterol+Budesonide Inhaler and Comparison of This Treatment Protocol With Standard National Treatment of the Disease,COVID
421,COVID,"February 08, 2021",10000000,NCT04331509,NO INTERVENTION,UNITED KINGDOM,Recruiting,King's College London,"March 23, 2020",Observational,COVID-19 Symptom Tracker,COVID
422,COVID,"February 08, 2021",2000,NCT04331574,,ITALY,Recruiting,Societa Italiana dell'Ipertensione Arteriosa,"March 10, 2020",Observational [Patient Registry],Phase IV Observational Study to Associate Hypertension and Hypertensinon Treatment to COVID19,COVID
423,COVID,"February 08, 2021",400,NCT04331600,CHLOROQUINE PHOSPHATE,POLAND,Recruiting,Wroclaw Medical University,"April 16, 2020",Interventional,"Multicenter, Randomized, Open-label, Non-commercial, Investigator-initiated Study to Evaluate the Efficacy and Safety of Chloroquine Phosphate in Combination With Telemedicine Care in the Risk Reduction of COVID-19 Related Hospitalization or Death, in Ambulatory Patients With COVID-19 Being at Risk of Serious Complications",COVID
424,COVID,"February 08, 2021",9,NCT04331613,CASTEM,CHINA,Recruiting,Chinese Academy of Sciences,"January 27, 2020",Interventional,Safety and Efficacy Study of Human Embryonic Stem Cells Derived M Cells (CAStem) for the Treatment of Severe COVID-19 Associated With or Without Acute Respiratory Distress Syndrome (ARDS),COVID
425,COVID,"February 08, 2021",64,NCT04331665,RUXOLITINIB,CANADA,Not yet recruiting,"University Health Network, Toronto","April 20, 2020",Interventional,A Single Arm Open-label Clinical Study to Investigate the Efficacy and Safety of Ruxolitinib for the Treatment of COVID-19 Pneumonia,COVID
426,COVID,"February 08, 2021",32,NCT04331795,TOCILIZUMAB,UNITED STATES,Completed,University of Chicago,"April 4, 2020",Interventional,Early Institution of Tocilizumab Titration in Non-Critical Hospitalized COVID-19 Pneumonitis,COVID
427,CORONAVIRUS INFECTION,"February 08, 2021",228,NCT04331808,TOCILIZUMAB,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 30, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Tocilizumab Trial - CORIMUNO-19 - TOCI (CORIMUNO-TOCI),COVID
428,COVID,"February 08, 2021",440,NCT04331834,HYDROXYCHLOROQUINE,SPAIN,Suspended,Barcelona Institute for Global Health,"April 3, 2020",Interventional,"Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic: A Multicentre, Double-Blinded Randomized Controlled Trial",COVID
429,COVID,"February 08, 2021",5000,NCT04331886,,UNITED STATES,Recruiting,"Target PharmaSolutions, Inc.","April 13, 2020",Observational,An Observational Study of Patients With Coronavirus Disease 2019,COVID
430,COVID,"February 08, 2021",120,NCT04331899,PEGINTERFERON LAMBDA-1A,UNITED STATES,"Active, not recruiting",Stanford University,"April 24, 2020",Interventional,"A Phase 2 Randomized, Single-Blind Study of a Single Dose of Peginterferon Lambda-1a (Lambda) Compared With Placebo in Outpatients With Mild COVID-19",COVID
431,INFECTION VIRAL,"February 08, 2021",2000,NCT04332016,BIOLOGICAL SAMPLES COLLECTION,FRANCE,Recruiting,"University Hospital, Bordeaux","April 2, 2020",Observational,Biological Samples Collection From Patients and Caregivers Treated at Bordeaux University Hospital for Asymptomatic and Symptomatic Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Infection (COVID-19).,Unrelated
432,SARS-CoV2 RELATED INTERSTITIAL PNEUMONIA,"February 08, 2021",50,NCT04332042,TOFACITINIB,ITALY,Not yet recruiting,Università Politecnica delle Marche,"April 10, 2020",Interventional,TOFAcitinib in Patients With Early Onset SARS-CoV2 Interstitial Pneumonia,COVID
433,COVID,"February 08, 2021",20,NCT04332081,HYPERBARIC OXYGEN THERAPY (HBOT),UNITED STATES,Terminated,NYU Langone Health,"April 6, 2020",Interventional,Open Label Single-Center Study of Emergency Hyperbaric Oxygen for Respiratory Distress in Patients With COVID-19,COVID
434,COVID,"February 08, 2021",276,NCT04332094,TOCILIZUMAB,SPAIN,Recruiting,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,"April 2, 2020",Interventional,"Pilot, Randomized, Multicenter, Open-label Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of SARS-CoV-2 Infection (COVID-19)",COVID
435,COVID,"February 08, 2021",2271,NCT04332107,AZITHROMYCIN,UNITED STATES,Recruiting,Thomas M. Lietman,"May 22, 2020",Interventional,Azithromycin for Prevention of Disease Progression in Patients With Mild or Moderate COVID-19,COVID
436,CORONAVIRUS,"February 08, 2021",10,NCT04332380,PLASMA,COLOMBIA,Completed,Universidad del Rosario,"May 1, 2020",Interventional,Convalescent Plasma for Patients With COVID-19: A Pilot Study,COVID
437,CORONAVIRUS,"February 08, 2021",60,NCT04332666,ANGIOTENSIN 1-7,,Not yet recruiting,Erasme University Hospital,"September 30, 2020",Interventional,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",COVID
438,CORONAVIRUS,"February 08, 2021",92,NCT04332835,PLASMA,COLOMBIA,Completed,Universidad del Rosario,"August 8, 2020",Interventional,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",COVID
439,COVID PNEUMONIA,"February 08, 2021",30,NCT04332913,,ITALY,Recruiting,University of L'Aquila,"April 1, 2020",Observational,Efficacy and Safety of Tocilizumab in the Treatment of Patients With Respiratory Distress Syndrome and Cytokine Release Syndrome Secondary to COVID-19: a Proof of Concept Study,COVID
440,CORONAVIRUS,"February 08, 2021",479,NCT04332991,HYDROXYCHLOROQUINE,UNITED STATES,Completed,Massachusetts General Hospital,"April 2, 2020",Interventional,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,COVID
441,COVID,"February 08, 2021",228,NCT04333225,HYDROXYCHLOROQUINE,UNITED STATES,Completed,Baylor Research Institute,"April 3, 2020",Interventional,A Prospective Clinical Study of Hydroxychloroquine in the Prevention of SARS- CoV-2 (COVID-19) Infection in Healthcare Workers After High-risk Exposures,COVID
442,"PNEUMONIA, INTERSTITIAL","February 08, 2021",115,NCT04333251,HIGH-TITER ANTI-SARS-COV-2 PLASMA,,Not yet recruiting,Baylor Research Institute,"April 1, 2020",Interventional,Evaluating Convalescent Plasma to Decrease Coronavirus Associated Complications. A Phase I Study Comparing the Efficacy and Safety of High-titer Anti-Sars-CoV-2 Plasma vs Best Supportive Care in Hospitalized Patients With Interstitial Pneumonia Due to COVID-19,Respiratory
443,COVID,"February 08, 2021",20,NCT04333355,CONVALESCENT PLASMA,MEXICO,Recruiting,Hospital San Jose Tec de Monterrey,"May 8, 2020",Interventional,Phase 1 Study to Evaluate the Safety of Convalescent Plasma as an Adjuvant Therapy in Patients With SARS-CoV-2 Infection,COVID
444,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",47,NCT04333368,UMBILICAL CORD WHARTON'S JELLY-DERIVED HUMAN,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"April 6, 2020",Interventional,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,COVID
445,COVID,"February 08, 2021",3170,NCT04333407,ASPIRIN 75MG,UNITED KINGDOM,Recruiting,Imperial College London,"April 3, 2020",Interventional,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,COVID
446,SEVERE COVID PNEUMONIA,"February 08, 2021",390,NCT04333420,SOC + IFX-1,GERMANY,Recruiting,InflaRx GmbH,"March 31, 2020",Interventional,"A Pragmatic Adaptive Randomized, Controlled Phase II/III Multicenter Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",COVID
447,COVID,"February 08, 2021",40,NCT04333472,PICLIDENOSON,ISRAEL,Recruiting,Can-Fite BioPharma,"January 6, 2021",Interventional,"Piclidenoson for Treatment of COVID-19 - A Randomized, Double-Blind, Placebo-Controlled Trial",COVID
448,COVID,"February 08, 2021",50,NCT04333550,DEFEROXAMINE,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Kermanshah University of Medical Sciences,April 2020,Interventional,Application of Iron Chelator (Desferal) to Reduce the Severity of COVID-19 Manifestations,COVID
449,COVID,"February 08, 2021",210,NCT04333589,FAVIPIRAVIR,CHINA,Recruiting,Peking University First Hospital,"April 1, 2020",Interventional,"The Mechanism, Clinical Outcome and Therapeutic Intervention of Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive",COVID
450,COVID,"February 08, 2021",5,NCT04333628,CHLOROQUINE,ISRAEL,Terminated,"HaEmek Medical Center, Israel","June 1, 2020",Interventional,"Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 in A Two Staged, Multicenter, Open Label and Randomized Trial",COVID
451,CORONAVIRUS INFECTION,"February 08, 2021",8,NCT04333654,HYDROXYCHLOROQUINE SAR321068,BELGIUM,Terminated,Sanofi,"April 12, 2020",Interventional,"A Phase 1b, Randomized, Double-blinded, Placebo-controlled Study of Hydroxychloroquine in Outpatient Adults With COVID-19",COVID
452,VASCULAR SURGICAL PROCEDURES,"February 08, 2021",50,NCT04333693,VASCULAR SURGERY,SPAIN,Not yet recruiting,Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery,"April 1, 2020",Observational [Patient Registry],Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study (Covid-VAS),Unrelated
453,COVID,"February 08, 2021",30000,NCT04333732,MR OR M-M-R II ® VACCINE,GHANA,Recruiting,Washington University School of Medicine,"September 4, 2020",Interventional,"An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults",COVID
454,CORONAVIRUS,"February 08, 2021",132,NCT04333849,,FRANCE,Completed,"University Hospital, Angers","March 25, 2020",Observational,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,COVID
455,SARS-CoV2,"February 08, 2021",500,NCT04333862,,SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","March 19, 2020",Observational,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,COVID
456,AORTIC VALVE STENOSIS,"February 08, 2021",71,NCT04333875,TAVR OR SAVR,SWITZERLAND,"Active, not recruiting","University Hospital Inselspital, Berne","March 20, 2020",Observational [Patient Registry],Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis - a Collateral Effect of the SARS-CoV-2 Pandemic (AS DEFER),Unrelated
457,SARS-CoV2 (COVID) INFECTION,"February 08, 2021",219,NCT04333914,AUTOPHAGY INHIBITOR (GNS651),FRANCE,Recruiting,Centre Leon Berard,"April 15, 2020",Interventional,"A Prospective, Controlled, Randomized, Multicenter Study of the Efficacy of an Autophagy Inhibitor (GNS561), an Anti-NKG2A (Monalizumab) and an Anti-C5aR (Avdoralimab) Compared to the Standard of Care in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection.",COVID
458,HIV/AIDS,"February 08, 2021",500,NCT04333953,NO INTERVENTION,UNITED STATES,Recruiting,University of Missouri-Columbia,"April 1, 2020",Observational [Patient Registry],Prospective Observational Study for Patients With HIV and Confirmed SARS-CoV-2,Unrelated
459,PATIENTS INFECTED WITH COVID,"February 08, 2021",200,NCT04334005,VITAMIN D,SPAIN,Not yet recruiting,Universidad de Granada,"April 10, 2020",Interventional,Effect of Vitamin D Administration on Prevention and Treatment of Mild Forms of Suspected Covid-19,COVID
460,COVID,"February 08, 2021",20,NCT04334044,RUXOLITINIB ORAL TABLET,MEXICO,Recruiting,Grupo Cooperativo de Hemopatías Malignas,"September 1, 2020",Interventional,Treatment of Severe Acute Respiratory Syndrome Caused by COVID-19 With Ruxolitinib,COVID
461,COVID,"February 08, 2021",1363,NCT04334148,HYDROXYCHLOROQUINE,UNITED STATES,"Active, not recruiting",Adrian Hernandez,"April 22, 2020",Interventional,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine Trial (HERO-HCQ Trial),COVID
462,COVID,"February 08, 2021",528,NCT04334252,QUESTIONNAIRE,BELGIUM,Completed,Jessa Hospital,"April 17, 2020",Observational,Descriptive Study Regarding the Ambulant Screening Protocol for COVID-19 in Times of High SARS CoV-2 Prevalence,COVID
463,COVID,"February 08, 2021",750,NCT04334265,ANLUOHUAXIAN,CHINA,Recruiting,Peking University First Hospital,"April 1, 2020",Interventional,"Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019-A Multicenter, Open, Randomized Controlled Study",COVID
464,COVID,"February 08, 2021",8168,NCT04334291,OBSERVATIONAL (REGISTRY),SPAIN,Completed,IVAN J NUÑEZ GIL,"March 23, 2020",Observational [Patient Registry],International COVID19 Clinical Evaluation Registry: HOPECOVID19. (Health Outcome Predictive Evaluation for COVID19),COVID
465,COVID,"February 08, 2021",1550,NCT04334382,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,"Intermountain Health Care, Inc.","April 2, 2020",Interventional,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT): A Prospective Pragmatic Trial,COVID
466,TELEREHABILITATION,"February 08, 2021",30,NCT04334434,TELEREHABILITATION,TURKEY,Completed,"Kubra Koce, MSc PT","July 30, 2020",Interventional,Investigation Of The Effectiveness Of The Telerehabilitation Applied To Individuals Over The Age Of 65 Who Experience Social Isolation At Houses Due To The Coronavirus (Covid-19) Pandemic,Unrelated
467,SARS-CoV2,"February 08, 2021",120,NCT04334460,BLD-2660,BRAZIL,"Active, not recruiting",Blade Therapeutics,"May 4, 2020",Interventional,"Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Antiviral Activity of BLD-2660 in Hospitalized Subjects With Recently Diagnosed COVID-19 Compared to Standard of Care Treatment",COVID
468,COVID,"February 08, 2021",600,NCT04334512,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,ProgenaBiome,"June 22, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Quintuple Therapy to Treat COVID-19 Infection",COVID
469,CORONAVIRUS,"February 08, 2021",230,NCT04334629,IBUPROFEN,UNITED KINGDOM,Recruiting,King's College London,"May 26, 2020",Interventional,"Lipid Ibuprofen Versus Standard of Care for Acute Hypoxemic Respiratory Failure Due to COVID-19: a Multicentre, Randomised, Controlled Trial",COVID
470,COVID,"February 08, 2021",194,NCT04334850,COMBINED USE OF A RESPIRATORY BROAD PANEL MULTIPLEX PCR AND PROCALCITONIN,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 20, 2020",Interventional,"Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia : a Multicenter, Parallel-group, Open-label, Randomized Controlled Trial",COVID
471,SARS-CoV2,"February 08, 2021",340,NCT04334876,SARS-COV-2 IGG ANTIBODY TESTING KIT,,Not yet recruiting,Indiana University,"April 1, 2020",Observational,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers and Candidacy for Convalescent Plasma Therapy/Prophylaxis,COVID
472,CORONAVIRUS INFECTION,"February 08, 2021",4000,NCT04334928,EMTRICITABINE/TENOFOVIR DISOPROXIL,SPAIN,Recruiting,Plan Nacional sobre el Sida (PNS),"April 15, 2020",Interventional,Prevention of SARS-CoV-2 (COVID-19) Through Pre-Exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Hydroxychloroquine in Healthcare Personnel: Randomized Clinical Trial Controlled With Placebo,COVID
473,SARS-CoV2 VIRUS,"February 08, 2021",15000,NCT04334954,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"August 26, 2020",Observational,SARS-COV2 Pandemic Serosurvey and Blood Sampling,COVID
474,COVID,"February 08, 2021",13,NCT04334967,HYDROXYCHLOROQUINE,UNITED STATES,Suspended,Providence Health & Services,"March 30, 2020",Interventional,Randomized Study to Evaluate the Safety and Antiviral Efficacy of Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care Treatment,COVID
475,COVID,"February 08, 2021",24,NCT04334980,BACTRL-SPIKE,AUSTRALIA,Recruiting,Symvivo Corporation,"November 2, 2020",Interventional,"A Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Immunogenicity of the bacTRL-Spike Oral Candidate Vaccine for the Prevention of COVID-19 in Healthy Adults",COVID
476,2019-NCOV (COVID),"February 08, 2021",300,NCT04335019,PULMONARY ULTRASOUND,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,April 2020,Observational,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,COVID
477,SARS-CoV2,"February 08, 2021",284,NCT04335032,EICOSAPENTAENOIC ACID GASTRO-RESISTANT CAPSULES,,Not yet recruiting,S.L.A. Pharma AG,"November 9, 2020",Interventional,"A Randomised, Double-blind, Placebo Controlled Study of Eicosapentaenoic Acid (EPA-FFA) Gastro-resistant Capsules to Treat Hospitalised Subjects With Confirmed SARS-CoV-2",COVID
478,SARS-CoV2 INFECTION,"February 08, 2021",5,NCT04335071,TOCILIZUMAB (TCZ),SWITZERLAND,Terminated,"University Hospital Inselspital, Berne","April 26, 2020",Interventional,"CORON-ACT - a Multicenter, Double-blind, Randomized Controlled Phase II Trial on the Efficacy and Safety of Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)",COVID
479,COVID,"February 08, 2021",600,NCT04335084,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,ProgenaBiome,"June 22, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",COVID
480,COVID,"February 08, 2021",214,NCT04335097,BIOSENSORS,NORWAY,Recruiting,Lars Wik,"April 22, 2020",Interventional,"Sensor Based Vital Signs Monitoring of Patients With Clinical Manifestation of Covid 19 Disease During Home Isolation, a Randomized Feasibility Study",COVID
481,COVID,"February 08, 2021",34,NCT04335123,LOSARTAN,UNITED STATES,Completed,University of Kansas Medical Center,"April 4, 2020",Interventional,An Open Label Phase 1 Trial of Losartan for Worsening Respiratory Illness in COVID-19,COVID
482,COVID,"February 08, 2021",200,NCT04335136,RHACE2 APN01,AUSTRIA,Completed,Apeiron Biologics,"April 30, 2020",Interventional,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,COVID
483,COVID,"February 08, 2021",100,NCT04335162,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"February 28, 2020",Observational,Cardiovascular Complications in Patients With COVID-19,COVID
484,COVID,"February 08, 2021",4000,NCT04335188,PROSPECTIVE OBERSERVATIONAL REGISTRY,GERMANY,Recruiting,IHF GmbH - Institut für Herzinfarktforschung,"April 6, 2020",Observational,"COVID-19 Registry Rhineland-Palatinate (Germany) - COVID-19 Disease Registry a National, Multicentre, Non-interventional, Prospective Observational Study",COVID
485,PATIENTS WITH COVID PNEUMONIA WILL ALLOW TO DETECT AN ABSOLUTE REDUCTION IN THE RATE OF RESPIRATORY-FAILURE,"February 08, 2021",50,NCT04335201,DEFIBROTIDE INJECTION,,Not yet recruiting,IRCCS San Raffaele,"April 6, 2020",Interventional,Use of Defibrotide to Reduce Progression of Acute Respiratory Failure Rate in Patients With COVID-19 Pneumonia,COVID
486,SCLERODERMA,"February 08, 2021",172,NCT04335279,SPIN-CHAT PROGRAM,CANADA,Completed,Lady Davis Institute,"April 9, 2020",Interventional,A Partially Nested RCT to Evaluate the Effectiveness of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together (SPIN-CHAT) Program to Reduce Anxiety Among At-Risk Scleroderma Patients,Unrelated
487,COVID,"February 08, 2021",24,NCT04335305,TOCILIZUMAB,SPAIN,Recruiting,MedSIR,"April 9, 2020",Interventional,"A Randomized, Controlled, Open-Label, Phase II Trial to Evaluate the Efficacy and Safety of Tocilizumab Combined With Pembrolizumab (MK-3475) in Patients With Coronavirus Disease 2019 (COVID-19)-Pneumonia",COVID
488,SARS-CoV2,"February 08, 2021",11,NCT04335552,STANDARD OF CARE,UNITED STATES,Terminated,Duke University,"April 17, 2020",Interventional,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",COVID
489,CARDIOVASCULAR DISEASES,"February 08, 2021",500,NCT04335630,"ELECTROCARDIOGRAM, TELEMETRY, ECHOCARDIOGRAM, LABORATORY VALUES",UNITED STATES,Recruiting,Memorial Hermann Health System,"March 30, 2020",Observational,Cardiovascular Manifestations of Hospitalized Patients With Coronavirus Disease 2019,Unrelated
490,RHEUMATOID ARTHRITIS,"February 08, 2021",333,NCT04335747,COVID-19 INFECTION,DENMARK,Recruiting,Salome Kristensen,"April 23, 2020",Observational,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Unrelated
491,PEDIATRIC RESPIRATORY DISEASES,"February 08, 2021",350,NCT04335773,,NORWAY,Recruiting,"University Hospital, Akershus","April 3, 2020",Observational [Patient Registry],"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",Respiratory
492,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",651,NCT04335786,VALSARTAN (DIOVAN),NETHERLANDS,Recruiting,Radboud University,"April 17, 2020",Interventional,"PRAETORIAN-COVID: A Double-blind, Placebo-controlled Randomized Clinical Trial With Valsartan for PRevention of Acute rEspiraTORy dIstress Syndrome in hospitAlized patieNts With SARS-COV-2 (COVID-19) Infection Disease",Respiratory
493,SOCIAL ISOLATION,"February 08, 2021",68,NCT04335851,VIDEO BASED AEROBIC EXERCISE,TURKEY,Completed,Biruni University,"April 6, 2020",Interventional,Effectiveness of Video-Based Exercises on Physical and Emotional Well-Being During COVID-19 Induced Social Isolation,Unrelated
494,CORONAVIRUS,"February 08, 2021",750,NCT04336215,NON-INTERVENTIONAL,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","April 7, 2020",Observational,"Cohort Study of SARS-CoV-2 Incidence, Transmission, and Disease Severity in Healthcare Workers",COVID
495,COVID,"February 08, 2021",20,NCT04336254,ALLOGENEIC HUMAN DENTAL PULP STEM CELLS (BSH BTC & UTOOTH BTC),CHINA,Recruiting,Renmin Hospital of Wuhan University,"April 6, 2020",Interventional,"Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe Pneumonia of COVID-19：a Single-center, Prospective, Randomised Clinical Trial",COVID
496,SARS-CoV2,"February 08, 2021",160,NCT04336332,HYDROXYCHLOROQUINE SULFATE + AZITHROMYCIN,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","April 1, 2020",Interventional,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,COVID
497,CORONAVIRUS INFECTION,"February 08, 2021",150,NCT04336345,,MEXICO,Completed,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"April 1, 2020",Observational [Patient Registry],Outcomes of Patients With COVID-19 in the Intensive Care Unit: A National Observational Study (Mexico COVID-19 ICU Study),COVID
498,CONGENITAL HEART DISEASE,"February 08, 2021",5000,NCT04336384,,FRANCE,Completed,"University Hospital, Montpellier","March 1, 2020",Observational,Impact of Covid-19 in Congenital Heart Disease - COVID-CHD,Unrelated
499,CORONAVIRUS INFECTION,"February 08, 2021",120,NCT04336410,INO-4800,UNITED STATES,"Active, not recruiting",Inovio Pharmaceuticals,"April 3, 2020",Interventional,"Phase 1 Open-label Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers",COVID
500,COVID,"February 08, 2021",100,NCT04336462,OXYHYDROGEN,CHINA,Recruiting,Shanghai Asclepius Meditec Inc.,"February 15, 2020",Interventional,"A Multi-center, Randomized, Parallel-Controlled Clinical Trial of the Application of A Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19",COVID
501,COVID,"February 08, 2021",100,NCT04336657,QUESTIONNAIRE,EGYPT,Recruiting,Assiut University,April 2020,Observational,COVID-19-Like Illness: Did we Have Unusual Severe Respiratory Tract Infections October-December 2019 Before WHO Announcement ?,COVID
502,SARS-CoV2,"February 08, 2021",440,NCT04336748,HYDROXYCHLOROQUINE,,Not yet recruiting,Medical University of Vienna,April 2020,Interventional,"Low-dose Hydroxychloroquine for Primary Prophylaxis Against SARS-CoV-2 in Health-care Workers - a Randomized, Double-blind, Controlled Trial",COVID
503,CORONAVIRUS,"February 08, 2021",914,NCT04336761,NASOPHARYNGEAL SWAB,FRANCE,Recruiting,"University Hospital, Lille","April 15, 2020",Observational,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,COVID
504,COVID,"February 08, 2021",0,NCT04336774,CAPTION AI,UNITED STATES,Withdrawn,Duke University,July 2020,Interventional,Use of Caption AI to Perform a Clinically Indicated Transthoracic Echocardiogram in Patients Being Evaluated for or Positive for COVID-19,COVID
505,COVID,"February 08, 2021",100,NCT04336787,SURVEY,TURKEY,Not yet recruiting,Istanbul Kültür University,"April 12, 2020",Observational,"Determination Of Physical Activity, Sleep And Stress Level Of Pregnant Women In The Covıd-19 Quarantine Period",COVID
506,COVID,"February 08, 2021",100,NCT04336904,FAVIPIRAVIR,ITALY,"Active, not recruiting",Giuliano Rizzardini,"March 25, 2020",Interventional,"A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Patients With COVID-19-Moderate Type",COVID
507,COVID,"February 08, 2021",250,NCT04336956,HOSPITALIZED CHILDREN WITH COVID19,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"April 7, 2020",Observational [Patient Registry],Covid-19 Pediatric Observatory,COVID
508,COVID,"February 08, 2021",50,NCT04337008,BLOOD DRAW,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"April 3, 2020",Interventional,Renin Angiotensin System - CoronaVirus,COVID
509,"STRESS, PSYCHOLOGICAL","February 08, 2021",2000,NCT04337047,QUESTIONNAIRE ASSESMENT,FRANCE,Completed,Wefight,"March 31, 2020",Observational,Distress During the COVID-19 Pandemic in France: a National Assessment of At-risk Populations,Unrelated
510,MAGEC ROD,"February 08, 2021",100,NCT04337151,MAGEC SPINE ROD,UNITED KINGDOM,Recruiting,Royal National Orthopaedic Hospital NHS Trust,April 2020,Observational,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,Unrelated
511,COVID,"February 08, 2021",100,NCT04337190,BLOOD SAMPLING,FRANCE,Recruiting,"University Hospital, Angers","April 3, 2020",Observational,Impact of Previous Treatment With Angiotensin II Receptor Blockers in Patients With SARS-Cov2 Infection Admitted to the Intensive Care Unit on Survival and Severity of the Disease (COVID-ARA2),COVID
512,COVID,"February 08, 2021",40,NCT04337320,NEWBORNS FROM COVID 19 POSITIVE MOTHERS,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 15, 2020",Observational,Maternal And Neonatal Outcome of Pregnant Patients With COVID-19,COVID
513,ENDOMETRIOSIS,"February 08, 2021",80,NCT04337346,,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"April 5, 2020",Observational [Patient Registry],Endometriosis Patients Covid 19 Anxiety,Unrelated
514,SEVERE/VERY SEVERE COVID ILLNESS,"February 08, 2021",,NCT04337359,RUXOLITINIB,,No longer available,Novartis Pharmaceuticals,,Expanded Access,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,COVID
515,SARS-CoV2,"February 08, 2021",627,NCT04337424,SAMPLING SALIVARY,FRANCE,Completed,"University Hospital, Montpellier","April 13, 2020",Observational,Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2,COVID
516,CORONAVIRUS,"February 08, 2021",200,NCT04337489,SENSIUMVITALS WEARABLE SENSOR,,Not yet recruiting,Imperial College London,"July 28, 2020",Observational,REmote MOniToring usE in Suspected Cases of COVID-19 (Coronavirus): REMOTE-COVID Trial,COVID
517,CORONAVIRUS,"February 08, 2021",300,NCT04337502,MACHINE LEARNING MODEL,CHINA,Completed,Maastricht University,"December 23, 2019",Observational,A Clinical and Radiological Model to Predict the Prognosis for COVID-19 Patients,COVID
518,COVID,"February 08, 2021",6000,NCT04337541,SURGICAL FACIAL MASK,DENMARK,Completed,"Rigshospitalet, Denmark","April 2, 2020",Interventional,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,COVID
519,COVID,"February 08, 2021",100000,NCT04337762,,UNITED STATES,Recruiting,Beat COVID LLC,"April 6, 2020",Observational,A Virtual Observational Protocol to Gain Longitudinal Data in Participants to Help Understand COVID-19 Spread and Disease Progression,COVID
520,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04337788,TELEHEALTH APPLICATIONS,,Not yet recruiting,"University Hospital, Limoges",May 2020,Interventional,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With Symptoms of Confirmed or Probable COVID-19 Disease,COVID
521,CORONAVIRUS INFECTION,"February 08, 2021",143,NCT04337918,NORS (NITRIC OXIDE RELEASING SOLUTION),CANADA,"Active, not recruiting",Sanotize Research and Development corp.,"May 8, 2020",Interventional,"Multi-Center, Randomized, Controlled, Phase II Clinical Efficacy Study Evaluating Nitric Oxide Releasing Solution Treatment for the Prevention and Treatment of COVID-19 in Healthcare Workers and Individuals at Risk of Infection",COVID
522,CORONAVIRUS,"February 08, 2021",200,NCT04337983,TRANSPULMONARY THERMODILUTION,FRANCE,Recruiting,Bicetre Hospital,"March 13, 2020",Observational,Hemodynamic Characteristics of Patients With SARS-CoV-2: PiCCOVID Study,COVID
523,COVID,"February 08, 2021",8,NCT04337996,COVID-19 DIAGNOSTIC TEST,FRANCE,Completed,Tourcoing Hospital,"July 13, 2020",Interventional,Dynamic Evaluation of COVID-19 Diagnostic Tests,COVID
524,COVID,"February 08, 2021",152,NCT04338009,DISCONTINUATION OF ARB/ACEI,UNITED STATES,Enrolling by invitation,University of Pennsylvania,"March 31, 2020",Interventional,The Randomized Elimination or Prolongation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Coronavirus Disease 2019,COVID
525,COVID,"February 08, 2021",100,NCT04338074,TRANEXAMIC ACID TABLETS,UNITED STATES,Recruiting,University of Alabama at Birmingham,"June 1, 2020",Interventional,Exploratory Studies of the Effect of Tranexamic Acid Treatment on the Progression of COVID19 in Outpatients,COVID
526,COVID,"February 08, 2021",300,NCT04338100,FOLLOW-UP AT 14 DAYS,,Not yet recruiting,"University Hospital, Angers","April 6, 2020",Observational,Point Of Care UltraSonography to Perform Risk-stratification of Patients With Suspected or Confirmed COVID-19 - POCUSCO Study,COVID
527,COVID,"February 08, 2021",60,NCT04338126,TRANEXAMIC ACID,UNITED STATES,Not yet recruiting,University of Alabama at Birmingham,"September 30, 2021",Interventional,Exploratory Studies of the Effect of Tranexamic Acid Treatment on the Progression of COVID19 in Inpatients,COVID
528,COVID,"February 08, 2021",,NCT04338347,CAP-1002 ALLOGENEIC CARDIOSPHERE-DERIVED CELLS,UNITED STATES,No longer available,Capricor Inc.,,Expanded Access,CAP-1002 Treatment in Patients With Severe COVID-19 and in Critical Condition as Indicated by Life Support Measurements,COVID
529,COVID,"February 08, 2021",,NCT04338360,COVID-19 CONVALESCENT PLASMA,UNITED STATES,Approved for marketing,Mayo Clinic,,Expanded Access,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,COVID
530,COVID PNEUMONIA,"February 08, 2021",50,NCT04338568,LUNG ULTRASOUND,BELGIUM,Recruiting,Hasselt University,"April 16, 2020",Interventional,Accuracy and Inter-observer Variability of Lung Ultrasound in COVID-19 Pneumonia,COVID
531,"EMERGENCY SERVICE, HOSPITAL","February 08, 2021",10000,NCT04338672,COVID-19 PANDEMIC,ISRAEL,Recruiting,Sheba Medical Center,"April 5, 2020",Observational,The Impact of the Coronavirus Disease 2019 (Covid-19) Outbreak on Emergency Room Attendances of Surgical Patients at a Tertiary Medical Center,Unrelated
532,COVID,"February 08, 2021",500,NCT04338698,HYDROXYCHLOROQUINE,PAKISTAN,Recruiting,Shehnoor Azhar,"April 22, 2020",Interventional,Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment,COVID
533,COVID,"February 08, 2021",96,NCT04338802,NINTEDANIB 150 MG,,Not yet recruiting,Huilan Zhang,"April 2, 2020",Interventional,"Efficacy and Safety of Nintedanib Ethanesulfonate Soft Capsule in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID-9(COVID 19) : a Single-center, Randomized, Placebo-controlled Study",COVID
534,COVID,"February 08, 2021",260,NCT04338828,NITRIC OXIDE GAS,UNITED STATES,Recruiting,Massachusetts General Hospital,"April 18, 2020",Interventional,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the Emergency Department,COVID
535,CORONAVIRUS INFECTION,"February 08, 2021",3133,NCT04338841,HOME-COV RULE IMPLEMENTATION,BELGIUM,Completed,"University Hospital, Angers","April 9, 2020",Interventional,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With Confirmed or Probable SARS-CoV-2 Infection. A Before and After Implementation of a Consensus Help-decision Making Rule Study,COVID
536,COVID,"February 08, 2021",0,NCT04338906,CAMOSTAT MESILATE,,Withdrawn,"Heinrich-Heine University, Duesseldorf",May 2020,Interventional,Evaluation of the Efficacy and Safety of Camostat Mesilate + Hydroxychloroquine Combination Therapy in Hospitalized Patients With Moderate COVID-19 Infection,COVID
537,COVID,"February 08, 2021",12,NCT04338932,,BELGIUM,Completed,Jessa Hospital,"April 17, 2020",Observational,COVID-19 and Deep Venous Thrombosis: a Cross-sectional Study,COVID
538,COVID,"February 08, 2021",800,NCT04338945,COVID-SURGRES QUESTIONAIRE,ITALY,Completed,Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia,"March 15, 2020",Observational,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy: an Italian Polispecialistic Society of Young Surgeons (S.P.I.G.C.) Survey,COVID
539,COVID,"February 08, 2021",200,NCT04338958,RUXOLITINIB,GERMANY,Recruiting,University of Jena,"April 22, 2020",Interventional,A Phase-II Clinical Trial for First Line Treatment of Stage II/III Covid-19 Patients to Treat Hyperinflammation,COVID
540,CHARACTERISTICS DISEASES,"February 08, 2021",200,NCT04339322,FOLLOW UP,,Not yet recruiting,Assiut University,"May 1, 2020",Observational,Characteristics and Outcome of COVID-19 Among Egyptian Patients,Unrelated
541,CORONAVIRUS,"February 08, 2021",1326,NCT04339387,,UNITED STATES,Completed,Brigham and Women's Hospital,"March 1, 2020",Observational,COVID-19 Risk Stratification,COVID
542,COVID,"February 08, 2021",25,NCT04339426,ATOVAQUONE/AZITHROMYCIN,UNITED STATES,Recruiting,HonorHealth Research Institute,"April 20, 2020",Interventional,"Open-Label, Non-Randomized Study to Evaluate Anti-Malarial/Anti-Infective Combination Therapies in Patients With Confirmed COVID-19 Infection",COVID
543,COVID,"February 08, 2021",10000,NCT04339608,,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 2, 2020",Observational,"A Prospective, Longitudinal, Observational Study of Healthcare Workers and the General Population to Watch for Flu-like Symptoms in Suspicion of COVID 19",COVID
544,COVID,"February 08, 2021",12123,NCT04339634,SIMULATION OF REPURPOSED DRUGS FOR COVID-19,UNITED STATES,"Active, not recruiting",Tabula Rasa HealthCare,"April 7, 2020",Observational,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,COVID
545,COVID,"February 08, 2021",30,NCT04339660,UC-MSCS,CHINA,Recruiting,Puren Hospital Affiliated to Wuhan University of Science and Technology,"February 1, 2020",Interventional,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,COVID
546,THE GOLD STANDARD FOR CURRENT SARS COV2 DETECTION IS RT-PCR,"February 08, 2021",56000,NCT04339686,THORACIC CT SCAN,FRANCE,Recruiting,Poitiers University Hospital,"April 20, 2020",Observational,Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. Comparison to Virological Testing and Multiparametric Gold Standard,Respiratory
547,COVID,"February 08, 2021",102,NCT04339712,ANAKINRA,GREECE,Completed,Hellenic Institute for the Study of Sepsis,"April 2, 2020",Interventional,Efficiency in Management of Organ Dysfunction Associated With Infection by the Novel SARS-CoV-2 Virus (COVID-19) Through a Personalized Immunotherapy Approach: the ESCAPE Clinical Trial,COVID
548,HEALTHY VOLUNTEER,"February 08, 2021",10000,NCT04339790,,UNITED STATES,"Active, not recruiting",National Institute of Mental Health (NIMH),"April 7, 2020",Observational,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,Unrelated
549,COVID,"February 08, 2021",3,NCT04339816,AZITHROMYCIN,CZECHIA,Terminated,"Frantisek Duska, MD, PhD","May 13, 2020",Interventional,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care Due to Coronavirus Disease 2019 (COVID-19)- Randomised Controlled Trial,COVID
550,HEALTH BEHAVIOR,"February 08, 2021",673,NCT04339842,ASSESSMENT OF DIETARY CHANGES IN ADULTS IN THE QUARANTINE,CYPRUS,Completed,Eliz Arter,"April 10, 2020",Observational,Eating Habits of Adults During the Quarantine,Unrelated
551,SARS-CoV2,"February 08, 2021",2523,NCT04339881,,FRANCE,Completed,Assistance Publique - Hôpitaux de Paris,"April 17, 2020",Observational [Patient Registry],NOsocomial Dissemination Risk of SARS-Cov2,COVID
552,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04339998,POINT-OF-CARE ULTRASONOGRAPHY (POCUS),UNITED STATES,Recruiting,University of Minnesota,"April 15, 2020",Observational,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),COVID
553,CORONAVIRUS,"February 08, 2021",10,NCT04340050,ANTI-SARS-COV-2 CONVALESCENT PLASMA,UNITED STATES,Completed,University of Chicago,"April 10, 2020",Interventional,Pilot Study for Use of Convalescent Plasma Collected From Patients Recovered From COVID-19 Disease for Transfusion as an Empiric Treatment During the 2020 Pandemic at the University of Chicago Medical Center,COVID
554,CANCER,"February 08, 2021",394,NCT04340219,SURVEY ADMINISTRATION,BELGIUM,Completed,"University Hospital, Ghent","March 30, 2020",Observational,"A Prospective Cohort Study Investigating Oncology-patient-reported Anxiety, Mood, and Quality of Life During the COVID-19 Pandemic (ONCOVID Trial)",Unrelated
555,COVID,"February 08, 2021",80,NCT04340232,BARICITINIB,UNITED STATES,Not yet recruiting,"University of Colorado, Denver",November 2020,Interventional,Safety and Efficacy of Baricitinib for COVID-19,COVID
556,HYDROXYCHLOROQUINE,"February 08, 2021",280,NCT04340349,HYDROXYCHLOROQUINE SULFATE,MEXICO,Enrolling by invitation,Instituto Nacional de Rehabilitacion,"May 11, 2020",Interventional,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE Trial),Unrelated
557,COVID,"February 08, 2021",10,NCT04340414,LOW FLOW ECMO DRIVING BY CVVH MACHINE,CHINA,Recruiting,Peking Union Medical College Hospital,"February 20, 2020",Interventional,Safety and Effectiveness Study of Low Flow Extracorporeal Membrane Oxygenation（CO2 Removal） Driving by Continuous Hemofiltration Machine the Severe New Corovirus Pneumonia (NCP),COVID
558,"PNEUMONIA, VIRAL","February 08, 2021",1003,NCT04340466,NO INTERVENTION,FRANCE,Completed,Centre Hospitalier Universitaire de Nīmes,"April 3, 2020",Observational [Patient Registry],French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management: the FRENCH CORONA Study,Respiratory
559,COVID,"February 08, 2021",20,NCT04340479,ULTRASOUND LUNG IMAGING AS PART OF FAST+ EVALUATION,UNITED STATES,Recruiting,"University of Colorado, Denver","July 30, 2020",Observational [Patient Registry],The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,COVID
560,COVID,"February 08, 2021",17,NCT04340544,HYDROXYCHLOROQUINE,GERMANY,Terminated,University Hospital Tuebingen,"April 22, 2020",Interventional,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,COVID
561,SARS-COV INFECTION,"February 08, 2021",200,NCT04340557,LOSARTAN,UNITED STATES,Recruiting,Sharp HealthCare,"March 27, 2020",Interventional,Randomized Open Label Study of Standard of Care Plus an Angiotensin II Receptor Blocker Compared to Standard of Care Alone to Minimize the Progression to Respiratory Failure in SARS-CoV-2 Infection,Respiratory
562,CARDIOVASCULAR DISEASE ACUTE,"February 08, 2021",140,NCT04340921,COVID-19 EXPOSURE,UNITED KINGDOM,Recruiting,Barts & The London NHS Trust,"May 14, 2020",Observational,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Unrelated
563,LIVER DISEASES,"February 08, 2021",120,NCT04341012,COLLECTION OF BREATH SAMPLE,UNITED STATES,Recruiting,Mayo Clinic,"September 10, 2019",Observational,Development of a Breath Analysis Test for Disease Diagnosis and Prognosis,Unrelated
564,COVID,"February 08, 2021",84,NCT04341038,TACROLIMUS,SPAIN,Recruiting,Hospital Universitari de Bellvitge,"April 1, 2020",Interventional,Open Randomized Single Centre Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With Severe Lung Injury Secondary to COVID-19,COVID
565,SOLID ORGAN TRANSPLANT REJECTION,"February 08, 2021",500,NCT04341103,,,Not yet recruiting,CareDx,"April 1, 2020",Observational,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,Unrelated
566,CORONAVIRUS DISEASE 2019 COVID,"February 08, 2021",384,NCT04341116,TJ003234,UNITED STATES,Recruiting,I-Mab Biopharma Co. Ltd.,"April 11, 2020",Interventional,"A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)",COVID
567,COV2 POSITIVE CAREGIVERS,"February 08, 2021",550,NCT04341142,SEROLOGICAL TESTS WILL BE APPLIED ON PATIENTS BLOOD SAMPLING,FRANCE,Recruiting,Hospices Civils de Lyon,"April 9, 2020",Interventional,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Unrelated
568,COVID,"February 08, 2021",160,NCT04341168,THIS STUDY IS NON- INTERVENTIONAL,GERMANY,Not yet recruiting,University Hospital of Cologne,April 2020,Observational,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",COVID
569,CANCER & COVID,"February 08, 2021",1000,NCT04341207,HYDROXYCHLOROQUINE,FRANCE,Recruiting,"Gustave Roussy, Cancer Campus, Grand Paris","April 3, 2020",Interventional,COVID 19 - Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease Upon Hydroxychloroquine and Azithromycin Therapy in French Cancer Patients,COVID
570,"ARDS, HUMAN","February 08, 2021",200,NCT04341285,ECMO IMPLANTATION,GERMANY,Not yet recruiting,University Hospital Tuebingen,"August 1, 2020",Interventional,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Unrelated
571,COVID,"February 08, 2021",508,NCT04341389,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR),CHINA,"Active, not recruiting","Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China","April 12, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of the Recombinant Novel Coronavirus Vaccine (Adenovirus Vector) in Healthy Adults Aged Above 18 Years",COVID
572,COVID,"February 08, 2021",60,NCT04341415,AURICULAR NEUROMODULATION,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"April 9, 2020",Interventional,Randomized Double Blinded Monocentric Clinical Trial to Assess the Impact of Auricular Vagus Nerve Neuromodulation in COVID-19 Positive Inpatients Outcome.,COVID
573,COVID,"February 08, 2021",624,NCT04341441,HYDROXYCHLOROQUINE - DAILY DOSING,UNITED STATES,Terminated,Henry Ford Health System,"April 7, 2020",Interventional,Will Hydroxychloroquine Impede or Prevent COVID-19: WHIP COVID-19 Study,COVID
574,GYNECOLOGICAL CANCER,"February 08, 2021",305,NCT04341480,CHEMOTHERAPY,CHINA,"Active, not recruiting",Tongji Hospital,"July 1, 2020",Observational,"The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19, a Prospective Cohort Study",Unrelated
575,CORONAVIRUS INFECTION,"February 08, 2021",86,NCT04341493,NITAZOXANIDE 500 MG,MEXICO,Recruiting,Hugo Mendieta Zeron,"April 6, 2020",Interventional,Treatment With Hydroxychloroquine vs Nitazoxanide + Hydroxychloroquine in Patients With COVID-19 With Risk Factors for Poor Outcome,COVID
576,COVID,"February 08, 2021",100,NCT04341506,NON-CONTACT ECG,UNITED STATES,Recruiting,Northwestern Medicine,"September 8, 2020",Observational,Evaluating Non-contact ECG Sensor System for Early Detection of COVID19,COVID
577,CORONAVIRUS INFECTION,"February 08, 2021",1464,NCT04341519,PTSD,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 6, 2020",Observational,"""Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers"" ""Impact Psychologique de l'épidémie COVID-19 Chez Les Patients, Familles et Soignants de Reanimation"" ""BURDENCOV""",COVID
578,CORONAVIRUS INFECTION,"February 08, 2021",161,NCT04341584,ANAKINRA,FRANCE,Completed,Assistance Publique - Hôpitaux de Paris,"April 8, 2020",Interventional,"CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection, Nested In The CORIMUNO-19",COVID
579,RESPIRATORY TRACT DISEASES,"February 08, 2021",0,NCT04341610,STEM CELL PRODUCT,DENMARK,Withdrawn,"Rigshospitalet, Denmark","April 20, 2020",Interventional,"Allogeneic Adipose Tissue Derived Mesenchymal Stromal Cell Therapy for Treating Patients With Severe Respiratory COVID-19. A Danish, Double-blind, Randomized Placebo-controlled Study",Respiratory
580,COVID,"February 08, 2021",30,NCT04341675,SIROLIMUS,UNITED STATES,Recruiting,University of Cincinnati,"April 24, 2020",Interventional,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia (The SCOPE Trial),COVID
581,COVID,"February 08, 2021",50,NCT04341688,GARGLE/MOUTHWASH,,Not yet recruiting,Aga Khan University,"February 1, 2021",Interventional,"A Double Blind, Randomized Controlled Pilot Trial of Gargling Agents in Reducing Intraoral Viral Load Among Laboratory Confirmed COVID-19 Patients: GARGLES STUDY",COVID
582,"EFFICACY, SELF","February 08, 2021",450,NCT04341714,SATISFACTION EVALUATION,FRANCE,Recruiting,Pierre and Marie Curie University,"March 16, 2020",Observational,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Unrelated
583,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04341727,HYDROXYCHLOROQUINE SULFATE,UNITED STATES,Suspended,Washington University School of Medicine,"April 4, 2020",Interventional,"WU 352: Open-label, Randomized Controlled Trial of Hydroxychloroquine Alone or Hydroxychloroquine Plus Azithromycin or Chloroquine Alone or Chloroquine Plus Azithromycin in the Treatment of SARS CoV-2 Infection",COVID
584,"PNEUMONIA, VIRAL","February 08, 2021",106,NCT04341766,NO SPECIAL INTERVENTION,FRANCE,Completed,Centre Hospitalier Intercommunal Creteil,"March 31, 2020",Observational [Patient Registry],Prospective Descriptive Study on the Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid19,Respiratory
585,INFECTION VIRAL,"February 08, 2021",1000,NCT04341792,,FRANCE,Recruiting,"University Hospital, Lille","April 11, 2020",Observational,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient Admitted to Emergency Departments During an Epidemic,Unrelated
586,COVID,"February 08, 2021",27,NCT04341870,SARILUMAB,FRANCE,Suspended,Assistance Publique - Hôpitaux de Paris,"April 11, 2020",Interventional,"Efficacy of Sarilumab + Azithromycin + Hydroxychloroquine, and Sarilumab Alone, for Adult Patients Hospitalized With Moderate to Severe COVID-19: a Multicenter Open-label 1:1 Randomized Controlled Trial",COVID
587,DYSFUNCTIONAL WORRY,"February 08, 2021",670,NCT04341922,INTERNET-DELIVERED COGNITIVE BEHAVIOR THERAPY (ICBT) FOR DYSFUNCTIONAL WORRY RELATED TO THE COVID-19 PANDEMIC,SWEDEN,"Active, not recruiting",Karolinska Institutet,"May 9, 2020",Interventional,Evaluation of a Brief Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic: A Randomized Controlled Trial,Unrelated
588,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04341935,LINAGLIPTIN,UNITED STATES,Not yet recruiting,University of Miami,"June 30, 2021",Interventional,Effects of DPP4 Inhibition on COVID-19 Patients With Type 2 Diabetes,COVID
589,RESPIRATORY FAILURE,"February 08, 2021",100,NCT04342104,MONITORING FOR AGGRAVATION,SPAIN,Recruiting,Hospital General Universitario Morales Meseguer,"April 1, 2020",Observational,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Respiratory
590,CORONAVIRUS INFECTION,"February 08, 2021",0,NCT04342156,HYDROXYCHLOROQUINE SULFATE 200 MILLIGRAM (MG) TAB,,Withdrawn,Tan Tock Seng Hospital,April 2020,Interventional,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19- A Cluster Randomized Controlled Trial (SHARP COVID-19 RCT),COVID
591,CORONAVIRUS INFECTION,"February 08, 2021",400,NCT04342169,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,University of Utah,"April 4, 2020",Interventional,Hydroxychloroquine for Outpatients With Confirmed COVID-19,COVID
592,COVID,"February 08, 2021",426,NCT04342182,CONVALESCENT PLASMA,NETHERLANDS,"Active, not recruiting",Erasmus Medical Center,"April 8, 2020",Interventional,Convalescent Plasma Therapy From Recovered Covid-19 Patients as Therapy for Hospitalized Patients With Covid-19,COVID
593,COVID,"February 08, 2021",50,NCT04342195,BLOOD DRAW,UNITED STATES,Recruiting,Columbia University,"March 25, 2020",Observational,Acquiring Convalescent Specimens to Isolate and Identify Potent Monoclonal Antibodies Against COVID-19,COVID
594,MUSCULOSKELETAL PAIN,"February 08, 2021",500,NCT04342208,,,Not yet recruiting,Istanbul University-Cerrahpasa,"April 10, 2020",Observational,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,Unrelated
595,"COVID, HYDROXYCHLOROQUINE SULFATE","February 08, 2021",220,NCT04342221,HYDROXYCHLOROQUINE SULFATE,GERMANY,Recruiting,University Hospital Tuebingen,"March 29, 2020",Interventional,Randomized Controlled Trial of Hydroxychloroquine Versus Placebo for the Treatment of Adult Patients With Acute Coronavirus Disease 2019 - COVID-19,COVID
596,COVID,"February 08, 2021",163,NCT04342637,PRACTICE DETAILS,EGYPT,Completed,Al-Azhar University,"April 10, 2020",Observational,Gastrointestinal Endoscopy in the Era of COVID-19: a Multinational Survey,COVID
597,COVID,"February 08, 2021",152,NCT04342650,CHLOROQUINE DIPHOSPHATE,BRAZIL,Completed,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,"April 8, 2020",Interventional,"Phase IIb Study to Evaluate the Efficacy and Safety of Chloroquine Diphosphate in the Treatment of Patients With Comorbidities, Without Severe Acute Respiratory Syndrome, Under the New Coronavirus (SARS-CoV2): a Double-blind, Randomized, Placebo-controlled Clinical Trial",COVID
598,COVID,"February 08, 2021",152,NCT04342663,FLUVOXAMINE,UNITED STATES,Completed,Washington University School of Medicine,"April 10, 2020",Interventional,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",COVID
599,COVID,"February 08, 2021",1500,NCT04342689,DIETARY SUPPLEMENT CONTAINING RESISTANT STARCH,UNITED STATES,Recruiting,Yale University,"June 3, 2020",Interventional,The Role of Resistant Starch in COVID-19 Infection,COVID
600,FOLLOW-UP,"February 08, 2021",504,NCT04342702,,CHINA,"Active, not recruiting",Second Affiliated Hospital of Wenzhou Medical University,"March 16, 2020",Observational,A Study on the Prospective Cohort Library of Novel Coronavirus Pneumonia in Southeran,Unrelated
601,COVID,"February 08, 2021",520,NCT04342728,ASCORBIC ACID,UNITED STATES,Enrolling by invitation,The Cleveland Clinic,"April 8, 2020",Interventional,"Coronavirus Disease 2019- Using Ascorbic Acid and Zinc Supplementation (COVIDAtoZ) Research Study A Randomized, Open Label Single Center Study",COVID
602,HEALTH CARE WORKER (HCW),"February 08, 2021",100000,NCT04342806,,UNITED STATES,Recruiting,Duke University,"April 10, 2020",Observational [Patient Registry],Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study,Unrelated
603,CORONAVIRUS,"February 08, 2021",150000,NCT04342884,,UNITED STATES,Recruiting,Wake Forest University Health Sciences,"April 8, 2020",Observational,"A Multicenter, Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records",COVID
604,COVID,"February 08, 2021",95,NCT04342897,LY3127804,UNITED STATES,Terminated,Eli Lilly and Company,"April 20, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19",COVID
605,COVID,"February 08, 2021",0,NCT04343001,ASPIRIN,NIGERIA,Withdrawn,London School of Hygiene and Tropical Medicine,October 2020,Interventional,"Aspirin, Losartan and Simvastatin in Hospitalised COVID-19 Patients: a Multinational Randomised Open-label Factorial Trial",COVID
606,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",54,NCT04343053,SARS-COV-2 INFECTION,ITALY,"Active, not recruiting",University Hospital of Ferrara,"April 8, 2020",Interventional,"Patterns and Changes in Platelet Reactivity, Thrombotic Status and Endothelial Function in Hospitalized Patients With SARS-Cov-2 Infection",COVID
607,COVID,"February 08, 2021",16,NCT04343092,IVERMECTIN (IVM),IRAQ,Completed,University of Baghdad,"April 18, 2020",Interventional,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (An Externally Controlled Pilot Trial),COVID
608,COVID- INFECTION WITH SARS-CoV2 VIRUS,"February 08, 2021",92,NCT04343144,NIVOLUMAB INJECTION,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 15, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients CORIMUNO-19-Nivolumab Trial,COVID
609,COVID,"February 08, 2021",48,NCT04343183,HYPERBARIC OXYGEN THERAPY,UNITED STATES,Not yet recruiting,Ochsner Health System,April 2020,Interventional,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,COVID
610,COVID,"February 08, 2021",800,NCT04343248,NITAZOXANIDE,UNITED STATES,Recruiting,Romark Laboratories L.C.,"May 12, 2020",Interventional,"A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)",COVID
611,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2),"February 08, 2021",48,NCT04343261,CONVALESCENT PLASMA,UNITED STATES,Completed,Saint Francis Care,"April 10, 2020",Interventional,Convalescent Plasma in the Treatment of COVID 19,COVID
612,"ADDICTION, SUBSTANCE","February 08, 2021",100,NCT04343339,,FRANCE,Completed,"University Hospital, Montpellier","April 8, 2020",Observational,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment - EPILOGUE,Unrelated
613,RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",100,NCT04343404,,FRANCE,Completed,"University Hospital, Strasbourg, France","April 1, 2020",Observational,STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19,Respiratory
614,CORONAVIRUS DISEASE 2019,"February 08, 2021",86,NCT04343651,PLACEBOS,UNITED STATES,"Active, not recruiting","CytoDyn, Inc.","April 1, 2020",Interventional,"A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate Coronavirus Disease 2019 (COVID-19)",COVID
615,MENTAL STRESS,"February 08, 2021",10000,NCT04343664,,INDONESIA,Not yet recruiting,Tjhin Wiguna,"August 1, 2020",Observational [Patient Registry],Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Unrelated
616,COVID,"February 08, 2021",0,NCT04343690,CRISIS MANAGEMENT COACHING,UNITED STATES,Withdrawn,Duke University,"March 27, 2020",Interventional,Effectiveness of Crisis Management Coaching on Faculty and Trainee Wellness During COVID-19 Crisis,COVID
617,SARS-COV INFECTION,"February 08, 2021",416,NCT04343729,METHYLPREDNISOLONE SODIUM SUCCINATE,BRAZIL,"Active, not recruiting",Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,"April 18, 2020",Interventional,"Efficacy of Injectable Methylprednisolone Sodium Succinate in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome Under the New Coronavirus (SARS-CoV2): a Phase IIb, Randomized, Double-blind, Placebo-controlled, Clinical Trial.",Respiratory
618,COVID,"February 08, 2021",20,NCT04343742,CHLORINE DIOXIDE 3000 PPM,COLOMBIA,Recruiting,Genesis Foundation,"April 1, 2020",Observational,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,COVID
619,COVID,"February 08, 2021",52,NCT04343755,CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",Hackensack Meridian Health,"April 9, 2020",Interventional,Phase IIa Study Exploring the Safety and Efficacy of Convalescent Plasma From Recovered COVID-19 Donors Collected by Plasmapheresis as Treatment for Hospitalized Subjects With COVID-19 Infection,COVID
620,COVID,"February 08, 2021",60,NCT04343768,HYDROXYCHLOROQUINE,"IRAN, ISLAMIC REPUBLIC OF",Completed,Shahid Beheshti University of Medical Sciences,"April 9, 2020",Interventional,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",COVID
621,SARS-CoV2,"February 08, 2021",353,NCT04343781,OBSERVATION,FRANCE,Completed,"University Hospital, Angers","March 22, 2020",Observational,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,COVID
622,COVID,"February 08, 2021",200,NCT04343794,BIOVITALS,HONG KONG,Recruiting,The University of Hong Kong,"April 1, 2020",Interventional,Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,COVID
623,CORONAVIRUS INFECTION,"February 08, 2021",5220,NCT04343898,NO INTERVENTION,UNITED STATES,"Active, not recruiting",Brigham and Women's Hospital,"April 1, 2020",Observational,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,COVID
624,COVID,"February 08, 2021",436,NCT04343963,PYRIDOSTIGMINE BROMIDE,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"April 4, 2020",Interventional,Pyridostigmine in Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2 Infection,COVID
625,COVID,"February 08, 2021",20,NCT04343976,PEGYLATED INTERFERON LAMBDA,UNITED STATES,Enrolling by invitation,Raymond Chung,"June 22, 2020",Interventional,A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Pegylated Interferon Lambda vs. Placebo in Subjects Infected With COVID-19,COVID
626,COVID,"February 08, 2021",90,NCT04343989,CLAZAKIZUMAB 25 MG,UNITED STATES,"Active, not recruiting",NYU Langone Health,"March 31, 2020",Interventional,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,COVID
627,COVID,"February 08, 2021",200,NCT04344002,,SPAIN,Recruiting,Spanish Lung Cancer Group,"April 21, 2020",Observational [Patient Registry],Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease,COVID
628,COVID,"February 08, 2021",2000,NCT04344015,PLASMA DONATION,UNITED STATES,Recruiting,Thomas Jefferson University,"April 13, 2020",Interventional,Collection of COVID-19 Convalescent Plasma,COVID
629,CORONAVIRUS,"February 08, 2021",260,NCT04344041,"CHOLECALCIFEROL 200,000 IU",FRANCE,Recruiting,"University Hospital, Angers","April 15, 2020",Interventional,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),COVID
630,COVID,"February 08, 2021",24,NCT04344080,CYTOSORB-THERAPY,GERMANY,Recruiting,Universitätsklinikum Hamburg-Eppendorf,"April 1, 2020",Interventional,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,COVID
631,CORONAVIRUS INFECTION,"February 08, 2021",25,NCT04344106,PRONE POSITIONING,FRANCE,Recruiting,ELHARRAR Xavier,"April 1, 2020",Interventional,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study (ProCov),COVID
632,SKIN MANIFESTATIONS,"February 08, 2021",30,NCT04344119,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"April 9, 2020",Observational,Assessment of Skin Manifestations Occuring During Covid-19 Infection With a Special Focus on Chilbains,Unrelated
633,COVID,"February 08, 2021",693,NCT04344145,,BELGIUM,Completed,Université Libre de Bruxelles,"April 16, 2020",Observational,"Burnout, Emotional Distress and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population",COVID
634,COVID,"February 08, 2021",5000,NCT04344171,,GERMANY,Recruiting,ClarData,"March 30, 2020",Observational,CovidDB: The Covid-19 Inpatient Database,COVID
635,COVID,"February 08, 2021",60,NCT04344184,L-ASCORBIC ACID,UNITED STATES,Not yet recruiting,Virginia Commonwealth University,January 2021,Interventional,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),COVID
636,SURGERY,"February 08, 2021",1200,NCT04344197,GLOBAL SURVEY,ITALY,Completed,University of Rome Tor Vergata,"April 2, 2020",Observational,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",Unrelated
637,COVID,"February 08, 2021",149,NCT04344210,TELE-INTERVENTIONS RELATED TO DIABETES MANAGEMENT AND MENTAL WELL-BEING,BRAZIL,Completed,Federal University of Rio Grande do Sul,"April 17, 2020",Interventional,Impact of Tele-Interventions During the COVID-19 Pandemic on Glycemic Control and Attitude Toward the Disease in Patients With Diabetes Mellitus - A Randomized Clinical Trial,COVID
638,COVID,"February 08, 2021",48,NCT04344236,SALINE ORAL/NASAL RINSE,UNITED STATES,Recruiting,NYU Langone Health,"April 9, 2020",Interventional,"A Phase II, Randomized, Open-label, Single-institution Study of the Effects of Povidone Iodine Oral Gargles and Nasal Rinses on Viral Load in Patients With COVID-19",COVID
639,IBD,"February 08, 2021",850,NCT04344249,,FRANCE,Recruiting,Nantes University Hospital,"April 10, 2020",Observational [Patient Registry],Prospective Multicenter Cohort of Patients With Inflammatory Bowel Disease Treated by Infliximab or Vedolizumab During COVID-19 Pandemic,Unrelated
640,VIRAL PNEUMONIA HUMAN CORONAVIRUS,"February 08, 2021",11,NCT04344288,PREDNISONE,FRANCE,Terminated,Hospices Civils de Lyon,"April 21, 2020",Interventional,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,COVID
641,INFECTION VIRAL,"February 08, 2021",2878,NCT04344327,,FRANCE,Completed,French Cardiology Society,"April 10, 2020",Observational,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,Unrelated
642,SARS-CoV2 INFECTION,"February 08, 2021",122,NCT04344379,HYDROXYCHLOROQUINE,FRANCE,Suspended,Assistance Publique - Hôpitaux de Paris,"April 17, 2020",Interventional,Randomized Multicenter Study Evaluating the Efficacy of Azithromycin and Hydroxychloroquine in the Prevention of SARS-CoV-2 Infection in the Hospital Population Exposed to Virus,COVID
643,COVID,"February 08, 2021",100,NCT04344431,HYPERBARIC OXYGEN TREATMENT (HBOT) I.E. INHALATION OF PRESSURIZED OXYGEN DELIVERED BY A HYPERBARIC CHAMBER (DRUG/DEVICE),FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"April 14, 2020",Interventional,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),COVID
644,COVID,"February 08, 2021",600,NCT04344444,HYDROXYCHLOROQUINE,UNITED STATES,"Active, not recruiting",LCMC Health,"April 13, 2020",Interventional,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease: A Randomized Clinical Trial,COVID
645,COVID,"February 08, 2021",80,NCT04344457,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,"Perseverance Research Center, LLC","April 16, 2020",Interventional,"An Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects Positive With SARS-CoV-2 With Mild Symptoms",COVID
646,VENTILATOR ASSOCIATED PNEUMONIA,"February 08, 2021",10000,NCT04344509,BACTERIAL SPECIES ISOLATED,,Not yet recruiting,Poitiers University Hospital,June 2020,Observational,Microbial Etiology of Ventilator-associated Pneumonia (VAP) in COVID-19 Infected Patients,Respiratory
647,COVID,"February 08, 2021",500,NCT04344535,CONVALESCENT PLASMA,UNITED STATES,Enrolling by invitation,Stony Brook University,"April 8, 2020",Interventional,Convalescent Plasma to Reduce Complications Associated With COVID-19 Infection: A Randomized Trial Comparing the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma vs. Standard Plasma in Hospitalized Patients With COVID- 19 Infection,COVID
648,COVID,"February 08, 2021",10,NCT04344548,ALLOGENEIC NK TRANSFER,COLOMBIA,Not yet recruiting,Universidad Nacional de Colombia,"April 13, 2020",Interventional,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,COVID
649,COVID,"February 08, 2021",70,NCT04344561,POSTURAL POSITIONING,UNITED STATES,Recruiting,Johns Hopkins University,"May 25, 2020",Interventional,UPright Incline Positioning in COVID-19 Patients for Oxygen SATuration Improvement With Hypoxemic Respiratory Failure (UPSAT),COVID
650,COVID,"February 08, 2021",560,NCT04344587,SELF-PRONE POSITION RECOMMENDATION,SPAIN,Enrolling by invitation,Boston University,"April 23, 2020",Interventional,Awake Prone Position for Early Hypoxemia in COVID-19,COVID
651,SARS-CoV2,"February 08, 2021",164,NCT04344600,PEGINTERFERON LAMBDA ALFA-1A SUBCUTANEOUS INJECTION,UNITED STATES,Recruiting,Johns Hopkins University,"May 29, 2020",Interventional,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 Infection,COVID
652,SURGERY,"February 08, 2021",905,NCT04344665,VIRTUAL CARE AND REMOTE AUTOMATED MONITORING,CANADA,"Active, not recruiting",Population Health Research Institute,"April 23, 2020",Interventional,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,Unrelated
653,ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",550,NCT04344730,DEXAMETHASONE INJECTION,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 10, 2020",Interventional,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 pneumonia_COVIDICUS,Respiratory
654,COVID PNEUMONIA,"February 08, 2021",808,NCT04344756,TINZAPARIN OR UNFRACTIONATED HEPARIN,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 20, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients CORIMUNO-COAG Trial,COVID
655,COVID PNEUMONIA,"February 08, 2021",130,NCT04344782,BEVACIZUMAB INJECTION,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 15, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients CORIMUNO-19- BEVA Trial,COVID
656,MENTAL HEALTH ISSUE,"February 08, 2021",300,NCT04344834,ONLINE QUESTIONNAIRE,,Not yet recruiting,Assiut University,May 2020,Observational,Impact of Covid-19 on Egyptian Population Mental Health,Unrelated
657,ACUTE CORONARY SYNDROME,"February 08, 2021",500,NCT04344912,DATA COLLECTION,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"March 20, 2020",Observational [Patient Registry],Impact of COVID19 Outbreak in Cardiac Patients Admitted in Intensive Care Unit : the CCU-COVID19 Study,Unrelated
658,COVID,"February 08, 2021",50,NCT04344925,AEROSOL-REDUCING MASK,CANADA,Recruiting,Lawson Health Research Institute,"April 18, 2020",Observational,Non-invasive Positive Pressure Ventilation Mask to Minimize Mask Leak and Potential Aerosolization Leading to Spread of Virus Such as COVID-19: A Non-inferiority Trial,COVID
659,COVID PANDEMIC FROM ETHICAL VIEW,"February 08, 2021",874,NCT04344938,QUESTIONNAIR ABOUT EMERGING LEGAL AND EHICAL DISPUTES OVER PATIENT CONFIDENTIALITY,,Not yet recruiting,Assiut University,April 2020,Observational,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,COVID
660,"PNEUMONIA, VIRAL","February 08, 2021",60,NCT04344951,UNIKINON (CHLOROQUINE PHOSPHATE) 200MG TABLETS,GREECE,Recruiting,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,"April 6, 2020",Interventional,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Respiratory
661,COLON POLYP,"February 08, 2021",186,NCT04344964,NONE - NA,AUSTRALIA,Completed,Austin Health,"April 15, 2020",Observational,Endoscopy-related Phone Consultation During the COVID-19 Outbreak: Impact on Attendance and Patient/Consultant Perspectives From a Tertiary Australian Hospital,Unrelated
662,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",1500,NCT04344977,,UNITED STATES,"Active, not recruiting",National Institute of Allergy and Infectious Diseases (NIAID),"June 1, 2020",Observational,A Pilot Study for Collection of Anti-SARS-CoV-2 Immune Plasma,COVID
663,SARS-CoV2,"February 08, 2021",572,NCT04345159,QUESTIONNAIRE BY PHONE CALL,FRANCE,Completed,Fondation Ophtalmologique Adolphe de Rothschild,"April 17, 2020",Observational,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,COVID
664,COVID,"February 08, 2021",10,NCT04345276,DANOPREVIR+RITONAVIR,CHINA,Completed,Huoshenshan Hospital,"March 18, 2020",Interventional,An Open Clinical Trial to Evaluate Danoprevir Sodium Tablets Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,COVID
665,COVID,"February 08, 2021",1100,NCT04345289,CONVALESCENT ANTI-SARS-COV-2 PLASMA,DENMARK,Recruiting,Thomas Benfield,"May 1, 2020",Interventional,"Efficacy and Safety of Treatment With Convalescent Plasma for Adults With COVID-19 Pneumonia. A Double-blinded, Randomized, Multicenter Placebo-controlled Trial",COVID
666,COVID,"February 08, 2021",500,NCT04345315,SEROLOGICAL TEST,ITALY,Recruiting,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,"March 27, 2020",Observational,Correlative Study on Cancer Patients and Healthcare Professionals Exposed to SARS-CoV-2 Infection,COVID
667,COVID,"February 08, 2021",60,NCT04345406,ACEIS,EGYPT,Not yet recruiting,Tanta University,"April 15, 2020",Interventional,Randomized Trial of ACEIs in Treatment of COVID-19,COVID
668,COVID,"February 08, 2021",120,NCT04345419,CHLOROQUINE OR HYDROXYCHLOROQUINE,EGYPT,Recruiting,Tanta University,"June 16, 2020",Interventional,Remdesivir in COVID-19 Treatment: A Randomised Trial,COVID
669,COVID,"February 08, 2021",310,NCT04345445,TOCILIZUMAB,MALAYSIA,Not yet recruiting,University of Malaya,"April 15, 2020",Interventional,"An Open-label, Randomized, Cross-over Interventional Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression",COVID
670,COVID INFECTION,"February 08, 2021",500,NCT04345510,,,Not yet recruiting,German Cancer Research Center,"April 20, 2020",Observational,Testing for COVID-19 Infection in Asymptomatic Persons,COVID
671,COVID,"February 08, 2021",278,NCT04345523,BLOOD AND DERIVATIVES.,SPAIN,Recruiting,Cristina Avendaño Solá,"April 3, 2020",Interventional,"Multi-center, Randomized Clinical Trial of Convalescent Plasma Therapy Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients",COVID
672,COVID,"February 08, 2021",400,NCT04345536,,NORWAY,Recruiting,Oslo University Hospital,"March 15, 2020",Observational [Patient Registry],Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,COVID
673,FLU LIKE SYMPTOM,"February 08, 2021",18,NCT04345549,INDIVIDUALISED AYURVEDA,UNITED KINGDOM,Completed,Aarogyam UK,"February 26, 2020",Interventional,Ayurveda Self-Management for Flu Like Symptoms in People Self-Isolated for 7 Days During the Coronavirus Disease 2019 (COVID-19) Outbreak,Respiratory
674,SARS-CoV2,"February 08, 2021",30,NCT04345601,MESENCHYMAL STROMAL CELLS,UNITED STATES,Recruiting,Baylor College of Medicine,January 2021,Interventional,"Single Donor Banked Bone Marrow Mesenchymal Stromal Cells for the Treatment of COVID-19 Induced ARDS: A Non-Blinded Randomized, Controlled Study",COVID
675,PNEUMONIA,"February 08, 2021",400,NCT04345614,AUXORA,PUERTO RICO,Recruiting,"CalciMedica, Inc.","April 8, 2020",Interventional,"A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA)",Respiratory
676,LIVER CIRRHOSES,"February 08, 2021",1000,NCT04345640,NO INTERVENTION,INDIA,Recruiting,"Institute of Liver and Biliary Sciences, India","April 10, 2020",Observational,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver - The Pan Asia-Pacific Prospective Multi-centre Observational Study (APCOLIS STUDY),Unrelated
677,COVID,"February 08, 2021",44,NCT04345653,HYDROXYCHLOROQUINE SULFATE (HCQ),UNITED STATES,"Active, not recruiting",Hackensack Meridian Health,"April 14, 2020",Interventional,"Feasibility, Safety and Early Efficacy Trial of Hydroxychloroquine as Primary Prevention of Corona Virus Disease 2019 in High Risk Health Care Providers",COVID
678,COVID,"February 08, 2021",20,NCT04345679,ANTI-SARS-COV-2 CONVALESCENT PLASMA,,Not yet recruiting,Orthosera Kft.,"April 14, 2020",Interventional,Anti COVID-19 Convalescent Plasma Therapy,COVID
679,COVID,"February 08, 2021",17,NCT04345692,HYDROXYCHLOROQUINE,UNITED STATES,Terminated,Queen's Medical Centre,"March 26, 2020",Interventional,"A Randomized, Controlled Clinical Trial of the Safety and Efficacy of Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients",COVID
680,COVID,"February 08, 2021",200,NCT04345848,ENOXAPARIN,SWITZERLAND,Recruiting,"University Hospital, Geneva","April 28, 2020",Interventional,"Preventing COVID-19-associated Thrombosis, Coagulopathy and Mortality With Low- and High-dose Anticoagulation: a Multicentric Randomized, Open-label Clinical Trial",COVID
681,CORONAVIRUS INFECTION,"February 08, 2021",7,NCT04345861,HYDROXYCHLOROQUINE + PLACEBO,FRANCE,Terminated,"University Hospital, Montpellier","April 11, 2020",Interventional,Randomized Trial Assessing Efficacy and Safety of Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for Hospitalized Adults With COVID-19 Pneumonia,COVID
682,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",60,NCT04345887,SPIRONOLACTONE 100MG,TURKEY,Not yet recruiting,Istanbul University-Cerrahpasa,"April 21, 2020",Interventional,The Effect of Spironolactone on Oxygenation in Covid-19 ARDS Patients,Respiratory
683,COVID,"February 08, 2021",120,NCT04345991,TRANSFUSION OF COVID-19 CONVALESCENT PLASMA,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 15, 2020",Interventional,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - CORIMUNO-CORIPLASM : EFFICACY OF CONVALESCENT PLASMA TO TREAT SARS-COV2 INFECTED PATIENTS,COVID
684,COVID,"February 08, 2021",200,NCT04346017,CYTOKINES DOSAGE,BELGIUM,Recruiting,Francis Corazza,"March 20, 2020",Interventional,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in SARS-Cov-2 Infected Patients With a Systemic Inflammatory Response Syndrome,COVID
685,CORONAVIRUS DISEASE (COVID),"February 08, 2021",100,NCT04346043,,EGYPT,Not yet recruiting,Ain Shams University,"April 20, 2020",Observational,Strain Study: To Access the Egyptian COVID-19 Whole Genome (Dominant Strain) by Next Generation Sequencing (NGS) and Compare to the International Worldwide Database,COVID
686,CORONAVIRUS DISEASE (COVID),"February 08, 2021",500,NCT04346056,,EGYPT,Recruiting,Ain Shams University,"April 14, 2020",Observational,Retrospective Study From November 2019 -Febrauary 2020 on Severe Respiratory Illness to Access the Presence or Absence of COVID-19 in Patients Samples by Real-time PcR,COVID
687,STRESS,"February 08, 2021",30,NCT04346082,ONLINE MINDFULNESS GROUP,HONG KONG,Not yet recruiting,Chinese University of Hong Kong,"August 1, 2020",Interventional,Feasibility and Acceptability of Online Based Mindfulness Interventions to Relieve Distress During COVID-19 Outbreak in a Chinese Population: a Proof-of-concept Trial,Unrelated
688,PATIENT SAFETY,"February 08, 2021",132,NCT04346121,"GPS REPORTS OF POTENTIAL PATIENT SAFETY INCIDENTS, NON-COVID-19 RELATED",FRANCE,Completed,Nantes University Hospital,"April 28, 2020",Observational,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.,Unrelated
689,COVID PNEUMONIA,"February 08, 2021",165,NCT04346147,IMATINIB TABLETS,SPAIN,Recruiting,Hospital Universitario de Fuenlabrada,"April 13, 2020",Interventional,"Prospective, Phase II, Randomized, Open-label, Parallel Group Study to Evaluate the Efficacy of Baricitinib, Imatinib or Supportive Treatment in Patients With SARS Cov2 Pneumonia",COVID
690,COVID,"February 08, 2021",25,NCT04346160,SCHIRMER TEST I,ITALY,Not yet recruiting,G. d'Annunzio University,"April 14, 2020",Observational,Tear Fluid miRNA Analysis in Sars-Cov2 Conjunctivitis,COVID
691,COVID,"February 08, 2021",30000,NCT04346186,IGM AND IGG DIAGNOSTIC KITS TO SARS-COV-2,DENMARK,Enrolling by invitation,Herlev Hospital,"April 15, 2020",Observational,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,COVID
692,COVID,"February 08, 2021",177,NCT04346199,ACALABRUTINIB,ARGENTINA,Completed,AstraZeneca,"June 12, 2020",Interventional,"A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19",COVID
693,OROPHARYNGEAL DYSPHAGIA,"February 08, 2021",300,NCT04346212,SWALLOWING EVALUATION WITH THE EAT-10 AND THE VOLUME-VISCOSITY SWALLOWING TEST (V-VST),SPAIN,Recruiting,Hospital de Mataró,"April 14, 2020",Observational,Oropharyngeal Dysphagia and Malnutrition in Patients Infected by SARS-CoV-2: Prevalence and Needs of Compensatory Treatment and Follow up in Patients Admitted by COVID-19 at the Consorci Sanitari Del Maresme,Unrelated
694,VIRUS DISEASES,"February 08, 2021",5500,NCT04346264,NO INTERVENTION PLANNED DUE TO THE OBSERVATIONAL STUDY DESIGN ONLY A DIAGNOSTIC TESTING,AUSTRIA,Enrolling by invitation,Ludwig Boltzmann Institute for Lung Health,"April 27, 2020",Observational,CoVid-19 - Infection and Antibody Formation in the Viennese Population - Data From the Vienna Health Study LEAD,Unrelated
695,COVID,"February 08, 2021",,NCT04346277,"IC14, A MONOCLONAL ANTIBODY AGAINST CD14",ITALY,Available,Implicit Bioscience,,Expanded Access,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),COVID
696,COVID,"February 08, 2021",86,NCT04346329,HYDROXYCHLOROQUINE,COLOMBIA,Not yet recruiting,Universidad Nacional de Colombia,"April 20, 2020",Interventional,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to SARS-Cov-2,COVID
697,COVID,"February 08, 2021",1122,NCT04346342,,NETHERLANDS,Completed,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"March 6, 2020",Observational,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) - an Observational Study of Invasively Ventilated Patients in the Netherlands,COVID
698,COVID PNEUMONIA,"February 08, 2021",126,NCT04346355,TOCILIZUMAB,ITALY,Terminated,Azienda Unità Sanitaria Locale Reggio Emilia,"March 31, 2020",Interventional,An Open-label Randomized Multicenter Study to Evaluate the Efficacy of Early Administration of Tocilizumab (TCZ) in Patients With COVID-19 Pneumonia,COVID
699,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",20,NCT04346368,BM-MSCS,CHINA,Not yet recruiting,Guangzhou Institute of Respiratory Disease,April 2020,Interventional,Safety and Efficacy of Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells in Severe Patients With Coronavirus Disease 2019 (COVID-19): A Phase 1/2 Randomized Controlled Trial,COVID
700,COVID,"February 08, 2021",12,NCT04346420,STANDARD INTERFACE,BELGIUM,Completed,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"April 9, 2020",Interventional,Impact of the Double-Trunk Mask on Oxygenation Titration in Patients With COVID-19,COVID
701,COVID,"February 08, 2021",29,NCT04346446,CONVALESCENT PLASMA TRANSFUSION,INDIA,Completed,"Institute of Liver and Biliary Sciences, India","April 20, 2020",Interventional,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients: A Pilot Randomized Controlled Trial,COVID
702,"PNEUMONIA, VENTILATOR-ASSOCIATED","February 08, 2021",10,NCT04346589,ANTI-CORONAVIRUS ANTIBODIES (IMMUNOGLOBULINS)OBTAINED WITH DFPP FROM CONVALESCENT PATIENTS,ITALY,Recruiting,A.O. Ospedale Papa Giovanni XXIII,"April 15, 2020",Interventional,A Pilot Study to Explore the Efficacy and Safety of Rescue Theraphy With Antibodies From Convalescent Patients Obtained With Double -Filtration Plasmapheresis (DFPP) and Infused in Critically Ill Ventilated Patients With Coronavirus Disease 2019 (COVID-19),Respiratory
703,COVID-2019,"February 08, 2021",132,NCT04346602,ALL TREATMENT ABOUT COVID-2019,CHINA,Recruiting,Jilin University,"February 1, 2020",Observational,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019,COVID
704,COVID INFECTION,"February 08, 2021",120,NCT04346615,ZAVEGEPANT (BHV-3500),UNITED STATES,Recruiting,"Biohaven Pharmaceuticals, Inc.","April 25, 2020",Interventional,"BHV3500-203: Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of Zavegepant* (BHV-3500) Intranasal (IN) for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen",COVID
705,SARS-CoV2,"February 08, 2021",120,NCT04346628,FAVIPIRAVIR,UNITED STATES,Enrolling by invitation,Stanford University,"July 12, 2020",Interventional,"A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild or Asymptomatic COVID-19",COVID
706,SARS-CoV2,"February 08, 2021",400,NCT04346667,HYDROXYCHLOROQUINE SULFATE REGULAR DOSE,PAKISTAN,Recruiting,"Government of Punjab, Specialized Healthcare and Medical Education Department","April 14, 2020",Interventional,Use and Dosage of Hydroxychloroquine and Chloroquine to Convert Real Time Polymerase Chain Reaction (RT-PCR) Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coronavirus Infectious Disease 2019 (COVID-19) Patients to RT- PCR-Negative as a Means to Reduce Hospitalization Rate,COVID
707,ACUTE RESPIRATORY TRACT INFECTION,"February 08, 2021",320,NCT04346693,STANDARD THERAPY RECOMMENDED BY THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION.,RUSSIAN FEDERATION,Completed,Burnasyan Federal Medical Biophysical Center,"April 8, 2020",Interventional,An Open Randomized Study of the Effectiveness of the Drug Dalargin for the Prevention and Treatment of Symptoms of Pulmonary Complications in Patients With Coronavirus Infection (SARS-COVID-19),Respiratory
708,SARS-CoV2,"February 08, 2021",120,NCT04346797,ECULIZUMAB,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 16, 2020",Interventional,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",COVID
709,COVID,"February 08, 2021",100,NCT04346810,PATIENT MANAGEMENT SUFFERING OF CORONAVIRUS INFECTION,,Not yet recruiting,Hôpital Raymond Poincaré,"April 15, 2020",Observational,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,COVID
710,TELEREHABILITATION,"February 08, 2021",30,NCT04346927,TELEREHABILITATION,,Not yet recruiting,Yasemin Çırak,"August 10, 2020",Interventional,Investigation of the Effects of Exercise Using Telerehabilitation in Patients Diagnosed With Coronavirus (COVID-19) and Followed at Home,Unrelated
711,TELEREHABILITATION,"February 08, 2021",30,NCT04346940,TELEREHABILITATION,,Not yet recruiting,Istinye University,"August 10, 2020",Interventional,The Effectiveness of Telerehabilitation-Based Exercises in Elderly People Under Social Isolation Process Due to Coronavirus,Unrelated
712,HEALTHY LIFESTYLE,"February 08, 2021",128,NCT04346953,VIDEO BASED EXERCISE,,Not yet recruiting,Istinye University,"August 20, 2020",Interventional,Investigation Of The Effectiveness Of Video-Based Exercise Program Applied To Adult Individuals Who Experience Social Isolation At Houses Due To The Coronavirus (COVID-19) Pandemic,Unrelated
713,SOCIAL ISOLATION,"February 08, 2021",128,NCT04346966,STUDY GROUP,,Not yet recruiting,Istinye University,"August 20, 2020",Interventional,The Effectiveness of Video-Based Exercises in Young Adults Under Social Isolation Process Due to Coronavirus,Unrelated
714,TELEREHABILITATION,"February 08, 2021",50,NCT04346979,TELEREHABILITATION-BASED,,Not yet recruiting,Istinye University,"August 1, 2020",Interventional,"The Effect of Telerehabilitation Based Yoga and Mindfulness Home Program on Psychological Resilience, Body Awareness and Physical Activity in Postmenopausal Women Having Social Isolation",Unrelated
715,"PNEUMONIA, VIRAL","February 08, 2021",320,NCT04347031,MEFLOQUINE,RUSSIAN FEDERATION,Completed,Burnasyan Federal Medical Biophysical Center,"April 8, 2020",Interventional,"An Open Randomized Study of the Effectiveness of the Drug Mefloquine, Tablets 250 mg, Produced by FSUE SPC ""Farmzashita"" of the Federal Medical Biological Agency, FMBA of Russia (Russia) for the Treatment of Patients With COVID19",Respiratory
716,SARS-CoV2,"February 08, 2021",150,NCT04347070,PHSYIOTHERAPY,FRANCE,"Active, not recruiting","University Hospital, Montpellier","April 1, 2017",Observational,"Implementation of Physiotherapy on COVID-19 Patients in Intensive Care Units : a Retrospective, Multicentric, International Study",COVID
717,COVID,"February 08, 2021",40,NCT04347174,SUSPENSION OF HEAT KILLED (AUTOCLAVED) MYCOBACTERIUM W,INDIA,Completed,Cadila Pharnmaceuticals,"April 30, 2020",Interventional,A Clinical Trial to Evaluate the Safety and Efficacy of Mycobacterium W in Critically Ill Patients Suffering From COVID 19 Infection,COVID
718,SOLID TUMOR,"February 08, 2021",138,NCT04347226,BMS-986253,UNITED STATES,Recruiting,Matthew Dallos,"April 16, 2020",Interventional,A Randomized Phase 2 Study of Anti-IL-8 Therapy Versus Standard of Care in the Treatment of Hospitalized Patients With Severe COVID-19,Unrelated
719,CORONAVIRUS DISEASE 2019,"February 08, 2021",390,NCT04347239,PLACEBOS,UNITED STATES,Recruiting,"CytoDyn, Inc.","April 15, 2020",Interventional,"A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)",COVID
720,SARS-CoV2,"February 08, 2021",1000,NCT04347278,PATIENTS WITH THE TREATMENT AGAINS COVID19,SPAIN,Recruiting,Instituto de Investigación Marqués de Valdecilla,"April 22, 2020",Observational [Patient Registry],Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,COVID
721,COVID DISEASE,"February 08, 2021",1000,NCT04347369,OTHER,CHINA,Recruiting,Xinqiao Hospital of Chongqing,"January 17, 2020",Observational,a Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,COVID
722,CORONAVIRUS INFECTION,"February 08, 2021",313,NCT04347382,HONEY,PAKISTAN,Completed,Sohaib Ashraf,"April 30, 2020",Interventional,"The Role of Honey and Nigella Sativa in the Management of COVID-19; A Randomized Controlled, Open-label, Add-on Trial in Pakistan",COVID
723,COVID,"February 08, 2021",1000,NCT04347408,COVID-19 ANTIBODY TESTING (IGG AND IGM),UNITED KINGDOM,Recruiting,"Queen's University, Belfast","May 6, 2020",Observational,Seroprevalence of SARS-Cov-2 Antibodies in Children - a Prospective Multicentre Cohort Study,COVID
724,COVID,"February 08, 2021",20,NCT04347460,,GERMANY,Recruiting,Technische Universität München,"March 27, 2020",Observational,"Establishing a Covid-19 Prospective Cohort to Document Cases of Secondary Hemophagocytic Lymphohistiocytosis (sHLH, Synonoums to Macrophage Activation Syndrome)",COVID
725,"SARS-CoV2, COMMUNITY-ACQUIRED PNEUMONIA,COVID","February 08, 2021",0,NCT04347512,HYDROXYCHLOROQUINE AND AZITHROMYCIN TREATMENT ARM.,,Withdrawn,"University Hospital, Strasbourg, France","June 2, 2020",Interventional,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,COVID
726,COVID,"February 08, 2021",90,NCT04347538,SALINE NASAL IRRIGATION,UNITED STATES,"Active, not recruiting",Vanderbilt University Medical Center,"May 1, 2020",Interventional,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,COVID
727,CONVALESCENT PLASMA FOR COVID,"February 08, 2021",575,NCT04347681,CONVALESCENT PLASMA FROM RECOVERED COVID 19 DONOR,SAUDI ARABIA,Recruiting,King Fahad Specialist Hospital Dammam,"April 18, 2020",Interventional,A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,COVID
728,SARS-CoV2,"February 08, 2021",400,NCT04347694,,AUSTRIA,Recruiting,Medical University of Vienna,"April 11, 2020",Observational,COVID-19 Serology in Nephrology Health Care Workers,COVID
729,COVID INFECTION,"February 08, 2021",500,NCT04347798,HYDROXYCHLOROQUINE/CHLOROQUINE,CANADA,Enrolling by invitation,University of Alberta,September 2020,Observational [Patient Registry],IMPACT RAPPORT: IMPact of Antimalarials on Covid Infections: a Case Control sTudy of RAPPORT,COVID
730,COVID,"February 08, 2021",100,NCT04347824,,GERMANY,Recruiting,University Hospital Goettingen,"April 27, 2020",Observational,Covid-19 Associated Nephritis as Early Predictor for Complicated Course of Disease,COVID
731,SARS-CoV2,"February 08, 2021",500,NCT04347850,BLOOD SAMPLE,FRANCE,Recruiting,"University Hospital, Montpellier","February 1, 2020",Observational,"A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) Infection, From Diagnosis to Long-term Follow-up",COVID
732,COVID,"February 08, 2021",100,NCT04347876,TUBERCULIN TEST,EGYPT,Recruiting,Assiut University,"April 11, 2020",Observational,Outcome of COVID-19 Cases Admitted to Hospital and ICU With Positive Tuberculin Test: Can Previous BCG Alter the Prognosis?,COVID
733,COVID,"February 08, 2021",0,NCT04347889,HYDROXYCHLOROQUINE,,Withdrawn,Stony Brook University,"April 20, 2020",Interventional,Prophylactic Hydroxychloroquine vs Vitamin C in Healthcare Workers at Risk of COVID-19: A RCT,COVID
734,COVID,"February 08, 2021",60,NCT04347915,CLEVUDINE,"KOREA, REPUBLIC OF",Recruiting,Bukwang Pharmaceutical,"May 6, 2020",Interventional,"A Single Blind, Randomized, Placebo-controlled, Multi-center Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients Diagnosed With Moderate COVID-19",COVID
735,COVID,"February 08, 2021",15,NCT04347928,,FRANCE,Completed,"University Hospital, Lille","April 20, 2020",Observational,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,COVID
736,"ARDS, HUMAN","February 08, 2021",200,NCT04347941,PRONE POSITIONING,IRELAND,Recruiting,University College Hospital Galway,"July 11, 2020",Interventional,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Unrelated
737,COVID,"February 08, 2021",40,NCT04347954,POVIDONE-IODINE 2%,UNITED STATES,Completed,Stanford University,"August 15, 2020",Interventional,Effect of PVP-I Nasal Sprays vs Normal Saline Nasal Sprays on SARS-CoV-2 Nasopharyngeal Titers,COVID
738,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",122,NCT04347980,DEXAMETHASONE AND HYDROXYCHLOROQUINE,FRANCE,Recruiting,Centre Chirurgical Marie Lannelongue,April 2020,Interventional,"Dexamethasone Combined With Hydroxychloroquine Compared to Hydroxychloroquine Alone for Treatment of Severe Acute Respiratory Distress Syndrome Induced by Coronavirus Disease 19 (COVID-19): a Multicentre, Randomised Controlled Trial",Respiratory
739,COVID,"February 08, 2021",5000,NCT04347993,,UNITED STATES,Recruiting,Hackensack Meridian Health,"March 27, 2020",Observational [Patient Registry],Real World Observational Database for COVID-19 Treatment and Outcomes,COVID
740,COVID,"February 08, 2021",80,NCT04348071,RUXOLITINIB,,Not yet recruiting,"University of Colorado, Denver",November 2020,Interventional,Safety and Efficacy of Ruxolitinib for COVID-19,COVID
741,CORONAVIRUS DISEASE (COVID),"February 08, 2021",3000,NCT04348214,,EGYPT,Recruiting,Ain Shams University,"April 22, 2020",Observational,Screening and Risk Assessment of Healthcare Workers and Infection Control in University and COVID-19 Quarantine Hospitals Using Real-time Geospatial Mapping for Emergency Healthcare Resource Mobilization and Management,COVID
742,VENTILATOR ASSOCIATED PNEUMONIA,"February 08, 2021",120,NCT04348227,ENHANCED HYGIENE MEASURES,TUNISIA,"Active, not recruiting",Hôpital Universitaire Fattouma Bourguiba,"January 1, 2019",Observational [Patient Registry],How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,Respiratory
743,COVID,"February 08, 2021",90,NCT04348240,,UNITED STATES,Recruiting,National Institute of Dental and Craniofacial Research (NIDCR),"April 16, 2020",Observational,Transmissibility and Viral Load of SARS-CoV-2 Through Oral Secretions,COVID
744,COVID,"February 08, 2021",1000,NCT04348305,HYDROCORTISONE,DENMARK,"Active, not recruiting",Scandinavian Critical Care Trials Group,"April 17, 2020",Interventional,Low-dose Hydrocortisone in Patients With COVID-19 and Severe Hypoxia - the COVID STEROID Trial,COVID
745,CORONAVIRUS,"February 08, 2021",1800,NCT04348370,BCG VACCINE,UNITED STATES,Recruiting,Texas A&M University,"April 20, 2020",Interventional,Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses,COVID
746,COVID,"February 08, 2021",150,NCT04348383,DEFIBROTIDE 25 MG/KG 24 HOURS CONTINUOUS INFUSION FOR 15 DAYS,SPAIN,Recruiting,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia,"April 8, 2020",Interventional,"Phase IIb Prospective, Multi-center, Randomized, Parallel, Double Blind, Placebo Controlled Trial to Evaluate Defibrotide Intravenous Infusion in the Prevention and Treatment of COVID-19 Respiratory Distress and Cytokine Release Syndrome",COVID
747,COVID,"February 08, 2021",300,NCT04348396,,ITALY,Recruiting,Istituto Nazionale di Ricovero e Cura per Anziani,"April 3, 2020",Observational,ReportAge-COVID Project: Clinical and Biological Predictors of COVID-19 Disease in Older Patients,COVID
748,COVID,"February 08, 2021",50,NCT04348409,NITAZOXANIDE TABLETS,BRAZIL,Recruiting,Azidus Brasil,"May 25, 2020",Interventional,"Proof of Concept, Multicentre, Parallel, Randomized, Double-blind Clinical Trial to Assess the Safety and Efficacy of Nitazoxanide 600 mg Compared to Placebo in the Treatment of Hospitalized Patients With COVID-19 in Moderate Condition.",COVID
749,COVID,"February 08, 2021",1000,NCT04348422,COVID-19 RT-PCR,ISRAEL,Recruiting,Assaf-Harofeh Medical Center,"May 1, 2020",Observational,Evaluation of the Immune Response in Symptomatic and Asymptomatic Patients' Diagnosed Witih COVID-19,COVID
750,COVID,"February 08, 2021",100,NCT04348435,HB-ADMSCS,UNITED STATES,Enrolling by invitation,Hope Biosciences,"May 14, 2020",Interventional,"A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs to Provide Immune Support Against COVID-19",COVID
751,COVID,"February 08, 2021",100,NCT04348448,CANAKINUMAB 150 MG/ML [ILARIS],,Not yet recruiting,AUSL Romagna Rimini,April 2020,Observational,Observational Study on the Use of Canakinumab Administered Subcutaneously in the Treatment of Patients With COVID-19 Pneumonia,COVID
752,COVID,"February 08, 2021",100,NCT04348461,ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STROMAL CELLS,,Not yet recruiting,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,"April 6, 2020",Interventional,"Two-treatment,Randomized, Controlled, Multicenter Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cells in Critically Ill Patients COVID-19",COVID
753,COVID,"February 08, 2021",200,NCT04348474,HYDROXYCHLOROQUINE SULFATE,BRAZIL,Suspended,Azidus Brasil,"April 20, 2020",Interventional,"Open Label, Multicentric, Non Randomized, Exploratory Clinical Trial to Assess the Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Mild Acute Respiratory Syndrome (COVID-19) Caused by SARS-CoV-2 Virus",COVID
754,COVID,"February 08, 2021",17,NCT04348500,CLAZAKIZUMAB,UNITED STATES,"Active, not recruiting",Cedars-Sinai Medical Center,"April 24, 2020",Interventional,A Phase II Trial to Evaluate the Safety and Tolerability of Clazakizumab® (Anti-IL- 6 Monoclonal) Compared to Placebo for the Treatment of COVID-19 Infection,COVID
755,PULMONARY INFECTION,"February 08, 2021",60,NCT04348513,T3 SOLUTION FOR INJECTION,GREECE,Recruiting,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,"May 29, 2020",Interventional,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection (Thy-Support),Unrelated
756,PATIENT SAFETY,"February 08, 2021",1000,NCT04348552,"PRIMARY CARE PROFESSIONALS REPORTS OF POTENTIAL PATIENT SAFETY INCIDENTS, NON-COVID-19 RELATED",FRANCE,Recruiting,Nantes University Hospital,"April 28, 2020",Observational,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,Unrelated
757,COVID,"February 08, 2021",1200,NCT04348656,CONVALESCENT PLASMA,CANADA,Recruiting,Hamilton Health Sciences Corporation,"May 14, 2020",Interventional,A Randomized Open-Label Trial of CONvalenscent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness (CONCOR-1),COVID
758,CORONAVIRUS INFECTION,"February 08, 2021",94,NCT04348695,RUXOLITINIB PLUS SIMVASTATIN,SPAIN,Recruiting,Fundación de investigación HM,"April 12, 2020",Interventional,Randomized Phase II Clinical Trial of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.Ruxo-Sim-20 Clinical Trial.,COVID
759,COMMUNICABLE DISEASE,"February 08, 2021",200,NCT04348864,"COVID-19 ANTIGEN/ANTIBODY RAPID TESTING, MOBILE DEVICE IMAGE CAPTURE AND TELEMEDICINE SUPPORT",UNITED STATES,Recruiting,Neuroganics LLC,"April 16, 2020",Interventional,Assessment of COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,Unrelated
760,CORONAVIRUS DISEASE (COVID),"February 08, 2021",20,NCT04348877,ANTIBODY-RICH PLASMA FROM COVID-19 RECOVERED PATIENTS,EGYPT,Not yet recruiting,Ain Shams University,"April 20, 2020",Interventional,Plasma Rich Antibodies From Recovered Patients From COVID19,COVID
761,POSTPARTUM DEPRESSION,"February 08, 2021",927,NCT04348929,SELF-ADMINISTERED QUESTIONNAIRES,FRANCE,Recruiting,"Central Hospital, Nancy, France","April 16, 2020",Interventional,Birth Experience During COVID-19 Confinement (Confinement and Fostering Intrapartum Care),Unrelated
762,COVID,"February 08, 2021",10000,NCT04348942,,UNITED STATES,"Active, not recruiting",ObvioHealth,"May 29, 2020",Observational [Patient Registry],COVID-19 Study - A Primarily Prospective Observational Study of COVID-19 Clinical Characteristics and Acquired Immune Response Within the General Population,COVID
763,CORONAVIRUS INFECTION,"February 08, 2021",202,NCT04349098,SELINEXOR,AUSTRIA,Completed,Karyopharm Therapeutics Inc,"April 17, 2020",Interventional,A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients With Severe COVID-19 Infection,COVID
764,PSYCHOLOGICAL,"February 08, 2021",280,NCT04349163,QUESTIONNAIRE,FRANCE,Completed,"University Hospital, Angers","May 10, 2020",Observational,Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period,Unrelated
765,COVID,"February 08, 2021",56000,NCT04349202,EUROIMMUN ASSAY,UNITED STATES,Recruiting,William Beaumont Hospitals,"April 10, 2020",Observational,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,COVID
766,COVID,"February 08, 2021",0,NCT04349228,HYDROXYCHLOROQUINE (HCQ),TUNISIA,Withdrawn,Abderrahmane Mami Hospital,"April 28, 2020",Interventional,"Assessment of the Efficacy and Safety of Hydroxychloroquine (HCQ) Administered as a Prophylaxis for Health Professionals Exposed to COVID19 and Working in Medical Intensive Care Units, in Tunisia. Multicentric Randomized Comparative Study",COVID
767,CORONAVIRUS DISEASE (COVID),"February 08, 2021",100,NCT04349241,FAVIPIRAVIR,EGYPT,Completed,Ain Shams University,"April 18, 2020",Interventional,Efficacy and Safety of Favipiravir in Management of COVID-19,COVID
768,MECHANICAL VENTILATION,"February 08, 2021",108,NCT04349332,HELMET NON-INVASIVE VENTILATION (NIV),UNITED STATES,Recruiting,University of Chicago,"August 13, 2020",Interventional,Early Extubation for Patients With Acute Hypoxemic Respiratory Failure,Unrelated
769,COVID,"February 08, 2021",350,NCT04349371,CHLOROQUINE,UNITED STATES,Recruiting,Columbia University,April 2020,Interventional,Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID,COVID
770,COVID POSITIVE,"February 08, 2021",1800,NCT04349410,"HYDROXYCHLOROQUINE, AZITHROMYCIN",UNITED STATES,Completed,The Camelot Foundation,"April 11, 2020",Interventional,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,COVID
771,COVID,"February 08, 2021",40,NCT04349540,NO INTERVENTION,UNITED KINGDOM,"Active, not recruiting",Great Ormond Street Hospital for Children NHS Foundation Trust,"April 15, 2020",Observational,A Prospective Non Interventional Study to Evaluate the Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 Infection,COVID
772,COVID,"February 08, 2021",456,NCT04349592,HYDROXYCHLOROQUINE,QATAR,Recruiting,Hamad Medical Corporation,"April 14, 2020",Interventional,Randomized Placebo-controlled Trial of Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,COVID
773,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",200,NCT04349618,PROTECTIVE VENTILATION,FRANCE,Recruiting,Hospices Civils de Lyon,"April 15, 2020",Interventional,Open Label Randomized Controlled Trial of Ultraprotective Ventilation Without Extracorporeal Circulation in Patients With COVID 19 Pneumonia and Moderate to Severe ARDS,Respiratory
774,COVID,"February 08, 2021",56,NCT04349631,HB-ADMSCS,UNITED STATES,"Active, not recruiting",Hope Biosciences,"April 22, 2020",Interventional,"A Phase II, Open Label, Single-Center, Clinical Trial to Assess Efficacy of HB-adMSCs to Provide Immune Support Against Coronavirus Disease",COVID
775,"RISK FACTOR, CARDIOVASCULAR","February 08, 2021",50,NCT04349982,"BIOMARKER (TROPT, MYOGLOBIN, CK, CK-MB, LDH, D-DIMER, CRP, PCT)",AUSTRIA,Recruiting,Medical University of Graz,"April 8, 2020",Observational [Patient Registry],Prospective Observational ICU Trial in Critical Ill COVID-19 Patients (POINT-C) Cardiovascular Risk and the Effects on Myocardial Events in Critical Ill COVID-19 Patients,Unrelated
776,COVID,"February 08, 2021",120,NCT04350073,Q-NRG METOBOLIC CART DEVICE,UNITED STATES,Recruiting,Duke University,"April 20, 2020",Observational,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),COVID
777,COVID INFECTION,"February 08, 2021",0,NCT04350086,TREATMENT WITH DEXMEDETOMIDINE,FRANCE,Withdrawn,"University Hospital, Limoges","April 20, 2020",Interventional,Prospective Study of the Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,COVID
778,EMOTIONNAL DISTRESS; COVID,"February 08, 2021",200,NCT04350099,QUETIONNARY,FRANCE,Recruiting,"University Hospital, Limoges","April 15, 2020",Observational,Emotional Burden of Healthcare Professionals and the Epidemic Related to Covid Infection 19 -,COVID
779,COVID,"February 08, 2021",60,NCT04350281,INTERFERON BETA-1B,HONG KONG,Completed,The University of Hong Kong,"April 9, 2020",Interventional,"An Open-label Randomized Controlled Trial on Interferon β-1b and Hydroxychloroquine Combination Versus Hydroxychloroquine Alone, as Treatment for COVID-19 Infection",COVID
780,COVID,"February 08, 2021",102,NCT04350320,COLCHICINE TABLETS,SPAIN,Completed,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia,"April 30, 2020",Interventional,"Administration of Colchicine Plus Standard Treatment vs. Standard Therapy, in Hospitalized Patients With COVID-19, Within the First 48 Hours, and no Severity Criteria.",COVID
781,COVID,"February 08, 2021",0,NCT04350450,HYDROXYCHLOROQUINE,UNITED STATES,Withdrawn,Montefiore Medical Center,April 2020,Interventional,"Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore: a Review of Process Feasibility, Safety, and Clinical Outcomes",COVID
782,COVID,"February 08, 2021",0,NCT04350476,VITALCONNECT VITAL SIGN PATCH,,Withdrawn,Vivek Reddy,"April 17, 2020",Interventional,Remote Monitoring in Patients With Coronavirus Disease (COVID-19),COVID
783,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",138,NCT04350580,HUMAN IMMUNOGLOBULIN,FRANCE,Recruiting,Centre Hospitalier St Anne,"April 11, 2020",Interventional,Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections,Respiratory
784,COVID,"February 08, 2021",1250,NCT04350593,DAPAGLIFLOZIN 10 MG,ARGENTINA,"Active, not recruiting",Saint Luke's Health System,"April 22, 2020",Interventional,"An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Patients With COVID-19",COVID
785,COVID,"February 08, 2021",40,NCT04350671,INTERFERON BETA-1A,"IRAN, ISLAMIC REPUBLIC OF",Enrolling by invitation,Shahid Beheshti University of Medical Sciences,"April 15, 2020",Interventional,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial",COVID
786,COVID,"February 08, 2021",40,NCT04350684,UMIFENOVIR,"IRAN, ISLAMIC REPUBLIC OF",Enrolling by invitation,Shahid Beheshti University of Medical Sciences,"April 15, 2020",Interventional,"Efficacy and Safety of Umifenovir as an Adjuvant Therapy Compared to the Control Therapeutic Regiment of Interferon Beta 1a, Lopinavir / Ritonavir and a Single Dose of Hydroxychloroquine in Moderate to Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial",COVID
787,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",50,NCT04350710,PEEP TRIAL,FRANCE,Recruiting,"University Hospital, Angers","March 18, 2020",Observational,Evaluation of Respiratory Mechanics and Lung Recruitment in Patients With SARS-CoV-2 Associated Acute Respiratory Distress Syndrome,Respiratory
788,CORONAVIRUS INFECTION,"February 08, 2021",350,NCT04350723,AWAKE PRONING,CANADA,Recruiting,St. Joseph's Healthcare Hamilton,"June 10, 2020",Interventional,Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,COVID
789,ACUTE LUNG INJURY (ALI) ASSOCIATED WITH COVID,"February 08, 2021",54,NCT04350736,TD-0903,UNITED KINGDOM,Completed,Theravance Biopharma,"April 23, 2020",Interventional,"A Phase 1, Double-blind, Randomized, Placebo-controlled, Sponsor-open, SAD and MAD Study in Healthy Subjects to Evaluate the Safety, Tolerability, and PK of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",COVID
790,CORONAVIRUS DISEASE (COVID),"February 08, 2021",900,NCT04350931,INTRADERMAL INJECTION OF BCG VACCINE,EGYPT,Not yet recruiting,Ain Shams University,"April 20, 2020",Interventional,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,COVID
791,GYNECOLOGIC CANCER,"February 08, 2021",205,NCT04351139,MODIFICATION OF THE PLANNED THERAPEUTIC MANAGEMENT,FRANCE,Completed,Hospices Civils de Lyon,"May 6, 2020",Observational,Impact of the COVID-19 Pandemic on Changes in Therapeutic Strategies in Gynecological Oncology,Unrelated
792,CORONAVIRUS DISEASE 2019 (COVID) PNEUMONIA,"February 08, 2021",516,NCT04351152,LENZILUMAB,BRAZIL,Recruiting,"Humanigen, Inc.","May 5, 2020",Interventional,"A Phase 3 Randomized, Placebo-Controlled Study of Lenzilumab in Hospitalized Patients With Severe and Critical COVID-19 Pneumonia",COVID
793,SARS-CoV2,"February 08, 2021",400,NCT04351191,HYDROXYCHLOROQUINE SULFATE REGULAR DOSE,PAKISTAN,Recruiting,"Government of Punjab, Specialized Healthcare and Medical Education Department","April 15, 2020",Interventional,Use and Dosage of Hydroxychloroquine and Chloroquine to Convert Symptomatic RT-PCR Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coronavirus Infectious Disease 2019 (COVID-19) Patients to RT- PCR-Negative as a Means to Reduce Hospitalization Rate,COVID
794,COVID,"February 08, 2021",227,NCT04351243,GIMSILUMAB,UNITED STATES,"Active, not recruiting",Kinevant Sciences GmbH,"April 12, 2020",Interventional,"A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)",COVID
795,COVID,"February 08, 2021",90,NCT04351295,FAVIPIRAVIR,EGYPT,Recruiting,Tanta University,"April 20, 2020",Interventional,Clinical Study Evaluating the Efficacy of Faviprevir in COVID-19 Treatment,COVID
796,COVID,"February 08, 2021",300,NCT04351347,IVERMECTIN,EGYPT,Recruiting,Tanta University,"June 16, 2020",Interventional,Clinical Study Evaluating the Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,COVID
797,SARS-CoV2,"February 08, 2021",318,NCT04351399,QUESTIONNAIRE ASSESMENT,FRANCE,Completed,"University Hospital, Lille","April 27, 2020",Observational,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,COVID
798,SARS-CoV2,"February 08, 2021",3140,NCT04351490,ZINC GLUCONATE,,Not yet recruiting,"University Hospital, Lille",April 2020,Interventional,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Institutionalized Aged Patients Infected With COVID-19,COVID
799,SARS CORONAVIRUS (SARS-CoV2) INFECTION,"February 08, 2021",10000,NCT04351503,STUDY A,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","April 9, 2020",Observational,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City,COVID
800,SARS-CoV2,"February 08, 2021",0,NCT04351516,HYDROXYCHLOROQUINE,GERMANY,Withdrawn,University Hospital Tuebingen,"April 21, 2020",Interventional,Randomized Controlled Trial of Hydroxychloroquine Versus Placebo in Early Ambulatory Diagnosis and Treatment of Elderly COVID19 Patients,COVID
801,INFECTIOUS DISEASE,"February 08, 2021",1000,NCT04351529,,AUSTRIA,Recruiting,Arbeitsgemeinschaft medikamentoese Tumortherapie,"April 1, 2020",Observational [Patient Registry],Austrian COVID-19 Registry (AGMT_COVID-19),Unrelated
802,FLU LIKE ILLNESS,"February 08, 2021",32,NCT04351542,AYURVEDA,UNITED KINGDOM,Completed,Aarogyam UK,"March 6, 2020",Interventional,Ayurveda for Flu-like Illness During the Covid 19 Outbreak: Non Randomised Single-blind Controlled Trial,Respiratory
803,EVALUATING THE EFFECT OF SOCIAL MEDIA USAGE IN PROVIDING HEALTHCARE SERVICES DURING THE PERIOD OF 19 COVID PANDEMICS,"February 08, 2021",874,NCT04351568,QUESIONNAIR,EGYPT,Recruiting,Assiut University,"April 1, 2020",Observational,Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services; During the Period of 19 Covid Pandemics,COVID
804,COVID,"February 08, 2021",215,NCT04351581,DISCONTINUATION OF ACEI/ARB,DENMARK,Recruiting,"University Hospital, Gentofte, Copenhagen","May 18, 2020",Interventional,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,COVID
805,COVID,"February 08, 2021",20,NCT04351620,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,University of Chicago,April 2020,Interventional,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,COVID
806,SARS-CoV2,"February 08, 2021",52,NCT04351633,QUESTIONNAIRE ASSESMENT,FRANCE,Completed,"University Hospital, Lille","April 23, 2020",Observational,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,COVID
807,COVID,"February 08, 2021",500,NCT04351646,,UNITED KINGDOM,Not yet recruiting,"St George's, University of London","April 15, 2020",Observational,Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak (DARTS),COVID
808,COVID,"February 08, 2021",8,NCT04351659,BLOOD DONATION FROM CONVALESCENT DONOR,SINGAPORE,Recruiting,KK Women's and Children's Hospital,"April 14, 2020",Observational,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,COVID
809,SARS-CoV2,"February 08, 2021",130,NCT04351711,IMMUNOLOGICAL PROFILING,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nīmes,"April 9, 2020",Observational,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,COVID
810,COVID,"February 08, 2021",500,NCT04351724,CHLOROQUINE OR HYDROXYCHLOROQUINE,AUSTRIA,Recruiting,Medical University of Vienna,"April 16, 2020",Interventional,"A Multicenter, Randomized, Active Controlled, Open Label, Platform Trial on the Efficacy and Safety of Experimental Therapeutics for Patients With COVID-19 (Caused by Infection With Severe Acute Respiratory Syndrome Coronavirus-2)",COVID
811,COVID,"February 08, 2021",804,NCT04351763,AMIODARONE,POLAND,Recruiting,Nicolaus Copernicus University,"April 27, 2020",Interventional,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,COVID
812,COVID,"February 08, 2021",66,NCT04351789,PSYCHOEDUCATIONAL INTERVENTION,DENMARK,Recruiting,"Copenhagen University Hospital, Hvidovre","May 1, 2020",Interventional,Impact of a Minimal Psychoeducational Intervention Versus Standard of Care on Anxiety Among Hospitalized COVID-19 Patients in Denmark: a Randomized Clinical Trial,COVID
813,COVID,"February 08, 2021",180,NCT04351802,LUNG ULTRASOUND,UNITED KINGDOM,Recruiting,University Hospital Plymouth NHS Trust,"May 11, 2020",Observational,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,COVID
814,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04351854,RETROSPECTIVE DATA COLLECTION,GERMANY,Recruiting,University of Cologne,"April 20, 2020",Observational,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,COVID
815,ARDS,"February 08, 2021",20,NCT04351906,ECCO2R,GERMANY,Recruiting,University of Giessen,"May 3, 2020",Interventional,Low-flow Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform for Correction of Hypercapnia in COVID-19-associated Acute Respiratory Distress Syndrome,Unrelated
816,PATIENTS WITH COVID,"February 08, 2021",0,NCT04351919,HYDROXYCHLOROQUINE,TUNISIA,Withdrawn,Abderrahmane Mami Hospital,"May 5, 2020",Interventional,"Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+), inTunisia",COVID
817,COVID,"February 08, 2021",2000,NCT04352348,BLOOD SAMPLES,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"March 31, 2020",Interventional,Cohort of Patients Infected With SARS-CoV2 or Suspected of Being (COVID-19 in Ile-de-France),COVID
818,COVID,"February 08, 2021",256,NCT04352400,NAFAMOSTAT MESILATE,,Not yet recruiting,University Hospital Padova,April 2020,Interventional,RAndomized Clinical Trial in COvid19 Patients to Assess the Efficacy of the Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor NAfamostat (RACONA Study),COVID
819,COVID,"February 08, 2021",42,NCT04352465,METHOTREXATE,BRAZIL,Not yet recruiting,Azidus Brasil,"May 1, 2020",Interventional,Treatment of Acute Respiratory Syndrome Resulting From the Inflammatory Process of COVID-19 Infection Using Methotrexate-loaded Nanoparticles: A Phase I/II Study,COVID
820,COVID,"February 08, 2021",347,NCT04352491,NO INTERVENTION,INDIA,Completed,"Institute of Liver and Biliary Sciences, India","April 24, 2020",Observational,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease (FEELIV COVID),COVID
821,SEDENTARY BEHAVIOR,"February 08, 2021",3500,NCT04352517,ONLINE SURVEY,BRAZIL,Recruiting,University of Extremadura,"March 16, 2020",Observational,Influence of Physical Activity on Psychological Responses During Coronavirus Disease (COVID-19) Pandemic: a Multi-center and Observational Study,Unrelated
822,SARS-CoV2 INFECTION,"February 08, 2021",250,NCT04352556,,ITALY,Recruiting,Ospedale di Circolo - Fondazione Macchi,"April 7, 2020",Observational,SARS-CoV-2 Infection in Patients With Hematological Malignancies: the Italian Hematology Alliance,COVID
823,COVID,"February 08, 2021",1194,NCT04352582,SURVEY,UNITED KINGDOM,Completed,"University Hospital, Geneva","April 14, 2020",Observational,COVID-19 and Vaccination Attitudes,COVID
824,COVID,"February 08, 2021",744,NCT04352608,TWO DOSES OF MEDIUM DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE EMERGENCY VACCINATION SCHEDULE,CHINA,"Active, not recruiting","Sinovac Research and Development Co., Ltd.","April 16, 2020",Interventional,"A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18~59 Years",COVID
825,COVID,"February 08, 2021",2000,NCT04352634,EXPOSURE TO THE SARS-COV-2 AND ITS CONSEQUENCES,ARGENTINA,Recruiting,University of Chile,"April 26, 2020",Observational,The Impact of the Covid-19 Pandemic on the Mental Health of Workers in Health Services: The Covid-19 HEalth caRe wOrkErS (HEROES) Study,COVID
826,SURGERY,"February 08, 2021",120,NCT04352699,,FRANCE,Completed,Centre Hospitalier Universitaire de Nice,"March 15, 2020",Observational,Outcomes of naïve Patients Operated on for an Urological Cancer or Emergency During Periods of Social COVID-19 Containment: is it Reasonable to Limit Access to Surgical Care for All?,Unrelated
827,COVID,"February 08, 2021",2000,NCT04352751,CONVALESCENT PLASMA,PAKISTAN,Recruiting,Hilton Pharma,"May 1, 2020",Interventional,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,COVID
828,COVID,"February 08, 2021",5000,NCT04352764,CORONACIDETM COVID-19 IGM/IGG RAPID TEST AND PREMIER BIOTECH COVID-19 IGM/IGG RAPID TEST,UNITED STATES,Recruiting,Texas Cardiac Arrhythmia Research Foundation,"March 27, 2020",Observational [Patient Registry],Use of the ANTIBODY BASED LATERAL FLOW IMMUNOASSAY TESTS FOR SARSCoV-2 THAT CAUSES CORONAVIRUS DISEASE 2019 (COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,COVID
829,COVID PNEUMONIA,"February 08, 2021",20,NCT04352803,AUTOLOGOUS ADIPOSE MSC'S,,Not yet recruiting,Regeneris Medical,April 2020,Interventional,IV Infusion of Autologous Adipose Derived Mesenchymal Cells for Abatement of Respiratory Compromise in SARS-CoV-2 Pandemic (COVID-19),COVID
830,COVID,"February 08, 2021",51,NCT04352842,ECHOCARDIOGRAPHY,CHINA,Completed,RenJi Hospital,"January 21, 2020",Observational,Cardiac Structural and Functional Characteristics in COVID-19: A Dynamic Echocardiographic Study,COVID
831,COVID,"February 08, 2021",1000,NCT04352933,HYDROXYCHLOROQUINE - DAILY DOSING,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"May 11, 2020",Interventional,ChemoPROphyLaxIs For covId-19 Infectious Disease (the PROLIFIC Trial),COVID
832,PROPHYLAXIS,"February 08, 2021",374,NCT04352946,HYDROXYCHLOROQUINE PRE-EXPOSURE PROPHYLAXIS,UNITED STATES,Not yet recruiting,GeoSentinel Foundation,"April 24, 2020",Interventional,"Protecting Health Care Workers From COVID-19 With Hydroxychloroquine Pre-exposure Prophylaxis: A Randomized, Placebo-controlled Trial",Unrelated
833,COVID,"February 08, 2021",175,NCT04352959,MOUTHRINSE WITH BÊTA-CYCLODEXTRIN AND CITROX,FRANCE,Completed,Claude Bernard University,"April 27, 2020",Interventional,"COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses: Double-blind, Randomized, Placebo-controlled Clinical Study",COVID
834,SEPTIC SHOCK,"February 08, 2021",,NCT04352985,TORAYMYXIN PMX-20R (PMX CARTRIDGE),UNITED STATES,Available,Spectral Diagnostics (US) Inc.,,Expanded Access,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,Unrelated
835,SARS-CoV2,"February 08, 2021",312,NCT04353011,QUESTIONNAIRE ASSESMENT,FRANCE,Completed,"University Hospital, Lille","April 20, 2020",Observational,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,COVID
836,CORONAVIRUS,"February 08, 2021",850,NCT04353037,GROUP A HCQ,UNITED STATES,Recruiting,UnitedHealth Group,"April 7, 2020",Interventional,PATCH 2 & 3: (Prevention and Treatment of COVID-19 With Hydroxychloroquine) An Open Label Multi-arm Randomized Trial of Hydroxychloroquine in the Prevention and Treatment of COVID-19,COVID
837,COVID,"February 08, 2021",450,NCT04353128,MELATONIN 2MG,SPAIN,Recruiting,Instituto de Investigación Hospital Universitario La Paz,"April 20, 2020",Interventional,Multicenter Randomized Controlled Trial of the Efficacy of Melatonin in the Prophylaxis of SARS-coronavirus-2 Infection Among High Risk Contacts.,COVID
838,COVID,"February 08, 2021",1850,NCT04353141,STANDARDIZED LUNG ULTRASOUND (LUS) EXAMINATION,BELGIUM,Recruiting,KU Leuven,"April 28, 2020",Observational,A Prospective International Lung UltraSound Analysis (ILUSA) Study in Tertiary Maternity Wards During the SARS-CoV-2 Pandemic,COVID
839,COVID,"February 08, 2021",20,NCT04353154,SPARTAN CUBE POINT-OF CARE COVID-19 TEST,,Not yet recruiting,Ottawa Heart Institute Research Corporation,"April 15, 2020",Observational,"Development and Evaluation of Applying a Point-of-Care COVID-19 Test Strategy to Triage Patients Presenting With Acute Coronary Syndromes, Respiratory or Hemodynamic Instability and Out of Hospital Cardiac Arrests",COVID
840,COVID,"February 08, 2021",100000,NCT04353180,DRUG ISOTRETINOIN (13 CIS RETINOIC ACID ) CAPSULES+STANDARD TREATMENT,EGYPT,Not yet recruiting,Kafrelsheikh University,February 2021,Interventional,Isotretinoin in Treatment of COVID-19 (Randomized),COVID
841,COVID,"February 08, 2021",60,NCT04353206,MULTIPLE DOSES OF ANTI-SARS-COV-2 CONVALESCENT PLASMA,UNITED STATES,Recruiting,Noah Merin,"June 27, 2020",Interventional,A Feasibility Study Assessing the Safety of Multiple Doses of Anti-SARS-CoV-2 Plasma in Mechanically Ventilated Intubated Patients With Respiratory Failure Due to COVID-19,COVID
842,COVID,"February 08, 2021",130,NCT04353245,BIOMARKERS IN THE LONG TERM IMPACT OF CORONAVIRUS INFECTION IN THE CARDIORRESPIRATORY SYSTEM,BRAZIL,Not yet recruiting,University of Sao Paulo General Hospital,"June 1, 2020",Observational [Patient Registry],Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System: Effect of Hydroxychloroquine / Azithromycin Combined Therapy,COVID
843,COVID,"February 08, 2021",58,NCT04353271,HYDROXYCHLOROQUINE,UNITED STATES,Terminated,University of South Alabama,"April 17, 2020",Interventional,A Randomized Phase 2/3 Trial of Hydroxychloroquine In Covid-19 Kinetics,COVID
844,COVID,"February 08, 2021",114,NCT04353284,CAMOSTAT MESILATE,UNITED STATES,Recruiting,Yale University,"June 19, 2020",Interventional,"The Effect of Camostat Mesylate on COVID-19 Infection in Ambulatory Patients: An Investigator-Initiated Randomized, Placebo-Controlled, Phase IIa Trial",COVID
845,"INFECTION, COVID","February 08, 2021",130,NCT04353323,BLOOD SAMPLING,FRANCE,Not yet recruiting,"University Hospital, Limoges","May 25, 2020",Observational,Comparison of the Proportion of Covid19 Seroconversion of Caregivers Working or Not in the COVID Sector,COVID
846,COVID,"February 08, 2021",200,NCT04353336,CHLOROQUINE OR HYDROXYCHLOROQUINE,EGYPT,Recruiting,Tanta University,"March 23, 2020",Interventional,Clinical Study Evaluating the Efficacy of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,COVID
847,CORONAVIRUS INFECTION,"February 08, 2021",5000,NCT04353401,,UNITED STATES,Enrolling by invitation,Vanda Pharmaceuticals,"August 3, 2020",Observational,Whole-Genome Sequencing Analysis of COVID-19 Positive Patients,COVID
848,COVID,"February 08, 2021",4000,NCT04353518,SUSPENSION OF HEAT KILLED (AUTOCLAVED) MYCOBACTERIUM W,INDIA,Recruiting,Cadila Pharnmaceuticals,"June 30, 2020",Interventional,"A Randomized, Double-blind, Two Arm, Placebo Controlled Clinical Trial to Evaluate the Efficacy and Safety of Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19.",COVID
849,"TRANSMISSION, PATIENT PROFESSIONAL","February 08, 2021",80,NCT04353531,HIGH-FLOW NASAL CANNULA,UNITED STATES,Recruiting,Rush University Medical Center,"May 20, 2020",Observational,An Observational Study to Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures,Unrelated
850,ACUTE KIDNEY INJURY,"February 08, 2021",400,NCT04353583,,GERMANY,Recruiting,University of Giessen,"April 21, 2020",Observational [Patient Registry],Renal Outcome in Patients With Coronavirus Disease 2019 (COVID-19),Unrelated
851,SARS-CoV2,"February 08, 2021",208,NCT04353596,"ACE INHIBITOR, ANGIOTENSIN RECEPTOR BLOCKER",AUSTRIA,Recruiting,Medical University Innsbruck,"April 15, 2020",Interventional,Stopping ACE-inhibitors in COVID-19: A Randomized Controlled Trial,COVID
852,SARS-CoV2,"February 08, 2021",13770,NCT04353609,,FRANCE,Recruiting,"University Hospital, Lille","April 18, 2020",Observational,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases : a Retrospective Multicenter Observational Study",COVID
853,COVID,"February 08, 2021",40,NCT04353674,CONTROL GROUP,CANADA,Recruiting,Lawson Health Research Institute,"April 28, 2020",Interventional,Novel Extracorporeal Treatment to Modulate Hyperinflammation in COVID-19 Patients,COVID
854,INFECTION VIRAL,"February 08, 2021",38,NCT04354155,ENOXAPARIN PREFILLED SYRINGE [LOVENOX],UNITED STATES,Recruiting,Johns Hopkins All Children's Hospital,"June 2, 2020",Interventional,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Unrelated
855,SARS-CoV2,"February 08, 2021",140,NCT04354259,PEGINTERFERON LAMBDA-1A,CANADA,Recruiting,"University Health Network, Toronto","May 13, 2020",Interventional,"Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19",COVID
856,OROFACIAL PAIN,"February 08, 2021",840,NCT04354272,QUESTIONNAIRE,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 13, 2020",Observational,Evaluation of the Management of Dental Emergencies During COVID 19 Crisis,Unrelated
857,COVID,"February 08, 2021",0,NCT04354389,DAS181,ITALY,Withdrawn,"Ansun Biopharma, Inc.","July 25, 2020",Interventional,"DAS181 for COVID-19: A Phase II Multicenter, Randomized, Placebo-Controlled, Double-Blind Study",COVID
858,COVID,"February 08, 2021",300,NCT04354428,ASCORBIC ACID,UNITED STATES,"Active, not recruiting",University of Washington,"April 16, 2020",Interventional,Efficacy of Novel Agents for Treatment of SARS-CoV-2 Infection Among High-Risk Outpatient Adults: An Adaptive Randomized Platform Trial,COVID
859,COVID,"February 08, 2021",0,NCT04354441,HYDROXYCHLOROQUINE SULFATE 200 MG,,Withdrawn,Sir Mortimer B. Davis - Jewish General Hospital,May 2020,Interventional,Randomized Trial Evaluating Effect of Outpatient Hydroxychloroquine on Reducing Hospital Admissions in Pregnant Women With SARS-CoV-2 Infection: HyPreC Trial,COVID
860,MULTIPLE SCLEROSIS,"February 08, 2021",3000,NCT04354519,,UNITED KINGDOM,Recruiting,Swansea University,"March 14, 2020",Observational [Patient Registry],The UK MS Regsiter COVID-19 Substudy,Unrelated
861,EPIDEMIOLOGY,"February 08, 2021",200,NCT04354558,,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","July 1, 2020",Observational,Epidemiology and Outcomes of Critically Ill Patients With Covid 19: a French Single Centre Experience,Unrelated
862,COVID,"February 08, 2021",20,NCT04354584,,DENMARK,Recruiting,Hvidovre University Hospital,"April 6, 2020",Observational,"Early and Late Pulmonary and Systemic Inflammation in Critically Ill, Mechanically Ventilated Patients With Verified COVID-19",COVID
863,COVID,"February 08, 2021",200,NCT04354597,HCQ & AZ,JORDAN,Not yet recruiting,King Hussein Cancer Center,"May 1, 2020",Interventional,"A Multicenter, Open-label, Pilot Study on Using Hydroxychloroquine (HCQ) and Azithromycin (AZ) Prophylaxis for Healthcare Workers With a Potential Risk of Exposure to COVID-19 Patients",COVID
864,COVID,"February 08, 2021",57,NCT04354610,BIOLOGICAL SAMPLES SPECIFIC TO RESEARCH,FRANCE,"Active, not recruiting","Central Hospital, Nancy, France","April 27, 2020",Interventional,Prediction of Acute Heart or Kidney Injury With Cardiovascular-renal Biomarkers in Patients Hospitalised for Severe or Critical Covid-19 Infection,COVID
865,COVID,"February 08, 2021",10000,NCT04354701,WEB-BASED REDCAP SURVEY,UNITED STATES,Recruiting,Vanderbilt-Ingram Cancer Center,"March 17, 2020",Observational [Patient Registry],The COVID-19 and Cancer Consortium (CCC19) Registry,COVID
866,COVID,"February 08, 2021",0,NCT04354714,RUXOLITINIB,,Withdrawn,Washington University School of Medicine,"June 30, 2020",Interventional,A Pilot Study of Ruxolitinib to Combat COVID-19,COVID
867,COVID,"February 08, 2021",80,NCT04354753,NO INTERVENTION,UNITED KINGDOM,Completed,Aarogyam UK,"March 28, 2020",Observational,AiM COVID for Covid 19 Tracking and Prediction,COVID
868,COVID,"February 08, 2021",10,NCT04354766,BLOOD SAMPLE,FRANCE,Recruiting,Hospices Civils de Lyon,"April 29, 2020",Observational,Generation of Human Monoclonal Antibodies Neutralizing SARS-Cov-2 From B Cells of Convalescent Patients,COVID
869,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",3301,NCT04354779,A SPECIFICALLY DESIGNED SELF-ADMINISTERED QUESTIONNAIRE,AUSTRIA,Completed,AUVA,"May 11, 2020",Observational,Antikörperseroprävalenz Und Hintergrundinfektionsrate Von SARS-CoV-2 in Einem österreichischen Schlüsselkollektiv an Arbeitnehmer*Innen,COVID
870,IMMUNOLOGIC ACTIVITY ALTERATION,"February 08, 2021",500,NCT04354792,SERUM SARS COV 2 IGG SCREENING IN HEALTH CARE WORKERS,EGYPT,Completed,Kasr El Aini Hospital,"May 1, 2020",Observational,Asymptomatic SARS- CoV2 Infection Among Healthcare Workers in Three University Hospitals: A Cross Sectional Study.,Unrelated
871,COVID,"February 08, 2021",100,NCT04354805,CHLORPROMAZINE,EGYPT,Not yet recruiting,Cairo University,"August 1, 2020",Interventional,Administration of Chlorpromazine as a Treatment for COVID-19,COVID
872,HIV-1-INFECTION,"February 08, 2021",1000,NCT04354818,,AUSTRALIA,Recruiting,Kirby Institute,"May 11, 2020",Observational [Patient Registry],Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function,Unrelated
873,COVID,"February 08, 2021",131,NCT04354831,ANTI-SARS-COV-2 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",Medical College of Wisconsin,"May 11, 2020",Interventional,"An Open Label, Phase 2 Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection",COVID
874,COVID,"February 08, 2021",454,NCT04354857,OLFACTORY AND GUSTATORY TESTS,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nīmes,"March 27, 2020",Observational,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,COVID
875,COVID,"February 08, 2021",130,NCT04354870,HYDROXYCHLOROQUINE (HCQ),UNITED STATES,Completed,NYU Langone Health,"April 3, 2020",Interventional,Off Label Study to Evaluate the Efficacy of HCQ for Pre-exposure Prophylaxis (PrEP) to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Health Care Workers (HCWs) Who Are at High Risk of Occupational Exposure to SARS-CoV-2,COVID
876,COVID,"February 08, 2021",90,NCT04355026,BROMHEXINE ORAL TABLET AND/OR HYDROXYCHLOROQUINE TABLET,SLOVENIA,Recruiting,General and Teaching Hospital Celje,"April 10, 2020",Interventional,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,COVID
877,COVID - 19,"February 08, 2021",250,NCT04355052,HYDROXYCHLOROQUINE IN COMBINATION WITH CAMOSTAT MESYLATE,ISRAEL,Recruiting,Sheba Medical Center,"April 11, 2020",Interventional,"An Open-Label Study to Compare the Efficacy, Safety, and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in Hospitalized Patients Suffering From a Mild or Moderate SARS CoV 2 Virus",COVID
878,COVID,"February 08, 2021",150,NCT04355143,COLCHICINE TABLETS,UNITED STATES,Recruiting,"University of California, Los Angeles","May 1, 2020",Interventional,"Randomized, Open-Label, Controlled Trial of Colchicine to Reduce Cardiac Injury in Hospitalized COVID-19 Patients (COLHEART-19)",COVID
879,PREGNANCY,"February 08, 2021",2200,NCT04355234,IDENTIFY SARS-COV-2 INFECTION BY SEROLOGY,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 4, 2020",Interventional,"Prevalence and Impact of SARS-COV-2 Infection in Pregnant Women, Fetuses and Newborns",Unrelated
880,COVID,"February 08, 2021",20,NCT04355247,METHYLPREDNISOLONE 80 MG/ML INJECTABLE SUSPENSION,PUERTO RICO,Recruiting,Auxilio Mutuo Cancer Center,"April 14, 2020",Interventional,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,COVID
881,COVID,"February 08, 2021",4100,NCT04355338,,BRAZIL,Recruiting,Butantan Institute,"October 25, 2020",Observational,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil,COVID
882,"NEW CORONAVIRUS DISEASE (COVID), INFECTION WITH SARS-CoV2","February 08, 2021",400,NCT04355351,BLOOD SAMPLING,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"May 5, 2020",Interventional,Study of Immune Response During SARS-CoV-2 Infection,COVID
883,COVID,"February 08, 2021",100,NCT04355364,DORNASE ALFA INHALATION SOLUTION [PULMOZYME],FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"April 21, 2020",Interventional,Efficacy and Safety of Dornase Alfa Aerosol in ARDS Secondary to SARS-CoV-2 Coronavirus Respiratory Infection - COVID-19,COVID
884,PNEUMONIA,"February 08, 2021",230,NCT04355429,CAPTOPRIL 25MG,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"May 5, 2020",Interventional,Efficacy of Captopril Nebulization in Covid-19 Patients Suffering of SARS CoV-2 Pneumonia. A Randomized Phase II Study,Respiratory
885,MAXILLOFACIAL INJURIES,"February 08, 2021",300,NCT04355442,FACIAL FRACTURES REDUCTION OR OSTEOSYNTHESIS,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Evolution of Maxillofacial Trauma Activity During COVID-19 Containment Measures: a French Multicentric Comparative Observational Study,Unrelated
886,COVID,"February 08, 2021",150,NCT04355481,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 17, 2020",Observational,Study of the Dissemination of SARS-COV-2 in the Environment of Infected Patients Admitted to Intensive Care Unit,COVID
887,COVID,"February 08, 2021",,NCT04355494,ECULIZUMAB,FRANCE,Available,Alexion Pharmaceuticals,,Expanded Access,SOLIRIS® (Eculizumab) for the Treatment of Participants With Coronavirus Disease 2019 (COVID 19) - An Expanded Access Program for Hospital-based Emergency Treatment,COVID
888,COVID,"February 08, 2021",10735,NCT04355507,CHEST COMPUTED TOMOGRAPHY (CT),FRANCE,Completed,Assistance Publique - Hôpitaux de Paris,"March 1, 2020",Observational,Computed Tomography for Coronavirus Disease 19 Diagnosis,COVID
889,COVID INFECTION,"February 08, 2021",1000,NCT04355533,SEROLOGY TEST,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"July 29, 2020",Interventional,Seroprevalence and Antibody Profiling Against SARS-CoV2 in Children and Their Parents,COVID
890,MULTIPLE SCLEROSIS,"February 08, 2021",2000,NCT04355611,EVALUATION OF THE EPIDEMIOLOGICAL CHARACTERISTICS OF CORONAVIRUS INFECTION (SARS-COV-2),FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 20, 2020",Observational,Cohort Study Evaluating the Epidemiological Characteristics of Coronavirus Infection (SARS-CoV-2) in Patients With MS or NMO,Unrelated
891,COVID,"February 08, 2021",80,NCT04355624,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"April 15, 2020",Observational,Characterization of Kidney Involvement in COVID-19 Disease: a French Multi-center Prospective Observational Study,COVID
892,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04355637,INHALED BUDESONIDE,ARGENTINA,Recruiting,Sara Varea,"April 21, 2020",Interventional,Treatment With Inhaled Corticosteroids in Patients Hospitalized Because of COVID19 Pneumonia,COVID
893,CORONAVIRUS INFECTION,"February 08, 2021",0,NCT04355676,SELINEXOR,,Withdrawn,Karyopharm Therapeutics Inc,"April 30, 2020",Interventional,"A Phase 2 Randomized, Open-Label, Multicenter Study to Evaluate the Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Patients With Moderate or Severe COVID-19",COVID
894,SYSTEMIC LUPUS ERYTHEMATOSUS,"February 08, 2021",130,NCT04355702,,FRANCE,Recruiting,"University Hospital, Montpellier","March 1, 2020",Observational,Manifestations Related to Covid-19 in Patients With Systemic Lupus Erythematosus,Unrelated
895,COVID,"February 08, 2021",200,NCT04355715,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2019",Observational,Evaluation of a COVID-19 Screening Strategy Combining Chest Low Dose CT and RT-PCR Test for Patients Admitted for Surgical or Interventional Procedures During the COVID 19 Outbreak,COVID
896,CORONAVIRUS INFECTION,"February 08, 2021",24,NCT04355728,UMBILICAL CORD MESENCHYMAL STEM CELLS + HEPARIN ALONG WITH BEST SUPPORTIVE CARE.,UNITED STATES,Completed,Camillo Ricordi,"April 25, 2020",Interventional,Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients With Acute Respiratory Distress Syndrome (ARDS),COVID
897,COVID,"February 08, 2021",115,NCT04355741,EXPOSURE,PORTUGAL,Completed,Universidade Nova de Lisboa,"April 20, 2020",Observational,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",COVID
898,RESPIRATORY INSUFFICIENCY,"February 08, 2021",40,NCT04355754,VENTIL - A GAS FLOW DIVIDER,POLAND,Recruiting,Medical University of Gdansk,"April 15, 2020",Interventional,Assesment of Usefulness of Ventil Device for Mechanical Ventilation in ICU Patients,Respiratory
899,COVID,"February 08, 2021",600,NCT04355767,CONVALESCENT PLASMA,UNITED STATES,Enrolling by invitation,Stanford University,"August 11, 2020",Interventional,Clinical-trial of COVID-19 Convalescent Plasma in Outpatients,COVID
900,COVID,"February 08, 2021",,NCT04355793,RUXOLITINIB,,Available,Incyte Corporation,,Expanded Access,An Open-Label Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,COVID
901,COVID,"February 08, 2021",4035,NCT04355871,,SPAIN,Completed,Fundacion SEIMC-GESIDA,"March 18, 2020",Observational,Characteristics and Predictors of Death Among Hospitalized Patients With COVID-19 in Spain,COVID
902,COVID,"February 08, 2021",100,NCT04355884,"STANDARD 12-LEAD ECG, NT-PROBNP, ECHOCARDIOGRAPHY",HONG KONG,Not yet recruiting,The University of Hong Kong,"April 20, 2020",Observational,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in COVID-19 Survivors,COVID
903,COVID,"February 08, 2021",100,NCT04355897,CONVALESCENT COVID 19 PLASMA,UNITED STATES,Recruiting,The Christ Hospital,"April 28, 2020",Interventional,Convalescent CoVID-19 Plasma in the Treatment of High Risk CoVID-19 Disease,COVID
904,COVID DRUG TREATMENT,"February 08, 2021",400,NCT04355936,TELMISARTAN ARM WILL RECEIVE 80 MG TELMISARTAN TWICE DAILY PLUS STANDARD CARE.,ARGENTINA,Completed,Laboratorio Elea Phoenix S.A.,"May 19, 2020",Interventional,Telmisartan for Treatment of COVID-19 Patients: an Open Label Randomized Trial,COVID
905,"ARDS, HUMAN","February 08, 2021",64,NCT04355962,SEVOFLURANE,SWITZERLAND,Recruiting,University of Zurich,"April 23, 2020",Interventional,Sevoflurane Sedation in COVID-19 ARDS Patients to Reduce Lung Injury: a Randomized Controlled Trial,Unrelated
906,DISSEMINATED INTRAVASCULAR COAGULATION,"February 08, 2021",60,NCT04356144,THROMBIN GENERATION ASSAY (TGA),AUSTRIA,Recruiting,Medical University of Vienna,"April 15, 2020",Observational,Coagulation Assays in the Critically Ill Patient: a New Approach Using the Thrombomodulin-modified Thrombin Generation Assay (TGA-TM),Unrelated
907,DEPRESSION,"February 08, 2021",10084,NCT04356365,CROSS-SECTIONAL STUDY INVESTIGATING THE ASSOCIATION OF NPIS WITH MENTAL HEALTH,NORWAY,Completed,University of Oslo,"March 31, 2020",Observational,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Unrelated
908,INFECTION WITH CORONAVIRUS SARS-CoV2,"February 08, 2021",300,NCT04356378,DATA RECORD,FRANCE,Recruiting,CHU de Reims,"June 2, 2020",Observational,Long Term Physical Functional Performance in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation: a Multicentric Observational Study,COVID
909,"AMD, ACEI'S/ARB PREVENT/WORSEN RISK OF COVID INFECTION","February 08, 2021",6000000,NCT04356417,- SYNTHETIC ANTI-MALARIAL DRUGS,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,April 2020,Observational,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse: Cases of Synthetic Antimalarial Drugs and Anti-hypertensive Drugs,COVID
910,RESPIRATORY FAILURE,"February 08, 2021",500,NCT04356443,AIRGO RESPIRATORY MONITOR,UNITED STATES,Recruiting,Massachusetts General Hospital,"April 15, 2020",Observational,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,Respiratory
911,COVID,"February 08, 2021",90,NCT04356482,CONVALESCENT PLASMA,MEXICO,Recruiting,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,"May 20, 2020",Interventional,DETERMINATION OF THE DOSE AND EFFECTIVENESS OF CONVALESCENT PLASMA IN SEVERELY AND VERY SEVERELY ILL PATIENTS BY COVID-19,COVID
912,CORONAVIRUS INFECTION,"February 08, 2021",820,NCT04356495,VITAMINS,FRANCE,Recruiting,"University Hospital, Bordeaux","July 29, 2020",Interventional,Randomized Trial to Evaluate the Safety and Efficacy of Outpatient Treatments to Reduce the Risk of Worsening in Individuals With COVID-19 With Risk Factors (COVERAGE France),COVID
913,COVID,"February 08, 2021",15,NCT04356508,NIVOLUMAB,,Not yet recruiting,Dr Gerry Gin Wai Kwok,"April 14, 2020",Interventional,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,COVID
914,SARS-CoV2,"February 08, 2021",40,NCT04356534,PLASMA THERAPY USING CONVALESCENT PLASMA WITH ANTIBODY AGAINST SARS-COV-2,BAHRAIN,Completed,Royal College of Surgeons in Ireland - Medical University of Bahrain,"April 19, 2020",Interventional,Use of Convalescent Plasma Therapy for COVID-19 Patients With Hypoxia: a Prospective Randomized Trial,COVID
915,COVID,"February 08, 2021",300,NCT04356560,"COVID-19 TEST, POLYMERASE CHAIN REACTION FOR SARS-COV-2",DENMARK,Enrolling by invitation,"Rigshospitalet, Denmark","March 23, 2020",Observational,"SARS-CoV-2 Surveillance of Patients and Healthcare Workers at the Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet University Hospital of Copenhagen, Denmark",COVID
916,COVID,"February 08, 2021",287,NCT04356586,,BELGIUM,Completed,Sciensano,"May 4, 2020",Observational [Patient Registry],Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,COVID
917,COVID,"February 08, 2021",50,NCT04356677,50 MG/ML VIRAZOLE,,Not yet recruiting,"Bausch Health Americas, Inc.",February 2021,Interventional,"An Open-Label Study to Evaluate the Safety and Efficacy of VIRAZOLE® (RIBAVIRIN FOR INHALATION SOLUTION, USP) in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19",COVID
918,COVID,"February 08, 2021",64,NCT04356690,ETOPOSIDE,UNITED STATES,Recruiting,Boston Medical Center,"May 8, 2020",Interventional,"A Phase II Single-Center, Randomized, Open-Label, Safety and Efficacy Study of Etoposide in Patients With COVID-19 Infection",COVID
919,COVID,"February 08, 2021",24,NCT04356833,NEBULISED RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA),UNITED KINGDOM,Recruiting,"University College, London","April 22, 2020",Interventional,"A Pilot, Open Label, Phase II Clinical Trial of Nebulised Recombinant Tissue-Plasminogen Activator (Rt-PA)",COVID
920,MENTAL DISORDER,"February 08, 2021",600,NCT04356885,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Impact of Containment and Quarantine During COVID-19 Outbreack on Psychotic Symptoms in the General Population in France,Unrelated
921,SARS-CoV2,"February 08, 2021",243,NCT04356937,TOCILIZUMAB,UNITED STATES,Completed,Massachusetts General Hospital,"April 20, 2020",Interventional,Tocilizumab to Prevent the Progression of Hypoxemic Respiratory Failure in Hospitalized Non-Critically Ill Patients With COVID-19,COVID
922,SEPSIS,"February 08, 2021",175,NCT04356950,THROMBIN GENERATION TEST ASSAY,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire de Nīmes,"April 28, 2020",Observational,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients: Thrombin Generation Potential in COVID-19 Infected Patients,Unrelated
923,COVID,"February 08, 2021",200,NCT04357028,MEASLES-MUMPS-RUBELLA VACCINE,EGYPT,Suspended,Kasr El Aini Hospital,"July 13, 2020",Interventional,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),COVID
924,"ALL, ADULT","February 08, 2021",500,NCT04357041,,UNITED STATES,"Active, not recruiting","Clinical Nutrition Research Center, Illinois Institute of Technology","April 17, 2020",Observational,"Effects of Stay-at-home Guidance on Dietary Intake, Physical Activity and Overall Well-being During COVID-19 Public Health Crisis",Unrelated
925,COVID,"February 08, 2021",10,NCT04357106,CONVALESCENT PLASMA,MEXICO,Recruiting,Centro de Hematología y Medicina Interna,"April 13, 2020",Interventional,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,COVID
926,CRITICAL ILLNESS,"February 08, 2021",10000,NCT04357275,ICU TREATMENT,SWITZERLAND,Recruiting,University of Zurich,"March 13, 2020",Observational [Patient Registry],The RIsk Stratification in COVID-19 Patients in the ICU Registry,Unrelated
927,MYOCARDIAL INFARCTION,"February 08, 2021",6332,NCT04357314,,FRANCE,Completed,French Cardiology Society,"March 1, 2020",Observational,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,Unrelated
928,COVID,"February 08, 2021",122,NCT04357327,RAPID SALIVARY TEST,ITALY,Completed,Università degli Studi dell'Insubria,"April 16, 2020",Interventional,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19): a Diagnostic Accuracy Study,COVID
929,COVID,"February 08, 2021",40,NCT04357340,PULMONARY PHYSIOTHERAPY TECHNIQUES,"IRAN, ISLAMIC REPUBLIC OF",Completed,Tehran University of Medical Sciences,"April 2, 2020",Interventional,Efficacy of Pulmonary Physiotherapy on Hospitalized Patients With Novel Coronavirus 2019 Pneumonia,COVID
930,COVID,"February 08, 2021",500,NCT04357366,ANAKINRA,GREECE,Recruiting,Hellenic Institute for the Study of Sepsis,"April 15, 2020",Interventional,"suPAR-guided Anakinra Treatment for Validation of the Risk and Early Management of Severe Respiratory Failure by COVID-19: The SAVE Open-label, Non-randomized Single-arm Trial",COVID
931,ANXIETY STATE,"February 08, 2021",187,NCT04357418,IT IS A SURVEY,FRANCE,Completed,"Centre hospitalier de Ville-Evrard, France","April 1, 2020",Observational,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives (ICOS),Unrelated
932,COVID,"February 08, 2021",565,NCT04357431,SELF-ADMINISTERED QUESTIONNAIRE,EGYPT,Completed,Assiut University,"April 22, 2020",Observational,"Knowledge, Attitude, Perceived Worry and Stigma About COVID-19 Among Egyptian Health Care Providers",COVID
933,COVID,"February 08, 2021",30,NCT04357444,1: ILT101,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 23, 2020",Interventional,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,COVID
934,COVID,"February 08, 2021",212,NCT04357457,ALMITRINE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"September 3, 2020",Interventional,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia: a Randomized Controlled Double-blind Study From the Skip-icu Consortium,COVID
935,FEVER,"February 08, 2021",400,NCT04357496,,,Not yet recruiting,Centogene AG Rostock,"December 20, 2020",Observational,COVID-19 Epidemic Response Study: A National Observational Longitudinal Non-Interventional Protocol,Unrelated
936,COVID,"February 08, 2021",314,NCT04357535,ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE-I) AND ANGIOTENSIN II RECEPTOR BLOCKERS (ARB),SAUDI ARABIA,Completed,Hakeam Abdulaziz Hakeam,"May 10, 2020",Observational,Prognosis of SARS-Cov 2 Positive Patients Receiving Angiotensin Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Antagonists (ARBs),COVID
937,COVID,"February 08, 2021",1000,NCT04357574,TELEHEALTH,UNITED STATES,Enrolling by invitation,Duke University,"April 14, 2020",Observational,Assessing the Provider Implementation and Experience of TeleHealth During COVID-19 and Impact on Acute Encounters,COVID
938,SARS VIRUS,"February 08, 2021",99,NCT04357613,EXPERIMENTAL DRUG,FRANCE,Not yet recruiting,Versailles Hospital,"September 1, 2020",Interventional,A RANDOMIZED NON-COMPARATIVE PHASE 2 PILOT STUDY TESTING THE VALUE OF IMATINIB MESYLATE AS AN EARLY TREATMENT OF COVID-19 DISEASE IN AGED HOSPITALIZED PATIENTS.,Respiratory
939,HIV PATIENTS,"February 08, 2021",1040,NCT04357639,NO INTERVENTION,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 28, 2020",Observational [Patient Registry],Prospective Description Study of the Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19,Unrelated
940,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",60,NCT04357730,ALTEPLASE 50 MG [ACTIVASE],UNITED STATES,Recruiting,Denver Health and Hospital Authority,"May 14, 2020",Interventional,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection: A Phase 2a Clinical Trial,Respiratory
941,PSYCHOLOGICAL DISTRESS,"February 08, 2021",400,NCT04357769,PSS (PERCEIVED STRESS SCALE),ITALY,Completed,Federico II University,"April 10, 2020",Observational,A Study of Perceived Distress and Psychological Burden in Patients Suffering From Severe Mental Diseases During the COVID-19 Pandemic in Italy,Unrelated
942,COVID,"February 08, 2021",20,NCT04357782,L-ASCORBIC ACID,UNITED STATES,Completed,Hunter Holmes Mcguire Veteran Affairs Medical Center,"April 16, 2020",Interventional,"Administration of Intravenous Vitamin C in Novel Coronavirus Infection and Decreased Oxygenation (AVoCaDO): A Phase I/II Safety, Tolerability, and Efficacy Clinical Trial",COVID
943,COVID,"February 08, 2021",30,NCT04357808,SARILUMAB,SPAIN,"Active, not recruiting",Maria del Rosario Garcia de Vicuña Pinedo,"April 13, 2020",Interventional,Randomized Open Pilot Study to Evaluate the Efficacy of Subcutaneous Sarilumab in Patients With Moderate-severe COVID-19 Infection,COVID
944,COVID,"February 08, 2021",100,NCT04357834,EQUIPMENT WITH SMARTWATCH THROUGHOUT HOSPITAL STAY ON THE GENERAL WARD,SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","May 1, 2020",Observational,Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories. The WAVE Study.,COVID
945,COVID,"February 08, 2021",100,NCT04357847,,FRANCE,Recruiting,"University Hospital, Rouen","April 9, 2020",Observational,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,COVID
946,SARS-CoV2,"February 08, 2021",120,NCT04357860,SARILUMAB 200 MG/1.14 ML SUBCUTANEOUS SOLUTION [KEVZARA],SPAIN,Not yet recruiting,Maimónides Biomedical Research Institute of Córdoba,"April 27, 2020",Interventional,Clinical Trial of Sarilumab in Adults Hospitalized With COVID-19 Presenting Cytokine Release Syndrome,COVID
947,HEALTHY,"February 08, 2021",1000,NCT04357886,,TURKEY,Not yet recruiting,Istanbul University-Cerrahpasa,May 2020,Observational,New Coronavirus Awareness,Unrelated
948,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",145,NCT04357938,CT-IMAGING,GERMANY,"Active, not recruiting",Jena University Hospital,"April 15, 2020",Observational,Risk Stratification With Chest Computed Tomography to Rule-out Suspected SARS-CoV-2 Infections of Unspecific Symptomatic Patients Before Hospital Admission,COVID
949,CORONAVIRUS,"February 08, 2021",300,NCT04357977,RBA-2,UNITED STATES,Not yet recruiting,"Kaligia Biosciences, LLC",April 2020,Observational,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,COVID
950,COVID,"February 08, 2021",128,NCT04357990,VIRUXAL ORAL AND NASAL SPRAY,ICELAND,Recruiting,Kerecis Ltd.,"September 4, 2020",Interventional,"Use of a Medical Device, Viruxal Oral and Nasal Spray, for Treating the Symptoms of COVID-19 Via Application to the Naso- and Oropharyngeal Mucosa",COVID
951,RESPIRATORY FAILURE,"February 08, 2021",2000,NCT04358003,MARKER THERAPEUTICS D2000 CARTRIDGE (D2000) FOR USE WITH THE SPECTRA OPTIA® APHERESIS SYSTEM (OPTIA SPD PROTOCOL),UNITED STATES,Recruiting,Marker Therapeutics AG,"May 20, 2020",Interventional,Plasma Adsorption in Patients With Confirmed COVID-19 Infection,Respiratory
952,COVID CARDIAC,"February 08, 2021",10000,NCT04358029,,UNITED STATES,Recruiting,Vivek Reddy,"April 9, 2020",Observational,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),COVID
953,PSYCHIATRIC DISORDER,"February 08, 2021",250,NCT04358042,BRIEF PSYCHIATRIC RATING SCALE,FRANCE,Recruiting,Nantes University Hospital,"April 24, 2020",Observational [Patient Registry],"PSYCHIatric Disorders and Covid-19 (PSYCHIC) : Observatory of the Psychiatric, Somatic and Pharmacological Impacts of the COVID-19 Pandemic on Patients Hospitalized for Psychiatric Disorders and Suspected to be Infected by COVID-19",Unrelated
954,COVID,"February 08, 2021",20,NCT04358068,HYDROXYCHLOROQUINE (HCQ),UNITED STATES,Completed,National Institute of Allergy and Infectious Diseases (NIAID),"May 1, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19",COVID
955,COVID,"February 08, 2021",20,NCT04358081,HCQ,UNITED STATES,Completed,Novartis Pharmaceuticals,"May 1, 2020",Interventional,"A Multi-center, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety and Efficacy of Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease",COVID
956,COVID,"February 08, 2021",,NCT04358211,BIOLOGICAL: COVID-19 CONVALESCENT PLASMA,UNITED STATES,Available,"Nakhle Saba, MD",,Expanded Access,Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,COVID
957,LIVER INJURY,"February 08, 2021",320,NCT04358380,LIVER INJURY,ARGENTINA,Enrolling by invitation,"Austral University, Argentina","April 15, 2020",Observational,Liver Injury in Hospitalized Patients With COVID-19 in Latin America: Clinical Characteristics and Prognostic Factors,Unrelated
958,SARS-CoV2,"February 08, 2021",60,NCT04358406,RECOMBINANT HUMAN PLASMA GELSOLIN (RHU-PGSN),ROMANIA,Recruiting,BioAegis Therapeutics Inc.,"July 30, 2020",Interventional,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Study To Evaluate Efficacy And Safety Of Recombinant Human Plasma Gelsolin (Rhu-pGSN) Added To Standard Of Care In Subjects With Severe Covid-19 Pneumonia",COVID
959,COVID,"February 08, 2021",114,NCT04358510,COVIAGE,UNITED STATES,Completed,Dascena,"April 1, 2020",Observational,"Mortality Prediction Model for the Triage of COVID-19, Pneumonia and Mechanically Ventilated ICU Patients",COVID
960,COVID,"February 08, 2021",230,NCT04358536,COVX,UNITED STATES,Completed,Dascena,"April 1, 2020",Observational,Classification of COVID-19 Infection in Posteroanterior Chest X-rays With Common Deep Learning Architectures,COVID
961,COVID,"February 08, 2021",50,NCT04358549,FAVIPIRAVIR + STANDARD OF CARE,UNITED STATES,"Active, not recruiting","Fujifilm Pharmaceuticals U.S.A., Inc.","April 17, 2020",Interventional,"Open Label, Randomized, Controlled Phase 2 Proof-of-Concept Study of the Use of Favipiravir Compared to Standard of Care in Hospitalized Subjects With COVID-19",COVID
962,CORONAVIRUS INFECTION,"February 08, 2021",,NCT04358588,INO (INHALED NITRIC OXIDE) DELIVERED VIA THE INOPULSE DELIVERY SYSTEM,,No longer available,Bellerophon,,Expanded Access,"Expanded Access: Pulsed, Inhaled Nitric Oxide (iNO) for the Treatment of Patients With Mild or Moderate Coronavirus Disease (COVID-19)",COVID
963,COVID,"February 08, 2021",12,NCT04358614,BARICITINIB 4 MG ORAL TABLET,ITALY,Completed,Fabrizio Cantini,"March 16, 2020",Interventional,Baricitinib Therapy in COVID-19: A Pilot Study on Safety and Clinical Impact,COVID
964,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",80,NCT04358627,DEXMEDETOMIDINE INJECTABLE PRODUCT,,Not yet recruiting,Hospital Clinic of Barcelona,"April 15, 2020",Observational,Impact of Dexmedetomidine Infusion on the Time Course and Outcomes of Acute Respiratory Distress Syndrome (ARDS) in Patients Affected by the SARS-CoV-2 (COVID-19) Admitted to Critical Care Unit,Respiratory
965,CRITICAL ILLNESS,"February 08, 2021",1784,NCT04358640,,FRANCE,Completed,Centre Hospitalier Universitaire de Nīmes,"April 9, 2020",Observational,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Unrelated
966,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04358783,PLASMA,MEXICO,Recruiting,Hospital Universitario Dr. Jose E. Gonzalez,"April 27, 2020",Interventional,"Phase II, Randomized, Double-blind, Controlled Clinical Trial Evaluating the Efficacy and Safety of Plasma From Patients Cured of COVID-19 Compared to the Best Available Therapy in Subjects With SARS-CoV-2 Pneumonia",COVID
967,COVID,"February 08, 2021",480,NCT04358809,SUSPENSION OF HEAT KILLED (AUTOCLAVED) MYCOBACTERIUM W,INDIA,Recruiting,Cadila Pharnmaceuticals,"June 30, 2020",Interventional,"A Randomized, Double-blind, Two Arm, Controlled Clinical Trial to Compare the Efficacy and Safety of Mycobacterium w (Mw) Administered Along With Standard of Care Versus Placebo Administered Along With Standard of Care, in Adult, COVID 19 Positive Patients Hospitalized But Not Critically Ill.",COVID
968,COVID,"February 08, 2021",0,NCT04358835,KETOGENIC DIET,,Withdrawn,Johns Hopkins University,"September 1, 2020",Interventional,Keto-diet for Intubated Critical Care COVID-19 (KICC-COVID19),COVID
969,COVID,"February 08, 2021",30,NCT04358926,HYPERBARIC OXYGEN THERAPY,ISRAEL,Completed,Assaf-Harofeh Medical Center,"April 30, 2020",Interventional,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),COVID
970,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",404,NCT04358939,PRONE DECUBITUS,FRANCE,Recruiting,"University Hospital, Tours","April 27, 2020",Interventional,Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome,Respiratory
971,CARDIOMYOPATHIES,"February 08, 2021",50,NCT04358952,GLOBAL LONGITUDINAL STRAIN,FRANCE,Recruiting,"University Hospital, Toulouse","April 4, 2020",Observational,Imaging Cardiac Phenotype of SARS-Cov-2 (Covid19) Infected Patients,Unrelated
972,COVID,"February 08, 2021",1200,NCT04359095,EMTRICITABINE/TENOFOVIR,COLOMBIA,Recruiting,Universidad Nacional de Colombia,"August 18, 2020",Interventional,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia: A Pragmatic Randomized Controlled Trial,COVID
973,COVID,"February 08, 2021",600,NCT04359121,QUESTIONNAIRES FOR SPECIFIC PHOBIA,AUSTRIA,Recruiting,Medical University of Graz,"April 15, 2020",Observational,COVID-19 and the Developement of Phobic Fears of Disease,COVID
974,COVID DISEASE,"February 08, 2021",90,NCT04359212,THROMBOPROPHYLAXIS WITH LOW-MOLECULAR-WEIGHT HEPARIN OR FONDAPARINUX,ITALY,Completed,Quovadis Associazione,"May 1, 2020",Observational,Increased Risk of Venous Thromboembolism and Higher Hypercoagulable State in Patients Recovered in Intensive Care Unit and in Medical Ward for Coronavirus Disease 2019 (COVID-19),COVID
975,TELEHEALTH,"February 08, 2021",80,NCT04359225,3D TELEMEDICINE,UNITED KINGDOM,Not yet recruiting,NHS Greater Glasgow and Clyde,"June 30, 2020",Interventional,A Comparison of 3D and 2D Telemedicine: Communication During Covid 19,Unrelated
976,COVID,"February 08, 2021",20,NCT04359251,GAS EXCHANGES AT DIFFERENT PEEP,CHINA,Completed,"Southeast University, China","March 5, 2020",Interventional,Avoiding High PEEP in COVID-19 Induced ARDS: a Multi-center Study,COVID
977,COVID,"February 08, 2021",392,NCT04359264,CASH TRANSFER,CANADA,"Active, not recruiting",Unity Health Toronto,"April 20, 2020",Interventional,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial (DISTANSE COVID-19 RCT),COVID
978,COVID,"February 08, 2021",77,NCT04359277,ENOXAPARIN HIGHER DOSE,UNITED STATES,Terminated,NYU Langone Health,"April 21, 2020",Interventional,A Randomized Trial of Anticoagulation Strategies in COVID-19,COVID
979,"ARDS, HUMAN","February 08, 2021",15,NCT04359290,RUXOLITINIB ADMINISTRATION,GERMANY,"Active, not recruiting",Philipps University Marburg Medical Center,"July 1, 2020",Interventional,"Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS A Single-arm, Open-label, Proof of Concept Study",Unrelated
980,COVID,"February 08, 2021",50,NCT04359303,SYSTEMIC INDIRECT ENDOVENOUS OZONE THERAPY,SPAIN,Not yet recruiting,Javier Hidalgo Tallón,July 2020,Interventional,Randomized Clinical Trial to Evaluate Efficacy and Safety of Systemic Indirect Endovenous Ozone Therapy (SIEVOT) as Adjuvant Treatment in COVID19 Non-intubated Patients,COVID
981,COVID,"February 08, 2021",40,NCT04359316,HYDROXYCHLOROQUINE,"IRAN, ISLAMIC REPUBLIC OF",Not yet recruiting,Shahid Beheshti University of Medical Sciences,"April 20, 2020",Interventional,"Efficacy and Safety of Azithromycin Compared to the Base Therapeutic Regiment of Hydroxychloroquine in Moderate to Severe COVID-19: A Randomized, Controlled, Double-Blind, Clinical Trial",COVID
982,COVID,"February 08, 2021",110,NCT04359329,ESTRADIOL PATCH,UNITED STATES,Recruiting,Sharon Nachman,"April 20, 2020",Interventional,Phase II Clinical Trial of Estradiol to Reduce Severity of COVID19 Infection in COVID19+ and Presumptive COVID19+ Patients,COVID
983,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",16,NCT04359407,PRONE POSITIONING,SWITZERLAND,Recruiting,Walid HABRE,"April 27, 2020",Observational,The Effect of Prone Positioning on Lung Aeration and Ventilation-perfusion Matching in Mechanically Ventilated Patients With Coronavirus Disease Related Acute Respiratory Distress Syndrome,COVID
984,COVID,"February 08, 2021",150,NCT04359459,,,Not yet recruiting,University Medical Center Groningen,June 2020,Observational,"Nasal CIliated EPithelial Genetic And Single Cell RNA prOfiLes of miLd, Severe and Very Severe COVID-Nineteen patIents (CIPOLLINI) Study",COVID
985,COVID,"February 08, 2021",210,NCT04359511,PREDNISONE,,Not yet recruiting,"University Hospital, Tours",June 2020,Interventional,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia in Grand Ouest Interregion France,COVID
986,COVID,"February 08, 2021",200,NCT04359537,HYDROXYCHLOROQUINE SULFATE 200 MG,PAKISTAN,Recruiting,Shaheed Zulfiqar Ali Bhutto Medical University,"May 1, 2020",Interventional,Comparative Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 in Healthcare Personnel,COVID
987,RECOVERED FROM COVID,"February 08, 2021",10000,NCT04359602,,UNITED STATES,Recruiting,"University of California, Los Angeles","April 8, 2020",Observational [Patient Registry],COVID-19 Recovered Volunteer Research Participant Pool Registry,COVID
988,COVID,"February 08, 2021",40,NCT04359615,FAVIPIRAVIR,"IRAN, ISLAMIC REPUBLIC OF",Not yet recruiting,Shahid Beheshti University of Medical Sciences,"April 20, 2020",Interventional,"Efficacy and Safety of Favipiravir Compared to the Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized, Controlled, Double-Blind, Clinical Trial",COVID
989,COVID,"February 08, 2021",50,NCT04359654,DORNASE ALFA INHALATION SOLUTION [PULMOZYME],UNITED KINGDOM,Recruiting,"University College, London","June 16, 2020",Interventional,"A Single-site, Randomised, Controlled, Parallel Design, Open-label Investigation of an Approved Nebulised Recombinant Human DNase Enzyme (Dornase Alfa) to Reduce Hyperinflammation in Hospitalised Participants With COVID-19",COVID
990,COVID,"February 08, 2021",30,NCT04359667,TOCILIZUMAB 20 MG/ML INTRAVENOUS SOLUTION [ACTEMRA],CROATIA,Recruiting,"University Hospital for Infectious Diseases, Croatia","June 16, 2020",Observational,Prognostic Value of Serum Interleukin-6 (IL-6) and Soluble Interleukin-6 Receptor (sIL-6R) in Severe Coronavirus Disease (COVID-19) Pneumonia Treated With Tocilizumab - a Prospective Single Center Study (UHID-COVID19),COVID
991,COVID,"February 08, 2021",1407,NCT04359680,NITAZOXANIDE,UNITED STATES,"Active, not recruiting",Romark Laboratories L.C.,"May 13, 2020",Interventional,"A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection",COVID
992,SARS-CoV2,"February 08, 2021",1576,NCT04359693,,FRANCE,Completed,"University Hospital, Lille","April 22, 2020",Observational,Impact of SARS-CoV-2 Infection on the Incidence of Ventilator-acquired Infections,COVID
993,SARS-CoV2,"February 08, 2021",30,NCT04359706,,FRANCE,Recruiting,"University Hospital, Lille","May 8, 2020",Observational,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With SARS-CoV2,COVID
994,COVID,"February 08, 2021",503,NCT04359797,PRONE,UNITED STATES,"Active, not recruiting",Vanderbilt University Medical Center,"April 27, 2020",Interventional,Pragmatic Trial Exploring Impact of Patient Positioning in the Management of Patients Infected With COVID-19: Supine vs. Prone,COVID
995,SARS-CoV2 INFECTION,"February 08, 2021",219,NCT04359810,CONVALESCENT PLASMA (ANTI-SARS-COV-2 PLASMA),BRAZIL,Recruiting,Max R. O'Donnell,"April 21, 2020",Interventional,"A Phase 2, Multi-Center, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Human Anti-SARS-CoV-2 Convalescent Plasma in Severely Ill Adults With COVID-19",COVID
996,GUT MICROBIOME,"February 08, 2021",250,NCT04359836,THERE IS NO INTERVENTION IN THIS STUDY,UNITED STATES,Recruiting,ProgenaBiome,"April 16, 2020",Observational,A Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection,Unrelated
997,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04359849,,UNITED KINGDOM,Recruiting,Portsmouth Hospitals NHS Trust,May 2020,Observational,Sequencing and Tracking of Phylogeny in COVID-19 Study,COVID
998,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",50,NCT04359862,SEVOFLURANE,SPAIN,Recruiting,Fundación para la Investigación del Hospital Clínico de Valencia,"April 16, 2020",Interventional,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,Respiratory
999,CARDIOVASCULAR DISEASES,"February 08, 2021",22000,NCT04359875,PHONE-CALL SCREENING AND MANAGEMENT BY A MEDICAL STUDENT/GENERAL PRACTITIONER TANDEM,FRANCE,Not yet recruiting,"University Hospital, Tours",April 2020,Interventional,Does a Systematic Phone-call by a Medical Student/General Practitioner Team in Patients Suffering From a Chronic Condition During the COVID-19 Containment Period Impact One-month Hospitalization's Rate in France? A Cluster Randomized Trial,Unrelated
1000,COVID,"February 08, 2021",120,NCT04359901,SARILUMAB,UNITED STATES,Recruiting,Westyn Branch-Elliman,"April 10, 2020",Interventional,Sarilumab for Patients With Moderate COVID-19 Disease: A Randomized Controlled Trial With a Play-The-Winner Design,COVID
1001,CRITICAL ILLNESS,"February 08, 2021",80,NCT04359914,,GERMANY,Recruiting,University of Rostock,"April 15, 2020",Observational,Biomarker-guided Assessment of Neurocognitive Impairment in Patients With COVID-19 - a Multicenter Case-control Study,Unrelated
1002,SARS-CoV2,"February 08, 2021",10000,NCT04359927,,SPAIN,Recruiting,Hospital Clinic of Barcelona,"April 20, 2020",Observational [Patient Registry],Long-term Effects of Coronavirus 2019 Disease on the Cardiovascular System in Patients Who Have Undergone a Diagnostic Nasopharyngeal Swab for SARS-CoV-2. CV COVID-19 Registry,COVID
1003,COVID INFECTION,"February 08, 2021",1600,NCT04359953,HYDROXYCHLOROQUINE,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 25, 2020",Interventional,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19: a Randomized, Multicenter, Adaptative Study",COVID
1004,COVID INFECTION,"February 08, 2021",50,NCT04359992,EXTRA BLOOD SAMPLE,,Not yet recruiting,"University Hospital, Strasbourg, France","April 17, 2020",Observational,Study of Hemostasis in Case of Severe COVID-19,COVID
1005,SARS-CoV2,"February 08, 2021",288,NCT04360096,RLF-100 (AVIPTADIL),,Not yet recruiting,"NeuroRx, Inc.","January 10, 2021",Interventional,Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19,COVID
1006,CORONAVIRUS DISEASE (COVID),"February 08, 2021",100,NCT04360122,LEVAMISOLE,EGYPT,Not yet recruiting,Ain Shams University,"May 20, 2020",Interventional,Impact of Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,COVID
1007,COVID,"February 08, 2021",1500,NCT04360278,,UNITED STATES,Recruiting,National Institutes of Health Clinical Center (CC),"April 21, 2020",Observational,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,COVID
1008,COVID,"February 08, 2021",100,NCT04360356,IVERMECTIN PLUS NITAZOXANIDE,,Not yet recruiting,Tanta University,May 2020,Interventional,Clinical Trial Evaluating Safety and Efficacy of Ivermectin and Nitazoxanide Combination as Adjuvant Therapy in COVID-19 Newly Diagnosed Egyptian Patients: A Tanta University Hope,COVID
1009,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",,NCT04360486,ANTI-SARS-COV-2 CONVALESCENT PLASMA,AFGHANISTAN,Available,U.S. Army Medical Research and Development Command,,Expanded Access,Expanded Access Protocol For The Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),COVID
1010,CRITICAL ILLNESS,"February 08, 2021",500,NCT04360538,QUALITY OF LIFE,UNITED STATES,Recruiting,University of Chicago,"April 8, 2020",Observational,Long Term Outcomes of Patients With COVID-19,Unrelated
1011,COVID,"February 08, 2021",40,NCT04360551,TELMISARTAN 40MG,UNITED STATES,Recruiting,University of Hawaii,"July 1, 2020",Interventional,"Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients",COVID
1012,SARS-CoV2,"February 08, 2021",300,NCT04360707,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 8, 2020",Observational,Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France,COVID
1013,SARS-CoV2,"February 08, 2021",200,NCT04360733,BLOOD DRAW,GERMANY,Recruiting,University of Bonn,"April 20, 2020",Observational,Precision Immunology Approach to Better Understand the Divergent Host Responses Towards Infection With SARS-CoV-2,COVID
1014,COVID,"February 08, 2021",0,NCT04360759,CHLOROQUINE OR HYDROXYCHLOROQUINE,SOUTH AFRICA,Withdrawn,University of Cape Town,"May 1, 2020",Interventional,Multi-centre Randomised Controlled Trial of Chloroquine/Hydroxychloroquine Versus Standard of Care for Treatment of Mild Covid-19 in HIV-positive Outpatients in South Africa,COVID
1015,PREGNANCY,"February 08, 2021",3600,NCT04360811,COVID 19 DIAGNOSTIC TEST BY PCR,FRANCE,Recruiting,"University Hospital, Toulouse","April 17, 2020",Interventional,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic by Creation and Analysis of a Biological and Tissue Collection of Pregnancy Outcomes",Unrelated
1016,COVID ASSOCIATED COAGULOPATHY,"February 08, 2021",170,NCT04360824,INTERMEDIATE DOSE THROMBOPROPHYLAXIS,UNITED STATES,Recruiting,University of Iowa,"May 6, 2020",Interventional,COVID-19-associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults With COVID-19,COVID
1017,COVID,"February 08, 2021",10,NCT04360837,ALVEOLAR RECRUITMENT,HUNGARY,Recruiting,Szeged University,"May 6, 2020",Interventional,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill COVID-19 Patients Under Electric Impedance Tomography (EIT),COVID
1018,ONLINE THERAPY,"February 08, 2021",10000,NCT04360850,ONLINE SURVEY,UNITED STATES,Recruiting,University of Washington,"April 24, 2020",Observational,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,Unrelated
1019,SMOKING CESSATION,"February 08, 2021",150,NCT04360863,TELEPHONE SURVEY,HONG KONG,Recruiting,The University of Hong Kong,"April 24, 2020",Observational,The Impact of Coronavirus Disease (COVID-19) Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong: A Survey Study,Unrelated
1020,COVID,"February 08, 2021",0,NCT04360876,DEXAMETHASONE INJECTION,,Withdrawn,"University of Colorado, Denver","September 1, 2020",Interventional,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,COVID
1021,COVID,"February 08, 2021",461,NCT04360954,DIAGNOSTIC TEST,UNITED STATES,Completed,Washington University School of Medicine,"April 23, 2020",Observational,Evaluation of Commerical Antibody Tests for COVID-19,COVID
1022,COVID,"February 08, 2021",80,NCT04360980,COLCHICINE TABLETS,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Shahid Beheshti University of Medical Sciences,"March 20, 2020",Interventional,Effects of Standard Protocol Therapy With or Without Colchicine in Covid-19 Infection: A Randomized Double Blind Clinical Trial,COVID
1023,PHYSICAL ACTIVITY,"February 08, 2021",25000,NCT04361019,ON-LINE SURVEY,SPAIN,Recruiting,Basque Country University,"April 16, 2020",Observational,Physical Activity in University Students Around COVID-19 Confinement: Determinants and Consequences on Health Status and Quality of Life,Unrelated
1024,COVID,"February 08, 2021",260,NCT04361032,TOCILIZUMAB INJECTION,TUNISIA,Not yet recruiting,Abderrahmane Mami Hospital,"September 4, 2020",Interventional,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia. Multicentric, Comparative, Randomized Study",COVID
1025,CORONAVIRUS,"February 08, 2021",450000,NCT04361123,DAILY SYNDROMIC SURVEILLANCE,UNITED STATES,Enrolling by invitation,"Michael Runyon, MD","May 6, 2020",Observational,"A Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records",COVID
1026,COVID,"February 08, 2021",20,NCT04361214,LEFLUNOMIDE,UNITED STATES,Recruiting,University of Chicago,"May 5, 2020",Interventional,Leflunomide for the Treatment of Ambulatory Patients With Mild COVID-19,COVID
1027,COVID,"February 08, 2021",220,NCT04361253,HIGH-TITER COVID-19 CONVALESCENT PLASMA (HT-CCP),UNITED STATES,Recruiting,Brigham and Women's Hospital,"April 30, 2020",Interventional,"A Prospective, Randomized, Double-Masked, Placebo-Controlled Trial of High-Titer COVID-19 Convalescent Plasma (HT-CCP) for the Treatment of Hospitalized Patients With COVID-19 of Moderate Severity",COVID
1028,COVID,"February 08, 2021",100,NCT04361318,HYDROXYCHLOROQUINE PLUS NITAZOXANIDE,,Not yet recruiting,Tanta University,May 2020,Interventional,Clinical Trial Evaluating Safety and Efficacy of Hydroxychloroquine and Nitazoxanide Combination as Adjuvant Therapy in Covid-19 Newly Diagnosed Egyptian Patients: A Tanta University Hope,COVID
1029,COVID INFECTION,"February 08, 2021",2,NCT04361344,BLOOD SAMPLES,FRANCE,Terminated,Centre Hospitalier de PAU,"May 19, 2020",Interventional,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection - MARNEVO-Covid,COVID
1030,CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04361396,COLLECTION OF SAMPLES,FRANCE,Recruiting,Centre Hospitalier René Dubos,"June 16, 2020",Interventional,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum During an Emergency Laparoscopy Conducted on Confirmed or Suspected COVID-19 Patients,COVID
1031,COVID,"February 08, 2021",300,NCT04361422,ISOTRETINOIN ONLY PRODUCT IN ORAL DOSE FORM,,Not yet recruiting,Tanta University,"December 1, 2020",Interventional,Evaluation of the Safety and Efficacy of Isotretinoin in Treatment of COVID-19: Clinical Study,COVID
1032,COVID,"February 08, 2021",50,NCT04361435,CHEST PHYSIOTHERAPY USING A NON-INVASIVE OSCILLATING DEVICE,,Not yet recruiting,St. Justine's Hospital,"May 1, 2020",Interventional,Comparison of Two Methods to Airway Clearance in Patients Admitted to Intensive Care Unit for COVID-19: A Pilot Corssover Randomized Controlled Trial,COVID
1033,COVID,"February 08, 2021",30,NCT04361448,SAMLING OF OROPHARYNX AND NASOPHARYNX,BELGIUM,Not yet recruiting,Jessa Hospital,"April 20, 2020",Interventional,Comparison of the Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,COVID
1034,CORONAVIRUS INFECTION,"February 08, 2021",0,NCT04361461,HYDROXYCHLOROQUINE SULFATE,BRAZIL,Withdrawn,Apsen Farmaceutica S.A.,"April 30, 2020",Interventional,Hydroxychloroquine or Hydroxychloroquine Associated With Azithromycin for Inpatients With Moderate or Severe Lung Disease Due to SARS-CoV-2 (COVID-19),COVID
1035,BUDESONIDE,"February 08, 2021",120,NCT04361474,BUDESONIDE NASAL,FRANCE,"Active, not recruiting",Fondation Ophtalmologique Adolphe de Rothschild,"May 18, 2020",Interventional,A Randomized Controlled Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Unrelated
1036,COVID,"February 08, 2021",100,NCT04361500,SERAPH 100,GERMANY,Recruiting,Hannover Medical School,"April 15, 2020",Observational [Patient Registry],Registry for the Evaluation of Safety and Effectiveness of the Seraph 100 Microbind Affinity Blood Filter in the Therapy of COVID-19 Patients (COSA),COVID
1037,CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04361526,CYTOKINE ADSORPTION,SPAIN,Recruiting,Manuel Castellà,"April 17, 2020",Interventional,Pilot Study on Cytokine Filtration in COVID-19 ARDS (CytokCOVID19),COVID
1038,CEREBROVASCULAR ACCIDENT,"February 08, 2021",0,NCT04361552,BEST PRACTICE,UNITED STATES,Withdrawn,Emory University,"April 7, 2020",Interventional,"Tociluzumab for Cytokine Release Syndrome With SARS-CoV-2: An Open-Labeled, Randomized Phase 3 Trial",Unrelated
1039,COVID BY SARS-CoV2 INFECTION,"February 08, 2021",50,NCT04361565,,FRANCE,Enrolling by invitation,Centre Hospitalier Universitaire de Nice,"March 20, 2020",Observational,Prevalence and Clinical Evolution of Olfactory and Taste Disorders in Patients Infected by SARS-CoV-2,COVID
1040,LIVER TRANSPLANT; COMPLICATIONS,"February 08, 2021",200,NCT04361591,OBSERVATIONAL ONLY,SPAIN,Recruiting,Hospital Clinic of Barcelona,"March 1, 2020",Observational [Patient Registry],COVID-19 in Liver Transplant Recipients in Spain: a Nationwide Prospective Study,Unrelated
1041,ADULT PATIENTS LIVING WITH HIV (PLWHIV) WITH CONFIRMED INFECTION WITH SARS-CoV2 SINCE 1ST JANUARY 2020,"February 08, 2021",270,NCT04361604,BIOLOGICAL COLLECTION (PATIENTS CO INFECTED HIV SRAS-COV-2),FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,April 2020,Observational,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,COVID
1042,COVID,"February 08, 2021",120,NCT04361643,"LENALIDOMIDE AS A 5 MG CAPSULE PO DAILY, DAYS 1, 3, AND 5.",SPAIN,Not yet recruiting,Hospital Universitario Getafe,"October 27, 2020",Interventional,Double-blind Randomized Controlled Clinical Trial of Low-dose Lenalidomide in the Treatment of COVID-19 Disease,COVID
1043,COVID,"February 08, 2021",10,NCT04361786,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection: Search for Acquired Thrombophilia and Interferon-alpha Signature,COVID
1044,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04361838,PRAYER,UNITED STATES,Recruiting,Kansas City Heart Rhythm Institute,"June 1, 2020",Interventional,Impact of Multi-Denominational Prayer on Morbidity and Mortality of Patients Admitted to the Intensive Care Unite With Corona Virus Infection,COVID
1045,CARDIOVASCULAR PREVENTION BEHAVIOUR,"February 08, 2021",1900,NCT04361877,,GERMANY,Recruiting,Klinikum der Universitaet Muenchen,"March 30, 2020",Observational,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),Unrelated
1046,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",13,NCT04361903,RUXOLITINIB ORAL TABLET,,Not yet recruiting,Azienda USL Toscana Nord Ovest,"April 25, 2020",Observational,COVID-19: Ruxolitinib for the Treatment of cytokinE Storm resPiratory dIstREss Syndrome. RESPIRE Study,COVID
1047,COVID,"February 08, 2021",37,NCT04361916,HOME CARE MONITORING,ITALY,Terminated,Mario Negri Institute for Pharmacological Research,"April 21, 2020",Interventional,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),COVID
1048,COVID PNEUMONIA,"February 08, 2021",24,NCT04361942,MESENCHYMAL STROMAL CELLS,SPAIN,Recruiting,Red de Terapia Celular,"May 1, 2020",Interventional,"Double Blind, Placebo-controlled, Phase II Trial to Evaluate Safety and Efficacy of Allogenic Mesenchymal Stromal Cells MSV_allo for Treatment of Acute Respiratory Failure in Patients With COVID-19 Pneumonia (COVID_MSV)",COVID
1049,COVID,"February 08, 2021",50,NCT04361981,DEEP VENOUS DISEASE DIAGNOSTIC,SPAIN,Not yet recruiting,Sociedad Espanola de Angiologia y Cirugia Vascular,April 2020,Observational [Patient Registry],National Cohort Study to Assess the Influence of COVID-19 Infection in Thromboembolic Venous Disease:,COVID
1050,RESPIRATORY INFECTIONS,"February 08, 2021",24,NCT04362059,COVSURF DRUG DELIVERY SYSTEM,UNITED KINGDOM,Recruiting,University Hospital Southampton NHS Foundation Trust,"June 18, 2020",Interventional,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Respiratory
1051,COVID,"February 08, 2021",462,NCT04362085,THERAPEUTIC ANTICOAGULATION,CANADA,Recruiting,Unity Health Toronto,"May 11, 2020",Interventional,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG),COVID
1052,CYTOKINE STORM,"February 08, 2021",30,NCT04362111,ANAKINRA,UNITED STATES,Recruiting,University of Alabama at Birmingham,"July 29, 2020",Interventional,Early Treatment of Cytokine Storm Syndrome in Covid-19,Unrelated
1053,COVID,"February 08, 2021",0,NCT04362124,VACCINE BCG,COLOMBIA,Withdrawn,Universidad de Antioquia,August 2020,Interventional,"Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection in Medellín, Colombia, 2020",COVID
1054,CYTOKINE STORM (COVID),"February 08, 2021",432,NCT04362137,RUXOLITINIB,ARGENTINA,Completed,Novartis Pharmaceuticals,"May 2, 2020",Interventional,"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",COVID
1055,COVID,"February 08, 2021",800,NCT04362150,,UNITED STATES,"Active, not recruiting","University of California, San Francisco","April 21, 2020",Observational,Long-term Impact of Infection With Novel Coronavirus (LIINC): An Observational Study,COVID
1056,HEALTHY,"February 08, 2021",10,NCT04362163,SNORKEL-BASED IMPROVISED PERSONAL PROTECTIVE EQUIPMENT,UNITED KINGDOM,Completed,Guy's and St Thomas' NHS Foundation Trust,"May 1, 2020",Observational,Study for Testing and Reviewing Improvised PPE Effectiveness 3 (STRIPE-3) - a Third Comparative Trial Assessing the Safety of Improvised PPE,Unrelated
1057,COVID,"February 08, 2021",1000,NCT04362176,PATHOGEN REDUCED SARS-COV-2 CONVALESCENT PLASMA,UNITED STATES,Recruiting,Vanderbilt University Medical Center,"April 24, 2020",Interventional,Passive Immunity Trial for Our Nation (PassItOn),COVID
1058,COVID,"February 08, 2021",100,NCT04362189,HB-ADMSC,UNITED STATES,"Active, not recruiting",Hope Biosciences,"June 30, 2020",Interventional,"A Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19",COVID
1059,SARS-CoV2,"February 08, 2021",150,NCT04362267,SELF-ADMINISTERED QUESTIONNAIRE,FRANCE,Recruiting,"University Hospital, Lille","June 15, 2020",Observational,Incidence of SARS-Cov2 Infection Among HCW in Lille University Hospital,COVID
1060,"BURNOUT, PROFESSIONAL","February 08, 2021",85,NCT04362319,QUESTIONNAIRE FORMS,MALAYSIA,Completed,University of Malaya,"May 15, 2020",Observational,Burnout and Medical Errors in the Anaesthesiology Fraternity in an Exclusively Covid-19 Hospital: the Malaysian Experience,Unrelated
1061,COVID,"February 08, 2021",25,NCT04362332,CHLOROQUINE SULFATE,NETHERLANDS,Terminated,UMC Utrecht,"April 14, 2020",Interventional,"An Open Label Cluster Randomized Controlled Trial of Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",COVID
1062,COVID,"February 08, 2021",100,NCT04362345,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 9, 2020",Observational,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia in France,COVID
1063,"STRESS - PREVENTION OF SLEEP DISORDERS, PTSD AND DEPRESSION","February 08, 2021",120,NCT04362358,ONLINE COGNITIVE BEHAVIORAL THERAPY (CBT),,Not yet recruiting,"University Hospital, Strasbourg, France","May 1, 2020",Interventional,Efficacy of an Online Cognitive Behavioral Therapy (CBT) Programme Aiming at Reducing the Stress of Health Workers Involved in the Care of Patients During the Covid-19 Epidemic: a Randomized-controlled Trial,Unrelated
1064,PNEUMONIA AND CYTOKINE RELEASE SYNDROME (COVID),"February 08, 2021",451,NCT04362813,CANAKINUMAB,FRANCE,"Active, not recruiting",Novartis Pharmaceuticals,"April 30, 2020",Interventional,"Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Canakinumab on Cytokine Release Syndrome in Patients With COVID-19-induced Pneumonia (CAN-COVID)",COVID
1065,COVID,"February 08, 2021",180,NCT04362865,,UNITED STATES,Recruiting,National Cancer Institute (NCI),"April 27, 2020",Observational,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,COVID
1066,NEUROLOGIC MANIFESTATIONS,"February 08, 2021",2000,NCT04362930,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 27, 2020",Observational,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders: An Observational Study of the Covid-19 Neurological and Psychiatric Manifestations,Unrelated
1067,COVID,"February 08, 2021",576,NCT04362943,BARICITINIB OR ANAKINRA,SPAIN,Recruiting,Complejo Hospitalario Universitario de Albacete,"April 20, 2020",Observational,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,COVID
1068,COVID,"February 08, 2021",200,NCT04362956,,ARGENTINA,Recruiting,Fundacion Infant,"July 10, 2020",Observational,Clinical and Immunologic Impact of SARS-CoV-2 in Hospitalized Pregnant Women and Neonates in Argentina,COVID
1069,COVID,"February 08, 2021",300,NCT04362969,,ECUADOR,Not yet recruiting,"Hospital San Carlos, Madrid",May 2020,Observational,"Clinical Characteristics of Patients With SARS-CoV-2 (COVID-19) Infection in Guayaquil, Ecuador: COVID-EC Study",COVID
1070,COVID,"February 08, 2021",1517,NCT04362995,,UNITED STATES,Recruiting,St. Jude Children's Research Hospital,"April 23, 2020",Observational,SJTRC-St. Jude Tracking of Viral and Host Factors Associated With COVID-19: A Prospective Adaptive Cohort Study,COVID
1071,COVID,"February 08, 2021",150,NCT04363008,SERUM INFLAMMATORY BIOMARKERS,CANADA,Recruiting,University of British Columbia,"March 30, 2020",Observational,"COVID-19 Inflammatory Blood Biomarkers for Clinical Management, Prognosis and Evaluation of Interventions",COVID
1072,COVID,"February 08, 2021",,NCT04363034,CONVALESCENT PLASMA,,Available,University of Arkansas,,Expanded Access,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,COVID
1073,SARS VIRUS,"February 08, 2021",125,NCT04363047,40ML BLOOD SAMPLE,UNITED KINGDOM,Enrolling by invitation,University of Manchester,"October 1, 2020",Observational,Immune Cells and the Coronavirus for Inflammatory Arthritis,Respiratory
1074,COVID PNEUMONIA,"February 08, 2021",104,NCT04363060,AZITHROMYCIN WITH AMOXICILLIN/CLAVULANATE,FRANCE,Not yet recruiting,Nantes University Hospital,"April 30, 2020",Interventional,Azithromycin With Amoxicillin/Clavulanate Versus Amoxicillin/Clavulanate Alone in COVID-19 Patients With Pneumonia and Hospitalized in a Non-intensive Care Unit Ward (AziA): a Superiority Open-label Randomized Controlled Trial,COVID
1075,COVID,"February 08, 2021",1000,NCT04363099,OBSERVATIONAL,FRANCE,Recruiting,Maison de Sante Pluridisciplinaire de Creil,"March 1, 2020",Observational,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,COVID
1076,PERINATAL DEPRESSION,"February 08, 2021",200,NCT04363177,WEB-BASED PSYCHOSOCIAL PEER-TO-PEER SUPPORT,CHINA,Not yet recruiting,Karolinska Institutet,"November 1, 2020",Interventional,Mental Health of Urban Mothers (MUM) Study: A Multi-center Randomized Controlled Trial,Unrelated
1077,SARS-CoV2,"February 08, 2021",300,NCT04363203,HYDROXYCHLOROQUINE,UNITED STATES,Suspended,Salomeh Keyhani MD,"April 30, 2020",Interventional,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),COVID
1078,COVID,"February 08, 2021",66,NCT04363216,ASCORBIC ACID,,Not yet recruiting,Thomas Jefferson University,May 2020,Interventional,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,COVID
1079,OCCUPATIONAL STRESS,"February 08, 2021",250,NCT04363229,MASLACH BURNOUT INVENTORY QUESTIONNAIR,,Not yet recruiting,Assiut University,July 2020,Observational,Psychological Impact of COVID19 Among Doctors in Assiut University Hospitals,Unrelated
1080,CORONAVIRUS,"February 08, 2021",1000000,NCT04363268,,UNITED STATES,Recruiting,Medable Inc.,"April 20, 2020",Observational,"ACCESS (American COVID-19 Collaborative, Enabling Seamless Science) Master Digital Surveillance and Associated Clinical Trials Protocol for COVID-19",COVID
1081,COVID,"February 08, 2021",320,NCT04363333,HOME SLEEP APNEA TESTING OR IN-HOSPITAL POLYSOMNOGRAPHY,TURKEY,"Active, not recruiting",Koç University,"April 27, 2020",Observational,Impact of Obstructive Sleep Apnea on Covid-19 Outcomes (OSACOVID-19 Study): A Prospective Observational Cohort Study,COVID
1082,COVID,"February 08, 2021",5,NCT04363346,FT516,UNITED STATES,"Active, not recruiting","Masonic Cancer Center, University of Minnesota","May 14, 2020",Interventional,Study of FT516 Safety and Feasibility for the Treatment of Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients With Hypoxia,COVID
1083,COVID,"February 08, 2021",90,NCT04363372,MRX-4DP0004,UNITED KINGDOM,Recruiting,4D pharma plc,June 2020,Interventional,"A Pilot, Multiple Dose Study to Evaluate the Efficacy and Safety of MRx-4DP0004 in Hospitalised Patients With Symptoms of COVID-19 (SARS-CoV-2 Infection)",COVID
1084,COVID,"February 08, 2021",500,NCT04363385,BIOLOGICAL TEST,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 31, 2020",Interventional,Cohort of Patients With Covid19: Constitution of Blood Samples Collections With Clinical Characterization,COVID
1085,CORONAVIRUS INFECTION,"February 08, 2021",70,NCT04363437,COLCHICINE,UNITED STATES,Recruiting,Maimonides Medical Center,"April 26, 2020",Interventional,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 (the COMBAT-COVID-19 Pilot Study),COVID
1086,COVID,"February 08, 2021",1700,NCT04363450,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,Louisiana State University Health Sciences Center in New Orleans,"April 27, 2020",Interventional,Hydroxychloroquine as Primary Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),COVID
1087,COVID,"February 08, 2021",400,NCT04363463,PRONE POSITION,FRANCE,Recruiting,Centre Hospitalier Régional d'Orléans,"August 28, 2020",Interventional,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,COVID
1088,COVID,"February 08, 2021",60,NCT04363489,WEARABLE MEDICAL DEVICE (EMPATICA E4),,Not yet recruiting,King's College London,"August 1, 2020",Observational,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers),COVID
1089,COVID,"February 08, 2021",30,NCT04363502,CLAZAKIZUMAB,UNITED STATES,Recruiting,Johns Hopkins University,"May 7, 2020",Interventional,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,COVID
1090,DEEP VEIN THROMBOSIS,"February 08, 2021",50,NCT04363528,DOPPLER ECHO,FRANCE,Recruiting,Versailles Hospital,"April 24, 2020",Interventional,Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Unrelated
1091,COVID,"February 08, 2021",274,NCT04363541,ELECTRIC PAD FOR HUMAN EXTERNAL PAIN THERAPY,MEXICO,Recruiting,Instituto Nacional de Perinatologia,"August 27, 2020",Interventional,"A Multicenter, Open-label, Parallel-group, Randomized, Adaptive Trial to Evaluate Local Thermotherapy in Patients With Mild-to-moderate COVID-19, to Prevent Disease Progression",COVID
1092,CORONAVIRUS INFECTION,"February 08, 2021",2587,NCT04363593,SEROLOGICAL TEST,FRANCE,Completed,Centre Hospitalier de Cornouaille,"May 4, 2020",Interventional,Serology COVID-19 From the Cornwall Hospital Union,COVID
1093,CHRONIC FATIGUE SYNDROME,"February 08, 2021",82,NCT04363606,QUESTIONNAIRES,FRANCE,Recruiting,Centre Hospitalier Universitaire de Saint Etienne,"May 27, 2020",Interventional,Chronic Fatigue Etiology and Recovery in Covid-19 Patients : the Role of Fatigability and Stay in Intensive Care,Unrelated
1094,SARS-CoV2,"February 08, 2021",1231,NCT04363632,,FRANCE,Completed,Centre Leon Berard,"April 2, 2020",Observational [Patient Registry],Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection,COVID
1095,REMOTE CONSULTATION,"February 08, 2021",30,NCT04363671,,FRANCE,Not yet recruiting,Hôpital Cochin,May 2020,Observational,Qualitative Study of the Experience of Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine,Unrelated
1096,COVID PNEUMONIA,"February 08, 2021",100,NCT04363736,TOCILIUZUMAB,UNITED STATES,Completed,Hoffmann-La Roche,"May 5, 2020",Interventional,"A Phase-II, Open-Label, Randomized, Multicenter Study to Investigate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of 8 mg/kg or 4mg/kg Intravenous Tocilizumab in Patients With Moderate to Severe COVID-19 Pneumonia",COVID
1097,COVID,"February 08, 2021",30,NCT04363749,"HYPOXIA : 14.3 AND 12.7% FIO2, HYPERCAPNIA 7% CO2, INSPIRATORY MECHANICAL CONSTRAINT",,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"April 27, 2020",Interventional,Do Respiratory Control Center Anomalies Explain the Lack of Respiratory Sensations Perceptions Observed in Patients Affected by COVID-19 ?,COVID
1098,TRACHEAL INTUBATION,"February 08, 2021",35,NCT04363775,THE STANDARD MACINTOSH LARYNGOSCOPE,POLAND,Completed,Lazarski University,"January 20, 2020",Interventional,Comparison of VieScope Versus Macintosh Laryngoscope for Emergency Intubation Under Level C Personal Protective Equipment Conditions,Unrelated
1099,CARDIAC ARREST,"February 08, 2021",300,NCT04363788,DOUBLE GLOVES,POLAND,Completed,Lazarski University,"February 28, 2020",Observational,Should we Use Double Gloves During Procedures With Suspected/Confirmed COVID-19 Patient?,Unrelated
1100,COVID,"February 08, 2021",100,NCT04363814,BACTEK-R,DOMINICAN REPUBLIC,Recruiting,Inmunotek S.L.,"June 10, 2020",Interventional,"A Prospective, Open-label, Randomized Pilot Study (Including a Control Group) of BACTEK-R (MV130), Administered Sublingually to Assess the Clinical Impact in Subjects With Mild Pneumonia Due to COVID-19",COVID
1101,COVID,"February 08, 2021",2300,NCT04363827,HYDROXYCHLOROQUINE,ITALY,Recruiting,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,"May 14, 2020",Interventional,PROTECT: A Randomized Study With Hydroxychloroquine Versus Observational Support for Prevention or Early Phase Treatment of Coronavirus Disease (COVID-19),COVID
1102,COVID,"February 08, 2021",1080,NCT04363840,ASPIRIN 81 MG,,Not yet recruiting,Louisiana State University Health Sciences Center in New Orleans,May 2020,Interventional,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",COVID
1103,SARS-CoV2,"February 08, 2021",200,NCT04363853,TOCILIZUMAB,MEXICO,"Active, not recruiting",Instituto Nacional de Cancerologia de Mexico,"June 1, 2020",Interventional,Treatment of Serious and Critical Patients With COVID-19 With Tocilizumab,COVID
1104,COVID,"February 08, 2021",0,NCT04363866,HYDROXYCHLOROQUINE,UNITED STATES,Withdrawn,Oregon Health and Science University,August 2020,Interventional,A Randomized-Control Pilot Study to Assess Hydroxychloroquine in Patients Infected With SARS-CoV-2 (COVID-19),COVID
1105,COVID INFECTION,"February 08, 2021",71,NCT04364009,ANAKINRA PLUS OSOC,FRANCE,Terminated,"University Hospital, Tours","April 27, 2020",Interventional,"Efficacy and Safety of ANAkinra During Adult "" COVID-19 "" With Aggravating Respiratory Symptoms: a Multicenter Open-label Controlled Randomized Trial",COVID
1106,PREVENTION OF COVID,"February 08, 2021",300,NCT04364022,LOPINAVIR/RITONAVIR,SWITZERLAND,Recruiting,Calmy Alexandra,"April 23, 2020",Interventional,Efficacy of Pragmatic Same-day Ring COVID-19 Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland: an Open-label Cluster Randomized Trial,COVID
1107,COVID,"February 08, 2021",50,NCT04364594,CONJUNCTIVAL SWAB,ITALY,Completed,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"March 26, 2020",Interventional,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Diagnostic Targets for Customized Medicine.,COVID
1108,COVID,"February 08, 2021",500,NCT04364698,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 7, 2020",Observational,Observational Cohort of COVID-19 Patients at Raymond-Poincare,COVID
1109,COVID,"February 08, 2021",2000,NCT04364711,,,Not yet recruiting,UMC Utrecht,"May 1, 2020",Observational,Multi-centre EuRopean Study of MAjor Infectious Disease Syndromes (MERMAIDS) - Acute Respiratory Infections (MERMAIDS ARI) 2.0,COVID
1110,COVID,"February 08, 2021",1000,NCT04364737,CONVALESCENT PLASMA,UNITED STATES,Recruiting,NYU Langone Health,"April 17, 2020",Interventional,CONTAIN COVID-19: Convalescent Plasma to Limit Coronavirus Associated Complications: a Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV2 Plasma to Placebo in COVID-19 Hospitalized Patients,COVID
1111,COVID,"February 08, 2021",252,NCT04364763,RBT-9 (90 MG),UNITED STATES,Recruiting,"Renibus Therapeutics, Inc.","August 5, 2020",Interventional,"A Phase 2, Randomized, Placebo-Controlled Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)",COVID
1112,COVID,"February 08, 2021",300,NCT04364802,POVIDONE-IODINE NASAL SPRAY AND GARGLE,UNITED STATES,Recruiting,Alexandra Kejner,"April 29, 2020",Interventional,Povidone-Iodine Intranasal for Prophylaxis in Front-line Health-care Personnel and Inpatients During the Sars-CoV-2 Pandemic,COVID
1113,COVID,"February 08, 2021",0,NCT04364815,HYDROXYCHLOROQUINE PLUS STANDARD PREVENTIVE MEASURES,PHILIPPINES,Withdrawn,University of the Philippines,December 2020,Interventional,"Efficacy and Safety of Hydroxychloroquine for COVID-19 Post-Exposure Prophylaxis of Healthcare Workers in the Philippine General Hospital and UP Manila National Institutes of Health: A Randomized, Double-blind, Placebo-controlled Trial",COVID
1114,COVID,"February 08, 2021",1000,NCT04364828,WHOLE GENOME ANALYSIS,,Not yet recruiting,University Hospital Tuebingen,January 2021,Interventional,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,COVID
1115,CORONAVIRUS INFECTION,"February 08, 2021",700,NCT04364893,SUSPENSION OR MAINTENANCE OF ANGIOTENSIN RECEPTOR BLOCKERS AND ANGIOTENSIN-CONVERTING ENZYME INHIBITORS,BRAZIL,Recruiting,D'Or Institute for Research and Education,"April 9, 2020",Interventional,Suspension of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Hospitalized Patients With Coronavirus Infection (COVID-19). A Randomized Trial,COVID
1116,HYPERTENSION,"February 08, 2021",10,NCT04364984,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,UKRAINE,Recruiting,Medical Practice Prof D. Ivanov,"April 1, 2020",Observational [Patient Registry],"ARB, ACEi, DRi Usage in COVID-19",Unrelated
1117,CORONAVIRUS,"February 08, 2021",86,NCT04365101,CYNK-001,UNITED STATES,Recruiting,Celularity Incorporated,"May 13, 2020",Interventional,A Phase I/II Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) for the Treatment of Adults With COVID-19,COVID
1118,COVID,"February 08, 2021",40,NCT04365127,PROGESTERONE 100 MG,UNITED STATES,Completed,Sara Ghandehari,"April 27, 2020",Interventional,"A Single Center, Randomized, Controlled Trial of the Safety and Efficacy of Progesterone for the Treatment of COVID-19 in Hospitalized Men",COVID
1119,COVID,"February 08, 2021",45,NCT04365153,CANAKINUMAB INJECTION 600MG,UNITED STATES,"Active, not recruiting",The Cleveland Clinic,"April 24, 2020",Interventional,Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function in SARSCoV2 Associated Acute Myocardial Injury With Heightened Inflammation,COVID
1120,RESPIRATORY TRACT INFECTIONS,"February 08, 2021",100,NCT04365166,,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"April 21, 2020",Observational,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2,Respiratory
1121,COVID,"February 08, 2021",0,NCT04365231,HYDROXYCHLOROQUINE AND AZITHROMYCIN TREATMENT,,Withdrawn,"Hospital St. Joseph, Marseille, France","April 1, 2020",Interventional,Efficacy Evaluation of Hydroxychloroquine Azithromycin in the Treatment of COVID-19 in Pregnant Women: an Open-label Randomized Clinical Trial,COVID
1122,COVID,"February 08, 2021",220,NCT04365257,PRAZOSIN,UNITED STATES,Recruiting,Johns Hopkins University,"May 13, 2020",Interventional,Alpha-1 Adrenergic Receptor Antagonism to Prevent COVID-19 Cytokine Storm Syndrome and Acute Respiratory Distress Syndrome: A Randomized Study Comparing the Efficacy of Prazosin vs. Standard of Care for SARS-CoV-2 Infection,COVID
1123,NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",128,NCT04365309,ASPIRIN 100MG,CHINA,Enrolling by invitation,Xijing Hospital,"February 10, 2020",Interventional,Protective Effect of Aspirin on COVID-19 Patients,COVID
1124,SARS-CoV2 INFECTION,"February 08, 2021",160,NCT04365322,ADDITIONAL BIOLOGICAL SAMPLES,FRANCE,Recruiting,Centre Hospitalier Universitaire de Besancon,"April 20, 2020",Observational [Patient Registry],Étude Des réponses Immunitaires Lymphocytaires spécifiques Chez Des Patients infectés Par le Virus SARS-CoV-2 : Caractéristiques Des Réponses Effectrices et Mémoires,COVID
1125,OCCUPATIONAL STRESS,"February 08, 2021",50,NCT04365335,ASSESSMENT OF WORK-RELATED STRESS,FRANCE,Completed,Direction Centrale du Service de Santé des Armées,"April 25, 2020",Observational,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,Unrelated
1126,MENTAL HEALTH WELLNESS 1,"February 08, 2021",300,NCT04365348,,HONG KONG,Recruiting,The University of Hong Kong,"April 27, 2020",Observational,Exploring the Psychological Impact of the COVID-19 Outbreak on COVID-19 Survivors and Their Families,Unrelated
1127,MENTAL HEALTH WELLNESS 1,"February 08, 2021",300,NCT04365361,,HONG KONG,Recruiting,The University of Hong Kong,"April 26, 2020",Observational,Exploring the Psychological Impact of the COVID-19 on Higher Education Students,Unrelated
1128,BLOOD PLASMA THERAPY,"February 08, 2021",10,NCT04365439,BLOOD PLASMA,,Not yet recruiting,Enos Bernasconi,"April 27, 2020",Interventional,Convalescent Plasma for the Treatment of Moderate-severe COVID-19: A Proof-of-principle Study,Unrelated
1129,COVID,"February 08, 2021",170,NCT04365517,SITAGLIPTIN,ITALY,Not yet recruiting,University of Milan,"December 29, 2020",Interventional,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,COVID
1130,COVID,"February 08, 2021",2000,NCT04365530,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"April 1, 2020",Observational,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,COVID
1131,COVID,"February 08, 2021",640,NCT04365582,AZITHROMYCIN,FRANCE,Suspended,Groupe Hospitalier Paris Saint Joseph,"May 7, 2020",Interventional,A Randomized Trial of Efficacy and Safety of an Early OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome: a Strategy to Prevent Hospitalization,COVID
1132,SARS-CoV2,"February 08, 2021",200,NCT04365595,"QUESTIONNAIRES, SPIROMETRY",SWITZERLAND,Recruiting,University of Zurich,"June 3, 2020",Observational,Recovery in Patients With SARS-CoV-2 Associated Respiratory Failure,COVID
1133,INTUBATION COMPLICATION,"February 08, 2021",90,NCT04365608,DIRECT LARYNGOSCOPY,POLAND,Completed,Lazarski University,"March 20, 2020",Interventional,Safety and Efficacy of Endotracheal Intubation by Paramedics in Suspected/Confirmed COVID-19 Patients Under Cardiac Arrest Using Vie Scope Laryngoscope,Unrelated
1134,COVID,"February 08, 2021",306,NCT04365634,,CHINA,Completed,Tongji Hospital,"February 2, 2020",Observational,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients by Univariate and Multivariate Analysis.,COVID
1135,COVID,"February 08, 2021",500,NCT04365699,AT-001,UNITED STATES,Recruiting,NYU Langone Health,"April 8, 2020",Interventional,A Single-center Registry and Embedded Interventional Study of the Effects of COVID-19 With and Without Treatment With AT-001 on Cardiac Structure and Function in Patients Hospitalized for Management of COVID-19 Infection,COVID
1136,COVID,"February 08, 2021",200,NCT04365725,REMDESIVIR,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 5, 2020",Observational,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections.",COVID
1137,COVID,"February 08, 2021",270,NCT04365738,REHABILITATION,TURKEY,Completed,Istanbul Bilgi University,"March 11, 2020",Interventional,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection: Prospective Randomized Controlled Trial,COVID
1138,COVID,"February 08, 2021",400,NCT04365764,,FRANCE,Recruiting,Groupe Hospitalier Pitie-Salpetriere,"March 14, 2020",Observational,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,COVID
1139,COVID,"February 08, 2021",403,NCT04365816,INTERVIEW,FRANCE,Completed,"University Hospital, Grenoble","April 30, 2020",Observational,Evaluation of the Repercussions of the Coronavirus (Covid 19) Infection on Nutritional Health Status and Nutritional Care : an Observational French Cohort Study One Month After Their Discharge From Hospital,COVID
1140,"LONELINESS, WORRY, RUMINATION, HEALTH ANXIETY, DEPRESSION, ANXIETY","February 08, 2021",10084,NCT04365881,CROSS-SECTIONAL OBSERVATIONAL STUDY,NORWAY,Completed,Modum Bad,"March 31, 2020",Observational,Loneliness During the Non-pharmacological Epidemiological Interventions for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Unrelated
1141,SARS-CoV2,"February 08, 2021",56,NCT04365959,PRONE POSITION,ITALY,"Active, not recruiting",University of Milano Bicocca,"March 20, 2020",Observational,"Study of the Feasibility and Usefulness of the Prone Position in Patients With Respiratory Distress From Covid-19 Not Intubated, in Spontaneous Breath in Oxygen Therapy or Cpap",COVID
1142,ANXIETY,"February 08, 2021",20,NCT04365972,ATTENTION BIAS MODIFICATION (ABM),ISRAEL,Completed,Tel Aviv University,"April 23, 2020",Interventional,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic: An Open Pilot Trial,Unrelated
1143,COVID,"February 08, 2021",500,NCT04365985,NALTREXONE,UNITED STATES,Recruiting,William Beaumont Hospitals,"April 29, 2020",Interventional,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,COVID
1144,COVID DISEASE,"February 08, 2021",1000,NCT04366024,OTHER,CHINA,Recruiting,Xinqiao Hospital of Chongqing,"January 17, 2020",Observational,A Novel Nomogram to Predict Severity of COVID-19,COVID
1145,COVID,"February 08, 2021",560,NCT04366050,RAMIPRIL 2.5 MG ORAL CAPSULE,UNITED STATES,Recruiting,"University of California, San Diego","May 11, 2020",Interventional,"A Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy of Ramipril to Prevent ICU Admission, Need for Mechanical Ventilation or Death in Persons With COVID-19",COVID
1146,COVID,"February 08, 2021",60,NCT04366063,CELL THERAPY PROTOCOL 1,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Royan Institute,"April 5, 2020",Interventional,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 2-3 Clinical Trial,COVID
1147,COVID,"February 08, 2021",152,NCT04366089,"OXYGEN-OZONE THERAPY, PROBIOTIC SUPPLEMENTATION AND STANDARD OF CARE",ITALY,Recruiting,"Roberto Poscia MD, PhD","March 26, 2020",Interventional,Oxygen-Ozone as Adjuvant Treatment in Early Control of Disease Progression in Patients With COVID-19 Associated With Modulation of the Gut Microbial Flora,COVID
1148,ARDS,"February 08, 2021",16,NCT04366115,AVM0703,,Not yet recruiting,AVM Biotechnology LLC,January 2021,Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study Evaluating AVM0703 in Patients With Acute Respiratory Distress Syndrome",Unrelated
1149,COVID,"February 08, 2021",120,NCT04366141,COVID-19 BARRIER BOX,CANADA,Recruiting,University of British Columbia,"May 1, 2020",Interventional,The Impact of a Barrier Enclosure on Endotracheal Intubation Duration and First Pass Attempt - A Randomized Controlled Trial,COVID
1150,COVID,"February 08, 2021",809,NCT04366154,QUESTIONNAIRE,FRANCE,"Active, not recruiting",Centre Francois Baclesse,"April 15, 2020",Observational,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,COVID
1151,CARDIAC SURGERY,"February 08, 2021",100,NCT04366167,CARDIAC SURGERY,UNITED KINGDOM,Recruiting,Barts & The London NHS Trust,"April 18, 2020",Observational,An Observational Cohort Study to Explore Patient Outcome From Heart Surgery During the Covid-19 Pandemic (CardiacCovid),Unrelated
1152,COVID,"February 08, 2021",314,NCT04366180,PROBIOTIC,SPAIN,Recruiting,Biosearch S.A.,"April 24, 2020",Interventional,Multicentric Study to Assess the Effect of Consumption of Lactobacillus Coryniformis K8 on Healthcare Personnel Exposed to COVID-19,COVID
1153,COVID,"February 08, 2021",143,NCT04366206,,FRANCE,Recruiting,Centre Hospitalier Intercommunal Robert Ballanger,"March 14, 2020",Observational [Patient Registry],Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,COVID
1154,COVID,"February 08, 2021",2000,NCT04366219,,,Not yet recruiting,Centre Hospitalier le Mans,June 2020,Observational,"Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer: an Ambispective Study Extended Over 2 Time Periods.",COVID
1155,COVID,"February 08, 2021",2,NCT04366232,ANAKINRA ALONE (STAGES 2B/3),FRANCE,Terminated,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"August 19, 2020",Interventional,"Interleukin-1 (IL-1) and Interferon Gamma (IFNg) Inhibition During COVID 19 Inflammation: Randomized, Controlled Study Assessing Efficacy and Safety of Anakinra and Ruxolitinib",COVID
1156,SARS-CoV2,"February 08, 2021",72,NCT04366245,HYPERIMMUNE PLASMA,SPAIN,Recruiting,Andalusian Network for Design and Translation of Advanced Therapies,"April 23, 2020",Interventional,"Phase I / II Multicentre, Randomized and Controlled Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection",COVID
1157,COVID,"February 08, 2021",106,NCT04366271,MESENCHYMAL CELLS,SPAIN,Recruiting,"Hospital Infantil Universitario Niño Jesús, Madrid, Spain","May 7, 2020",Interventional,Phase II Clinical Trial to Explore the Efficacy of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With Severe Pulmonary Involvement by COVID-19,COVID
1158,CARDIAC ARREST,"February 08, 2021",41,NCT04366297,INTRAVENOUS ACCESS,POLAND,Completed,Lazarski University,"January 12, 2020",Interventional,Intraosseous Versus Intravenous Access During COVID-19 Patients Performed by Paramedics Wearing Level C Personal Protective Equipment. A Multi-center Prospective Randomized Crossover Single-blinded Simulation Trial,Unrelated
1159,SARS-CoV2,"February 08, 2021",26,NCT04366323,ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS,SPAIN,"Active, not recruiting",Andalusian Network for Design and Translation of Advanced Therapies,"April 27, 2020",Interventional,"Phase I / II Clinical Trial, Multicenter, Randomized and Controlled, to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",COVID
1160,COVID,"February 08, 2021",40,NCT04366739,CHLORPROMAZINE (CPZ),FRANCE,Not yet recruiting,Centre Hospitalier St Anne,"April 29, 2020",Interventional,Repurposing of Chlorpromazine in Covid-19 Treatment,COVID
1161,COVID,"February 08, 2021",100,NCT04366752,VENOUS ULTRASOUND,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","April 22, 2020",Observational,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,COVID
1162,COVID,"February 08, 2021",1500,NCT04366765,,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","March 19, 2020",Observational,Coronavirus Disease 19 Survival - The COVIVA Study,COVID
1163,THROMBOSIS,"February 08, 2021",341,NCT04366778,TEM-TPA,FRANCE,Completed,Hospices Civils de Lyon,"May 1, 2020",Observational,Evaluation of TEM-tPA (Thromboelastometry With tPA) to Detect Covid-19 Patients at High Risk of Thrombosis,Unrelated
1164,PNEUMONIA,"February 08, 2021",10,NCT04366791,LOW DOSE RADIATION THERAPY,UNITED STATES,Suspended,Emory University,"April 23, 2020",Interventional,The RESCUE 1-19 Trial: Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Respiratory
1165,POST PARTUM DEPRESSION,"February 08, 2021",120,NCT04366817,PSYCHOLOGICAL ASSESSMENT,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,April 2020,Interventional,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic,Unrelated
1166,MODERATE TO SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH COVID,"February 08, 2021",,NCT04366830,REMESTEMCEL-L,UNITED STATES,No longer available,Mesoblast International Sàrl,,Expanded Access,"Intermediate-size Expanded Access of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells for Acute Respiratory Distress Syndrome Due to COVID-19 Infection",COVID
1167,COVID,"February 08, 2021",500,NCT04366856,1: PRONE POSITIONING,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 26, 2020",Interventional,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),COVID
1168,COVID,"February 08, 2021",45,NCT04366882,CT-SCAN WITH MINIMAL INVASIVE AUTOPSY,BELGIUM,Recruiting,Jessa Hospital,"April 14, 2020",Interventional,"Increasing Our Understanding of COVID-19: Minimal Invasive Autopsies to Investigate Clinical, Radiological, Microbiological and Histopathological Changes in Deceased COVID-19 Patients",COVID
1169,SARS-CoV2,"February 08, 2021",1008,NCT04366908,BAT + CALCIFEDIOL,,Not yet recruiting,Maimónides Biomedical Research Institute of Córdoba,"April 28, 2020",Interventional,Prevention and Treatment With Calcifediol of COVID-19 Coronavirus-induced Acute Respiratory Syndrome (SARS),COVID
1170,COVID,"February 08, 2021",150,NCT04366921,,AUSTRIA,Recruiting,Maastricht University Medical Center,"April 10, 2020",Observational,European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID Patients in ECMO,COVID
1171,CORONAVIRUS INFECTION,"February 08, 2021",26,NCT04366934,NASAL SWAB,FRANCE,Completed,Institut Pasteur,"May 4, 2020",Observational,Study of the Pathogenesis of Olfactory Disorders in COVID-19,COVID
1172,EMERGENCY MEDICINE,"February 08, 2021",60,NCT04366947,NIO® (INTRAOSSEOUS ACCESS),POLAND,Completed,Lazarski University,"April 14, 2020",Interventional,Comparison of Intraosseous Versus Intravenous Access in Suspected/Confirmed COVID-19 Patient in Prehospital Setting,Unrelated
1173,COVID,"February 08, 2021",2712,NCT04366960,ENOXAPARIN,ITALY,Recruiting,Niguarda Hospital,"May 14, 2020",Interventional,Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients: Comparison of 40 mg o.d. Versus 40 mg b.i.d. A Randomized Clinical Trial,COVID
1174,COVID,"February 08, 2021",25000,NCT04366986,TESTED FOR SARS-COV-2 (REGARDLESS OF THE RESULT),UNITED STATES,Recruiting,Pregistry,"June 23, 2020",Observational [Patient Registry],International Registry of Coronavirus Exposure in Pregnancy (IRCEP),COVID
1175,COVID,"February 08, 2021",1000,NCT04367064,,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 25, 2020",Observational,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),COVID
1176,ARDS,"February 08, 2021",400,NCT04367077,MULTISTEM,UNITED STATES,Recruiting,"Athersys, Inc","April 28, 2020",Interventional,A Phase 2/3 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease (COVID-19),Unrelated
1177,SARS-COV INFECTION,"February 08, 2021",1000,NCT04367129,ECG,ITALY,Recruiting,University Hospital of Ferrara,"April 14, 2020",Observational,Electrocardiogram Analysis in COVID-19 Patients,Respiratory
1178,SARS-CoV2,"February 08, 2021",200,NCT04367142,COVID-19 RT-PCR,,Not yet recruiting,"University Hospital, Lille",September 2020,Observational,Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept,COVID
1179,COVID,"February 08, 2021",174,NCT04367168,COLCHICINE,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"May 27, 2020",Interventional,"Double-blind, Placebo-controlled Clinical Trial of the Use of Colchicine for the Management of Patients With Mild and Severe SARS-Cov2 Infection",COVID
1180,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",2000,NCT04367207,,SOUTH AFRICA,Recruiting,University of Cape Town,"May 1, 2020",Observational [Patient Registry],"African Covid-19 Critical Care Outcomes Study: An African, Multi-centre Evaluation of Patient Care and Clinical Outcomes for Patients With COVID-19 Admitted to High-care or Intensive Care Units",COVID
1181,HEALTH BEHAVIOR,"February 08, 2021",6079,NCT04367337,NO INTERVENTION,AUSTRALIA,"Active, not recruiting","University of Social Sciences and Humanities, Warsaw","March 25, 2020",Observational,Health Behavior Change During COVID-19 Pandemic: the Focus on Handwashing,Unrelated
1182,COVID,"February 08, 2021",500,NCT04367350,LABORATORY BIOMARKERS,GERMANY,Recruiting,University Hospital Tuebingen,"March 20, 2020",Observational [Patient Registry],Prospective Registry for Multimodal Assessment of Neuromuscular Pathology Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,COVID
1183,CORONAVIRUS,"February 08, 2021",151,NCT04367363,SOCIAL MEDIA & NEWS CONSUMPTION,SINGAPORE,Completed,Jean Liu,"March 17, 2020",Observational,Tracking WhatsApp Behaviors During a Crisis: A Longitudinal Observation of Messaging Activities During the COVID-19 Pandemic,COVID
1184,COVID,"February 08, 2021",600,NCT04367402,BIOMEDOMICS COVID-19 IGM-IGG RAPID TEST,ITALY,Recruiting,Azienda Ospedaliera San Paolo,"March 30, 2020",Observational,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients",COVID
1185,COVID,"February 08, 2021",130,NCT04367545,SALIVA COLLECTION,FRANCE,Completed,"University Hospital, Rouen","April 16, 2020",Interventional,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,COVID
1186,RUMINATION,"February 08, 2021",100,NCT04367636,BEHAVIORAL: OCAT-SHAM,BELGIUM,Not yet recruiting,University Ghent,"April 20, 2020",Interventional,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19: Validation of a New Online Treatment,Unrelated
1187,COVID,"February 08, 2021",99,NCT04367662,BLOOD SAMPLING,FRANCE,Completed,"University Hospital, Rouen","April 9, 2020",Interventional,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,COVID
1188,COVID,"February 08, 2021",300,NCT04367714,,DENMARK,Recruiting,Region MidtJylland Denmark,"March 15, 2020",Observational [Patient Registry],Antistof Respons Mod SARS-CoV-2 Hos Dialysepatienter i Forbindelse Med COVID-19,COVID
1189,ASYMPTOMATIC CONDITION,"February 08, 2021",10000,NCT04367740,TO ASSESS FOR DEVELOPMENT OF IGG ANTIBODIES AGAINST SARS-COV2,UNITED STATES,Enrolling by invitation,"University of North Carolina, Chapel Hill","April 28, 2020",Observational,ScreenNC: A Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the SARS-CoV-2 Infection,Unrelated
1190,COVID,"February 08, 2021",60,NCT04367792,,ITALY,"Active, not recruiting",A.O. Ospedale Papa Giovanni XXIII,"April 23, 2020",Observational,Pathology and Pathogenesis of Cardiac Injury in COVID-19 Infections in Humans,COVID
1191,HEPATOCELLULAR CARCINOMA,"February 08, 2021",50,NCT04367805,NASOPHARYNGEAL COVID 19 RT-PCR,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","April 27, 2020",Observational,Impact of COVID-19 Infection in Patients With Hepatocellular Carcinoma: An Ambispective Study Nestled in the CHIEF Cohort,Unrelated
1192,COVID,"February 08, 2021",100,NCT04367831,ENOXAPARIN PROPHYLACTIC DOSE,UNITED STATES,Recruiting,Columbia University,"May 2, 2020",Interventional,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19: A Cluster Based Randomized Selection Trial (IMPROVE-COVID),COVID
1193,COVID,"February 08, 2021",1000,NCT04367857,COVID-19 SEROLOGY,UNITED STATES,Recruiting,Columbia University,"April 18, 2020",Observational [Patient Registry],SARS-CoV-2 Seroprevalence Among Healthcare Workers: ARMOR Study Demonstration Project,COVID
1194,ONCOLOGY,"February 08, 2021",2500,NCT04367870,,FRANCE,Recruiting,UNICANCER,"May 23, 2020",Observational,COVID-19 Serodiagnosis in Oncology,Unrelated
1195,COVID,"February 08, 2021",2574,NCT04367883,ACE INHIBITOR,SPAIN,Recruiting,Consorci Sanitari de Terrassa,"March 1, 2020",Observational,Evaluation of Influenza Vaccination and Treatment With ACEI and ARB in the Evolution of SARS-Covid19 Infection,COVID
1196,COVID OUTBREAK AND SOLID ORGAN TRANSPLANTATION,"February 08, 2021",1819,NCT04367896,SURVEY GROUP,ITALY,Completed,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"March 24, 2020",Observational,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,COVID
1197,ANXIETY,"February 08, 2021",1000,NCT04367922,POSITIVE EMOTION SKILLS COURSE,UNITED STATES,Recruiting,Northwestern University,"April 27, 2020",Interventional,"A Positive Affect Regulation sKills Intervention to Decrease Stress During a Pandemic: A Single Arm, Non-Randomized Trial of a Public Platform",Unrelated
1198,RESPIRATORY FAILURE,"February 08, 2021",30,NCT04368000,INTERMITTENT PRONE POSITIONING INSTRUCTIONS,UNITED STATES,Terminated,University of Utah,"April 29, 2020",Interventional,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Respiratory
1199,COVID,"February 08, 2021",400,NCT04368013,EXTENDED SAMPLING AND PROCEDURES,SWEDEN,Not yet recruiting,Johan Normark,"April 28, 2020",Interventional,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",COVID
1200,"SURGICAL PROCEDURE, UNSPECIFIED","February 08, 2021",350,NCT04368026,NO INTERVENTION (SURVEY STUDY FOR MEDICAL DOCTORS).,POLAND,Recruiting,Jagiellonian University,"March 30, 2020",Observational,Surgical Care in Poland After COVID19 Outbreak - a National Survey Study,Unrelated
1201,COVID,"February 08, 2021",100000,NCT04368065,,UNITED KINGDOM,Recruiting,Iqvia Pty Ltd,"April 2, 2020",Observational [Patient Registry],Registry to Study Factors That May Impact COVID-19 Occurrence and Severity,COVID
1202,COVID,"February 08, 2021",100,NCT04368143,,BELGIUM,Recruiting,"Institute of Tropical Medicine, Belgium","April 1, 2020",Observational [Patient Registry],COVID-19 Immune Repertoire Sequencing,COVID
1203,COVID,"February 08, 2021",90,NCT04368156,GAMMACORE® (VAGUS NERVE STIMULATION),SPAIN,Recruiting,Carlos Tornero,"April 20, 2020",Interventional,"A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIOR)",COVID
1204,POSTNATAL DEPRESSION,"February 08, 2021",501,NCT04368208,ASSESSMENT OF POSTNATAL DEPRESSION USING THE THE EDINBURGH QUESTIONNAIRE BETWEEN 4 AND 6 WEEKS AFTER DELIVERY,FRANCE,Completed,Poitiers University Hospital,"April 29, 2020",Observational,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,Unrelated
1205,COVID,"February 08, 2021",576,NCT04368221,,FRANCE,"Active, not recruiting",Rennes University Hospital,"May 4, 2020",Observational,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,COVID
1206,COVID,"February 08, 2021",100000,NCT04368234,,UNITED STATES,Recruiting,Duke University,"April 18, 2020",Observational [Patient Registry],Duke Shared Data and Specimen Repository Regarding COVID-19 Patients,COVID
1207,COVID,"February 08, 2021",40,NCT04368260,CONTROL SWAB,UNITED STATES,Recruiting,University of Virginia,"April 24, 2020",Interventional,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,COVID
1208,SLE,"February 08, 2021",150,NCT04368299,TELEMEDICINE,HONG KONG,Recruiting,Chinese University of Hong Kong,"May 1, 2020",Interventional,"Use of Telemedicine for Follow-up of Systemic Lupus Erythematosus (""TeleSLE"") in the COVID-19 Outbreak: a Pragmatic Randomised Controlled Trial",Unrelated
1209,PSYCHOLOGICAL DISTRESS,"February 08, 2021",100,NCT04368312,NO INTERVENTION,,Not yet recruiting,"University Hospital, Essen","May 6, 2020",Observational,Psychological Impairment Due to Covid-19 in Hospital Staff,Unrelated
1210,COVID,"February 08, 2021",100,NCT04368338,COVID-19 RT-PCR,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","April 28, 2020",Observational,Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room,COVID
1211,COVID,"February 08, 2021",70,NCT04368351,SIVOMIXX (200 BILLION),ITALY,"Active, not recruiting",University of Roma La Sapienza,"March 1, 2020",Observational,Evaluation of the Impact of Bacteriotherapy in the Treatment of COVID-19,COVID
1212,"PNEUMONIA, VIRAL","February 08, 2021",5,NCT04368377,TIROFIBAN INJECTION,ITALY,Completed,University of Milan,"April 6, 2020",Interventional,Platelet Inhibition With GP IIb/IIIa Inhibitor in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). A Compassionate Use Protocol,Respiratory
1213,COVID,"February 08, 2021",100,NCT04368390,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 3, 2020",Observational,Imaging Analysis of COVID-19 + Patients With Abnormal Neurological Examination,COVID
1214,ACUTE MYOCARDIAL INFARCTION,"February 08, 2021",50,NCT04368637,,JORDAN,Recruiting,Jordan Collaborating Cardiology Group,"May 3, 2020",Observational,"Acute Cardiovascular Events Triggered by COVID-19-Related, Non-infectious Stress The Jordan COVID-9 caRdiovascular Events (JoCORE) Study",Unrelated
1215,JOB STRESS,"February 08, 2021",60,NCT04368676,SUDARSHAN KRIYA YOGA (SKY),CANADA,Recruiting,Lawson Health Research Institute,"June 25, 2020",Interventional,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness (BREATH): an RCT for Frontline Hospital and Long-term Care Home Staff Managing the COVID-19 Pandemic,Unrelated
1216,SARS-CoV2 INFECTION,"February 08, 2021",43998,NCT04368728,BNT162B1,ARGENTINA,"Active, not recruiting",BioNTech SE,"April 29, 2020",Interventional,"A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS",COVID
1217,COVID-2019 PNEUMONIA,"February 08, 2021",200,NCT04368793,REMOTE PULMONARY REHABILITATION,CHINA,Recruiting,China-Japan Friendship Hospital,"April 6, 2020",Observational,Intelligence-based Remote Pulmonary Rehabilitation and Efficacy Among Discharged COVID-19 Patients,COVID
1218,PREGNANCY RELATED,"February 08, 2021",108,NCT04368832,REMOTE CONSULTATION,FRANCE,"Active, not recruiting","Central Hospital, Nancy, France","April 25, 2020",Observational,ImPROving prenaTal carE During ConfinemenT: Impact of Confinement on the Quality of Prenatal Care Perceived in Low-risk Pregnancy,Unrelated
1219,COVID,"February 08, 2021",100,NCT04368845,TELEREHABILITATION,GREECE,Recruiting,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,"May 11, 2020",Interventional,"A Telerehabilitation Approach to Improve Long-term Physical Ability and Quality of Life in Patients With Severe Acute Respiratory Syndrome Coronavirus (SARSCoV-2, COVID-19) Immediately After Hospitalization. The ATHLOS Study",COVID
1220,COVID,"February 08, 2021",200,NCT04368871,,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 28, 2020",Observational,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,COVID
1221,COVID,"February 08, 2021",1000,NCT04368884,,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 22, 2020",Observational,"A Prospective, Longitudinal, Observational Study to Assess the Seroconversion Status of Front Line Health Care Workers and Comparison With the Suspected or Confirmed Cases of COVID-19 Patients at Max Health Care (Project D)",COVID
1222,SARS-CoV2,"February 08, 2021",200,NCT04368897,CAG LENGTH <22,SPAIN,Recruiting,"Applied Biology, Inc.","May 1, 2020",Observational,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,COVID
1223,COVID,"February 08, 2021",60,NCT04368923,OXYGEN THERAPY,EGYPT,"Active, not recruiting",Cairo University,"March 15, 2020",Interventional,Management of Covid-19 Patients During Home Isolation,COVID
1224,ACUTE RESPIRATORY FAILURE WITH HYPOXIA,"February 08, 2021",500,NCT04368975,,SPAIN,Recruiting,Hospital Clinic of Barcelona,"March 12, 2020",Observational [Patient Registry],Main Features and Ventilatory Management of Patients With ARDS Caused by COVID-19,Respiratory
1225,COVID,"February 08, 2021",1419,NCT04368988,SARS-COV-2 RS - PHASE 1,AUSTRALIA,"Active, not recruiting",Novavax,"May 25, 2020",Interventional,"A 2-Part, Phase 1/2, Randomized, Observer-Blinded Study To Evaluate The Safety And Immunogenicity Of A SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Or Without MATRIX-M™ Adjuvant In Healthy Subjects",COVID
1226,VOLUNTEERS FROM THE INSTITUTE CURIE AND INSTITUTE PASTEUR STAFF WHO ARE NOT SHOWING ACTIVE SARS-CoV2 INFECTION,"February 08, 2021",2800,NCT04369066,BLOOD SAMPLES (COLLECTION OF 5 ML OF BLOOD IN A DRY TUBE),FRANCE,Recruiting,Institut Curie,"April 28, 2020",Interventional,"COVID-19 Study of the Serological Response Against the SARS-CoV-2 Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",COVID
1227,RESPIRATORY FAILURE,"February 08, 2021",30,NCT04369274,MECHANICAL VENTILATION WITH THE AUTOMATED BVM COMPRESSOR,,Not yet recruiting,Massachusetts General Hospital,May 2020,Interventional,A Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Ventilation for the Treatment of COVID-19 ARDS,Respiratory
1228,COVID,"February 08, 2021",1000,NCT04369300,REGISTERY DATA COLLECTION,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 24, 2020",Observational [Patient Registry],Prevalence Of Anxiety And Depression During COVID-19,COVID
1229,COVID,"February 08, 2021",200,NCT04369365,AZITHROMYCIN 500 MILLIGRAM (MG) ORAL TABLET,AUSTRIA,Recruiting,Prof. Dr. Matthias Preusser,"April 27, 2020",Interventional,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",COVID
1230,ANXIETY,"February 08, 2021",200,NCT04369378,MEDITATION APP USAGE,UNITED STATES,Recruiting,Lake Erie College of Osteopathic Medicine,"August 19, 2020",Interventional,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Unrelated
1231,KIDNEY TRANSPLANT; COMPLICATIONS,"February 08, 2021",115,NCT04369456,BLOOD SAMPLE,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"April 22, 2020",Interventional,Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Unrelated
1232,COVID SEVERE PNEUMONIA,"February 08, 2021",270,NCT04369469,RAVULIZUMAB,FRANCE,"Active, not recruiting",Alexion Pharmaceuticals,"May 11, 2020",Interventional,"A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared With Best Supportive Care in Patients With COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome",COVID
1233,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",24,NCT04369599,V/Q VEST,UNITED STATES,Suspended,Emory University,"August 11, 2020",Interventional,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest,Respiratory
1234,COVID,"February 08, 2021",1000,NCT04369690,,CANADA,Recruiting,University of Ottawa,"April 3, 2020",Observational,"How Are You Coping? Assessing the Psychological, Social, and Economic Impacts of an Emerging Pandemic",COVID
1235,COVID,"February 08, 2021",626,NCT04369742,HYDROXYCHLOROQUINE (HCQ),UNITED STATES,Suspended,NYU Langone Health,"April 15, 2020",Interventional,"Treating COVID-19 With Hydroxychloroquine: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial in Hospitalized Adults",COVID
1236,COVID,"February 08, 2021",1000,NCT04369794,BCG,BRAZIL,Recruiting,"University of Campinas, Brazil","August 10, 2020",Interventional,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",COVID
1237,COVID,"February 08, 2021",507,NCT04369807,OUTPATIENT MRI,UNITED KINGDOM,Recruiting,Perspectum,"April 21, 2020",Observational,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,COVID
1238,COVID,"February 08, 2021",100,NCT04369820,DRAW BLOOD,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"March 31, 2020",Interventional,C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19,COVID
1239,PREGNANT WOMEN,"February 08, 2021",1300,NCT04369859,EXAMINE THE IMPACT OF COVID-19 DURING PREGNANCY,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"April 23, 2020",Observational,Obstetric and Perinatal Outcomes of Women With COVID-19: A Prospective Cohort Study,Unrelated
1240,CORONAVIRUS,"February 08, 2021",1000,NCT04369989,NO INTERVENTION,UNITED STATES,Enrolling by invitation,OSF Healthcare System,"April 14, 2020",Observational,Observational Study of COVID-19 Treatment Efficacy,COVID
1241,SARS-CoV2,"February 08, 2021",374,NCT04370015,HYDROXYCHLOROQUINE,,Not yet recruiting,"Services Institute of Medical Sciences, Pakistan","May 15, 2020",Interventional,Efficacy and Safety of Hydroxychloroquine in Primary Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers at Risk of Exposure: Randomised Control Trial,COVID
1242,CORONAVIRUS INFECTION,"February 08, 2021",11200,NCT04370067,,HUNGARY,Recruiting,Semmelweis University Heart and Vascular Center,"May 1, 2020",Observational [Patient Registry],Hungarian CoronaVirus Disease-19 Epidemiological Research,COVID
1243,SARS-CoV2,"February 08, 2021",4000,NCT04370119,NASAL SWAB,GERMANY,Recruiting,University Medicine Greifswald,"April 27, 2020",Observational,Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers,COVID
1244,DIABETES,"February 08, 2021",610,NCT04370171,CARE MODALITIES,FRANCE,Completed,"University Hospital, Strasbourg, France","May 4, 2020",Observational,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic: Prospective Observational Study,Unrelated
1245,"STROKE, ACUTE","February 08, 2021",300,NCT04370197,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","March 3, 2020",Observational,Impact of th Covid-19 Epidemic on Acute Stroke Management,Unrelated
1246,SLEEP DISTURBANCE,"February 08, 2021",247,NCT04370210,QUESTIONNAIRES,FRANCE,Completed,Centre Hospitalier René Dubos,"May 4, 2020",Observational,"Sleep Quality During COVID-19 Containment in Children 7 to 12 Years Old, Whether or Not Usually Followed in Child Psychiatry",Unrelated
1247,COVID PNEUMONIA,"February 08, 2021",208,NCT04370223,OZONE AUTO-HEMOTHERAPY,SPAIN,Not yet recruiting,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,"May 25, 2020",Interventional,A Trial of Ozone Auto-hemotherapy in Adults Hospitalized With Covid-19 Pneumonia,COVID
1248,COVID,"February 08, 2021",366,NCT04370236,INB03,UNITED STATES,Recruiting,"Inmune Bio, Inc.","October 21, 2020",Interventional,"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of INB03 in the Treatment of Participants With Pulmonary Complications From Coronavirus Disease (COVID-19)",COVID
1249,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",400,NCT04370249,PULMONARY ULTRASOUND,FRANCE,Recruiting,Nantes University Hospital,"April 9, 2020",Observational,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,Respiratory
1250,COVID,"February 08, 2021",233,NCT04370262,SOC + INTRAVENOUS FAMOTIDINE,UNITED STATES,Completed,Northwell Health,"April 7, 2020",Interventional,"A Multi-site, Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Standard of Care (SOC) Plus Famotidine vs SOC Plus Placebo for the Treatment of COVID-19 in Hospitalized Adults",COVID
1251,COVID,"February 08, 2021",235,NCT04370275,,ITALY,Recruiting,Ospedale di Latisana,"April 23, 2020",Observational,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia: a Multicenter Study in the Italian Outbreak,COVID
1252,COVID,"February 08, 2021",20,NCT04370288,"MCN (METHYLENE BLUE, VITAMIN C, N-ACETYL CYSTEINE)","IRAN, ISLAMIC REPUBLIC OF",Recruiting,Mashhad University of Medical Sciences,"April 19, 2020",Interventional,The Clinical Trial of Application of Methylene Blue Vial for Treatment of Covid-19 Patients,COVID
1253,ARTHROSCOPY,"February 08, 2021",79,NCT04370678,CHANGE IN PREFERENCE TO SURGERY UNDER COVID-19 PANDEMIC.,DENMARK,Completed,Region Zealand,"April 17, 2020",Observational,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures: COVID-19 Effect on Arthroscopic Patients in a University Hospital in Denmark,Unrelated
1254,COVID,"February 08, 2021",18,NCT04370782,HYDROXYCHLOROQUINE,UNITED STATES,Completed,"St. Francis Hospital, New York","April 28, 2020",Interventional,A Randomized Study Evaluating the Safety and Efficacy of Hydroxychloroquine and Zinc in Combination With Either Azithromycin or Doxycycline for the Treatment of COVID-19 in the Outpatient Setting,COVID
1255,COVID,"February 08, 2021",500,NCT04370808,EXPOSURE,PORTUGAL,Not yet recruiting,University of Lisbon,June 2020,Observational,VITACOV: Vitamin D-related Polymorphisms and Vitamin D Levels as Risk Biomarkers of COVID-19 Infection Severity,COVID
1256,OCCUPATIONAL EXPOSURE TO SARS-CoV2,"February 08, 2021",20000,NCT04370821,,UNITED STATES,Recruiting,Villanova University,"May 9, 2020",Observational [Patient Registry],"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",COVID
1257,HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM,"February 08, 2021",1,NCT04370834,TOCILIZUMAB,UNITED STATES,Terminated,National Cancer Institute (NCI),"May 28, 2020",Interventional,Tocilizumab in Hospitalized Cancer Patients With Coronavirus 2019 (SARS-CoV-2) and Severe Complications of Coronavirus Disease 19 (COVID-19),Unrelated
1258,BLOOD DONATION,"February 08, 2021",456517,NCT04370886,BLOOD DONATION SMS,CHINA,Completed,Guangzhou Blood Center,"April 30, 2020",Interventional,Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19,Unrelated
1259,"PERCEIVED ORGANIZATIONAL SUPPORT, ANXIETY, BURNOUT","February 08, 2021",0,NCT04370938,COPING STRATEGIES VIDEO,UNITED STATES,Withdrawn,University of Pittsburgh,"April 29, 2020",Interventional,Exploring Provider Burnout During the COVID-19 Pandemic,Unrelated
1260,ARDS,"February 08, 2021",25,NCT04371029,PSG,FRANCE,Recruiting,"University Hospital, Bordeaux","April 28, 2020",Interventional,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Unrelated
1261,COVID,"February 08, 2021",64,NCT04371107,CONSULTATION,FRANCE,Not yet recruiting,"Centre Hospitalier Universitaire, Amiens","April 29, 2020",Interventional,Proactive Care of Ambulatory COVID19 Patients: Open-labeled Randomized Trial,COVID
1262,"RESILIENCE, PSYCHOLOGICAL","February 08, 2021",800,NCT04371250,SURVEY AND QUESTIONNAIRE,BELGIUM,"Active, not recruiting",Erasme University Hospital,"April 30, 2020",Observational,Mental Health Implications During and After the COVID-19 Pandemic Lock-down Measures in Youth (18 - 25 Years Old) in French-Speaking Belgium and Italy: Resilience and Loneliness Evaluation.,Unrelated
1263,COVID,"February 08, 2021",5500,NCT04371289,,ITALY,Not yet recruiting,Istituto Auxologico Italiano,April 2020,Observational,"Cardiovascular Risk in COVID-19 Patients: Metabolic, Prothrombotic and Proinflammatory Mechaninsms Associated With Outcome and With Cardiorespiratory Features During the Acute Viral Disease and at Short Term Follow-up",COVID
1264,"BURNOUT, PROFESSIONAL","February 08, 2021",145,NCT04371302,QUESTIONNAIRE,,Not yet recruiting,University of Malaya,"May 1, 2020",Observational,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit of an Exclusively Covid-19 Hospital: the Malaysian Experience,Unrelated
1265,CORONAVIRUS INFECTION,"February 08, 2021",400,NCT04371315,,UNITED STATES,Recruiting,St. Jude Children's Research Hospital,"April 27, 2020",Observational,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",COVID
1266,EMERGENCIES,"February 08, 2021",1860,NCT04371328,RECOP UNIT PATIENT,FRANCE,"Active, not recruiting","University Hospital, Toulouse","March 13, 2020",Observational [Patient Registry],"Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection (Unit ""COVID Possible"")",Unrelated
1267,COVID DISEASE,"February 08, 2021",100,NCT04371354,,SPAIN,Recruiting,Fundacion Miguel Servet,"April 27, 2020",Observational,Outcomes After Implementation of a Protective Protocol for Covid-19 in Large Spanish Endoscopy Units.,COVID
1268,COVID,"February 08, 2021",208,NCT04371367,AVDORALIMAB,FRANCE,"Active, not recruiting",Assistance Publique Hopitaux De Marseille,"April 27, 2020",Interventional,"A Double-blind, Randomized Study Versus Placebo of Avdoralimab (IPH5401), an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia",COVID
1269,MESENCHYMAL STROMAL CELLS,"February 08, 2021",223,NCT04371393,REMESTEMCEL-L,UNITED STATES,"Active, not recruiting",Icahn School of Medicine at Mount Sinai,"April 30, 2020",Interventional,Mesenchymal Stromal Cells for the Treatment of Moderate to Severe COVID-19 Acute Respiratory Distress Syndrome,Unrelated
1270,COVID,"February 08, 2021",0,NCT04371406,HYDROXYCHLOROQUINE AND AZITHROMYCIN,,Withdrawn,Assistance Publique - Hôpitaux de Paris,April 2020,Interventional,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients: Randomized Controlled Trial: MG-COVID,COVID
1271,CORONAVIRUS,"February 08, 2021",15475,NCT04371419,MESSAGING,UNITED STATES,Completed,"National Bureau of Economic Research, Inc.","May 13, 2020",Interventional,COVID-19 Health Messaging to Underserved Communities,COVID
1272,COVID,"February 08, 2021",2500,NCT04371432,,UNITED STATES,Recruiting,National Human Genome Research Institute (NHGRI),"February 11, 2021",Observational,Genetics of COVID-19 Susceptibility and Manifestations,COVID
1273,SARS-CoV2,"February 08, 2021",50,NCT04371471,STC-19 SCORE,FRANCE,Completed,Groupe Hospitalier de la Rochelle Ré Aunis,"March 1, 2020",Observational,Covid-19 Pandemic Triage Score in Patients With Known or Suspected SARS-CoV-2 Infection,COVID
1274,COVID BY SARS-CoV2 INFECTION,"February 08, 2021",115,NCT04371510,BLOOD SAMPLE,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"April 22, 2020",Interventional,Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,COVID
1275,CORONAVIRUS INFECTION,"February 08, 2021",1100,NCT04371523,APO-HYDROXYCHLOROQUINE,CANADA,Not yet recruiting,St. Joseph's Healthcare Hamilton,"May 1, 2020",Interventional,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers (PROVIDE): A Parallel Randomized Controlled Trial,COVID
1276,COVID,"February 08, 2021",300,NCT04371562,,ITALY,Completed,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"March 1, 2020",Observational,Predicting ICU Admission and Death for COVID-19 Patients in the Emergency Department. Comparison of Five Scoring Systems.,COVID
1277,COVID PNEUMONIA,"February 08, 2021",60,NCT04371601,OSELTAMIVIR,CHINA,"Active, not recruiting",Fuzhou General Hospital,"March 1, 2020",Interventional,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,COVID
1278,SARS-CoV2,"February 08, 2021",0,NCT04371640,SIROLIMUS 1 MG/ML,UNITED STATES,Withdrawn,Walter K. Kraft,"July 6, 2020",Interventional,"A Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Virological Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sirolimus Adjuvant Therapy in Patients With Coronavirus Disease (COVID-19)",COVID
1279,COVID,"February 08, 2021",40,NCT04371679,NO INTERVENTIONS PLANNED,BELGIUM,Recruiting,Hasselt University,"April 1, 2020",Observational,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,COVID
1280,SARS-CoV2,"February 08, 2021",100,NCT04371692,SELF-ADMINISTERED QUESTIONNAIRE,,Not yet recruiting,"University Hospital, Lille",April 2020,Observational,Prevalence of SARS-Cov2 Infection Among HCW in Lille University Hospital,COVID
1281,COVID,"February 08, 2021",100,NCT04371744,,FRANCE,Completed,Assistance Publique Hopitaux De Marseille,"April 17, 2020",Observational [Patient Registry],"QT-Logs : a Clinical Study to Monitor Cardiac Safety, With Artificial Intelligence for QT Interval Analysis of ECG Data From Smartwatches, in Patients Receiving Hydroxychloroquine Treatment for COVID-19",COVID
1282,COVID,"February 08, 2021",56,NCT04371822,SNPP PROTOPORPHYRIN PLUS SUNLIGHT EXPOSURE,EGYPT,Not yet recruiting,Kafrelsheikh University,August 2020,Interventional,Efficacy of Based MRI Contrast Media Against Covid-19,COVID
1283,HIV-INFECTION/AIDS,"February 08, 2021",1500,NCT04371835,,NIGERIA,Recruiting,Kirby Institute,"August 12, 2020",Observational,"COVID-19 in People Living With HIV: Evaluation of Risk Factors and Outcomes in Resource-limited Settings. A Pooled Substudy of ADVANCE, D²EFT, DolPHIN2 and NAMSAL",Unrelated
1284,EATING HABITS,"February 08, 2021",2465,NCT04371848,,CANADA,"Active, not recruiting",Laval University,"April 16, 2020",Observational,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity Among Adults From the Province of Québec in Canada: a NutriQuébec Sub-study,Unrelated
1285,COVID,"February 08, 2021",0,NCT04371926,HYDROXYCHLOROQUINE SULFATE,,Withdrawn,Texas Cardiac Arrhythmia Research Foundation,June 2020,Interventional,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk (PREVENT),COVID
1286,COVID,"February 08, 2021",330,NCT04371952,DOXYCYCLINE,FRANCE,Not yet recruiting,Nantes University Hospital,"June 1, 2020",Interventional,"Doxycycline Versus Placebo in COVID-19 + Patients Without Hospitalization Criteria: Prospective, Multicenter, Randomized, Double-blind Study",COVID
1287,COVID,"February 08, 2021",24,NCT04371965,POVIDONE-IODINE,FRANCE,Completed,Poitiers University Hospital,"September 1, 2020",Interventional,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With SARS-CoV-2",COVID
1288,COVID,"February 08, 2021",100,NCT04371978,LINAGLIPTIN 5 MG,ISRAEL,Recruiting,Rabin Medical Center,"October 1, 2020",Interventional,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,COVID
1289,COVID,"February 08, 2021",100,NCT04372004,DIAGNOSTIC TESTS FOR COVID-19 INFECTION,UNITED STATES,Recruiting,Texas Cardiac Arrhythmia Research Foundation,"May 8, 2020",Interventional,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),COVID
1290,COVID,"February 08, 2021",1,NCT04372017,HYDROXYCHLOROQUINE,UNITED STATES,"Active, not recruiting",Sanford Health,"May 14, 2020",Interventional,"Randomized, Double-Blind, Controlled Trial of Hydroxychloroquine vs Placebo as Post-Exposure Prophylaxis Against COVID-19 Infection",COVID
1291,HEALTH CARE UTILIZATION,"February 08, 2021",10000,NCT04372030,ONLINE QUESTIONNAIRE,,Not yet recruiting,Université Catholique de Louvain,"May 1, 2020",Interventional,"Utilisation de Soins Pendant la Crise Covid-19 : Recours, Report et Renoncement (US3R)",Unrelated
1292,SLEEP HYGIENE,"February 08, 2021",1200,NCT04372043,QUESTIONNAIRE,LEBANON,Not yet recruiting,Saint-Joseph University,"April 30, 2020",Observational,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,Unrelated
1293,COVID,"February 08, 2021",2200,NCT04372056,VIEWS AND EXPERIENCES OF HEALTH CARE PROFESSIONALS WORKING IN INTENSIVE CARE UNITS DURING THE COVID-19 PANDEMIC,NORWAY,Recruiting,Oslo University Hospital,"May 6, 2020",Observational,A Norwegian Study on Views and Experiences of Health Care Professionals Working in Intensive Care Units During the COVID-19 Pandemic.,COVID
1294,SARS-CoV2,"February 08, 2021",480,NCT04372082,STANDARD OF CARE (SOC),,Not yet recruiting,"University Hospital, Lille",May 2020,Interventional,"Efficacy of HYdroxychloroquine and DILtiazem-nIClosamide Combination for the Treatment of Non-severe Forms of SARS-CoV2 Infection in Patients With Co-morbidities: Multicenter, Randomized, Open-labeled Controlled Trial",COVID
1295,COVID PNEUMONIA,"February 08, 2021",379,NCT04372186,PLACEBO,BRAZIL,"Active, not recruiting","Genentech, Inc.","May 14, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia",COVID
1296,COVID,"February 08, 2021",248,NCT04372199,,ITALY,Recruiting,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"April 29, 2020",Observational [Patient Registry],VALIDATION OF A SEVERITY SCORE TO IDENTIFY PATIENTS ADMITTED FOR COVID-19 PNEUMONIA AT HIGH RISK FOR AN INTENSIVE APPROACH,COVID
1297,COVID,"February 08, 2021",,NCT04372368,COVID-19 CONVALESCENT PLASMA,UNITED STATES,No longer available,"University of Colorado, Denver",,Expanded Access,Convalescent Plasma for the Treatment of Patients With COVID-19,COVID
1298,SEPSIS,"February 08, 2021",300,NCT04372472,,UNITED STATES,"Active, not recruiting","Cytovale, Inc.","April 7, 2020",Observational,SQuISH-COVID: A Pilot Study,Unrelated
1299,VENTILATOR ASSOCIATED PNEUMONIA,"February 08, 2021",30,NCT04372576,ASSESSMENT OF VENTILATOR-ASSOCIATED PNEUMONIA CRITERIA,HUNGARY,Recruiting,Semmelweis University,"April 16, 2020",Observational,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,Respiratory
1300,COVID,"February 08, 2021",1203,NCT04372589,HEPARIN,BRAZIL,"Active, not recruiting",University of Manitoba,"May 20, 2020",Interventional,"Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC), in Collaboration With Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-4)",COVID
1301,COVID,"February 08, 2021",28,NCT04372602,DUVELISIB,UNITED STATES,Recruiting,Washington University School of Medicine,"October 12, 2020",Interventional,A Pilot Study of Duvelisib to Combat COVID-19,COVID
1302,COVID,"February 08, 2021",600,NCT04372628,LOPINAVIR/RITONAVIR 400 MG/100 MG,UNITED STATES,Recruiting,Vanderbilt University Medical Center,"June 1, 2020",Interventional,Trial of Early Therapies During Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19,COVID
1303,COVID,"February 08, 2021",200,NCT04372680,CTUS EXAMINATION,FRANCE,Recruiting,"University Hospital, Toulouse","April 22, 2020",Interventional,"WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound: a Prospective, Multicenter, Randomized, Open-label, Parallel-group Clinical Trial",COVID
1304,DISTANCE LEARNING-ONLINE LEARNING,"February 08, 2021",180,NCT04372693,IMPLIMINTING ONLINE DISTANCE LEARNING,EGYPT,Enrolling by invitation,Cairo University,"September 1, 2020",Interventional,Unplanned Shifting the Traditional Classroom-Based to Online Distance Learning as a Result of (COVID-19) Social Distancing Measures: Nursing Students' Perception and Achievement,Unrelated
1305,COVID,"February 08, 2021",80,NCT04372979,TRANSFUSION OF SARS-COV-2 CONVALESCENT PLASMA.,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 14, 2020",Interventional,Evaluation Of Efficacy Of COVID-19 Convalescent Plasma Versus Standard Plasma In The Early Care Of COVID-19 Patients Hospitalized Outside Intensive Care Units.,COVID
1306,COVID,"February 08, 2021",1000,NCT04373005,NASOPHARYNGEAL (NP) SWAB,CANADA,"Active, not recruiting","University Health Network, Toronto","May 11, 2020",Observational,A Research Platform to Screen Patients in Oncology and Assess Impact - RESPONSE,COVID
1307,SYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",144,NCT04373044,BARICITINIB,UNITED STATES,Recruiting,University of Southern California,"May 1, 2020",Interventional,A Phase II Randomized Double-Blind Trial of Baricitinib or Placebo Combined With Antiviral Therapy in Patients With Moderate and Severe COVID-19,COVID
1308,COVID,"February 08, 2021",42,NCT04373096,CURRENT IPAC-UHN PPE,CANADA,Recruiting,"University Health Network, Toronto","December 7, 2020",Interventional,Development of a Novel Hood Shield to Enhance PPE Security and Minimize COVID-19 Transmission to Front-line Health Care Workers Performing High-risk Procedures,COVID
1309,STROKE,"February 08, 2021",36,NCT04373109,OBSERVATION,SWITZERLAND,Completed,Jeremia Held,"April 16, 2020",Observational,Stroke Rehabilitation Outcome During COVID-19 Lockdown,Unrelated
1310,COVID,"February 08, 2021",2500,NCT04373135,BRIEF EDUCATIONAL VIDEO,UNITED STATES,"Active, not recruiting","University of California, Los Angeles","May 8, 2020",Interventional,A Study to Evaluate Health Behavior and Access Impacts Due to COVID-19 and for Community Engagement of Stakeholders Surrounding Scarce Resource Allocation Policy.,COVID
1311,CORONAVIRUS,"February 08, 2021",1000,NCT04373148,THERE IS NO INTERVENTION,UNITED STATES,Recruiting,Stanford University,"April 8, 2020",Observational,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",COVID
1312,SARS-CoV2,"February 08, 2021",209,NCT04373161,HOME PULSE OXIMETRY MONITORING,UNITED STATES,Completed,Swedish Hospital,"March 20, 2020",Interventional,Utilizing Home Pulse Oximetry for Patients With COVID-19 To Monitor Disease Progression,COVID
1313,SARS-CoV2 CORONAVIRUS,"February 08, 2021",75,NCT04373200,BLOOD SAMPLES COLLECTION,FRANCE,Recruiting,Rennes University Hospital,"May 25, 2020",Interventional,Human Ab Response & immunoMONItoring of COVID-19 Patients,COVID
1314,PLETH VARIABILITY INDEX,"February 08, 2021",30,NCT04373213,PLETH VARIABILITY INDEX,TURKEY,Not yet recruiting,Erzincan University,"May 5, 2020",Observational,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,Unrelated
1315,COVID,"February 08, 2021",1293,NCT04373291,BCG-DENMARK,DENMARK,"Active, not recruiting",Bandim Health Project,"May 18, 2020",Interventional,Using BCG Vaccine to Enhance Non-specific Protection of Health Care Workers During the COVID-19 Pandemic. A Randomized Controlled Multi-center Trial,COVID
1316,BURNOUT,"February 08, 2021",882,NCT04373382,PEER RESILIENCE CHAMPION,CANADA,"Active, not recruiting","Mount Sinai Hospital, Canada","July 27, 2020",Interventional,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Unrelated
1317,SARS-CoV2,"February 08, 2021",1344,NCT04373460,SARS-COV-2 CONVALESCENT PLASMA,UNITED STATES,Recruiting,Johns Hopkins University,"June 3, 2020",Interventional,Comparison of the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune) Plasma Among Outpatients With Symptomatic COVID-19,COVID
1318,COVID WITH POSITIVE RT-PCR,"February 08, 2021",160,NCT04373486,,FRANCE,Completed,"University Hospital, Strasbourg, France","March 3, 2020",Observational,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,COVID
1319,COVID,"February 08, 2021",602,NCT04373707,ENOXAPARIN,FRANCE,Recruiting,"Central Hospital, Nancy, France","May 13, 2020",Interventional,Effectiveness of Weight-adjusted Prophylactic Low Molecular Weight Heparin Doses Compared With Lower Fixed Prophylactic Doses to Prevent Venous Thromboembolism in COVID-2019. The Multicenter Randomized Controlled Open-label Trial COVI-DOSE,COVID
1320,CORONAVIRUS INFECTION,"February 08, 2021",450,NCT04373733,FAVIPIRAVIR,UNITED KINGDOM,Recruiting,Chelsea and Westminster NHS Foundation Trust,"May 1, 2020",Interventional,A Randomised Controlled Trial of Early Intervention in Patients HospItalised With COVID-19: Favipiravir and StaNdard Care vErsEs Standard CaRe,COVID
1321,SARS-CoV2,"February 08, 2021",186,NCT04373759,CARDIOPULMONARY RESUSCITATION,FRANCE,Completed,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"May 2, 2020",Observational [Patient Registry],Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs,COVID
1322,CORONAVIRUS INFECTION,"February 08, 2021",3000,NCT04373798,C-REACTIVE PROTEIN,DENMARK,Recruiting,Henning Bliddal,"May 4, 2020",Observational,Triage Strategies Based on C-reactive Protein Levels Among Individuals With COVID-19: A Prospective Cohort Study,COVID
1323,COVID,"February 08, 2021",60,NCT04373811,LUNG ULTRASOUND,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"April 16, 2020",Observational,Quality of Life and Functional Prognosis at One Year of Patients With COVID-19 Admitted in Post-ICU Setting,COVID
1324,COVID,"February 08, 2021",50,NCT04373824,IVERMECTIN,INDIA,Recruiting,Max Healthcare Insititute Limited,"April 25, 2020",Interventional,To Study the Effectiveness of Ivermectin With Standard of Care Treatment Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,COVID
1325,SARS-CoV2,"February 08, 2021",850,NCT04373889,,BELGIUM,"Active, not recruiting",Sciensano,"April 22, 2020",Observational,"SARS-COV-2 Prevalence, Seroprevalence and Seroconversion Among Healthcare Workers in Belgium During the 2020 COVID-19 Outbreak",COVID
1326,COVID,"February 08, 2021",240,NCT04374019,IVERMECTIN,UNITED STATES,Recruiting,Susanne Arnold,"May 1, 2020",Interventional,"Randomized, Multi-arm Phase II Trial of Novel Agents for Treatment of High-risk COVID-19 Positive Patients",COVID
1327,COVID INFECTION,"February 08, 2021",120,NCT04374032,METENKEFALIN + TRIDECACTIDE,BOSNIA AND HERZEGOVINA,Completed,Bosnalijek D.D,"May 1, 2020",Interventional,"An Open-label, Prospective, Randomized, Comparative Clinical Trial to Evaluate the Efficacy and Safety of ENKORTEN® as an Immunomodulatory Therapy, Within the Usual Therapeutically Established Protocol, for the Treatment of Patients With Moderate to Severe COVID-19 Infection",COVID
1328,SARS-CoV2,"February 08, 2021",50,NCT04374045,ECG-HOLTER,FRANCE,Completed,Centre Hospitalier Universitaire de Saint Etienne,"April 30, 2020",Observational [Patient Registry],Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,COVID
1329,END STAGE RENAL DISEASE,"February 08, 2021",50,NCT04374058,LESS-FREQUENCY HEMODIALYSIS,ARGENTINA,"Active, not recruiting",Dialisis Madariaga,"March 20, 2020",Observational,Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease,Unrelated
1330,COVID,"February 08, 2021",250,NCT04374071,METHYLPREDNISOLONE,UNITED STATES,Completed,Henry Ford Health System,"March 12, 2020",Observational,Early Short Course Corticosteroids in Hospitalized Patients With COVID-19,COVID
1331,COVID,"February 08, 2021",60,NCT04374084,MOXIBUSTION PLUS CUPPING,CHINA,Recruiting,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,"May 10, 2020",Interventional,Moxibustion Plus Cupping in Convalescent Patients With COVID-19: A Randomized Clinical Trial,COVID
1332,POST TRAUMATIC STRESS DISORDER,"February 08, 2021",1778,NCT04374097,,NORWAY,Completed,University of Oslo,"March 31, 2020",Observational,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,Unrelated
1333,COVID,"February 08, 2021",1000,NCT04374110,CLINICAL DATA,POLAND,Recruiting,"Institute of Cardiology, Warsaw, Poland","May 5, 2020",Observational [Patient Registry],Prospective Monitoring of Drug Safety and the Occurrence of Complications During Hospitalization in Patients With Cardiovascular Diseases With COVID-19,COVID
1334,COVID,"February 08, 2021",111,NCT04374123,SEROLOGICAL SCREENING FOR IGG AND IGM ANTIBODIES AGAINST COVID-19,ECUADOR,Completed,Instituto Ecuatoriano de Enfermedades Digestivas,"April 20, 2020",Observational,COVID-19 Serologic Screening and a Strict Protocol in the Management of a Referral Gastrointestinal Endoscopy Unit: a Prospective Study,COVID
1335,CYTOKINE RELEASE SYNDROME,"February 08, 2021",20,NCT04374149,THERAPEUTIC PLASMA EXCHANGE,UNITED STATES,"Active, not recruiting",Prisma Health-Upstate,"April 30, 2020",Interventional,"Interventional Study to Evaluate the Efficacy of Therapeutic Plasma Exchange (TPE) Alone or in Combination With Ruxolitinib in COVID-19 Positive Patients With PENN Grade 2, 3, 4 Cytokine Released Syndrome (CRS)",Unrelated
1336,COVID,"February 08, 2021",60,NCT04374279,BICALUTAMIDE 150 MG ORAL TABLET,UNITED STATES,Not yet recruiting,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"February 5, 2021",Interventional,A Phase II Trial to Promote Recovery From COVID-19 With Endocrine Therapy,COVID
1337,COVID,"February 08, 2021",,NCT04374370,SARSCOV2 CONVALESCENT PLASMA,UNITED STATES,Available,AdventHealth,,Expanded Access,Severe Acute Respiratory Syndrome Coronavirus 2 of the Genus Betacoronavirus (SARSCoV2) Convalescent Plasma (CP) Expanded Access Protocol (EAP),COVID
1338,SEXUAL BEHAVIOR,"February 08, 2021",58,NCT04374422,FSFI SURVEY,TURKEY,Completed,Acibadem University,"April 10, 2020",Observational,Effect of SARS- COVID-19 Pandemic on Female Sexual Behavior,Unrelated
1339,COVID,"February 08, 2021",84,NCT04374461,N-ACETYLCYSTEINE,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"May 1, 2020",Interventional,Phase II Study of N-acetylcysteine in Severe or Critically Ill Patients With Refractory COVID-19 Infection,COVID
1340,OLFACTORY DISORDER,"February 08, 2021",0,NCT04374474,OLFACTORY RETRAINING,CANADA,Withdrawn,Lawson Health Research Institute,"January 10, 2021",Interventional,Olfactory Retraining Therapy and Budesonide Nasal Rinse for Anosmia Treatment in Patients Post-CoVID 19. A Randomized Controlled Trial,Unrelated
1341,COVID,"February 08, 2021",100,NCT04374487,CONVALESCENT PLASMA,INDIA,"Active, not recruiting",Max Healthcare Insititute Limited,"May 9, 2020",Interventional,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",COVID
1342,COVID,"February 08, 2021",318,NCT04374513,,EGYPT,Completed,Damanhour University,"April 2, 2020",Observational,"SURVEY of RETAIL PHARMACISTS KNOWLEDGE, ROLE & BEHAVIOR DURING COVID-19 VIRUS OUTBREAK",COVID
1343,CORONAVIRUS DISEASE 2019 )COVID),"February 08, 2021",182,NCT04374526,COVID-19 CONVALESCENT PLASMA,ITALY,Recruiting,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"May 27, 2020",Interventional,Early transfusIon of COVID-19 Convalescent Plasma in Elderly COVID-19 Patients to Prevent Disease Progression.,COVID
1344,CORONAVIRUS,"February 08, 2021",116,NCT04374539,PLASMA EXCHANGE,SPAIN,Recruiting,Fundacion Clinic per a la Recerca Biomédica,"April 29, 2020",Interventional,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,COVID
1345,SARS-CoV2 INFECTION,"February 08, 2021",0,NCT04374552,HYDROXYCHLOROQUINE SULFATE &AZITHROMYCIN,UNITED STATES,Withdrawn,"Rutgers, The State University of New Jersey","May 5, 2020",Interventional,RCT in Asymptomatic Volunteers With COVID-19 Comparing Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone vs Standard of Care Without Antibiotics,COVID
1346,CORONAVIRUS INFECTION,"February 08, 2021",29,NCT04374565,HIGH-TITER ANTI-SARS-COV-2 (COVID 19) CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",University of Virginia,"May 5, 2020",Interventional,Efficacy and Safety of High-Titer Anti-SARS-CoV-2 (COVID19) Convalescent Plasma for Hospitalized Patients With Infection Due to COVID-19 to Decrease Complications: A Phase II Trial,COVID
1347,PNEUMONIA,"February 08, 2021",180,NCT04374591,SODIUM BICARBONATE,EGYPT,"Active, not recruiting",Mansoura University,"August 1, 2020",Interventional,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia: A Preliminary Report of Short Term Follow up,Respiratory
1348,COVID,"February 08, 2021",230,NCT04374617,DUPLEX ULTRASOUND AND COMPUTED TOMOGRAPHY ANGIOGRAPHY,SPAIN,Completed,Hospital Universitari Vall d'Hebron Research Institute,"April 1, 2020",Observational,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,COVID
1349,DEPRESSION,"February 08, 2021",500,NCT04374643,SLEF QUESTIONNAIRES FULFILMENT,FRANCE,Recruiting,"University Hospital, Montpellier","April 1, 2020",Observational,Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population : PsyConfPop,Unrelated
1350,CONJUNCTIVITIS,"February 08, 2021",50,NCT04374656,,UNITED STATES,Recruiting,Johns Hopkins University,"May 18, 2020",Observational,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients Presenting With Conjunctivitis to the Ophthalmology Clinics During the COVID-19 Pandemic,Unrelated
1351,COVID,"February 08, 2021",700,NCT04374695,,,Not yet recruiting,Versailles Hospital,"May 1, 2020",Observational,"Association Between Hypertension, Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19",COVID
1352,PERCEIVED STRESS,"February 08, 2021",328,NCT04374786,CALM MEDITATION APP,UNITED STATES,Enrolling by invitation,University of Arizona,"May 15, 2020",Interventional,Effects of a Mobile App on Health and Well-being During COVID-19 Pandemic in House Staff at Banner University Medical Center Phoenix,Unrelated
1353,COVID,"February 08, 2021",20,NCT04374838,,EGYPT,Recruiting,South Egypt Cancer Institute,"May 15, 2020",Observational,Effect of COVID-19 Pandemic on Pediatric Cancer Care,COVID
1354,COVID PATIENTS,"February 08, 2021",58,NCT04374903,HCQ & AZ VS HCQ+SIR,JORDAN,Not yet recruiting,King Hussein Cancer Center,"May 1, 2020",Interventional,"Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients: A Pilot, Multicenter Randomized Open-Label Trial",COVID
1355,PRE-EXPOSURE PROPHYLAXIS,"February 08, 2021",988,NCT04374942,HYDROXYCHLOROQUINE,CANADA,Enrolling by invitation,Megan Landes,"April 30, 2020",Interventional,"Protecting Frontline Health Care Workers From COVID-19 With Hydroxychloroquine Pre-exposure Prophylaxis: A Randomized, Placebo-controlled Multi-Site Trial in Toronto, Canada",Unrelated
1356,COVID,"February 08, 2021",24,NCT04375046,RECOMBINANT BACTERIAL ACE2 RECEPTORS -LIKE ENZYME OF B38-CAP (RBACE2),,Not yet recruiting,Kafrelsheikh University,September 2020,Interventional,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,COVID
1357,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",58,NCT04375098,COVID-19 CONVALESCENT PLASMA,CHILE,Completed,Pontificia Universidad Catolica de Chile,"May 4, 2020",Interventional,Efficacy and Safety of Early Anti-SARS-COV-2 Convalescent Plasma in Patients Admitted for COVID-19 Infection: a Randomized Phase II Trial,COVID
1358,COVID,"February 08, 2021",20,NCT04375124,BIOLOGICAL/VACCINE: ANGIOTENSIN PEPTIDE (1-7) DERIVED PLASMA,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"April 25, 2020",Interventional,Evaluation of the Possible Role of Angiotensin Peptide (1-7) on Treatment of COVID-19,COVID
1359,OXIDATIVE STRESS,"February 08, 2021",90,NCT04375137,OXIDATIVE STRESS ELISA KIT,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Shahid Beheshti University of Medical Sciences,"April 20, 2020",Observational,Correlation Between Oxidative Stress Markers and COVID-19 Severity Index,Unrelated
1360,COVID,"February 08, 2021",150,NCT04375176,STUDY OF IMMUNE-MEDIATED MECHANISMS IN PATIENTS TESTED POSITIVE FOR SARS-COV-2,ITALY,Recruiting,Università degli Studi dell'Insubria,"April 27, 2020",Observational,Study of Immune-mediated Mechanisms in Patients Tested Positive for SARS-CoV-2: Phenotypic and Functional Analysis of Monocytes and NK Cells in the Blood of Subjects Affected by Covid 19,COVID
1361,COVID,"February 08, 2021",308,NCT04375202,COLCHICINE 1 MG ORAL TABLET,ITALY,Recruiting,University Of Perugia,"April 18, 2020",Interventional,Treatment With COLchicine of Patients Affected by COVID-19: a Pilot Study,COVID
1362,CORONAVIRUS INDUCED DISEASE-2019 (COVID),"February 08, 2021",46,NCT04375397,IBRUTINIB,UNITED STATES,Recruiting,AbbVie,"June 6, 2020",Interventional,IbrutiNib in SARS CoV-2 Induced Pulmonary Injury and Respiratory Failure (iNSPIRE),COVID
1363,HAND ECZEMA,"February 08, 2021",7000,NCT04375410,,DENMARK,Enrolling by invitation,Vendsyssel Hospital,"April 22, 2020",Observational,Re-opening of the Country and Dermal Consequences of Mandatory Intensified Handwash and Hand Disinfection Among a Danish Pediatric Population During the COVID19 Pandemic,Unrelated
1364,FEMORAL NECK FRACTURES,"February 08, 2021",442,NCT04375501,"SURGERY: DYNAMIC HIP SCREW, HEMIARTHROPLASTY, HIP REPLACEMENT, INTRAMEDULLARY NAIL",UNITED KINGDOM,Completed,Barts & The London NHS Trust,"February 1, 2020",Observational,The Effects of Coronavirus on Perioperative Morbidity and Mortality in a High-risk Population: A Multicentre Cohort Study,Unrelated
1365,COVID,"February 08, 2021",1565,NCT04375644,QUESTIONNAIRES ON PSYCHOLOGICAL QUALITY OF LIFE,FRANCE,Completed,Hospices Civils de Lyon,"May 7, 2020",Observational,Impact of the COVID-19 Pandemic on the Quality of Psychological Life of Healthcare Professionals,COVID
1366,EPIGENETIC AGING,"February 08, 2021",85,NCT04375657,TRIIM TREATMENT,UNITED STATES,Recruiting,"Intervene Immune, Inc.",October 2020,Interventional,"Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial",Unrelated
1367,LIVER DISEASES,"February 08, 2021",1000,NCT04375670,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 11, 2020",Observational,COVID19-FOIE National Observatory. An Ambispective Cohort Study of All Consecutive Patients,Unrelated
1368,COVID (NEW CORONAVIRUS) INFECTION,"February 08, 2021",60,NCT04375709,PHYSICAL EXERCISE,SWITZERLAND,Recruiting,Kantonsspital Winterthur KSW,"March 15, 2020",Observational,Health-related Quality of Life (HRQOL) and Physical Performance in Individuals After COVID-19 Induced Hospitalisation and the Impact of a Standard Care Follow-up Program: a Longitudinal Observational Cohort Study,COVID
1369,"ARDS, HUMAN","February 08, 2021",20,NCT04375735,BOVINE LIPID EXTRACT SURFACTANT,,Not yet recruiting,Lawson Health Research Institute,"July 1, 2020",Interventional,Phase I/II Trial: Exogenous Surfactant Administration for Patients With COVID-19,Unrelated
1370,ACUTE MYOCARDITIS,"February 08, 2021",400,NCT04375748,PERFORMING ROUTINE CARE (CLINICAL AND PARACLINICAL TESTS),FRANCE,Recruiting,"University Hospital, Toulouse","April 15, 2020",Observational,"Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 Cases During the Covid-19 Pandemic, Case Characteristics and Prognoses",Unrelated
1371,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",5605,NCT04375761,COLLECTION OF BIOLOGICAL SAMPLES,UNITED STATES,"Active, not recruiting",National Institute of Allergy and Infectious Diseases (NIAID),"May 1, 2020",Observational,Human Epidemiology and Response to SARS-CoV-2 (DAIT-COVID-19-001),COVID
1372,COVID,"February 08, 2021",10,NCT04375774,FFP2,BELGIUM,Recruiting,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,May 2020,Interventional,Verification of Alternative Do-it-yourself Equipment Respirators,COVID
1373,COVID,"February 08, 2021",240,NCT04376034,CONVALESCENT PLASMA 1 UNIT,UNITED STATES,Recruiting,West Virginia University,"April 16, 2020",Interventional,Convalescent Plasma Collection From Individuals That Recovered From COVID19 and Treatment of Critically Ill Individuals With Donor Convalescent Plasma,COVID
1374,COVID,"February 08, 2021",200,NCT04376398,,BELGIUM,Completed,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"April 6, 2020",Observational [Patient Registry],Survey on Patients With Suspected or Confirmed COVID-19 Requiring Anesthesia Care for Their Intervention,COVID
1375,"INFECTION, CORONAVIRUS","February 08, 2021",450,NCT04376476,BLOOD SAMPLE,FRANCE,Recruiting,Hospices Civils de Lyon,"May 5, 2020",Interventional,Host-pathogen Interactions During Paediatric and Adult SARS-CoV-2 Infection (COVID-19),COVID
1376,ANXIETY,"February 08, 2021",300,NCT04376515,HOPE INTERVENTION,UNITED STATES,"Active, not recruiting","University of California, Irvine","March 20, 2020",Interventional,HOPE Intervention for COVID-19,Unrelated
1377,COVID,"February 08, 2021",100,NCT04376580,,ARGENTINA,Enrolling by invitation,Tiva Group,"April 30, 2020",Observational,Incidence and Implications With the Use of Nasal Cannulas During COVID-19,COVID
1378,COVID,"February 08, 2021",10,NCT04376593,18F-ΑVΒ6-BP,UNITED STATES,Enrolling by invitation,"University of California, Davis","May 1, 2020",Interventional,18F-αvβ6-binding-peptide PET/CT in Patients Post SARS CoV2 Infection,COVID
1379,QUALITY OF LIFE,"February 08, 2021",1000,NCT04376658,COVID-19,BRAZIL,Recruiting,Hospital Moinhos de Vento,"July 15, 2020",Observational,Assessment of Health-related Quality of Life and Long-term Outcomes After Hospitalization for COVID-19: A Multicenter Prospective Cohort Study,Unrelated
1380,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",800,NCT04376684,OTILIMAB,ARGENTINA,"Active, not recruiting",GlaxoSmithKline,"May 28, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease",Respiratory
1381,COVID,"February 08, 2021",180,NCT04376710,COMPLETION OF PRE-PANDEMIC SURVEY,UNITED STATES,Completed,"University of Colorado, Denver","July 1, 2020",Observational,Surgical Telemedicine in the COVID-19 Pandemic Era,COVID
1382,TRANSPLANTATION,"February 08, 2021",3602,NCT04376775,TRANSPLANT PATIENT,FRANCE,"Active, not recruiting","University Hospital, Bordeaux","May 11, 2020",Observational,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,Unrelated
1383,COVID,"February 08, 2021",15,NCT04376788,EXCHANGE BLOOD TRANSFUSION FROM NORMAL DONOR,EGYPT,Recruiting,Ain Shams University,"May 20, 2020",Interventional,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,COVID
1384,COVID,"February 08, 2021",40,NCT04376814,FAVIPIRAVIR,"IRAN, ISLAMIC REPUBLIC OF",Completed,Baqiyatallah Medical Sciences University,"March 29, 2020",Interventional,"The Regimen of Favipiravir Plus Hydroxychloroquine Can Accelerate Recovery of the COVID-19 Patients With Moderate Severity in Comparison to Lopinavir/Ritonavir Plus Hydroxychloroquine Regimen: an Open-label, Non-randomized Clinical Trial Study",COVID
1385,SEVERE SARS-CoV2 PNEUMONIA,"February 08, 2021",270,NCT04376840,BLOOD SAMPLE AND DATA RECORD,FRANCE,Recruiting,CHU de Reims,"May 28, 2020",Interventional,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia,COVID
1386,COVID,"February 08, 2021",50,NCT04376853,APPLE WATCH SERIES 5,GERMANY,Recruiting,University Hospital Heidelberg,"April 15, 2020",Observational,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,COVID
1387,COVID,"February 08, 2021",384,NCT04376879,DATA MONITORING FOR 48H WITHIN THE FIRST 24 HOURS OF ADMISSION FOR COVID-19,FRANCE,Recruiting,"Central Hospital, Nancy, France","May 16, 2020",Observational,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),COVID
1388,COVID,"February 08, 2021",30,NCT04376905,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Assessment of Extra Vascular Lung Water and Pulmonary Permeability by Transpulmonary Thermodilution in Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),COVID
1389,CAREGIVERS,"February 08, 2021",300,NCT04376944,SURVEY,FRANCE,Recruiting,"University Hospital, Montpellier","April 1, 2020",Observational,Evaluating Effectiveness of Barrier Measures to Limit Nosocomial Transmission: Covid-19 Prevalence Survey Among Caregivers With Various Exposures,Unrelated
1390,COVID,"February 08, 2021",3000,NCT04376996,NO INTERVENTION PLANNED DUE TO THE OBSERVATIONAL STUDY DESIGN - ONLY A DIAGNOSTIC TESTING,SLOVENIA,Recruiting,University of Ljubljana,"April 20, 2020",Observational,Slovenian National COVID-19 Prevalence Study,COVID
1391,COVID,"February 08, 2021",1000,NCT04377035,,DENMARK,Recruiting,"University Hospital, Gentofte, Copenhagen","March 31, 2020",Observational,The ECHOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart and Lung by Ultrasound,COVID
1392,PARENTAL STRESS,"February 08, 2021",2880,NCT04377074,,NORWAY,Completed,University of Oslo,"March 31, 2020",Observational,Parenting in a Pandemic: Parental Stress During the COVID-19 and Its Association With Depression and Anxiety,Unrelated
1393,ANXIETY,"February 08, 2021",5000,NCT04377100,COMPUTER TASK QUESTIONNAIRES,UNITED STATES,Recruiting,National Institute of Mental Health (NIMH),"February 11, 2021",Interventional,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Unrelated
1394,COVID,"February 08, 2021",34,NCT04377165,GAMIFICATION,,Terminated,The University of Queensland,"May 6, 2020",Interventional,Innovative Tool to Limit Spread of SARS-CoV-2(COVID 19) in Residential Aged Care,COVID
1395,COVID,"February 08, 2021",2000,NCT04377308,FLUOXETINE,UNITED STATES,Recruiting,University of Toledo Health Science Campus,"May 1, 2020",Interventional,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,COVID
1396,ARDS,"February 08, 2021",40,NCT04377334,MSC,GERMANY,Not yet recruiting,University Hospital Tuebingen,October 2020,Interventional,Prospective Phase II Study: MSCs in Inflammation-Resolution Programs of SARS-CoV-2 Induced ARDS,Unrelated
1397,ANXIETY,"February 08, 2021",8500,NCT04377412,PANDEMIC CONTROL MEASURES,ALBANIA,Recruiting,"Żelazna Medical Centre, LLC","May 1, 2020",Observational,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic - a Web-based Cross-sectional Survey,Unrelated
1398,NEUROLOGICAL DISEASES OR CONDITIONS,"February 08, 2021",0,NCT04377425,COVID-19 SWAP TEST PCR,DENMARK,Withdrawn,Aarhus University Hospital,"May 7, 2020",Observational,"COVID-19 Prevalence, Morbidity and Long Term Cognitive Deficits in Consecutive Patients Presenting With Acute Neurological Symptoms",Unrelated
1399,COVID,"February 08, 2021",200,NCT04377464,"SF12, EQ-5D-5L AND WORK STATUS STANDARDIZED QUANTITATIVE ASSESSMENTS",,Not yet recruiting,Chinese University of Hong Kong,"May 5, 2020",Observational,COVID-19 - Quality of Life After Infection,COVID
1400,COVID,"February 08, 2021",30,NCT04377477,SINGLE FRACTION WHOLE LUNG RADIOTHERAPY,ITALY,Recruiting,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,"May 10, 2020",Interventional,Pilot Study on the Feasibility of Low Dose Radiotherapy for SARS-Cov-2 Pneumonitis (COVID-19 Low Dose Radiotherapy - COLOR 19),COVID
1401,COVID,"February 08, 2021",100,NCT04377490,VENOUS ULTRASOUND,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","May 4, 2020",Observational,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,COVID
1402,CYTOKINE RELEASE SYNDROME,"February 08, 2021",40,NCT04377503,TOCILIZUMAB 180 MG/ML,,Not yet recruiting,Hospital Sao Domingos,May 2020,Interventional,Comparison of the Efficacy and Safety of Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19. A Prospective Randomized Controlled Phase II Trial,Unrelated
1403,HOSPITALIZED CHILDREN,"February 08, 2021",100,NCT04377568,CONVALESCENT PLASMA (CP),CANADA,Recruiting,The Hospital for Sick Children,"October 7, 2020",Interventional,"A Randomized, Multicentered, Open-label Phase 2 Clinical Trial of the Safety and Efficacy of Human Coronavirus- Immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children",Unrelated
1404,PUBLIC HEALTH,"February 08, 2021",18251,NCT04377581,,UNITED STATES,Completed,Milton S. Hershey Medical Center,"April 9, 2020",Observational,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",Unrelated
1405,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04377607,FILE SCANNING,TURKEY,Recruiting,Nevsehir Public Hospital,"November 1, 2020",Observational,An Important Index on Severity of Coronavirus Disease: Erythrocyte Haemoglobin Concentration,COVID
1406,COVID,"February 08, 2021",500,NCT04377620,PLACEBO,RUSSIAN FEDERATION,Recruiting,Incyte Corporation,"May 24, 2020",Interventional,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)",COVID
1407,SARS-CoV2,"February 08, 2021",660,NCT04377646,HYDROXYCHLOROQUINE,TUNISIA,Not yet recruiting,Military Hospital of Tunis,"May 4, 2020",Interventional,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers (COVID-Milit),COVID
1408,COVID,"February 08, 2021",9,NCT04377659,TOCILIZUMAB,UNITED STATES,"Active, not recruiting",Memorial Sloan Kettering Cancer Center,"May 1, 2020",Interventional,A Phase II Study of IL-6 Receptor Antagonist Tocilizumab to Prevent Respiratory Failure and Death in Patients With Severe COVID-19 Infection,COVID
1409,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04377672,ANTI-SARS-COV-2 HUMAN CONVALESCENT PLASMA,UNITED STATES,Recruiting,Johns Hopkins University,"May 28, 2020",Interventional,Safety and Pharmacokinetics of Human Convalescent Plasma in High Risk Children Exposed or Infected With SARS-CoV-2,COVID
1410,COVID,"February 08, 2021",800,NCT04377685,CT-SCAN,FRANCE,Recruiting,Centre Hospitalier Universitaire de Saint Etienne,"March 1, 2020",Observational,"Prediction of Clinical Course in COVID19 Patients Using Unsupervised Classification Approaches of Clinical, Biological and the Multiparametric Signature of the Chest CT Scan Performed at Admission",COVID
1411,COVID,"February 08, 2021",400,NCT04377711,CICLESONIDE,UNITED STATES,Recruiting,Covis Pharma S.à.r.l.,"June 8, 2020",Interventional,"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ciclesonide Metered-Dose Inhaler in Non-hospitalized Patients 12 Years of Age and Older With Symptomatic COVID-19 Infection",COVID
1412,COVID,"February 08, 2021",3000,NCT04377724,,SWITZERLAND,"Active, not recruiting",Goldhahn Jörg,"April 27, 2020",Observational,Longitudinal Serological Study on the Spread and Course of COVID-19 Infections,COVID
1413,"INFECTION; VIRAL, CORONAVIRUS","February 08, 2021",0,NCT04377737,RT-PCR COVID-19,FRANCE,Withdrawn,Fondation Lenval,"May 15, 2020",Interventional,Incidence of Covid-19 in School Children During the Pandemic Period in Nice,COVID
1414,COVID PNEUMONIA,"February 08, 2021",500,NCT04377750,TOCILIZUMAB,ISRAEL,Recruiting,Hadassah Medical Organization,"April 8, 2020",Interventional,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,COVID
1415,COVID,"February 08, 2021",500,NCT04377763,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"July 15, 2020",Observational,Developement and Evaluation of Serological Assays for COVID-19,COVID
1416,KIDNEY TRANSPLANT,"February 08, 2021",644,NCT04377776,PRACTICE DETAILS,ITALY,Completed,IRCCS San Raffaele,"May 4, 2020",Observational,Observational Study to Assess the Health Status of Transplanted Patients (Kidney or Pancreas or Pancreatic Islet Transplantation) at Transplant Medicine Unit (MITRA) During the COVID-19 Pandemic,Unrelated
1417,COVID,"February 08, 2021",447,NCT04377789,QUERCETIN PROPHYLAXIS,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 20, 2020",Interventional,The Possible Effect of Quercetin on Prophylaxis and Treatment of COVID-19,COVID
1418,COVID,"February 08, 2021",400,NCT04377802,MOLECULAR TESTING FOR VIRUS RNA USING RT-PCR,SAUDI ARABIA,Not yet recruiting,King Fahad Specialist Hospital Dammam,"May 17, 2020",Interventional,"Safe Return to Regular Clinical Operation After COVID-19 Pandemic; (Oncology Center, Prospective Cohort)",COVID
1419,COVID,"February 08, 2021",569,NCT04377815,GENERAL PUBLIC COHORT,UNITED KINGDOM,Completed,"University College, London","April 23, 2020",Observational,FORECAST Study: Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,COVID
1420,CARDIOVASCULAR DISEASES,"February 08, 2021",300,NCT04377997,ENOXAPARIN,,Not yet recruiting,Massachusetts General Hospital,"May 15, 2020",Interventional,"A Randomized, Open-Label Trial of Therapeutic Anticoagulation in COVID-19 Patients With an Elevated D-Dimer",Unrelated
1421,COVID,"February 08, 2021",18,NCT04378244,DELTAREX-G,,Not yet recruiting,Aveni Foundation,"January 12, 2021",Interventional,CORONA: A Phase 1/2 Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,COVID
1422,DEPRESSIVE SYMPTOMS,"February 08, 2021",70,NCT04378257,THERAPIST GUIDED E-THERAPY,,Not yet recruiting,Sultan Qaboos University,"June 1, 2020",Interventional,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic: An Open-Label 12 - Weeks Randomized Controlled Trail,Unrelated
1423,SARS-CoV2,"February 08, 2021",56442,NCT04378452,COM-COVID ANONIMOUS SURVEY,SPAIN,"Active, not recruiting",Fundació Institut Germans Trias i Pujol,"March 31, 2020",Observational [Patient Registry],Assessment of the Psycho-social Impact of COVID-19 Outbreak (COM-COVID),COVID
1424,STRESS,"February 08, 2021",174,NCT04378530,PERSONALIZED ANCHORING STRATEGY,UNITED STATES,"Active, not recruiting",Arizona State University,"July 27, 2020",Interventional,Mindfulness Takes Practice: mHealth Tools for Building Persistent Mindfulness Meditation Habits,Unrelated
1425,SARS-CoV2,"February 08, 2021",1589,NCT04378582,RISK FACTORS,BRAZIL,Completed,University of Sao Paulo General Hospital,"May 7, 2020",Observational,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,COVID
1426,FOOD INSECURITY,"February 08, 2021",1000,NCT04378595,DURING COVID-19 PANDEMIC,UNITED STATES,Recruiting,University of Texas at Austin,"April 10, 2020",Observational,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin Federally Qualified Health Centers,Unrelated
1427,SARS-CoV2,"February 08, 2021",500,NCT04378686,DIALYSIS,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"April 23, 2020",Observational,A Comparative Study of Symptom-driven Surveillance vs. Cross-sectional Serological Screening of SARS-CoV-2 Infection of Patients With End-stage Kidney Disease Receiving Renal Replacement Therapy,COVID
1428,COVID,"February 08, 2021",90,NCT04378712,HYDROGEN OXYGEN GENERATOR WITH NEBULIZER,CHINA,Completed,Guangzhou Institute of Respiratory Disease,"January 21, 2020",Interventional,"Effects of Hydrogen/Oxygen Mixed Gas Inhalation for Patients With Coronavirus Disease 2019 (COVID-19) Who Had Dyspnea: A Multicenter, Open-label Clinical Trial",COVID
1429,SOCIAL MEDIA,"February 08, 2021",212,NCT04378738,SURVEY,TURKEY,Enrolling by invitation,Acibadem University,"May 1, 2020",Interventional,The Role of Social Media as an Information Source in Covid19 Pandemic,Unrelated
1430,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",2000,NCT04378777,BIOLOGICAL SAMPLE COLLECTION,UNITED STATES,Enrolling by invitation,National Institute of Allergy and Infectious Diseases (NIAID),"May 1, 2020",Observational,A Prospective Cohort Study to Assess Longitudinal Immune Responses in Hospitalized Patients With COVID-19 (DAIT-COVID-19-002),COVID
1431,WELL AGING,"February 08, 2021",53,NCT04378803,MINDFULNESS TRAINING (MT) CONNECT,UNITED STATES,Completed,University of Miami,"May 13, 2020",Interventional,Mindfulness Training for Older Adults During the COVID-19 Pandemic,Unrelated
1432,COVID,"February 08, 2021",40,NCT04378829,"PLATELET COUNT, PLATELET, MEAN PLATELET VOLUME AND PLATELET DISTRIBUTION WIDTH IN COVID-19",TURKEY,Recruiting,Konya Training and Research Hospital,"September 12, 2020",Observational,"Does the Platelet Count, Mean Platelet Volume and Platelet Distribution Width Change in COVID-19 Pandemic, ?",COVID
1433,SARS-CoV2,"February 08, 2021",690,NCT04378842,,FRANCE,Recruiting,"University Hospital, Lille","May 18, 2020",Observational,Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria,COVID
1434,COVID,"February 08, 2021",100,NCT04378881,,UNITED STATES,"Active, not recruiting",Tabula Rasa HealthCare,"June 1, 2020",Observational,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,COVID
1435,"COVID, SEPSIS OR OTHER CAUSES","February 08, 2021",90,NCT04378920,LEAF-4L6715,FRANCE,Recruiting,Institut de cancérologie Strasbourg Europe,"April 14, 2020",Interventional,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes",COVID
1436,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",50,NCT04379037,TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION,ARGENTINA,Recruiting,Nemechek Technologies,"June 27, 2020",Interventional,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,COVID
1437,"BURNOUT, PROFESSIONAL","February 08, 2021",342,NCT04379063,COVID-19 PANDEMIC,CANADA,"Active, not recruiting",Jon Bailey,"May 13, 2020",Observational,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress Among Physicians (COPING Survey): A Longitudinal Survey,Unrelated
1438,COVID,"February 08, 2021",48,NCT04379076,INTERLEUKIN-7,UNITED KINGDOM,Recruiting,Revimmune,"May 14, 2020",Interventional,"A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection in UK",COVID
1439,COVID,"February 08, 2021",500,NCT04379089,OBSERVATIONAL STUDY ONLY,UNITED STATES,Recruiting,University of Pittsburgh,"April 29, 2020",Observational,Neurologic Manifestations of COVID 19 in Children,COVID
1440,COVID,"February 08, 2021",60,NCT04379154,VOLATILE ORGANIC COMPOUNDS ANALYSIS,FRANCE,Recruiting,Hopital Foch,"April 14, 2020",Interventional,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by (SARS-CoV-2): Predictive Interest in Short-term Evolution,COVID
1441,DIGESTIVE CANCER,"February 08, 2021",112,NCT04379232,SCREENING TEST FOR COVID ( RT PCR AND CT CHEST),FRANCE,Completed,Hospices Civils de Lyon,"March 19, 2020",Observational,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center: A Retrospective Observational Cohort Study,Unrelated
1442,HIV,"February 08, 2021",4200,NCT04379245,"DATA RESEARCH, DATABASE ANALYSIS",FRANCE,Completed,Hospices Civils de Lyon,"April 30, 2020",Observational,Study of the Attack Rate of COVID-19 Infection in Patients Infected With HIV and/or on Pre-exposure Prophylaxis (PrEP) and Possible Impact of Treatment With an HIV Protease Inhibitor,Unrelated
1443,COVID,"February 08, 2021",650,NCT04379258,,,Not yet recruiting,Hospital Universitario Getafe,"May 11, 2020",Observational [Patient Registry],"Epidemiological Analysis of the Mortality of Critically Ill Patients With the COVID-19 Admitted to the Intensive Care Unit: An Observational, Prospective and Multicenter Study",COVID
1444,COVID,"February 08, 2021",230,NCT04379271,IMU-838,BULGARIA,Recruiting,Immunic AG,"June 11, 2020",Interventional,"A Prospective, Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19",COVID
1445,COVID,"February 08, 2021",100,NCT04379284,BIOSPECIMEN COLLECTION,UNITED STATES,Recruiting,Mayo Clinic,"May 8, 2020",Observational,Risks of COVID19 in the Pregnant Population,COVID
1446,COVID,"February 08, 2021",1800,NCT04379297,,LUXEMBOURG,"Active, not recruiting",Luxembourg Institute of Health,"April 10, 2020",Observational,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),COVID
1447,COVID,"February 08, 2021",54,NCT04379310,ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS,TURKEY,Completed,Nisantasi University,"May 1, 2020",Observational,Evaluation of Demographic and Clinical Parameters on Admission and Medications Used for Comorbidities in Patients With Covid-19 Pneumonia: A Single Center Experience in Turkey,COVID
1448,COVID,"February 08, 2021",500,NCT04379336,BACILLE CALMETTE-GUÉRIN (BCG),SOUTH AFRICA,Recruiting,TASK Applied Science,"May 4, 2020",Interventional,"Reducing Morbidity and Mortality in Health Care Workers Exposed to SARS-CoV-2 by Enhancing Non-specific Immune Responses Through Bacillus Calmette-Guérin Vaccination, a Randomized Controlled Trial",COVID
1449,HEALTH BEHAVIOR,"February 08, 2021",45,NCT04379375,NUDGE,UNITED STATES,Terminated,Medical College of Wisconsin,"July 27, 2020",Interventional,Using Behavioral Nudges to Improve Preventive Health Behaviors That Limit COVID-19 Spread,Unrelated
1450,COVID,"February 08, 2021",1500,NCT04379440,,ITALY,Recruiting,Raffaele Antonelli Incalzi,"April 25, 2020",Observational [Patient Registry],"Geriatric Population COVID-19 Syndromic Characteristics and Clinical Outcomes: a Multi-setting, Multi-domain Observational Study (GEROCOVID Observational)",COVID
1451,CORONARY ARTERY DISEASE,"February 08, 2021",10,NCT04379453,ROBOT ASSISTED PERCUTANEOUS CARDIOVASCULAR INTERVENTION,BRAZIL,Recruiting,Hospital Israelita Albert Einstein,"April 27, 2020",Interventional,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,Unrelated
1452,COVID,"February 08, 2021",60,NCT04379466,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 5, 2020",Observational,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,COVID
1453,COVID,"February 08, 2021",562,NCT04379479,DIALYZABLE LEUKOCYTE EXTRACT,MEXICO,Not yet recruiting,"National Polytechnic Institute, Mexico",May 2020,Interventional,Assessment of the Clinical Effect of Dialyzable Leukocyte Extracts in Individuals With Acute Respiratory Infection (Suspected or Confirmed Cases of COVID-19) (FUTURE-T),COVID
1454,COVID,"February 08, 2021",0,NCT04379492,HYDROXYCHLOROQUINE,UNITED STATES,Withdrawn,Memorial Sloan Kettering Cancer Center,"May 5, 2020",Interventional,"Single-center, Phase II, Randomized Double-blind, Placebo-controlled Study of Hydroxychloroquine Compared to Placebo as Treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection",COVID
1455,MALIGNANT NEOPLASM,"February 08, 2021",44,NCT04379518,RECOMBINANT INTERFERON ALFA-2B,UNITED STATES,Recruiting,Roswell Park Cancer Institute,"September 4, 2020",Interventional,Phase 1/2A Study of Rintatolimod and IFN-Alpha Regimen in Cancer Patients With Mild or Moderate COVID-19 Infection,Unrelated
1456,PNEUMONIA,"February 08, 2021",230,NCT04379531,LOW-DOSE CHEST CT,RUSSIAN FEDERATION,Completed,Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department,"April 25, 2020",Interventional,Low-dose Computed Tomography in COVID-19 Pneumonia: a Prospective Moscow Study,Respiratory
1457,CORONAVIRUS,"February 08, 2021",125,NCT04379544,OBSERVATION ONLY,UNITED STATES,"Active, not recruiting",University of Pennsylvania,"April 23, 2020",Observational [Patient Registry],Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,COVID
1458,"DIET, HEALTHY","February 08, 2021",93,NCT04379622,"DIETARY INTAKE, BODY COMPOSITION, LIFESTYLE, AND CVD RISK FACTORS",SLOVENIA,Completed,Barbara Jakše s.p.,"May 22, 2020",Observational,"Differences in Dietary Intake, Body Composition, Lifestyle and Various Cardiovascular Diseases Risk Factors Among Healthy and Active Vegetrians and Non Vegetarians",Unrelated
1459,MS (MULTIPLE SCLEROSIS),"February 08, 2021",32,NCT04379661,ONLINE SUPPORT GROUP,UNITED STATES,Completed,Columbia University,"May 7, 2020",Interventional,SUNLIGHT Study: Online Support Groups for Multiple Sclerosis (MS) to Address COVID-19,Unrelated
1460,BLOOD PRESSURE,"February 08, 2021",30,NCT04379986,SENSBIOSYS,SWITZERLAND,Not yet recruiting,"Stéphane Cook, Prof","May 1, 2020",Interventional,Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device,Unrelated
1461,COVID,"February 08, 2021",60,NCT04380376,MELPHALAN,RUSSIAN FEDERATION,Recruiting,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute","April 30, 2020",Interventional,"Single-center, Prospective, Open-label, Comparator Study, Blind for Central Accessor to Access the Efficacy, Safety, and Tolerability of Inhalations of Low-doses of Melphalan in Patients With Pneumonia With Confirmed or Suspected COVID-19",COVID
1462,COVID,"February 08, 2021",300,NCT04380402,ATORVASTATIN,,Not yet recruiting,Mount Auburn Hospital,"May 20, 2020",Interventional,Prospective Randomized Open-label Trial of Atorvastatin as Adjunctive Treatment of COVID-19,COVID
1463,COVID,"February 08, 2021",372,NCT04380519,RPH-104 80 MG,RUSSIAN FEDERATION,Completed,"R-Pharm International, LLC","April 23, 2020",Interventional,"An International, Multicenter, Randomized, Double-blind, Adaptive Placebo-controlled Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe SARS-CoV-2 Infection (COVID-19)",COVID
1464,COVID,"February 08, 2021",20,NCT04380532,V-SARS,CANADA,"Active, not recruiting",Immunitor LLC,"May 15, 2020",Interventional,Clinical Trial of COVID-19 Therapeutic Vaccine Formulated as an Oral Pill,COVID
1465,COVID,"February 08, 2021",800,NCT04380662,RISK FACTORS,FRANCE,Not yet recruiting,"University Hospital, Grenoble","June 30, 2020",Observational,RRisk Factors Worsening COVID19 (Coronavirus Infectious Disease 2019) for Outpatient With Home Monitoring (COVID-A-DOMEVA Study),COVID
1466,COVID,"February 08, 2021",62,NCT04380688,ACALABRUTINIB,UNITED STATES,Completed,AstraZeneca,"June 13, 2020",Interventional,"A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19",COVID
1467,"INFECTIONS, RESPIRATORY","February 08, 2021",456,NCT04380701,BNT162A1,GERMANY,Recruiting,BioNTech SE,"April 23, 2020",Interventional,"A Multi-site, Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of Four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-2019 Using Different Dosing Regimens in Healthy and Immunocompromised Adults",Respiratory
1468,PEOPLE INCARCERATED,"February 08, 2021",700,NCT04380714,,FRANCE,Completed,"University Hospital, Montpellier","May 1, 2020",Observational,Changes in the Consumption of Psychoactive Substances by People Incarcerated at the Villeneuve-Lès-Maguelone Prison During Containment Linked to COVID-19.,Unrelated
1469,COVID,"February 08, 2021",17,NCT04380727,,FRANCE,Completed,"Central Hospital, Nancy, France","March 20, 2020",Observational [Patient Registry],Almitrine and Severe COVID-19 Patients in ICU [Almitrine et Patients COVID-19 en Reanimation (French)],COVID
1470,PANCREATIC CANCER,"February 08, 2021",730,NCT04380766,EVALUATION OF CHANGES IN THE DIAGNOSTIC-THERAPEUTIC PATHWAY FOR PATIENTS AFFECTED BY PANCREATIC CANCER,ITALY,Completed,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,"January 1, 2019",Observational [Patient Registry],Effects of Covid-19 Pandemic on Pancreatic Surgery in Italy. A Multicenter Observational Clinical Study,Unrelated
1471,COVID,"February 08, 2021",2430,NCT04380779,,SPAIN,Completed,Manuel Monreal,"April 13, 2020",Observational,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses (BLEEDING Study),COVID
1472,COVID,"February 08, 2021",2497,NCT04380792,,SPAIN,Completed,Manuel Monreal,"April 13, 2020",Observational,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital (SCREENING Study),COVID
1473,"PNEUMONIA, VIRAL","February 08, 2021",106,NCT04380818,LOW-DOSE RADIOTHERAPY,SPAIN,Recruiting,Grupo de Investigación Clínica en Oncología Radioterapia,"June 5, 2020",Interventional,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19: Multi-central Prospective Study,Respiratory
1474,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04380870,CHINESE HERBAL MEDICINE,UNITED STATES,Recruiting,Center for Integrated Care,"April 11, 2020",Observational,"Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19: A Descriptive, Longitudinal, Pragmatic Cohort Study",COVID
1475,SARS-CoV2 INFECTION,"February 08, 2021",1000,NCT04380896,BLOOD TEST,UNITED KINGDOM,Recruiting,Great Ormond Street Hospital for Children NHS Foundation Trust,"April 27, 2020",Observational,COVID-19 Staff Testing of Antibody Responses Study (CO-STARS),COVID
1476,PSYCHOLOGICAL DISTRESS,"February 08, 2021",80,NCT04380909,INTERNET-BASED SELF-HELP,SWITZERLAND,Recruiting,University of Bern,"May 6, 2020",Interventional,Randomized Controlled Trial (RCT) to Evaluate the Efficacy of an Internet-based Self-help Program for People With Psychological Distress Due to Covid-19,Unrelated
1477,COVID,"February 08, 2021",60,NCT04380935,CONVALESCENT PLASMA,INDONESIA,Recruiting,Indonesia University,"May 18, 2020",Interventional,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome in Referral Hospitals in Indonesia,COVID
1478,SEVERE OR CRITICAL CONFIRMED CORONAVIRUS DISEASE (COVID)-19,"February 08, 2021",270,NCT04380961,SIRUKUMAB,UNITED STATES,Recruiting,"Janssen Pharmaceutica N.V., Belgium","April 24, 2020",Interventional,"Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical COVID-19 Disease",COVID
1479,COVID,"February 08, 2021",200,NCT04380987,BIOLOGICAL SAMPLING,LUXEMBOURG,Recruiting,Luxembourg Institute of Health,"May 4, 2020",Observational,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,COVID
1480,CHRONIC PAIN,"February 08, 2021",170,NCT04381000,EXERCISE GROUP,GREECE,Completed,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,"April 1, 2020",Interventional,The Impact of Quarantine and the Effectiveness of Telerehabilitation in Patients With Chronic Pain During COVID-19 Pandemic.,Unrelated
1481,COVID,"February 08, 2021",4,NCT04381013,EMERGENCY VENTILATOR SPLITTER,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Interventional,Emergency Ventilator Splitting Between Two or More Patients Using a Single Ventilator to Address Critical Ventilator Shortages During a Pandemic,COVID
1482,COVID,"February 08, 2021",30,NCT04381052,CLAZAKIZUMAB,UNITED STATES,Not yet recruiting,Columbia University,May 2020,Interventional,A Randomized Placebo-Controlled Safety and Dose-Finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,COVID
1483,COVID,"February 08, 2021",1000,NCT04381273,NO INTERVENTION,GERMANY,Recruiting,Heidelberg University,"May 8, 2020",Observational,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,COVID
1484,MECHANICAL VENTILATION,"February 08, 2021",40,NCT04381286,,FRANCE,Recruiting,"University Hospital, Montpellier","April 1, 2019",Observational,Transpulmonary Driving Pressure in ARDS COVID19 Patients / TRANSPULMONARY-COVID19,Unrelated
1485,RISK FACTORS FOR COVID OUTCOMES IN ELDERLY POPULATIONS,"February 08, 2021",1000,NCT04381312,,FRANCE,Recruiting,"University Hospital, Grenoble","April 9, 2020",Observational,COVID-19 Chez la Personne âgée de Plus de 70 Ans : Impact Direct et Indirect à 3 Mois.,COVID
1486,CORONA VIRUS DISEASE 19 (COVID),"February 08, 2021",92,NCT04381338,PULMONARY AND MOTOR REHABILITATION,ITALY,Not yet recruiting,University of Padova,"May 10, 2020",Interventional,Pulmonary and Motor Rehabilitation for People With COVID-19 in Intensive Care Units to Reduce Length of Stay in Hospital,COVID
1487,COVID,"February 08, 2021",50,NCT04381351,,GERMANY,Recruiting,"Heinrich-Heine University, Duesseldorf","April 16, 2020",Observational,The Role of Noncoding RNAs in COVID-19 and COVID-19 Associated Acute Kidney Injury (MiRCOVID),COVID
1488,COVID,"February 08, 2021",446,NCT04381364,CICLESONIDE INHALATION AEROSOL,SWEDEN,Recruiting,"Ola Blennow, MD, PhD","May 29, 2020",Interventional,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),COVID
1489,"INFECTIONS, CORONAVIRUS","February 08, 2021",394,NCT04381377,AZOXIMER BROMIDE,RUSSIAN FEDERATION,Recruiting,NPO Petrovax,"April 29, 2020",Interventional,"A Multi-centre, Adaptive, Randomized, Double-blind, Placebo-controlled Comparative Clinical Study of the Safety and Efficacy of Polyoxidonium®, Lyophilizate for Solution for Injections and Topical Application, 6 mg (NPO Petrovax Pharm LLC, Russia) in Patients With Coronavirus Disease (COVID-19).",COVID
1490,SARS VIRUS,"February 08, 2021",1000,NCT04381819,SARS-COV-2 PCR,NORWAY,Recruiting,Oslo University Hospital,"March 2, 2020",Observational,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of Inpatients During the COVID-19 Outbreak: A Prospective Cohort Study",Respiratory
1491,COVID,"February 08, 2021",200,NCT04381845,COVID19 IMMUNIZATION TESTING,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"December 10, 2020",Interventional,Immunity and COVID Infections in the Psychiatric Population,COVID
1492,COVID PNEUMONIA,"February 08, 2021",196,NCT04381858,PLASMA FROM COVID-19 CONVALESCENT PATIENT,MEXICO,Completed,Centenario Hospital Miguel Hidalgo,"May 6, 2020",Interventional,Efficacy and Safety of Convalescent Plasma vs Human Immunoglobulin for the Treatment of COVID-19 Pneumonia: A Randomized Controlled Trial,COVID
1493,COVID,"February 08, 2021",110,NCT04381871,ACACIA SENEGAL,SUDAN,Not yet recruiting,Al-Neelain University,"June 1, 2020",Interventional,"Phase II ,III Randomized Double Blind Parallel Arms Clinical Trial of Potential Role of Gum Arabic ( Acacia Senegal) as Immunomodulatory Agent Among COVID 19 Patients in Sudan",COVID
1494,COVID DRUG TREATMENT,"February 08, 2021",45,NCT04381884,IVERMECTIN (IVER P®) ARM WILL RECEIVE IVM 600 ΜG / KG ONCE DAILY PLUS STANDARD CARE. CONTROL ARM WILL RECEIVE STANDARD CARE.,ARGENTINA,Completed,Laboratorio Elea Phoenix S.A.,"May 18, 2020",Interventional,"A Pilot, Proof of Concept Trial to Prove Ivermectin Efficacy in the Reduction of SARS-CoV-2 Replication at Early Stages of COVID-19",COVID
1495,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",200,NCT04381923,HELMET CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP),UNITED STATES,Not yet recruiting,University of Pennsylvania,"February 15, 2021",Interventional,High Flow Nasal Oxygen Versus Continuous Positive Airway Pressure Helmet Evaluation: A Randomized Crossover Trial in COVID-19 Pneumonia,COVID
1496,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",20000,NCT04381936,LOPINAVIR-RITONAVIR,UNITED KINGDOM,Recruiting,University of Oxford,"March 19, 2020",Interventional,Randomised Evaluation of COVID-19 Therapy,Respiratory
1497,COVID,"February 08, 2021",800,NCT04381962,AZITHROMYCIN CAPSULE,UNITED KINGDOM,Recruiting,University of Oxford,"May 29, 2020",Interventional,A Multi-centre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID-19 (ATOMIC2),COVID
1498,COVID,"February 08, 2021",132,NCT04381988,HYDROXYCHLOROQUINE,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"May 7, 2020",Interventional,A Phase II Randomized Double-Blind Placebo-Controlled Clinical Trial Of Hydroxychloroquine For Prophylaxis Against Covid-19 In Patients Receiving Radiotherapy (COVID),COVID
1499,COVID,"February 08, 2021",50,NCT04382040,ARTEMIC,INDIA,Recruiting,MGC Pharmaceuticals d.o.o,"May 8, 2020",Interventional,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",COVID
1500,"COVID PNEUMONIA, IMPAIRED RESPIRATORY FUNCTION","February 08, 2021",143,NCT04382053,DFV890,ARGENTINA,Completed,Novartis Pharmaceuticals,"May 27, 2020",Interventional,"Phase 2, Randomized, Controlled, Open Label Multi-center Study to Assess Efficacy and Safety of DFV890 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients With Coronavirus Disease 2019 (COVID-19) Pneumonia and Impaired Respiratory Function",COVID
1501,COVID,"February 08, 2021",46,NCT04382066,PLITIDEPSIN 1.5 MG/DAY,SPAIN,Completed,PharmaMar,"May 12, 2020",Interventional,"Multicenter, Randomized, Parallel and Proof of Concept Study to Evaluate the Safety Profile of Three Doses of Plitidepsin in Patients With COVID-19 Requiring Hospitalization",COVID
1502,COVID,"February 08, 2021",32,NCT04382092,FILMARRAY PNEUMONIA,BELGIUM,Completed,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"March 23, 2020",Interventional,Co-infections in COVID-19 Critically Ill and Antibiotic Management,COVID
1503,UPPER RESPIRATORY TRACT INFECTIONS,"February 08, 2021",405,NCT04382131,NACL SOLUTION,UNITED KINGDOM,Recruiting,University of Edinburgh,"June 23, 2020",Interventional,Hypertonic Saline Nasal Irrigation and Gargling for Suspected or Confirmed COVID-19: Pragmatic Web-based Bayesian Adaptive Randomised Controlled Trial (ELVIS COVID-19),Respiratory
1504,MENTAL HEALTH,"February 08, 2021",497,NCT04382196,ONLINE SURVEY,BELGIUM,"Active, not recruiting","University Hospital, Ghent","April 17, 2020",Observational,The Impact of the COVID-19 Pandemic on Mental Health and Quality of Life of Healthcare Workers in a University Hospital,Unrelated
1505,COVID,"February 08, 2021",900,NCT04382235,NON-INVASIVE VENTILATORY SUPPORT,ITALY,"Active, not recruiting",University of Milano Bicocca,"March 26, 2020",Observational,Management Through Non-invasive Ventilatory Support of Patients Showing an Acute Respiratory Failure Related to COVID-19 in Non-intensive Wards,COVID
1506,COVID,"February 08, 2021",20,NCT04382391,GAMMACORE® SAPPHIRE (NON-INVASIVE VAGUS NERVE STIMULATOR),UNITED STATES,Recruiting,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),"May 8, 2020",Interventional,"A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIORII)",COVID
1507,COVID,"February 08, 2021",57,NCT04382417,OBSERVATIONAL STUDY,SWEDEN,Completed,Region Västmanland,"March 26, 2020",Observational,Characteristics and Outcomes of Critically Ill Patients With Covid-19 in a Large Swedish County Hospital - a Prospective Observational Cohort Study,COVID
1508,COVID,"February 08, 2021",48,NCT04382469,,EGYPT,Completed,Alexandria University,"February 1, 2020",Observational,Egyptian Initial Experience About 2019 Novel Corona Virus Disease (COVID-19): Single-center Study Analysis of 48 Patients in Alexandria-Egypt Regarding Radiological Patterns and Co-morbid Lung Diseases,COVID
1509,CANCER,"February 08, 2021",400,NCT04382495,SURVEY,EGYPT,Recruiting,El Zaitoun Specialized Hospital,"June 15, 2020",Observational,The Impact of COVID-19 Pandemic on Cancer Care From Patients' and Survivors' Perspective,Unrelated
1510,IMMUNE SUPPRESSION,"February 08, 2021",1500,NCT04382508,QUESTIONNAIRE,UNITED KINGDOM,Enrolling by invitation,University Hospital Southampton NHS Foundation Trust,"March 22, 2020",Observational,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,Unrelated
1511,COVID,"February 08, 2021",300,NCT04382534,RESPIRATORY REHABILITATION,CHINA,Recruiting,Peking University Third Hospital,"March 10, 2020",Observational,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction,COVID
1512,COVID,"February 08, 2021",40,NCT04382547,ALLOGENIC POOLED OLFACTORY MUCOSA-DERIVED MESENCHYMAL STEM CELLS,BELARUS,Enrolling by invitation,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,"May 11, 2020",Interventional,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,COVID
1513,"BEHAVIOR, SOCIAL","February 08, 2021",69,NCT04382560,DEEP BREATHING TRAINING,ITALY,Completed,University of Parma,"May 2, 2020",Interventional,Resting Heart Rate Variability as a Predictor of Coping Strategies and Responsiveness to a Brief Online Intervention During Forced Quarantine,Unrelated
1514,COVID PULMONARY COMPLICATIONS,"February 08, 2021",52,NCT04382586,ZANUBRUTINIB,BRAZIL,Recruiting,BeiGene,"July 6, 2020",Interventional,"A Phase 2, Randomized, Double Blind, Placebo-Controlled Study of Zanubrutinib Treatment in Patients Hospitalized for COVID-19 Infection and Pulmonary Distress",COVID
1515,SARS-CoV2 PNEUMONIA,"February 08, 2021",0,NCT04382625,HYDROXYCHLOROQUINE,UNITED STATES,Withdrawn,Kootenai Health,October 2020,Interventional,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,COVID
1516,"COVID PNEUMONIA, IMPAIRED RESPIRATORY FUNCTION","February 08, 2021",140,NCT04382651,MAS825,UNITED STATES,"Active, not recruiting",Novartis Pharmaceuticals,"June 7, 2020",Interventional,"A Phase 2, Randomized, Placebo-controlled, Participant and Investigator Blinded, Multi-center Study to Assess Efficacy and Safety of MAS825 for the Treatment of SARS-CoV-2 Infected Patients With COVID-19 Pneumonia and Impaired Respiratory Function",COVID
1517,COVID PNEUMONIA,"February 08, 2021",80,NCT04382729,NEUROMUSCULAR ELECTRICAL STIMULATION,ITALY,Recruiting,"University of Turin, Italy","April 17, 2020",Interventional,Effects of Neuromuscular Electrical Stimulation Therapy on Physical Function in Patients With COVID-19 Associated Pneumonia: Study Protocol of a Randomized Controlled Trial,COVID
1518,COVID,"February 08, 2021",81,NCT04382755,ZILUCOPLAN®,BELGIUM,"Active, not recruiting","University Hospital, Ghent","May 22, 2020",Interventional,"A Prospective, Randomized, Open-label, Interventional Study to Investigate the Efficacy of Complement C5 Inhibition With Zilucoplan® in Improving Oxygenation and short-and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure",COVID
1519,CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04382768,INHALED HYPERTONIC IBUPROFEN,ARGENTINA,Recruiting,Química Luar SRL,"May 1, 2020",Interventional,"Extended Compassionate Use Program (UCA) With Inhalational Ibuprofen in Patients With Acute Respiratory Pathology, Mediated by COVID-19.",COVID
1520,COVID INFECTION,"February 08, 2021",500,NCT04382781,NO-IMMUNOSUPPRESSIVE,SPAIN,Recruiting,Spanish Network for Research in Infectious Diseases,May 2020,Observational,Effect of Immunosupressive Treatment in COVID-19 Patients Whit SAM-LIKE Profile: Retrospective Cohort Study (SAM-COVID Project),COVID
1521,COVID,"February 08, 2021",338,NCT04382794,RETROSPECTIVE CASE-CONTROL ANALYSIS,ITALY,Completed,University of Milan,"May 14, 2020",Observational,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients: Retrospective Study,COVID
1522,COVID,"February 08, 2021",160,NCT04382846,NITAZOXANIDE,EGYPT,Recruiting,Tanta University,"May 8, 2020",Interventional,Nitazoxanide in Treatment of COVID-19,COVID
1523,COVID,"February 08, 2021",682,NCT04382924,NP-120 (IFENPRODIL),AUSTRALIA,"Active, not recruiting",Algernon Pharmaceuticals,"August 5, 2020",Interventional,A Randomized Open Label Phase 2b/3 Study of the Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,COVID
1524,COVID,"February 08, 2021",24,NCT04382950,RECOMBINANT BACTERIAL ACE2 RECEPTORS -LIKE ENZYME OF B38-CAP (RBACE2) PLUS AEROSOLIZED 13 CIS RETINOIC ACID,,Not yet recruiting,Kafrelsheikh University,July 2020,Interventional,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,COVID
1525,COVID,"February 08, 2021",20,NCT04383002,NITRIC OXIDE,CANADA,Recruiting,"University Health Network, Toronto","September 2, 2020",Interventional,Use of High Dose Inhaled Nitric Oxide in Intubated Patients Admitted With COVID-19,COVID
1526,COVID,"February 08, 2021",1050,NCT04383444,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"July 7, 2020",Observational,Surveillance of Individuals Following SARS-CoV-2 Infection,COVID
1527,CORONAVIRUS INFECTION,"February 08, 2021",214,NCT04383457,RIA-DEVICE (REMOTE INVESTIGATION AND ASSESSMENT),SWEDEN,Completed,Vastra Gotaland Region,"June 15, 2020",Observational [Patient Registry],Covid-19 Triage Using Camera-based AI,COVID
1528,MENTAL HEALTH WELLNESS 1,"February 08, 2021",100000,NCT04383470,,GREECE,Recruiting,University of Padova,"April 26, 2020",Observational,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,Unrelated
1529,CORONAVIRUS AS THE CAUSE OF DISEASES CLASSIFIED ELSEWHERE,"February 08, 2021",100,NCT04383483,COVICU,TURKEY,Recruiting,Bursa Yüksek İhtisas Education and Research Hospital,"June 15, 2020",Observational,CoV-ICU Score: Who Will Need Intensive Care in the Course of Corona Virus Disease?,COVID
1530,SARS VIRUS,"February 08, 2021",333,NCT04383535,CONVALESCENT SARS COVID-19 PLASMA,ARGENTINA,Completed,Hospital Italiano de Buenos Aires,"May 15, 2020",Interventional,"Randomized, Double-blind, Placebo-controlled Clinical Trial of Convalescent Plasma for the Treatment of COVID-19 Pneumonia With Severity Criteria",Respiratory
1531,COVID,"February 08, 2021",100,NCT04383548,HYPER IMMUNOGLOBULINS CONTAINING ANTI-CORONA VS2 IMMUNOGLOBULIN,,Not yet recruiting,Assiut University,"June 1, 2020",Interventional,Randomized Prospective Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma in Prevention of Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,COVID
1532,COVID,"February 08, 2021",422,NCT04383574,"TWO DOSES OF LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,28",CHINA,"Active, not recruiting","Sinovac Research and Development Co., Ltd.","May 22, 2020",Interventional,"A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) in Healthy Population Aged ≥60 Years",COVID
1533,SARS-CoV2,"February 08, 2021",300,NCT04383587,SEROLOGIC TESTING,UNITED STATES,Completed,Mayo Clinic,"May 6, 2020",Interventional,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,COVID
1534,COVID,"February 08, 2021",350,NCT04383613,PRONE POSITIONING,CANADA,Recruiting,Unity Health Toronto,"May 15, 2020",Interventional,Prone Positioning for Patients on General Medical Wards With COVID19: A Multicenter Pragmatic Randomized Trial [COVID-PRONE],COVID
1535,COVID,"February 08, 2021",216,NCT04383626,,EGYPT,Completed,Cairo University,"March 2, 2020",Observational,Fear and Practice Modification Among Dentists During COVID-19 Pandemic,COVID
1536,COVID,"February 08, 2021",200,NCT04383652,BIOLOGICAL SAMPLE AND CLINICAL DATA COLLECTION,AUSTRALIA,Recruiting,Kirby Institute,"May 6, 2020",Observational,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,COVID
1537,COVID,"February 08, 2021",200,NCT04383678,EXTRACORPOREAL MEMBRANE OXYGENATION,FINLAND,Recruiting,Helsinki University Central Hospital,"March 1, 2020",Observational,Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Multicenter European Study,COVID
1538,RESPIRATORY TRACT INFECTIONS,"February 08, 2021",60,NCT04383717,LEVAMISOLE AND ISOPRINOSINE,,Not yet recruiting,Cairo University,"May 5, 2020",Interventional,The Efficacy of Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,Respiratory
1539,CRITICALLY ILLNESS,"February 08, 2021",400,NCT04383730,INTRAVENOUS SEDATION,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 26, 2020",Observational,Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),Unrelated
1540,EMERGENCY DEPARTMENT STAFF DURING THE COVID PANDEMIC,"February 08, 2021",200,NCT04383886,STRESS AND ANXIETY QUESTIONNAIRE,FRANCE,Recruiting,Hospices Civils de Lyon,"April 18, 2020",Observational,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic,COVID
1541,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04383899,QUESTIONNAIRE,FRANCE,Recruiting,"University Hospital, Bordeaux","September 30, 2020",Observational,Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019 (COVID-19) Infections: a Case-control Study,COVID
1542,COVID,"February 08, 2021",7000,NCT04384029,COVID-19 + PATIENTS,SWITZERLAND,"Active, not recruiting",François MACH,"March 24, 2020",Observational,"Retrospective Observational Study to Compare the Short, Mid- and Long-term Prognosis and Outcomes of SRAS-CoV-2 Infected Hospitalized Patients With Cardiovascular Disease (CVD) to SARS-CoV-2 Infected Hospitalized Patients Without CVD: The Geneva Covid-19 CVD Study",COVID
1543,SARS-COV INFECTION,"February 08, 2021",60,NCT04384042,PATIENT-REPORTED ONLINE QUESTIONNAIRE ON OLFACTORY & TASTE DISTURBANCES,MALAYSIA,Not yet recruiting,Hospital Sultanah Bahiyah,May 2020,Observational,Olfactory and Gustatory Disturbances as a Clinical Presentation of Coronavirus Disease 2019 (COVID-19) Infection in Malaysia - A Nationwide Multicentre Case-Control Study,Respiratory
1544,COVID,"February 08, 2021",200,NCT04384055,LUNG ULTRASOUND,UNITED STATES,Enrolling by invitation,Stanford University,"March 21, 2020",Observational,Predicting Outcomes for Covid-19 Using Sonography,COVID
1545,GENETIC BASIS OF COVID INFECTION,"February 08, 2021",50,NCT04384250,WHOLE EXOME SEQUENCING,EGYPT,Recruiting,Mansoura University,"May 10, 2020",Observational,Genetic Factors Influencing the Response to Infection With SARS-COV-2,COVID
1546,CORONAVIRUS INFECTION,"February 08, 2021",33,NCT04384380,HYDROXYCHLOROQUINE SULFATE 200 MG [PLAQUENIL],TAIWAN,Completed,Taoyuan General Hospital,"April 1, 2020",Interventional,"A Multi-center, Randomized, Open-label, Controlled Trial to Evaluate the Efficacy and Tolerability of Hydroxychloroquine (HCQ) in Adult Patients With Mild to Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment",COVID
1547,CHRONIC DISABLING,"February 08, 2021",467,NCT04384406,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Assessment of the Consequences of the Abrupt Interruption of Physical and Rehabilitation Medicine Consultations During the Quarantine Period in France Between 2020 March 17th and May 11th,Unrelated
1548,MENTAL DISORDER,"February 08, 2021",1000,NCT04384419,,FRANCE,Recruiting,"University Hospital, Montpellier","May 29, 2020",Observational,"Real or Concieved Death Number Perception in Depression, Anxiety and in Schizotypal Personality Disorder Following Covid-19 Pandemic Lockdown",Unrelated
1549,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04384445,ZOFIN,UNITED STATES,Recruiting,Organicell Regenerative Medicine,"September 8, 2020",Interventional,"A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Zofin for the Treatment of Moderate to SARS Related to COVID-19 Infection vs Placebo",COVID
1550,CORONAVIRUS INFECTION,"February 08, 2021",400,NCT04384458,HYDROXYCHLOROQUINE,BRAZIL,Recruiting,Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara,"July 20, 2020",Interventional,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,COVID
1551,TYPE1DIABETES,"February 08, 2021",384,NCT04384471,ONLINE SURVEY,CANADA,Enrolling by invitation,McGill University,"April 29, 2020",Observational,Patient Living With Type 1 Diabetes' Experience During the COVID-19 Pandemic in Quebec,Unrelated
1552,COVID,"February 08, 2021",50,NCT04384497,SARS-COV-2 CONVALESCENT PLASMA,SWEDEN,Recruiting,Joakim Dillner,"May 7, 2020",Interventional,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,COVID
1553,INFECTION,"February 08, 2021",1120,NCT04384549,BCG GROUP,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 20, 2020",Interventional,Randomized Controlled Trial Evaluating the Efficacy of Vaccination With Bacillus Calmette and Guérin (BCG) in the Prevention of COVID-19 Via the Strengthening of Innate Immunity in Health Care Workers,Unrelated
1554,COVID INFECTION,"February 08, 2021",100,NCT04384588,CONVALESCENT PLASMA FROM COVID-19 DONORS,CHILE,Recruiting,Fundacion Arturo Lopez Perez,"April 7, 2020",Interventional,Investigational- Compassionate Use of Convalescent Plasma From COVID-19 Donors in Oncological and Non-Oncological Patients With Severity Criteria: FALP 001-2020 Trial (FALP-COVID),COVID
1555,COVID,"February 08, 2021",0,NCT04384614,TEST PCR,TUNISIA,Withdrawn,Direction des Soins de Santé de Base,"May 15, 2020",Observational [Patient Registry],Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study Multicentric Study,COVID
1556,SARS-COV INFECTION,"February 08, 2021",500,NCT04384705,RESEARCH SPECIFIC BLOOD SAMPLE,FRANCE,Recruiting,Centre Hospitalier Universitaire de la Réunion,"June 17, 2020",Observational,HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital,Respiratory
1557,COVID,"February 08, 2021",20,NCT04384731,PORACTANT ALFA,FRANCE,Recruiting,Dr Christophe LENCLUD,"May 29, 2020",Interventional,Randomized Controlled Phase II Trial of Poractant Alfa (Curosurf®) by Fiberoptic Bronchoscopy-directed Endobronchial Administration in Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Viral Pneumonia,COVID
1558,COVID,"February 08, 2021",100,NCT04384887,COVID-19 POSITIVE PREGNANT WOMEN,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"April 25, 2020",Observational,"''(COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",COVID
1559,COVID,"February 08, 2021",150,NCT04384900,PRONE POSITION VENTILATION,DENMARK,Recruiting,Nordsjaellands Hospital,"May 11, 2020",Interventional,Accelerated Prone Position Ventilation of Patients With COVID-19,COVID
1560,COVID,"February 08, 2021",1000,NCT04384926,ELECTIVE CANCER SURGERY,SPAIN,Recruiting,University of Birmingham,"March 30, 2020",Observational,"Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis: an International, Multicentre, Observational Cohort Study (CovidSurg-Cancer)",COVID
1561,MAJOR DEPRESSIVE DISORDER,"February 08, 2021",200,NCT04384965,"MAGPRO X100 STIMULATOR, B70 FLUID-COOLED COIL",CANADA,Recruiting,Centre for Addiction and Mental Health,"May 12, 2020",Interventional,A Novel and Practical Accelerated Intermittent Theta Burst Protocol as a Substitute for Depressed Patients Needing Electroconvulsive Therapy During the COVID-19 Pandemic,Unrelated
1562,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",320,NCT04385004,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 27, 2020",Observational,"Characterization of the Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in the Intensive Care Unit",Respiratory
1563,COVID BY SARS-CoV2 INFECTION,"February 08, 2021",40,NCT04385017,COVID-19 PATIENTS,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"May 11, 2020",Interventional,Role of Inflammasomes in COVID-19 Disease,COVID
1564,COVID,"February 08, 2021",400,NCT04385043,PLASMA HYPERIMMUNE,ITALY,Recruiting,University of Catanzaro,"May 1, 2020",Interventional,Efficacy and Safety of Hyperimmune Plasma Treatment in Patients With COVID-19 Severe Infection,COVID
1565,COV-HI,"February 08, 2021",500,NCT04385069,,UNITED KINGDOM,Recruiting,"University College, London","April 16, 2020",Observational,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,Unrelated
1566,SARS-CoV2,"February 08, 2021",820,NCT04385095,SNG001,UNITED KINGDOM,Recruiting,Synairgen Research Ltd.,"March 16, 2020",Interventional,A Randomised Double-blind Placebo-controlled Trial to Determine the Safety and Efficacy of Inhaled SNG001 (IFN-β1a for Nebulisation) for the Treatment of Patients With Confirmed SARS-CoV-2 Infection,COVID
1567,COVID,"February 08, 2021",400,NCT04385108,BLOOD COLLECTION ON ADMISSION AND LONGITUDINALLY,FRANCE,Recruiting,"University Hospital, Toulouse","March 4, 2020",Interventional,Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management,COVID
1568,COVID,"February 08, 2021",60,NCT04385121,QUESTIONNARY,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 16, 2020",Observational,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,COVID
1569,"CHOLANGITIS, SECONDARY BILIARY","February 08, 2021",670,NCT04385147,ENDOSCOPIC MANAGEMENT ACCORDING TO STANDARD OF CARE,EGYPT,Completed,Al-Azhar University,"May 18, 2020",Observational,The Status of Advanced Endoscopy in the Era of COVID-19: a Multicenter Study,Unrelated
1570,MYELOPROLIFERATIVE NEOPLASM,"February 08, 2021",80,NCT04385160,,FRANCE,Recruiting,Fondazione per la Ricerca Ospedale Maggiore,"May 13, 2020",Observational,Myeloproliferative Neoplasms (MPN) and COVID-19,Unrelated
1571,"INFECTIONS, CORONAVIRUS","February 08, 2021",60,NCT04385186,INACTIVATED CONVALESCENT PLASMA,COLOMBIA,Not yet recruiting,"National Blood Center Foundation, Hemolife","June 20, 2020",Interventional,Inactivated Convalescent Plasma as a Therapeutic Alternative in Hospitalized Patients CoViD-19,COVID
1572,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04385199,CONVALESCENT PLASMA,UNITED STATES,Recruiting,Henry Ford Health System,"May 4, 2020",Interventional,The Use of Convalescent Plasma for Patients Hospitalized With COVID-19 Disease,COVID
1573,CORONAVIRUS INFECTION,"February 08, 2021",230,NCT04385212,,SWITZERLAND,Completed,"University Hospital, Geneva","March 13, 2020",Observational,COVIDAge Study- Hospital Des Trois-Chêne,COVID
1574,COVID,"February 08, 2021",6894,NCT04385238,THIS IS AN ONLINE SURVEY WITH NO INTERVENTION.,UNITED STATES,Completed,Pregistry,"May 15, 2020",Observational,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,COVID
1575,COVID,"February 08, 2021",10000,NCT04385251,DATA COLLECTION,ARGENTINA,Recruiting,University of Minnesota,"June 18, 2020",Observational,An International Observational Study of Outpatients With SARS-CoV-2 Infection,COVID
1576,COVID,"February 08, 2021",800,NCT04385264,HYDROXYCHLOROQUINE,SWITZERLAND,Not yet recruiting,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland","May 12, 2020",Interventional,"#StayHome: Efficacy of Early Hydroxychloroquine in Outpatients to Reduce Secondary Hospitalisation and Household Transmission of COVID-19 in Switzerland: A Double-blind, Randomised, Placebo-controlled Trial",COVID
1577,COVID,"February 08, 2021",30,NCT04385576,AEROSOL BOX,MALAYSIA,Recruiting,University of Malaya,"May 15, 2020",Interventional,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box"" : Clinical Evaluation of the ""Intubation Box"" for Ease of Intubation",COVID
1578,CORONAVIRUS INFECTION,"February 08, 2021",80,NCT04385771,VV-ECMO + CYTOKINE ADSORPTION (CYTOSORB ADSORBER),GERMANY,Recruiting,Dr. Alexander Supady,"September 1, 2020",Interventional,"Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation - Randomized, Controlled, Open-label Intervention, Multi-center Trial (CYCOV-II-study)",COVID
1579,MILD COGNITIVE IMPAIRMENT,"February 08, 2021",200,NCT04385797,TELEPHONE INTERVIEW,SPAIN,"Active, not recruiting",Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud,"May 4, 2020",Observational [Patient Registry],Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia,Unrelated
1580,COVID,"February 08, 2021",23,NCT04385810,OPHTHALMOLOGIC EXAM,FRANCE,Completed,Fondation Ophtalmologique Adolphe de Rothschild,"April 27, 2020",Interventional,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,COVID
1581,"RESPIRATORY SYNDROME, ACUTE, SEVERE","February 08, 2021",62,NCT04385823,PATIENTS RECEIVING NASAL HIGH FLOW,FRANCE,Completed,Hôpital Louis Mourier,"March 1, 2020",Observational,Use of High Flow Nasal Cannula Oxygen During Acute Hypoxemic Respiratory Failure Related to Covid-19 and Interest of the Respiratory-oxygenation Index (ROX Index): an Observational Study,Respiratory
1582,CORONAVIRUS,"February 08, 2021",150,NCT04385836,ALPHA ONE ANTITRYPSIN INHALATION,SAUDI ARABIA,Recruiting,"Ministry of Health, Saudi Arabia","June 1, 2020",Interventional,Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),COVID
1583,COVID,"February 08, 2021",30,NCT04385849,N-803,,Not yet recruiting,"ImmunityBio, Inc.","June 1, 2020",Interventional,"Phase 1b, Randomized, Blinded, Placebo-controlled Study of the Safety of Therapeutic Treatment With an Immunomodulary Agent (N-803 in Adults With COVID-19",COVID
1584,CONTINUOUS GLUCOSE MONITORING,"February 08, 2021",30,NCT04385862,,CANADA,Not yet recruiting,Centre hospitalier de l'Université de Montréal (CHUM),"July 27, 2020",Observational,The Use of a Continuous Glucose Monitoring System (Dexcom G6) in Hospitalized Patients for Acute Care,Unrelated
1585,SARS-CoV2,"February 08, 2021",26,NCT04385901,THERAPY INTERVENTION,UNITED STATES,Completed,University of Missouri-Columbia,"May 19, 2020",Interventional,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,COVID
1586,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04385914,COVID POSITIVE VIA TESTING,,Not yet recruiting,Atlantic Health System,May 2020,Observational,Demographics and Outcomes of Pregnant COVID 19 Positive Women in a Community Health System,COVID
1587,COVID,"February 08, 2021",64,NCT04385940,"DDROPS® PRODUCTS, 50,000 IU, ORAL",,Not yet recruiting,University of Alberta,June 2020,Interventional,Improving Vitamin D Status in the Management of COVID-19,COVID
1588,COVID,"February 08, 2021",1000,NCT04386044,,UNITED KINGDOM,Not yet recruiting,Tameside General Hospital,"June 1, 2020",Observational,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,COVID
1589,PULMONARY COMPLICATIONS IN SURGICAL PATIENTS,"February 08, 2021",6400,NCT04386070,LOPINAVIR-RITONAVIR,,Not yet recruiting,University of Birmingham,"November 15, 2020",Interventional,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Unrelated
1590,CORONAVIRUS DISEASE 2019,"February 08, 2021",1342,NCT04386083,,PHILIPPINES,Recruiting,University of the Philippines,"June 10, 2020",Observational,COVID-19 Outcomes: A Retrospective Study of Neurological Manifestations and Associated Symptoms (The Philippine CORONA Study),COVID
1591,NEONATAL COVID DISEASE,"February 08, 2021",500,NCT04386109,NO INTERVENTION - EXPOSURE IS TO COVID-19,UNITED KINGDOM,Recruiting,University of Oxford,"April 1, 2020",Observational,Neonatal Complications of Coronavirus Disease (COVID-19),COVID
1592,COVID,"February 08, 2021",40,NCT04386239,SARILUMAB PREFILLED SYRINGE,ITALY,Recruiting,ASST Fatebenefratelli Sacco,January 2021,Interventional,Pilot Study on the Use of Sarilumab in Patients With COVID-19 Infection,COVID
1593,COVID,"February 08, 2021",175,NCT04386252,AV-COVID-19,,Not yet recruiting,"Aivita Biomedical, Inc.",February 2021,Interventional,"Adaptive Phase I-II Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies",COVID
1594,COVID,"February 08, 2021",100,NCT04386265,,POLAND,Enrolling by invitation,"SerenaGroup, Inc.","April 15, 2020",Observational [Patient Registry],The Compassionate Use of Hyperbaric Oxygen Therapy in the Treatment of COVID-19,COVID
1595,GENERALIZED ANXIETY,"February 08, 2021",360,NCT04386291,ANXIETY REDUCTION TRAINING,UNITED STATES,Recruiting,"Research Foundation for Mental Hygiene, Inc.","May 25, 2020",Interventional,Meditation and Yoga for Heightened Anxiety Related to COVID-19,Unrelated
1596,ARDS,"February 08, 2021",17,NCT04386369,AIRWAY PRESSURE RELEASE VENTILATION,FRANCE,Completed,"Central Hospital, Nancy, France","April 15, 2020",Observational,Evaluation of Airway Pressure Release Ventilation on Oxygenation in Acute Respiratory Distress Syndrome in Adult Patients With COVID-19 Pneumonia,Unrelated
1597,SARS-CoV2,"February 08, 2021",15,NCT04386395,,FRANCE,"Active, not recruiting","Central Hospital, Nancy, France","March 30, 2020",Observational,Whole Blood Immune Cells Characterization in Critically Ill COVID-19 Patients: A Prospective Study,COVID
1598,COVID,"February 08, 2021",0,NCT04386447,OXYTOCIN,FRANCE,Withdrawn,Azienda Ospedaliero-Universitaria di Parma,"September 1, 2020",Interventional,"Phase II, Multicenter, Open-label, Rct With an Adaptive Design, to Assess Efficacy of Intravenous Administration of Oxytocin in Hospitalized Patients Affected by COVID-19",COVID
1599,NUTRITION POOR,"February 08, 2021",100,NCT04386460,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"May 11, 2020",Observational,Covid-19 and Prevention of Malnutrition After Confinement by Dentists: Prospective Study Among 100 Adults Received in Dental Consultation at Nice University Hospital and Sent to Their Physician for Assessment and Nutritional Care,Unrelated
1600,COVID,"February 08, 2021",89,NCT04386512,,FRANCE,Completed,Versailles Hospital,"May 15, 2020",Observational,Épidémiologie Clinique et caractéristiques Des Cas de Covid-19 Survenus Dans un Contexte de Lymphome Lors de la première Phase épidémique,COVID
1601,SARS-CoV2,"February 08, 2021",501,NCT04386551,,FRANCE,Completed,"Centre Hospitalier Universitaire, Amiens","May 6, 2020",Observational,Evaluation of the Performance of a Saliva Sample Versus a Nasopharyngeal Sample in the Diagnosis of COVID-19 by RT-PCR,COVID
1602,COVID,"February 08, 2021",120,NCT04386564,MRNA IN URINE TEST,RUSSIAN FEDERATION,"Active, not recruiting",I.M. Sechenov First Moscow State Medical University,"May 15, 2020",Observational,Prospective Parallel-Group Study of the Relationship Between Kidney Injury Severity and Severity of COVID-19,COVID
1603,COVID PNEUMONIA,"February 08, 2021",410,NCT04386616,MSTT1041A,BRAZIL,"Active, not recruiting","Genentech, Inc.","June 2, 2020",Interventional,"A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MSTT1041A or UTTR1147A in Patients With Severe COVID-19 Pneumonia",COVID
1604,COVID,"February 08, 2021",80,NCT04386668,LET IT OUT (LIO)-C,UNITED KINGDOM,Terminated,"University College, London","May 26, 2020",Interventional,Let It Out (LIO) and COVID19: a Randomised Controlled Trial of an Online Emotional Disclosure-based Intervention for Adults During the COVID19 Pandemic,COVID
1605,COVID,"February 08, 2021",30,NCT04386694,ACTIVE PBMT/SMF,BRAZIL,Completed,University of Nove de Julho,"May 18, 2020",Interventional,Is Photobiomodulation Therapy (PBMT) Combined With Static Magnetic Field (sMF) Able to Decrease the Intensive Care Unit (ICU) Length of Stay for Patients With COVID-19?,COVID
1606,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",20,NCT04386720,,FRANCE,Recruiting,"University Hospital, Bordeaux","May 25, 2020",Observational,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom With Pressure Volume Curve on the Ventilator and With Electrical Impedance Tomography (EIT) Derived Method in Comparison of the Curves in Patients With or Without Covid 19 Pneumoniae.,Respiratory
1607,COVID,"February 08, 2021",6000,NCT04386759,COHORT,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,May 2020,Observational,COVID-19 Infection in Healthcare Workers: a Cohort Study,COVID
1608,NEWBORN,"February 08, 2021",60,NCT04386798,SURVEY WORK,TURKEY,Recruiting,Eskisehir Osmangazi University,"July 25, 2020",Interventional,Determination of Stress and Anxiety Levels of Mothers Lying in the Newborn Intensive Care Unit During Coronavirus Disease Pandemic Period,Unrelated
1609,COVID,"February 08, 2021",1500,NCT04386850,ORAL 25-HYDROXYVITAMIN D3,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Tehran University of Medical Sciences,"April 14, 2020",Interventional,Preventive and Therapeutic Effects of Oral 25-hydroxyvitamin D3 on Coronavirus (COVID-19) in Adults,COVID
1610,BIOEQUIVALENCE,"February 08, 2021",30,NCT04386876,LOPINAVIR/RITONAVIR 200 MG/50 MG FILM TABLET,TURKEY,Completed,World Medicine ILAC SAN. ve TIC. A.S.,"April 30, 2020",Interventional,"Randomized, Single Oral Dose,Two Treatment,Four-period,Full-replicated,Cross-over Trial to Assess the BE of Orvical 200 mg/50 mg FT in Comparison With Kaletra 200 mg/50 mg FT in Healthy Male Subjects Under Fasting Conditions",Unrelated
1611,COVID,"February 08, 2021",1426,NCT04387214,SURVEY,EGYPT,Completed,South Valley University,"April 13, 2020",Observational,The Impact of COVID-19 Pandemic on the Academic Performance of Veterinary Medical Students and Researchers,COVID
1612,COVID POSITIVE,"February 08, 2021",22,NCT04387240,ARTEMISININ / ARTESUNATE,SAUDI ARABIA,Not yet recruiting,Princess Nourah Bint Abdulrahman University,December 2020,Interventional,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,COVID
1613,IDENTIFICATION OF THE MOTHER OR FETUS CONTAMINATION BY SARS COV-2,"February 08, 2021",80,NCT04387253,IDENTIFICATION BY PCR OF THE SARS-COV-2 VIRUS IN SAMPLES TAKEN FROM THE FETUS,FRANCE,Recruiting,Poitiers University Hospital,"May 23, 2020",Interventional,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,Respiratory
1614,COVID,"February 08, 2021",800,NCT04387279,INTERVIEW,"KOREA, REPUBLIC OF",Recruiting,Keimyung University Dongsan Medical Center,"April 24, 2020",Observational,The Effect of Patient's Perceptions for COVID-19 on the Inflammatory Bowel Disease-related Healthcare Utilization in the Hyperepidemic Area,COVID
1615,COVID,"February 08, 2021",100,NCT04387292,OPHTHALMOLOGIC EXAM,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"September 7, 2020",Interventional,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,COVID
1616,"INFECTION, RESPIRATORY TRACT","February 08, 2021",59,NCT04387409,VPM1002,GERMANY,"Active, not recruiting",Vakzine Projekt Management GmbH,"May 25, 2020",Interventional,"A Phase III, Double-blind, Randomized, Placebo-controlled Multicentre Clinical Trial to Assess the Efficacy and Safety of VPM1002 in Reducing Healthcare Professionals' Absenteeism in the SARS-CoV-2 Pandemic by Modulating the Immune System",Respiratory
1617,COVID,"February 08, 2021",52,NCT04387643,AYURVEDIC KADHA,INDIA,Completed,Aarogyam UK,"March 1, 2020",Observational,Protecting Health Care Workers During the COVID-19 Outbreak:Qualitative Study of AYUSH Initiative,COVID
1618,COVID INFECTION,"February 08, 2021",2000,NCT04387656,BIOSPECIMEN COLLECTION,CANADA,Recruiting,National Cancer Institute (NCI),"May 21, 2020",Observational,NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study,COVID
1619,ANOREXIA NERVOSA,"February 08, 2021",18,NCT04387708,,,Not yet recruiting,Centre Psychothérapique de Nancy,"May 14, 2020",Observational,Reorganization of Care in Patients Hospitalized in Child Psychiatry for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic in France: Qualitative Study Carried Out on Patients and Their Parents,Unrelated
1620,SARS-CoV2,"February 08, 2021",150,NCT04387760,HYDROXYCHLOROQUINE,BAHRAIN,Recruiting,Royal College of Surgeons in Ireland - Medical University of Bahrain,"August 11, 2020",Interventional,Treatment of Covid-19 With Favipiravir Versus Hydroxychloroquine: a Randomized Comparator Trial,COVID
1621,COVID,"February 08, 2021",5,NCT04387786,DORNASE ALFA,UNITED STATES,Completed,Feinstein Institute for Medical Research,"March 31, 2020",Observational,Nebulized In-line Endotracheal Dornase Alfa and Albuterol Administered to Mechanically Ventilated COVID-19 Patients: A Case Series,COVID
1622,"PNEUMONIA, VIRAL","February 08, 2021",520,NCT04387799,SEROLOGY FOR COVID-19,ITALY,Completed,Catholic University of the Sacred Heart,"May 13, 2020",Observational,Major Determinants of COVID-19 Associated Pneumonia,Respiratory
1623,SARS-CoV2,"February 08, 2021",900,NCT04387838,ANTI-SARS-COV2 SEROLOGY,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"May 14, 2020",Observational,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff,COVID
1624,COVID,"February 08, 2021",50,NCT04387890,SEROLOGIC SARS-COV-2 SCREENING,,Not yet recruiting,Hospital Italiano de Buenos Aires,"June 1, 2020",Observational,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care,COVID
1625,COVID,"February 08, 2021",6000,NCT04387929,DETECTION OF ANTI-COVID-19 ANTIBODY LEVEL,ITALY,Recruiting,Istituto Clinico Humanitas,"May 4, 2020",Observational [Patient Registry],Observational Cohort Study for the Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,COVID
1626,COVID,"February 08, 2021",30,NCT04387955,BIOLOGICAL SAMPLE COLLECTION,FRANCE,Recruiting,Poitiers University Hospital,"April 30, 2020",Interventional,Analysis of Chilblains Profile During COVID-19 Epidemic,COVID
1627,CORONAVIRUS INFECTION,"February 08, 2021",5000,NCT04387968,COVID-19 PRESTO TEST,FRANCE,Recruiting,Raphael Serreau,"August 24, 2020",Observational,"Epidemiological Study of the Covid-19 Presto Test Among Agents of the Local Authorities of CCTVL, Region Centre Val de Loire and Orleans Métropole. Correlation of IgM Level According to Contact With the Public",COVID
1628,COVID,"February 08, 2021",410,NCT04388410,CONVALESCENT PLASMA,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"August 25, 2020",Interventional,Phase 2b/3 Trial to Evaluate the Safety and Efficacy of Plasma Transfusion From Convalescent Patients With SARS-CoV-2 Infection on Severity and Mortality of COVID-19 in Hospitalized Patients.,COVID
1629,COVID,"February 08, 2021",100,NCT04388436,,EGYPT,"Active, not recruiting",Mansoura University,"May 11, 2020",Observational [Patient Registry],Cardiopulmonary and Immunological Impacts of Covid-19 in a Cohort of Survivors,COVID
1630,SARS-CoV2 RESPIRATORY FAILURE,"February 08, 2021",90,NCT04388514,MEDICAL OZONE PROCEDURE,ITALY,Recruiting,Azienda Sanitaria-Universitaria Integrata di Udine,"April 8, 2020",Interventional,Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure,COVID
1631,COVID,"February 08, 2021",50,NCT04388527,COVID-19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",University of Pennsylvania,"April 30, 2020",Interventional,"An Open-Label, Single Arm, Phase 1, Safety and Exploratory Efficacy Study of Convalescent Plasma for Severely Ill Mechanically Ventilated Participants With COVID-19 Caused by SARS-CoV-2",COVID
1632,RESPIRATORY DISEASE,"February 08, 2021",100,NCT04388579,PULMONARY REHABILITATION,PORTUGAL,Completed,University of Lisbon,"March 20, 2020",Observational,PRAISE@COVID-19: Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation,Respiratory
1633,CORONAVIRUS INFECTION,"February 08, 2021",11000,NCT04388605,,UNITED STATES,Recruiting,"University of California, San Francisco","April 21, 2020",Observational [Patient Registry],Assessing the Safety of Pregnancy In the CoRonavirus pandEmic: a Nationwide Prospective Study,COVID
1634,ANOSMIA,"February 08, 2021",250,NCT04388618,NHANES SMELL AND TASTE TESTS,SAUDI ARABIA,Recruiting,Princess Nourah Bint Abdulrahman University,"June 15, 2020",Observational,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,Unrelated
1635,CORONAVIRUS DISEASE 2019,"February 08, 2021",200,NCT04388631,CORONAVIRUS DISEASE 2019,CHINA,Recruiting,Tongji Hospital,"May 10, 2020",Observational [Patient Registry],Detection Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Male Genitourinary System and Its Impact on Male Reproductive Health: an Observational Clinical Study.,COVID
1636,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04388644,,TAIWAN,Recruiting,Taipei City Hospital,"February 20, 2020",Observational,"Department of Chinese Medicine, Branch of Linsen, Chinese Medicine, and Kunming, Taipei City Hospital, Taipei, Taiwan Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan.",COVID
1637,COVID,"February 08, 2021",100,NCT04388657,ECHO-DOPPLER,FRANCE,Recruiting,Ramsay Générale de Santé,"May 1, 2020",Observational,Study of the Prevalence of Deep Vein Thrombosis in Patients Hospitalized in Intensive Care for Acute Respiratory Failure Linked to Pneumonia Documented With SARS-COV2,COVID
1638,COVID,"February 08, 2021",1500,NCT04388670,,ITALY,Recruiting,Policlinico Hospital,"February 22, 2020",Observational,Epidemiological and Clinical Characteristics of Patients With COVID-19 Admitted in Italian Intensive Care Units: a Multicentric Retrospective-prospective Cohort Study.,COVID
1639,COVID,"February 08, 2021",42,NCT04388683,NITRIC OXIDE,UNITED STATES,"Active, not recruiting",Tufts Medical Center,"May 12, 2020",Interventional,Prevention of COVID-19 Progression Through Early Administration of Inhaled Nitric Oxide.,COVID
1640,SARS-CoV2,"February 08, 2021",66,NCT04388709,PEGINTERFERON LAMBDA-1A,UNITED STATES,Not yet recruiting,Icahn School of Medicine at Mount Sinai,September 2020,Interventional,A Randomized Phase 2 Trial of Peginterferon Lambda-1a (Lambda) for the Treatment of Hospitalized Patients Infected With SARS-CoV-2 With Non-critical Illness,COVID
1641,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",1500,NCT04388813,,UNITED STATES,Recruiting,Verily Life Sciences LLC,"May 28, 2020",Observational,Predictors of Severe COVID-19 Outcomes (PRESCO),Respiratory
1642,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",40,NCT04388826,VERU-111,UNITED STATES,"Active, not recruiting",Veru Inc.,"June 18, 2020",Interventional,"Randomized, Placebo-Controlled, Phase 2 Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS)",Respiratory
1643,COVID,"February 08, 2021",300,NCT04389294,SARS-COV2 SERUM ANTIBODY TESTING,UNITED STATES,Recruiting,"Hospital for Special Surgery, New York","May 5, 2020",Interventional,Hospital for Special Surgery COVID-19 Antibody Serology Among Anesthesiologists and Surgeons 2020,COVID
1644,RHEUMATOID ARTHRITIS,"February 08, 2021",60,NCT04389320,HYDROXYCHLOROQUINE,EGYPT,Completed,Assiut University,"March 15, 2020",Observational,Antimalarial and Covid 19 in Rheumatoid Arthritis,Unrelated
1645,GASTROINTESTINAL DISEASE,"February 08, 2021",40,NCT04389333,NON-CONTACT MAGNETICALLY-CONTROLLED CAPSULE ENDOSCOPY,CHINA,Completed,Changhai Hospital,"March 26, 2020",Interventional,"Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic: a Prospective, Open-label, Pilot, Randomized Trial",Unrelated
1646,COVID,"February 08, 2021",1500,NCT04389359,HYDROXYCHLOROQUINE SULFATE 200 MG,,Not yet recruiting,Cambridge University Hospitals NHS Foundation Trust,September 2020,Interventional,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion (PROTECT): a Basket Trial of Prophylactic Interventions Amongst At-risk Patients,COVID
1647,MIGRAINE HEADACHE,"February 08, 2021",50,NCT04389372,MINDFULNESS,ITALY,Recruiting,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"March 15, 2020",Interventional,Feasibility and Effectiveness of Mindfulness Program by Smartphone for Patients With Chronic Migraine and Medication Overuse During Covid-19 Emergency,Unrelated
1648,CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04389385,COVID-19 SPECIFIC T CELL DERIVED EXOSOMES (CSTC-EXO),TURKEY,"Active, not recruiting",TC Erciyes University,"May 1, 2020",Interventional,Aerosol Inhalation of the Exosomes Derived From Allogenic COVID-19 T Cell in the Treatment of Early Stage Novel Coronavirus Pneumonia,COVID
1649,COVID,"February 08, 2021",600,NCT04389411,MONTELUKAST 10MG,,Not yet recruiting,McGill University,"October 1, 2020",Interventional,Repurposing Montelukast for the Attenuation and Prophylaxis of Severe COVID-19 Symptoms: The COvid-19 Symptom MOntelukast (COSMO) Trial,COVID
1650,COVID,"February 08, 2021",140,NCT04389450,PLX-PAD,UNITED STATES,Recruiting,Pluristem Ltd.,"October 1, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX PAD for the Treatment of Severe COVID-19",COVID
1651,PATIENTS UNDERGOING CARDIAC OR THORACIC SURGERY,"February 08, 2021",350,NCT04389463,NO INTERVENTION,FRANCE,Recruiting,Nantes University Hospital,"May 11, 2020",Observational,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic ; International Cohort Study,Unrelated
1652,THE PSYCHOLOGICAL IMPACT OF COVID,"February 08, 2021",2500,NCT04389476,STANDARDIZED CRISIS MANAGEMENT AND COPING PROTOCOL PLAN TOWARD CORONAVIRUS DISEASE 2019 (COVID-19),,Not yet recruiting,Kaohsiung Kai-Suan Psychiatric Hospital,"June 15, 2020",Observational,The Impact and Coping Strategy of Taiwan Society and Medical and Nursing Institutes Toward the Biological Disaster-- Corona Virus Disease 2019 (COVID-19) as An Example,COVID
1653,COVID,"February 08, 2021",140,NCT04389489,,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"May 14, 2020",Observational,Evaluation of Pregnant Women Diagnosed With COVID-19 Using Carol Postpartum Sexual Function and Dyspareunia Scale,COVID
1654,COVID,"February 08, 2021",75,NCT04389515,,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"May 14, 2020",Observational,"Evaluation of Pregnant Women Diagnosed With COVID-19 With ""Post-operative Recovery Index"" and ""Prenatal Care Satisfaction and Patient Expectations Scale""",COVID
1655,COVID,"February 08, 2021",300,NCT04389554,BLOOD D-DIMER ASSAY,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"May 14, 2020",Observational [Patient Registry],Assessment of D-dimer Levels in Pregnant Women Diagnosed With COVID-19,COVID
1656,COVID,"February 08, 2021",10,NCT04389567,FAMOTIDINE,UNITED STATES,Completed,Northwell Health,"May 12, 2020",Observational,Famotidine Use in Non-hospitalized Patients With COVID-19: A Case Series,COVID
1657,COVID,"February 08, 2021",160,NCT04389580,DRUG: ISOTRETINOIN PLUS TAMOXIFEN,,Not yet recruiting,Kafrelsheikh University,June 2020,Interventional,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,COVID
1658,COVID,"February 08, 2021",52,NCT04389645,IP-10 IN CDS PROTOCOL,ISRAEL,Completed,MeMed Diagnostics Ltd.,"April 7, 2020",Observational,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,COVID
1659,COVID,"February 08, 2021",1526,NCT04389658,,SPAIN,Completed,Igenomix,"May 7, 2020",Observational,Retrospective Observational Study to Determine COVID-19 Contagious and Immunological Status in Asymptomatic Population of Highly Affected Areas,COVID
1660,COVID,"February 08, 2021",30,NCT04389671,LUCINACTANT,UNITED STATES,Not yet recruiting,Windtree Therapeutics,October 2020,Interventional,"A Multicenter, Single-Treatment Study to Assess the Safety and Preliminary Efficacy of Lyophilized Lucinactant in Adults With COVID-19 Associated Acute Lung Injury",COVID
1661,CHEMEOTHERAPY,"February 08, 2021",120,NCT04389684,PSYCHO-SOCIAL QUESTIONNAIRE,FRANCE,Recruiting,Poitiers University Hospital,"May 27, 2020",Observational,Clinical and Psycho-Social Impact on Patients With Digestive Tumors of Treatment and Care Modifications Linked to COVID-19 in France,Unrelated
1662,COVID,"February 08, 2021",100,NCT04389710,CONVALESCENT PLASMA,UNITED STATES,Recruiting,Thomas Jefferson University,"April 15, 2020",Interventional,Convalescent Plasma for the Treatment of Patients With COVID-19,COVID
1663,COVID,"February 08, 2021",200,NCT04389801,DESFERAL 500 MG INJECTION,,Not yet recruiting,Hesham Al-Inany,"June 1, 2020",Interventional,The Use of Desferal and Adjuvants for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection: A Randomized Controlled Trial,COVID
1664,COVID,"February 08, 2021",524,NCT04389840,DOCIPARASTAT SODIUM,UNITED STATES,Recruiting,Chimerix,"June 3, 2020",Interventional,A Phase 2/3 Study to Evaluate the Safety and Efficacy of Dociparstat Sodium for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,COVID
1665,CORONAVIRUS DISEASE 2019 INFECTIOUS DISEASE (COVID INFECTION),"February 08, 2021",15,NCT04389944,CONVALESCENT PLASMA APPLICATION TO SARS-COV-2 INFECTED PATIENTS,SWITZERLAND,Completed,"University Hospital, Basel, Switzerland","March 31, 2020",Interventional,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe Coronavirus Disease 2019 Infectious Disease (COVID-19),COVID
1666,CANCER,"February 08, 2021",5000,NCT04389996,NO INTERVENTION,DENMARK,"Active, not recruiting",Odense University Hospital,"May 14, 2020",Observational [Patient Registry],COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,Unrelated
1667,COVID,"February 08, 2021",24,NCT04390022,IVERMECTIN,SPAIN,Completed,"Clinica Universidad de Navarra, Universidad de Navarra","July 31, 2020",Interventional,Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission,COVID
1668,"PNEUMONITIS, INTERSTITIAL","February 08, 2021",116,NCT04390061,TOFACITINIB,,Not yet recruiting,Università Politecnica delle Marche,June 2020,Interventional,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With Early Onset SARS-CoV2 (COVID-19) Interstitial Pneumonia:a Multicenter Randomized Controlled Open Label Trial,Unrelated
1669,COVID,"February 08, 2021",9905,NCT04390074,COVID-19 AND INTENSIVE CARE,SWEDEN,Completed,Uppsala University,"May 27, 2020",Observational,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,COVID
1670,CHRONIC CORONARY SYNDROME,"February 08, 2021",1200,NCT04390126,LIFE QUESTIONNAIRES,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire Dijon,"April 20, 2020",Observational,COVID-19 Related Lockdown Effects On Chronic Diseases,Unrelated
1671,COVID,"February 08, 2021",30,NCT04390139,XCEL-UMC-BETA,SPAIN,Recruiting,Banc de Sang i Teixits,"May 13, 2020",Interventional,"A Prospective, Double-blind, Randomized, Parallel, Placebo-controlled Pilot Clinical Trial for the Evaluation of the Efficacy and Safety of Two Doses of WJ-MSC in Patients With Acute Respiratory Distress Syndrome Secondary to Infection by COVID-19",COVID
1672,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",40,NCT04390152,WHARTON'S JELLY DERIVED MESENCHYMAL STEM CELLS.,COLOMBIA,Recruiting,BioXcellerator,"January 13, 2020",Interventional,Safety and Efficacy of Intravenous Infusion of Wharton's Jelly Derived Mesenchymal Stem Cell Plus Standard Therapy for the Treatment of Patients With Acute Respiratory Distress Syndrome Diagnosis Due to COVID 19: A Randomized Controlled Trial,Respiratory
1673,SARS-COV INFECTION,"February 08, 2021",760,NCT04390165,PATIENT-REPORTED ONLINE QUESTIONNAIRE ON OLFACTORY & TASTE DISTURBANCES,MALAYSIA,Not yet recruiting,Hospital Sultanah Bahiyah,May 2020,Observational,Olfactory and Gustatory Disturbances as a Clinical Presentation of Coronavirus Disease 2019 (COVID-19) Infection in Malaysia - A Nationwide Multicentre Cross-Sectional Study,Respiratory
1674,COVID,"February 08, 2021",10,NCT04390178,SARS-COV-2 CONVALESCENT PLASMA,SWEDEN,"Active, not recruiting",Joakim Dillner,"April 10, 2020",Interventional,Plasma From Individuals Who Have Recovered From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection as Treatment for Acute COVID-19 Disease,COVID
1675,COVID,"February 08, 2021",200,NCT04390191,CONTINUOUS POSITIVE AIRWAY PRESSURE,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,"May 7, 2020",Interventional,Early Continuous Positive Airway Pressure (CPAP) in COVID-19 Confirmed or Suspected Patients,COVID
1676,COVID,"February 08, 2021",120,NCT04390217,LB1148,,Not yet recruiting,"Leading BioSciences, Inc","October 31, 2020",Interventional,A Phase 2 Study to Evaluate LB1148 for the Treatment of Pulmonary Dysfunction Associated With COVID-19 Pneumonia,COVID
1677,GENETIC PREDISPOSITION TO DISEASE,"February 08, 2021",200,NCT04390269,,EGYPT,Not yet recruiting,Mansoura University,"September 10, 2020",Observational,Various Molecular Markers With Predictive and Prognostic Significance in COVID-19 Outcome,Unrelated
1678,COVID,"February 08, 2021",5,NCT04390412,LOW DOSE RADIOTHERAPY,"IRAN, ISLAMIC REPUBLIC OF","Active, not recruiting",Shahid Beheshti University of Medical Sciences,"May 4, 2020",Interventional,Assessment of Adding Low Dose Pulmonary Radiotherapy to the National Protocol of COVID-19 Management: A Pilot Trial,COVID
1679,COVID,"February 08, 2021",1167,NCT04390464,RAVULIZUMAB,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"May 8, 2020",Interventional,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),COVID
1680,COVID,"February 08, 2021",40,NCT04390477,PROBIOTIC,SPAIN,Recruiting,Bioithas SL,"May 4, 2020",Interventional,The Intestinal Microbiota as a Therapeutic Target in Hospitalized Patients With COVID-19 Infection,COVID
1681,SARS-CoV2,"February 08, 2021",200,NCT04390503,CONVALESCENT PLASMA (ANTI-SARS-COV-2 PLASMA),UNITED STATES,Recruiting,Columbia University,May 2020,Interventional,"A Phase 2 Randomized, Double-blinded Trial to Evaluate the Efficacy and Safety of Human Anti- SARS-CoV-2 Plasma in Close Contacts of COVID-19 Cases",COVID
1682,COVID,"February 08, 2021",197,NCT04390516,COVIAGE,UNITED STATES,Completed,Dascena,"March 24, 2020",Interventional,Prediction Of Respiratory Decompensation In Covid-19 Patients Using Machine Learning: The READY Trial,COVID
1683,BLOOD CANCER,"February 08, 2021",40,NCT04390542,PSYCHOEDUCATION,UNITED STATES,Not yet recruiting,Case Comprehensive Cancer Center,"February 1, 2021",Interventional,"A Pilot Study Evaluating Feasibility, Acceptability, Usability, Satisfaction and Preliminary Efficacy of an Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy",Unrelated
1684,COVID,"February 08, 2021",1500,NCT04390555,,SWITZERLAND,Recruiting,University of Zurich,"April 30, 2020",Observational [Patient Registry],COVID-19 in Hospitalised Patients With Preexisting CArdioVascular Diseases and/or Cardiac Involvement and/or Cardiovascular Risk Factors: the Global PCHF-COVICAV Registry,COVID
1685,COVID,"February 08, 2021",186,NCT04390594,NAFAMOSTAT MESILATE,SENEGAL,Recruiting,Institut Pasteur de Dakar,"August 13, 2020",Interventional,"Multicentre, Open Label, Randomised, Adaptative Clinical Trial of Efficacy and Safety of Treatment Regimens in Adult COVID-19 Patients in Senegal",COVID
1686,SARS-CoV2,"February 08, 2021",231,NCT04391101,CONVALESCENT PLASMA,COLOMBIA,Not yet recruiting,Hospital San Vicente Fundación,June 2020,Interventional,"Efficacy of Convalescent Plasma for the Treatment of Severe SARS-CoV-2 Infection: A Randomized, Open Label Clinical Trial",COVID
1687,COVID,"February 08, 2021",108,NCT04391127,HYDROXYCHLOROQUINE,MEXICO,Completed,Centenario Hospital Miguel Hidalgo,"May 4, 2020",Interventional,Efficacy and Safety of Hydroxychloroquine and Ivermectin in Hospitalized no Critical Patients Secondary to COVID-19 Infection: Randomized Controlled Trial,COVID
1688,COVID,"February 08, 2021",248,NCT04391140,PRONE POSITION,SPAIN,Recruiting,Hospital Universitari Vall d'Hebron Research Institute,"May 13, 2020",Interventional,Effectiveness of Prone Positioning Combined With High-flow Nasal Cannula for Patients With COVID-19 Induced ARDS,COVID
1689,VISUAL IMPAIRMENT,"February 08, 2021",150,NCT04391166,NON INVASIVE VISUAL ACUITY TESTING,UNITED STATES,"Active, not recruiting",Vanderbilt University Medical Center,"May 20, 2020",Observational,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic,Unrelated
1690,COVID,"February 08, 2021",160,NCT04391179,DIPYRIDAMOLE 100 MILLIGRAM(MG),UNITED STATES,"Active, not recruiting",University of Michigan,"May 31, 2020",Interventional,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,COVID
1691,SARS-CoV2,"February 08, 2021",300,NCT04391309,IC14,UNITED STATES,Not yet recruiting,Implicit Bioscience,July 2020,Interventional,"Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)",COVID
1692,SARS-CoV2,"February 08, 2021",500,NCT04391400,NASAL PHARYNGEAL (NP) SWAB SAMPLES,,Not yet recruiting,"Invivoscribe, Inc.","June 1, 2020",Observational,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",COVID
1693,COVID,"February 08, 2021",90,NCT04391686,INDIRECT CALORIMETRY,FRANCE,Recruiting,Centre Hospitalier Arras,"July 3, 2020",Observational [Patient Registry],Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context,COVID
1694,COVID,"February 08, 2021",10,NCT04391712,MLS LASER,UNITED STATES,Completed,Lowell General Hospital,"April 30, 2020",Interventional,Multiwave Locked System (MLS) Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,COVID
1695,SARS-CoV2,"February 08, 2021",1200,NCT04391738,PATIENTS ADMITTED TO INTENSIVE CARE UNIT WITH SARS-COV2,FRANCE,"Active, not recruiting","University Hospital, Lille","February 1, 2020",Observational,Relationship Between Obesity and Severe Acute Respiratory Syndrome Coronavirus-2 in Patient With SARS-CoV-2 Admitted in Intensive Care : A Multicenter Retrospective Cohort Study,COVID
1696,ALCOHOL DRINKING,"February 08, 2021",700,NCT04391816,,UNITED STATES,Recruiting,National Institute on Alcohol Abuse and Alcoholism (NIAAA),"February 11, 2021",Observational,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,Unrelated
1697,COVID,"February 08, 2021",20,NCT04391829,EJACULATED SEMEN SAMPLE,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"August 31, 2020",Interventional,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,COVID
1698,ORAL HEALTH AND COVID,"February 08, 2021",500,NCT04391881,,EGYPT,Recruiting,Cairo University,"May 30, 2020",Observational,Oral Manifestation of COVID19,COVID
1699,COVID,"February 08, 2021",500,NCT04391920,CYTOSORB 300 ML DEVICE,UNITED STATES,Recruiting,"CytoSorbents, Inc","August 28, 2020",Observational [Patient Registry],"Registry of CytoSorb Therapy in COVID-19 ICU Patients (CTC REGISTRY): Registry of Patient-level Clinical Data on CytoSorb Hemoadsorption Provided Via Integration of the CytoSorb Device Into Extracorporeal Membrane Oxygenation (ECMO), Continuous Renal Replacement Therapy (CRRT), or Hemoperfusion Extracorporeal Circuits in COVID-19 ICU Patients",COVID
1700,"CHRONIC LYMPHOCYTIC LEUKEMIA, LYMPHOCYTIC LYMPHOMA OR WALDENSTROM DISEASE","February 08, 2021",50,NCT04391946,DATA REGISTRY,FRANCE,Recruiting,French Innovative Leukemia Organisation,"March 14, 2020",Observational [Patient Registry],National Prospective and Retrospective Follow-up of Patients With COVID-19 Infected Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenström Disease,Unrelated
1701,COVID,"February 08, 2021",20,NCT04392089,"MASIMO, LIDCO",DENMARK,Recruiting,Hvidovre University Hospital,"May 1, 2020",Observational,Effects of Cardiovascular and Pulmonary Optimisation on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS,COVID
1702,COMORBIDITIES AND COEXISTING CONDITIONS,"February 08, 2021",372,NCT04392115,THE PREPARE PROGRAM,,Not yet recruiting,Ottawa Hospital Research Institute,"June 15, 2020",Interventional,PRomoting Exercise During the Pandemic to Increase Activity and Reduce Effects of Social Isolation for COVID: The PREPARE for COVID Trial,Unrelated
1703,COVID,"February 08, 2021",0,NCT04392128,HYDROXYCHLOROQUINE SULFATE 200 MG [PLAQUENIL],FRANCE,Withdrawn,Institut de cancérologie Strasbourg Europe,"September 2, 2020",Interventional,"Randomised, Double-blind, Placebo-controlled Phase 2 Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies",COVID
1704,COVID,"February 08, 2021",200,NCT04392141,STANDARD TREATMENT,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Kermanshah University of Medical Sciences,"April 1, 2020",Interventional,Application of Colchicine Plus Herbal Phenolic Monoterpene Fractions to Treat COVID-19,COVID
1705,CORONAVIRUS,"February 08, 2021",130,NCT04392219,EIDD-2801,UNITED KINGDOM,Completed,"Ridgeback Biotherapeutics, LP","April 10, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Study Designed to Evaluate the Safety, Tolerability, and Pharmacokinetics of EIDD-2801 Following Oral Administration to Healthy Volunteers",COVID
1706,CORONAVIRUS,"February 08, 2021",100,NCT04392232,CONVALESCENT PLASMA,UNITED STATES,Recruiting,TriHealth Inc.,"May 5, 2020",Interventional,A Phase 2 Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,COVID
1707,PROCTOLOGIC PRACTICE DURING COVID,"February 08, 2021",1050,NCT04392245,,ITALY,Completed,Societa Italiana di Chirurgia ColoRettale,"April 15, 2020",Observational,A Worldwide Survey on Proctologic Practice During Covid-19 Lockdown,COVID
1708,SARS-CoV2,"February 08, 2021",500,NCT04392323,COVID-19 PCR AND SEROLOGY,UNITED STATES,Recruiting,Northwell Health,"May 13, 2020",Interventional,Incidence of COVID-19 Test Conversion in Post-surgical Patients,COVID
1709,SARS-CoV2,"February 08, 2021",110000,NCT04392388,NON APPLICABLE,FRANCE,Recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","May 1, 2020",Observational,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis - Serology",COVID
1710,INTENSIVE CARE UNIT,"February 08, 2021",200,NCT04392401,COLLECTION OF BLOOD SAMPLES IN ORDER TO CREATE A BIOCOLLECTION,FRANCE,Recruiting,Hospices Civils de Lyon,"May 11, 2020",Observational,Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,Unrelated
1711,COVID,"February 08, 2021",60,NCT04392414,COVID-19 CONVALESCENT HYPERIMMUNE PLASMA,RUSSIAN FEDERATION,Completed,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia","May 1, 2020",Interventional,"Randomized, Open Label, Prospective Study of the Safety and Efficacy of Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease",COVID
1712,COVID,"February 08, 2021",100,NCT04392427,"TREATMENT GROUP: WILL RECEIVE A COMBINATION OF NITAZOXANIDE, RIBAVIRIN AND IVERMECTIN FOR A DURATION OF SEVEN DAYS :",EGYPT,Not yet recruiting,Mansoura University,October 2020,Interventional,"Effect of a Combination of Nitazoxanide, Ribavirin and Ivermectin Plus Zinc Supplement on the Clearance of COVID-19: a Pilot Sequential Clinical Trial",COVID
1713,STROKE,"February 08, 2021",40,NCT04392453,ROBOTIC THERAPY,,Not yet recruiting,Fondazione Don Carlo Gnocchi Onlus,May 2020,Interventional,Upper Limb Robotic Rehabilitation in Stroke Survivors Using a Portable Device During the COVID-19 Outbreak. A Feasibility Study,Unrelated
1714,COVID INFECTION,"February 08, 2021",120,NCT04392531,CYCLOSPORINE,SPAIN,Recruiting,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,"April 16, 2020",Interventional,"Open, Controlled, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Cyclosporine Plus Standard Treatment vs Standard Treatment Only in Hospitalized Patients With COVID-19 Infection",COVID
1715,COVID,"February 08, 2021",100,NCT04392713,IVERMECTIN 6 MG ORAL TABLET (2 TABLETS),PAKISTAN,Recruiting,"Combined Military Hospital, Pakistan","April 15, 2020",Interventional,Efficacy of Ivermectin in COVID-19 : A Randomized Controlled Trial,COVID
1716,COVID,"February 08, 2021",30,NCT04392778,MSC TREATMENT,TURKEY,Recruiting,SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi,"April 1, 2020",Interventional,What is the Effect of Mesenchymal Stem Cell Therapy on Seriously Ill Patients With Covid 19 in Intensive Care? (Prospective Double Controlled Study),COVID
1717,PSYCHOLOGICAL DISTRESS,"February 08, 2021",75,NCT04392869,THE CRAFT PROGRAM (ADAPTED DUE TO COVID-19),SPAIN,Completed,Universidad de Granada,"October 23, 2019",Interventional,Testing the Effects of Two Mindfulness-based Programs on Well Being and Academic Performance of Undergraduate Students of Translation and Interpreting: An Interventional Study,Unrelated
1718,COVID,"February 08, 2021",520,NCT04392973,FAVIPIRAVIR AND HYDROXYCHLOROQUINE,SAUDI ARABIA,Recruiting,King Abdullah International Medical Research Center,"May 21, 2020",Interventional,A Trial of Favipiravir and Hydroxychloroquine Combination in Adults Hospitalized With Moderate and Severe Covid-19,COVID
1719,COVID,"February 08, 2021",1034,NCT04393038,ABX464,BELGIUM,Recruiting,Abivax S.A.,"May 1, 2020",Interventional,"A Phase 2/3, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and the Safety of ABX464 in Treating Inflammation and Preventing COVID-19 Associated Acute Respiratory Failure in Patients Aged ≥ 65 and Patients Aged ≥18 With at Least One Additional Risk Factor Who Are Infected With SARS-CoV-2.",COVID
1720,COVID,"February 08, 2021",126,NCT04393051,BARICITINIB ORAL TABLET,ITALY,Not yet recruiting,"Azienda Ospedaliero, Universitaria Pisana","May 20, 2020",Interventional,"BARICIVID-19 STUDY: MultiCentre, Randomised, Phase IIa Clinical Trial Evaluating Efficacy and Tolerability of Baricitinib as add-on Treatment of In-patients With COVID-19 Compared to Standard Therapy",COVID
1721,STRESS,"February 08, 2021",80,NCT04393077,EMOTIONAL FREEDOM TECHNIQUE,TURKEY,Completed,Istanbul Saglik Bilimleri University,"May 10, 2020",Interventional,"Emotional Freedom Technique (EFT) Effect on Nurses' Stress, Anxiety and Burnout Levels During the COVID-19 Pandemic Process: A Randomized Controlled Study",Unrelated
1722,CORONAVIRUS INFECTION,"February 08, 2021",92,NCT04393142,,MEXICO,Recruiting,Hospital Universitario Dr. Jose E. Gonzalez,"May 5, 2020",Observational [Patient Registry],Observational Trial Evaluating the Serologic Status of Household Contacts of Patients Diagnosed With COVID-19,COVID
1723,COVID,"February 08, 2021",225,NCT04393155,COVID-19+ OBSERVATIONAL,UNITED STATES,Recruiting,University of Vermont,"April 16, 2020",Observational,"Inflammatory, Pulmonary, Physical & Neuropsychological Sequelae of COVID-19 Acute Respiratory Failure: A 1-Year Longitudinal Study",COVID
1724,RHEUMATOID ARTHRITIS,"February 08, 2021",300,NCT04393233,,FRANCE,Recruiting,"University Hospital, Brest","April 23, 2020",Observational,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation,Unrelated
1725,COVID,"February 08, 2021",1407,NCT04393246,EDP1815,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"July 3, 2020",Interventional,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms (TACTIC-E),COVID
1726,COVID,"February 08, 2021",160,NCT04393311,ULINASTATIN,UNITED STATES,Not yet recruiting,Stanford University,February 2021,Interventional,"A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Safety and Efficacy of Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients",COVID
1727,COVID,"February 08, 2021",2500,NCT04393324,,SPAIN,Recruiting,"Hospital San Carlos, Madrid","April 24, 2020",Observational [Patient Registry],The Critical Care Resources Adaptation to the SARS-CoV-2 Pandemic in Madrid,COVID
1728,COVID,"February 08, 2021",14,NCT04393402,LUNG ULTRASOUND (LUS),FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"March 20, 2020",Observational,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care,COVID
1729,VIRUS,"February 08, 2021",100,NCT04393415,STEM CELLS,EGYPT,Recruiting,Aljazeera Hospital,"May 25, 2020",Interventional,the Effect of PRP and Cord Blood in Improving the Symptoms of Covid-19,Unrelated
1730,COVID,"February 08, 2021",100,NCT04393428,[TIMP-2]*[IGFBP-7],FRANCE,Completed,"University Hospital, Montpellier","March 1, 2020",Observational,Urinary Biomarkers (TIMP-2 and IGFBP7) for Early Diagnostic Assessment of Acute Kidney Injury in Patients With SARS-CoV-2 (COVID-19),COVID
1731,COVID,"February 08, 2021",100,NCT04393558,ADAM SENSOR,UNITED STATES,Recruiting,Shirley Ryan AbilityLab,"April 20, 2020",Observational,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,COVID
1732,CARDIOVASCULAR DISEASES,"February 08, 2021",394,NCT04393636,DIGITAL CARDIAC COUNSELING,NETHERLANDS,Recruiting,Academisch Ziekenhuis Maastricht,"June 5, 2020",Interventional,Randomized Controlled Trial of Digital Cardiac Counseling in Patients With Delayed Cardiac Surgical Treatment Due to Covid-19 Pandemic (DCC Trial),Unrelated
1733,COVID,"February 08, 2021",20000,NCT04393649,ESOGER,CANADA,Recruiting,Jewish General Hospital,"April 20, 2020",Observational [Patient Registry],First Level Socio-geriatric Evaluation in Period of Physical and Social Distancing in Frail Older Patients and Older Community Dwellers: ESOGER Databank,COVID
1734,COVID,"February 08, 2021",1,NCT04393727,CONVALESCENT PLASMA,ITALY,Terminated,"Azienda Ospedaliero, Universitaria Pisana","May 1, 2020",Interventional,Transfusion of Convalescent Plasma for the Early Treatment of pneumonIa Due to SARSCoV2: a Multicenter Open Label Randomized Control Trial,COVID
1735,CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04393792,POVIDONE-IODINE,UNITED KINGDOM,Recruiting,Hampshire Hospitals NHS Foundation Trust,May 2020,Interventional,Can a Sinus Rinse and Mouth Wash Reduce Viral Load in COVID-19 Positive Individuals and Their Co-residents?,COVID
1736,COVID,"February 08, 2021",877,NCT04393805,LOW MOLECULAR WEIGHT HEPARIN,ITALY,Recruiting,Quovadis Associazione,"June 1, 2020",Observational,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,COVID
1737,MENTAL HEALTH DISORDER,"February 08, 2021",560,NCT04393818,INTERVENTION APP,SPAIN,Completed,Fundació d'investigació Sanitària de les Illes Balears,"May 5, 2020",Interventional,A Double-blinded Randomized Controlled Trial to Examine the Effectiveness of a Mobile-based Intervention to Reduce Mental Health Problems in Healthcare Workers at the Frontline Against COVID-19 in Spain: the PsyCovidApp Trial,Unrelated
1738,SARS-CoV2,"February 08, 2021",48,NCT04393948,PHASE 1,UNITED STATES,Recruiting,Brigham and Women's Hospital,June 2020,Interventional,Pilot Study of Low-Dose Single or Bilateral Whole Lung Irradiation for SARS-CoV-2 Pneumonia,COVID
1739,COVID,"February 08, 2021",600,NCT04393961,PREMIER BIOTECH COVID-19 IGG/IGM RAPID TEST CASSETTE,UNITED STATES,Recruiting,ProofPilot,"April 5, 2020",Interventional,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,COVID
1740,CANCER,"February 08, 2021",1000,NCT04393974,,UNITED KINGDOM,Recruiting,Imperial College London,"March 24, 2020",Observational,OnCovid: Natural History and Outcomes of Cancer Patients During the COVID19 Epidemic,Unrelated
1741,COVID,"February 08, 2021",72,NCT04394000,THROMBOPROFYLAXIS PROTOCOL,BELGIUM,Completed,Jessa Hospital,"May 4, 2020",Observational [Patient Registry],Impact of Implementation of an Intensified Thromboprofylaxis Protocol in in Critically Ill ICU Patients With COVID-19: a Longitudinal Controlled Before-after Study,COVID
1742,MENTAL HEALTH ISSUE,"February 08, 2021",70,NCT04394013,MINDFULNESS INTERVENTION,MALAYSIA,Recruiting,Monash University Malaysia,"August 26, 2020",Interventional,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,Unrelated
1743,VIRAL PNEUMONIA,"February 08, 2021",500,NCT04394026,,ITALY,Recruiting,Francesco De Cobelli,"April 16, 2020",Observational,COVID-19 Imaging Features,Respiratory
1744,STRESS,"February 08, 2021",34,NCT04394039,PUBLIC SPACE EXPOSURE,SINGAPORE,Not yet recruiting,"National University, Singapore","June 1, 2020",Interventional,Effects of COVID-19-Related Self-isolation on Psychological Response to Different Outdoor Environments in Singapore - Before & After Brain and Behavior Study,Unrelated
1745,DEPRESSION,"February 08, 2021",543,NCT04394078,ONLINE SURVEY,TURKEY,Completed,Okan University,"May 6, 2020",Observational,Impact of COVID-19 Pandemic on Depression and Quality of Life: Cross Sectional Study on Turkish Society and Suggestions on Potential Solution,Unrelated
1746,HEALTH BEHAVIOR,"February 08, 2021",593,NCT04394104,SURVEY,UNITED STATES,Terminated,"Rutgers, The State University of New Jersey","May 27, 2020",Observational,COVID-19 Health and Wellness Self-Assessment Survey,Unrelated
1747,SARS-CoV2,"February 08, 2021",1500,NCT04394117,ANGIOTENSIN RECEPTOR BLOCKERS,AUSTRALIA,Recruiting,The George Institute,"June 19, 2020",Interventional,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,COVID
1748,POST ICU SYNDROME,"February 08, 2021",102,NCT04394169,INTERVENTION PROGRAM,SPAIN,Recruiting,Hospital Clinic of Barcelona,"May 25, 2020",Interventional,"Early Care, Therapeutic Education, and Psychological Intervention for the Management of Post-intensive Care Syndrome and Chronic Pain After Coronavirus Disease 2019 Infection. Simple-blind, Controlled, Randomized Trial.",Unrelated
1749,"PNEUMONIA, VIRAL","February 08, 2021",15,NCT04394182,ULTRA-LOW-DOSE RADIOTHERAPY,SPAIN,Recruiting,Fundacion GenesisCare,"April 21, 2020",Interventional,Low Doses of Lung Radiation Therapy in Cases of COVID-19 Pneumonia: Prospective Multicentric Study in Radiation Oncology Centers,Respiratory
1750,CORONAVIRUS INFECTION,"February 08, 2021",200,NCT04394195,MEASUREMENT OF CIRCULATING SFLT1 CONCENTRATION,FRANCE,Recruiting,CHU de Reims,"March 25, 2020",Observational,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?,COVID
1751,COVID,"February 08, 2021",50,NCT04394208,SILYMARIN,EGYPT,Recruiting,Cairo University,"August 16, 2020",Interventional,Trial of Silymarin in Adults With COVID-19 Pneumonia,COVID
1752,CORONAVIRUS INFECTION,"February 08, 2021",600,NCT04394377,GROUP 1: RIVAROXABAN 20MG/D FOLLOWED BY ENOXAPARIN/UNFRACTIONATED HEPARIN WHEN NEEDED,BRAZIL,Recruiting,Brazilian Clinical Research Institute,"June 21, 2020",Interventional,Randomized Clinical Trial to Evaluate a Routine Full Anticoagulation Strategy in Patients With Coronavirus (COVID-19) - COALIZAO ACTION Trial,COVID
1753,COVID,"February 08, 2021",100,NCT04394390,VITAMIN D,TURKEY,Enrolling by invitation,Bursa City Hospital,"May 1, 2020",Observational [Patient Registry],Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients?,COVID
1754,STRESS,"February 08, 2021",120,NCT04394403,INTERNET-BASED GUIDED SELF-HELP BASED ON CBT PRINCIPLES,ISRAEL,Recruiting,Hebrew University of Jerusalem,"May 14, 2020",Interventional,Pilot Internet-based Self-Help Program for Managing Corona Stress vs. Waitlist Control,Unrelated
1755,COVID,"February 08, 2021",204,NCT04394416,IMATINIB,UNITED STATES,Recruiting,"University of Maryland, Baltimore","June 2, 2020",Interventional,Randomized Double-Blind Placebo-Controlled Trial on the Safety and Efficacy of Imatinib for Hospitalized Adults With COVID-19,COVID
1756,SARS-CoV2,"February 08, 2021",184,NCT04394429,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 24, 2020",Observational,Analysis of Events of Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation,COVID
1757,COVID,"February 08, 2021",200,NCT04394442,HYDROXYCHLOROQUINE,SAUDI ARABIA,Recruiting,Samah Lutfy,"March 21, 2020",Interventional,Use of Hydroxychloroquine in Patients With COVID-19: A Randomized Controlled Clinical Trial,COVID
1758,ANXIETY,"February 08, 2021",236,NCT04394455,BRIEF COGNITIVE BEHAVIORAL THERAPY,HONDURAS,Enrolling by invitation,Universidad Nacional Autonoma de Honduras,"June 30, 2020",Interventional,Effect of Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry in Medical Staff During the COVID-19 Pandemic: A Multicentric Randomized Controlled Trial,Unrelated
1759,COVID,"February 08, 2021",10,NCT04394793,LOW DOSE RADIATION THERAPY,INDIA,"Active, not recruiting","All India Institute of Medical Sciences, New Delhi","June 13, 2020",Interventional,Low Dose Radiation Therapy for Covid-19 Pneumonia: A Pilot Study,COVID
1760,COVID,"February 08, 2021",120,NCT04394884,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"February 11, 2021",Observational,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19,COVID
1761,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",284,NCT04395105,DEXAMETHASONE (HIGH DOSE),ARGENTINA,Recruiting,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,"May 21, 2020",Interventional,High Versus Low Dose Dexamethasone for the Treatment of COVID-19 Related ARDS: a Multicenter and Randomized Open-label Clinical Trial,Respiratory
1762,CORONAVIRUS INFECTION,"February 08, 2021",346,NCT04395144,AWAKE PRONE POSITIONING,CANADA,Recruiting,Hôpital de Verdun,"May 15, 2020",Interventional,Randomized-controlled Trial of HFNC Alone vs HFNC and Awake Self-proning for Treatment of Severe COVID-19,COVID
1763,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",75,NCT04395170,COVID-19 CONVALESCENT PLASMA,COLOMBIA,Not yet recruiting,"Lifefactors Zona Franca, SAS",September 2020,Interventional,"A Randomized, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Use of Convalescent Plasma (PC) and Human Intravenous Anti COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.",COVID
1764,COVID,"February 08, 2021",143,NCT04395300,WEB BASED SURVEY,EGYPT,Completed,Assiut University,"March 30, 2020",Observational,Sleep Quality and Effect on General Health in Healthcare Personnel During COVID-19 Pandemic,COVID
1765,COVID,"February 08, 2021",30,NCT04395391,SARS-COV-2,UNITED STATES,Completed,Exact Sciences Corporation,"May 18, 2020",Observational,Usability Study of Home Collection and Mailing With SARS-CoV-2 Test Specimen Collection Materials (2020-06),COVID
1766,PEDIATRIC OBESITY,"February 08, 2021",40,NCT04395430,USUAL CARE,,Not yet recruiting,KK Women's and Children's Hospital,"September 1, 2020",Interventional,Adapting the US-based Clinic-community Model of Child Obesity Treatment Into an Online Intervention Model in Singapore During COVID-19,Unrelated
1767,ACUTE RESPIRATORY DISTRESS SYNDROME DUE TO SARS-CoV2 INFECTION (SEVERE COVID),"February 08, 2021",144,NCT04395456,AMY-101,,Not yet recruiting,Amyndas Pharmaceuticals S.A.,July 2020,Interventional,"A Phase 2 Clinical Trial to Assess the Safety and Efficacy of Complement 3 Inhibitor, AMY-101, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 (SAVE)",COVID
1768,COVID,"February 08, 2021",500,NCT04395482,LUNG CT SCAN ANALYSIS IN COVID-19 PATIENTS,ITALY,Recruiting,University of Milano Bicocca,"May 7, 2020",Observational,Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury by Machine Learning: a Multicenter Retrospective Cohort Study.,COVID
1769,HER2-POSITIVE BREAST CANCER,"February 08, 2021",,NCT04395508,FIXED-DOSE COMBINATION OF PERTUZUMAB AND TRASTUZUMAB FOR SUBCUTANEOUS ADMINISTRATION (PH FDC SC),UNITED STATES,Available,"Genentech, Inc.",,Expanded Access,"An Expanded Access, Single-Arm, Multicenter Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic",Unrelated
1770,SARS-CoV2,"February 08, 2021",40,NCT04395599,"CARTOGRAPHY OF AIR CONTAMINATION, ENVIRONMENT CONTAMINATION AND BIOLOGICAL FLUID BY SARS-COV2 DURING VISCERAL SURGERY IN COVID19 PATIENTS.",,Not yet recruiting,"University Hospital, Lille",May 2020,Interventional,Assessment of Air Contamination Risk by Sars-Cov2 During Visceral Surgery in COVID19 Patients: Pilot Study.,COVID
1771,COVID,"February 08, 2021",1000,NCT04395664,C3+ HOLTER MONITOR,DENMARK,Completed,Herlev and Gentofte Hospital,"April 16, 2020",Observational,The ACOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart by Continuous ECG Monitoring,COVID
1772,COVID,"February 08, 2021",50,NCT04395716,RESCURE™,UNITED STATES,Not yet recruiting,ProgenaBiome,July 2020,Interventional,A Phase I Study of ResCure™ to Treat COVID-19 Infection,COVID
1773,CORONAVIRUS DISEASE 2019,"February 08, 2021",93,NCT04395742,DATA COLLECTION,,Not yet recruiting,Poitiers University Hospital,May 2020,Observational,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study",COVID
1774,"INFERTILITY, FEMALE","February 08, 2021",503,NCT04395755,GENERALIZED ANXIETY DISORDER-7 (GAD-7),ITALY,Completed,Ospedale Policlinico San Martino,"April 1, 2020",Observational,Impact of COVID-19 Pandemic on the Psychological Status of Infertile Patients Who Had in Vitro Fertilization Treatment Interrupted or Postponed,Unrelated
1775,COVID,"February 08, 2021",200,NCT04395768,VITAMIN C,AUSTRALIA,Recruiting,"National Institute of Integrative Medicine, Australia","September 9, 2020",Interventional,"Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, Vitamin D, Vitamin B12 With or Without Vitamin C, a Multi-centre, International, Randomized Trial: The International ALLIANCE Study",COVID
1776,COVID,"February 08, 2021",2000,NCT04395781,,CHINA,Recruiting,KK Women's and Children's Hospital,"May 18, 2020",Observational [Patient Registry],Pediatric Acute and Critical Care COVID-19 Registry of Asia,COVID
1777,SARS-CoV2,"February 08, 2021",900,NCT04395794,SARS-COV-2-TEST,RUSSIAN FEDERATION,Recruiting,Meshalkin Research Institute of Pathology of Circulation,"May 7, 2020",Observational [Patient Registry],SARS-CoV-2 Positive Carriers Among Asymptomatic meDIcal employeeS in hiGh-volUme cardIovaScular cEnter,COVID
1778,COVID,"February 08, 2021",120,NCT04395807,HELMET CPAP,SWEDEN,Recruiting,Lund University,"June 3, 2020",Interventional,Helmet Continuous Positive Airway Pressure Versus High-Flow Nasal Cannula in COVID-19: A Pragmatic Randomised Clinical Trial,COVID
1779,IDENTIFY EMERGING HEALTH CHALLENGES FOR CHILDREN WITH MOTOR DISABILITIES AND THEIR PARENTS FACING THE COVID PANDEMIC,"February 08, 2021",2500,NCT04395833,,FRANCE,Completed,"University Hospital, Brest","April 7, 2020",Observational,Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic: Messages From Families Answering the ECHO French National Survey,COVID
1780,AGE RELATED MACULAR DEGENERATION,"February 08, 2021",1500,NCT04395859,QUESTIONNAIRE,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"May 27, 2020",Observational,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,Unrelated
1781,COVID,"February 08, 2021",54,NCT04395872,PSYCHIATRIC COUNSELING,,Not yet recruiting,Daegu Catholic University Medical Center,"May 28, 2020",Observational,Psychiatric Consultation for COVID-19 Patients,COVID
1782,SEXUAL DYSFUNCTION,"February 08, 2021",306,NCT04395885,ELECTRONIC QUESTIONNAIRE,EGYPT,Completed,Assiut University,"June 1, 2020",Observational,Sexual Function Among Egyptian Healthcare Professionals During COVID 19 Pandemic,Unrelated
1783,AKI,"February 08, 2021",30,NCT04395911,SCD,UNITED STATES,Recruiting,SeaStar Medical,"September 10, 2020",Interventional,A Multi-Center Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Patients Developing Acute Kidney Injury (AKI) or Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 Infection,Unrelated
1784,MATERNAL FETAL INFECTION TRANSMISSION,"February 08, 2021",50,NCT04395924,"DIAGNOSIS OF SARS-COV2 BY RT-PCR AND : IGG, IG M SEROLOGIES IN THE AMNIOTOC FLUID, THE BLOOD CORD AND THE PLACENTA",FRANCE,Recruiting,Centre Hospitalier Régional d'Orléans,"May 5, 2020",Observational,Maternal-Foetal Transmission of COVID-19,Unrelated
1785,COVID,"February 08, 2021",120,NCT04395976,AYURVEDA,UNITED KINGDOM,Not yet recruiting,British Ayurvedic Medical Council,"June 10, 2020",Interventional,Effect of Ayurveda as Prophylaxis for Suspected Covid-19 Patients: Randomised Controlled Trial,COVID
1786,COVID,"February 08, 2021",360,NCT04396067,AEROSOLIZED 13 CIS RETINOIC ACID,,Not yet recruiting,Kafrelsheikh University,October 2020,Interventional,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,COVID
1787,COVID,"February 08, 2021",190,NCT04396106,AT-527,BELGIUM,Recruiting,"Atea Pharmaceuticals, Inc.","May 26, 2020",Interventional,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-527 in Subjects With Moderate COVID-19",COVID
1788,COVID,"February 08, 2021",92,NCT04396197,PHYSIOTHERAPY,UNITED KINGDOM,Completed,University Hospital Birmingham NHS Foundation Trust,"March 1, 2020",Observational,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care Requiring Invasive Ventilation: An Observational Study,COVID
1789,CORONAVIRUS,"February 08, 2021",389,NCT04396210,QUESTIONNAIRE,BELGIUM,Completed,"University Hospital, Ghent","May 14, 2020",Observational,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,COVID
1790,POSTTRAUMATIC STRESS DISORDER,"February 08, 2021",54,NCT04396314,BASIC BODY AWARENESS THERAPY,,Not yet recruiting,Universitat de Lleida,"February 1, 2021",Interventional,"Effectiveness of Basic Body Awareness Therapy in Survivors of Covid-19, Health Workers and Women Suffering From Gender-based Violence Regarding Post-traumatic Stress Disorders: A Randomized Clinical Trial",Unrelated
1791,COVID,"February 08, 2021",1574,NCT04396353,ELECTRONIC QUESTIONNAIRE,BRAZIL,Completed,University of Sao Paulo General Hospital,"June 4, 2020",Observational,"The Impact of EXercise TRAining, Physical Activity and Sedentary Lifestyle on Clinical Outcomes in Surviving Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2: Cross-sectional Study",COVID
1792,STRESS,"February 08, 2021",1200,NCT04396600,MINNRAP PEER SUPPORT PROGRAM,UNITED STATES,Enrolling by invitation,University of Minnesota,"June 8, 2020",Observational,The Professional Peer Resilience Initiative: Leveraging a Data-Driven Model to Maximize the Resilience of Healthcare Workers During the COVID-19 Pandemic,Unrelated
1793,COVID,"February 08, 2021",50,NCT04397172,STUDY ARM,SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","April 9, 2020",Observational,"Characterization of ARDS, Critical Illness Myopathy and Their Long-term Consequences in Patients With Covid-19 Disease: Effects of Inflammation, Mitochondrial Dysfunction and Plasma Concentrations of Various Sedative Drugs",COVID
1794,COVID,"February 08, 2021",3100,NCT04397237,,FRANCE,"Active, not recruiting",Pitié-Salpêtrière Hospital,"June 10, 2020",Observational,"Prevalence, Seroconversion and Impact of COVID-19 in Autoimmune Diseases in Europe",COVID
1795,COVID,"February 08, 2021",336,NCT04397328,HYDROXYCHLOROQUINE,,Not yet recruiting,Lawson Health Research Institute,"May 19, 2020",Interventional,Safety and Efficacy of Post-exposure Prophylaxis With Hydroxychloroquine (HCQ) for the Prevention of COVID-19 in High-risk Older Individuals in Long-term and Specialized Care: A Double-blind Randomized Control Trial,COVID
1796,PYREXIA,"February 08, 2021",100,NCT04397380,THERMOGRAPHY,UNITED KINGDOM,Not yet recruiting,NHS Greater Clyde and Glasgow,"May 20, 2020",Observational,COVID-19 Response - Thermography Based Fever Detection for Triaging of Patients - A Feasibility Study,Unrelated
1797,HEALTHY VOLUNTEERS FOR BONE MARROW DONATION,"February 08, 2021",10,NCT04397471,BONE MARROW HARVEST,UNITED KINGDOM,Not yet recruiting,CCTU- Cancer Theme,May 2020,Observational,A Study to Collect Bone Marrow for Process Development and Production of Bone Marrow Mesenchymal Stromal Cells to Treat Severe COVID19 Pneumonitis,Unrelated
1798,COVID,"February 08, 2021",50,NCT04397497,MAVRILIMUMAB,ITALY,Not yet recruiting,Ospedale San Raffaele,"May 22, 2020",Interventional,"A Randomized, Double Blind, Placebo-controlled Trial of Mavrilimumab for Acute Respiratory Failure Due to COVID-19 Pneumonia With Hyper-inflammation (the COMBAT-19 Trial)",COVID
1799,COVID,"February 08, 2021",50,NCT04397510,HEPARIN,UNITED STATES,Enrolling by invitation,Frederick Health,"June 1, 2020",Interventional,Nebulized Heparin vs. Placebo for the Treatment of COVID-19 Induced Lung Injury,COVID
1800,CONVALESCENT PLASMA,"February 08, 2021",20,NCT04397523,ANTI-SARS-COV-2 CONVALESCENT PLASMA,NORTH MACEDONIA,Recruiting,Institute for Transfusion Medicine of RNM,"April 30, 2020",Interventional,Use of COVID-19 Convalescent Plasma in the Patients Infected With COVID-19 (SARS-CoV-2) - Efficacy and Safety,Unrelated
1801,COVID,"February 08, 2021",206,NCT04397562,LEVILIMAB,RUSSIAN FEDERATION,Completed,Biocad,"April 29, 2020",Interventional,"A Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptively Designed Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19",COVID
1802,CANCER,"February 08, 2021",1509,NCT04397575,,FRANCE,"Active, not recruiting",Federation Francophone de Cancerologie Digestive,"April 3, 2020",Observational [Patient Registry],Cohorte Non Interventionnelle Ambispective Nationale Multicentrique de Patients Suivis Pour Cancer et infectés Par le SARS-CoV-2,Unrelated
1803,ARDS RELATED TO SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS (SARS-COV) 2,"February 08, 2021",300,NCT04397588,,FRANCE,Recruiting,Rennes University Hospital,"April 21, 2020",Observational,Extracorporeal Membrane Oxygenation (ECMO) as a Therapeutic Option in Severe Form of COVID-19: a Nationwide Cohort Study,COVID
1804,SARS-CoV2,"February 08, 2021",500,NCT04397614,MHEALTH ASSESSMENTS,UNITED STATES,Recruiting,University of Oklahoma,"July 22, 2020",Observational,Mobile Health Study and Enhanced Symptom Monitoring to Prevent Severe Illness From COVID-19 in Cancer Patients,COVID
1805,SARS-COV INFECTION,"February 08, 2021",68,NCT04397666,CONJUNCTIVAL RT PCR,FRANCE,Recruiting,Versailles Hospital,"May 15, 2020",Interventional,RT-PCR on Conjunctival Sample for the Detection of SARS-Cov-2 in Patients With Covid-19,Respiratory
1806,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04397692,NITRIC OXIDE DELIVERED VIA LUNGFIT™ SYSTEM,UNITED STATES,Recruiting,Beyond Air Inc.,"June 13, 2020",Interventional,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),COVID
1807,COVID,"February 08, 2021",30,NCT04397705,PATIENT STATUS ENGINE,UNITED KINGDOM,Not yet recruiting,The Christie NHS Foundation Trust,June 2020,Interventional,Remote Monitoring of Cancer Patients Presenting With Symptoms Suggestive of Covid-19 - Pilot Phase.,COVID
1808,COVID,"February 08, 2021",198,NCT04397718,DEGARELIX,UNITED STATES,Recruiting,VA Office of Research and Development,"July 6, 2020",Interventional,"Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization (HITCH): A Multicenter, Phase 2 Randomized Controlled Trial of Best Supportive Care (BSC) vs BSC Plus Degarelix",COVID
1809,COVID,"February 08, 2021",80,NCT04397757,COVID-19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",University of Pennsylvania,"May 13, 2020",Interventional,"An Open-Label, Controlled, Phase 1, Safety and Exploratory Efficacy Study of Convalescent Plasma for Severely Ill, Hospitalized Participants With COVID-19 Pneumonia Caused by SARS-CoV-2.",COVID
1810,COVID,"February 08, 2021",45,NCT04397796,BM-ALLO.MSC,UNITED STATES,Recruiting,"NantKwest, Inc.","August 3, 2020",Interventional,"Phase 1b Randomized, Double-Blind, Placebo-Controlled Study Of The Safety Of Therapeutic Treatment With Immunomodulatory Mesenchymal Stem Cells In Adults With COVID-19 Infection Requiring Mechanical Ventilation",COVID
1811,COVID,"February 08, 2021",110,NCT04397822,BLOOD SAMPLES,FRANCE,Recruiting,"University Hospital, Toulouse","April 16, 2020",Observational,Study of INFLAmmasome NLRP3 and PLAtelets Functions During Severe COVID-19 Infection,COVID
1812,COVID,"February 08, 2021",800,NCT04397835,,FRANCE,Recruiting,"University Hospital, Toulouse","April 17, 2020",Observational,Psychological Impact of Quarantine During the COVID-19 Outbreak and Worsening of Cardiovascular Risk in the French General Population: a Prospective Cohort Study,COVID
1813,MENTAL HEALTH WELLNESS 1,"February 08, 2021",3852,NCT04397848,,CANADA,Completed,"University Health Network, Toronto","May 14, 2020",Observational,Hearing and Supporting the Healthcare Workers: Mental Health Outcomes in Healthcare Workers During COVID-19,Unrelated
1814,IDENTIFY THE VIRAL EPITOPES OF MEMORY CD8 T CELLS FROM INDIVIDUALS THAT HAVE RECOVERED FROM SARS-CoV2 INFECTION,"February 08, 2021",80,NCT04397900,,UNITED STATES,Recruiting,"TScan Therapeutics, Inc.","April 9, 2020",Observational,A Blood Collection Study From Volunteers Who Have Recovered From COVID-19 Infection to Identify Immunogenic Viral Epitopes in SARS-CoV-2,COVID
1815,COVID,"February 08, 2021",5000,NCT04397939,,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,"May 8, 2020",Observational,Association of Early Myocardial Injury With Major Adverse Outcomes in Patients With COVID-19,COVID
1816,COVID,"February 08, 2021",90,NCT04398004,CLARITHROMYCIN,GREECE,Completed,Hellenic Institute for the Study of Sepsis,"May 6, 2020",Interventional,Anti-inflammatory Clarithromycin to Improve SARS-CoV-2 (COVID-19) Infection Early: The ACHIEVE Open-label Non-randomized Clinical Trial,COVID
1817,RT PCR,"February 08, 2021",16,NCT04398043,,,Not yet recruiting,Hospital de Clinicas José de San Martín,"May 15, 2020",Observational,Searching for SARS-CoV 2 in Personal Protective Equipment in Physicians in a University Hospital,Unrelated
1818,COVID,"February 08, 2021",696,NCT04398147,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR),CANADA,Not yet recruiting,CanSino Biologics Inc.,"August 1, 2020",Interventional,"A Randomized, Observer-Blind, Dose-escalation Phase I/II Clinical Trial of Ad5-nCoV Vaccine in Healthy Adults From 18 to <85 Years of Age in Canada",COVID
1819,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04398264,COVID-19 POSITIVE VIA TESTING,UNITED STATES,Recruiting,Inova Health System,"July 22, 2020",Observational [Patient Registry],Characteristics of COVID-19 Infection Among PREGnant Women,COVID
1820,PSYCHOLOGICAL STRESS,"February 08, 2021",1000,NCT04398277,DAILY COPING TOOLKIT,UNITED STATES,Recruiting,Kent State University,"May 1, 2020",Interventional,A Daily Coping Toolkit for Medical Personnel and First-Responders During the COVID-19 Pandemic,Unrelated
1821,COVID,"February 08, 2021",0,NCT04398290,INHALED NITRIC OXIDE (INO),UNITED STATES,Withdrawn,Roger Alvarez,"December 1, 2020",Interventional,Randomized Controlled Trial Of A Delivered Continuously By Nasal Cannula For The Treatment Of Patients With COVID-19 And Mild To Moderate Hypoxemia Requiring Supplemental Oxygen,COVID
1822,COVID PNEUMONIA,"February 08, 2021",70,NCT04398303,ACT-20-MSC,,Not yet recruiting,Aspire Health Science,May 2020,Interventional,"A Phase 1/2 Randomized, Placebo-Controlled Trial of ACT-20 in Patients With Severe COVID-19 Pneumonia",COVID
1823,LONELINESS,"February 08, 2021",9000,NCT04398472,KIND CHALLENGE,AUSTRALIA,Not yet recruiting,Swinburne University of Technology,"July 7, 2020",Interventional,Evaluation of the Nextdoor KIND Challenge,Unrelated
1824,DAILY ROOM DISINFECTION,"February 08, 2021",240,NCT04399005,AFTER-EACH-CASE ROOM DISINFECTION,CHINA,Completed,The First Affiliated Hospital of Zhejiang Chinese Medical University,"May 25, 2020",Interventional,The Efficacy Comparing Daily and After-each-case Room Disinfection in the Endoscopy Unit During the COVID-19 Pandemic.,Unrelated
1825,COVID,"February 08, 2021",2000,NCT04399109,TCC-COVID MHEALTH SOLUTION,AUSTRALIA,Recruiting,Dr Sze-Yuan Ooi,"May 20, 2020",Interventional,ReCOVER (Remote COVID-19 Evaluation and Response): a Prospective Non-randomised Controlled Trial to Evaluate the Effect of a Novel Smartphone Application-centric Model of Care for the Remote Monitoring of COVID-19 Patients in the Community.,COVID
1826,MICROBIOME,"February 08, 2021",1000,NCT04399252,LACTOBACILTUS RHAMNOSUS GG,UNITED STATES,Recruiting,Duke University,"June 24, 2020",Interventional,A Randomized Trial of the Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,Unrelated
1827,ARDS ASSOCIATED WITH COVID,"February 08, 2021",20,NCT04399317,FLOW CONTROLLED VENTILATION (EVONE-VENTILATOR),QATAR,Recruiting,Hamad Medical Corporation,"May 28, 2020",Interventional,Flow Controlled Ventilation in ARDS Associated With COVID-19,COVID
1828,COVID,"February 08, 2021",100,NCT04399356,NICLOSAMIDE,UNITED STATES,Recruiting,Tufts Medical Center,"October 1, 2020",Interventional,Niclosamide for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19),COVID
1829,COVID,"February 08, 2021",120,NCT04399603,NO INTERVENTION-MECHANISTIC STUDY,UNITED KINGDOM,Not yet recruiting,Imperial College London,"May 18, 2020",Observational,Multi-organ Failure in SARS-CoV2: Identifying Mechanisms and Potential Therapeutic Targets,COVID
1830,COVID,"February 08, 2021",100,NCT04399681,BEDSIDE LUNG ULTRASOUND,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"May 10, 2020",Interventional,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 at Emergency Department,COVID
1831,"COVID, SARS-CoV2 INFECTION","February 08, 2021",12800,NCT04399733,,UNITED KINGDOM,Not yet recruiting,Future Genetics Limited,"February 1, 2021",Observational,EMPOWER - BAME vs COVID: A Multi-site Clinical Cohort Research Study to Identify Genetic Associations and Candidate Therapeutic Targets to Reduce COVID-19 Morbidity & Mortality Rates in BAME Populations,COVID
1832,COVID,"February 08, 2021",30,NCT04399746,IVERMECTIN,MEXICO,Recruiting,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,"March 15, 2020",Interventional,A Pilot Study for COVID-19 Outpatient Treatment With the Combination of Ivermectin-azithromycin-cholecalciferol,COVID
1833,CORONAVIRUS INFECTION,"February 08, 2021",13,NCT04399798,BARICITINIB,,Not yet recruiting,IRCCS Policlinico S. Matteo,"May 15, 2020",Interventional,"A proof-of Concept Study of the Use of Janus Kinase 1 and 2 Inhibitor, Baricitinib, in the Treatment of COVID-19-related Pneumonia",COVID
1834,COVID,"February 08, 2021",30,NCT04399889,HUMAN CORD TISSUE MESENCHYMAL STROMAL CELLS,UNITED STATES,Recruiting,"Joanne Kurtzberg, MD","June 18, 2020",Interventional,Pilot Study of Safety and Efficacy of Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC) in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS),COVID
1835,SMOKING CESSATION,"February 08, 2021",842,NCT04399967,CHAT-BASED SUPPORT,CHINA,Recruiting,The University of Hong Kong,"June 13, 2020",Interventional,"Building Capacity and Promoting Smoking Cessation in the Community Via ""Quit to Win"" Contest 2020: a Single-blind Randomized Controlled Trial on COVID-19 Related Brief Advice and Personalized Chat-based Intervention for Smoking Cessation",Unrelated
1836,COVID,"February 08, 2021",30,NCT04399980,MAVRILIMUMAB,UNITED STATES,"Active, not recruiting",The Cleveland Clinic,"May 20, 2020",Interventional,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,COVID
1837,CORONAVIRUS INFECTION,"February 08, 2021",71,NCT04400006,,TURKEY,Completed,Marmara University,"May 6, 2020",Observational,The Effectiveness of Ozone Therapy in the Prevention of COVID-19 Infection,COVID
1838,SARS-CoV2,"February 08, 2021",1930,NCT04400019,HYDROXYCHLOROQUINE ONLY PRODUCT IN ORAL DOSE FORM,,Not yet recruiting,University of Malaga,September 2020,Interventional,"Prevention of COVID19 Infection by the Administration of Hydroxychloroquine to Institutionalized Older People and Nursing Home Staff. Controlled Clinical Trial, Randomized Triple Blind by Clusters (PREVICHARM Study)",COVID
1839,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",9,NCT04400032,MESENCHYMAL STROMAL CELLS,CANADA,Recruiting,Ottawa Hospital Research Institute,"May 15, 2020",Interventional,Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19) the Vanguard Study,Respiratory
1840,COVID,"February 08, 2021",208,NCT04400058,OCTAGAM 10%,RUSSIAN FEDERATION,"Active, not recruiting",Octapharma,"June 1, 2020",Interventional,Efficacy and Safety of Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,COVID
1841,DEPRESSIVE SYMPTOMATOLOGY,"February 08, 2021",334,NCT04400279,YOGA GROUP,CANADA,Completed,University of British Columbia,"June 1, 2020",Interventional,COvid-19 Pandemic and Exercise (COPE) Trial: A Randomized Study Examining Physical Activities and Wellbeing in Individuals Mandated to Stay at Home,Unrelated
1842,"PHYSICAL ACTIVITY, HEALTHY PROMOTION","February 08, 2021",40,NCT04400305,DIGITAL HEALTH ONLINE PLATFORM,CANADA,Recruiting,University of Victoria,"May 20, 2020",Interventional,"""Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",Unrelated
1843,COVID,"February 08, 2021",200,NCT04400448,,,Not yet recruiting,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,"June 1, 2020",Observational [Patient Registry],"Acceptance of Telemedicine in Outpatient Clinic Consultations During COVID-19 Pandemic. An International, Cross-sectional Study",COVID
1844,COVID,"February 08, 2021",50,NCT04400461,DATA COLLECTION AND CLINICAL TESTING OF SUBJECTS,SPAIN,Recruiting,Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal,"May 15, 2020",Observational,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation: A Cross-sectional Study,COVID
1845,BIOEQUIVALENCE,"February 08, 2021",30,NCT04400682,FAVIRA 200 MG FILM TABLET,TURKEY,Completed,Novelfarma Ilaç San. ve Tic. Ltd. Sti.,"May 28, 2020",Interventional,"Open-label, Randomised, Single Oral Dose, Two-period, Cross-over Trial to Assess to Bioequivalence of Favira 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions",Unrelated
1846,"AEROSOL-GENERATING PROCEDURE, ESOPHAGOGASTRODUODENOSCOPY","February 08, 2021",60,NCT04400734,"NO INTERVENTION, OBSERVATIONAL STUDY",HONG KONG,Recruiting,Chinese University of Hong Kong,"May 7, 2020",Observational,Esophagogastroduodenoscopy (EGD) is an Aerosol-generating Procedure: Proof of Concept Study,Unrelated
1847,COVID,"February 08, 2021",1000,NCT04400799,ENOXAPARIN 40MG/0.4ML INJ SYRINGE 0.4ML,SWITZERLAND,Recruiting,University of Zurich,"June 15, 2020",Interventional,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With Coronavirus: The Multicenter Randomized Controlled Ovid Trial,COVID
1848,COVID,"February 08, 2021",5000,NCT04400812,QUESTIONNAIRE,EGYPT,Enrolling by invitation,Zagazig University,"May 19, 2020",Observational,Attitude and Perception of General Population in Sharkia Governerate Towards COVID-19 Pandemic,COVID
1849,CORONAVIRUS,"February 08, 2021",12390,NCT04400838,CHADOX1 NCOV-19 (ABS 260),UNITED KINGDOM,Recruiting,University of Oxford,"May 28, 2020",Interventional,"A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19",COVID
1850,COVID,"February 08, 2021",7795,NCT04400877,DIAGNOSTIC EXAMINATION FOR VENOUS THROMBOEMBOLISM,SWEDEN,Completed,"University Hospital, Linkoeping","June 8, 2020",Observational,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,COVID
1851,COVID,"February 08, 2021",200,NCT04400890,PLANT POLYPHENOL,UNITED STATES,Recruiting,"Marvin McCreary, MD","September 12, 2020",Interventional,Randomized Double-Blind Placebo-Controlled Proof-of-Concept Trial of a Plant Polyphenol for the Outpatient Treatment of Mild Coronavirus Disease (COVID-19),COVID
1852,COVID,"February 08, 2021",30,NCT04400929,SARGRAMOSTIM,SINGAPORE,Recruiting,Singapore General Hospital,"June 2, 2020",Interventional,Using GM-CSF as a Host Directed Therapeutic Against COVID-19 - a Phase 2 Investigator Initiated Trial,COVID
1853,SARS-CoV2,"February 08, 2021",450,NCT04401033,TELEPHONIC MEDICAL VISIT,SPAIN,Completed,Hospital del Río Hortega,"May 11, 2020",Observational [Patient Registry],Prospective Observational Study Evaluating the Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopic Procedures (DECORE Study),COVID
1854,CANCER,"February 08, 2021",4000,NCT04401046,SURVEY TO ASSESS POST TRAUMATIC STRESS AND ANXIETY AT INCLUSION AND 6 MONTHS LATER,FRANCE,Recruiting,Institut Paoli-Calmettes,"May 20, 2020",Interventional,COVID-19 EPIDEMIC Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,Unrelated
1855,COVID,"February 08, 2021",500,NCT04401072,,EGYPT,Recruiting,Damanhour University,"April 24, 2020",Observational,Survey Studying the Change in the Attitude and Behaviour of the Egyptian Population Toward COVID 19 Pandemic During the Holy Month Ramadan .,COVID
1856,COVID,"February 08, 2021",27000,NCT04401085,SARS-COV-2 DIAGNOSTIC RAPID TEST,CZECHIA,Completed,Institute of Health Information and Statistics of the Czech Republic,"April 23, 2020",Observational,Herd Immunity Study SARS-CoV-2-CZ-Preval,COVID
1857,COVID,"February 08, 2021",700,NCT04401098,,EGYPT,Recruiting,Damanhour University,"May 2, 2020",Observational,"Survey Of Egyptian Population Change in Knowledge, Attitude and Behaviour Towards COVID 19 Outbreak",COVID
1858,COVID,"February 08, 2021",150,NCT04401111,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"June 16, 2020",Observational,Multiparametric Evaluation of One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia After Intensive Care Unit,COVID
1859,GASTRIC CANCER,"February 08, 2021",500,NCT04401124,NO INTERVENTION,,Not yet recruiting,Beijing Friendship Hospital,"May 25, 2020",Observational,"A Descriptive Study on the Proper Management of Gastrointestinal Surgeries During the COVID-19 Pandemic, With an Emphasis on the Alteration of Surgical Protocol and Workflow",Unrelated
1860,VITAMIN C,"February 08, 2021",800,NCT04401150,VITAMIN C,CANADA,Recruiting,Université de Sherbrooke,"August 14, 2020",Interventional,Lessening Organ Dysfunction With VITamin C - COVID,Unrelated
1861,SARS-CoV2,"February 08, 2021",180,NCT04401163,IMAGING OF THE LUNGS,DENMARK,Not yet recruiting,University of Aarhus,May 2020,Observational [Patient Registry],Long-term Pulmonary Outcomes After Infection With Sars-CoV-2,COVID
1862,COVID,"February 08, 2021",200,NCT04401202,NIGELLA SATIVA,SAUDI ARABIA,Recruiting,King Abdulaziz University,"May 21, 2020",Interventional,"Effects of Nigella Sativa as a Treatment of Patients With Upper Respiratory Tract Infection Caused by SARS-coronavirus-2: a Prospective, Randomized, Open-label, Controlled Clinical Study",COVID
1863,COVID,"February 08, 2021",60,NCT04401228,"PREDICT ADMISSION OF COVID-19 PATIENTS TO ICU AND DEATH WITH ROUTINE AND QUICKLY AVALAIBLE CLINICAL, BIOLOGICAL AND RADIOLOGICAL VARIABLES?",BELGIUM,"Active, not recruiting",Clinique Saint Pierre Ottignies,"March 1, 2020",Observational,Development and Validation of Predictive Models for Intensive Care Admission and Death of COVID-19 Patients in a Secondary Care Hospital in Belgium.,COVID
1864,COVID,"February 08, 2021",257,NCT04401241,,MONACO,Completed,Centre Hospitalier Princesse Grace,"February 1, 2020",Observational,Accuracy of Routine Biomarkers and Blood Leucocytes Count to Assist Diagnosis of COVID-19-related Pneumonia in Adult Patients Visiting the Emergency Department,COVID
1865,COVID,"February 08, 2021",300,NCT04401254,,AUSTRALIA,Recruiting,Australian and New Zealand Intensive Care Research Centre,"July 1, 2020",Observational,The COVID-Recovery Study,COVID
1866,SARS-CoV2,"February 08, 2021",308,NCT04401293,ENOXAPARIN,UNITED STATES,Recruiting,Northwell Health,"April 26, 2020",Interventional,Systemic Anticoagulation With Full Dose Low Molecular Weight Heparin (LMWH) Vs. Prophylactic or Intermediate Dose LMWH in High Risk COVID-19 Patients (HEP-COVID Trial),COVID
1867,DISTANCE EDUCATION LEARNING ENVIRONMENT DURING COVID PANDEMIC,"February 08, 2021",418,NCT04401371,,EGYPT,Completed,Cairo University,"May 1, 2020",Observational,Assessment of Dental Students Opinion About Distance Education Learning Environment During COVID-19 Pandemic (Cross-Sectional Study),COVID
1868,SARS-CoV2,"February 08, 2021",58,NCT04401410,DOSE FINDING PHASE (MTD),UNITED STATES,Recruiting,Baylor College of Medicine,"November 4, 2020",Interventional,BAT IT: Banked Anti-SARS Cov-2 T Cell Infusions for Treatment of COVID 19,COVID
1869,COVID,"February 08, 2021",100,NCT04401423,TXA127,UNITED STATES,Recruiting,Columbia University,August 2020,Interventional,Randomized Controlled Trial of Angiotensin 1-7 (TXA127) for the Treatment of Severe COVID-19,COVID
1870,CORONA VIRUS DISEASE 2019,"February 08, 2021",350,NCT04401436,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"May 22, 2020",Observational,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO),Unrelated
1871,ACUTE AND LONG TERM EFFECTS OF COVID:ON SYSTEMIC INFLAMMATION,"February 08, 2021",180,NCT04401449,,UNITED STATES,Recruiting,National Institutes of Health Clinical Center (CC),"January 8, 2020",Observational,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons (COVID ARC 19),COVID
1872,COVID,"February 08, 2021",396,NCT04401475,SOC PLUS 15MG/KG EB05 IV,CANADA,Recruiting,Edesa Biotech Inc.,"November 25, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19",COVID
1873,COVID,"February 08, 2021",0,NCT04401527,SODIUM NITRITE,UNITED STATES,Withdrawn,Hope Pharmaceuticals,"July 22, 2020",Interventional,"Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Study",COVID
1874,COVID,"February 08, 2021",90,NCT04401540,,TURKEY,Recruiting,Recep Tayyip Erdogan University Training and Research Hospital,"May 1, 2020",Observational [Patient Registry],Clinical and Epidemiological Characteristics of COVID-19 Infection on Babies of Prenatal COVID-19 Positive Women in Turkey,COVID
1875,COVID,"February 08, 2021",1034,NCT04401579,PLACEBO,DENMARK,Completed,National Institute of Allergy and Infectious Diseases (NIAID),"May 8, 2020",Interventional,"A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-2)",COVID
1876,DIAGNOSES DISEASE,"February 08, 2021",250,NCT04401644,NOVEL LASER INFEROMETRY TEST FOR CORONA VIRUS,UNITED KINGDOM,Not yet recruiting,Somerset NHS Foundation Trust,June 2020,Interventional,Laser Interferometry of Single Virus Particles Flowing Through Glass Microcapillaries to Detect Novel Coronavirus COVID-19,Unrelated
1877,DISABILITY PHYSICAL,"February 08, 2021",40,NCT04402034,APPLICATION OF TELE-REHABILITATION,BRAZIL,Completed,University of Sao Paulo,"May 15, 2020",Interventional,Telerehabilitation in Disabled People: Proposal for Practical Intervention With Virtual Reality,Unrelated
1878,COVID,"February 08, 2021",66,NCT04402060,APL-9,BRAZIL,Recruiting,"Apellis Pharmaceuticals, Inc.","May 28, 2020",Interventional,"A Randomized, Double-Blinded, Vehicle-Controlled, Multicenter, Parallel-Group Study of APL-9 in Mild to Moderate Acute Respiratory Distress Syndrome Due to COVID-19",COVID
1879,COVID,"February 08, 2021",50,NCT04402203,FAVIPIRAVIR,BANGLADESH,Recruiting,Bangladesh Medical Research Council (BMRC),May 2020,Interventional,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,COVID
1880,NURSE,"February 08, 2021",2000,NCT04402229,,FRANCE,Completed,Versailles Hospital,"May 12, 2020",Observational,Psychological Impact of the Covid-19 Pandemic on Student Nurses :Prevalence and Risk Factors of Acute Post-traumatic Stress Symptoms 1 Month After the Epidemic Peak,Unrelated
1881,CYSTIC FIBROSIS,"February 08, 2021",140,NCT04402801,,UNITED STATES,Enrolling by invitation,University of Virginia,"June 1, 2020",Observational,Impact on Patient Outcomes of Clinic Transition From Face to Face Encounters to Telemedicine in the Cystic Fibrosis (CF) Adult Population at UVA,Unrelated
1882,SARS-CoV2,"February 08, 2021",90,NCT04402814,CLUNGENE RAPID TEST CASSETTE,UNITED STATES,Recruiting,"Fadi Haddad, M.D.","May 5, 2020",Observational,Evaluation and Correlation of SARS-Cov2 Virus IgG/IgM Rapid Test Cassette Clungene Test With the Standard Method of COVID19 Testing in Inpatients With or Without COVID19,COVID
1883,HEALTH CARE WORKER PATIENT TRANSMISSION,"February 08, 2021",60,NCT04402827,SUSCEPTIBILITY TO INFECTION,SPAIN,Recruiting,Asociacion para el Estudio de las Enfermedades Infecciosas,"August 1, 2020",Observational,"Differences in Susceptibility to SARS CoV-2 Infection According to ACE2 and CD26 Receptors, Specific CD4/CD8 T Cell Response to Viral Peptides, and KIR Receptors Among Health Care Workers Highly Exposed to Patients With COVID-19 Diagnosis.",Unrelated
1884,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",5,NCT04402840,STELLATE GANGLION BLOCK,UNITED STATES,Recruiting,West Virginia University,"April 24, 2020",Interventional,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),Respiratory
1885,SARS-CoV2,"February 08, 2021",100,NCT04402853,TEARS SWAB,ITALY,Completed,Università degli Studi dell'Insubria,"February 1, 2020",Observational,SARS Cov-2 in Conjunctival Secretions in an Italian Lombardia Cohort of Patients,COVID
1886,ACUTE LUNG INJURY (ALI) ASSOCIATED WITH COVID,"February 08, 2021",222,NCT04402866,TD-0903,"MOLDOVA, REPUBLIC OF",Recruiting,Theravance Biopharma,"June 24, 2020",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-center Study of an Inhaled Pan-Janus Kinase Inhibitor, TD-0903, to Treat Symptomatic Acute Lung Injury Associated With COVID-19",COVID
1887,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",596,NCT04402879,PRONE POSITIONING (PP),CANADA,Recruiting,University of Calgary,"November 10, 2020",Interventional,A Prospective Randomized Trial of Prone Positioning Versus Usual Care for Patients With Do-not-intubate Goals of Care and Hypoxemic Respiratory Failure During the Coronavirus SARS-CoV-2 (COVID-19) Pandemic,COVID
1888,COVID,"February 08, 2021",60,NCT04402892,"35 ML BLOOD, 5 TUBES LITHIUM HEPARINATE AT EACH TIME (HOSPITALIZED PATIENTS )",,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"June 1, 2020",Interventional,SARS-CoV-2 Specific Memory B and T- CD4+ Cells,COVID
1889,CORONAVIRUS INFECTION,"February 08, 2021",450,NCT04402905,,FRANCE,Completed,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,"June 15, 2020",Observational,"Observational Study in Diagnosed Patients Covid-19, Supported on an Outpatient Basis.",COVID
1890,SARS-CoV2,"February 08, 2021",160,NCT04402918,BIOLOGICAL SAMPLES DAY OF DELIVERY,FRANCE,Recruiting,Centre Hospitalier Universitaire de Besancon,"May 17, 2020",Interventional,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 During Pregnancy,COVID
1891,COVID,"February 08, 2021",60,NCT04402944,PULMOZYME,UNITED STATES,Recruiting,Boston Children's Hospital,"July 5, 2020",Interventional,Pulmozyme to Improve COVID-19 ARDS Outcomes,COVID
1892,COVID,"February 08, 2021",60,NCT04402957,LSALT PEPTIDE,CANADA,Recruiting,Arch Biopartners Inc.,"October 14, 2020",Interventional,"Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study of LSALT Peptide as Prevention of Acute Respiratory Distress Syndrome (ARDS) and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)",COVID
1893,SARS-CoV2,"February 08, 2021",10,NCT04402970,DORNASE ALFA INHALATION SOLUTION,UNITED STATES,Completed,University of Missouri-Columbia,"June 19, 2020",Interventional,Inhaled Dornase Alfa for Treatment of ARDS in Patients With SARS-CoV-2,COVID
1894,COVID,"February 08, 2021",34,NCT04402983,PHYSIOTHERAPY,TURKEY,Completed,Istanbul Medipol University Hospital,"May 27, 2020",Interventional,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,COVID
1895,CORONAVIRUS DISEASE 2019,"February 08, 2021",100,NCT04403009,NO INTERVENTION,CHINA,Recruiting,The First Affiliated Hospital of Guangzhou Medical University,"February 1, 2020",Observational,The Clinical Difference Between the Nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the Fatal Cases With Severe COVID-19,COVID
1896,COVID,"February 08, 2021",100,NCT04403035,ID NOW VS. ACCULA,UNITED STATES,Recruiting,Ascension South East Michigan,"May 10, 2020",Observational,Comparison of the ID NOW and Accula Point-of-Care Assays for the Detection of Severe Acute Respiratory System CoV-2 (SARS-CoV-2),COVID
1897,"DISEASE, VIRAL","February 08, 2021",106,NCT04403061,CYTOKINES MEASUREMENT,SPAIN,Completed,Asociacion para el Estudio de las Enfermedades Infecciosas,"May 22, 2020",Observational,Th1/Th2/Th17/TREG Response and TLRs Activation/KIR Receptors for Predicting the Evolution of the SARS Cov-2 Infected Patients,Unrelated
1898,COVID,"February 08, 2021",1968,NCT04403100,HYDROXYCHLOROQUINE SULFATE TABLETS,BRAZIL,Recruiting,Cardresearch,"June 3, 2020",Interventional,"Hydroxychloroquine and Lopinavir/ Ritonavir for Hospitalization and Mortality Reduction in Patients With COVID-19 and Mild Disease Symptoms: ""The Hope Coalition""",COVID
1899,COVID,"February 08, 2021",70,NCT04403243,COLCHICINE,RUSSIAN FEDERATION,Recruiting,Lomonosov Moscow State University Medical Research and Educational Center,"May 8, 2020",Interventional,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,COVID
1900,SARS-CoV2,"February 08, 2021",35,NCT04403269,IGIV,FRANCE,Recruiting,Versailles Hospital,"May 5, 2020",Interventional,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19",COVID
1901,COVID,"February 08, 2021",200,NCT04403386,,UNITED STATES,Recruiting,National Institute of Environmental Health Sciences (NIEHS),"June 1, 2020",Observational,"A Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",COVID
1902,BEHCET DISEASE,"February 08, 2021",45,NCT04403438,"IT WILL BE COMPARED PAIN, SLEEP, FATIGUE, PHYSICAL ACTIVITY LEVEL AND QUALITY OF LIFE AND QUESTIONING EXERCISE HABITS BEFORE AND AFTER THE COVID-19 OUTBREAK IN PATIENTS WITH BEHÇET AND FMF.",TURKEY,Enrolling by invitation,Istanbul University,"April 1, 2020",Observational,"Pain, Sleep, Fatigue, Physical Activity Level, Quality of Life and Exercise Habits in Patients With Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic",Unrelated
1903,COVID,"February 08, 2021",20,NCT04403477,CONVALESCENT PLASMA,BANGLADESH,Recruiting,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","May 20, 2020",Interventional,"Convalescent Plasma Transfusion Therapy in Severe COVID-19 Patients- a Tolerability, Efficacy and Dose-response Phase II RCT",COVID
1904,COVID,"February 08, 2021",160,NCT04403555,IVERMECTIN,EGYPT,Recruiting,Tanta University,"June 1, 2020",Interventional,The Efficacy of Ivermectin in COVID-19 Treatment,COVID
1905,COVID,"February 08, 2021",384,NCT04403581,QUESTIONNAIRE,,Not yet recruiting,Ain Shams University,May 2020,Observational,"Cross-sectional Descriptive Study: Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",COVID
1906,COVID,"February 08, 2021",180,NCT04403607,,UNITED KINGDOM,Recruiting,NHS Greater Glasgow and Clyde,"May 22, 2020",Observational,"Cardiovascular and Pulmonary Imaging in SARS-CoV-2: A Study of the Heart, Lungs and Wellbeing After COVID-19.",COVID
1907,COVID,"February 08, 2021",124,NCT04403646,ARBOX,ARGENTINA,Terminated,Hospital de Clinicas José de San Martín,"June 12, 2020",Interventional,Efficacy of Tannin Specific Natural Extract for Coronavirus Disease (COVID-19): Randomized Controlled Trial,COVID
1908,HIGH SENSITIVITY AND SPECIFICITY (WITH 95% CONFIDENCE INTERVAL) OF REALDETECT™ COVID RT-PCR KIT,"February 08, 2021",120,NCT04403672,PERFORMANCE EVALUATION STUDY OF REALDETECT RT-PCR KIT FOR COVID-19 DETECTION,BANGLADESH,Recruiting,Bangladesh Medical Research Council (BMRC),"May 18, 2020",Observational [Patient Registry],Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,COVID
1909,COVID,"February 08, 2021",129,NCT04403685,TOCILIZUMAB,BRAZIL,Terminated,Beneficência Portuguesa de São Paulo,"May 8, 2020",Interventional,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 and Increased Inflammatory Markers: a Phase III Randomized Clinical Trial (COVID-19 Coalition Brazil VI) (TOCIBRAS),COVID
1910,COVID,"February 08, 2021",323,NCT04403828,SURVEY,EGYPT,Completed,Fayoum University,"May 20, 2020",Observational,Impact of COVID-19 on Personal Protection Among Dentist in Egypt: A Quick Online Survey,COVID
1911,SARS-CoV2,"February 08, 2021",727,NCT04403880,SAMPLE COLLECTION,MALAWI,Recruiting,HIV Vaccine Trials Network,"May 13, 2020",Observational,Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals,COVID
1912,COVID,"February 08, 2021",200,NCT04403906,PCL COV05 - COVID 19 AG RAPID FIA TEST (RAPID ANTIGEN TEST),UNITED KINGDOM,Not yet recruiting,Somerset NHS Foundation Trust,June 2020,Interventional,Evaluation of the PCL Rapid Point of Care Antigen Test for Severe Acute Respiratory Syndrome Coronavirus 2,COVID
1913,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",300,NCT04403932,,SPAIN,Completed,"Hospital San Carlos, Madrid","April 17, 2020",Observational,Cohort Study to Determine the Association Between Vitamin D Deficiency and Severity of the Disease in Patients With Coronarvirus Disease 2019 (COVID-19),COVID
1914,COVID,"February 08, 2021",500,NCT04404062,COVID-19 RAPID TEST KIT (RAPG-COV-019),UNITED KINGDOM,"Active, not recruiting",Richmond Pharmacology Limited,"March 16, 2020",Observational,Validation of a Membrane-based Immunoassay for the Detection of IgG and IgM Antibodies to SARS-CoV-2/COVID-19,COVID
1915,COVID,"February 08, 2021",69,NCT04404179,COVID-19 FACILITY,PAKISTAN,Completed,"Services Institute of Medical Sciences, Pakistan","March 27, 2020",Observational,Setting up a COVID-19 Care Facility at a Prison in Pakistan,COVID
1916,ADJUSTMENT DISORDER WITH ANXIOUS MOOD,"February 08, 2021",30,NCT04404192,PH94B,UNITED STATES,Not yet recruiting,"VistaGen Therapeutics, Inc.",November 2020,Interventional,A Phase 2a Open-label Study of the Efficacy and Safety of PRN PH94B Neuroactive Nasal Spray in the Treatment of Adjustment Disorder With Anxiety (AjDA) Associated With COVID-19,Unrelated
1917,COVID,"February 08, 2021",480,NCT04404218,AÇAÍ PALM BERRY EXTRACT - NATURAL PRODUCT,CANADA,Recruiting,"University Health Network, Toronto","August 4, 2020",Interventional,Randomized Clinical Trial of Açaí Palm Berry Extract as an Intervention in Patients Diagnosed With COVID-19,COVID
1918,CORONAVIRUS COVID,"February 08, 2021",100,NCT04404244,,EGYPT,Recruiting,Fatma Soliman Elsayed Ebeid,"January 1, 2020",Observational,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,COVID
1919,SARS-CoV2,"February 08, 2021",2500,NCT04404270,ANTI-SARS-COV2 SEROLOGY,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"May 26, 2020",Observational,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110),COVID
1920,COVID,"February 08, 2021",364,NCT04404361,PACRITINIB,UNITED STATES,Recruiting,CTI BioPharma,"May 22, 2020",Interventional,"A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of Pacritinib Plus Standard of Care Versus Placebo and Standard of Care in Hospitalized Patients With Severe COVID-19 With or Without Cancer",COVID
1921,ARDS SECONDARY TO COVID PNEUMONIA,"February 08, 2021",32,NCT04404426,L-CITRULLINE,FRANCE,Recruiting,Rennes University Hospital,"November 2, 2020",Interventional,CACOLAC : Randomized Trial of Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,COVID
1922,LYMPHOPENIA,"February 08, 2021",90,NCT04404608,"COMPLETE BLOOD PICTURE, BONE MARROW ASPIRATION CYTOLOGY",,Not yet recruiting,Dr Medhat Khafagy,June 2020,Observational,Study of the Etiology of Lymphopenia in Covid19 Viral Infection,Unrelated
1923,SARS-CoV2,"February 08, 2021",600,NCT04405076,BIOLOGICAL: MRNA-1273,UNITED STATES,"Active, not recruiting","ModernaTX, Inc.","May 29, 2020",Interventional,"A Phase 2a, Randomized, Observer-Blind, Placebo Controlled, Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 SARS-COV-2 Vaccine in Adults Aged 18 Years and Older",COVID
1924,COVID,"February 08, 2021",48,NCT04405102,OZANIMOD,CANADA,Recruiting,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,"September 16, 2020",Interventional,A Randomized Trial on Efficacy and Safety of Ozanimod for the Treatment of COVID-19 Patients Requiring Oxygen Support - A Pilot Trial,COVID
1925,COVID,"February 08, 2021",5000,NCT04405232,NON-INTERVENTIONAL,UNITED KINGDOM,Recruiting,Imperial College London,"May 25, 2020",Observational,Coagulopathy Associated With Coronavirus disease19 (CA-COVID19) A Multi-Centre Observational Study in UK,COVID
1926,HEALTHCARE WORKERS,"February 08, 2021",1378,NCT04405271,EMTRICITABINE/TENOFOVIR ALAFENAMIDE 200 MG-25 MG ORAL TABLET,ARGENTINA,Not yet recruiting,Hospital Italiano de Buenos Aires,"July 31, 2020",Interventional,"Randomized, Double-blind, Placebo-controlled Trial of TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)",Unrelated
1927,TOXICITY BY BLEACH,"February 08, 2021",425,NCT04405284,USE AND EXPOSURE TO DISINFECTANTS DURING THE CORONAVIRUS PANDEMIC,EGYPT,Completed,Helwan University,"June 4, 2020",Observational,Disinfection Practices Among Women in Egypt During the Coronavirus Pandemic.,Unrelated
1928,SARS PNEUMONIA,"February 08, 2021",42,NCT04405310,CONVALESCENT PLASMA OF PATIENTS WITH COVID-19,MEXICO,Completed,Grupo Mexicano para el Estudio de la Medicina Intensiva,"May 20, 2020",Interventional,"Plasma From Covalescent Donors With Covid-19 for the Management of Patients With SARS-COV-2 Fase II and III, a Doble Center Randomized Doble Blind Trial",Respiratory
1929,SARS-CoV2,"February 08, 2021",753,NCT04405362,,,Not yet recruiting,"University Hospital, Lille",May 2020,Observational,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,COVID
1930,COVID,"February 08, 2021",500,NCT04405466,BLOOD SAMPLING,GERMANY,Recruiting,Miltenyi Biomedicine GmbH,"April 22, 2020",Observational,"A Prospective, Epidemiological, Cohort Study to Assess the Feasibility of Screening Healthy Asymptomatic Workers for the Presence of SARS-CoV-2 by Pharyngeal Swaps and Serology at Baseline, Day 21 and Day 40",COVID
1931,SARS-CoV2,"February 08, 2021",1210,NCT04405492,"TAKING BLOOD SAMPLES (CAPILLARY AND VENOUS), SALIVA SAMPLING AND NASOPHARYNGEAL SAMPLING.",,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"May 25, 2020",Interventional,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",COVID
1932,ENCEPHALOPATHY,"February 08, 2021",51,NCT04405544,CT-SCAN,RUSSIAN FEDERATION,Completed,"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","May 22, 2020",Interventional,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,Unrelated
1933,SARS-CoV2,"February 08, 2021",204,NCT04405570,EIDD-2801,UNITED STATES,"Active, not recruiting","Ridgeback Biotherapeutics, LP","June 16, 2020",Interventional,"A Phase IIa Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of EIDD-2801 to Eliminate Infectious Virus Detection in Persons With COVID-19",COVID
1934,SARS-CoV2,"February 08, 2021",500,NCT04405726,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","March 27, 2020",Observational,"Study of Clinical, Biological and Genetic Prognostic Factors of SARS-CoV-2 Infection in Patients Admitted in the Strasbourg University Hospitals",COVID
1935,SARS-CoV2,"February 08, 2021",80,NCT04405739,EIDD-2801,UNITED STATES,Recruiting,"Ridgeback Biotherapeutics, LP","June 16, 2020",Interventional,The Safety of EIDD-2801 and Its Effect on Viral Shedding of SARS-CoV-2,COVID
1936,COVID,"February 08, 2021",476,NCT04405843,IVERMECTIN ORAL PRODUCT,COLOMBIA,Completed,Centro de Estudios en Infectogía Pediatrica,"July 14, 2020",Interventional,"Randomized, Placebo Controlled, Double Blind Clinical Trial to Evaluate the Efficacy of Molecule D11AX22 in Adults Patients From Valle Del Cauca, Colombia With Early Stages of SARS COV2 / COVID-19",COVID
1937,PULMONARY THROMBOEMBOLISM,"February 08, 2021",300,NCT04405869,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 29, 2020",Observational,Incidence of Thromboembolic Events and Prognosis of COVID-19 Patients Hospitalized in Intensive Care Units in France,Unrelated
1938,COVID,"February 08, 2021",150,NCT04405908,SCB-2019,AUSTRALIA,"Active, not recruiting",Clover Biopharmaceuticals AUS Pty Ltd,"June 19, 2020",Interventional,"A Phase 1, Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety and Immunogenicity of SCB 2019, a Recombinant SARS-CoV-2 Trimeric S Protein Subunit Vaccine for COVID-19 in Healthy Volunteers.",COVID
1939,SARS-CoV2 PNEUMONIA,"February 08, 2021",200,NCT04405921,HYDROXYCHLOROQUINE 200 MG ORAL TABLET,TUNISIA,Not yet recruiting,Centre Hôpital Universitaire Farhat Hached,July 2020,Interventional,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 Pneumonia: A Randomized,Open-label,Controlled Clinical Trial",COVID
1940,COVID,"February 08, 2021",2000,NCT04405934,USE OF VIRUS (COVID-19) GENOME SEQUENCE REPORT TO INFORM INFECTION PREVENTION CONTROL PROCEDURES,,Not yet recruiting,"University College, London",July 2020,Interventional,"A Phase III Prospective, Interventional, Cohort, Superiority Study to Evaluate the Benefit of Rapid COVID-19 Genomic Sequencing (the COVID-19 GENOMICS UK Project) on Infection Control in Preventing the Spread of the Virus in United Kingdom NHS Hospitals",COVID
1941,COVID,"February 08, 2021",133,NCT04405973,VV-ECMO,GERMANY,Completed,Dr. Alexander Supady,"May 19, 2020",Observational,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation - a Retrospective Multi-center Registry Study,COVID
1942,SARS-CoV2,"February 08, 2021",38,NCT04405986,AUDITORY EVOKED POTENTIALS (AEP),FRANCE,Recruiting,"University Hospital, Bordeaux","May 19, 2020",Interventional,Exploring Brain Damages After COVID-19 Infection,COVID
1943,INCREASED RISK OF SARS-CoV2 INFECTION,"February 08, 2021",50,NCT04405999,BROMHEXINE HYDROCHLORIDE,RUSSIAN FEDERATION,Completed,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","May 14, 2020",Interventional,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease: a Randomised Controlled Trial,COVID
1944,COVID,"February 08, 2021",1038,NCT04406038,,RUSSIAN FEDERATION,"Active, not recruiting",European University at St. Petersburg,"May 27, 2020",Observational,"A Population-Based Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Saint Petersburg, Russia: Longitudinal Cohort Study",COVID
1945,VIRAL INFECTION,"February 08, 2021",0,NCT04406064,VIRAL SPECIFIC T-CELLS (VSTS),UNITED STATES,Withdrawn,"Children's Hospital Medical Center, Cincinnati",January 2021,Interventional,Viral Specific T-cells (VSTs) for Treatment of SARS-CoV-2/COVID-19,Unrelated
1946,ISCHEMIC STROKE,"February 08, 2021",50,NCT04406090,MECHANICAL TROMBECTOMY,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Endovascular Thrombectomy in COVID-19 Infected Patients: Intrahospital and Peri-operative Outcomes,Unrelated
1947,ANXIETY AND FEAR,"February 08, 2021",200,NCT04406181,HADS,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"May 18, 2020",Interventional,Effect on the COVID-19 Pandemic-induced Reduction in Elective Surgery on Medical Events and Psychological Well-being of Patients Waiting for Cardiac Surgery,Unrelated
1948,BIOEQUIVALENCE,"February 08, 2021",30,NCT04406194,FAVICOVIR 200 MG FILM TABLET,TURKEY,Completed,Atabay Kimya Sanayi Ticaret A.S.,"May 14, 2020",Interventional,"Open-label,Randomised,Single Oral Dose,Two-period,Cross-over Trial to Assess to Bioequivalence of Favicovir 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions",Unrelated
1949,SARS-CoV2,"February 08, 2021",176,NCT04406233,,BRAZIL,Recruiting,University of Sao Paulo,"May 23, 2020",Observational,Muscle Mass and Strength as Predictors of Time to Medical Discharge and Mortality in Patients Hospitalized With COVID-19: A Prospective Observational Study,COVID
1950,CORONAVIRUS INFECTION,"February 08, 2021",150,NCT04406246,NITAZOXANIDE 500MG ORAL TABLET,MEXICO,Recruiting,Materno-Perinatal Hospital of the State of Mexico,"May 21, 2020",Interventional,Prevention of Coronavirus Disease (COVID-19) Outbreaks by Prophylactic Treatment With Nitazoxanide,COVID
1951,COVID,"February 08, 2021",400,NCT04406324,NO INTERVENTION,FRANCE,Recruiting,"University Hospital, Grenoble","June 1, 2020",Observational,"COVID-19: Prospective Follow-up of Pulmonary Function, Sleep Disorders, Quality of Life and Post-traumatic Stress",COVID
1952,CHRONIC LOW-BACK PAIN,"February 08, 2021",300,NCT04406363,NON INTERVENTIONAL,FRANCE,Not yet recruiting,"University Hospital, Angers","June 2, 2020",Observational,Confinement Effect on Low Back Pain Intensity in Chronic Low Back Pain Patients,Unrelated
1953,COVID,"February 08, 2021",186,NCT04406389,ENOXAPARIN SODIUM,UNITED STATES,Recruiting,Weill Medical College of Cornell University,"October 13, 2020",Interventional,InterMediate ProphylACtic Versus Therapeutic Dose Anticoagulation in Critically Ill Patients With COVID-19: A Prospective Randomized Study (The IMPACT Trial),COVID
1954,ARDS,"February 08, 2021",50,NCT04406493,LUNG IMPEDANCE TECHNIQUE,ISRAEL,Recruiting,Hillel Yaffe Medical Center,"April 28, 2020",Interventional,Monitoring of Lung Fluid Status of Hospitalized COVID-19 Patients by Lung Impedance Technique,Unrelated
1955,COVID,"February 08, 2021",100,NCT04406532,PT-PAL,,Not yet recruiting,Albert Einstein College of Medicine,February 2021,Interventional,Home Based Covid-19 Rehabilitation Program: Pilot Clinical Trial,COVID
1956,CORONAVIRUS INFECTION,"February 08, 2021",25,NCT04406545,EVALUATION OF SKIN MICROVASCULAR FLOW AND REACTIVITY,BRAZIL,Recruiting,"National Institute of Cardiology, Laranjeiras, Brazil","May 15, 2020",Observational,Investigation of Systemic Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of Coronavirus Disease-19.,COVID
1957,PSYCHOLOGICAL ADAPTATION,"February 08, 2021",400,NCT04406558,QUESTIONNAIRE,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 27, 2020",Observational,Psychological Impact of the Health Measures Generated by the SarsCov-2 Pandemic in Adolescents (COVADO),Unrelated
1958,PANCREATIC ADENOCARCINOMA,"February 08, 2021",700,NCT04406571,DATA RECORD,FRANCE,Recruiting,CHU de Reims,"April 1, 2020",Observational,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer,Unrelated
1959,ACUTE KIDNEY INJURY,"February 08, 2021",300,NCT04406688,,GERMANY,Recruiting,University Hospital Muenster,"June 22, 2020",Observational,Prediction of Acute Kidney Injury in Patients With COVID-19 Associated Acute Respiratory Distress Syndrome,Unrelated
1960,ONCOLOGY PATIENTS,"February 08, 2021",150,NCT04406844,,INDIA,Recruiting,Max Healthcare Insititute Limited,"May 9, 2020",Observational,An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown,Unrelated
1961,TRAINING,"February 08, 2021",4000,NCT04406909,ACCESS TO TRAINING FACILITY,NORWAY,"Active, not recruiting",Norwegian Department of Health and Social Affairs,"May 22, 2020",Interventional,Rapid-Cycle Re-Implementation of TRAining Facilities in Norway,Unrelated
1962,BIOEQUIVALENCE,"February 08, 2021",30,NCT04407000,TEST: FAVIPIRAVIR 200 MG (LOQULAR),TURKEY,Completed,World Medicine ILAC SAN. ve TIC. A.S.,"June 23, 2020",Interventional,"Open-label,Randomised,Single Oral Dose,Two-period,Cross-over Trial to Assess to Bioequivalence of Loqular 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions",Unrelated
1963,APPENDICITIS,"February 08, 2021",6000000,NCT04407117,LOCK-DOWN AND SOCIAL DISTANCING,DENMARK,Completed,"Claus Anders Bertelsen, PhD, MD","March 23, 2017",Observational,Change in the Incidence of Appendicitis in a Controlled Environment During the National Lockdown Throughout the COVID-19 Pandemic,Unrelated
1964,COVID PATIENTS,"February 08, 2021",72,NCT04407130,IVERMECTIN + DOXYCYCLINE + PLACEBO,BANGLADESH,Completed,"International Centre for Diarrhoeal Disease Research, Bangladesh","June 16, 2020",Interventional,"Ivermectin and Doxycycline in Combination or Ivermectin Alone for the Treatment of Adult Bangladeshi Patients Hospitalized for COVID-19: a Randomised, Double-blind, Placebo-controlled Trial.",COVID
1965,LUNG CANCER,"February 08, 2021",128,NCT04407143,IGG TEST,SPAIN,Recruiting,Fundación GECP,"April 15, 2020",Observational,Study of Acquired Immunity in Patients With Lung Cancer and COVID-19 Infection,Unrelated
1966,COVID,"February 08, 2021",724,NCT04407156,ACUTE KIDNEY INJURY,UNITED KINGDOM,Completed,University Hospitals of Derby and Burton NHS Foundation Trust,"June 1, 2020",Observational,Acute Kidney Injury In Corona Virus Infection Disease (COVID19) in United Kingdom,COVID
1967,COVID,"February 08, 2021",617,NCT04407169,NO INTERVENTION,FRANCE,Completed,"Central Hospital, Nancy, France","June 1, 2020",Observational,Evaluation of the Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease Hospitalized for Severe Forms,COVID
1968,COVID,"February 08, 2021",60,NCT04407182,VIUSID AND ASBRIP,ECUADOR,Completed,Catalysis SL,"May 4, 2020",Interventional,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients in Teodoro Maldonado Carbo Specialty's Hospital Infected and Diagnosed by SARS-Cov-2 With COVID-19,COVID
1969,COVID,"February 08, 2021",2000,NCT04407195,EXPOSURE TO THE SARS-COV-2,UNITED STATES,"Active, not recruiting",Northeastern University,"June 1, 2020",Observational,Mental Health Outcomes Among US Healthcare Workers Exposed to COVID-19,COVID
1970,CONVALESCENCE,"February 08, 2021",10,NCT04407208,CONVALESCENT PLASMA,INDONESIA,Completed,Biofarma,"May 1, 2020",Interventional,Convalescent Plasma Therapy in Patients With COVID-19,Unrelated
1971,TRANSPLANT RECIPIENTS,"February 08, 2021",1100,NCT04407221,,SWEDEN,Enrolling by invitation,Vastra Gotaland Region,"June 16, 2020",Observational,COVID-19 Research in Organ Transplant Recipients,Unrelated
1972,COVID -19,"February 08, 2021",136,NCT04407260,OXYGEN HOOD,UNITED STATES,Completed,Northwell Health,"March 6, 2020",Observational,"The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic Patients With COVID-19. A Prospective Controlled Cohort Study.",COVID
1973,COVID,"February 08, 2021",1200,NCT04407273,OBSERVATIONAL,SPAIN,"Active, not recruiting",Institut Investigacio Sanitaria Pere Virgili,"May 14, 2020",Observational,STATIN THERAPY AND COVID-19 INFECTION (STACOV PROJECT),COVID
1974,COVID,"February 08, 2021",41,NCT04407286,VITAMIN D3,UNITED STATES,Completed,Arizona State University,"May 19, 2020",Interventional,Vitamin D Testing and Treatment for Adults With COVID 19,COVID
1975,COVID,"February 08, 2021",360,NCT04407299,SELF-ADMINISTERED STRUCTURED QUESTIONNAIRE,EGYPT,Completed,Cairo University,"April 20, 2020",Observational,"Impact of COVID-19 Pandemic on Attitude, Behaviour and Mental Health of Patients With Rheumatic Diseases",COVID
1976,COVID,"February 08, 2021",100,NCT04407390,NICOTINAMIDE RIBOSIDE,DENMARK,Recruiting,University of Copenhagen,"June 1, 2020",Interventional,"Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly. A Randomized Double-blind, Placebo-controlled Trial of Nicotinamide Riboside NR-COVID19",COVID
1977,SARS-CoV2,"February 08, 2021",12000,NCT04407429,LABORATORY ANALYSES,AUSTRIA,Recruiting,Medical University of Vienna,"May 27, 2020",Observational,Vienna Versus SARS-CoV-2 Virus: A Prospective Large-scale Antibody Study of SARS-CoV-2 in Patients and Health Care Workers,COVID
1978,COVID,"February 08, 2021",827,NCT04407468,PRONE POSITION,MEXICO,Completed,Hospital General San Juan del Rio,"May 1, 2020",Observational,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 (APRONOX),COVID
1979,COVID,"February 08, 2021",809,NCT04407494,"REPORTING OF ANOSMIA, AGEUSIA AND OTHER CLINICAL SYMPTOMS",FRANCE,Completed,"University Hospital, Montpellier","March 1, 2020",Observational,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders in a Population Tested for COVID-19,COVID
1980,COVID,"February 08, 2021",66,NCT04407507,IVERMECTIN,,Not yet recruiting,Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.,June 2020,Interventional,"Multicenter, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of Ivermectin in Mild Virus-positive Subjects (SARS-CoV)-2 With or Without Symptoms",COVID
1981,COVID,"February 08, 2021",1920,NCT04407533,DIET TRACKING AND SURVEY,CANADA,Recruiting,McGill University,"May 25, 2020",Observational,Dietary Intake and Eating Habits During the COVID-19 Pandemic,COVID
1982,IMMUNOSUPPRESSION,"February 08, 2021",300,NCT04407546,,UNITED STATES,Recruiting,Jonsson Comprehensive Cancer Center,"May 27, 2020",Observational,Role of Children in the Transmission of SARS-CoV-2 in Households of Immunocompromised Persons,Unrelated
1983,COVID,"February 08, 2021",216,NCT04407559,SEROLOGICAL ANALYSES TO BE LEAD ON A PRE-EXISTING BIOBANK,FRANCE,Completed,"University Hospital, Montpellier","May 1, 2020",Observational,Impact of the Rheumatoid Factor on Serological Testing Performance for Covid-19 in Rheumatoid Arthritis Patients,COVID
1984,COVID,"February 08, 2021",44,NCT04407572,"SERUM ZINC, VITAMIN D VITAMIN B12 LEVELS .",TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"April 20, 2020",Observational,Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women,COVID
1985,COVID,"February 08, 2021",1000000,NCT04407585,COVID-19 SWAB PCR TEST,UNITED KINGDOM,Recruiting,King's College London,"June 1, 2020",Observational,Validation of Machine Learning (ML) Models as Diagnostic Tools to Predict Infection With SARS-CoV-2,COVID
1986,COPD EXACERBATION,"February 08, 2021",160,NCT04407598,,UNITED KINGDOM,"Active, not recruiting",University of Leicester,"May 1, 2020",Observational,Cross-Sectional Observation Telephone Survey Study to Understand the Changes in COPD Exacerbation Patterns and Potential Causes of These During the COVID-19 Pandemic,Unrelated
1987,BARIATRIC SURGERY CANDIDATE,"February 08, 2021",138,NCT04407663,TELEMEDICINE TO REMOTE OUTPATIENT VISIT IN BARIATRIC PATIENT,ITALY,Completed,"University of Campania ""Luigi Vanvitelli""","March 3, 2020",Observational,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near. Brief Correspondence on a Single Center Experience. Cohort Study",Unrelated
1988,COVID,"February 08, 2021",48,NCT04407689,INTERLEUKIN-7,FRANCE,Recruiting,Revimmune,"June 8, 2020",Interventional,"A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection in France and Belgium",COVID
1989,JUVENILE IDIOPATHIC ARTHRITIS,"February 08, 2021",150,NCT04407923,,FRANCE,Recruiting,"University Hospital, Brest","May 25, 2020",Observational,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context,Unrelated
1990,SARS-CoV2,"February 08, 2021",800,NCT04408001,CLINICAL INTERVIEW,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"June 4, 2020",Observational,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,COVID
1991,COVID,"February 08, 2021",18901,NCT04408014,SEROLOGICAL TEST,,Not yet recruiting,Butantan Institute,"June 1, 2020",Observational,Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo,COVID
1992,ANXIETY DISORDER OF CHILDHOOD OR ADOLESCENCE,"February 08, 2021",20,NCT04408027,VIRTUAL-CARE COGNITIVE BEHAVIOURAL THERAPY,CANADA,Not yet recruiting,The Hospital for Sick Children,"June 1, 2020",Interventional,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,Unrelated
1993,COVID,"February 08, 2021",700,NCT04408040,CONVALESCENT PLASMA,UNITED STATES,Recruiting,"Northside Hospital, Inc.","July 14, 2020",Interventional,"Use of Convalescent Plasma Collected From Donors Recovered From COVID-19 Virus Disease for Transfusion, as an Empirical and Preemptive Treatment During Viral Pandemic Outbreak",COVID
1994,COVID,"February 08, 2021",2000,NCT04408066,SAMPLE COLLECTION/PERFORMANCE EVALUATION (A),UNITED KINGDOM,Recruiting,LumiraDx UK Limited,"April 30, 2020",Interventional,Specimen Collection for Development and Performance Evaluation of the LumiraDx Platform Point of Care Tests for Sars-Cov-2 IgG/IgM & Antigen to be Used as an Aid in Diagnosis of COVID-19,COVID
1995,HOMELESS,"February 08, 2021",2000,NCT04408131,BLOOD SAMPLE,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"May 28, 2020",Interventional,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,Unrelated
1996,COVID,"February 08, 2021",548,NCT04408157,SELF-MANAGEMENT BOOKLET (SWITCH: STAY WELL DURING COVID-19),UNITED KINGDOM,Recruiting,King's College London,"May 20, 2020",Interventional,A Research Study to Evaluate the Efficacy of a Self-management Booklet (Stay Well During COVID-19; SWitCh) to Promote Wellbeing During the COVID-19 Pandemic,COVID
1997,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04408170,POINT-OF-CARE TEST FOR SARS-COV-2,UNITED KINGDOM,Recruiting,Manchester University NHS Foundation Trust,"June 19, 2020",Observational,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),COVID
1998,SARS-CoV2,"February 08, 2021",225,NCT04408183,GLS-1200,UNITED STATES,Recruiting,"GeneOne Life Science, Inc.","June 1, 2020",Interventional,"Efficacy, Safety, and Tolerability of GLS-1200 Topical Nasal Spray in the Prevention of Incident Confirmed, Symptomatic SARS-CoV-2 Infection in Healthcare Personnel",COVID
1999,REHABILITATION,"February 08, 2021",200,NCT04408196,,ITALY,Recruiting,Fondazione Don Carlo Gnocchi Onlus,"May 26, 2020",Observational,Effects of Social Distancing on the Quality of Life and on the Emotional-affective Sphere of Caregivers and Patients Hospitalized in Residential Rehabilitation Departments: an Observational Study.,Unrelated
2000,COVID INFECTION,"February 08, 2021",60,NCT04408209,CONVALESCENT PLASMA,GREECE,Recruiting,National and Kapodistrian University of Athens,"April 23, 2020",Interventional,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection - A Multicenter Phase II Trial,COVID
2001,OXYGEN DEFICIENCY,"February 08, 2021",29,NCT04408222,AWAKE PRONING,UNITED STATES,"Active, not recruiting",Columbia University,"April 16, 2020",Observational,Awake Proning in Patients With COVID-19-Induced Acute Hypoxemic Respiratory Failure,Unrelated
2002,COVID,"February 08, 2021",300,NCT04408235,ENOXAPARIN,ITALY,Not yet recruiting,Azienda Ospedaliero-Universitaria di Modena,June 2020,Interventional,Randomised Controlled Trial Comparing High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy Not Requiring Invasive Mechanical Ventilation,COVID
2003,COVID,"February 08, 2021",30,NCT04408248,,UNITED KINGDOM,Recruiting,Guy's and St Thomas' NHS Foundation Trust,"August 20, 2020",Observational,AKI Biomarkers for Prediction of Acute Kidney Injury in Critically Ill Patients With COVID-19 and Respiratory Disease,COVID
2004,SPINAL CORD INJURIES,"February 08, 2021",50,NCT04408287,WEBEX PHYSICAL ACTIVITY PROGRAM,CANADA,Not yet recruiting,Lawson Health Research Institute,"September 15, 2020",Interventional,Improving Activity Engagement Among Persons With SCI During COVID-19,Unrelated
2005,COVID,"February 08, 2021",50,NCT04408326,ANGIOTENSIN II,UNITED KINGDOM,Recruiting,Guy's and St Thomas' NHS Foundation Trust,"June 1, 2020",Observational,Efficacy and Safety of Angiotensin II Use in COVID-19 Patients With Acute Respiratory Distress Syndrome,COVID
2006,CANCER,"February 08, 2021",500,NCT04408339,NO INTERVENTION,GERMANY,Recruiting,Universitätsklinikum Hamburg-Eppendorf,"April 15, 2020",Observational [Patient Registry],COVID-19 Disease in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care in the Hamburg Metropolitan Area Including Prospective Biobanking,Unrelated
2007,COVID,"February 08, 2021",82,NCT04408365,,UNITED KINGDOM,Recruiting,Guy's and St Thomas' NHS Foundation Trust,"August 5, 2020",Observational,"Endothelial Function, Inflammation, and Organ Dysfunction in Critically Ill Patients With COVID-19",COVID
2008,CORONAVIRUS INFECTION,"February 08, 2021",156,NCT04408378,OBSERVATION OF COVID 19 PNEUMONIA,TURKEY,Recruiting,Gaziosmanpasa Taksim Research and Education Hospital,"June 5, 2020",Observational,Retrospective Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients,COVID
2009,COVID,"February 08, 2021",0,NCT04408391,BRAIN MRI SCAN,FRANCE,Withdrawn,Centre Hospitalier Universitaire de Nīmes,"May 20, 2020",Observational,Descriptive Pilot Study of Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia,COVID
2010,COVID,"February 08, 2021",325,NCT04408456,HCQ,INDIA,Completed,Postgraduate Institute of Medical Education and Research,"March 1, 2020",Interventional,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 in Asymptomatic Individual at Risk for SARS-CoV-2 Infection-A Open Level Control Clinical Trial,COVID
2011,CHRONIC MEDICAL CONDITIONS,"February 08, 2021",54,NCT04408651,LIIT.CI ACT,PORTUGAL,"Active, not recruiting",University of Coimbra,"May 1, 2020",Interventional,Testing the Efficacy of a Low Intensity Internet Therapy for Chronic Illness (@LIIT.CI): The Contribute of Explicit Compassion Practices in ACT,Unrelated
2012,COVID,"February 08, 2021",0,NCT04409184,,,Withdrawn,Medical College of Wisconsin,"August 14, 2020",Observational,Evaluation of Whole Blood Samples From Coronavirus Disease 2019 (COVID-19) Convalescent Patients to Study Immune Response and Severity of Disease Predictors,COVID
2013,COMORBIDITIES,"February 08, 2021",4789,NCT04409197,,FRANCE,Completed,"University Hospital, Grenoble","May 8, 2020",Observational,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",Unrelated
2014,COVID,"February 08, 2021",155,NCT04409249,"IMAGING, BLOOD TESTS",TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 15, 2020",Observational,Prognostic Factors in Pregnant Women With COVID-19,COVID
2015,COVID PNEUMONIA,"February 08, 2021",650,NCT04409262,REMDESIVIR,BRAZIL,"Active, not recruiting",Hoffmann-La Roche,"June 16, 2020",Interventional,"A Phase III, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Patients With Severe COVID-19 Pneumonia",COVID
2016,PULMONARY FIBROSIS,"February 08, 2021",500,NCT04409275,,SPAIN,Recruiting,Fundación para la Investigación del Hospital Clínico de Valencia,"May 21, 2020",Observational,STUDY OF THE APPEARANCE OF LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION,Unrelated
2017,COVID,"February 08, 2021",36,NCT04409327,RTB101,UNITED STATES,"Active, not recruiting",Restorbio Inc.,"July 11, 2020",Interventional,Randomized Double Blind Placebo-Controlled Study to Determine if Prophylaxis With RTB101 Compared to Placebo Reduces Severity of Lab Confirmed COVID19 in Adults ≥65 Years in a Nursing Home in Which ≥1 Person(s) Have Lab Confirmed COVID19,COVID
2018,COVID,"February 08, 2021",0,NCT04409483,LOPINAVIR-RITONAVIR DRUG COMBINATION,,Withdrawn,Epicentre,"June 1, 2020",Interventional,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,COVID
2019,SMOKING CESSATION,"February 08, 2021",108,NCT04409496,CHAT-BASED INSTANT MESSAGING SUPPORT,HONG KONG,"Active, not recruiting",The University of Hong Kong,"June 2, 2020",Interventional,Chat-based Instant Messaging Support for Preventing Smoking Relapse in the Context of COVID-19 Outbreak: a Pilot Randomised Clinical Trial,Unrelated
2020,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",124,NCT04409509,"GARADACIMAB, FACTOR XIIA ANTAGONIST MONOCLONAL ANTIBODY",UNITED STATES,Completed,CSL Behring,"July 1, 2020",Interventional,"A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 2019 (COVID 19)",COVID
2021,COVID,"February 08, 2021",55,NCT04409522,MELATONIN,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Mohammad Sadegh Bagheri Baghdasht,"May 12, 2020",Interventional,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,COVID
2022,ACTIVITIES,"February 08, 2021",500,NCT04409535,WHOQOL-BREF SURVEY,UNITED STATES,"Active, not recruiting",University of New Mexico,"May 7, 2020",Observational,Effects of the COVID-19 Health Emergency on the Biopsychosocial Health of Rural Residents of New Mexico Using Mixed Methods Research,Unrelated
2023,"INFECTION, CORONAVIRUS","February 08, 2021",31,NCT04409574,,,Not yet recruiting,Assiut University,June 2020,Observational,COVID19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals,COVID
2024,SLEEP DISTURBANCE,"February 08, 2021",50,NCT04409743,REMOTE COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA,UNITED STATES,Recruiting,Stanford University,"June 7, 2020",Interventional,"Harnessing Telehealth to Mitigate the Impact of the COVID-19 Pandemic on Sleep, Suicidality, and Neuropsychiatric Symptoms",Unrelated
2025,POSTTRAUMATIC STRESS DISORDER,"February 08, 2021",50,NCT04409821,TELE-DELIVERED PSYCHOLOGICAL INTERVENTION,DENMARK,Recruiting,"Rigshospitalet, Denmark","May 29, 2020",Interventional,COVID-19 Caregiver Emotional Support,Unrelated
2026,COVID,"February 08, 2021",750,NCT04409834,UNFRACTIONATED HEPARIN IV,UNITED STATES,Recruiting,The TIMI Study Group,"August 5, 2020",Interventional,"A Multicenter, Randomized-Controlled Trial to Evaluate the Efficacy and Safety of Antithrombotic Therapy for Prevention of Arterial and Venous Thrombotic Complications in Critically-Ill COVID-19 Patients",COVID
2027,COVID,"February 08, 2021",70,NCT04409847,ABPM,UNITED KINGDOM,Recruiting,NHS Greater Glasgow and Clyde,"June 1, 2020",Observational,COVID-19 Blood Pressure Endothelium Interaction Study,COVID
2028,COVID,"February 08, 2021",150,NCT04409873,ORAL-B MOUTH SORE MOUTHWASH,UNITED STATES,Not yet recruiting,"University of California, San Francisco","December 7, 2020",Interventional,Effect of Antiseptic Mouthwash/Gargling Solutions and Pre-procedural Rinse on SARS-CoV-2 Load (COVID-19),COVID
2029,"COVID, CORONAVIRUS","February 08, 2021",30,NCT04409886,HYPERBARIC CHAMBER,,Not yet recruiting,Maimonides Medical Center,"June 1, 2020",Interventional,The Application of Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients - Randomized Controlled Trial,COVID
2030,COVID,"February 08, 2021",300,NCT04409899,BLOOD TESTS,SPAIN,"Active, not recruiting",Fundacio Puigvert,"March 20, 2020",Observational,The Utility of Enhanced Pre- and Post-surgical Protocols to Prevent the Spread of COVID-19 in a Large Urological Department (UroCovid Study),COVID
2031,COVID INFECTION,"February 08, 2021",25,NCT04409925,RHDNASE I,CANADA,Recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,"December 25, 2020",Interventional,Phase I Pilot Study Investigating the Safety and Feasibility of Inhaled rhDNase1 and Its Impact on Neutrophil Extracellular Traps (NETs) in Non-Ventilated COVID-19 Infected Patients,COVID
2032,"EVENT, LIFE CHANGE","February 08, 2021",100,NCT04409951,,EGYPT,Not yet recruiting,Damanhour University,November 2020,Observational,Impact of Covid-19 on Pharmacist Student Education in Egypt,Unrelated
2033,MENTAL HEALTH WELLNESS 1,"February 08, 2021",45,NCT04410016,STAFF WELLBEING CENTRES,UNITED KINGDOM,Recruiting,University of Nottingham,"May 25, 2020",Interventional,Evaluation of a Workplace Intervention to Implement Supported COVID-19 Wellbeing Centres in a Healthcare Workplace During and After the Coronavirus Pandemic: The COVID-WELL Study,Unrelated
2034,COVID,"February 08, 2021",134,NCT04410107,LUNG FUNCTION TESTS,BRAZIL,Recruiting,Federal University of Rio Grande do Sul,"May 15, 2020",Observational,"Short and Long Term Assessment of Lung Function, Exercise Capacity and Health-Related Quality of Life in Survivors of Severe COVID-19",COVID
2035,COVID,"February 08, 2021",20,NCT04410159,POVIDONE-IODINE,MALAYSIA,Completed,Universiti Sains Islam Malaysia,"June 22, 2020",Interventional,"A Pilot, Open-Labelled, Randomised Controlled Trial Of Povidone-Iodine Vs Essential Oil And Tap Water Gargling For COVID-19 Patients",COVID
2036,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04410263,"SAMPLING (EDTA BLOOD, PHARYNGEAL AND NOSE SWABS, BRONCHOALVEOLAR LAVAGE ,URINE)",SWITZERLAND,Recruiting,University of Zurich,"April 9, 2020",Observational,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,COVID
2037,COVID,"February 08, 2021",132,NCT04410328,DIPYRIDAMOLE ER 200MG/ ASPIRIN 25MG ORALLY/ENTERALLY AND STANDARD OF CARE,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","October 21, 2020",Interventional,A Randomized Controlled Trial to Evaluate the Outcomes With Aggrenox in Patients With SARS-CoV-2 Infection,COVID
2038,COVID,"February 08, 2021",44,NCT04410354,MERIMEPODIB,UNITED STATES,Terminated,"ViralClear Pharmaceuticals, Inc.","June 16, 2020",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Oral Merimepodib in Combination With Intravenous Remdesivir in Adult Patients With Advanced Coronavirus Disease 2019 (COVID-19)",COVID
2039,"SARS COV2, IMMUNE RESPONSE","February 08, 2021",63,NCT04410432,BLOOD SAMPLE COLLECTION,FRANCE,Recruiting,Centre Hospitalier Universitaire Dijon,"September 29, 2020",Observational,Immune Response and Risk of Serious Infection to SARS-Cov2,Respiratory
2040,BLOOD DONATION,"February 08, 2021",506517,NCT04410458,BLOOD DONATION SMS,CHINA,Enrolling by invitation,Guangzhou Blood Center,"May 31, 2020",Interventional,Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19（Repeat Trial）,Unrelated
2041,LIVER TRANSPLANT INFECTION,"February 08, 2021",300,NCT04410471,CLIA OF IGG AND IGM AGAINST SARS-COV-2,SPAIN,Recruiting,Magdalena Salcedo,"May 29, 2020",Observational [Patient Registry],Development and Persistence of Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients in Comparison With Immunocompetent Patients,Unrelated
2042,INFLAMMATORY BOWEL DISEASES,"February 08, 2021",1500,NCT04410484,,UNITED KINGDOM,"Active, not recruiting",Hull University Teaching Hospitals NHS Trust,"May 22, 2020",Observational,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,Unrelated
2043,COVID,"February 08, 2021",100,NCT04410510,P2ET (CAESALPINIA SPINOSA EXTRACT),COLOMBIA,Recruiting,Hospital Universitario San Ignacio,"September 30, 2020",Interventional,"Study of the P2Et Extract Obtained From Caesalpinia Spinosa in the Symptomatic Treatment of Subjects With COVID-19 at the Hospital Universitario San Ignacio, Colombia.",COVID
2044,"MIGRAINE, HEMICRANIA","February 08, 2021",25,NCT04410536,SYMPTOMATIC DRUGS,ITALY,Recruiting,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"June 15, 2020",Interventional,Home-withdrawal Program Combined With Behavioural Approach in Patients With Medication Overuse Headache During Covid-19 Emergency: Incidence of Relapses in Overuse and Changes in Impact at One Year Follow up,Unrelated
2045,COVID,"February 08, 2021",10,NCT04410549,OPTICAL COHERENCE TOMOGRAPHY (OCT),BRAZIL,Recruiting,IRCCS San Raffaele,"June 1, 2020",Interventional,Optical Coherence Tomography for Microvascular Lung Vessels Obstructive Thromboinflammatory Syndrome Assessment in Patients With COVID-19: an Exploratory Study,COVID
2046,PREGNANCY RELATED,"February 08, 2021",714,NCT04410562,HYDROXYCHLOROQUINE,SPAIN,Recruiting,Barcelona Institute for Global Health,"May 13, 2020",Interventional,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum,Unrelated
2047,"HEALTH KNOWLEDGE, ATTITUDES, PRACTICE","February 08, 2021",560,NCT04410692,PREDICTION MARKET,SINGAPORE,Completed,"National University, Singapore","May 15, 2020",Interventional,Can the Prediction Market Improve Predictions of COVID-19?,Unrelated
2048,DIABETES MELLITUS,"February 08, 2021",100,NCT04410718,GLYCAEMIC LEVELS,DENMARK,Recruiting,Steno Diabetes Center Copenhagen,"April 20, 2020",Observational,Glycaemia and Cardiac Function in Patients With COVID-19,Unrelated
2049,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04410835,ONLINE SURVEY,AUSTRIA,Recruiting,Medical University of Graz,"April 28, 2020",Observational,Psychological Impact and Effect of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders - an Online Survey,COVID
2050,COVID,"February 08, 2021",179,NCT04410939,REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION,TURKEY,Completed,Istanbul Medipol University Hospital,"April 10, 2020",Observational,COVID-19 PCR Test Results in Asymptomatic Pregnants Admitted for Birth and Other Interventions in Our Clinic,COVID
2051,INTUBATION,"February 08, 2021",78,NCT04411056,BARRIER BOX,UNITED STATES,Completed,The Guthrie Clinic,"May 7, 2020",Interventional,Time to Adapt in the Pandemic Era: A Prospective Randomized Study Comparing Time to Intubate With and Without the Barrier Box,Unrelated
2052,COVID,"February 08, 2021",900,NCT04411147,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"June 17, 2020",Observational,A Longitudinal Study of COVID-19 Sequelae and Immunity,COVID
2053,SARS-CoV2,"February 08, 2021",1008,NCT04411433,FAVIPIRAVIR (3200 MG + 1200 MG),TURKEY,"Active, not recruiting","Ministry of Health, Turkey","May 8, 2020",Interventional,"An Open-Label, Multicenter, Parallel-Group, Randomized, Phase III Study to Evaluate the Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19",COVID
2054,COVID,"February 08, 2021",1264,NCT04411446,VITAMIN D,ARGENTINA,Recruiting,Vitamin D Study Group,"August 11, 2020",Interventional,Randomized Controlled Trial of High Dose of Vitamin D as Compared With Placebo to Prevent Complications Among COVID-19 Patients,COVID
2055,COVID,"February 08, 2021",470,NCT04411459,INVASIVE MECHANICAL VENTILATION,ITALY,Completed,Azienda Usl di Bologna,"February 1, 2020",Observational,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,COVID
2056,ACUTE KIDNEY INJURY DUE TO SEPSIS,"February 08, 2021",1600,NCT04411472,RECOMBINANT HUMAN ALKALINE PHOSPHATASE,NETHERLANDS,Recruiting,AM-Pharma,"November 2, 2020",Interventional,"A DB, Placebo-Controlled, Two-Arm Parallel-Group, Phase 3 RCT to Investigate the Efficacy and Safety of Recombinant Human Alkaline Phosphatase for Treatment of Patients With SA-AKI",Unrelated
2057,COVID,"February 08, 2021",4000,NCT04411511,EXPOSURE TO THE DUTCH MEASURES DUE TO THE COVID-19 PANDEMIC.,NETHERLANDS,Recruiting,Maastricht University Medical Center,"May 6, 2020",Observational,"The Influence of the Covid-19 Pandemia on the Health Behaviour of Primary School Children (and Their Parents) - COVID-19, Obesity and Lifestyle in Children",COVID
2058,PROGNOSIS,"February 08, 2021",105,NCT04411563,TAKING BIOLOGICAL SAMPLES,TURKEY,Recruiting,Bakirkoy Dr. Sadi Konuk Research and Training Hospital,"May 21, 2020",Observational [Patient Registry],The Effect of miRNA and Epigenetic Modifications on Prognosis in Covid-19 Infection,Unrelated
2059,SARS-CoV2,"February 08, 2021",40000,NCT04411576,THROAT SWAB SAMPLE FOR MEASURING CURRENT INFECTION WITH SARS-COV-2,SWEDEN,Recruiting,Karolinska University Hospital,"April 23, 2020",Observational,"Studies on Current and Past SARS-CoV-2 Infection (and COVID-19) in Healthcare in Stockholm, Sweden",COVID
2060,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",90,NCT04411602,SARS-COV-2 PLASMA,UNITED STATES,Recruiting,Ascension South East Michigan,"April 7, 2020",Interventional,Convalescent Plasma to Treat Coronavirus - Associated Severe Pulmonary Complications: A Feasibility Study Assessing the Safety of Multiple Doses of Anti-SARS-CoV-2 Plasma in Patients With Severe Respiratory Distress Due to COVID-19,Respiratory
2061,COVID,"February 08, 2021",24,NCT04411628,LY3819253,UNITED STATES,Completed,Eli Lilly and Company,"May 28, 2020",Interventional,"A Randomized, Placebo-Controlled, Double-Blind, Sponsor Unblinded, Single Ascending Dose, Phase 1 First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous LY3819253 in Participants Hospitalized for COVID-19",COVID
2062,SARS-CoV2,"February 08, 2021",34,NCT04411667,OCTAGAM,UNITED STATES,"Active, not recruiting","George Sakoulas, MD","April 28, 2020",Interventional,Randomized Open Label Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection,COVID
2063,COVID,"February 08, 2021",120,NCT04411680,SARGRAMOSTIM,UNITED STATES,Recruiting,"Partner Therapeutics, Inc.","August 18, 2020",Interventional,A Phase 2 Trial Evaluating Sargramostim in Patients With COVID-19 Associated Acute Hypoxemia,COVID
2064,INFLAMMATORY BOWEL DISEASES,"February 08, 2021",200,NCT04411784,,UNITED KINGDOM,"Active, not recruiting",Hull University Teaching Hospitals NHS Trust,"May 20, 2020",Observational,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis: A Multi-centre Observational Case- Control Study",Unrelated
2065,COVID,"February 08, 2021",100,NCT04412018,ICOSAPENT ETHYL,CANADA,Recruiting,Canadian Medical and Surgical Knowledge Translation Research Group,"June 4, 2020",Interventional,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 (VASCEPA-COVID-19),COVID
2066,TO PREDICT AN UNFAVORABLE EVOLUTION OF COVID AT THE HOSPITAL ADMISSION OF PATIENTS,"February 08, 2021",802,NCT04412031,NON APPLICABLE,FRANCE,Completed,Hospices Civils de Lyon,"November 11, 2019",Observational,Bayesian Network to Predict Transfer in Intensive Care Units or Death in Newly Covid-19 Hospitalized Patient,COVID
2067,COVID PNEUMONIA,"February 08, 2021",82,NCT04412057,CERC-002,UNITED STATES,Recruiting,"Aevi Genomic Medicine, LLC, a Cerecor company","June 9, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of CERC-002 in Adults With COVID 19 Pneumonia and Acute Lung Injury",COVID
2068,"INTUBATION, INTRATRACHEAL","February 08, 2021",13,NCT04412226,AEROSOL BOX,TURKEY,Completed,Derince Training and Research Hospital,"June 10, 2020",Observational,"Effect of Using Barrier Devices for Intubation in COVID-19 Patients: Randomized, Prospective, Manikin Study",Unrelated
2069,TB - TUBERCULOSIS,"February 08, 2021",200,NCT04412239,PATIENT-CENTRED ADVICE ON TELEPHONE CONSULTATION IN TB PATIENTS:,PAKISTAN,Recruiting,Health Science Center of Xi'an Jiaotong University,"April 20, 2020",Interventional,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,Unrelated
2070,COVID,"February 08, 2021",0,NCT04412252,TOFACITINIB,UNITED STATES,Withdrawn,Pfizer,"July 6, 2020",Interventional,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY ASSESSING THE SAFETY AND EFFICACY OF TOFACITINIB IN HOSPITALIZED PARTICIPANTS WITH COVID-19 PNEUMONIA WHO ARE RECEIVING STANDARD OF CARE THERAPY",COVID
2071,COVID,"February 08, 2021",300,NCT04412265,RELATION BETWEEN FRAILTY AND CLINICAL OUTCOMES IN ELDERLY PATIENTS WITH COVID-19.,ITALY,Recruiting,University of Milano Bicocca,"April 16, 2020",Observational,Relationship Between Frailty and Clinical Outcomes in Elderly Patients With COVID-19,COVID
2072,COVID,"February 08, 2021",392,NCT04412278,ONLINE SURVEY,TURKEY,Completed,Okan University,"June 1, 2020",Observational,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers: Cross Sectional Study on Turkish Society and Interpretation With Physical Activity Level,COVID
2073,COVID,"February 08, 2021",120,NCT04412291,ANAKINRA PREFILLED SYRINGE,SWEDEN,Recruiting,Karolinska University Hospital,"June 11, 2020",Interventional,"A Single-center, Randomized, Open-label Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",COVID
2074,COVID,"February 08, 2021",166,NCT04412304,DOSE OF TINZAPARIN OR DALTEPARIN,SWEDEN,Completed,Karolinska Institutet,"March 6, 2020",Observational,"Patient Characteristics, Outcome and Thromboembolic Events Among Adult Critically Ill COVID-19 Patients With Different Anticoagulant Regimes at One of the Biggest Emergency Hospitals in Northern Europe, Sweden",COVID
2075,COVID,"February 08, 2021",600,NCT04412317,,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"June 3, 2020",Observational [Patient Registry],"National Observatory of the Care of Young Sick Children in Community or Not, Indications and Cost-effectiveness of PCR-Sars-CoV-2 - VIGIL Study",COVID
2076,COVID,"February 08, 2021",20,NCT04412330,ICU RECOVERY + PHYSICAL THERAPY,UNITED STATES,Recruiting,University of Kentucky,"May 1, 2020",Interventional,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 (OPTImAL) - a Single Center Prospective Study,COVID
2077,WELL-BEING (PSYCHOLOGICAL FLOURISHING),"February 08, 2021",241,NCT04412343,VIRTUAL GROUP INTERVENTION,CANADA,Completed,University of British Columbia,"May 23, 2020",Interventional,The Seniors COvid-19 Pandemic and Exercise Study: A Randomized Controlled Trial,Unrelated
2078,COVID,"February 08, 2021",180,NCT04412356,TRACHEOTOMY,SWEDEN,Recruiting,"Sahlgrenska University Hospital, Sweden","June 4, 2020",Interventional,"Timing of Tracheotomy in Covid-19 Positive Patients: a Randomized, Controlled Trial",COVID
2079,COVID,"February 08, 2021",20,NCT04412369,NON-INVASIVE CARDIAC IMAGING,UNITED KINGDOM,Not yet recruiting,University of Cambridge,June 2020,Observational,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,COVID
2080,COVID,"February 08, 2021",100,NCT04412382,NETOSIS MARKERS,ITALY,Recruiting,Azienda Ospedaliera Universitaria Integrata Verona,"June 1, 2020",Observational [Patient Registry],Covid-19: Possible Role of Neutrophil Extracellular Traps,COVID
2081,CORONAVIRUS INFECTION,"February 08, 2021",516,NCT04412395,LACTOFERRIN (APOLACTOFERRIN),EGYPT,Not yet recruiting,"National Research Centre, Egypt","June 1, 2020",Interventional,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory Therapy in Patients Diagnosed With COVID-19 Disease,COVID
2082,COVID,"February 08, 2021",500,NCT04412460,,GERMANY,Recruiting,University Hospital Tuebingen,"March 20, 2020",Observational,Echocardiography in Patients With Covid-19 Undergoing Intensive Care Therapy,COVID
2083,SARS-CoV2,"February 08, 2021",1000,NCT04412473,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 30, 2020",Observational,COVID-19 Respiratory Distress and Antithrombotic Drugs inSubject's Habits,COVID
2084,COVID,"February 08, 2021",100,NCT04412486,COVID CONVALESCENT PLASMA,UNITED STATES,Recruiting,"Gailen D. Marshall Jr., MD PhD","June 1, 2020",Interventional,An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients With Moderate to Severe COVID-19,COVID
2085,COVID,"February 08, 2021",942,NCT04412538,LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 28-DAY SCHEDULE,CHINA,Recruiting,Chinese Academy of Medical Sciences,"May 15, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Phase Ia/IIa Trial of an Inactivated SARS-CoV-2 Vaccine in Healthy People Aged 18 to 59 Years",COVID
2086,CORONAVIRUS INFECTION,"February 08, 2021",50,NCT04412551,,SWEDEN,Recruiting,"Dalarna County Council, Sweden","May 20, 2020",Observational [Patient Registry],Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19,COVID
2087,ST ELEVATED MYOCARDIAL INFARCTION UNDERGOING MECHANICAL REPERFUSION,"February 08, 2021",6609,NCT04412655,PERCUTANEOUS CORONARY REVASCULARIZATION FOR STEMI,ITALY,"Active, not recruiting","Università degli Studi del Piemonte Orientale ""Amedeo Avogadro""","May 5, 2020",Observational,International Study on Acute Coronary Syndromes - ST-segment Elevation Myocardial Infarction COVID 19,Unrelated
2088,SARS-CoV2 (COVID) SEVERE PNEUMONIA,"February 08, 2021",32,NCT04412668,ATYR1923 1 MG/KG,PUERTO RICO,Completed,"aTyr Pharma, Inc.","June 12, 2020",Interventional,A Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of ATYR1923 In Adult Patients With Severe Pneumonia Related to SARS-CoV-2 Infection (COVID-19),COVID
2089,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04412746,MANAGEMENT OF COVID-19,ALGERIA,Recruiting,"Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen","April 1, 2020",Observational,Prevalence of Diabetes Among Hospitalized Patients With Covid-19 in West of Algeria. Identification of Diabetes-related Associated Factors Severe Forms,COVID
2090,COVID,"February 08, 2021",300,NCT04412772,TOCILIZUMAB,UNITED STATES,Recruiting,Queen's Medical Centre,"June 12, 2020",Interventional,"A Randomized, Controlled Clinical Trial of the Safety and Efficacy of Tocilizumab for the Treatment of Severe COVID-19",COVID
2091,COVID,"February 08, 2021",20,NCT04412785,CYCLOSPORINE,UNITED STATES,Recruiting,University of Pennsylvania,"June 30, 2020",Interventional,Phase I Trial for the Prevention of Cytokine Release Syndrome (CRS) With Cyclosporine in Patients With Moderate COVID-19,COVID
2092,CHRONIC PAIN,"February 08, 2021",28,NCT04413006,SELF-COMPASSION FOR CHRONIC PAIN VIRTUAL GROUP TREATMENT PROGRAM,CANADA,Recruiting,University of Manitoba,"May 25, 2020",Interventional,A Self-compassion Group-based Treatment for Chronic Pain Via Video Conferencing During the COVID-19 Pandemic: Feasibility Study for a Potential New Mode of Treatment Delivery,Unrelated
2093,COVID,"February 08, 2021",61,NCT04413045,PREVALENCE OF COVID-19,EGYPT,Completed,Assiut University,"May 20, 2020",Observational,Prevalence and Clinical Characteristics of Novel COVID-19 Cases at One Quarantine Hospital; a National Analysis,COVID
2094,MENSTRUAL IRREGULARITY,"February 08, 2021",260,NCT04413058,,TURKEY,Completed,Haydarpasa Numune Training and Research Hospital,"April 10, 2020",Observational,Menstrual Cycle Characteristics of Healthcare Professionals at Covid 19 Pandemic Hospital,Unrelated
2095,SARS-CoV2,"February 08, 2021",142,NCT04413071,PASSED INFECTION OF SARS-COV-2,SPAIN,Completed,AORTICA Group,"May 25, 2020",Observational,Cardiac Involvement in Coronavirus (SARS-Cov-2) Infected Health Care Workers: The CCC Study,COVID
2096,CORONAVIRUS INFECTION,"February 08, 2021",105,NCT04413435,FILE SCANNING,TURKEY,Completed,Nevsehir Public Hospital,"October 30, 2020",Observational,Clinical Characteristics of Critically Ill Patients With 2019 Novel Coronavirus (COVID-19): Do We Need a New Triage System?,COVID
2097,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04413747,MORNING YOGA-BASED BREATHING SUPPORT,ITALY,Not yet recruiting,Health Ricerca e Sviluppo S.R.L.,"August 15, 2020",Interventional,Yoga- Based Breathing for Vagus Nerve Stimulation as Home-care Adjuvant Treatment Against Burden COVID-19,COVID
2098,BARIATRIC SURGERY,"February 08, 2021",40,NCT04413812,FREEBASE EXERCISE PROGRAMME,SWITZERLAND,"Active, not recruiting",Lia Bally,"July 1, 2020",Interventional,Fostering Exercise After Bariatric Surgery,Unrelated
2099,"OBESITY, COVID INFECTION","February 08, 2021",120,NCT04413838,NIVOLUMAB,FRANCE,Not yet recruiting,Hospices Civils de Lyon,"June 15, 2020",Interventional,"Study of the Efficiency and Security of NIVOLUMAB Therapy, Used in Immuno-stimulation, in Hospitalized Obese Individuals at Risk to Evolve Towards Severe Forms of COVID-19 Infection. Multicentric, Paralleled, Randomized, Controlled Trial",COVID
2100,SARS-CoV2,"February 08, 2021",50,NCT04413864,INFLAMMATORY CYTOKINES AND CHEMOKINES PROFILES OF PATIENTS WITH DEXMEDETOMIDINE ADMINISTRATION,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"April 24, 2020",Interventional,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,COVID
2101,FRAILTY SYNDROME,"February 08, 2021",600,NCT04413877,,,Not yet recruiting,University of Liege,October 2020,Observational [Patient Registry],Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),Unrelated
2102,COVID,"February 08, 2021",100,NCT04413955,SERAPH®-100 MICROBIND® AFFINITY BLOOD FILTER,UNITED STATES,Recruiting,"Children's Hospital Medical Center, Cincinnati","June 1, 2020",Observational [Patient Registry],Seraph®-100 Microbind® Affinity Blood Filter for the Treatment of COVID-19 Under Emergency Use Authorization: Data Registry,COVID
2103,CORONAVIRUS,"February 08, 2021",600,NCT04413968,RAPID DETECTION TEST,FRANCE,Completed,Assistance Publique - Hôpitaux de Paris,"June 2, 2020",Interventional,"Contamination and Transmission of the SARS-CoV-2 Virus in Exposed, Confined and Community-based Infants: A Cross-sectional, Multicentre, Interventional Seroprevalence Study",COVID
2104,SARS-CoV2,"February 08, 2021",155,NCT04414059,,FRANCE,Not yet recruiting,Elsan,March 2021,Observational,Complications Risk Factors in Patients Hospitalized for COVID-19 Infection: Role of Proteins Electrophoresis,COVID
2105,COVID,"February 08, 2021",100,NCT04414098,INC424 / RUXOLITINIB,,Not yet recruiting,Marcelo Iastrebner,"June 1, 2020",Interventional,Safety and Efficacy Study of Ruxolitinib in the Treatment of Severe Acute Respiratory Syndrome Due to SARS-COV-2,COVID
2106,MILD-TO-MODERATE COVID,"February 08, 2021",350,NCT04414124,KB109 + SELF SUPPORTIVE CARE (SSC),UNITED STATES,"Active, not recruiting",Kaleido Biosciences,"August 2, 2020",Interventional,"A Randomized, Open Label, Prospective, Parallel Group Study to Assess the Natural History of COVID-19 and Effects of KB109 in Addition to Supportive Self Care (SSC) Compared to SSC Alone on Measures of Health in Non-hospitalized Patients With Mild-Moderate COVID-19",COVID
2107,SARS-CoV2,"February 08, 2021",320,NCT04414241,HYDROXYCHLOROQUINE,PERU,Not yet recruiting,Universidad Peruana Cayetano Heredia,June 2020,Interventional,"Hydroxychloroquine to Prevent SARS-CoV-2 Infection Among Healthcare Workers: Randomized Controlled, Open-label, Phase 3 Clinical Trial",COVID
2108,COVID,"February 08, 2021",900,NCT04414267,BCG VACCINE,GREECE,Recruiting,Hellenic Institute for the Study of Sepsis,"May 26, 2020",Interventional,A Randomized Clinical Trial for Enhanced Trained Immune Responses Through Bacillus Calmette-Guérin Vaccination to Prevent Infections by COVID-19: The ACTIVATE II Trial,COVID
2109,COVID,"February 08, 2021",41,NCT04414293,LUNG LOW DOSE RADIATION,SPAIN,Not yet recruiting,Hospital Provincial de Castellon,"October 1, 2020",Interventional,Phase II Study of Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,COVID
2110,SARS-CoV2,"February 08, 2021",350,NCT04414319,,FRANCE,Recruiting,University Hospital Center of Martinique,"April 15, 2020",Observational,Impact of SARS-CoV-2 Infection in a Population Aged 70 Years or Older on Loss of Autonomy,COVID
2111,STRESS,"February 08, 2021",200,NCT04414371,YOGA,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","May 20, 2020",Interventional,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,Unrelated
2112,COVID,"February 08, 2021",1500,NCT04414410,,FRANCE,Enrolling by invitation,Hospital Ambroise Paré Paris,"May 12, 2020",Observational,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia,COVID
2113,CORONAVIRUS INFECTION,"February 08, 2021",42,NCT04414618,OPAGANIB,ISRAEL,"Active, not recruiting",RedHill Biopharma Limited,"July 2, 2020",Interventional,"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled Phase 2a Study, in Adult Subjects Hospitalized With SARS-CoV-2 Positive Pneumonia",COVID
2114,CORONAVIRUS INFECTION,"February 08, 2021",120,NCT04414631,CONESTAT ALFA,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","August 6, 2020",Interventional,"Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19: a Randomized, Parallel-group, Open-label, Multi-center Pilot Trial (PROTECT-COVID-19).",COVID
2115,COVID,"February 08, 2021",500,NCT04414657,BLOOD SAMPLING FOR BIOBANK,SWITZERLAND,Recruiting,Regina Grossmann,"April 9, 2020",Observational,Development of a SARS-CoV-2 Research Biobank,COVID
2116,LONELINESS,"February 08, 2021",120,NCT04414826,MINDFULNESS ALONE (MO) INTERVENTION,UNITED STATES,Recruiting,University of Texas at Austin,"May 25, 2020",Interventional,Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness,Unrelated
2117,"INFERTILITY, MALE","February 08, 2021",0,NCT04414904,EXPOSURE: COVID-19 INFECTION,UNITED KINGDOM,Withdrawn,Imperial College London,"June 10, 2020",Observational,Determining the Reproductive Health of Men Post-COVID-19 Infection,Unrelated
2118,COVID,"February 08, 2021",752,NCT04415060,ISOFLURANE INHALANT PRODUCT,CANADA,Recruiting,Sunnybrook Health Sciences Centre,"June 15, 2020",Interventional,"SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival. Multicentre Open-label, Pragmatic, Randomized Controlled Trial and a Parallel Prospective (Non-randomized) Cohort Study",COVID
2119,CORONAVIRUS,"February 08, 2021",186,NCT04415073,SNDX-6352,UNITED STATES,Suspended,Syndax Pharmaceuticals,"May 30, 2020",Interventional,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Axatilimab for the Treatment of Hospitalized Patients With Respiratory Signs and Symptoms Secondary to Novel Coronavirus Disease (COVID-19)",COVID
2120,COVID,"February 08, 2021",120,NCT04415086,CONVALESCENT PLASMA,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"June 1, 2020",Interventional,"Treatment of Patients With COVID-19 With Convalescent Plasma Transfusion: a Multicenter, Open-labeled, Randomized and Controlled Study",COVID
2121,COVID,"February 08, 2021",60,NCT04415151,TOFACITINIB 10 MG,UNITED STATES,"Active, not recruiting",Yale University,"July 29, 2020",Interventional,Investigation of Tofacitinib to Mitigate the Impact of COVID-19 (I-TOMIC) in Moderate SARS-CoV-2 (MODERATE I-TOMIC),COVID
2122,COVID,"February 08, 2021",700,NCT04415359,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","May 20, 2020",Observational,Evaluation of the Evolution of Pregnancies in the First Trimester Following a Medically Assisted Procreation (MAR) Management During a COVD-19 Pandemic Period,COVID
2123,COVID,"February 08, 2021",20,NCT04415879,N-95 RESPIRATOR,UNITED STATES,Completed,The Cleveland Clinic,"June 1, 2020",Interventional,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,COVID
2124,EXTRACELLULAR FLUID ALTERATION,"February 08, 2021",52,NCT04416009,NİCAS,TURKEY,Recruiting,Gaziosmanpasa Taksim Research and Education Hospital,"July 5, 2020",Observational [Patient Registry],the Determination of Extracellular Water (ECW) Which is Detected by Bioimpedence Method on Severe and Mild Covid 19 Pneumonia Clinical Course,Respiratory
2125,COVID,"February 08, 2021",400,NCT04416048,RIVAROXABAN,GERMANY,Not yet recruiting,"Charite University, Berlin, Germany","August 1, 2020",Interventional,Effect of Anticoagulation Therapy on Clinical Outcomes in Moderate to Severe Coronavirus Disease 2019 (COVID-19),COVID
2126,COVID,"February 08, 2021",2500,NCT04416061,COVID 19 DIAGNOSTIC TEST,HONG KONG,"Active, not recruiting",Hong Kong Sanatorium & Hospital,"May 25, 2020",Observational,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic: A Descriptive Study of Patients With SARS-CoV-2 RT-PCR Performed,COVID
2127,COVID,"February 08, 2021",130,NCT04416100,PULMONARY FUNCTION TESTS,AUSTRIA,Recruiting,Medical University Innsbruck,"April 29, 2020",Observational,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection,COVID
2128,PHOTODYNAMIC THERAPY& LOW LEVEL LASER IN MANAGEMENT OF COVID,"February 08, 2021",60,NCT04416113,PHOTOBIOMODULATION AND PHOTODYNAMIC THERAPY,,Not yet recruiting,Cairo University,August 2020,Interventional,Photobiomodulation and Photodynamic Therapy for the Treatment of COVID-19 A Randomized Controlled Clinical Trials,COVID
2129,COVID,"February 08, 2021",10,NCT04416139,INFUSION IV OF MESENCHYMAL STEM CELLS,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"May 1, 2020",Interventional,Mesenchymal Stem Cells for the Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID-19. Pilot Study,COVID
2130,COVID,"February 08, 2021",230000,NCT04416256,,FRANCE,Recruiting,Paris Translational Research Center for Organ Transplantation,"February 1, 2020",Observational,Consequences of the COVID-19 Pandemic on Worldwide Organ Procurement and Transplantation,COVID
2131,CORONAVIRUS,"February 08, 2021",13000,NCT04416308,NG TEST,FRANCE,Recruiting,Rennes University Hospital,"May 29, 2020",Interventional,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne,COVID
2132,SARS-CoV2 INFECTION (COVID),"February 08, 2021",954,NCT04416334,COLCHICINE PLUS SYMPTOMATIC TREATMENT (PARACETAMOL),SPAIN,Recruiting,Instituto de Investigación Marqués de Valdecilla,"August 19, 2020",Interventional,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS SARS-CoV2 (COVID-19),COVID
2133,COVID,"February 08, 2021",800,NCT04416347,SARS-COV2 INFECTION,UNITED KINGDOM,Recruiting,St George's University Hospitals NHS Foundation Trust,"June 15, 2020",Observational,"COVID-19, Clinical Predictors and Evolution of Disease in Hospitalised and Intensive Care Patients at St George's Hospital",COVID
2134,AUTISM SPECTRUM DISORDER,"February 08, 2021",40,NCT04416360,INTERVIEW BY PSYCHOLOGISTS,FRANCE,Recruiting,"University Hospital, Toulouse","May 5, 2020",Interventional,Clinical Evolution and Parenting in Children and Adolescents With Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder Quarantined Because of Covid-19 Outbreak,Unrelated
2135,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04416373,RT PCR SARS-COV-2,PORTUGAL,Recruiting,Universidade Nova de Lisboa,"March 22, 2020",Observational,COVID-19 and Pregnancy Outcomes: a Portuguese Collaboration Study,COVID
2136,CORONAVIRUS INFECTION,"February 08, 2021",146,NCT04416399,BUDESONIDE DRY POWDER INHALER,UNITED KINGDOM,Terminated,University of Oxford,"July 16, 2020",Interventional,Use of High Dose Inhaled Corticosteroids as Treatment of Early COVID-19 Infection to Prevent Clinical Deterioration and Hospitalisation,COVID
2137,MYELOPROLIFERATIVE NEOPLASM,"February 08, 2021",50,NCT04416438,,FRANCE,Recruiting,French Innovative Leukemia Organisation,"May 18, 2020",Observational,Observational Study of the Impact of the COronaVirus Disease 2019 (COVID-19) Epidemic on Patients With Myeloproliferative Neoplasias,Unrelated
2138,QUALITY OF LIFE,"February 08, 2021",230,NCT04416464,COVID-19 PNEUMONIA,PORTUGAL,Not yet recruiting,Universidade do Porto,"June 15, 2020",Observational,"Quality of Life and Long-term Outcomes in Patients With Pneumonia Associated With SARS-Cov2 Infection, Survivors of Intensive Care Units: a Prospective Multicenter Cohort Study",Unrelated
2139,COVID,"February 08, 2021",630,NCT04416893,RT-PCR SARS-COV2,,Not yet recruiting,Centre Hospitalier Intercommunal Creteil,"June 7, 2020",Observational,"Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children, a Cross-sectional, Prospective, Multicentre, Observational Study in Primary Care-Part 2 After the Lifting of the Lockdown",COVID
2140,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04416919,ASSEMBLED MASK,UNITED STATES,Recruiting,University of Oklahoma,"July 15, 2020",Interventional,A Proposed Alternative to the N-95 Mask Shortage in the COVID-19 Pandemic. A Feasibility Study,COVID
2141,"STRESS, PSYCHOLOGICAL","February 08, 2021",1000,NCT04417153,MINDFULNESS BASED INTERVENTION,SINGAPORE,Recruiting,"National University, Singapore","September 20, 2019",Observational,Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes,Unrelated
2142,COVID DISEASE,"February 08, 2021",240,NCT04417257,LAU-7B,CANADA,Recruiting,Laurent Pharmaceuticals Inc.,"June 29, 2020",Interventional,"RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Pilot Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease",COVID
2143,DIABETES MELLITUS,"February 08, 2021",50,NCT04417270,FREESTYLE LIBRE 14 DAY CGM SYSTEM,UNITED STATES,Recruiting,Northwell Health,"June 12, 2020",Interventional,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,Unrelated
2144,COVID,"February 08, 2021",2014,NCT04417335,BCG VACCINE,NETHERLANDS,"Active, not recruiting",Radboud University,"April 16, 2020",Interventional,"Reducing Hospital Admission of Elderly in SARS-CoV-2 Pandemic Via the Induction of Trained Immunity by Bacillus Calmette-Guérin Vaccination, a Randomized Controlled Trial",COVID
2145,COVID,"February 08, 2021",94,NCT04417374,DESCRIPTION OF GROUPS CARACTERISTICS,FRANCE,Completed,"University Hospital, Montpellier","May 1, 2020",Observational,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context",COVID
2146,ISOLATION,"February 08, 2021",1000,NCT04417673,,UNITED STATES,Not yet recruiting,National Human Genome Research Institute (NHGRI),"February 11, 2021",Observational,A Longitudinal Survey Study on Living With Sickle Cell Disease in the COVID-19 Pandemic,Unrelated
2147,CORONAVIRUS INFECTION,"February 08, 2021",84,NCT04418128,NAFAMOSTAT MESYLATE,,Not yet recruiting,Gyeongsang National University Hospital,"June 10, 2020",Interventional,Treatment Effect of Nafamostat Mesylate in Patients With COVID-19 Pneumonia: Open Labelled Randomized Controlled Clinical Trial,COVID
2148,CORONAVIRUS,"February 08, 2021",100,NCT04418193,,MONACO,Recruiting,Centre Hospitalier Princesse Grace,"April 6, 2020",Observational,"Therapeutic Management in Patients With COVID-19 Infection at Risk of Secondary Aggravation: Patient Preference Trial Comparing Routine Care, Treatment With Hydroxychloroquine or Treatment With Hydroxychloroquine Plus Azithromycin",COVID
2149,COVID,"February 08, 2021",300,NCT04418206,PATIENTS COVID 19,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"June 1, 2020",Interventional,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,COVID
2150,COVID,"February 08, 2021",1000,NCT04418245,IMAGING BY THORACIC SCANNER,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire de Nīmes,"March 1, 2020",Observational,Identification of Thoracic CT Scan Biomarkers by Deep Learning for Evaluating the Prognosis of Patients With COVID-19 Disease,COVID
2151,COVID,"February 08, 2021",400,NCT04418284,SURVEY,EGYPT,Recruiting,South Valley University,"June 5, 2020",Observational,Evaluation of the Online Learning of Veterinary Anatomy During COVID-19 Pandemic,COVID
2152,COVID,"February 08, 2021",4000,NCT04418375,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 8, 2020",Observational,Identification of Markers Associated With the Risk of COVID-19 Infection and Symptomatic COVID+ Versus Asymptomatic COVID+ Status Through the Establishment of a Biological Collection During Serological Screening in APHP Professionals,COVID
2153,COVID,"February 08, 2021",280,NCT04418505,VIELIGHT RX PLUS,CANADA,Recruiting,Vielight Inc.,"September 2, 2020",Interventional,A Randomized Study Evaluating the Efficacy of the Vielight RX Plus in the Treatment of COVID-19 Respiratory Symptoms,COVID
2154,COVID,"February 08, 2021",1200,NCT04418518,CONVALESCENT PLASMA,UNITED STATES,Recruiting,Weill Medical College of Cornell University,"June 24, 2020",Interventional,CONCOR-1: A Randomized Open-Label Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,COVID
2155,"PNEUMONIA, VIRAL","February 08, 2021",10,NCT04418531,ANTI-CORONAVIRUS ANTIBODIES (IMMUNOGLOBULINS) OBTAINED WITH DFPP FORM CONVALESCENT PATIENTS,ITALY,Not yet recruiting,Piero Luigi Ruggenenti,June 2020,Interventional,A Pilot Study to Explore the Efficacy and Safety of Rescue Therapy With Antibodies From Convalescent Patients Obtained With Double-filtration Plasmapheresis (DFPP) and Infused in Patients With Coronavirus Disease 2019 (COVID-19) and Need of Oxygen Support Without Mechanical Ventilation,Respiratory
2156,COVID,"February 08, 2021",400,NCT04418544,DEVICE USED TO RECORD VOICE FOR SCREENING,UNITED STATES,Recruiting,Soniphi LLC,"June 1, 2020",Observational,Testing of Soniphi Vocal Feature Analysis Algorithm for COVID-19,COVID
2157,COVID,"February 08, 2021",200,NCT04418557,RT-PCR AND ANTIBODY TESTING,UNITED STATES,Recruiting,University Hospitals Cleveland Medical Center,"April 28, 2020",Observational [Patient Registry],COVID-19 and Obstetric Transmission,COVID
2158,NEUROLOGIC COMPLICATION,"February 08, 2021",30,NCT04418609,FURTHER PROCESSING OF HEALTH DATA,SWITZERLAND,Recruiting,Emanuela Keller,"May 1, 2020",Observational,Neuro-COVID-19: Neurological Complications of COVID-19,Unrelated
2159,WHOLE BLOOD DONATIONS AND LEUKOREDUCTION,"February 08, 2021",0,NCT04418934,HEMANEXT ONE,UNITED STATES,Withdrawn,Hemanext,"July 1, 2020",Interventional,Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells With CP2D Anticoagulant and AS-3 Additive - Pivotal Trial,Unrelated
2160,COMMUNICATION RESEARCH,"February 08, 2021",11120,NCT04418947,COMMUNICATION TYPE,UNITED STATES,Completed,University of Pennsylvania,"June 15, 2020",Interventional,Comparison of the Effectiveness of Communication Strategies on the Return to In-Person Visits to a Medical Center After the Emergence of COVID-19: A Randomized Trial,Unrelated
2161,COVID,"February 08, 2021",200,NCT04419025,N-ACETYLCYSTEINE,UNITED STATES,Recruiting,Cambridge Health Alliance,"September 23, 2020",Interventional,Determination of Efficacy of N-Acetylcysteine in Preventing Those With Mild or Moderate COVID-19 From Progressing to Severe Disease,COVID
2162,CRITICAL ILLNESS,"February 08, 2021",118,NCT04419064,POINT OF CARE ULTRASOUND,UNITED STATES,Completed,University of Pittsburgh,"January 1, 2019",Observational,Confirmation of Ventilation and Intubation by Determination With Ultrasonography: A Multicenter Observational Study,Unrelated
2163,RADIOLOGY,"February 08, 2021",2500,NCT04419545,NEURAL NETWORK DIAGNOSIS ALGORITHM,ITALY,Recruiting,Azienda Ospedaliera Città della Salute e della Scienza di Torino,"March 24, 2020",Observational,Covid Radiographic Images Data-set for A.I,Unrelated
2164,COVID,"February 08, 2021",94,NCT04419571,EMERGENCY LAPAROTOMY,UNITED KINGDOM,Completed,"Barking, Havering and Redbridge University Hospitals NHS Trust","March 23, 2020",Observational,Emergency Laparotomies and Outcomes During the COVID-19 Pandemic - a Retrospective Cohort Study,COVID
2165,COVID,"February 08, 2021",60,NCT04419610,TRV027,UNITED KINGDOM,Recruiting,Imperial College London,"October 9, 2020",Interventional,Investigating the Relationship Between the Renin Angiotensin System and the Coagulopathy Associated With COVID-19,COVID
2166,COVID,"February 08, 2021",146,NCT04419623,PART 1 - TL-895,UNITED STATES,Recruiting,"Telios Pharma, Inc.","July 9, 2020",Interventional,"A Phase 1/2, Double-Blind, Randomized, Placebo-Controlled Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer",COVID
2167,MITOCHONDRIAL DISEASE,"February 08, 2021",200,NCT04419870,,UNITED STATES,Recruiting,National Human Genome Research Institute (NHGRI),"February 11, 2021",Observational,"Acute Infection in Mitochondrial Disease: An Observational Prospective Natural History Study of Metabolism, Infection and Immunity During the COVID19 Pandemic",Unrelated
2168,COVID,"February 08, 2021",2000,NCT04420182,VIRTUAL CARE AT HOME,CANADA,Recruiting,Lawson Health Research Institute,"August 17, 2020",Interventional,COVID-19 Virtual Care at Home,COVID
2169,COVID,"February 08, 2021",142,NCT04420247,CHLOROQUINE,BRAZIL,Completed,Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva,"April 16, 2020",Interventional,Multicentric Pragmatic Randomized Controled Trial to Evaluate the Efficacy Chloroquine or Hydroxychloroquine for Five Days in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,COVID
2170,COVID,"February 08, 2021",300,NCT04420260,GROUP A: OROPHARYGEAL SPRAY AND IMMUNOSTIMULANT,,Not yet recruiting,Unidad de Investigación Genética Molecular,July 2020,Interventional,"Scheme of Primary Prevention of Infection by COVID-19, in Health Providers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia",COVID
2171,MELANOMA,"February 08, 2021",1000,NCT04420273,SSE EDUCATIONAL INTERVENTION,UNITED STATES,"Active, not recruiting",Northwestern University,"July 2, 2020",Interventional,Targeted Melanoma Detection With Skin Self-examination: Leveraging the Mammogram Encounter,Unrelated
2172,CORONAVIRUS INFECTION,"February 08, 2021",9000,NCT04420286,,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nīmes,"May 6, 2020",Observational,Study of the Increase in ICU Beds Capacity and Caregivers During COVID-19 Pandemic in France : the FRENCH ICU Study,COVID
2173,COVID,"February 08, 2021",120,NCT04420299,BEMIPARIN,SPAIN,Recruiting,Fundación de investigación HM,"June 4, 2020",Interventional,"A Randomized, Single-blind Study With a Parallel Control Group on the Efficacy and Safety of Bemiparin at Therapeutic Dose vs. Prophylactic Dose in Patients Hospitalized for COVID-19",COVID
2174,PULMONARY EMBOLISM,"February 08, 2021",1024,NCT04420312,,FRANCE,Completed,Groupe Hospitalier Paris Saint Joseph,"March 1, 2020",Observational,Incidence and Characteristics of Pulmonary Embolism in COVID-19 Patients Hospitalized for Acute Respiratory Syndrome,Unrelated
2175,CHRONIC HEMODIALYSIS PATIENTS,"February 08, 2021",800,NCT04420338,BLOOD SAMPLE,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"June 5, 2020",Interventional,"SeroCOVIDial Study: Assessment of SARS-COV2 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",Unrelated
2176,COVID,"February 08, 2021",50,NCT04420364,MAINTENANCE OR REDUCTION OF IMMUNOSUPPRESSION,,Not yet recruiting,Brigham and Women's Hospital,"March 1, 2021",Interventional,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,COVID
2177,COVID,"February 08, 2021",41,NCT04420390,RADIOTHERAPY,SPAIN,Recruiting,"Hospital San Carlos, Madrid","May 1, 2020",Interventional,Low Dose Radiotherapy as Antinflammatory Treatment for COVID-19 Pneumonitis,COVID
2178,"DEPRESSION, ANXIETY","February 08, 2021",720,NCT04420416,SURVEY,MEXICO,Recruiting,Instituto Mexicano del Seguro Social,"April 1, 2020",Observational,"dePression, Anxiety, aNd acaDemic pErforMance In Covid-19: PANDEMIC Study.",Unrelated
2179,COVID,"February 08, 2021",20,NCT04420468,,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,June 2020,Observational,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,COVID
2180,COVID,"February 08, 2021",1000,NCT04420637,,AUSTRIA,Enrolling by invitation,Medical University of Graz,"June 15, 2020",Observational,Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases,COVID
2181,COVID,"February 08, 2021",120,NCT04420676,OMNIBIOTIC AAD,AUSTRIA,Recruiting,Medical University of Graz,"September 24, 2020",Interventional,"Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection: A Randomized, Double-blind, Placebo Controlled, Telemedicine Study (SynCov Study)",COVID
2182,COVID,"February 08, 2021",80,NCT04420741,ILOPROST,DENMARK,Recruiting,Pär Johansson,"June 15, 2020",Interventional,Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy,COVID
2183,EXERCISE,"February 08, 2021",21,NCT04420806,HIT-EXERCISE,GERMANY,Completed,University of Erlangen-Nürnberg Medical School,"March 14, 2020",Interventional,Effects of Three Months of COVID-19 Lockdown Induced Deconditioning After 13 Months of High Intensity Exercise Training in Early Postmenopausal Women,Unrelated
2184,COVID,"February 08, 2021",,NCT04420988,COVID-19 CONVALESCENT PLASMA,UNITED STATES,Available,"Rutgers, The State University of New Jersey",,Expanded Access,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients,COVID
2185,COVID,"February 08, 2021",1400,NCT04421027,BARICITINIB,ARGENTINA,Recruiting,Eli Lilly and Company,"June 12, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection",COVID
2186,COVID,"February 08, 2021",500,NCT04421391,QUADRAMUNE(TM),UNITED STATES,Recruiting,Therapeutic Solutions International,"June 8, 2020",Interventional,Phase II Study of QuadraMune(TM) for Prevention of COVID-19 in High Risk Populations,COVID
2187,COVID,"February 08, 2021",50,NCT04421404,COVID-19 CONVALESCENT PLASMA (CCP),UNITED STATES,"Active, not recruiting","Priscilla Hsue, MD","June 9, 2020",Interventional,A Randomized Controlled Adaptive Study Comparing COVID-19 Convalescent Plasma (CCP) to Non-immune Plasma to Limit Coronavirus-associated Complications in Hospitalized Patients,COVID
2188,COVID,"February 08, 2021",500,NCT04421508,INOPULSE,UNITED STATES,"Active, not recruiting",Bellerophon Pulse Technologies,"July 12, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus (COVID-19)",COVID
2189,COVID,"February 08, 2021",150,NCT04421534,LACTOFERRIN,,Not yet recruiting,Cairo University,June 2020,Interventional,Efficacy and Safety of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,COVID
2190,COVID,"February 08, 2021",400,NCT04421612,CO-MESTRING (CO-COPING),NORWAY,Recruiting,Haukeland University Hospital,"April 2, 2020",Interventional,Coping With 2020 - No Health Without Mental Health,COVID
2191,COVID,"February 08, 2021",12000,NCT04421625,DIAGNOSTIC TEST FOR SARS-COV2 FOR PATIENTS AND HEALTH STAFF,FRANCE,Recruiting,Institut Cancerologie de l'Ouest,"June 15, 2020",Interventional,"Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic: Constitution of a Biological Collection Linked to a Prospective, Multicenter Cohort Study",COVID
2192,CORONAVIRUS INFECTION,"February 08, 2021",70,NCT04421664,HYDROXYCHLOROQUINE,CANADA,Terminated,McGill University Health Centre/Research Institute of the McGill University Health Centre,"March 25, 2020",Interventional,Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),COVID
2193,GENERALIZED ANXIETY DISORDER,"February 08, 2021",30,NCT04421690,COGNITIVE TRAINING,UNITED STATES,Recruiting,University of Missouri-Columbia,"June 8, 2020",Interventional,Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA),Unrelated
2194,ANOSMIA,"February 08, 2021",200,NCT04422275,BUDESONIDE,UNITED STATES,Not yet recruiting,Washington University School of Medicine,"June 1, 2021",Interventional,Coronavirus Smell Therapy for Anosmia Recovery,Unrelated
2195,"COVID DISEASE, SEVERE FORM","February 08, 2021",185,NCT04422340,GROUP1,FRANCE,Recruiting,Hospices Civils de Lyon,"April 1, 2020",Observational,A Multicentric Survey on Patients Over 60 Admitted to Intensive Care for Severe Forms of COVID Infection: Search for Prognostic Criteria Associated With Survival,COVID
2196,PARKINSON DISEASE,"February 08, 2021",60,NCT04422353,VIDEO DANCE CLASSES,BRAZIL,Recruiting,Federal University of Rio Grande do Sul,"May 1, 2020",Interventional,The Impact of Video Dance Class and Unsupervised Physical Activity on Parkinson's People During the Covid-19 Pandemic: Interventional,Unrelated
2197,COVID,"February 08, 2021",314,NCT04422379,,INDIA,Not yet recruiting,Max Healthcare Insititute Limited,"June 7, 2020",Observational,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,COVID
2198,CARDIOVASCULAR RISK FACTOR,"February 08, 2021",200,NCT04422418,,UNITED ARAB EMIRATES,Recruiting,Khalifa University for Science and Technology,"July 1, 2020",Observational,Multi-Center Prospective Cohort Study: Impact of Burnout on Cardiovascular and Immune Biomarkers Among Frontline Healthcare Professionals During Covid-19 Pandemic in Abu Dhabi Emirate,Unrelated
2199,COVID,"February 08, 2021",100,NCT04422444,QUESTIONNAIRES,SPAIN,Recruiting,Corporacion Parc Tauli,"June 1, 2020",Observational [Patient Registry],Characterization and Management of Post Intensive Care Syndrome in COVID19 Patients.,COVID
2200,SOLID TUMOR,"February 08, 2021",100,NCT04422457,68GA-DX600 PET/CT,CHINA,Recruiting,Beijing Cancer Hospital,"June 13, 2020",Interventional,Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients,Unrelated
2201,CORONAVIRUS INFECTION AND HEMATOLOGIC DISEASES,"February 08, 2021",200,NCT04422470,NON-INTERVENTIONAL STUDY,RUSSIAN FEDERATION,Recruiting,"National Research Center for Hematology, Russia","June 22, 2020",Observational [Patient Registry],Observational Prospective Cohort Study - Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19),COVID
2202,COVID,"February 08, 2021",80,NCT04422509,LANADELUMAB,NETHERLANDS,Recruiting,Radboud University,"October 3, 2020",Interventional,Lanadelumab for Treatment of COVID-19 Disease,COVID
2203,"FIBROMYALGIA, PRIMARY","February 08, 2021",45,NCT04422522,,EGYPT,"Active, not recruiting",Al-Azhar University,"March 15, 2020",Observational,Prevalence of Fibromyalgia in the Rheumatology Outpatient Clinics in the UAE During the COVID-19 Pandemic: a Cross-sectional Study,Unrelated
2204,CORONAVIRUS INFECTION,"February 08, 2021",80,NCT04422535,,SPAIN,Recruiting,Matilde Zaballos,"May 29, 2020",Observational,Observational Study to Evaluate the Effects on the Qt Interval of COVID-19 Coronavirus Infection in Critically Ill Patients,COVID
2205,COVID,"February 08, 2021",340,NCT04422561,IVERMECTIN TABLETS,EGYPT,Completed,Zagazig University,"May 31, 2020",Interventional,Use of Ivermectin as a Prophylactic Option in Asymptomatic Family Close Contact for Patient With COVID-19,COVID
2206,COVID,"February 08, 2021",97,NCT04422574,,FRANCE,Completed,"University Hospital, Montpellier","May 1, 2020",Observational,COVID 19 Serology in Pulmonologists : Pneumo Sero Cov,COVID
2207,EMERGENCIES,"February 08, 2021",1860,NCT04422587,RECOP UNIT PATIENT,FRANCE,Completed,"University Hospital, Toulouse","March 13, 2020",Observational [Patient Registry],Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,Unrelated
2208,"PNEUMONIA, VIRAL","February 08, 2021",73,NCT04422613,PULMONARY ANOMALIES 4 MONTHS AFTER DOCUMENTED COVID-19 PNEUMONIA,FRANCE,"Active, not recruiting","University Hospital, Toulouse","May 28, 2020",Interventional,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,Respiratory
2209,SARS-CoV2,"February 08, 2021",42,NCT04422626,,,Not yet recruiting,University of Pecs,"July 1, 2020",Observational,Data Collection on the Application of Cytokine Adsorption Therapy on Patients With Acute Respiratory Failure Caused by COVID-19,COVID
2210,COVID,"February 08, 2021",30,NCT04422678,IMATINIB MESYLATE,,Not yet recruiting,Alexandria University,June 2020,Interventional,Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia: A Pilot Study,COVID
2211,COVID,"February 08, 2021",200,NCT04422691,LUNG ULTRASOUND,NORWAY,Recruiting,St. Olavs Hospital,"July 1, 2020",Observational,Bruk av Ultralyd i Evaluering av Pasienter Med Mistenkt COVID-19 Infeksjon i Norge,COVID
2212,SPINAL CORD INJURIES,"February 08, 2021",250,NCT04422769,,UNITED STATES,"Active, not recruiting",Washington University School of Medicine,"May 22, 2020",Observational,Tracking Needs of Persons With a Spinal Cord Injury (SCI) During the COVID-19 Pandemic,Unrelated
2213,END STAGE RENAL DISEASE,"February 08, 2021",40,NCT04422873,,UNITED KINGDOM,Recruiting,University of Portsmouth,"June 3, 2020",Observational,"The Impact of Coronavirus (COVID-19) Restrictions on Wellbeing, Quality of Life and Physical Activity in People With End-stage Renal Disease, Currently Dialysing In-centre Versus at Home in the UK and Their Experience of Telemedicine",Unrelated
2214,SARS-CoV2,"February 08, 2021",900,NCT04422977,SARS-COV-2 SEROLOGY,,Not yet recruiting,Centre Hospitalier Saint Joseph Saint Luc de Lyon,"June 8, 2020",Interventional,Serological Study of the Exposure of Personnel to Sars-cov-2 in an Urban Hospital Two Months After Managing an Influx of COVID Patients 19,COVID
2215,"CHANGE; ENDOSCOPY, COVID","February 08, 2021",10,NCT04423003,ENDOSCOPIC INTERVENTION,GERMANY,Completed,University Hospital Tuebingen,"March 1, 2020",Observational [Patient Registry],"Impact of the COVID-19 Pandemic on an Interdisciplinary Endoscopy Unit in a German ""Hotspot"" Area: a Single Center Experience",COVID
2216,COVID,"February 08, 2021",30,NCT04423042,TOCILIZUMAB,,Not yet recruiting,University of Calgary,"July 30, 2020",Interventional,A Nested Interventional Cohort Study to Assess the Efficacy and Safety of Adjunctive Humanized Monoclonal Interleukin-6 Receptor Blocker Tocilizumab (TCZ) Therapy to Standard of Care for the Reduction of Hyperinflammation Related Mortality in SARS-Cov2 Positive Patients,COVID
2217,FACE-TO-FACE RECONSULTATION TO EMERGENCY ROOM,"February 08, 2021",150,NCT04423289,FARMALARM,SPAIN,Completed,Hospital Universitari Vall d'Hebron Research Institute,"March 31, 2020",Interventional,COVID Follow-App: Telematic Monitoring Through a Mobile Application of Patients With COVID-19: A Randomized Clinical Trial,Unrelated
2218,CORONAVIRUS INFECTION,"February 08, 2021",70,NCT04423315,,TURKEY,Completed,Nisantasi University,"June 8, 2020",Observational,Thrombosis Risk Assessment May Predict Clinical Presentation and Length of Hospital Stay in Covid-19 Pneumonia,COVID
2219,MECHANICAL VENTILATION COMPLICATION,"February 08, 2021",40,NCT04423614,INSPIRATORY MUSCLE TRAINING,UNITED STATES,Not yet recruiting,University of Florida,February 2021,Interventional,Telehealth-Delivered Preoperative Inspiratory Muscle Training: An Innovative Solution to Conserve Scarce ICU Resources,Unrelated
2220,SARS-CoV2,"February 08, 2021",200,NCT04423640,ACTIVE COVID-19 DISEASE,MEXICO,Recruiting,"Coordinación de Investigación en Salud, Mexico","April 15, 2020",Observational,The Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With Coronavirus Disease 2019 (COVID-19),COVID
2221,VIRAL INFECTION,"February 08, 2021",30,NCT04423692,LABS,EGYPT,Recruiting,Aljazeera Hospital,"June 1, 2020",Observational,Knowledge About Covid-19 Infection in Pregnant Women,Unrelated
2222,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",4000,NCT04423770,NO INTERVENTION,UNITED STATES,"Active, not recruiting",American Dental Association,"June 8, 2020",Observational,COVID-19 Related Health and Infection Control Practices Among Dentists,COVID
2223,COVID,"February 08, 2021",380,NCT04423861,NITAZOXANIDE,,Not yet recruiting,Azidus Brasil,December 2020,Interventional,"A Phase III, Multicentre, Parallel, Randomized, Double-blind Clinical Trial to Assess the Efficacy and Safety of Nitazoxanide 600 mg Compared to Placebo in the Treatment of Hospitalized Patients With COVID-19 in Non-critical Condition",COVID
2224,COVID,"February 08, 2021",1826,NCT04423978,,ITALY,Completed,Azienda Unità Sanitaria Locale Reggio Emilia,"May 4, 2020",Observational,Implications of Covid-19 on the Lifestyle Changes and Supports Used (ICOLS): a Survey in the Province of Reggio Emilia,COVID
2225,COVID,"February 08, 2021",290,NCT04423991,COVIAGE,UNITED STATES,Completed,Dascena,"March 10, 2020",Interventional,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning: the IDENTIFY Trial,COVID
2226,COVID,"February 08, 2021",500,NCT04424004,COVID-19 PCR AND SEROLOGY TESTING,UNITED STATES,"Active, not recruiting",Duke University,"June 9, 2020",Observational,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,COVID
2227,COVID,"February 08, 2021",726,NCT04424017,SPECIFIC ANTI-SARS-COV-2 ANTIBODIES,EGYPT,Recruiting,Egyptian Center for Research and Regenerative Medicine,"June 7, 2020",Observational,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers,COVID
2228,COVID,"February 08, 2021",216,NCT04424056,ANAKINRA +/- RUXOLITINIB (STAGES 2B/3),FRANCE,Not yet recruiting,Assistance Publique Hopitaux De Marseille,"September 1, 2020",Interventional,"An Open Randomized Therapeutic Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",COVID
2229,CORONAVIRUS,"February 08, 2021",40,NCT04424082,REMOVAL OF DEAD SPACE FILTER,SWEDEN,Recruiting,Karolinska Institutet,"June 9, 2020",Interventional,Influence of External Dead Space on Volumetric Capnography Derived Parameters in Mechanically Ventilated COVID-19 Patients,COVID
2230,COVID,"February 08, 2021",80,NCT04424134,BROMHEXINE AND SPIRONOLACTONE,RUSSIAN FEDERATION,Recruiting,Lomonosov Moscow State University Medical Research and Educational Center,"May 16, 2020",Interventional,Open Label Randomized Clinical Trial BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization,COVID
2231,DEPRESSION AND QUALITY OF LIFE RELATED TO THE CORONAVIRUS PANDEMIC,"February 08, 2021",120,NCT04424212,INTERVENTION GROUP CORONACOPE,SWEDEN,Recruiting,Linkoeping University,"June 10, 2020",Interventional,CoronaCope - Internet-based Cognitive Behavioural Therapy for Adults Suffering From Mental Health Problems Related to the Coronavirus Pandemic,COVID
2232,CORONAVIRUS INFECTION,"February 08, 2021",115,NCT04424355,CHEST MRI,RUSSIAN FEDERATION,Recruiting,Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department,"May 19, 2020",Observational,Possibilities of Chest Magnetic Resonance Imaging (MRI) in Diagnostics of COVID-19. The Use of MRI to Assess Lung Damage in Patients With Coronavirus Infection,COVID
2233,COVID,"February 08, 2021",5000,NCT04424446,,UNITED STATES,Recruiting,National Institutes of Health Clinical Center (CC),"July 13, 2020",Observational,Evaluation of Saliva as Source of Detection for SARS-CoV-2,COVID
2234,COVID,"February 08, 2021",800,NCT04424771,MASLACH BURNOUT INVENTORY (MBI),ITALY,Completed,Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia,"March 1, 2020",Observational,PTSD in Health Workers During COVID-19 Pandemia,COVID
2235,COVID,"February 08, 2021",100,NCT04424797,PRONE POSITIONING,UNITED STATES,Recruiting,Poudre Valley Health System,"July 13, 2020",Interventional,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,COVID
2236,CORONAVIRUS INFECTION,"February 08, 2021",43,NCT04424836,HIGH FLOW NASAL CANNULA DEVICE,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"May 15, 2020",Observational,the Effect of HFNC Treatment on Mortality and Length of ICU Stay in Patient With COVID-19 Pneumonia,COVID
2237,COVID,"February 08, 2021",40,NCT04424849,CT-SCAN,TURKEY,Recruiting,Tepecik Training and Research Hospital,"March 15, 2020",Observational,Initial Thoracic CT Findings and Mechanical Ventilation Requirement in Patients Admitted to Intensive Care Unit With COVID-19,COVID
2238,COVID PNEUMONIA,"February 08, 2021",100,NCT04424901,DIPYRIDAMOLE,UNITED STATES,Recruiting,UConn Health,"May 3, 2020",Interventional,"A Randomized, Open-label Study of the Vascular and Microbiologic Efficacy of Dipyridamole Plus Standard Care vs. Standard Care in Hospitalized COVID19 Patients",COVID
2239,COVID,"February 08, 2021",800,NCT04424940,,"CONGO, THE DEMOCRATIC REPUBLIC OF THE",Not yet recruiting,University of Kinshasa,"September 1, 2020",Observational [Patient Registry],TOMEKA® Project Was Sponsored by the University of Kinshasa: it's an Observational Study by Its Reviewed Documentation,COVID
2240,CORONAVIRUS INFECTION,"February 08, 2021",28,NCT04424953,MCGRATH VIDEOLARYNGOSCOPE,SINGAPORE,"Active, not recruiting",Singapore General Hospital,"June 1, 2020",Interventional,A Randomised Controlled Trial to Compare McGrath Videolaryngoscope Against Direct Laryngoscope for Endotracheal Intubation When Powered Air Purifying Respirator is Worn During the Current Coronavirus Disease 2019 Pandemic,COVID
2241,SARS-CoV2,"February 08, 2021",1433,NCT04424992,OBSERVATIONAL COHORT STUDY ON THE NATURAL HISTORY OF HOSPITALIZED SARS-COV-2 PATIENTS.,ITALY,Recruiting,University of Milano Bicocca,"February 28, 2020",Observational,Observational Cohort Study on the Natural History of Hospitalized SARS-COV-2 Patients: the STORM Trial,COVID
2242,BARIATRIC SURGERY,"February 08, 2021",55,NCT04425005,HOME-BASED EXERCISE,BRAZIL,Completed,University of Sao Paulo,"May 10, 2020",Interventional,Effect of Home-based Exercise Training Program During the Covid-19 Pandemic in Post-bariatric Patients: A Randomized Controlled Trial,Unrelated
2243,HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",780,NCT04425031,OXYGEN,DENMARK,Recruiting,Aalborg University Hospital,"August 25, 2020",Interventional,Handling Oxygenation Targets in COVID-19 Patients With Acute Hypoxaemic Respiratory Failure in the Intensive Care Unit: A Randomised Clinical Trial of a Lower Versus a Higher Oxygenation Target,Respiratory
2244,COVID,"February 08, 2021",1000,NCT04425044,OTHER,INDIA,Completed,Aarogyam UK,"April 12, 2020",Observational,Efficacy of AiM Covid Self Monitoring in Detecting Infection of COVID-19,COVID
2245,COVID,"February 08, 2021",250,NCT04425213,,FRANCE,Completed,"Central Hospital, Nancy, France","May 12, 2020",Observational,"Obesity as a Risk Factor for Mortality of Critically Ill Patients With Coronavirus Disease 2019 (COVID-19): a Cohort Study of the First Wave in Nancy, France",COVID
2246,COVID,"February 08, 2021",23,NCT04425252,BREQUINAR,UNITED STATES,Completed,"Clear Creek Bio, Inc.","August 1, 2020",Interventional,The CRISIS Study: A Randomized Open-label Study Assessing the Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Hospitalized Adults With Coronavirus-19 (COVID-19),COVID
2247,INFERTILITY,"February 08, 2021",20,NCT04425317,BLOOD SAMPLE,BELGIUM,Recruiting,CRG UZ Brussel,"June 24, 2020",Interventional,Detection of SARS-CoV-2 in Follicular Fluid and Cumu-lus-oocyte-complexes From COVID-19 Patients During Controlled Ovarian Stimulation for ICSI Treatment,Unrelated
2248,CORONAVIRUS,"February 08, 2021",200,NCT04425382,DARUNAVIR/COBICISTAT,QATAR,Recruiting,Hamad Medical Corporation,"March 1, 2020",Observational,Efficacy and Safety of Darunavir/Cobicistat vs. Lopinavir/Ritonavir in the Management of Patients With COVID-19 Pneumonia in Qatar,COVID
2249,COVID,"February 08, 2021",256,NCT04425460,FAVIPIRAVIR,CHINA,Not yet recruiting,Zhejiang Hisun Pharmaceutical Co. Ltd.,June 2020,Interventional,"A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Adult Patients With COVID-19-Moderate Type",COVID
2250,ADVANCED SUTURING SKILLS,"February 08, 2021",60,NCT04425499,LEARNING RUNNING SUBCUTICULAR SUTURES ON THE GAMIFIED EDUCATIONAL NETWORK,,Not yet recruiting,Université de Montréal,June 2020,Interventional,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,Unrelated
2251,COVID,"February 08, 2021",17,NCT04425538,INFLIXIMAB,UNITED STATES,"Active, not recruiting",Tufts Medical Center,"June 1, 2020",Interventional,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,COVID
2252,CANCER,"February 08, 2021",1100,NCT04425616,EXERCISE,UNITED KINGDOM,Recruiting,University Hospital Southampton NHS Foundation Trust,"June 4, 2020",Interventional,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions to Maintain and Improve Mental and Physical Health in People With Cancer Who Are Following Social Distancing Guidance: A COVID-19 Targeted Trial,Unrelated
2253,COVID,"February 08, 2021",6420,NCT04425629,REGN10933+REGN10987 COMBINATION THERAPY,ROMANIA,Recruiting,Regeneron Pharmaceuticals,"June 16, 2020",Interventional,"A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients With COVID-19",COVID
2254,COVID,"February 08, 2021",100,NCT04425707,IVERMECTIN,EGYPT,Recruiting,"Ministry of Health and Population, Egypt","June 9, 2020",Interventional,The Use of Ivermectin In the Treatment of COVID 19 Patients,COVID
2255,COVID,"February 08, 2021",300,NCT04425720,LIFESIGNALS BIOSENSOR 1AX*,UNITED STATES,Recruiting,Montefiore Medical Center,"September 1, 2020",Interventional,Use of Remote Patient Monitoring (RPM) Platform for COVID-19 Patient,COVID
2256,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",0,NCT04425733,MK-5475,,Withdrawn,Merck Sharp & Dohme Corp.,"July 7, 2020",Interventional,"A Study to Assess the Safety, Tolerability, and Pharmacodynamics of Multiple Dose MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia",COVID
2257,COVID,"February 08, 2021",2400,NCT04425759,BLOOD SAMPLE,SPAIN,Recruiting,Hospital de Mataró,"June 8, 2020",Observational [Patient Registry],"Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses and Assymptomatic Carriers Among a Cohort of 2,300 Healthcare Workers at the Consorci Sanitari Del Maresme (CSdM)",COVID
2258,COVID,"February 08, 2021",342,NCT04425772,FNC+STANDARD OF CARE,,Not yet recruiting,"HeNan Sincere Biotech Co., Ltd","June 12, 2020",Interventional,"A Randomized,Double Blinded, Double Dummy, Parallel Controlled Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）",COVID
2259,SARS-CoV2,"February 08, 2021",236,NCT04425837,SARS-COV-2 CONVALESCENT PLASMA TREATMENT,COLOMBIA,Not yet recruiting,Fundación Santa Fe de Bogota,July 2020,Interventional,"Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19: A Randomized, Controlled Study CRI-CP (Coronavirus Investigation - Convalescent Plasma)",COVID
2260,COVID,"February 08, 2021",229,NCT04425850,IOTA CARRAGEENAN NASAL SPRAY AND IVERMECTIN ORAL DROPS (USED AS BUCCAL DROPS),ARGENTINA,Completed,Eurnekian Public Hospital,"June 1, 2020",Observational,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid Among Healthy People and Health Personnel,COVID
2261,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",167,NCT04425863,"IVERMECTIN 5 MG/ML ORAL SOLUTION, ASPIRIN 250 MG TABLETS",ARGENTINA,Completed,Eurnekian Public Hospital,"May 1, 2020",Observational,"Evaluation of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of covid19",Respiratory
2262,COVID,"February 08, 2021",156,NCT04425889,"COVID-19 IGG/IGM RAPID TEST CASSETTE TEST (HEALGEN SCIENTIFIC, HOUSTON, TEXAS, USA)",MEXICO,Completed,Hospital Universitario Dr. Jose E. Gonzalez,"May 5, 2020",Observational,Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers in a COVID-19 Unit,COVID
2263,COVID,"February 08, 2021",400,NCT04425915,CONVALESCENT PLASMA,INDIA,Recruiting,"Institute of Liver and Biliary Sciences, India","June 14, 2020",Interventional,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19: A Randomized Control Trial,COVID
2264,SARS-CoV2,"February 08, 2021",550,NCT04426006,PRO-SERO-COV,FRANCE,"Active, not recruiting",Institut Bergonié,"June 1, 2020",Interventional,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic - PRO-SERO-COV,COVID
2265,BRAIN INJURIES,"February 08, 2021",142,NCT04426071,,CANADA,Not yet recruiting,Lawson Health Research Institute,June 2020,Observational,COVID-19 and Disability: The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,Unrelated
2266,COVID,"February 08, 2021",22784,NCT04426084,HYPERTENSION,SWEDEN,"Active, not recruiting",Karolinska Institutet,"March 1, 2020",Observational [Patient Registry],"Cardiovascular Disease, Cardiovascular Risk Factors, Treatments and Severe COVID-19 Outcomes. A Nationwide Registry-based Case-Control Study",COVID
2267,COVID,"February 08, 2021",48,NCT04426201,CYT107,,Not yet recruiting,Revimmune,"December 20, 2020",Interventional,"A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Oncology Cohort",COVID
2268,COVID,"February 08, 2021",1000,NCT04426253,,HUNGARY,"Active, not recruiting",Szeged University,"June 5, 2020",Observational,"Identification of Genetic Factors Determining Disease Course and Preparation of Pharmacogenetic Applications in the New Type of Coronavirus Infection, COVID-19",COVID
2269,QUESTIONNAIRE DESIGNS,"February 08, 2021",441,NCT04426266,,HUNGARY,Completed,Szeged University,"May 1, 2020",Observational,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,Unrelated
2270,SARS-CoV2,"February 08, 2021",1500,NCT04426279,QUESTIONNAIRE ASSESMENT,FRANCE,Recruiting,"University Hospital, Lille","August 18, 2020",Observational,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,COVID
2271,SARS-CoV2,"February 08, 2021",3500,NCT04426292,SEROLOGICAL TESTING,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"May 12, 2020",Interventional,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,COVID
2272,COVID,"February 08, 2021",140,NCT04426305,COMMUNITY HEALTH WORKER SUPPORT,BELGIUM,Enrolling by invitation,University Ghent,"May 21, 2020",Interventional,Community Health Workers Against COVID19 Tackling Psychosocial Suffering Due to Physical Distancing,COVID
2273,ANXIETY,"February 08, 2021",733,NCT04426318,HEALTHY MINDS PROGRAM FOUNDATIONS TRAINING,UNITED STATES,Completed,"University of Wisconsin, Madison","June 14, 2020",Interventional,COVID-19 and the Healthy Minds Program for Educators,Unrelated
2274,COVID,"February 08, 2021",0,NCT04426344,ENSOETM DEVICE,UNITED STATES,Withdrawn,Washington University School of Medicine,October 2020,Interventional,"Core Warming of COVID-19 Patients Undergoing Mechanical Ventilation: a Randomized, Single Center Pilot Study",COVID
2275,COVID,"February 08, 2021",6900,NCT04426695,REGN10933+REGN10987 COMBINATION THERAPY,BRAZIL,Recruiting,Regeneron Pharmaceuticals,"June 11, 2020",Interventional,"A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients With COVID-19",COVID
2276,COVID,"February 08, 2021",300,NCT04427098,ENOXAPARIN 40 MG/0.4 ML INJECTABLE SOLUTION,ITALY,Recruiting,Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi,"May 22, 2020",Interventional,"Intermediate Dose Enoxaparin in Hospitalized Patients With Moderate-severe COVID19: A Pilot Phase II Single-arm Study, INHIXACOVID19",COVID
2277,BIPOLAR DEPRESSION,"February 08, 2021",50,NCT04427137,"MAGPRO X100 STIMULATOR, B70 FLUID-COOLED COIL",CANADA,Recruiting,Centre for Addiction and Mental Health,"June 9, 2020",Interventional,A Novel and Practical Accelerated Low-frequency Right-sided Stimulation Protocol as a Substitute for Patients With Bipolar Depression Needing Electroconvulsive Therapy During the COVID-19 Pandemic,Unrelated
2278,NURSE,"February 08, 2021",15,NCT04427176,ARFC MASK,FRANCE,Completed,Centre Hospitalier Universitaire de Saint Etienne,"April 29, 2020",Observational,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,Unrelated
2279,COVID,"February 08, 2021",500,NCT04427254,"CEREBROSPINAL FLUID SAMPLING, MENINGEAL AND BRAIN PARENCHYMA BIOPSIES",FRANCE,Not yet recruiting,Fondation Ophtalmologique Adolphe de Rothschild,January 2021,Interventional,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,COVID
2280,THERMAL CONDITION OF HEALTH WORKERS WHO USE PERSONAL PROTECTIVE EQUIPMENT FROM BIOLOGICAL HAZARDS DURING THEIR WORK WITH COVID PATIENTS,"February 08, 2021",6,NCT04427267,PERSONAL PROTECTIVE EQUIPMENT FROM BIOLOGICAL HAZARD,RUSSIAN FEDERATION,Completed,"Federal State Budgetary Scientific Institution ""Izmerov Research Institute of Occupational Health""","June 3, 2020",Observational,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment for Biological Factors During Their Work With COVID-19 Patients,COVID
2281,INFECTIOUS DISEASE,"February 08, 2021",60,NCT04427280,,UNITED KINGDOM,Recruiting,Royal Marsden NHS Foundation Trust,"May 26, 2020",Observational,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),Unrelated
2282,COVID,"February 08, 2021",376,NCT04427332,INVESTIGATION OF SMELL AND TASTE DISORDERS,ITALY,Completed,University of Milano Bicocca,"June 11, 2020",Observational,Smell and Taste Disorders in COVID-19 Patients: Prospective Observational Study,COVID
2283,COVID,"February 08, 2021",1000,NCT04427345,PREDICTIVE FACTORS FOR CLINICAL RESPONSE IN PATIENTS WITH COVID-19.,ITALY,Recruiting,University of Milano Bicocca,"April 30, 2020",Observational,Predictive Clinical Response Factors in COVID-19 Patients,COVID
2284,COVID,"February 08, 2021",100,NCT04427358,,FRANCE,Completed,"University Hospital, Strasbourg, France","May 7, 2020",Observational,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,COVID
2285,COVID,"February 08, 2021",3300,NCT04427501,LY3819253,PUERTO RICO,Recruiting,Eli Lilly and Company,"November 17, 2019",Interventional,"A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness",COVID
2286,COVID,"February 08, 2021",24,NCT04427566,RADIATION THERAPY,UNITED STATES,Recruiting,Ohio State University Comprehensive Cancer Center,"July 23, 2020",Interventional,Vented COVID: A Phase II Study Of The Use Of Ultra Low-Dose Bilateral Whole Lung Radiation Therapy in the Treatment Of Critically Ill Patients With COVID-19 Respiratory Compromise,COVID
2287,HEARING IMPAIRED CHILDREN,"February 08, 2021",20,NCT04427631,BONE CONDUCTION HEADPHONES,UNITED KINGDOM,Not yet recruiting,Cambridgeshire Community Services NHS Trust,"June 22, 2020",Interventional,Exploring Interventions for Children With Chronic Otitis Media With Effusion ('Glue Ear') When Services Are Reduced During Covid-19,Unrelated
2288,STEMI,"February 08, 2021",200,NCT04427735,,CHINA,Recruiting,Beijing Friendship Hospital,"January 24, 2019",Observational,Effect of Covid-19 Epidemic on Primary PCI and Prognosis in Patients With Acute STEMI,Unrelated
2289,SEXUAL BEHAVIOR,"February 08, 2021",400,NCT04427813,QUESTIONAIRE TO HUSBAND AND WIFE,EGYPT,Not yet recruiting,Aljazeera Hospital,"June 11, 2020",Observational,Sexual and Marital Health and Problems During the Covid -19 in the Last Months,Unrelated
2290,COVID,"February 08, 2021",200,NCT04427865,PROPHYLACTIC LACTOFERRIN DAILY,,Not yet recruiting,Cairo University,July 2020,Interventional,Efficacy of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,COVID
2291,COVID PATIENTS,"February 08, 2021",5,NCT04427878,BIOPSIES OF SUBCUTANEOUS ADIPOSE TISSUE,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Nice,"July 1, 2020",Interventional,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread?,COVID
2292,COVID,"February 08, 2021",240,NCT04428008,THYMALFASIN,UNITED STATES,Recruiting,Inova Health System,"January 12, 2021",Interventional,A Pilot Trial of Thymalfasin (Ta1) to Prevent COVID-19 Infection in Renal Dialysis Patients,COVID
2293,COVID,"February 08, 2021",180,NCT04428021,STANDARD THERAPY PROTOCOL (STP),ITALY,Recruiting,Azienda Ospedaliera Città della Salute e della Scienza di Torino,"June 15, 2020",Interventional,"Effectiveness of Adding Standard Plasma or COVID-19 Convalescent Plasma to Standard Treatment, Versus Standard Treatment Alone, in Patients With Recent Onset of COVID-19 Respiratory Failure. A Randomized, Three-arms, Phase 2 Trial",COVID
2294,COVID,"February 08, 2021",32,NCT04428073,COVAX-19™,,Not yet recruiting,GeneCure Biotechnologies,July 2020,Interventional,A Phase I Trial of a Therapeutic Vaccine (Covax-19™) in SARS-CoV-2 Infected Patients,COVID
2295,"DEPRESSIVE DISORDER, TREATMENT-RESISTANT","February 08, 2021",186,NCT04428099,LIFESTYLE CHANGE PROMOTION PROGRAM,SPAIN,Recruiting,University of the Balearic Islands,"January 13, 2020",Interventional,Effectiveness of a Healthy Lifestyle Promotion Program as Adjunctive Teletherapy for Treatment-resistant Major Depression During Covid 19 Pandemic: A Randomized Clinical Trial Protocol,Unrelated
2296,COVID PNEUMONIA,"February 08, 2021",20,NCT04428268,CHLOROQUINE PHOSPHATE TABLETS,MEXICO,Recruiting,Hospital Universitario Dr. Jose E. Gonzalez,"March 10, 2020",Interventional,"Phase II, Randomized, Double-blind, Controlled Clinical Trial Evaluating the Efficacy and Safety of Chloroquine + Low Dose Losartan Compared to Chloroquine Monotherapy in Subjects With SARS-CoV-2 Pneumonia",COVID
2297,COVID,"February 08, 2021",200,NCT04428801,AUTOLOGOUS ADIPOSE-DERIVED STEM CELLS,,Not yet recruiting,Celltex Therapeutics Corporation,"January 10, 2021",Interventional,Clinical Study for the Prophylactic Efficacy of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) Against Coronavirus 2019 (COVID-19),COVID
2298,HIV INFECTIONS,"February 08, 2021",3200,NCT04429061,SKILLZ-GIRL ENHANCED FOOTBALL CURRICULUM,ZAMBIA,Recruiting,University of Alabama at Birmingham,"March 1, 2020",Interventional,Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ,Unrelated
2299,COVID,"February 08, 2021",60,NCT04429334,NANGIBOTIDE,FRANCE,Not yet recruiting,Inotrem,August 2020,Interventional,"Exploratory Study of the Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation A Randomized, Double-blind, Placebo-controlled Study With Adaptive Features",COVID
2300,INTRACRANIAL HYPERTENSION,"February 08, 2021",50,NCT04429477,CEREBRAL COMPLIANCE AND HEMODYNAMICS MONITORING,BRAZIL,Completed,University of Sao Paulo,"May 1, 2020",Observational [Patient Registry],Assessment of Cerebral Compliance and Hemodynamics in Severe COVID-19,Unrelated
2301,CORONAVIRUS DISEASE-2019 (COVID),"February 08, 2021",32,NCT04429529,TY027,SINGAPORE,"Active, not recruiting",Tychan Pte Ltd.,"June 9, 2020",Interventional,"Phase 1 First-in-Human, Time Lagged, Randomised, Placebo Controlled, Double Blind, Single Ascending Dose Study of TY027 in Healthy Adult Volunteers",COVID
2302,"PNEUMONIA, VIRAL","February 08, 2021",40,NCT04429555,IBUDILAST,UNITED STATES,Recruiting,MediciNova,"January 11, 2021",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, Tolerability, Biomarkers and Pharmacokinetics of Ibudilast (MN-166) in COVID-19 Subjects at Risk for Developing Acute Respiratory Distress Syndrome",Respiratory
2303,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04429594,BLOOD SAMPLING,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"July 28, 2020",Interventional,Study of the Incidence of SARS-CoV-2 Infection in the Alpes-Maritimes Department by Analysis of the Specific Humoral and Cellular Response During Deconfinement,COVID
2304,SARS-CoV2,"February 08, 2021",100,NCT04429620,IMMUNFLUORESCENCE,HUNGARY,Recruiting,Szeged University,"May 30, 2020",Observational,Prospective Assay for SARS-CoV-2 Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,COVID
2305,COVID,"February 08, 2021",100,NCT04429711,IVERMECTIN ORAL PRODUCT,ISRAEL,Recruiting,Sheba Medical Center,"May 12, 2020",Interventional,"Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection and to Decrease Viral Shedding - A Double Blind , Randomized Controlled Trial",COVID
2306,COVID,"February 08, 2021",2129,NCT04429724,DIAGNOSTIC TEST COVID-19,FRANCE,"Active, not recruiting",Tourcoing Hospital,"July 6, 2020",Interventional,Health Professional Exposure Assessment to Covid-19,COVID
2307,COVID,"February 08, 2021",30,NCT04429763,UMBILICAL CORD DERIVED MESENCHYMAL STEM CELLS,,Not yet recruiting,Trustem,July 2020,Interventional,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19,COVID
2308,SMOKING BEHAVIORS,"February 08, 2021",489,NCT04429815,SEROLOGICAL TEST FOR COVID-19.,,Not yet recruiting,"Central Hospital, Nancy, France","July 1, 2020",Observational,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,Unrelated
2309,PSYCHOLOGICAL WELLBEING,"February 08, 2021",45,NCT04429828,COVID-19 E-PACKAGE: PSYCHOLOGICAL WELLBEING FOR HEALTHCARE WORKERS,,Not yet recruiting,University of Nottingham,"June 13, 2020",Interventional,PoWerS Study: Psychological Wellbeing for Healthcare Students: Evaluation of a COVID-19 Digital Learning Package,Unrelated
2310,COVID,"February 08, 2021",483,NCT04429854,CONVALESCENT PLASMA,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"May 2, 2020",Interventional,"A Randomized, Open-label, Adaptive, Proof-of-concept Clinical Trial of Donated Antibodies Working Against With COVID-19: DAWN-PLASMA",COVID
2311,COVID,"February 08, 2021",700,NCT04429867,HYDROXYCHLOROQUINE,UNITED STATES,"Active, not recruiting",WellStar Health System,"May 7, 2020",Interventional,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,COVID
2312,COVID,"February 08, 2021",480,NCT04430049,COVID ICU CONTAINMENT MEASURES,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 22, 2020",Observational,"Impact of the Restrictive Visiting Policy During the Covid-19 Pandemic on Anxiety, Depression and Post-traumatic Stress Disorder for Relatives of ICU Patients",COVID
2313,GENERAL SURGERY,"February 08, 2021",14,NCT04430062,SURGICAL PROCEDURES PERFORMED UNDER GENERAL ANESTHESIA,ITALY,Completed,Azienda Socio Sanitaria Territoriale di Lodi,"May 1, 2020",Observational,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital,Unrelated
2314,COLORECTAL CANCER,"February 08, 2021",602,NCT04430231,WAIT LIST TIME,,Completed,Fundación para la Investigación del Hospital Clínico de Valencia,"January 1, 2012",Observational,Does Delaying Curative Surgery for Colorectal Cancer Influence Long-term Disease Free Survival.: A COHORT STUDY,Unrelated
2315,COVID,"February 08, 2021",330,NCT04430322,,FRANCE,Recruiting,Centre Hospitalier Régional Metz-Thionville,"March 1, 2020",Observational,Coronavirus Disease 2019 (Covid-19) at the Regional Hospital Center Metz-Thionville: a Descriptive Study,COVID
2316,CARDIOVASCULAR DISEASES,"February 08, 2021",100,NCT04430374,NO INTERVERNTION,QATAR,Recruiting,Hamad Medical Corporation,"June 2, 2020",Observational [Patient Registry],Qatar Cardiovascular COVID-19 Registry,Unrelated
2317,DENTAL PLAQUE,"February 08, 2021",180,NCT04430387,THE SALIVA EJECTOR,UNITED STATES,Not yet recruiting,"The University of Texas Health Science Center, Houston","November 1, 2021",Interventional,Evaluation of Impact on Environmental Spatter Using Different Isolation Methods During Hygiene Appointment Among Pediatric Patients,Unrelated
2318,DIABETES,"February 08, 2021",72,NCT04430608,DEXCOM G6,DENMARK,Recruiting,Nordsjaellands Hospital,"May 25, 2020",Interventional,Remote Glucose Monitoring of Patients With Diabetes Quarantined During the COVID-19 Pandemic - a Hospital-Based Randomized Controlled Trial of the Effect of Remote Continuous Glucose Monitoring Compared to Usual Glucose Monitoring,Unrelated
2319,BLOOD DONATION,"February 08, 2021",403535,NCT04431180,BLOOD DONATION SMS,CHINA,Enrolling by invitation,Guangzhou Blood Center,"June 13, 2020",Interventional,Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19#Second Repeat Trial#,Unrelated
2320,FEEDING AND EATING DISORDERS,"February 08, 2021",37,NCT04431284,QUESTIONNAIRES,FRANCE,Completed,Hospices Civils de Lyon,"June 16, 2020",Observational,Impact of COVID-19 Lockdown on Severely Obese Patients With or Without Binge Eating Behaviors,Unrelated
2321,CHRONIC STRESS,"February 08, 2021",30,NCT04431297,MINDFULNESS ROUNDS,UNITED STATES,Not yet recruiting,Icahn School of Medicine at Mount Sinai,January 2021,Interventional,The Impact of Virtual Mindfulness Education Sessions on Staff Perceived Stress During COVID-19,Unrelated
2322,COVID,"February 08, 2021",300,NCT04431310,SERIAL SEROCONVERSION MEASUREMENTS IN HOSPITAL EMPLOYEES DURING THE COVID-19 PANDEMIC,DENMARK,Recruiting,Nordsjaellands Hospital,"March 27, 2020",Observational,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,COVID
2323,MULTIPLE SCLEROSIS,"February 08, 2021",60,NCT04431323,ESPRIMO,ITALY,Recruiting,Azienda Ospedaliera Universitaria Integrata Verona,"May 13, 2020",Interventional,ESPRIMO: A Bio-psycho-social Co-created Intervention for Young Adults With Multiple Sclerosis: Study Protocol for a Feasibility Study,Unrelated
2324,SARS-CoV2,"February 08, 2021",800,NCT04431414,SAMPLE COLLECTION,ARGENTINA,Recruiting,COVID-19 Prevention Network,"July 20, 2020",Observational,A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection,COVID
2325,COVID,"February 08, 2021",52,NCT04431453,REMDESIVIR,ITALY,Recruiting,Gilead Sciences,"July 21, 2020",Interventional,"A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With COVID-19",COVID
2326,CORONAVIRUS INFECTION,"February 08, 2021",64,NCT04431466,IVERMECTIN,BRAZIL,Recruiting,Universidade Federal de Sao Carlos,"July 1, 2020",Interventional,Phase 2 Clinical Trial to Compare the Efficacy and Safety of Different Doses of Ivermectin in Patients Diagnosed With the New Coronavirus Infection (SARS-CoV-2),COVID
2327,ANXIETY,"February 08, 2021",80,NCT04431856,UNIFIED PROTOCOL FOR COVID-19 PARENTING STRESS (UP-COVID),UNITED STATES,Completed,University of Miami,"May 15, 2020",Interventional,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Unrelated
2328,PREGNANCY RELATED,"February 08, 2021",200,NCT04431869,,UNITED STATES,Recruiting,"University of Colorado, Denver","August 18, 2020",Observational [Patient Registry],In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers,Unrelated
2329,COVID,"February 08, 2021",250,NCT04431908,OLFACTORY DEVICE,UNITED STATES,Recruiting,Yale University,"June 15, 2020",Observational,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects,COVID
2330,ADULT,"February 08, 2021",50000,NCT04432038,,POLAND,Recruiting,Gdansk University of Physical Education and Sport,"June 19, 2020",Observational,Healthy Lifestyle or Pro-health Obsession During the Pandemic - a Multinational Study,Unrelated
2331,ULTRASONOGRAPHY,"February 08, 2021",100,NCT04432051,MECHANICAL VENTILATOR SETTINGS AND POSITION,TURKEY,Recruiting,Gaziosmanpasa Taksim Research and Education Hospital,"May 26, 2020",Interventional,The Significance of Lung Ultrasonography in the Follow-up and Treatment of COVID-19 Patients With Respiratory Failure,Unrelated
2332,COVID,"February 08, 2021",36,NCT04432103,ANTI SARS-COV 2 CONVALESCENT PLASMA IN SEVERE COVID-19 PATIENTS,,Not yet recruiting,Centro Medico ABC,"June 19, 2020",Interventional,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,COVID
2333,COVID,"February 08, 2021",500,NCT04432272,COVID-19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",William Beaumont Hospitals,"July 16, 2020",Interventional,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),COVID
2334,COVID,"February 08, 2021",130,NCT04432298,PAMREVLUMAB,UNITED STATES,Recruiting,FibroGen,"June 20, 2020",Interventional,"Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Efficacy and Safety of Intravenous Pamrevlumab, a Monoclonal Antibody Against Connective Tissue Growth Factor (CTGF), in Hospitalized Patients With Acute COVID-19 Disease",COVID
2335,COVID,"February 08, 2021",100,NCT04432324,INTRAVENOUS IMMUNE GLOBULIN,SPAIN,Recruiting,"Instituto Grifols, S.A.","June 2, 2020",Interventional,"A Multicenter, Randomized, Open-label Parallel Group Pilot Study to Evaluate Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Hospitalized Subjects With COVID-19",COVID
2336,COVID,"February 08, 2021",50000,NCT04432350,,,Not yet recruiting,Tabula Rasa HealthCare,"June 15, 2020",Observational,Assessment of Mortality Rates in SARS-CoV-2 Infected Populations Treated With Repurposed Medications,COVID
2337,COVID,"February 08, 2021",174,NCT04432766,BAT2020,UNITED STATES,Not yet recruiting,Bio-Thera Solutions,"October 20, 2020",Interventional,"A Phase 1/2, Multi-Center, Randomized Study to Assess Safety, Pharmacokinetics, Immunogenicity, and Efficacy of BAT2020 in Hospitalized Patients Infected With SARS-CoV-2 (COVID-19)",COVID
2338,PREGNANCY,"February 08, 2021",3000,NCT04432779,NO INTERVENTION,BELGIUM,Recruiting,Centre Hospitalier Universitaire Saint Pierre,"May 25, 2020",Observational,Impact of SARS-CoV-2 Infection During Pregnancy on Newborns and Young Children,Unrelated
2339,ABORTION EARLY,"February 08, 2021",700,NCT04432792,TELEHEALTH CONSULTATION,UNITED STATES,Not yet recruiting,"University of California, San Francisco",November 2020,Interventional,The California Home Abortion by Telehealth (CHAT) Study,Unrelated
2340,PREGNANT WOMEN SUSPECTED OF COVID,"February 08, 2021",160,NCT04432805,PERFORMING OF LUNG ULTRASOUND,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"June 15, 2020",Interventional,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,COVID
2341,COLON CANCER,"February 08, 2021",200,NCT04432870,,UNITED STATES,Enrolling by invitation,Massachusetts General Hospital,"June 9, 2020",Observational,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study,Unrelated
2342,COVID,"February 08, 2021",15,NCT04432922,HOSPITALIZED PATIENTS FOR COVID-19 INFECTION,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"November 1, 2020",Observational,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized",COVID
2343,COVID,"February 08, 2021",200,NCT04432948,PHQ-9 DEPRESSION SCALE,GREECE,Recruiting,General and Maternity Hospital of Athens Elena Venizelou,"May 15, 2020",Observational,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,COVID
2344,COVID,"February 08, 2021",200,NCT04432961,,,Not yet recruiting,Cambridge University Hospitals NHS Foundation Trust,July 2020,Observational,A Database and Analytics Study of Free Text Clinical Notes and Structured Data to Investigate Phenotype Associations With Outcomes in Patients With COVID-19,COVID
2345,COVID,"February 08, 2021",60,NCT04432987,PULMOZYME,TURKEY,Recruiting,Acibadem University,"May 25, 2020",Interventional,Determination of Dornase Alpha Effectiveness in COVID-19 Treatment,COVID
2346,COVID PNEUMONIA,"February 08, 2021",34,NCT04433000,BUTTERFLY,ITALY,Recruiting,University of Siena,"March 15, 2020",Observational,Comparison Between a Pocket Sized and a High End Ultrasound Scanner in the Evaluation of Lung Involvement in Patients With Covid-19 Pneumonia,COVID
2347,COVID,"February 08, 2021",300,NCT04433013,LIANHUA QINGWEN,,Not yet recruiting,Nanyang Technological University,July 2020,Interventional,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,COVID
2348,COVID,"February 08, 2021",90,NCT04433026,"N TERMINAL PRO B TYPE NATRIURETIC PEPTIDE (NTPROBNP), D-DIMER, AND SERUM TROPININ - I",,Not yet recruiting,Assiut University,August 2020,Observational,"B-natriuretic Peptide (BNP), Serum Troponin-I, and D-dimer as Risk Factors for In-hospital Death in Patients With COVID-19",COVID
2349,COVID,"February 08, 2021",130,NCT04433039,,EGYPT,Completed,Alexandria University,"May 22, 2020",Observational,COVID-19 Versus H1N1 Viral Pneumonia: A Retrospective Comparative Study for Spectrum of HRCT Findings Among 130 Patients,COVID
2350,CYTOKINE STORM,"February 08, 2021",20,NCT04433078,DOXYCYCLINE,UNITED STATES,Recruiting,Temple University,"June 22, 2020",Interventional,RepurpoSing Old Drugs TO SuppRess a Modern Threat: The STORM Trial,Unrelated
2351,MENTAL HEALTH,"February 08, 2021",1050,NCT04433260,"QUESTIONNAIRE INCLUDING VALIDATED TOOLS SUCH AS PATIENT HEALTH QUESTIONNAIRE (PHQ-9), THE 7-ITEM GENERALISED ANXIETY DISORDER (GAD- 7), THE 7-ITEM INSOMNIA SEVERITY INDEX",UNITED KINGDOM,Recruiting,Queen Mary University of London,"July 25, 2020",Observational,"Immediate and Mid-term Implications of the Covid-19 Pandemic on the Physical, Behavioural and Mental Health of Healthcare Workers: A Cohort Study of Doctor, Nurses and Other Health Care Workers",Unrelated
2352,PHYSICAL STRESS,"February 08, 2021",1000,NCT04433286,QUESTIONNAIRE,EGYPT,Not yet recruiting,Mansoura University,"June 15, 2020",Observational,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,Unrelated
2353,"SATISFACTION, PATIENT","February 08, 2021",10000,NCT04433312,QUESTIONNAIRE,EGYPT,Not yet recruiting,Mansoura University,"July 1, 2020",Observational [Patient Registry],Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,Unrelated
2354,COVID,"February 08, 2021",150,NCT04433325,,FRANCE,Not yet recruiting,Rennes University Hospital,June 2020,Observational,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units,COVID
2355,SARS-CoV2,"February 08, 2021",1200,NCT04433364,"BIOLOGICAL SAMPLES, QUESTIONNAIRES AND INTERVIEWS",SWEDEN,Recruiting,"Sahlgrenska University Hospital, Sweden","June 2, 2020",Observational [Patient Registry],COPE - COVID-19 in Pregnancy and Early Childhood - a Study Protocol for a Prospective Multicentre Cohort Study,COVID
2356,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",54,NCT04433546,PEMZIVIPTADIL (PB1046),UNITED STATES,Terminated,PhaseBio Pharmaceuticals Inc.,"July 15, 2020",Interventional,"A Randomized, Double-Blind, Parallel Group Study to Assess the Efficacy and Safety of Once Weekly Subcutaneous Injections of Pemziviptadil (PB1046), a Sustained-Release VIP (Vasoactive Intestinal Peptide) ANalogue, in Hospitalized COVID-19 Patients at HiGh Risk for Rapid Clinical Deterioration and ARDS (PB1046 VANGARD Study)",Respiratory
2357,PANCREATITIS,"February 08, 2021",500,NCT04433754,BIOCHEMICAL ANALYSIS,TURKEY,Completed,Uşak University,"March 1, 2020",Observational,Pancreatic Injury in Patients With COVID-19 Disease,Unrelated
2358,COVID,"February 08, 2021",300,NCT04433871,"NO INTERVENTION, OBSERVATIONAL",FRANCE,Recruiting,"University Hospital, Caen","April 27, 2020",Observational [Patient Registry],National SFCE Cohort of SARS-CoV-2 Infections (COVID-19) in Pediatric Oncology and Hematology,COVID
2359,COVID,"February 08, 2021",106,NCT04433910,CONVALESSCENT PLASMA,GERMANY,"Active, not recruiting",Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,"August 30, 2020",Interventional,"A Randomized, Prospective, Open Label Clinical Trial on the Use of Convalescent Plasma Compared to Best Supportive Care in Patients With Severe COVID-19",COVID
2360,PNEUMONIA,"February 08, 2021",52,NCT04433949,BEST PRACTICE,UNITED STATES,Recruiting,Emory University,"June 12, 2020",Interventional,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19): A Randomized Phase III of Best Supportive Care +/- Whole Lung Low-Dose Radiation Therapy in Hospitalized Patients,Respiratory
2361,COVID,"February 08, 2021",200,NCT04433988,PENTOXIFYLLINE,EGYPT,Not yet recruiting,Sadat City University,"June 13, 2021",Interventional,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,COVID
2362,"DIET, HEALTHY","February 08, 2021",300,NCT04434014,PROPER DIET,EGYPT,Recruiting,October University for Modern Sciences and Arts,"June 8, 2020",Observational,Proper Nutrition and Its Relationship to Oral Diseases in the Era of Corona,Unrelated
2363,RHEUMATOID ARTHRITIS,"February 08, 2021",600,NCT04434118,TRADITIONAL ANTIRHEUMATIC DRUGS,EGYPT,Enrolling by invitation,Sadat City University,"March 20, 2020",Observational,"Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients: A Retrospective, Case-control Study",Unrelated
2364,COVID,"February 08, 2021",30,NCT04434131,CONVALESCENT PLASMA,UNITED STATES,Recruiting,University of New Mexico,"April 28, 2020",Interventional,"Open, Non-comparative Pilot Study to Provide Access to Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19",COVID
2365,IVERMECTIN,"February 08, 2021",116,NCT04434144,IVERMECTIN + DOXYCYCLINE,BANGLADESH,Completed,"Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar","May 2, 2020",Observational [Patient Registry],A Comparative Observational Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,Unrelated
2366,COVID,"February 08, 2021",221,NCT04434157,,MEXICO,Completed,Hospital Regional de Alta especialidad de Ixtapaluca,"March 28, 2020",Observational,Association of the Neutrophil/Lymphocyte Ratio and Lymphocyte /Platelet Ratio With Clinical Complications and Mortality in COVID-19 Patients,COVID
2367,COVID,"February 08, 2021",330,NCT04434248,FAVIPIRAVIR,RUSSIAN FEDERATION,"Active, not recruiting",Chromis LLC,"April 23, 2020",Interventional,"An Adaptive, Multicenter, Randomized, Open-label, Comparative Clinical Study to Assess Efficacy and Safety of Favipiravir in Hospitalized Patients With COVID-19",COVID
2368,SARS-CoV2,"February 08, 2021",1500,NCT04434261,PT-PCR TEST FOR SARS-COV-2,BRAZIL,"Active, not recruiting",Instituto Brasileiro de Controle do Cancer,"May 11, 2020",Observational,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,COVID
2369,COVID,"February 08, 2021",1000,NCT04434417,2019-NCOV IGG/IGM RAPID TEST CASSETTE,ITALY,Recruiting,European Institute of Oncology,"April 15, 2020",Observational,"Clinical Validation of a Simple and Fast Immunochromatographic Assay for Qualitative Determination of Specific ImmunoGLObulin IgG/IgM Antibodies to 2019- nCoV in Whole bLood, Serum or Plasma Specimen",COVID
2370,COAGULOPATHY,"February 08, 2021",200,NCT04435015,CAMOSTAT MESYLATE,,Not yet recruiting,Yale University,"February 1, 2021",Interventional,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,Unrelated
2371,BREAST CANCER,"February 08, 2021",111,NCT04435028,KETOTIFEN 1 MG,EGYPT,Completed,Horus University,"January 14, 2019",Observational,Ketotifen: Novel Use as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy as Well as the Potential Beneficial Effects of Ketotifen in the Hypothetical Management of COVID-19,Unrelated
2372,COVID,"February 08, 2021",1,NCT04435041,,UNITED KINGDOM,"Active, not recruiting",University of Oxford,"June 1, 2020",Observational [Patient Registry],"Remote-by-Default Care in the COVID-19 Pandemic: Addressing the Micro-, Meso-, and Macro-level Challenges of a Radical New Service Model",COVID
2373,COVID,"February 08, 2021",35,NCT04435080,,TURKEY,Completed,Koç University,"March 15, 2020",Observational,Physical Rehabilitation in Intensive Care Unit in Acute Respiratory Distress Syndrome Patients With COVID-19,COVID
2374,CORONAVIRUS INFECTION,"February 08, 2021",23,NCT04435106,OPAGANIB,ISRAEL,Completed,Shaare Zedek Medical Center,"April 3, 2020",Observational,Compassionate Use of Opaganib in Patients With Severe COVID-19,COVID
2375,CORONAVIRUS,"February 08, 2021",96,NCT04435119,,FRANCE,Completed,"University Hospital, Angers","March 15, 2020",Observational,COvid-19 et VITamine d en EHPAD,COVID
2376,COVID,"February 08, 2021",50,NCT04435184,CRIZANLIZUMAB,UNITED STATES,Completed,Johns Hopkins University,"July 9, 2020",Interventional,Crizanlizumab for Treating COVID-19 Vasculopathy,COVID
2377,COVID SEVERE PNEUMONIA,"February 08, 2021",62,NCT04435223,BIOLOGICAL ASSAYS IN PARTICULAR ON THE LIPID METABOLISM,FRANCE,Completed,Centre Hospitalier Universitaire Dijon,"April 7, 2020",Observational,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen,COVID
2378,COVID,"February 08, 2021",50,NCT04435275,"VIRTUAL ASSISTANT FIRST, THEN HUMAN COACH",CANADA,Recruiting,"University Health Network, Toronto","January 2, 2021",Interventional,Development of an Automated and Scalable Virtual Assistant to Aid in PPE Adherence and Clinical Protocols for Healthcare Worker Safety,COVID
2379,COVID,"February 08, 2021",200,NCT04435314,NITAZOXANIDE,,Not yet recruiting,Azidus Brasil,June 2020,Interventional,"Prospective, Randomized, Double-blind, Parallel, Placebo Controlled Study to Evaluate the Safety and Efficacy of Nitazoxanide 600 mg Three Times a Day for Post Exposure Prophylaxis of COVID-19 in Subjects From Vulnerable Communities",COVID
2380,COVID,"February 08, 2021",300,NCT04435327,,ITALY,Recruiting,University of Milano Bicocca,"August 17, 2020",Observational,SequelaeCov: a Prospective Study on Lung Damage Caused by SARS-CoV-2 Pneumonia,COVID
2381,RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",200,NCT04435353,VIBROLUNG,KAZAKHSTAN,Recruiting,Astana Medical University,"March 22, 2020",Interventional,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,Respiratory
2382,"INFECTION, RESPIRATORY TRACT","February 08, 2021",2038,NCT04435379,VPM1002,GERMANY,"Active, not recruiting",Vakzine Projekt Management GmbH,"June 18, 2020",Interventional,"A Phase III, Randomized, Double-blind, Placebo-controlled, Multicentre, Clinical Trial to Assess the Efficacy and Safety of VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in the SARS-CoV-2 Pandemic by Modulating the Immune System",Respiratory
2383,SARS-CoV2,"February 08, 2021",70,NCT04435457,,UNITED STATES,Recruiting,University of Texas Southwestern Medical Center,"September 1, 2020",Observational [Patient Registry],Uncovering the Cardiac Phenotype of Individuals With SARS-COV-2 and Cardiac Injury,COVID
2384,COVID,"February 08, 2021",9,NCT04435522,MARAVIROC,UNITED STATES,Completed,Rhode Island Hospital,"October 1, 2020",Interventional,Open-Label Study of Maraviroc in Hospitalized Individuals Diagnosed With SARS-CoV-2,COVID
2385,ASYMPTOMATIC INFECTIONS,"February 08, 2021",80,NCT04435587,IVERMECTIN PILL,THAILAND,Recruiting,Mahidol University,"July 13, 2020",Interventional,Comparative Efficacy of Ivermectin Versus Combination of Hydroxychloroquine Plus Darunavir/ Ritonavir for Shortening Duration of SARS-CoV2 Detection From Respiratory Secretion Among Asymptomatic or Afebrile COVID-19 Infection,Unrelated
2386,COVID,"February 08, 2021",78,NCT04435717,TOCILIZUMAB 20 MG/ML INTRAVENOUS SOLUTION [ACTEMRA]_#1,SPAIN,Recruiting,Hospital Universitario Ramon y Cajal,"May 4, 2020",Interventional,"Unicenter, Randomized, Open-label Clinical Trial on the Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19",COVID
2387,COVID,"February 08, 2021",454,NCT04435795,NORMAL SALINE INTRANASAL,CANADA,Recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,"September 14, 2020",Interventional,Ciclesonide Clinical Trial for COVID-19 Treatment,COVID
2388,COVID,"February 08, 2021",1,NCT04435808,HYDROXYCHLOROQUINE,UNITED STATES,Terminated,University of New Mexico,"April 14, 2020",Interventional,Off Label Study to Evaluate the Efficacy of Hydroxychloroquine as Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Health Care Workers at High Risk of Occupational Exposure to SARS-CoV-2,COVID
2389,HEALTHY,"February 08, 2021",1045,NCT04436276,AD26.COV2.S,BELGIUM,Recruiting,Janssen Vaccines & Prevention B.V.,"July 15, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 1/2a Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26COVS1 in Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Years and Older",Unrelated
2390,COVID,"February 08, 2021",100,NCT04436458,NICLOSAMIDE ORAL TABLET,,Not yet recruiting,"First Wave Bio, Inc.",December 2020,Interventional,"Phase 2, Multicentre, Randomized, Double Blind, 2 Arms Placebo-controlled Study in Adults With Moderate COVID-19 With Gastrointestinal Signs and Symptoms",COVID
2391,PREVENTIVE IMMUNIZATION COVID,"February 08, 2021",38,NCT04436471,GAM-COVID-VAC,RUSSIAN FEDERATION,Completed,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","June 17, 2020",Interventional,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" a Solution for Intramuscular Injection With the Participation of Healthy Volunteers",COVID
2392,COVID,"February 08, 2021",200,NCT04436484,PERIPHERAL BLOOD SAMPLING,UNITED KINGDOM,Recruiting,University Hospital Plymouth NHS Trust,"April 29, 2020",Observational,Immune Dysfunction in COVID-19: Investigation of Mechanisms and Identification of Immune Biomarkers of Clinical Outcome,COVID
2393,EATING BEHAVIOR,"February 08, 2021",397,NCT04437121,ONLINE SURVEY ABOUT DIETARY AND LIFESTYLE HABITS,GREECE,Completed,University of Thessaly,"April 30, 2020",Observational,Dietary and Lifestyle Habits of Children and Adolescents and Their Parents During the Pandemic of COVID-19 in Greece: The COV-EAT Study,Unrelated
2394,KNEE OSTEOARTHRITIS,"February 08, 2021",500,NCT04437134,ON-LINE EXERCISE AND EDUCATION,DENMARK,Recruiting,Slagelse Hospital,"June 12, 2020",Observational [Patient Registry],On-line Neuromuscular Exercise and Education for Knee Osteoarthritis,Unrelated
2395,POSTPARTUM DEPRESSION,"February 08, 2021",330,NCT04437342,PHQ-9 (PATIENT HEALTH QUESTIONNAIRE) DEPRESSION SCALE,GREECE,Completed,General and Maternity Hospital of Athens Elena Venizelou,"June 30, 2020",Observational,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,Unrelated
2396,COVID,"February 08, 2021",500,NCT04437693,HYDROXYCHLOROQUINE,,Not yet recruiting,Hamad Medical Corporation,"August 31, 2020",Interventional,Post Exposure Prophylaxis (PEP) in Healthcare Workers Exposed to COVID-19 Patients: A Double-blind Randomized Clinical Trial,COVID
2397,COVID,"February 08, 2021",200,NCT04437706,,UNITED STATES,Enrolling by invitation,Duke University,"December 11, 2020",Observational,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling,COVID
2398,ONCOLOGY,"February 08, 2021",100,NCT04437719,OBVIO-19 APP,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"June 29, 2020",Interventional,"Longitudinal Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group, Paris, France for a Period of 6 Months During the COVID-19 Pandemic in 2020",Unrelated
2399,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04437823,INTRAVENOUS INFUSIONS OF STEM CELLS,PAKISTAN,Recruiting,Jinnah Hospital,"June 1, 2020",Interventional,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,COVID
2400,PREVENTIVE IMMUNIZATION COVID,"February 08, 2021",38,NCT04437875,GAM-COVID-VAC LYO,RUSSIAN FEDERATION,Completed,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","June 17, 2020",Interventional,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac Lyo"" Lyophilizate for the Preparation of a Solution for Intramuscular Injection With the Participation of Healthy Volunteers",COVID
2401,COVID,"February 08, 2021",10000,NCT04437901,,BELGIUM,Not yet recruiting,Hospital Clinic of Barcelona,June 2020,Observational [Patient Registry],COVIDAR - International Registry on Arrhythmias in COVID-19,COVID
2402,COVID,"February 08, 2021",38,NCT04437940,VAGINAL FLUID COVID-19 PCR TEST,TURKEY,Completed,Acibadem University,"June 15, 2020",Observational,Evaluation of Vaginal Fluid for Covid-19 Positivity,COVID
2403,HYPERTENSION,"February 08, 2021",384,NCT04437966,ENHANCED CHRONIC DISEASE SELF-MANAGEMENT PROGRAM,BARBADOS,Recruiting,The University of The West Indies,"October 11, 2020",Interventional,Assessing Effectiveness of a Chronic Disease Self-management Program in Faith-based Organizations in Barbados: a Cluster Randomized Trial,Unrelated
2404,COVID,"February 08, 2021",150,NCT04438057,CCP,UNITED STATES,Recruiting,Metro Infectious Disease Consultants,"August 12, 2020",Interventional,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,COVID
2405,COVID,"February 08, 2021",400,NCT04438070,COVID-19 SWAB,CANADA,Recruiting,St. Joseph's Healthcare Hamilton,"April 10, 2020",Interventional,COVID Screening Strategies in Homeless Shelters,COVID
2406,COVID,"February 08, 2021",150,NCT04438239,"NONE, THIS STUDY IS OBSERVATIONAL",ITALY,Completed,Azienda Unità Sanitaria Locale Reggio Emilia,"June 22, 2020",Observational,Rehabilitation Needs After COVID-19 Hospital Treatment (REACT): an Observational Study,COVID
2407,ALLERGY AND IMMUNOLOGY,"February 08, 2021",80,NCT04438629,COVID-19 TREATMENT,ITALY,Recruiting,Azienda Ospedaliera Universitaria Integrata Verona,"March 26, 2020",Observational,Evaluation of Immune Response in COVID-19 Patients,Unrelated
2408,COVID,"February 08, 2021",67,NCT04438694,CONVALESCENT PLASMA,EGYPT,Recruiting,Cairo University,"June 1, 2020",Interventional,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,COVID
2409,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",582,NCT04438837,HYDROXYCHLOROQUINE,ISRAEL,Not yet recruiting,Rambam Health Care Campus,July 2020,Interventional,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers: A Randomized-Controlled Trial,COVID
2410,COVID,"February 08, 2021",102,NCT04438850,IVERMECTIN,ITALY,Recruiting,IRCCS Sacro Cuore Don Calabria di Negrar,"July 31, 2020",Interventional,"Randomized, Double-blind, Multi Centre Phase II, Proof of Concept, Dose Finding Clinical Trial on Ivermectin for the Early Treatment of COVID-19",COVID
2411,COVID,"February 08, 2021",90,NCT04438863,HOME SPIROMETRY,ISRAEL,Recruiting,Sheba Medical Center,"August 8, 2020",Observational,A Descriptive Pilot Study of Daily Home Spirometry for Early Detection of Pulmonary Complications in High Risk Patients With COVID19,COVID
2412,SARS-CoV2,"February 08, 2021",100,NCT04438941,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","March 25, 2020",Observational,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic,COVID
2413,MULTIPLE SCLEROSIS,"February 08, 2021",30,NCT04438954,,TURKEY,Completed,Ankara Yildirim Beyazıt University,"May 5, 2020",Observational,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels of Multiple Sclerosis Patients in the COVID-19 Pandemic",Unrelated
2414,BRAIN HEALTH,"February 08, 2021",10000,NCT04438967,,UNITED STATES,Recruiting,Miro Health,"June 16, 2020",Observational,Brain Health in the Time of COVID-19,Unrelated
2415,COVID PNEUMONIA,"February 08, 2021",72,NCT04438980,METHYLPREDNISOLONE,SPAIN,Recruiting,Fundacion Miguel Servet,"May 15, 2020",Interventional,Treatment of COVID-19 Pneumonia With Glucocorticoids. A Randomized Controlled Trial,COVID
2416,COVID,"February 08, 2021",100,NCT04438993,,UNITED KINGDOM,Recruiting,NHS Lanarkshire,"May 29, 2020",Observational,"An Observational Study of Hospitalised Patients With Coronavirus Disease 2019 (COVID-19) to Determine the Degree of Myocardial Injury Using Biomarkers and Echocardiography, and the Impact of This on Cardiovascular Outcomes",COVID
2417,APLASTIC ANEMIA,"February 08, 2021",72,NCT04439006,BEST PRACTICE,UNITED STATES,Recruiting,Jennifer Woyach,"July 22, 2020",Interventional,Randomized Double-Blind Phase 2 Trial of Ibrutinib Versus Standard Treatment for COVID-19 Illness Requiring Hospitalization With Safety Lead-In,Unrelated
2418,SARS-CoV2 INFECTION,"February 08, 2021",3626,NCT04439045,VPM1002,CANADA,Recruiting,"University Health Network, Toronto","June 24, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 3 Study: Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 Infection Rate and COVID-19 Severity",COVID
2419,PNEUMONIA,"February 08, 2021",380,NCT04439071,PTC299,AUSTRALIA,Recruiting,PTC Therapeutics,"July 9, 2020",Interventional,Evaluation of the Efficacy and Safety of PTC299 in Hospitalized Subjects With COVID-19 (FITE19),Respiratory
2420,COVID,"February 08, 2021",1000,NCT04439084,PROSPECTIVE CHART REVIEW,UNITED STATES,Enrolling by invitation,Stanford University,"March 6, 2020",Observational,COVID-19 in Patients With Chronic Liver Diseases,COVID
2421,MOOD,"February 08, 2021",45,NCT04439825,BOTULINUM NEUROTOXIN,UNITED STATES,Not yet recruiting,DeNova Research,"July 15, 2020",Interventional,Randomized Controlled Single Blind Cross Over Trial Evaluating the Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction in a Post Covid Period.,Unrelated
2422,COVID,"February 08, 2021",80,NCT04440007,ABIVERTINIB,UNITED STATES,Recruiting,"Sorrento Therapeutics, Inc.","October 9, 2020",Interventional,"A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19",COVID
2423,LONELINESS,"February 08, 2021",1008,NCT04440098,,UNITED STATES,Completed,University of Miami,"April 22, 2020",Observational,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,Unrelated
2424,ACUTE APPENDICITIS,"February 08, 2021",70,NCT04440150,APPENDECTOMY,TURKEY,Completed,Kahramanmaras Sutcu Imam University,"June 1, 2018",Interventional,Preoperative Immature Granulocyte Count and Percentage for Complicated and Uncomplicated Appendisitis,Unrelated
2425,VIRUS DISEASES,"February 08, 2021",40,NCT04441047,ALLOSTIM,UNITED STATES,Not yet recruiting,"Immunovative Therapies, Ltd.","March 6, 2021",Interventional,Safety and Efficacy of ALLOSTIM® Universal Anti-Viral Immunodulatory Vaccine for Healthy Elderly Adults,Unrelated
2426,WEAKNESS OF THE LOWER LIMBS,"February 08, 2021",0,NCT04441164,OBSERVATION OF VIRTUAL ACTIONS,FRANCE,Withdrawn,Rennes University Hospital,"August 1, 2020",Interventional,VERARE : Effectiveness of Virtual Motor Actions for Improving Walking in Patients With Post-resuscitation Muscle Weakness,Unrelated
2427,SARS-CoV2,"February 08, 2021",1200,NCT04441372,,BANGLADESH,Not yet recruiting,"Medecins Sans Frontieres, Spain","October 1, 2020",Observational [Patient Registry],Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection,COVID
2428,COVID,"February 08, 2021",200,NCT04441385,MARAVIROC 300 MG,SPAIN,Recruiting,Hospital Universitario Infanta Leonor,"June 26, 2020",Interventional,"Bicentric, Phase 2, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Maraviroc Associated With Standard Treatment in Hospitalized Patients With Pulmonary SARS-CoV-2 Infection (COVID-19).",COVID
2429,COVID,"February 08, 2021",300,NCT04441398,NITAZOXANIDE,,Not yet recruiting,Azidus Brasil,July 2020,Interventional,"Prospective, Randomized, Double-blind, Parallel, Placebo Controlled Study to Evaluate the Safety and Efficacy of Nitazoxanide 600 mg Three Times a Day to Treat Ambulatory Adult Subjects Diagnosed With COVID-19 With Mild Symptoms Assisted in the Public Health System of the City of Mesquita -RJ",COVID
2430,IMMUNOTHERAPY,"February 08, 2021",49,NCT04441424,CONVALESCENT PLASMA,IRAQ,Completed,Alkarkh Health Directorate-Baghdad,"April 3, 2020",Interventional,"The Therapeutic Potential of Convalescent Plasma Therapy on Treating Critically-ill COVID-19 Patients Residing in Respiratory Care Units in Hospitals in Baghdad, Iraq",Unrelated
2431,PSYCHOLOGICAL STRAIN,"February 08, 2021",3000,NCT04441476,QUESTIONNAIRES,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire Dijon,"April 21, 2020",Observational,Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis,Unrelated
2432,COVID,"February 08, 2021",13,NCT04441489,,MONACO,Completed,Centre Hospitalier Princesse Grace,"March 27, 2020",Observational,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,COVID
2433,COVID,"February 08, 2021",240,NCT04441502,,ITALY,Recruiting,IRCCS Policlinico S. Donato,"March 30, 2020",Observational,Identification of Predictors for the Evolution of COVID-19 Related Interstitial Pneumonia by Transcriptomic and Seroproteomic Techniques,COVID
2434,BURNOUT,"February 08, 2021",24,NCT04441632,POSITIVE FEEDBACK,UNITED STATES,Completed,Cedars-Sinai Medical Center,"June 15, 2020",Interventional,"The Impact of Positive Reinforcement on Teamwork Climate, Resiliency, and Burnout During the COVID-19 Pandemic: the TEAM-ICU Study (Transforming Employee Attitudes Via Messaging Strengthens Interconnection, Communication, and Unity)",Unrelated
2435,SARS-CoV2 SEROLOGICAL STATUS,"February 08, 2021",1800,NCT04441684,BLOOD SAMPLE FOR SEROLOGICAL TEST,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 17, 2020",Interventional,"Study of the Seroprevalence of SARS-CoV-2 in Hospital Staff in Strasbourg University Hospital, Strasbourg, France",COVID
2436,COVID,"February 08, 2021",2500,NCT04441710,QUESTIONNAIRE,FRANCE,Recruiting,Hospices Civils de Lyon,"October 27, 2020",Observational [Patient Registry],Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,COVID
2437,COVID,"February 08, 2021",960,NCT04441814,,ITALY,Enrolling by invitation,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","July 23, 2019",Observational,Frequency and OUtcome of Sub-solid Pulmonary Nodules in Asymptomatic Subjects Tested by Chest CT Screening Versus COVID-19 Patients (FOUND) - Ancillary Study to Smile Protocol NCT03654105,COVID
2438,COVID; AND HIGH INFECTION RISK OF SARS-CoV2,"February 08, 2021",40,NCT04441918,JS016 (ANTI-SARS-COV-2 MONOCLONAL ANTIBODY),CHINA,Recruiting,"Shanghai Junshi Bioscience Co., Ltd.","June 5, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Phase I Clinical Study to Evaluate the Tolerability, Safety, Pharmacokinetic Profile and Immunogenicity of JS016 (Anti-SARS-CoV-2 Monoclonal Antibody) Injection in Chinese Healthy Subjects After Intravenous Infusion of Single Dose",COVID
2439,COVID,"February 08, 2021",20,NCT04441996,THERAPEUTIC PLASMA EXCHANGE (TPE),UNITED STATES,"Active, not recruiting",Emory University,"July 17, 2020",Interventional,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,COVID
2440,CANCER,"February 08, 2021",1500,NCT04442048,IMM-101,CANADA,Recruiting,Canadian Cancer Trials Group,"June 25, 2020",Interventional,"COV-IMMUNO: A Randomized, Phase III Trial of Immunization With IMM-101 Versus Observation for the Prevention of Severe Respiratory and COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure",Unrelated
2441,SARS-CoV2,"February 08, 2021",400,NCT04442087,SEROLOGY SARS-COV2,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 19, 2020",Interventional,Seroprevalence of Anti-SARS-CoV2 Among Children According to Parents' SARS-CoV2 Serological Status. Study in a Hospital Population Assistance Publique-Hôpitaux Paris,COVID
2442,GENDER RELATIONS,"February 08, 2021",1000,NCT04442152,MENCARE+/BANDEBEREHO FATHERS'/COUPLES' GROUP EDUCATION,RWANDA,Enrolling by invitation,"Promundo, United States",June 2020,Interventional,Phone Survey for Understanding the Impact of COVID-19 on Caregiving and Family Dynamics on Bandebereho Study Participants,Unrelated
2443,COVID,"February 08, 2021",15393,NCT04442165,,,Not yet recruiting,"Institute of Tropical Medicine, Belgium","July 15, 2020",Observational,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique Using Population-based (Sero)Surveillance,COVID
2444,COVID,"February 08, 2021",48,NCT04442178,CYT107,UNITED STATES,Recruiting,Revimmune,"September 15, 2020",Interventional,"A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Infectious Cohort",COVID
2445,COVID,"February 08, 2021",50,NCT04442191,CONVALESCENT PLASMA,UNITED STATES,Recruiting,University of Illinois at Chicago,"May 5, 2020",Interventional,"Infusion of Convalescent Plasma for the Treatment of Patients Infected With Severe Acute Respiratory Syndrome-Coronavirus-2 (COVID-19): A Double-blinded, Placebo-controlled, Proof-of-concept Study",COVID
2446,DEPRESSION,"February 08, 2021",4000,NCT04442204,PROSPECTIVE STUDY ACROSS TWO TIME-POINTS EXAMINING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON MENTAL HEALTH,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,Unrelated
2447,ADHERENCE TO WHO-ADVISED HYGIENE-RELATED BEHAVIOR,"February 08, 2021",4000,NCT04442217,PROSPECTIVE STUDY WITH TWO MEASUREMENT POINTS INVESTIGATING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON MENTAL HEALTH,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,Unrelated
2448,CORONAVIRUS INFECTION,"February 08, 2021",96,NCT04442230,NASOVAX,UNITED STATES,Recruiting,"Altimmune, Inc.","October 10, 2020",Interventional,"Phase 2, Double-blind, Randomized, Placebo-controlled Study of NasoVAX in the Prevention of Clinical Worsening in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)",COVID
2449,POST TRAUMATIC STRESS DISORDER,"February 08, 2021",889,NCT04442243,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,Unrelated
2450,ANXIETY,"February 08, 2021",5041,NCT04442282,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,"Difficulties in Emotion-regulation and Interpersonal Problems, and Their Association With Anxiety and Depression During and After the COVID-19 Pandemic",Unrelated
2451,PARENTING,"February 08, 2021",1440,NCT04442308,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Parental Stress After the Covid-19 Pandemic: Predictors and Outcome,Unrelated
2452,DEPRESSION,"February 08, 2021",4000,NCT04442360,PROSPECTIVE STUDY WITH TWO MEASUREMENT POINTS INVESTIGATING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON MENTAL HEALTH,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Unrelated
2453,PARENTAL BURNOUT,"February 08, 2021",1500,NCT04442386,PROSPECTIVE STUDY WITH TWO MEASUREMENT POINTS INVESTIGATING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON PARENTAL BURNOUT,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Unrelated
2454,LUNG DISEASES,"February 08, 2021",30,NCT04442789,,GERMANY,Recruiting,University of Giessen,"May 20, 2020",Observational,Long-term Sequelae of Severe Sars-CoV-2 Infections,Unrelated
2455,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",60,NCT04442958,CONVALESCENT IMMUNE PLASMA,TURKEY,Completed,Bagcilar Training and Research Hospital,"May 15, 2020",Interventional,Effectiveness of Convalescent Immune Plasma Therapy in Severe COVID-19 Patients With Acute Respiratory Distress Syndrome,Respiratory
2456,"STRESS DISORDERS, POST-TRAUMATIC","February 08, 2021",180,NCT04443075,FAECAL SAMPLE COLLECTOR,CHINA,Recruiting,First Affiliated Hospital Xi'an Jiaotong University,"June 24, 2020",Observational,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress of Fighting Against 2019-nCoV,Unrelated
2457,COVID,"February 08, 2021",131,NCT04443140,"PCR, LUNG ULTRASOUND",TURKEY,Completed,Zeynep Kamil Maternity and Pediatric Research and Training Hospital,"March 15, 2020",Observational [Patient Registry],Evaluation of COVID-19 Incidence in Patients With Preeclampsia During Pandemic,COVID
2458,AUTISM SPECTRUM DISORDER,"February 08, 2021",790,NCT04443179,,UNITED KINGDOM,Recruiting,King's College London,"April 5, 2013",Observational,Brain Imaging and Infant Development,Unrelated
2459,SARS-CoV2,"February 08, 2021",200,NCT04443257,ASSESSMENT OF THE SEQUELAE AFTER HOSPITALIZATION FOR SARS-COV-2,FRANCE,Enrolling by invitation,"University Hospital, Montpellier","July 8, 2020",Observational,REassessement After Hospitalization for Sars-COV-2 Infection : Standardized Assessment of Sequelae and Comorbidities 3 to 6 Months After Hospitalization,COVID
2460,COVID,"February 08, 2021",200,NCT04443270,CHLOROQUINE PHOSPHATE,MEXICO,Not yet recruiting,"CMN ""20 de Noviembre""","July 27, 2020",Interventional,Efficacy of Chloroquine Phosphate Prophylactic Use in First-line Health Personnel Exposed to COVID-19 Patients,COVID
2461,INSOMNIA,"February 08, 2021",5000,NCT04443361,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Insomnia After the COVID-19 Pandemic,Unrelated
2462,COVID,"February 08, 2021",82,NCT04443673,GLYCINE,MEXICO,Recruiting,Instituto Nacional de Enfermedades Respiratorias,"August 20, 2020",Interventional,Controlled and Randomized Clinical Trial for Evaluating the Effect of a Supplement of Glycine as Adjuvant in the Treatment of COVID-19 Pneumonia in Patients Initiating Mechanical Ventilation,COVID
2463,MENTAL WELL-BEING,"February 08, 2021",4000,NCT04443699,PROSPECTIVE STUDY WITH TWO MEASUREMENT POINTS INVESTIGATING THE IMPACT OF VIRAL MITIGATION PROTOCOLS ON MENTAL HEALTH,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Predictors of Mental Well-being During the COVID-19 Pandemic,Unrelated
2464,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",1900,NCT04443712,,EGYPT,Recruiting,Samia Girgis,"May 29, 2020",Observational,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19),COVID
2465,COVID,"February 08, 2021",100,NCT04443725,"HYDROXYCHLOROQUINE , SOFOSBUVIR, DACLATASVIR",,Not yet recruiting,Cairo University,July 2020,Interventional,Efficacy and Safety of Anti-hepatitis C Drugs in the Treatment of COVID-19,COVID
2466,MIGRANTS,"February 08, 2021",287,NCT04443764,,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,Unrelated
2467,COVID,"February 08, 2021",9,NCT04443803,,,Not yet recruiting,Randy Loftus,"July 1, 2020",Observational,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program,COVID
2468,SARS-COV INFECTION,"February 08, 2021",50,NCT04443868,NITRIC OXIDE-RELEASING DRUG,,Not yet recruiting,Sanotize Research and Development corp.,January 2021,Interventional,"Double-Blinded, Placebo-Controlled Parallel, Phase II Clinical Efficacy Study Evaluating NORS To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Mild COVID-19",Respiratory
2469,COVID PNEMONIA,"February 08, 2021",180,NCT04443881,ANAKINRA 149 MG/ML PREFILLED SYRINGE [KINERET],SPAIN,Recruiting,Fundacion Miguel Servet,"May 8, 2020",Interventional,"Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19. A Phase 2/3, Randomized, Open-label, Parallel Group, 2-arm, Multicenter Study Investigating the Efficacy and Safety of Intravenous Administrations of Anakinra, an Interleukin-1(IL-1) Receptor Antagonist, Added to Standard of Care, Versus Standard of Care, in Reducing Hyper-inflammation and Respiratory Distress in Patients With SARS- CoV-2 Infection",COVID
2470,LONELINESS DURING COVID,"February 08, 2021",10084,NCT04444115,,,Not yet recruiting,Modum Bad,"June 22, 2020",Observational,Loneliness During the COVID-19 Pandemic: Change and Predictors of Change From Strict to Lifted Social Distancing Protocols,COVID
2471,MYOCARDITIS,"February 08, 2021",3000,NCT04444128,CMR WITH T1 AND T2 MAPPING,GERMANY,Recruiting,Johann Wolfgang Goethe University Hospital,"November 15, 2016",Observational [Patient Registry],IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION,Unrelated
2472,COVID,"February 08, 2021",20,NCT04444271,MESENCHYMAL STEM CELLS,PAKISTAN,Recruiting,Dr. Zaineb Akram,"May 1, 2020",Interventional,"Prospective, Randomized Phase 2 Clinical Trial of Mesenchymal Stem Cells(MSCs) for the Treatment of Coronavirus Disease 2019(COVID-19)",COVID
2473,TELEMEDICINE,"February 08, 2021",40,NCT04444297,3D TELEMEDICINE,UNITED KINGDOM,Not yet recruiting,NHS Greater Glasgow and Clyde,"July 31, 2020",Interventional,3D Telemedicine During COVID-19: Non-clinical Validation,Unrelated
2474,COVID,"February 08, 2021",100,NCT04444310,,EGYPT,"Active, not recruiting",Assiut University,"June 15, 2020",Observational [Patient Registry],Antibody Responses in Asymptomatic Close Contacts of COVID-19 Patients and Their Implications,COVID
2475,TELEMEDICINE,"February 08, 2021",50,NCT04444323,3D TELEMEDICINE,UNITED KINGDOM,Not yet recruiting,NHS Greater Glasgow and Clyde,"September 1, 2020",Interventional,3D Telemedicine During COVID-19: Cohort Study,Unrelated
2476,DEPRESSION,"February 08, 2021",4000,NCT04444336,CROSS-SECTIONAL STUDY EXAMINING THE IMPACT OF INFORMATION SOURCES TO OBTAIN INFORMATION ABOUT COVID-19 ON DEPRESSION AND ANXIETY SYMPTOMS,,Not yet recruiting,University of Oslo,"June 22, 2020",Observational,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,Unrelated
2477,NEUROENDOCRINE TUMORS,"February 08, 2021",50,NCT04444401,,ITALY,Recruiting,European Institute of Oncology,"June 15, 2020",Observational,InterNaTional rEgistry oN Sars-cov-2posItiVe nEuroendocrine Neoplasm Patients (INTENSIVE),Unrelated
2478,COVID PNEUMONIA,"February 08, 2021",18,NCT04444531,,SPAIN,Completed,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,"March 20, 2020",Observational,Ozone Therapy for Patients With COVID-19 Pneumonia: Preliminary Report of a Prospective Case-control Study,COVID
2479,DEPRESSION,"February 08, 2021",97,NCT04444557,BECK DEPRESSION INVENTORY (BDI),TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"April 17, 2020",Observational,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,Unrelated
2480,COVID,"February 08, 2021",100,NCT04444596,CONJUNCTIVAL SWAB AND NASOPHARYNGEAL SWAB,AUSTRIA,Recruiting,Medical University Innsbruck,"June 17, 2020",Interventional,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,COVID
2481,COVID,"February 08, 2021",230,NCT04444609,"BLOOD TESTS SPUTUM, NASAL LAVAGE AND BRUSHING",UNITED KINGDOM,Recruiting,Imperial College London,"June 18, 2020",Observational,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,COVID
2482,OSTEOPOROSIS,"February 08, 2021",21,NCT04444661,,GERMANY,"Active, not recruiting",University of Erlangen-Nürnberg Medical School,"June 10, 2020",Observational,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise in Older Men With Osteosarcopenia A Randomized Controlled Trial,Unrelated
2483,CORONAVIRUS,"February 08, 2021",2130,NCT04444674,CHADOX1 NCOV-19,SOUTH AFRICA,"Active, not recruiting",University of Oxford,"June 24, 2020",Interventional,"An Adaptive Phase I/II Randomized Placebo-controlled Trial to Determine Safety, Immunogenicity and Efficacy of Non-replicating ChAdOx1 SARS-CoV-2 Vaccine in South African Adults Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV",COVID
2484,COVID,"February 08, 2021",20,NCT04444687,TEST FOR SARS-COV-2,,Not yet recruiting,"University Hospital, Basel, Switzerland",August 2020,Observational,Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,COVID
2485,COVID,"February 08, 2021",462,NCT04444700,THERAPEUTIC ANTICOAGULATION,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"July 4, 2020",Interventional,Utilização da Enoxaparina em Dose Anticoagulante em Pacientes Hospitalizados Com síndrome respiratória Aguda Grave Por COVID-19,COVID
2486,DEPRESSIVE SYMPTOMS,"February 08, 2021",10084,NCT04444713,,,Not yet recruiting,Modum Bad,"June 22, 2020",Observational,Centrality in the Cross-sectional Network of Depressive Symptom and Metacognitive Variables During COVID-19: Do Central Variables Predict Overall Symptom Reduction From Periods of Strict to Lifted Social Distancing Protocols?,Unrelated
2487,BIOEQUIVALENCE,"February 08, 2021",30,NCT04444986,FAVIR 200 MG FT,TURKEY,Completed,Kocak Farma,"June 5, 2020",Interventional,"Open-Label, Randomised, Single Oral Dose, Two-Period, Cross-Over Trial To Assess The Bioequivalence Of Favir 200 Mg Ft In Comparison With Avigan 200 Mg Ft In Healthy Male Subjects Under Fasting Conditions",Unrelated
2488,CORONAVIRUS,"February 08, 2021",50,NCT04445194,RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) LOW-DOSE GROUP,CHINA,"Active, not recruiting","Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","June 22, 2020",Interventional,"A Multi-center, Double-blind, Randomized, Placebo Parallel Controlled, Safety and Tolerability Phase I Clinical Trial of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Healthy People Between 18 and 59 Years of Age",COVID
2489,COVID,"February 08, 2021",,NCT04445207,CONVALESCENT PLASMA,UNITED STATES,Available,Jonathan Gerber,,Expanded Access,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19,COVID
2490,COVID,"February 08, 2021",22,NCT04445220,SBI-101,UNITED STATES,Recruiting,"Sentien Biotechnologies, Inc.","November 19, 2020",Interventional,"A Multi-center, Randomized, Case Controlled, Double-blind, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 Therapy) in COVID-19 Subjects With Acute Kidney Injury Receiving Renal Replacement Therapy",COVID
2491,COVID,"February 08, 2021",315,NCT04445233,,UNITED STATES,"Active, not recruiting","University of North Carolina, Chapel Hill","April 29, 2020",Observational,The COVID-19 Household Transmission Study (CO-HOST) - Epidemiology of SARS-CoV-2 Transmission Within the Household,COVID
2492,COVID,"February 08, 2021",40,NCT04445246,INHALED ILOPROST,QATAR,Recruiting,Hamad Medical Corporation,"May 23, 2020",Interventional,Inhaled Iloprost for the Treatment of Suspected COVID-19 Respiratory Failure,COVID
2493,COVID,"February 08, 2021",300,NCT04445259,,UNITED KINGDOM,Recruiting,Guy's and St Thomas' NHS Foundation Trust,"June 20, 2020",Observational,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,COVID
2494,COVID,"February 08, 2021",495,NCT04445272,TOCILIZUMAB,SPAIN,Completed,Fundacion SEIMC-GESIDA,"May 22, 2020",Interventional,"A Multicentre, Open-label Clinical Trial to Evaluate the Effectiveness and Safety of Intravenous Tocilizumab for Treating Patients With COVID-19 Pneumonia: the BREATH-19 Study",COVID
2495,COVID,"February 08, 2021",44,NCT04445285,PULMOZYME/ RECOMBINANT HUMAN DEOXYRIBONUCLEASE (RH-DNASE),UNITED STATES,Recruiting,Jon Simmons,"April 28, 2020",Interventional,Double Blind Randomized Phase 2 Placebo Controlled Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,COVID
2496,COVID,"February 08, 2021",100,NCT04445311,IVERMECTIN,EGYPT,Recruiting,Zagazig University,"May 31, 2020",Interventional,Use of Ivermectin as a Therapeutic Option for Patients With COVID-19,COVID
2497,PSYCHOTIC DISORDERS,"February 08, 2021",30,NCT04445324,TRANSITIONAL ONLINE PEER SUPPORT GROUP (N=20),CANADA,"Active, not recruiting",Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal,"August 25, 2020",Interventional,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 : A Feasibility Study of a Trial,Unrelated
2498,COVID,"February 08, 2021",10,NCT04445337,STELLATE GANGLION BLOCK,,Not yet recruiting,University of Nebraska,July 2020,Interventional,Stellate Ganglion Blockade in COVID-19 Positive Patients,COVID
2499,COVID,"February 08, 2021",20,NCT04445376,PHYSICAL EXERCISES,PAKISTAN,Completed,Government College University Faisalabad,"July 3, 2020",Interventional,Effect of Aerobic Exercises on Cardio-respiratory Fitness and Quality of Life in Recovered COVID 19 Recovered Patients.,COVID
2500,SARS-CoV2,"February 08, 2021",210,NCT04445389,GX-19,"KOREA, REPUBLIC OF",Recruiting,"Genexine, Inc.","June 17, 2020",Interventional,"A Phase 1/2a, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Immunogenicity of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Subjects",COVID
2501,PEDIATRIC CANCER,"February 08, 2021",1500,NCT04445402,,UNITED STATES,Recruiting,Columbia University,"April 30, 2020",Observational [Patient Registry],Retrospective and Prospective Database of COVID-19 Prevalence and Clinical Course in Pediatric and Young Adult Hematology/ Oncology/Stem Cell Therapy Patients in the New York Tri-State Area.,Unrelated
2502,COVID,"February 08, 2021",250,NCT04445415,COVID-19 ANTIBODIES TESTING,,Not yet recruiting,Assiut University,"July 1, 2020",Observational,Diagnostic Value of New- Covid 19 Antibodies Testing Among Laboratory Healthcare Workers,COVID
2503,"POLIOVIRUS VACCINE, ORAL","February 08, 2021",3400,NCT04445428,ORAL POLIO VACCINE + INFORMATION,GUINEA-BISSAU,Enrolling by invitation,Bandim Health Project,"July 15, 2020",Interventional,Oral Polio Vaccine as Potential Protection Against COVID-19: A Cluster-randomised Trial in Guinea-Bissau,Unrelated
2504,CORONAVIRUS INFECTION,"February 08, 2021",153,NCT04445441,,BURKINA FASO,Completed,Centre Muraz,"April 24, 2020",Observational,An Observational Study to Assess the Effectiveness of the Standard of Care (Hydroxychloroquine+Azythromicin or Chloroquine+Azythromicin) Recommended by the Ministry of Health for the Treatment of the Coronavirus Infection in Burkina Faso,COVID
2505,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04445454,MESENCHYMAL STROMAL CELLS,BELGIUM,Recruiting,University of Liege,"June 12, 2020",Interventional,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,COVID
2506,COVID,"February 08, 2021",190,NCT04445467,FAVIPIRAVIR,AUSTRALIA,Recruiting,Bayside Health,"August 1, 2020",Interventional,An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection,COVID
2507,"STROKE, ACUTE","February 08, 2021",250,NCT04445493,MINDRHYTHM HARMONY,,Not yet recruiting,"MindRhythm, Inc.","October 1, 2020",Observational,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic,Unrelated
2508,CORTICOSTEROIDS,"February 08, 2021",50,NCT04445506,DEXAMETHASONE,UNITED STATES,Completed,The Miriam Hospital,"April 1, 2020",Observational,"The Effect of the Short-term Use of Systemic Corticosteroids in COVID-19 Patients in Regard to Hospital Length of Stay, Morbidly and/or Mortality.",Unrelated
2509,SARS-CoV2,"February 08, 2021",90,NCT04445597,SAMPLING OF TISSUE,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"May 7, 2020",Interventional,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,COVID
2510,CORONAVIRUS (COVID),"February 08, 2021",60,NCT04445610,,EGYPT,Not yet recruiting,Ain Shams University,"July 1, 2020",Observational,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,COVID
2511,COVID,"February 08, 2021",128,NCT04445623,PRASUGREL HYDROCHLORIDE 10 MG ORAL TABLET,ITALY,Not yet recruiting,Azienda Ospedaliera Universitaria Integrata Verona,July 2020,Interventional,Prasugrel in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients,COVID
2512,CANCER,"February 08, 2021",100,NCT04445870,DATA RECORD,FRANCE,Recruiting,CHU de Reims,"May 1, 2020",Observational,Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study,Unrelated
2513,ANTICOAGULATION IN COVID ARDS,"February 08, 2021",100,NCT04445935,BIVALIRUDIN INJECTION,QATAR,Recruiting,Hamad Medical Corporation,"June 28, 2020",Interventional,Anticoagulation in Patients Suffering From COVID-19 Disease-The Anti-Co Trial,COVID
2514,SARS PNEUMONIA,"February 08, 2021",117,NCT04445961,RESPIRATORY MECHANICS MEASUREMENT,RUSSIAN FEDERATION,Completed,I.M. Sechenov First Moscow State Medical University,"May 1, 2020",Observational,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure: Multicentral Observational Study,Respiratory
2515,COVID,"February 08, 2021",524,NCT04446065,PREVIFENON®,,Not yet recruiting,MELISA Institute Genomics & Proteomics Research SpA,"September 30, 2020",Interventional,"A Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Protect Health Workers Against COVID-19 by Using Previfenon® as Chemoprophylaxis During a SARS-CoV-2 Outbreak. The HERD Study",COVID
2516,COVID,"February 08, 2021",4257,NCT04446104,HYDROXYCHLOROQUINE SULFATE TABLETS,SINGAPORE,Completed,"National University Hospital, Singapore","May 13, 2020",Interventional,A Randomized Open-label Prophylaxis Trial Among Migrant Workers at High-risk of COVID-19 (DORM Trial),COVID
2517,SARS-CoV2,"February 08, 2021",43,NCT04446169,SARS-COV 2 RNA PCR URINE,ITALY,"Active, not recruiting",University of Florence,"June 27, 2020",Observational,"COVID-19 (SARS-CoV-2) in Urine and Semen: Qualitative and Quantitative Analyses and Evaluation of STD, Sexual Function, Fertility and Urinary Function",COVID
2518,COVID,"February 08, 2021",50,NCT04446286,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","June 18, 2020",Observational,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19,COVID
2519,"HISTORY OF COVID, SEROPREVALENCE","February 08, 2021",300,NCT04446338,ANTIBODY TEST,GERMANY,Recruiting,University Hospital Tuebingen,"May 13, 2020",Observational,Immune Status: Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Sample of the Eye Department (University Eye Hospital and Research Institute Tübingen),COVID
2520,COVID DISEASE,"February 08, 2021",142,NCT04446377,APILIMOD DIMESYLATE CAPSULE,UNITED STATES,Recruiting,"AI Therapeutics, Inc.","July 15, 2020",Interventional,"A Phase II Randomized, Double-Blind, Placebo-Controlled Study of LAM-002A for the Prevention of Progression of COVID-19",COVID
2521,COVID,"February 08, 2021",262,NCT04446429,PROXALUTAMIDE,BRAZIL,Completed,"Applied Biology, Inc.","September 15, 2020",Interventional,Anti-Androgen Treatment for COVID-19,COVID
2522,COVID,"February 08, 2021",200,NCT04447131,VENIPUNCTURE IN PERIPHERAL VEIN,BRAZIL,Recruiting,University of Sao Paulo,"April 29, 2020",Observational,Effect of SARS-CoV-2 Infection on Platelet Aggregation and Other Coagulation Parameters,COVID
2523,COVID,"February 08, 2021",200,NCT04447144,,EGYPT,Recruiting,Cairo University,"June 1, 2020",Observational,"Nutritional Habits, Does it Affect Coronavirus Disease 2019 (COVID-19) Infection Outcome? An Egyptian Experience",COVID
2524,DIETARY DIVERSITY,"February 08, 2021",300,NCT04447209,"DIETARY COUNSELLING ON FOOD GROUPS ACCORDING TO IYC FEEDING PRACTICES, WHO",MALAYSIA,Recruiting,University of Malaya,"June 6, 2020",Observational,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,Unrelated
2525,COVID INFECTION,"February 08, 2021",1242,NCT04447222,QUALITY-OF-LIFE ASSESSMENT,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"May 12, 2020",Observational,COVID-19: Well-Being and HRQOL in Cancer Patients Who Participated in Prior Behavioral Clinical Trials,COVID
2526,CANCER,"February 08, 2021",176,NCT04447235,PLACEBO,BRAZIL,Recruiting,Instituto do Cancer do Estado de São Paulo,"July 23, 2020",Interventional,"Randomized, Doubled-blind Phase II Trial Evaluating the Use of Ivermectin Plus Losartan for Prophylaxis of Severe Events in Cancer Patients With Recent Diagnosis of COVID-19",Unrelated
2527,SARS-CoV2,"February 08, 2021",80,NCT04447404,DUR-928,UNITED STATES,Recruiting,Durect,"September 21, 2020",Interventional,"A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Safety and Efficacy of DUR-928 in Subjects Infected With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury",COVID
2528,COVID,"February 08, 2021",573,NCT04447469,MAVRILIMUMAB,BRAZIL,Recruiting,"Kiniksa Pharmaceuticals, Ltd.","July 27, 2020",Interventional,"A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Mavrilimumab (KPL-301) Treatment in Adult Subjects Hospitalized With Severe COVID-19 Pneumonia and Hyper-inflammation",COVID
2529,CORONAVIRUS,"February 08, 2021",500,NCT04447495,IAMP TEST,,Not yet recruiting,Medical College of Wisconsin,"July 1, 2020",Observational,Self-sampling for the Study of COVID-19,COVID
2530,COVID,"February 08, 2021",200,NCT04447534,CHLOROQUINE,EGYPT,Recruiting,Tanta University,"June 23, 2020",Interventional,Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine in Treatment of COVID-19?,COVID
2531,TRACHEOSTOMY,"February 08, 2021",24,NCT04447638,TRACHEOSTOMY WITH AEROSOL BOX IN COVID-19 POSITIVE PATIENTS,TURKEY,Completed,Çanakkale Onsekiz Mart University,"March 20, 2020",Observational,Percutaneous Tracheostomy With Aerosol Box in COVID-19 Positive Patients in Intensive Care Unit: a Clinical Trial,Unrelated
2532,STUDENT,"February 08, 2021",5553,NCT04447690,,CHILE,"Active, not recruiting","Universidad de los Andes, Chile","August 3, 2020",Observational,Prevalence of Mental Health Problems Among Undergraduate Students at the Universidad de Los Andes,Unrelated
2533,CORONAVIRUS INFECTION,"February 08, 2021",160,NCT04447781,INO-4800,"KOREA, REPUBLIC OF",Recruiting,International Vaccine Institute,"July 15, 2020",Interventional,"A Phase I/IIa, Dose-Ranging Trial to Evaluate Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers",COVID
2534,"ARDS, HUMAN","February 08, 2021",9,NCT04447833,MESENCHYMAL STROMAL STEM CELLS - KI-MSC-PL-205,SWEDEN,Recruiting,Uppsala University,"June 17, 2020",Interventional,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome Validation of Mechanistic Pathways and Clinical Efficacy,Unrelated
2535,LIVER CIRRHOSIS,"February 08, 2021",476,NCT04448028,PLACEBO,GERMANY,Not yet recruiting,Universitätsklinikum Hamburg-Eppendorf,January 2021,Interventional,"Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial",Unrelated
2536,"ESTIMATE, WITH THE CONTRIBUTION OF OPTIMIZED MRI, THE PREVALENCE OF NEUROLOGICAL AND NEUROVASCULAR MANIFESTATIONS ON IMAGING IN THE EVENT OF SARS-CoV2","February 08, 2021",100,NCT04448054,MRI,FRANCE,Recruiting,Fondation Ophtalmologique Adolphe de Rothschild,"May 20, 2020",Observational,"Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas",COVID
2537,COVID,"February 08, 2021",760,NCT04448119,FAVIPIRAVIR,CANADA,Recruiting,Appili Therapeutics Inc.,"October 16, 2020",Interventional,Control of COVID-19 Outbreaks in Long Term Care (CONTROL-COVID),COVID
2538,COVID,"February 08, 2021",250,NCT04448145,,UNITED STATES,Recruiting,Columbia University,"March 26, 2020",Observational,"Characterizing SARS-CoV-2 Persistence in Host Reservoirs, Post-viral Sequelae, and Associations With Host and Viral Determinants in a Cohort of Convalescent COVID-19 Cases",COVID
2539,DEVIANT SEXUAL FANTASIES,"February 08, 2021",100,NCT04448405,QUESTIONNAIRE FOR EVALUATION OF CONFINEMENT ON DEVIANT SEXUAL FANTASIES,FRANCE,Completed,"University Hospital, Montpellier","June 18, 2020",Observational,Descriptive Study on the Impact of Covid-19 Lockdown on Deviant Sexual Fantasies,Unrelated
2540,TRANSGENDER PERSONS,"February 08, 2021",300,NCT04448418,WEB BASED SURVEY,ITALY,"Active, not recruiting",Unita Complessa di Ostetricia e Ginecologia,"May 20, 2020",Observational,Observational Evaluation of the Impact of COVID-19 Outbreak on Transgender Subject's Health and on the Organization of Trans-population Health Care Services,Unrelated
2541,MENTAL HEALTH ISSUE,"February 08, 2021",1288,NCT04448704,,SINGAPORE,Completed,Yale-NUS College,"June 22, 2020",Observational,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak,Unrelated
2542,SARS-CoV2,"February 08, 2021",8000,NCT04448717,COVID-19 ANTIBODY TESTING,SWITZERLAND,Recruiting,University of Zurich,"June 16, 2020",Observational,Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in a Public School Population - a Population-based Observational Study to Inform Policy Making,COVID
2543,COVID,"February 08, 2021",175,NCT04448743,BLOOD SAMPLE,,Not yet recruiting,"University Hospital, Strasbourg, France",June 2020,Observational,Role of Circulating Microparticles in Covid-19 Infection,COVID
2544,CORONAVIRUS DISEASE 2019,"February 08, 2021",150,NCT04448756,M5049,BRAZIL,Recruiting,"EMD Serono Research & Development Institute, Inc.","July 29, 2020",Interventional,"A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of M5049 in Hospitalized Participants With COVID-19 Pneumonia",COVID
2545,CORONAVIRUS INFECTION,"February 08, 2021",2006,NCT04448769,ANTI-SARS-COV-2 IGT SEROPOSITIVITY,FRANCE,Completed,"Central Hospital, Nancy, France","June 26, 2020",Interventional,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) in the Population of the Grand Nancy Metropolitan Area,COVID
2546,MECHANICAL VENTILATION COMPLICATION,"February 08, 2021",32,NCT04448782,ASYNCHRONIES DETECTION,SPAIN,Completed,Corporacion Parc Tauli,"March 9, 2020",Observational,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation,Unrelated
2547,AIRWAY MANAGEMENT,"February 08, 2021",15000,NCT04449042,AIRWAY MANAGEMENT DURING SEDATION OR GENERAL ANESTHESIA,UNITED STATES,Recruiting,Boston Children's Hospital,"April 1, 2020",Observational [Patient Registry],"Pediatric Airway Management Complications During the COVID-19 Pandemic. An International, Multicenter, Observational Registry: The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry",Unrelated
2548,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",215,NCT04449081,"KNOWLEDGE, ATTITUDE, PRACTICE, AWARENESS, PREFERENCE",MALAYSIA,Completed,Melaka Manipal Medical College,"April 25, 2020",Observational,"Knowledge, Attitude and Practice About COVID-19 and Awareness of Infection Control to Prevent COVID-19 Transmission in Clinics and Perception About Online Learning During Lock Down Period: A Cross-sectional Study",Respiratory
2549,COVID,"February 08, 2021",200,NCT04449094,,FRANCE,Completed,Centre Hospitalier Universitaire de Nice,"February 28, 2020",Observational,Socio-demographic Factors and Emergence of the COVID 19 Epidemic in the City of Nice in 2020,COVID
2550,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",280,NCT04449276,CVNCOV VACCINE,BELGIUM,"Active, not recruiting",CureVac AG,"June 18, 2020",Interventional,"COVID-19: A Phase 1, Partially Blind, Placebo-controlled, Dose Escalation, First-in-human, Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity After 1 and 2 Doses of the Investigational SARS-CoV-2 mRNA Vaccine CVnCoV Administered Intramuscularly in Healthy Adults",Respiratory
2551,COVID VIRUS INFECTION,"February 08, 2021",126,NCT04449380,INTERFERON-SS-1A,ITALY,Recruiting,Emanuele Bosi,"November 2, 2020",Interventional,"Randomized, Controlled, Open Label, Phase 2 Clinical Trial of Interferon-β-1a (IFNβ-1a) in COVID-19 Patients",COVID
2552,COVID PNEUMONIA,"February 08, 2021",368,NCT04449588,BDB-001 INJECTION,CHINA,Recruiting,"Staidson (Beijing) Biopharmaceuticals Co., Ltd","July 23, 2020",Interventional,"A Multi-center, Open-label, Randomized Parallel Controlled Evaluation on the Efficacy and Safety of BDB-001 Injection in the Treatment of Progressive Severe COVID-19 in Phase II/III",COVID
2553,ANXIETY DISORDERS,"February 08, 2021",125,NCT04449627,FEELING GOOD DIGITAL APP,,Not yet recruiting,Royal Free Hospital NHS Foundation Trust,"August 31, 2020",Observational,Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention,Unrelated
2554,COVID,"February 08, 2021",240,NCT04449718,VITAMIN D,BRAZIL,Completed,University of Sao Paulo,"June 1, 2020",Interventional,"Vitamin D Supplementation in Patients With COVID-19: A Randomized, Double-blind, Placebo-controlled Trial",COVID
2555,COVID,"February 08, 2021",30000,NCT04449731,,SPAIN,Recruiting,Universidad de Granada,"March 20, 2020",Observational,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population,COVID
2556,OPIOID-USE DISORDER,"February 08, 2021",30,NCT04449744,MYSAFERX INSPIRE PLUS,UNITED STATES,Recruiting,University of South Florida,"July 13, 2020",Interventional,Effects of Remote Motivational Enhancement & MySafeRx on Post-Detox Engagement and Retention in Buprenorphine Treatment (MySafeRx) - A Pilot Study,Unrelated
2557,COVID,"February 08, 2021",150,NCT04449783,PRE-OPERATIVE SCREENING,UNITED KINGDOM,Recruiting,Liverpool University Hospitals NHS Foundation Trust,"June 25, 2020",Observational,A Cohort Study to Assess the Effectiveness of Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery Patients in the COVID-19 Pandemic,COVID
2558,COVID,"February 08, 2021",81,NCT04449965,POVIDONE-IODINE,,Not yet recruiting,"St. Paul's Hospital, Canada","July 1, 2020",Interventional,The Efficacy of Topical Povidone-Iodine Rinses in the Management of the Coronavirus Disease 2019 (COVID-19),COVID
2559,CORONAVIRUS,"February 08, 2021",1082,NCT04449978,,CANADA,Recruiting,The Hospital for Sick Children,"April 9, 2020",Observational,TARGet Kids! COVID-19 Study of Children and Families,COVID
2560,SARS-CoV2,"February 08, 2021",180,NCT04450004,INTRAMUSCULAR VACCINE,CANADA,"Active, not recruiting",Medicago,"July 10, 2020",Interventional,"A Randomized, Partially-Blinded, Dose-Ranging Phase 1 Study to Assess the Safety, Tolerability, and Immunogenicity of a Recombinant Coronavirus-Like Particle COVID 19 Vaccine in Adults 18-55 Years of Age",COVID
2561,SARS-CoV2,"February 08, 2021",150,NCT04450017,"THE DEMOGRAPHIC, CLINICAL, LABORATORY, AND INSTRUMENTAL DATA",RUSSIAN FEDERATION,Recruiting,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia","April 6, 2020",Observational,Clinical Features of Severe Patients With COVID-19,COVID
2562,COVID,"February 08, 2021",15,NCT04450277,EMERGENCY SURGERY,SINGAPORE,Completed,Khoo Teck Puat Hospital,"April 1, 2020",Observational [Patient Registry],Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic Based on Case Series,COVID
2563,SOCIAL ANXIETY,"February 08, 2021",25,NCT04450303,TELEHEALTH CBT,,Not yet recruiting,Stanford University,"October 30, 2020",Interventional,Social Anxiety Telehealth Therapy Study,Unrelated
2564,COVID,"February 08, 2021",184,NCT04451174,PREDNISONE,CHILE,Recruiting,University of Chile,"June 23, 2020",Interventional,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia (PREDCOVID),COVID
2565,KERATONJUNCTIVITIS,"February 08, 2021",12,NCT04451239,TOPICAL STEROIDS AND CYCLOSPORIN-A,KUWAIT,Not yet recruiting,Ameera Gamal Abdelhameed,"June 30, 2020",Interventional,Combined Topical Corticosteroid and Topical Cyclosporine-A for Management of COVID-19 Keratoconjunctivitis; a Pilot Study,Unrelated
2566,COVID,"February 08, 2021",20,NCT04451291,DECIDUAL STROMAL CELLS (DSC),CANADA,Not yet recruiting,"University Health Network, Toronto","August 24, 2020",Interventional,DSC-COVID-19: An Open-label Study on the Safety and Efficacy of Decidual Stromal Cells in Respiratory Failure Induced by COVID-19,COVID
2567,PHYSICAL ACTIVITY,"February 08, 2021",600,NCT04451317,"QUESTIONNAIRE, PHONE CALL",FRANCE,Recruiting,"University Hospital, Toulouse","June 12, 2020",Observational,"Changes in Physical and Sports Activity, Anxiety and Sleep Patterns Following the Containment Period Imposed by the COVID-19 Pandemic in Patients With Chronic Medical Conditions and in Healthy Athletes.",Unrelated
2568,COVID,"February 08, 2021",5000,NCT04451577,NO INTERVENTION,ITALY,Recruiting,Istituto Clinico Humanitas,"June 1, 2020",Observational,"Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection: a Retrospective-prospective Cohort Study",COVID
2569,COVID,"February 08, 2021",800,NCT04451694,NUTRITIONAL INTERVENTION,FRANCE,Recruiting,"Central Hospital, Nancy, France","April 1, 2020",Observational,Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19,COVID
2570,COVID,"February 08, 2021",15,NCT04451889,MINIPROBE ALVEOFLEX,RUSSIAN FEDERATION,Recruiting,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia","August 1, 2020",Interventional,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,COVID
2571,RARE DISEASES,"February 08, 2021",80,NCT04451902,,,Not yet recruiting,Imagine Institute,"June 30, 2020",Observational [Patient Registry],COVID-19 and Rare Skin Diseases. European Observational Study (Data Research) During an Epidemic,Unrelated
2572,OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROME,"February 08, 2021",63,NCT04451993,,TURKEY,Completed,Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital,"June 25, 2020",Observational,"Are the Sleep Quality and Physical Activity Levels of Osas Patients Differently From Healthy People During the COVID-19 Pandemic:a Prospective, Descriptive Study",Unrelated
2573,COVID,"February 08, 2021",39,NCT04452097,HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS + BEST SUPPORTIVE CARE,,Not yet recruiting,Baylx Inc.,"March 1, 2021",Interventional,A Phase 1/2a Study of the Safety and Efficacy of BX-U001 for the Treatment of Severe COVID-19 Pneumonia With Moderate to Severe Acute Respiratory Distress Syndrome (ARDS).,COVID
2574,HEALTHY PARTICIPANTS,"February 08, 2021",2450,NCT04452318,REGN10933 + REGN10987,"MOLDOVA, REPUBLIC OF",Recruiting,Regeneron Pharmaceuticals,"July 13, 2020",Interventional,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-CoV-2 Infection in Household Contacts of Individuals Infected With SARS-CoV-2",Unrelated
2575,DEEP VENOUS THROMBOSIS,"February 08, 2021",30,NCT04452422,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","June 23, 2020",Observational,High Prevalence of Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology,Unrelated
2576,COVID,"February 08, 2021",106,NCT04452435,C21,INDIA,Completed,Vicore Pharma AB,"July 21, 2020",Interventional,"A Randomised, Double-blind, Placebo-controlled, Phase 2 Trial Investigating the Safety and Efficacy of C21 in Hospitalised Subjects With COVID-19 Infection Not Requiring Mechanical Ventilation",COVID
2577,COVID,"February 08, 2021",376,NCT04452474,OLOKIZUMAB 64 MG,UNITED STATES,Not yet recruiting,R-Pharm,"June 30, 2020",Interventional,"A Multicenter, Randomized, Double-blind, Adaptive, Placebo-controlled Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe SARS-CoV-2 Infection (COVID-19)",COVID
2578,PATIENT HOSPITALIZED IN DISEASE INFECTIOUS UNIT,"February 08, 2021",2500,NCT04452487,DECISIONS OF LIMITATIONS AND STOP PROCESSING,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 1, 2020",Observational,Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments,Unrelated
2579,CORONAVIRUS INFECTION,"February 08, 2021",525,NCT04452565,DRUG: NA-831,UNITED STATES,Recruiting,"NeuroActiva, Inc.","October 15, 2020",Interventional,"Randomized Controlled Phase 2/3 Clinical Trial of NA-831 Alone or With Atazanavir, or NA-831 With Dexamethasone, or Atazanavir With Dexamethasone in the Treatment of COVID-19 Infection",COVID
2580,ACUTE MYELOBLASTIC LEUKEMIA,"February 08, 2021",30,NCT04452604,,,Not yet recruiting,French Innovative Leukemia Organisation,"August 1, 2020",Observational,National Retrospective Monitoring of Patients With Acute Leukemia Infected by COronaVirus Disease 2019 (COVID-19),Unrelated
2581,COVID,"February 08, 2021",40,NCT04452617,,FRANCE,Completed,Institut Mutualiste Montsouris,"March 19, 2020",Observational,Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19,COVID
2582,CARDIOVASCULAR CONSEQUENCES AFTER AN EPISODE OF COVID,"February 08, 2021",200,NCT04452630,INFECTIOUS DISEASE AND CARDIOLOGY CLINICAL CONSULTATIONS,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"June 23, 2020",Observational,The CardioPostCovid Study: Cardiovascular Consequences After COVID-19,COVID
2583,COVID,"February 08, 2021",0,NCT04452643,BACMUNE (MV130),MEXICO,Withdrawn,Inmunotek S.L.,October 2020,Interventional,"Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial on the Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to SARS-CoV-2 Infection in Healthcare Personnel",COVID
2584,COVID,"February 08, 2021",20,NCT04452669,VENTAPROST (INHALED EPOPROSTENOL DELIVERED VIA A DEDICATED DELIVERY SYSTEM),UNITED STATES,Recruiting,Aerogen Pharma Limited,"September 15, 2020",Interventional,"Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of VentaProst (Inhaled Epoprostenol Delivered Via Dedicated Delivery System) in Subjects With COVID-19 Requiring Mechanical Ventilation",COVID
2585,COVID,"February 08, 2021",998,NCT04452682,COVID 19 IMPACT,EGYPT,Completed,Mansoura University,"May 25, 2020",Observational,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice,COVID
2586,COVID,"February 08, 2021",40,NCT04452695,DOCTOR SPOT,UNITED STATES,Completed,Brigham and Women's Hospital,"March 10, 2020",Observational,Acceptability of Telehealth Triage Using Robotic Systems in COVID-19,COVID
2587,RESPIRATORY FAILURE,"February 08, 2021",15,NCT04452708,HFNC,HONG KONG,Recruiting,Chinese University of Hong Kong,"June 11, 2020",Observational,The Safety of High Flow Nasal Cannula and Noninvasive Ventilation for Treatment of Patients With COVID-19 Complicated by Respiratory Failure,Respiratory
2588,COVID,"February 08, 2021",315,NCT04452773,MANREMYC,SPAIN,Recruiting,Reig Jofre Group,"July 14, 2020",Interventional,"Double-blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of the Manremyc® Food Supplement to Prevent SARS-CoV-2 Infection",COVID
2589,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04452799,HESPERIDIN AND DIOSMIN MIXTURE,,Not yet recruiting,Tanta University,"July 1, 2020",Interventional,Randomized Double-blind Controlled Parallel Study of (Hesperidin and Diosmin Mixture) for Treatment of COVID-19 Newly Diagnosed Patients in Egypt,COVID
2590,COVID PNEUMONIA,"February 08, 2021",15,NCT04452812,CONVALESCENT PLASMA,MEXICO,Not yet recruiting,Universidad Autonoma de Coahuila,"July 6, 2020",Interventional,"Pilot Clinical, Statistical and Epidemiological Study on Efficacy and Safety of Convalescent Plasma for the Management of Patients With COVID-19",COVID
2591,COVID,"February 08, 2021",30,NCT04452942,,UNITED STATES,Not yet recruiting,EicOsis Human Health Inc.,July 2020,Observational,Dynamic Changes in Cytokine and Eicosanoid Mediators Among Hospitalized Patients With Coronavirus Infectious Disease 2019 (COVID-19),COVID
2592,COVID,"February 08, 2021",695,NCT04453280,QUANTITATIVE ANALYSIS OF ANTI-SARS-COV-2-ANTIBODIES,CZECHIA,Completed,Institute of Health Information and Statistics of the Czech Republic,"May 18, 2020",Observational,Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity),COVID
2593,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",50,NCT04453371,TISSUE PLASMINOGEN ACTIVATOR,,Not yet recruiting,Negovsky Reanimatology Research Institute,"October 15, 2020",Interventional,Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (Microvascular COVID-19 Lung Vessels Obstructive Thromboinflammatory Syndrome (MicroCLOTS): A Multicentral Randomized Trial (AtTAC-trial),Respiratory
2594,SARS VIRUS,"February 08, 2021",414,NCT04453384,XAV-19,FRANCE,Recruiting,Nantes University Hospital,"September 1, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 2 (2a and 2b) Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia",Respiratory
2595,PSYCHOSOMATIC DISORDER,"February 08, 2021",1230,NCT04453475,TRAINING SESSION ADRESSING INFORMATION AND HEALTH LITERACY,GERMANY,Recruiting,Jacobs University Bremen gGmbH,"July 1, 2020",Interventional,Therapies to Achieve Treatment Goals While Being Exposed to Hygiene and Distance Rules: Feasibility and Benefits of Digital Services During the COVID19 Pandemic (Anhand-COVID19),Unrelated
2596,COVID,"February 08, 2021",315,NCT04453488,RUTI® VACCINE,SPAIN,Not yet recruiting,Fundació Institut Germans Trias i Pujol,"July 30, 2020",Interventional,"Double-blind, Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of the RUTI® Vaccine to Prevent SARS-CoV-2 Infection",COVID
2597,COVID,"February 08, 2021",132,NCT04453501,FAVORABLE OUTCOME,FRANCE,Completed,Centre d'Investigation Clinique et Technologique 805,"March 2, 2020",Observational,Interest of Azithromycin With or Without Hydroxychloroquine for the Treatment of COVID-19 Pneumonia : a Retrospective Observational Study,COVID
2598,ANXIETY,"February 08, 2021",200,NCT04453514,TRAUMA-INFORMED YOGA VIDEO RECORDING,UNITED STATES,Recruiting,National University of Natural Medicine,"July 21, 2020",Interventional,Cultivating Calm During COVID-19: A Feasibility Study of Video-based Trauma-informed Yoga,Unrelated
2599,CORONAVIRUS,"February 08, 2021",100,NCT04453527,,UNITED KINGDOM,Recruiting,Portsmouth Hospitals NHS Trust,"May 28, 2020",Observational,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Coronavirus Disease 2019,COVID
2600,INFECTIOUS DISEASE,"February 08, 2021",150,NCT04453540,FILMARRAY PCR ON RESPIRATORY SAMPLES,,Not yet recruiting,"Central Hospital, Nancy, France","July 1, 2020",Observational,Impact of the Syndromic PCR System FilmArray on Management of ICU Patients With Severe Pulmonary Disease in the Context of the Covid-19 Pandemic.,Unrelated
2601,COVID,"February 08, 2021",50,NCT04453553,Q16 TESTING,UNITED KINGDOM,Not yet recruiting,Queen Mary University of London,"July 2, 2020",Interventional,COVID-19 in Vitro Diagnostic Near-patient Testing in Care Environments Using a Cluster Randomised Open-label Trial Design in an East London Care Home Population,COVID
2602,COVID,"February 08, 2021",120,NCT04453566,ONLINE SURVEY,TURKEY,Recruiting,Uskudar University,"May 27, 2020",Observational,"Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes.",COVID
2603,OBESE,"February 08, 2021",116,NCT04453579,TELEPHONIC INTERVIEW DURING THE ITALIAN LOCKDOWN.,ITALY,Completed,University of Rome Tor Vergata,"March 9, 2020",Observational [Patient Registry],Was it Right to Stop Bariatric Surgery During COVID-19 Lockdown?,Unrelated
2604,"STRESS, PSYCHOLOGICAL","February 08, 2021",270,NCT04453657,FAMILYCHILDCARE (PROVISIONAL NAME OF APP),UNITED STATES,Enrolling by invitation,Johns Hopkins University,"February 4, 2021",Interventional,"Adapting and Delivering a Tele-Wellness Supported Digital Toolkit to Baltimore City's Approved Family Child Care Home Providers Caring for Children of Essential Workers: Promoting Health, Early Literacy, and Quality Parent Engagement Amid COVID-19: A Pilot Study",Unrelated
2605,COVID,"February 08, 2021",7,NCT04453670,AUTOPSY,FRANCE,Completed,University of Versailles,"March 10, 2020",Observational,A Prospective Observational Autopsy Study of Neuropathology in Adults Intensive Care Unit Patients With COVID 19,COVID
2606,COVID,"February 08, 2021",200,NCT04453748,COMPLEX DIAGNOSTIC PANEL,POLAND,Enrolling by invitation,Silesian Centre for Heart Diseases,"June 8, 2020",Observational [Patient Registry],"The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications",COVID
2607,CORONAVIRUS,"February 08, 2021",1000,NCT04453774,COVIDFREE@HOME,CANADA,Not yet recruiting,"University Health Network, Toronto","October 16, 2020",Interventional,Covidfree@Home: At Home Monitoring Using Mobile Devices for Patients With Covid19,COVID
2608,CRITICAL COVID WITH RESPIRATORY FAILURE,"February 08, 2021",,NCT04453839,RLF-100 (AVIPTADIL),UNITED STATES,Available,"NeuroRx, Inc.",,Expanded Access,RLF-100 (Aviptadil) Intermediate Population Expanded Access Protocol,COVID
2609,CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04453852,COVID19 VACCINE,AUSTRALIA,Recruiting,Vaxine Pty Ltd,"June 30, 2020",Interventional,"A Randomised, Controlled, Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Adjuvanted Recombinant Protein SARS-COV-2 Vaccine in Healthy Adult Subjects",COVID
2610,COVID,"February 08, 2021",16,NCT04453891,MONITORING PHYSIOLOGICAL DATA WITH THE HEXOSKIN SMART SHIRT,,Not yet recruiting,Nguyen Thu Ngan Trinh,"July 15, 2020",Observational,"Evaluating the Feasibility of Monitoring Symptomatic COVID-19 Patients, and Predicting Disease Progression Using a Validated Digital Health Program",COVID
2611,SARS-CoV2,"February 08, 2021",50,NCT04453969,COVID-19,CANADA,Recruiting,Deborah O'Connor,"May 24, 2020",Observational,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a,COVID
2612,SARS-CoV2,"February 08, 2021",500,NCT04453982,HUMAN MILK DONORS,CANADA,Recruiting,Deborah O'Connor,"June 21, 2020",Observational,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b,COVID
2613,COVID,"February 08, 2021",100,NCT04454307,TRAMADOL,,Not yet recruiting,Tanta University,July 2020,Interventional,Safety and Efficacy of Tramadol Adjuvant Therapy to Standard Care for COVID-19 Egyptian Patients: A Randomized Double Blind Controlled Clinical Trial,COVID
2614,INFECTION,"February 08, 2021",466,NCT04454333,,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"June 3, 2020",Observational,COVID-19 in Pain Perspective,Unrelated
2615,COVID,"February 08, 2021",187,NCT04454372,DEMOGRAPHIC AND CLINICAL DATA OBTAINED FROM HOSPITAL'S ELECTRONIC MEDICAL RECORD.,,Not yet recruiting,Hospital Sao Domingos,"July 15, 2020",Observational,Clinical Characteristics and Outcomes of 187 Critically Ill Patients With COVID-19,COVID
2616,COVID,"February 08, 2021",0,NCT04454398,COVI-GUARD,,Withdrawn,"Sorrento Therapeutics, Inc.",September 2020,Interventional,"A Randomized, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Efficacy of a Single Dose of STI-1499 (COVI-GUARD™) in Hospitalized Patients With Moderate COVID-19",COVID
2617,COVID,"February 08, 2021",43,NCT04454606,FIT TEST,THAILAND,Completed,Bangkok Metropolitan Administration Medical College and Vajira Hospital,"May 1, 2020",Interventional,The New Silicone N99 Half-Piece Respirator:VJR-NMU N99:New and Effective Tool to Prevent COVID-19,COVID
2618,COVID,"February 08, 2021",1180,NCT04455243,N-ACETYL CYSTEINE,,Not yet recruiting,Dr. Tariq Alhawassi,"August 1, 2020",Interventional,Pilot Double Blinded Randomized Placebo Controlled Multi Central Clinical Trial on Inflammatory Regulation Effect of NAC on COVID-19,COVID
2619,CHILBLAINS,"February 08, 2021",269,NCT04455308,BIOLOGICAL SAMPLE COLLECTION,FRANCE,Completed,Rennes University Hospital,"July 21, 2020",Interventional,"Chilblains, COVID-19 and Lockdown: Epidemiologic Study",Unrelated
2620,COVID INFECTION,"February 08, 2021",80,NCT04455347,,FRANCE,Recruiting,Imagine Institute,"June 15, 2020",Observational [Patient Registry],Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked,COVID
2621,POST TRAUMATIC STRESS DISORDER,"February 08, 2021",26,NCT04455360,EYE MOVEMENT DESENSITISATION AND REPROCESSING RECENT TRAUMATIC EVENT PROTOCOL,UNITED KINGDOM,Recruiting,University Hospital Southampton NHS Foundation Trust,"October 1, 2020",Interventional,EMERALD: Can a Virtual Eye Movement Desensitisation and Reprocessing Intervention Improve Psychological Outcome Following Covid-19 Related Critical Illness: A Feasibility Trial,Unrelated
2622,COVID,"February 08, 2021",2000,NCT04455451,,GERMANY,Recruiting,University Hospital Tuebingen,"August 6, 2020",Observational,Intensive Care Therapy of Covid-19 Disease in Germany an Multi-center Observational Study,COVID
2623,COVID INFECTION,"February 08, 2021",389,NCT04455815,CAMOSTAT,UNITED KINGDOM,Recruiting,Cancer Research UK,"September 25, 2020",Interventional,"A Randomised Phase II/III Trial in a Community Setting, Assessing Use of Camostat in Reducing the Clinical Progression of COVID-19 by Blocking SARS-CoV-2 Spike Protein-initiated Membrane Fusion",COVID
2624,HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM,"February 08, 2021",75,NCT04455958,LOPINAVIR/RITONAVIR,UNITED STATES,Not yet recruiting,OHSU Knight Cancer Institute,"November 1, 2020",Interventional,"A Double-Blind, Randomized, Placebo-Controlled Phase II Study of Lopinavir/Ritonavir Versus Placebo in COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year",Unrelated
2625,COVID,"February 08, 2021",600,NCT04456010,QUESTIONNAIRE,FRANCE,Completed,"University Hospital, Montpellier","June 1, 2020",Observational,Assessing the Perception and the Personal Experience of the COVID19 Pandemic Among Infertile Couples Undergoing Assisted Reproductive Treatment (ART),COVID
2626,COVID,"February 08, 2021",100,NCT04456036,,ITALY,Recruiting,Università Politecnica delle Marche,"July 1, 2020",Observational [Patient Registry],"Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care: Study of Functional Evolution, Predictors of Activities and Participation Recovery After Severe Covid-19 and Rehabilitation Role",COVID
2627,COVID INFECTION,"February 08, 2021",90,NCT04456049,ENZALUTAMIDE,SWITZERLAND,Not yet recruiting,Ricardo Pereira Mestre,July 2020,Interventional,COVID_ENZA Trial: Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1,COVID
2628,PSYCHIATRIC HOSPITALIZATION,"February 08, 2021",150,NCT04456062,CARING CONTACTS,CANADA,Recruiting,Sunnybrook Health Sciences Centre,"August 4, 2020",Interventional,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,Unrelated
2629,SARS-CoV2,"February 08, 2021",100,NCT04456075,,GERMANY,Recruiting,Heidelberg University,"April 1, 2020",Observational,Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19,COVID
2630,COVID,"February 08, 2021",0,NCT04456088,150 PPM NITRIC OXIDE DELIVERED THROUGH LUNGFIT DELIVERY SYSTEM,,Withdrawn,Beyond Air Inc.,"July 15, 2020",Interventional,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2,COVID
2631,COVID,"February 08, 2021",240,NCT04456101,,CHINA,Recruiting,"Wuhan Union Hospital, China","June 19, 2020",Observational,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",COVID
2632,COVID,"February 08, 2021",60,NCT04456153,EXPERIMENTAL GROUP,UNITED STATES,Recruiting,University of Texas Southwestern Medical Center,"July 22, 2020",Interventional,Atovaquone for Treatment of COVID-19,COVID
2633,"ARDS, HUMAN","February 08, 2021",9,NCT04456361,MESENCHYMAL STEM CELLS DERIVED FROM WHARTON JELLY OF UMBILICAL CORDS,MEXICO,"Active, not recruiting",Instituto de Medicina Regenerativa,"April 16, 2020",Interventional,A Study of Mesenchymal Stem Cells as a Treatment in Patients With Acute Respiratory Distress Syndrome Caused by COVID-19,Unrelated
2634,COVID,"February 08, 2021",306,NCT04456413,CONVALESCENT PLASMA,UNITED STATES,Recruiting,Hackensack Meridian Health,"November 6, 2020",Interventional,Phase II Randomized Study of Convalescent Plasma From Recovered COVID-19 Donors Collected by Plasmapheresis as Treatment for Subjects With Early COVID-19 Infection,COVID
2635,COVID,"February 08, 2021",250,NCT04456426,,,Not yet recruiting,Hospital Departamental de Villavicencio,July 2020,Observational,"Evaluation of the Characteristics of Patients and Healthcare Workers With Suspected or Confirmed of COVID-19 in Villavicencio and Meta State, Colombia",COVID
2636,MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) ASSOCIATED WITH CORONAVIRUS DISEASE (COVID),"February 08, 2021",,NCT04456439,REMESTEMCEL-L,,Available,Mesoblast International Sàrl,,Expanded Access,"Intermediate-size Expanded Access of Remestemcel-L, Human Mesenchymal Stromal Cells, for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",COVID
2637,COVID,"February 08, 2021",10,NCT04456452,AMPION,UNITED STATES,Completed,Ampio Pharmaceuticals. Inc.,"July 27, 2020",Interventional,A Randomized Controlled Trial to Evaluate the Safety of Intravenous Ampion™ in Adult COVID-19 Patients Requiring Oxygen Supplementation,COVID
2638,ENDOPHTHALMITIS AND ORBITAL CELLULITIS,"February 08, 2021",5,NCT04456556,,EGYPT,Completed,Minia University,"April 27, 2020",Observational,Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19),Unrelated
2639,COVID,"February 08, 2021",13060,NCT04456595,ADSORBED COVID-19 (INACTIVATED) VACCINE,BRAZIL,Recruiting,Butantan Institute,"July 21, 2020",Interventional,"Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety in Healthcare Professionals of the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac",COVID
2640,COLON CANCER,"February 08, 2021",148,NCT04456933,EXTRACORPOREAL LEFT HEMICOLECTOMY ANASTOMOSIS,SPAIN,Recruiting,Corporacion Parc Tauli,"June 29, 2020",Observational,RESECTION AND INTRACORPOREAL ANASTOMOSIS IN LAPAROSCOPIC LEFT COLECTOMY AS AN ADAPTATION TO THE PANDEMIC CAUSED BY SARS-CoV-2 (COVID19). A COMPARATIVE COHORT STUDY,Unrelated
2641,COVID,"February 08, 2021",10,NCT04457349,THERAPEUTIC PLASMA EXCHANGE (TPE),EGYPT,Recruiting,Alexandria University,"July 25, 2020",Interventional,Does Therapeutic Plasma Exchange Have A Role in Resistant Cytokine Storm State Of COVID-19 Infection?,COVID
2642,CHRONIC PAIN,"February 08, 2021",18,NCT04457388,TELE-YOGA THERAPY,UNITED KINGDOM,Completed,Aarogyam UK,"March 25, 2020",Interventional,Tele- Yoga Therapy for Patients With Chronic Pain During Covid-19 Lockdown: A Prospective Non-randomized Single Arm Clinical Trial,Unrelated
2643,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",5000,NCT04457505,,SPAIN,Recruiting,"Consorcio Centro de Investigación Biomédica en Red, M.P.","May 8, 2020",Observational [Patient Registry],"Risk Factors, Personalized Prognoses and 1-year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19",Respiratory
2644,"COVID, CANCER","February 08, 2021",600,NCT04457570,MORTALITY,FRANCE,Recruiting,Hospices Civils de Lyon,"June 15, 2020",Observational,ONCOVID-AURA: Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer,COVID
2645,COVID,"February 08, 2021",40,NCT04457609,OSELTAMIVIR,INDONESIA,Recruiting,Indonesia University,July 2020,Interventional,Application of Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy for Critically-Ill COVID-19 Patients,COVID
2646,COVID,"February 08, 2021",18,NCT04457726,SARS-COV-2 SPECIFIC T CELLS,SINGAPORE,Recruiting,KK Women's and Children's Hospital,"July 1, 2020",Interventional,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,COVID
2647,RHINOPLASTY,"February 08, 2021",30,NCT04457765,POVIDONE-IODINE (PVP-I),UNITED STATES,Not yet recruiting,Boston Medical Center,April 2021,Interventional,Povidine-Iodine Effect on Nasal Mucosa Cilia in Rhinoplasty Patients,Unrelated
2648,COVID,"February 08, 2021",100,NCT04457817,CRI MANAGEMENT,UNITED STATES,Enrolling by invitation,"University of Colorado, Denver","December 1, 2020",Interventional,CRI and Continuous Assessment of Hemodynamic Compensation to Guide Fluid and Pressor Management in Severely Ill Patients With COVID-19,COVID
2649,CHRONIC DISEASE,"February 08, 2021",140,NCT04458246,EXERCISE TRAINING GROUP,BRAZIL,Recruiting,University of Sao Paulo,July 2020,Interventional,"Online, Home-based, Aerobic Training Program Among Adolescents With Chronic Diseases During COVID-19 Pandemic: A Randomized Controlled Trial",Unrelated
2650,COVID,"February 08, 2021",24,NCT04458298,OP-101,UNITED STATES,Recruiting,"Orpheris, Inc.","July 1, 2020",Interventional,"A Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of OP-101 (Dendrimer N-acetyl-cysteine) in Patients With Severe COVID-19",COVID
2651,COVID,"February 08, 2021",120,NCT04458337,,CANADA,Recruiting,Centre hospitalier de l'Université de Montréal (CHUM),"March 13, 2020",Observational,SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study,COVID
2652,COVID,"February 08, 2021",3,NCT04458363,CONVALESCENT PLASMA (CP),UNITED STATES,Completed,Emory University,"July 4, 2020",Interventional,Convalescent Plasma to Optimize Treatment of COVID-19 Disease in Pediatric Patients: A Feasibility Study,COVID
2653,COVID INFECTION,"February 08, 2021",40,NCT04458519,PROBIORINSE,CANADA,Recruiting,Centre hospitalier de l'Université de Montréal (CHUM),"July 16, 2020",Interventional,Randomised Single Blinded Clinical Study of Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,COVID
2654,COVID,"February 08, 2021",10000,NCT04458948,HYDROXYCHLOROQUINE,UNITED STATES,"Active, not recruiting",University of New Mexico,"March 24, 2020",Interventional,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients With Moderate or Severe COVID-19 Infection,COVID
2655,COVID,"February 08, 2021",30,NCT04459247,VIT D,INDIA,"Active, not recruiting",Postgraduate Institute of Medical Education and Research,"June 15, 2020",Interventional,"Short Term, High Dose Vitamin D Supplementation for COVID-19 Disease: Double Blind, Controlled, Study",COVID
2656,COVID,"February 08, 2021",98,NCT04459286,NITAZOXANIDE AND ATAZANAVIR/RITONAVIR,NIGERIA,Recruiting,Obafemi Awolowo University,"October 9, 2020",Interventional,"A Randomized, Open Label Trial to Investigate the Efficacy and Safety of Nitazoxanide Plus Atazanavir/Ritonavir for the Treatment of COVID-19: a Pilot Study",COVID
2657,ANTIBODY COVID,"February 08, 2021",600,NCT04459312,ANTIBODY TEST (SARS-COV2),GERMANY,Recruiting,"Heinrich-Heine University, Duesseldorf","June 1, 2020",Observational,National Covid-Surveillance Physicians,COVID
2658,COVID,"February 08, 2021",100,NCT04459325,TIGERASE® AND BEST AVAILABLE CARE,RUSSIAN FEDERATION,Completed,AO GENERIUM,"June 1, 2020",Interventional,A Prospective Open-label Study of the Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,COVID
2659,CORONAVIRUS,"February 08, 2021",500,NCT04459351,,UNITED KINGDOM,Recruiting,Chelsea and Westminster NHS Foundation Trust,"June 19, 2020",Observational,PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs,COVID
2660,"HYPERTENSION, PULMONARY","February 08, 2021",67,NCT04459364,,SWEDEN,Completed,Attgeno AB,"June 1, 2020",Observational [Patient Registry],"The Prevalence of Pulmonary Hypertension, With or Without Right Ventricular Loading, in Patients With COVID-19 Who Are Being Treated With a Respirator in the Intensive Care Unit.",Unrelated
2661,COVID,"February 08, 2021",100,NCT04459390,REALTIME PCR,EGYPT,Recruiting,Assiut University,"July 20, 2020",Observational,Impact of Comorbidities on COVID19 Outcome,COVID
2662,CORONAVIRUS INFECTION,"February 08, 2021",400,NCT04459403,,EGYPT,Completed,Cairo University,"June 8, 2020",Observational,Psychiatric Disturbances in Patients Infected With COVID-19: A Cross Sectional Study,COVID
2663,ANXIETY,"February 08, 2021",500,NCT04459455,CONTAIN COVID ANXIETY SSI,UNITED STATES,Completed,Stony Brook University,"August 19, 2020",Interventional,"Project HF-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic",Unrelated
2664,COVID,"February 08, 2021",1400,NCT04459520,POSITIVE COVID TEST RESULT - HYPOTHETICAL SCENARIO,UNITED STATES,Completed,"University of California, Los Angeles","July 23, 2020",Interventional,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,COVID
2665,NEUROMUSCULAR BLOCKADE,"February 08, 2021",250,NCT04459533,TOF PROTOCOL,FRANCE,Completed,Hospices Civils de Lyon,"June 1, 2020",Observational,The Use of Neuromuscular Blockade Monitor as a Strategy for Neuromuscular Blockade Agents Saving in ICU COVID-19 Patients,Unrelated
2666,COVID,"February 08, 2021",200,NCT04459637,,CHINA,Not yet recruiting,Peking University First Hospital,"July 1, 2020",Observational [Patient Registry],Surveillance of COVID-19 Using Smart Wearable Devices: a Prospective Study,COVID
2667,COVID,"February 08, 2021",100,NCT04459676,STANDARD OF CARE (SOC) + ANG-3777,BRAZIL,Recruiting,Angion Biomedica Corp,"July 31, 2020",Interventional,"A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess Safety and Efficacy of ANG- 3777 in Patients Hospitalized With Confirmed COVID-19 Pneumonia",COVID
2668,PRIMARY IMMUNE DEFICIENCY,"February 08, 2021",200,NCT04459689,,FRANCE,Recruiting,Imagine Institute,"March 15, 2020",Observational [Patient Registry],Worldwide COVID-19 in Children and Adult Patients With Primary ImmunoDeficiencies (PID) Survey,Unrelated
2669,COVID,"February 08, 2021",200,NCT04459702,HYDROXYCHLOROQUINE,UNITED STATES,Not yet recruiting,ProgenaBiome,July 2020,Interventional,"A Phase IIa Randomized, Controlled Study of Combination Therapies to Treat COVID-19 Infection",COVID
2670,COVID,"February 08, 2021",80,NCT04459819,RESPIRATORY PHYSIOTHERAPY,ITALY,Recruiting,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","March 1, 2020",Observational,"Monocentric, Observational, Retrospective Study on Respiratory Physiotherapy in Severe COVID-19 Patients: the FTR-COVID Study.",COVID
2671,COVID INFECTION,"February 08, 2021",330,NCT04459962,BREATH TEST & CHEEK SWAB,UNITED KINGDOM,Completed,Ancon Technologies Ltd,"June 29, 2020",Interventional,Breath Test Feasibility Trial for Covid-19 Infection Diagnosis,COVID
2672,ON OCCURRENCE OF ACURATE KIDNEY INJURY DURING INTENSIVE CARE UNIT,"February 08, 2021",200,NCT04459975,NON INTERVENTIONAL STUDY,FRANCE,Recruiting,Hospices Civils de Lyon,"April 1, 2020",Observational,Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units,Unrelated
2673,INTRUSIVE MEMORIES OF TRAUMATIC EVENT(S),"February 08, 2021",164,NCT04460014,SIMPLE COGNITIVE TASK INTERVENTION,SWEDEN,Recruiting,Karolinska Institutet,"September 30, 2020",Interventional,"Reducing Intrusive Memories After Trauma Via a Simple Cognitive Intervention During COVID-19 in Hospital Staff: ""EKUT-P"" (Enkel Kognitiv Uppgift Efter Trauma Under COVID-19 - sjukvårdspersonal) - A Randomized Controlled Trial (RCT)",Unrelated
2674,SUBSTANCE USE DISORDERS,"February 08, 2021",180,NCT04460027,WOEBOT SUBSTANCE USE DISORDER,UNITED STATES,Completed,Athena Robinson,"June 22, 2020",Interventional,Woebot for Substance Use Disorders During COVID-19,Unrelated
2675,COVID PNEUMONIA,"February 08, 2021",0,NCT04460105,LANADELUMAB,,Withdrawn,Shire,"October 31, 2020",Interventional,"A Phase 1b, Randomized, Double-blind, Single and Repeat Dosing Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Lanadelumab When Added to Standard-of-Care in Subjects Hospitalized With COVID-19 Pneumonia",COVID
2676,QUALITY OF LIFE,"February 08, 2021",100,NCT04460170,,NETHERLANDS,Recruiting,University Medical Center Groningen,"July 1, 2020",Observational [Patient Registry],COVID-19 Follow up Intensive Care Studies,Unrelated
2677,COVID,"February 08, 2021",300,NCT04460183,"RESP301, A NITRIC OXIDE GENERATING SOLUTION",UNITED KINGDOM,Recruiting,Thirty Respiratory Limited,"July 29, 2020",Interventional,"An Open-label, Adaptive Randomized, Controlled Multicenter Study to Evaluate the Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 WHO Grade 3&4 (NOCoV2)",COVID
2678,EMERGENCY MEDICINE,"February 08, 2021",900,NCT04460196,SURVEY,FRANCE,Completed,"University Hospital, Angers","July 8, 2020",Observational [Patient Registry],Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments,Unrelated
2679,COVID,"February 08, 2021",7882471,NCT04460274,MODEL BUILDING,TURKEY,Completed,Turkish Ministry of Health Izmir Teaching Hospital,"December 31, 2019",Observational,Time Series Model For Forecasting the Number of Covid-19 Cases Worldwide - A Prospective Cohort Study,COVID
2680,COVID,"February 08, 2021",60,NCT04460443,SOFOSBUVIR,EGYPT,Recruiting,Tanta University,"August 1, 2020",Interventional,Sofosbuvir Based Regimens in Treatment of COVID 19 Patients,COVID
2681,ANXIETY,"February 08, 2021",1500,NCT04460469,,EGYPT,Recruiting,Cairo University,"July 1, 2020",Observational,Self-assessment of Anxiety Level and Oral Hygiene Practice in Dental Students of Cairo University During Covid-19 Pandemic,Unrelated
2682,COVID,"February 08, 2021",100,NCT04460534,DIAGNOSTIC,FRANCE,Recruiting,GCS Ramsay Santé pour l'Enseignement et la Recherche,"May 7, 2020",Interventional,Detection of SARS-CoV-2 in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),COVID
2683,COVID,"February 08, 2021",200,NCT04460547,CONVALESCENT PLASMA TRANSFUSION,,Not yet recruiting,Qassim University,"July 25, 2020",Observational,Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic: An Observational Study,COVID
2684,ENCEPHALITIS,"February 08, 2021",30,NCT04460599,OBSERVATION,FRANCE,Recruiting,Centre d'Investigation Clinique et Technologique 805,"March 8, 2020",Observational,Description of neurolOgical Involvement Observed During SARS COV2 Infection,Unrelated
2685,SARS-CoV2,"February 08, 2021",600,NCT04460638,SALIVA COLLECTION,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"July 23, 2020",Observational,SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling,COVID
2686,COVID,"February 08, 2021",2000,NCT04460651,ICOSAPENT ETHYL (IPE),ARGENTINA,Recruiting,Estudios Clínicos Latino América,"August 14, 2020",Interventional,PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial,COVID
2687,COVID,"February 08, 2021",50,NCT04460664,QUANTRA SYSTEM,UNITED STATES,Enrolling by invitation,HemoSonics LLC,"August 14, 2020",Observational,Exploratory Assessment of the Coagulation Changes Associated With Severe Inflammation in COVID-19 Patients,COVID
2688,PSYCHOLOGICAL DISTRESS,"February 08, 2021",80,NCT04460677,EMOTIONAL SUPPORT PLAN,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","August 12, 2020",Interventional,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19 (Coronavirus Disease),Unrelated
2689,COVID,"February 08, 2021",10000,NCT04460690,RAPID ONSITE COVID-19 DETECTION,UNITED STATES,Enrolling by invitation,"University of Wisconsin, Madison","July 13, 2020",Interventional,"Rapid, Onsite COVID-19 Detection",COVID
2690,VACCINATION,"February 08, 2021",4000,NCT04460703,CONTROL MESSAGE,UNITED STATES,Completed,Yale University,"July 3, 2020",Interventional,"Persuasive Messages for COVID-19 Vaccine Uptake: a Randomized Controlled Trial, Part 1",Unrelated
2691,COVID,"February 08, 2021",40,NCT04461340,SIROLIMUS,EGYPT,Recruiting,Alexandria University,"August 15, 2020",Interventional,Efficacy and Safety of Sirolimus for Treating COVID-19 Infection,COVID
2692,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",12,NCT04461353,AEROLIZED HYDROXYCHLOROQUINE SULFATE,UNITED STATES,Completed,"Pulmoquine Therapeutics, Inc","June 25, 2020",Interventional,"A Phase 1 Randomized Double Blind Placebo Controlled, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers",COVID
2693,BCG,"February 08, 2021",908,NCT04461379,BCG VACCINE,MEXICO,"Active, not recruiting",Hospital Universitario Dr. Jose E. Gonzalez,"July 21, 2020",Interventional,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19- Randomized Clinical Trial",Unrelated
2694,SLEEP,"February 08, 2021",13,NCT04461769,TRANSCRANIAL ELECTRICAL STIMULATION,UNITED STATES,Completed,Brain Electrophysiology Laboratory Company,"September 1, 2019",Interventional,Electrical Synchronization of Slow Oscillations to Enhance Deep Sleep,Unrelated
2695,COVID PNEUMONIA,"February 08, 2021",30,NCT04461925,PLACENTA-DERIVED MMSCS; CRYOPRESERVED PLACENTA-DERIVED MULTIPOTENT MESENCHYMAL STROMAL CELLS,UKRAINE,Recruiting,Institute of Cell Therapy,"May 2, 2020",Interventional,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic Multipotent Mesenchymal Stem Cells of the Placenta and Umbilical Cord,COVID
2696,COVID,"February 08, 2021",100,NCT04462120,,EGYPT,"Active, not recruiting",Assiut University,"June 16, 2020",Observational,Association Between IL-12RB and TNF-alpha Gene Polymorphism With Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study,COVID
2697,OPIOID USE,"February 08, 2021",15,NCT04462250,PRESCRIPTION OPIOID MANAGEMENT APP,UNITED STATES,Not yet recruiting,"Rutgers, The State University of New Jersey","March 1, 2021",Interventional,"Development of a Mobile Health App to Improve the Safe Use, Storage, and Disposal of Opioid Medications",Unrelated
2698,COVID,"February 08, 2021",180,NCT04462367,,BRAZIL,Not yet recruiting,Instituto Materno Infantil Prof. Fernando Figueira,"July 1, 2020",Observational,Clinical and Laboratory Predictors of COVID-19 Progression and Maternal and Perinatal Outcomes in Infected Pregnant and Postpartum Women in Six Reference Centers in the Northeast of Brazil,COVID
2699,COVID,"February 08, 2021",1563,NCT04462393,ADMISSION TO ICU FOR COVID-19,SWEDEN,Completed,Linkoeping University,"March 6, 2020",Observational,Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19 During the First 60 Days of the 2020 Pandemic,COVID
2700,COVID,"February 08, 2021",500,NCT04462627,BLOOD GROUP DETERMINATION,BELGIUM,Recruiting,Hanane EL KENZ,"April 14, 2020",Interventional,Reduction of COVID 19 Transmission to Health Care Professionals,COVID
2701,COVID,"February 08, 2021",5,NCT04462757,ANAKINRA 100MG/0.67ML INJ SYRINGE,UNITED KINGDOM,Suspended,University of Manchester,"May 28, 2020",Interventional,Subcutaneous and Intravenous IL-1Ra (Anakinra) in COVID-19 Infection - Feasibility & Pharmacokinetics/Pharmacodynamics Study,COVID
2702,COVID,"February 08, 2021",200,NCT04462783,SYMPTOMS ENTERED INTO THE COVIDX APPLICATION,,Not yet recruiting,University of Michigan,February 2021,Interventional,Feasibility of Self-monitoring and Patient Decision Support for Suspected COVID-19 Patients After Emergency Department Discharge,COVID
2703,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04462848,ANTI-SARS-COV-2 HUMAN CONVALESCENT PLASMA,UNITED STATES,Not yet recruiting,"University of California, Los Angeles",August 2020,Interventional,Phase I Study of the Safety and Pharmacokinetics of Human Convalescent Plasma in High Risk Children Exposed or Infected With SARS-CoV-2,COVID
2704,COVID,"February 08, 2021",60,NCT04463004,MAVRILIMUMAB,UNITED STATES,Recruiting,Virginia Commonwealth University,"September 2, 2020",Interventional,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,COVID
2705,COVID,"February 08, 2021",135,NCT04463264,NITAZOXANIDE,ARGENTINA,Recruiting,Laboratorios Roemmers S.A.I.C.F.,"June 26, 2020",Interventional,"Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoC-2 Virus Infection (COVID-19). A Pilot, Randomized, Simple Blind, Placebo-controlled, Parallel-group Study",COVID
2706,COVID,"February 08, 2021",224,NCT04463420,PHR160 SPRAY,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Baqiyatallah Medical Sciences University,"August 15, 2020",Interventional,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 a Multi-center Randomized Blinding Clinical Trial Study,COVID
2707,PARENT-CHILD RELATIONSHIP AND COUPLE RELATIONSHIP UNDER COVID IN CHINA,"February 08, 2021",300,NCT04463433,COGNITIVE AND BEHAVIORAL INTERVENTION.,CHINA,Recruiting,Beijing Normal University,"February 1, 2020",Interventional,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,COVID
2708,COVID,"February 08, 2021",30,NCT04463472,AG0301-COVID19,JAPAN,"Active, not recruiting","AnGes, Inc.","June 29, 2020",Interventional,"A Non-randomized, Open-label, Non-controlled Phase I/II Study to Assess Safety and Immunogenicity of Two Doses of Intramuscular AG0301-COVID19 (1mg/2mg) in Healthy Adults",COVID
2709,COVID,"February 08, 2021",24,NCT04463602,DESIDUSTAT,MEXICO,"Active, not recruiting",Cadila Healthcare Limited,"July 25, 2020",Interventional,"A Phase 2b, Multicenter, Open-label, Randomized, Comparator-Controlled, Study to Evaluate the Efficacy and Safety of Desidustat Tablet for the Management of COVID-19 Patients",COVID
2710,CYSTIC FIBROSIS IN CHILDREN,"February 08, 2021",1200,NCT04463628,QUESTIONNAIRE,FRANCE,Recruiting,Centre Hospitalier Intercommunal Creteil,"May 15, 2020",Observational,"Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic",Unrelated
2711,COVID,"February 08, 2021",20000,NCT04463706,PREDICTORS ADVERSE EVOLUTION,SPAIN,Recruiting,Hospital Galdakao-Usansolo,"June 1, 2020",Observational,Clinical Characterization of CoVid19 Infection: Prognostic Stratification and Complications,COVID
2712,COVID INFECTION,"February 08, 2021",3060,NCT04463758,AN AUTO-QUESTIONNAIRE COMPRISING THREE PSYCHOMETRIC SCALES,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"May 11, 2020",Observational,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns,COVID
2713,COVID,"February 08, 2021",500,NCT04463823,,NORWAY,Not yet recruiting,Oslo University Hospital,"July 6, 2020",Observational,Covid-19 Convalescent Plasma Used for Treatment of Patients in Norway - a Monitoring Study,COVID
2714,COVID,"February 08, 2021",24,NCT04463849,STIMULATION TEST WITH ARGININE INFUSION IN ORDER TO VERIFY THE POSSIBLE EXISTENCE OF DAMAGE TO THE BETA CELL FUNCTION INDUCED BY COVID-19 INFECTION,ITALY,Recruiting,University of Milan,"June 30, 2020",Interventional,Effects of SARS-CoV-2 Infection on Beta-cell Function in Euglycemic Patients,COVID
2715,COVID CONFIRMED CASES,"February 08, 2021",250,NCT04463862,,BELGIUM,Recruiting,"University Hospital, Strasbourg, France","June 4, 2020",Observational [Patient Registry],Air Pollution and COVID-19 Mortality in Geriatric Patients: a Multicenter Study,COVID
2716,COVID,"February 08, 2021",70,NCT04464395,CPI-006,UNITED STATES,Recruiting,"Corvus Pharmaceuticals, Inc.","July 1, 2020",Interventional,Immunotherapy of COVID-19 With B-Cell Activating CPI-006 Monoclonal Antibody,COVID
2717,COVID,"February 08, 2021",576,NCT04464408,FAVIPIRAVIR,SAUDI ARABIA,Recruiting,King Abdullah International Medical Research Center,"July 23, 2020",Interventional,A Trial of Favipiravir Therapy in Adults With Mild Coronavirus Disease COVID-19,COVID
2718,CORONAVIRUS DISEASE,"February 08, 2021",0,NCT04464460,TAK-671,,Withdrawn,Takeda,"September 25, 2020",Interventional,"A Randomized, Double-blind, Placebo-Controlled Multicenter Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of 2 Different Intravenous Doses of TAK-671 for the Treatment of Coronavirus Disease 2019 in Adults",COVID
2719,ONCOLOGY,"February 08, 2021",300,NCT04464486,SCH INTERVENTION,UNITED STATES,Enrolling by invitation,University of Utah,"April 21, 2020",Interventional,Remote COVID-19 Symptom Tracking and Improved Cancer Symptom Control for Cancer Patients at Home During the Pandemic,Unrelated
2720,COVID,"February 08, 2021",50,NCT04465058,COVID19,EGYPT,Recruiting,Assiut University,"July 8, 2020",Observational,Clinical Characteristics and Outcome in Critically Ill COVID 19 Patients,COVID
2721,MENTAL HEALTH ISSUE,"February 08, 2021",5000,NCT04465435,WEB-BASED SELF-REPORT QUESTIONNAIRES,SWEDEN,Enrolling by invitation,Sophiahemmet University,"August 19, 2019",Observational,Sustainable UNiversity Life (SUN): Mental Illness and Pain Conditions Among Students - a Cohort Study to Identify Modifiable Risk and Prognostic Factors,Unrelated
2722,COVID,"February 08, 2021",3000,NCT04465474,NON INTERVENTION,CHINA,Recruiting,Chinese University of Hong Kong,"May 1, 2020",Observational [Patient Registry],"Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)",COVID
2723,ASTHMA; EOSINOPHILIC,"February 08, 2021",100,NCT04465513,BEST STANDARD OF CARE + CARDIO,CANADA,Not yet recruiting,Hofseth Biocare ASA,"August 31, 2020",Interventional,"Randomized, Open-label, Parallel Study to Investigate Safety and Efficacy of CARDIO Softgels Plus Best Standard-of-care vs. Best Standard-of-care Alone on a Former Smoker and/or Steroid-resistant Asthma Population With COVID-19 Infection",Unrelated
2724,CORONAVIRUS INFECTION,"February 08, 2021",750,NCT04465552,PATIENTS RECEIVED STANDARD OF CARE TREATMENT DURING HOSPITALIZATION,UNITED STATES,Recruiting,Kansas City Heart Rhythm Research Foundation,"July 10, 2020",Observational,Arrhythmic Manifestations and Management Strategies in Hospitalized COVID-19 Patients: Proposal for a Multicenter Registry,COVID
2725,COVID,"February 08, 2021",50,NCT04465604,WEARING SURGICAL FACE MASK SPRAYED WITH HYPERTONIC SALINE,SAUDI ARABIA,Recruiting,King Faisal Specialist Hospital & Research Center,"July 1, 2020",Interventional,HYPERTONIC SALINE COATED FACE MASK FOR REDUCING RESPIRATORY SYMPTOM SEVERITY IN PATIENTS WITH COVID-19,COVID
2726,PULMONARY EMBOLISM,"February 08, 2021",250,NCT04465656,SEROLOGY TEST FOR COVID-19,FRANCE,Recruiting,"Hospital St. Joseph, Marseille, France","July 7, 2020",Observational,Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic: Retrospective and Prospective Multicentric Study.,Unrelated
2727,COVID,"February 08, 2021",81,NCT04465695,INTERFERON BETA-1B,CHINA,Recruiting,The University of Hong Kong,"July 14, 2020",Interventional,"An Open-label Randomised Controlled Trial on Dual Therapy With Interferon Beta-1b and Clofazimine Combination, as Treatment for COVID-19 Infection",COVID
2728,COVID,"February 08, 2021",80,NCT04465981,SAMPLING,UNITED STATES,Recruiting,INanoBio Inc.,July 2020,Observational,"A Longitudinal, Non-randomized Study to Evaluate the Utility of the INanoBio's Protein Arrays in Detecting Unique Antibodies in COVID-19 Patients",COVID
2729,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",30,NCT04466098,MESENCHYMAL STROMAL CELLS,UNITED STATES,Recruiting,"Masonic Cancer Center, University of Minnesota","July 30, 2020",Interventional,"Multi-center, Randomized, Placebo Controlled, Interventional Phase 2A Clinical Trial Evaluating the Safety and Potential Efficacy of Multiple Dosing of Mesenchymal Stromal Cells in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2)",Respiratory
2730,COVID,"February 08, 2021",294,NCT04466241,LOPINAVIR/RITONAVIR 200 MG-50 MG ORAL TABLET,CÔTE D'IVOIRE,Recruiting,French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS),"November 27, 2020",Interventional,Combination Therapies to Reduce the Nasopharyngeal Carriage of SARS-CoV-2 and Improve the Outcome of COVID-19 Infection in Ivory Coast (INTENSE-COV): a Phase IIb Randomized Clinical Trial,COVID
2731,COVID,"February 08, 2021",180,NCT04466280,HYDROXYCHLOROQUINE,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Baqiyatallah Medical Sciences University,"July 15, 2020",Interventional,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 Disease in Healthcare Providers at Baqiyatallah Hospital in Tehran",COVID
2732,ACUTE KIDNEY INJURY,"February 08, 2021",250,NCT04466306,,CANADA,Enrolling by invitation,Children's Healthcare of Atlanta,"April 15, 2020",Observational [Patient Registry],SARS-CoV2 Pediatric Acute Kidney Injury Registry and Collaborative,Unrelated
2733,COVID,"February 08, 2021",9209,NCT04466371,QUESTIONNAIRE,,Not yet recruiting,Misr International University,"October 15, 2020",Observational,Perceptions of Undergraduate Students and Teaching Staff on Online Teaching and Learning in the Wake of COVID-19 Pandemic in an Egyptian Private University: A Cross-Sectional Study,COVID
2734,SARS-CoV2 INFECTION,"February 08, 2021",1000,NCT04466462,,SPAIN,Completed,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","May 26, 2020",Observational,Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel,COVID
2735,COVID,"February 08, 2021",1300,NCT04466540,HYDROXYCHLOROQUINE,BRAZIL,Recruiting,Hospital Alemão Oswaldo Cruz,"May 12, 2020",Interventional,"Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19",COVID
2736,CHRONIC MUSCULOSKELETAL PAIN,"February 08, 2021",64,NCT04466605,TELE-YOGA THERAPY,INDIA,Completed,Aarogyam UK,"March 30, 2020",Interventional,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown: Randomized Clinical Trial,Unrelated
2737,COVID,"February 08, 2021",340,NCT04466644,ELISA,UNITED STATES,Completed,Igenomix,"June 8, 2020",Observational,"A Multicenter, Prevalence Study to Evaluate the Infectious and Immunological Status of COVID-19 in Asymptomatic Subjects Attending ART Centres After the Pandemic Lockdown in the USA",COVID
2738,COVID,"February 08, 2021",90,NCT04466657,ANTIOXIDATION THERAPY,NIGERIA,Not yet recruiting,Obafemi Awolowo University,"November 1, 2020",Interventional,A Study to Evaluate Antioxidant Therapy for Moderate to Severe COVID-19 With or Without Comorbidities,COVID
2739,COVID,"February 08, 2021",310,NCT04466670,UNFRACTIONATED HEPARIN,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"July 8, 2020",Interventional,Dynamics of Hemostatic Parameters in COVID-19 and Comparison of Intervention Strategies Through Adaptive Clinical Trial,COVID
2740,COVID,"February 08, 2021",100,NCT04466683,LOW DOSE RADIATION 35 CGY,UNITED STATES,Recruiting,Ohio State University Comprehensive Cancer Center,"August 28, 2020",Interventional,Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia,COVID
2741,COVID,"February 08, 2021",160,NCT04466800,INTERVENTION GROUP_REHABILITATION PROGRAM,FRANCE,Recruiting,Rennes University Hospital,"July 30, 2020",Interventional,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients,COVID
2742,PARKINSON DISEASE,"February 08, 2021",411,NCT04466839,QUESTIONNAIRE AND INTERVIEW,FRANCE,Completed,"University Hospital, Toulouse","July 2, 2020",Observational,Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients,Unrelated
2743,OLFACTORY DISORDER,"February 08, 2021",90,NCT04466982,,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"July 2, 2020",Observational,"Objective Assessment of Olfactory Dysfunction and Impact on Quality of Life in SARS CoV-2 (COVID-19)Infection Using the UPSIT, eQOD and SNOT-22 Questionnaires: A Prospective Observational Cohort Study",Unrelated
2744,COVID,"February 08, 2021",113,NCT04467008,,FRANCE,Completed,CMC Ambroise Paré,"July 15, 2020",Observational,Evaluation of Covid-19 Rapid Diagnostic Tests on Blood Drop,COVID
2745,COVID,"February 08, 2021",10,NCT04467047,MESENCHYMAL STROMAL CELLS INFUSION,,Not yet recruiting,Hospital de Clinicas de Porto Alegre,"July 25, 2020",Interventional,Safety and Feasibility of Allogenic Mesenchymal Stromal Cells in the Treatment of COVID-19,COVID
2746,MECHANICAL VENTILATION,"February 08, 2021",108,NCT04467086,PROPRANOLOL HYDROCHLORIDE,CANADA,Recruiting,Ottawa Hospital Research Institute,"December 11, 2020",Interventional,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation: An Open-label Randomized Controlled Trial (PROACTIVE),Unrelated
2747,COVID,"February 08, 2021",100,NCT04467112,BREATH BIOPSY FACE MASKS WITH REMOVABLE FILTERS AND FITTED PVA STRIP,UNITED KINGDOM,Recruiting,Owlstone Ltd,"July 30, 2020",Observational,Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols,COVID
2748,COVID,"February 08, 2021",0,NCT04467151,ANTI-SARS-COV-2 PLASMA,,Withdrawn,Kashif Khan,October 2020,Interventional,"A Randomized, Double-blind, Placebo-controlled Trial of Anti-SARS-CoV-2 Plasma in Hospitalized Non-ICU Patients With COVID-19",COVID
2749,COVID,"February 08, 2021",270,NCT04467840,OPAGANIB,BRAZIL,Recruiting,RedHill Biopharma Limited,"August 21, 2020",Interventional,"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled Phase 2/3 Study, in Adult Subjects Hospitalized With Severe SARS-CoV-2 Positive Pneumonia",COVID
2750,SARS-CoV2,"February 08, 2021",100,NCT04467918,CANNABIDIOL,BRAZIL,"Active, not recruiting",University of Sao Paulo,"July 6, 2020",Interventional,"Cannabidiol (CBD) in Patients With Mild to Moderate Symptoms of Coronavirus 2019: A Randomized, Double-blind, Placebo-controlled Clinical Trial",COVID
2751,HYPERTENSION,"February 08, 2021",10000,NCT04467931,ACEI/ARB,UNITED STATES,"Active, not recruiting",University of Utah,"January 19, 2020",Observational,Association Between Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and COVID-19 Severity and Mortality Among US Veterans,Unrelated
2752,SARS-ASSOCIATED CORONAVIRUS,"February 08, 2021",36,NCT04468009,CONVALESCENT PLASMA,ARGENTINA,Recruiting,Hospital de Infecciosas Francisco Javier Muniz,"June 25, 2020",Interventional,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,COVID
2753,COVID,"February 08, 2021",30,NCT04468035,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"June 1, 2020",Observational,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS (Acute Respiratory Distress Syndrome) on SARS-CoV2 Viral Pneumonia Requiring Mechanical Ventilation,COVID
2754,COVID,"February 08, 2021",1005,NCT04468087,ATAZANAVIR,BRAZIL,Not yet recruiting,Hospital do Coracao,"December 1, 2020",Interventional,"Antiviral for Adult Patients Hospitalized for SARS-CoV-2 Infection: a Randomized, Phase 2/3, Multicenter, Placebo Controlled, Adaptive, Multi-arm, Multi-stage Clinical Trial - Coalition Brazil COVID-19 IX: REVOLUTIOn",COVID
2755,COVID,"February 08, 2021",60,NCT04468139,QUERCETIN,SAUDI ARABIA,Recruiting,"Ministry of Health, Saudi Arabia","June 20, 2020",Interventional,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",COVID
2756,COVID,"February 08, 2021",150,NCT04468217,"OBTAINMENT OF NASOPHARYNGEAL, OROPHARYNGEAL, BUCCAL, NASAL AND SALIVA SAMPLES",CHILE,Recruiting,Neurognos,"June 2, 2020",Observational,Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR,COVID
2757,COVID,"February 08, 2021",1000,NCT04468256,COVID-19 EXPERIENCE SURVEYS,UNITED KINGDOM,Recruiting,Imperial College London,"July 26, 2020",Observational,The Heart Hive COVID-19 Study: A Longitudinal Observational Study of the Impact and Clinical Outcomes of the COVID-19 Pandemic on Individuals With Heart Muscle Disease,COVID
2758,SENILE CATARACT,"February 08, 2021",116,NCT04468308,QUESTIONNAIRE,AUSTRIA,Recruiting,Medical University Innsbruck,"September 8, 2020",Observational,Assessment of Vision-related Quality of Life (VRQOL) in Cataract Patients During the COVID-19 Pandemic,Unrelated
2759,FOCUS IN ON COLLECTING PAIRED SPECIMENS FOR MATRIX EQUIVALENCY,"February 08, 2021",40,NCT04468386,,UNITED STATES,"Active, not recruiting",Biomerica,"July 7, 2020",Observational,Specimen Collection Study Protocol; Internal Biomerica Normal Specimen Collection and Banking for Use in COVID-19 Serological Product Development,Unrelated
2760,COVID,"February 08, 2021",203,NCT04468412,CAROTID ARTERY REACTIVITY TESTING,NETHERLANDS,"Active, not recruiting",Radboud University,"July 14, 2020",Observational,Influence of COVID-19 on Vascular Endothelial Function,COVID
2761,CORONAVIRUS,"February 08, 2021",505,NCT04468581,USE OF MOBILE APPLICATION,SINGAPORE,Completed,Yale-NUS College,"April 3, 2020",Observational,Characteristics of TraceTogether Users,COVID
2762,"NEUROKININ 1 RECEPTOR, SUBSTANCE P, RESPIRATORY ILLNESS, INFLAMMATION, COVID, CORONAVIRUS","February 08, 2021",100,NCT04468646,NK-1R ANTAGONIST,PAKISTAN,Recruiting,Prof. Dr. Fridoon Jawad Ahmad,"June 15, 2020",Interventional,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,COVID
2763,HIV,"February 08, 2021",150945,NCT04468789,SIX-MONTH ARV DISPENSING,SOUTH AFRICA,Not yet recruiting,Boston University,April 2021,Observational,Evaluation of the National Department of Health's Six-month Antiretroviral Treatment Dispensing Demonstration Pilot in Primary Health Care Clinics in the Context of the COVID-19 Pandemic and Response in South Africa,Unrelated
2764,COVID,"February 08, 2021",32,NCT04468802,CASE FATALITY RATE,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"February 1, 2020",Observational,Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by SARS CoV-2 in OECD Countries?,COVID
2765,ANXIETY,"February 08, 2021",128,NCT04468893,ONLINE INTERVENTION MENTAL HEALTH COVID-19,MEXICO,Recruiting,Universidad Internacional de Valencia,"May 20, 2020",Interventional,"Effectiveness of a Self-applied Positive Psychology Online Intervention Program ""Mental Health COVID-19"" in Mexican Population: A Randomized Controlled Trial.",Unrelated
2766,COVID,"February 08, 2021",28,NCT04468958,SAB-185,UNITED STATES,Recruiting,"SAb Biotherapeutics, Inc.","August 5, 2020",Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of SAB-185 in Healthy Subjects",COVID
2767,COVID,"February 08, 2021",45,NCT04468971,CK0802,UNITED STATES,Recruiting,"Cellenkos, Inc.","September 29, 2020",Interventional,"Phase 1 Double-Blinded, Randomized, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) In The Treatment Of COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS)",COVID
2768,COVID,"February 08, 2021",260,NCT04469114,TOFACITINIB 10 MG,BRAZIL,"Active, not recruiting",Hospital Israelita Albert Einstein,"September 16, 2020",Interventional,"A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-design Trial of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia",COVID
2769,THE PROGNOSTIC VALUE OF FERRITIN,"February 08, 2021",57,NCT04469153,NO INTERVENTION / EVALUATION OF THE FERRITIN AND GLYCOSYLATED FERRITIN BY STANDARD APPROVED SEROLOGICAL TESTS,FRANCE,Recruiting,Hospices Civils de Lyon,"June 29, 2020",Observational,Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19,Unrelated
2770,COVID,"February 08, 2021",21,NCT04469179,SAB-185,UNITED STATES,Recruiting,"SAb Biotherapeutics, Inc.","August 20, 2020",Interventional,"A Phase 1B, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of SAB-185 in Ambulatory Subjects With COVID-19",COVID
2771,COVID,"February 08, 2021",60,NCT04469491,INHALED TYPE I INTERFERON,FRANCE,Suspended,"Centre Hospitalier Universitaire, Amiens","September 20, 2020",Interventional,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,COVID
2772,CORONAVIRUS INFECTION,"February 08, 2021",68,NCT04469621,SAR443122,ARGENTINA,Completed,Sanofi,"July 17, 2020",Interventional,"A Phase 1b, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety and Immunomodulatory Effect of the RIPK1 Inhibitor SAR443122 in Hospitalized Patients With Severe COVID-19",COVID
2773,SARS-CoV2,"February 08, 2021",150,NCT04469634,"ASSESSING ANTIBODY RESPONSES, NEUTRALIZING CAPACITY AND MEMORY B-CELL FUNCTION",BELGIUM,"Active, not recruiting","Institute of Tropical Medicine, Belgium","July 31, 2020",Interventional,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,COVID
2774,COVID,"February 08, 2021",1200,NCT04469647,SEROLOGY TEST,SAUDI ARABIA,Enrolling by invitation,Johns Hopkins Aramco Healthcare,"July 19, 2020",Observational,COVID 19 Antibody Seroprevalence Amongst Healthcare Workers in Johns Hopkins Aramco Healthcare,COVID
2775,PSYCHOLOGICAL STRESS,"February 08, 2021",1300,NCT04469660,,INDIA,Recruiting,Max Healthcare Insititute Limited,"May 18, 2020",Observational,Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare,Unrelated
2776,COVID,"February 08, 2021",10,NCT04470258,ELMO PROJECT AT COVID-19: STUDY IN HUMANS,BRAZIL,Recruiting,Escola de Saúde Pública do Ceará,"August 2, 2020",Interventional,Elmo Respiratory Support Project for Patients With Hypoxemic Respiratory Insufficiency in Covid-19: Proof Of Concept and Usability,COVID
2777,COVID,"February 08, 2021",100,NCT04470297,RAMELTEON 8MG,,Not yet recruiting,Associação Fundo de Incentivo à Pesquisa,September 2020,Interventional,Adjuvant Therapeutic Effects of Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,COVID
2778,T CELL DEFICIENCY,"February 08, 2021",100,NCT04470323,FLOW CYTOMETRY,EGYPT,Recruiting,Assiut University,"July 22, 2020",Observational,Functional Exhaustion of T Cells in COVID19 Patients,Unrelated
2779,COVID,"February 08, 2021",100,NCT04470414,IGG ANTIBODIES IMMUNOASSAY,EGYPT,Not yet recruiting,Assiut University,"August 1, 2020",Observational,COVID-19 IgG Antibodies in the Serum of Recovered Patients: a Longitudinal Study,COVID
2780,SARS-CoV2,"February 08, 2021",30000,NCT04470427,MRNA-1273,UNITED STATES,"Active, not recruiting","ModernaTX, Inc.","July 27, 2020",Interventional,"A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older",COVID
2781,COVID,"February 08, 2021",94,NCT04470531,ORAL CO-TRIMOXAZOLE,BANGLADESH,Recruiting,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","July 12, 2020",Interventional,Role of Co-trimoxazole in Severe COVID-19 Patients,COVID
2782,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",264,NCT04470544,CAMOSTAT MESILATE,UNITED STATES,Recruiting,Alan Bryce,"July 28, 2020",Interventional,"RECOVER: Phase 2 Randomized, Double-Blind Trial TREating Hospitalized Patients With COVID-19 With Camostat MesilatE, a TMPRSS2 Inhibitor",Respiratory
2783,COVID,"February 08, 2021",100,NCT04470557,"D-DIMER,CBC.ESR,CRP,",,Not yet recruiting,Assiut University,"July 15, 2020",Observational,The Relationship Between Lab Finding and COVID-19 Severity: Multicenter Study,COVID
2784,COVID,"February 08, 2021",116,NCT04470583,,UNITED KINGDOM,Recruiting,Chelsea and Westminster NHS Foundation Trust,"October 9, 2020",Observational,Evaluation of Clinical Parameters Following COVID-19 Infection in Pregnancy (COpregVID),COVID
2785,COVID,"February 08, 2021",471,NCT04470609,LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE ON A 0- AND 28-DAY SCHEDULE,CHINA,Enrolling by invitation,Chinese Academy of Medical Sciences,"July 10, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Phase Ib/IIb Trial of an Inactivated SARS-CoV-2 Vaccine in Healthy People Aged ⩾60 Years",COVID
2786,COVID,"February 08, 2021",100,NCT04470622,APREPITANT INJECTABLE EMULSION,PUERTO RICO,Recruiting,Heron Therapeutics,"July 20, 2020",Interventional,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Aprepitant Injectable Emulsion in Early Hospitalized Adult Patients With COVID-19",COVID
2787,SARS-CoV2 INFECTION,"February 08, 2021",220,NCT04470648,BLOOD TEST FOR SARS-COV2 SEROLOGY,FRANCE,Not yet recruiting,"Institut National de la Santé Et de la Recherche Médicale, France",July 2020,Observational,COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey,COVID
2788,COVID,"February 08, 2021",20,NCT04470739,CHEST X-RAY,TURKEY,Recruiting,Kanuni Sultan Suleyman Training and Research Hospital,"May 30, 2020",Interventional,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,COVID
2789,POST TRAUMATIC STRESS DISORDER,"February 08, 2021",130,NCT04470869,PHONE CALL,FRANCE,Recruiting,"University Hospital, Toulouse","June 12, 2020",Interventional,Impact of the Psychiatric Intervention OLAF on the Post Traumatic Disorder in the Relatives of Patients Hospitalized in Intensive Care Unit During the SARS-Cov-2 Pandemic Confinement in France.,Unrelated
2790,COVID,"February 08, 2021",25,NCT04470999,LEUKAPHERESIS,UNITED STATES,Recruiting,"Serhat Gumrukcu, MD PhD","April 15, 2020",Interventional,Cellular Immune Profile Changes in Individuals With Active or Past COVID-19 Infection,COVID
2791,COVID,"February 08, 2021",150,NCT04471051,,UNITED STATES,Recruiting,"University of Colorado, Denver","April 30, 2020",Observational,An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients,COVID
2792,COVID,"February 08, 2021",755,NCT04471519,BBV152A - PHASE I,INDIA,"Active, not recruiting",Bharat Biotech International Limited,"July 13, 2020",Interventional,"An Adaptive Phase 1, Followed by Phase 2 Randomized, Double-blind, Multicenter Study to Evaluate the Safety, Reactogenicity, Tolerability, and Immunogenicity of BBV152 in Healthy Volunteers",COVID
2793,COVID,"February 08, 2021",600,NCT04471636,WITHINGS SCANWATCH,GERMANY,Recruiting,Ludwig-Maximilians - University of Munich,"September 18, 2020",Interventional,Munich Remote SpO2 and Electrocardiogram Assessment in Covid-19 Patients,COVID
2794,COVID,"February 08, 2021",80,NCT04471649,,EGYPT,Recruiting,Tanta University,"June 15, 2020",Observational,Clinical Course of COVID-19 in Patients With Rheumatoid Arthritis Treated With or Without Hydroxychloroquine: a Case-control Study,COVID
2795,COVID,"February 08, 2021",200000,NCT04471701,ENVIRONMENTAL EXPOSURE AND CLINICAL FEATURES,ITALY,Recruiting,"Institute of Biomedical Technologies-National Research Council, Italy","April 13, 2020",Observational,Italian Web-based EPICOVID19 Cross-sectional Survey,COVID
2796,COVID,"February 08, 2021",40000,NCT04471766,CERTIFIED CLOTH FACE MASK PLUS PREVENTIVE INFORMATION,GUINEA-BISSAU,Enrolling by invitation,Bandim Health Project,"July 20, 2020",Interventional,Evaluation of Locally Produced Cloth Face Mask on COVID-19 and Respiratory Illnesses Prevention at the Community Level - a Cluster-randomized Trial,COVID
2797,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04471831,REHABILITATION EXERCISE PROTOCOL,,Not yet recruiting,"University of Lagos, Nigeria","July 13, 2020",Interventional,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study",COVID
2798,COVID DISEASE,"February 08, 2021",40,NCT04472013,DATA COLLECTION FROM LUMBAR PUNCTURE,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","August 12, 2020",Observational,"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19",COVID
2799,PERFORATED APPENDICITIS,"February 08, 2021",143,NCT04472052,APPENDECTOMY,GERMANY,Completed,University Hospital Tuebingen,"March 16, 2020",Observational,Incidence of Perforated Appendicitis in Times of Corona Crisis,Unrelated
2800,SARS-CoV2,"February 08, 2021",873,NCT04472078,SEROLOGICAL ASSAY OR IGG FOR SARS-COV-2,ARGENTINA,Completed,Hospital Italiano de Buenos Aires,"June 10, 2020",Observational [Patient Registry],"Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) in a Vulnerable Neighbourhood, Buenos Aries Argentina",COVID
2801,COVID,"February 08, 2021",129,NCT04472494,ABATACEPT,PUERTO RICO,Recruiting,Bristol-Myers Squibb,"August 24, 2020",Interventional,"Phase 2, Randomized, Double-Blind Placebo Controlled Study of Intravenous Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise",COVID
2802,QUALITY OF LIFE,"February 08, 2021",200,NCT04472559,SELF-ACUPRESSURE,,Not yet recruiting,"University of California, Los Angeles","December 25, 2020",Interventional,Randomized Controlled Trial of Acupressure for Health-Related Quality of Life and Perception of Stress Among Health Care Providers During the COVID-19 Pandemic,Unrelated
2803,COVID,"February 08, 2021",,NCT04472572,CONVALESCENT PLASMA,UNITED STATES,Available,Hackensack Meridian Health,,Expanded Access,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,COVID
2804,CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04472585,IVERMECTIN INJECTABLE SOLUTION,PAKISTAN,Recruiting,Sohaib Ashraf,"November 14, 2020",Interventional,Sub-cutaneous Ivermectin in Combination With and Without Oral Zinc: a Placebo Randomized Control Trial on Mild to Moderate COVID-19 Patients,COVID
2805,SARS-CoV2,"February 08, 2021",466,NCT04472611,STANDARD OF CARE (SOC) AND COLCHICINE+ROSUVASTATIN,UNITED STATES,Not yet recruiting,Yale University,"August 1, 2020",Interventional,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,COVID
2806,COVID,"February 08, 2021",310,NCT04472728,BIO101,BELGIUM,Recruiting,Biophytis,"June 16, 2020",Interventional,"Adaptive Design Phase 2 to 3, Randomized, Double-blind, to Evaluate Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BIO101 in the Prevention of the Respiratory Deterioration in Hospitalized COVID-19 Patients",COVID
2807,COVID,"February 08, 2021",200,NCT04472793,SARS-COV-2,UNITED STATES,Recruiting,"Children's Hospital Medical Center, Cincinnati","May 11, 2020",Observational,Repeated Employee Testing for Understanding Our Recovery to Normal,COVID
2808,COVID,"February 08, 2021",60,NCT04473053,NAFAMOSTAT MESILATE,UNITED KINGDOM,Recruiting,University of Edinburgh,"July 3, 2020",Interventional,Rapid Experimental Medicine for COVID-19 - DEFINE COVID-19,COVID
2809,COVID,"February 08, 2021",500,NCT04473105,,UNITED KINGDOM,Recruiting,Nottingham University Hospitals NHS Trust,"May 1, 2020",Observational,Optimising Resource Allocation Via Prediction of Outcomes for Suspected and Proven Covid-19,COVID
2810,COVID,"February 08, 2021",25000,NCT04473118,SURVEY,QATAR,Recruiting,Hamad Medical Corporation,"July 11, 2020",Observational,"Burnout, Anxiety, Depression, Stress (BADS) and Post-Trauma Stress Disorder (PTSD) in Healthcare Workers Exposed to COVID-19 Patients",COVID
2811,COVID,"February 08, 2021",300,NCT04473131,NO INTERVENTION,QATAR,Recruiting,Hamad Medical Corporation,"April 27, 2020",Observational,Immune Profiling of COVID-19-infected Patients Admitted to the Intensive Care Unit (ICU): the IMPROVISE Study,COVID
2812,ANOSMIA,"February 08, 2021",58,NCT04473157,,EGYPT,Completed,Ain Shams University,"July 1, 2020",Observational,Detection of SARS-CoV-2 in Patients Presenting With Anosmia During COVID-19 Pandemic Era in Egypt,Unrelated
2813,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",146,NCT04473170,AUTOLOGOUS NON-HEMATOPOIETIC PERIPHERAL BLOOD STEM CELLS (NHPBSC),UNITED ARAB EMIRATES,Completed,Abu Dhabi Stem Cells Center,"April 4, 2020",Interventional,"Adaptive Open-label Study Evaluating the Safety and Efficacy of Autologous Non- Hematopoietic Peripheral Blood Stem Cells Therapy in COVID-19 Outbreak in Abu Dhabi, 2020 (SENTAD-COVID Study)",COVID
2814,COVID,"February 08, 2021",3000,NCT04473183,SPECIMEN COLLECTION,UNITED STATES,Recruiting,University of Minnesota,"July 21, 2020",Observational,Epidemiologic Assessment of SARS-CoV-2 Prevalence in Minnesota,COVID
2815,COVID,"February 08, 2021",27,NCT04473248,SPARTAN COVID-19 SYSTEM,CANADA,Completed,Spartan Bioscience Inc.,"June 28, 2020",Interventional,Evaluation of Clinical Sample Collection Project: Spartan COVID-19,COVID
2816,COVID,"February 08, 2021",200,NCT04473261,IODINE COMPLEX,PAKISTAN,Recruiting,Sohaib Ashraf,"July 14, 2020",Interventional,Efficacy of Iodine Complex in Mild to Moderate COVID-19 Patients,COVID
2817,CORONAVIRUS INFECTION,"February 08, 2021",10,NCT04473274,PIOGLITAZONE,UNITED STATES,Completed,Samaritan Health Services,"May 21, 2020",Interventional,"GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study",COVID
2818,CRITICAL ILLNESS,"February 08, 2021",20,NCT04473300,,JAPAN,Recruiting,Osaka University,"May 11, 2020",Observational,Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography: a Prospective Observational Study,Unrelated
2819,COVID,"February 08, 2021",80,NCT04473352,,,Not yet recruiting,Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara,September 2020,Observational [Patient Registry],Diagnostic Accuracy of COVID-19 Detection Tests in Different Body Fluids of Infected Men and Concordance With Viral Cultures,COVID
2820,SARS-CoV2,"February 08, 2021",186,NCT04473365,,ETHIOPIA,Recruiting,Mekelle University,"July 20, 2020",Observational,Rapid Diagnostic Profiling of SARS-CoV-2 in the Context of Persistent Immune Activation in Sub-Saharan Africa (Profile-Cov),COVID
2821,PROCEDURE TIME,"February 08, 2021",51,NCT04473456,SIMULTANEOUS EGD AND COLONOSCOPY,COLOMBIA,Completed,EmuraCenter LatinoAmerica,"June 13, 2020",Interventional,Combined Simultaneous EGD-colonoscopy (CoSi Endoscopy) Harmlessly Reduces Procedure Times: a Randomized Control Trial,Unrelated
2822,COVID,"February 08, 2021",215,NCT04473547,,EGYPT,Recruiting,Mansoura University,"July 15, 2020",Observational,Adherence of Nursing Students to Preventive Measures Towards Coronavirus Disease 19 During Written Exams,COVID
2823,DEPRESSIVE SYMPTOMS,"February 08, 2021",200,NCT04473599,UNIFORM RANDOM MESSAGE DELIVERY,UNITED STATES,Recruiting,"University of California, Berkeley","April 17, 2020",Interventional,Stay Well at Home: A Text-messaging Study to Improve Mood and Help Cope With Social Distancing,Unrelated
2824,COVID,"February 08, 2021",180,NCT04473690,LOW DOSE OF KBP-COVID-19,UNITED STATES,Recruiting,"Kentucky BioProcessing, Inc.","December 30, 2020",Interventional,"A First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of KBP-COVID-19 SARS-CoV-2 Vaccine With Adjuvant in Healthy Seronegative Adults Aged 18-49 and 50-70",COVID
2825,COVID,"February 08, 2021",36,NCT04473898,AEROBIC EXERCISE TRAINING,TURKEY,Recruiting,KTO Karatay University,"June 19, 2020",Interventional,Telerehabilitation After Covid-19: Effectiveness of Respiratory and Aerobic Training,COVID
2826,RESPIRATORY INFECTIOUS DISEASES,"February 08, 2021",6000,NCT04474028,,CHINA,Completed,Fuwai Yunnan Cardiovascular Hospital,"June 19, 2020",Observational,An Epidemiological Investigation on the Prevention of Respiratory Infectious Diseases by Wearing Mask Correctly,Respiratory
2827,COVID,"February 08, 2021",300,NCT04474067,NO INTERVENTION,ISRAEL,Recruiting,Hadassah Medical Organization,"June 28, 2020",Observational,A Multi-Center Study Evaluating Clinical Course in Patients With COVID-19 and Its Relationship to Cytokine Storm,COVID
2828,BURNOUT,"February 08, 2021",1080,NCT04474080,VIRTUAL PEER SUPPORT PLATFORM,CANADA,Not yet recruiting,St. Joseph's Healthcare Hamilton,"January 15, 2021",Interventional,The Role of Virtual Peer Support Platforms for Reducing Stress and Burnout Among Frontline Healthcare Workers During COVID-19: A Randomized Controlled Trial,Unrelated
2829,COVID,"February 08, 2021",148,NCT04474236,THORACIC LUNG ULTRASOUND,FRANCE,Recruiting,"University Hospital, Toulouse","May 27, 2020",Observational,Use of Lung Ultrasound for COVID-19 Patient's Initial Triage Assessment and Early Monitoring: a Pilot Study,COVID
2830,COVID,"February 08, 2021",300,NCT04474249,,SWEDEN,Recruiting,Uppsala University,"June 25, 2020",Observational,Uppföljning av Patienter Som intensivvårdats för COVID-19,COVID
2831,COVID IMMUNOLOGY,"February 08, 2021",400,NCT04474288,SARS-COV-2 ANTIBODY TESTING,UNITED STATES,Recruiting,Bassett Healthcare,"July 16, 2020",Observational,SARS-CoV-2 Specific Immune Responses in Hospitalized Persons Under Investigation (PUIs) With Negative Nasopharyngeal PCR Swabs - The COVID-19 PUI Reality Check (CPRC) Study,COVID
2832,COVID INFECTION,"February 08, 2021",1152,NCT04474301,SURVEY ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"June 11, 2020",Observational,Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic,COVID
2833,"MODERATE COVID PNEUMONIA, SEVERE COVID PNEUMONIA","February 08, 2021",300,NCT04474340,COVID-19 CONVALSCENT PLASMA,KUWAIT,Recruiting,"Ministry of Health, Kuwait","May 21, 2020",Interventional,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients: Multicenter Interventional Study,COVID
2834,"ALCOHOL USE, UNSPECIFIED","February 08, 2021",55000,NCT04474444,ATTENDANCE BY AMBULANCE CREW,UNITED KINGDOM,Recruiting,University of Lincoln,"March 23, 2019",Observational,Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP): Exploring Attendance at Incidents Involving Substance and/or Alcohol Use During COVID-19 Pandemic,Unrelated
2835,COVID,"February 08, 2021",1000,NCT04474457,FAVIPIRAVIR,TURKEY,"Active, not recruiting","Ministry of Health, Turkey","June 11, 2020",Observational,An ObservationaI Study to Evaluate the Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age Who Are Receiving Favipiravir,COVID
2836,COVID,"February 08, 2021",30,NCT04474483,MELATONIN,UNITED STATES,Recruiting,State University of New York at Buffalo,"November 6, 2020",Interventional,A Pilot Placebo-controlled Randomized Double-blind Trial of Melatonin in Outpatients With COVID-19 Infection,COVID
2837,COVID,"February 08, 2021",2000,NCT04474496,ASSESSING IMPACT OF COVID19,UNITED STATES,Enrolling by invitation,University of Arkansas,"July 27, 2020",Observational,Impact of COVID-19 on Marshallese Communities in the U.S.,COVID
2838,SARS-CoV2,"February 08, 2021",12,NCT04475068,LATERAL POSITION (LEFT AND RIGHT LATERAL DECUBITUS),PERU,Recruiting,Hospital Nacional Edgardo Rebagliati Martins,"July 17, 2020",Observational,Feasibility and Physiological Effects of a Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection,COVID
2839,SEPSIS SYNDROME,"February 08, 2021",60,NCT04475081,MMR VACCINE,,Not yet recruiting,Louisiana State University Health Sciences Center in New Orleans,"August 17, 2020",Interventional,Use of a Live Attenuated Vaccine Repurposed as an Innate Immune-based Preventive Against COVID-19-associated Sepsis/Inflammation,Unrelated
2840,COVID,"February 08, 2021",76,NCT04475107,PYRONARIDINE-ARTESUNATE,"KOREA, REPUBLIC OF",Recruiting,Shin Poong Pharmaceutical Co. Ltd.,"July 9, 2020",Interventional,"A Multi-center, Randomized, Double-blind, Parallel, Placebo-Controlled, Phase Ⅱ Clinical Trial to Evaluate Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients",COVID
2841,COVID,"February 08, 2021",60,NCT04475120,LIPOSOMAL LACTOFERRIN,ITALY,Completed,University of Rome Tor Vergata,"April 15, 2020",Interventional,Interventional Pilot Study to Assess the Use of Oral and Intra-nasal Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,COVID
2842,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",117,NCT04475185,MAKAIR,FRANCE,Recruiting,Nantes University Hospital,"July 20, 2020",Interventional,"Interventional, Open, Non-comparative, Multicenter Study to Assess the Safety and Effectiveness of the Use of the MakAir Artificial Ventilator in the Expected Situation of a Shortage of Technical Devices for Invasive Mechanical Ventilation, Linked to the Coronavirus COVID-19",Respiratory
2843,SARS-CoV2,"February 08, 2021",1000,NCT04475211,,FRANCE,Recruiting,"University Hospital, Lille","August 10, 2020",Observational,Predictors of Mortality at Day 28 of Patients Treated at Lille University Hospital for COVID-19,COVID
2844,COVID,"February 08, 2021",2175,NCT04475302,BCG VACCINE (FREEZE-DRIED),INDIA,Recruiting,"Tuberculosis Research Centre, India","July 1, 2020",Interventional,Study to Evaluate the Effectiveness of BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots in India,COVID
2845,COVID,"February 08, 2021",5200,NCT04475471,,ARGENTINA,Recruiting,Public Health Foundation of India,"June 11, 2020",Observational,WHF COVID-19 and Cardiovascular Disease Survey,COVID
2846,INVESTIGATING PSYCHOLOGICAL IMPACT,"February 08, 2021",30000,NCT04475484,ONLINE QUESTIONNAIRE,FRANCE,Recruiting,Hospices Civils de Lyon,"June 10, 2020",Observational,Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children,Unrelated
2847,SARS-COV INFECTION,"February 08, 2021",219,NCT04475562,AEONOSE,NETHERLANDS,Completed,Maastricht University Medical Center,"April 6, 2020",Interventional,Can the Electronic Nose Smell COVID-19? A Proof-of-principle Study,Respiratory
2848,SARS-COV INFECTION,"February 08, 2021",222,NCT04475575,AEONOSE,NETHERLANDS,Completed,Maastricht University Medical Center,"April 6, 2020",Interventional,Can the Electronic Nose Smell COVID-19 Antibodies? A Proof-of-principle Study,Respiratory
2849,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",30,NCT04475588,ITOLIZUMAB IV INFUSION,INDIA,Completed,Biocon Limited,"May 1, 2020",Interventional,"A Multi-Centre, Open Label, Two Arm Randomized, Pivotal Phase 2 Trial to Study the Efficacy and Safety of Itolizumab in COVID-19 Complications",Respiratory
2850,COVID,"February 08, 2021",500,NCT04475601,ENZALUTAMIDE PILL,SWEDEN,Recruiting,Andreas Josefsson,"July 15, 2020",Interventional,"A Prospective, Multicenter, Randomized PHASE II Clinical Trial of Enzalutamide Treatment to Decrease the Morbidity in Patients With Corona Virus Disease 2019 (COVID-19)",COVID
2851,PREGNANCY RELATED,"February 08, 2021",85,NCT04475718,FOURTH TRIMESTER MOBILE TOOL,UNITED STATES,Recruiting,HealthCore-NERI,"July 6, 2020",Interventional,Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women,Unrelated
2852,EDENTULOUS MOUTH,"February 08, 2021",56,NCT04475913,DIG AXIAL,EGYPT,"Active, not recruiting",October University for Modern Sciences and Arts,"July 11, 2018",Interventional,"In a Post -Covid-19 World, What is the Clinical Influence of Digital vs Analog Impression in Cases of All-on-4 - Prosthesis ?",Unrelated
2853,COVID,"February 08, 2021",100,NCT04475991,MARAVIROC + CURRENTLY USED THERAPY,MEXICO,Not yet recruiting,Hospital General de México Dr. Eduardo Liceaga,January 2021,Interventional,"Phase2, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Maraviroc and/or Favipiravir Plus Standard Therapy in Adult Patients With Severe Non-critical COVID-19""",COVID
2854,COVID,"February 08, 2021",100,NCT04476589,FUNCTIONAL MRI,UNITED STATES,Recruiting,Massachusetts General Hospital,"July 1, 2020",Observational,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19,COVID
2855,COVID (SARS-CoV2),"February 08, 2021",500,NCT04476602,,UNITED STATES,Recruiting,Northwell Health,"April 27, 2020",Observational,Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol,COVID
2856,MENTAL HEALTH ISSUE,"February 08, 2021",80,NCT04476667,E-PSYCHOTHERAPY,CANADA,Recruiting,Queen's University,"June 15, 2020",Interventional,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",Unrelated
2857,SARS-COV INFECTION,"February 08, 2021",4400,NCT04476680,VITAMIN D 1000 IU,UNITED KINGDOM,Not yet recruiting,Royal Centre for Defence Medicine,"September 1, 2020",Interventional,Reducing Asymptomatic Infection With Vitamin D in Coronavirus Disease,Respiratory
2858,CYTOKINE RELEASE SYNDROME IN COVID-INDUCED PNEUMONIA,"February 08, 2021",,NCT04476706,CANAKINUMAB,,No longer available,Novartis Pharmaceuticals,,Expanded Access,Managed Access Program (MAP) to Provide Access to Canakinumab Treatment of Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia,COVID
2859,BIOEQUIVALENCE,"February 08, 2021",18,NCT04476719,ATAFENOVIR 200 MG KAPSUL,TURKEY,"Active, not recruiting",Atabay Kimya Sanayi Ticaret A.S.,"July 9, 2020",Interventional,"Open-Label, Randomised, Single Oral Dose, Two-Period, Cross-Over Trial To Assess The Bioequivalence Of Atafenovir 200 Mg Kapsul In Comparison With Arbidol 100 Mg Kapsul In Healthy Male Subjects Under Fasting Conditions",Unrelated
2860,CYTOKINE STORM,"February 08, 2021",100,NCT04476745,VITAMIN D3,JORDAN,Enrolling by invitation,Applied Science Private University,"October 5, 2020",Interventional,"The Effect of Weekly 50,000 IU Vitamin D3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm of Covid-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People With Vitamin D Deficiency",Unrelated
2861,CLINICAL PRACTICE DURING THE COVID CRISIS,"February 08, 2021",71,NCT04476823,ACTIVITY,FRANCE,Completed,Centre Hospitalier Universitaire de Nice,"March 15, 2020",Observational,Practice in Clinical and Molecular Thoracic European Pathology Laboratories During the COVID-19 Pandemic.,COVID
2862,COVID,"February 08, 2021",110,NCT04476888,CONVALESCENT PLASMA (CP),PAKISTAN,Completed,Aga Khan University,"April 26, 2020",Interventional,Convalescent Plasma Treatment in COVID-19 Patients at a Tertiary Care Center in Pakistan,COVID
2863,RESPIRATORY FAILURE,"February 08, 2021",250,NCT04476914,,UNITED STATES,Recruiting,"University of Colorado, Denver","June 29, 2020",Observational,Psychological Distress Symptoms in Family Members of Patients With COVID-19 Respiratory Failure in Intensive Care Units,Respiratory
2864,COVID,"February 08, 2021",300,NCT04476927,DIANOSE,,Not yet recruiting,Nanose Medical Ltd.,"August 1, 2020",Interventional,Collecting and Evaluating Data of Potential Volatile Biomarkers in the Exhaled Air of Subjects With and Without COVID-19 by DiaNose,COVID
2865,COVID,"February 08, 2021",200,NCT04476940,COVID-19 BREASTFEEDING SUPPORT,UNITED STATES,Not yet recruiting,Meharry Medical College,September 2020,Interventional,An Intervention to Promote COVID-19 Breastfeeding Guideline Adherence Among African American Mothers,COVID
2866,COVID,"February 08, 2021",70,NCT04476953,PLACEBO,UNITED STATES,Enrolling by invitation,Mayo Clinic,"August 3, 2020",Interventional,COVID-FISETIN: A Phase 2 Placebo-Controlled Pilot Study in Covid-19 of Fisetin to Alleviate Dysfunction and Excessive Inflammatory Response in Hospitalized Adults,COVID
2867,CORONAVIRUS INFECTION,"February 08, 2021",120,NCT04476979,TOCILIZUMAB,FRENCH GUIANA,Recruiting,Assistance Publique - Hôpitaux de Paris,"July 16, 2020",Interventional,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,COVID
2868,HYPOXEMIA,"February 08, 2021",20,NCT04476992,NITRIC OXIDE-SESSIONS,RUSSIAN FEDERATION,"Active, not recruiting","Federal State Budgetary Scientific Institution, Research Institute of Cardiology","July 24, 2020",Interventional,A Safety Study on the Use of Intermittent Versus Continuous Inhalation of NO in Spontaneous Breathing COVID-19 Patients,Unrelated
2869,COVID,"February 08, 2021",40,NCT04477083,INHALABLE HYDROXYCHLOROQUINE (HCQ),EGYPT,"Active, not recruiting",Mansoura University,"July 15, 2020",Interventional,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",COVID
2870,COVID,"February 08, 2021",600,NCT04477213,,,Not yet recruiting,NMC Specialty Hospital,"January 15, 2021",Observational,Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers- A Multicentric Retrospective Study,COVID
2871,COVID PANDEMIC,"February 08, 2021",100,NCT04477473,QUESTIONNAIRE-BASED OBSERVATIONAL STUDY,SWITZERLAND,Recruiting,"University Hospital, Geneva","June 30, 2020",Observational,Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group: Patients Under Long Term Noninvasive Ventilation for Chronic Hypercapnic Respiratory Failure in Geneva. An Observational Monocentric Study,COVID
2872,COVID,"February 08, 2021",0,NCT04477642,ABATACEPT,UNITED STATES,Withdrawn,Beth Israel Deaconess Medical Center,August 2020,Interventional,Abatacept for Patients With COVID-19 and Respiratory Distress,COVID
2873,COVID,"February 08, 2021",200,NCT04477655,AWAKE PRONE POSITIONING,MEXICO,Recruiting,Hospital Civil de Guadalajara,"May 3, 2020",Interventional,Prone Positioning in Non-intubated Patients With Severe COVID-19: a Randomized Controlled Trial,COVID
2874,COVID,"February 08, 2021",320,NCT04477668,HELMET NON-INVASIVE VENTILATION,SAUDI ARABIA,Not yet recruiting,King Abdullah International Medical Research Center,October 2020,Interventional,Helmet Non-Invasive Ventilation for COVID-19 Patients,COVID
2875,COVID,"February 08, 2021",500,NCT04477889,TREATMENT FOR COVID-19,UNITED STATES,Recruiting,Methodist Health System,"June 20, 2020",Observational,Methodist Health System COVID-19 Patient Registry,COVID
2876,COVID,"February 08, 2021",50000,NCT04477902,NONE - OBSERVATIONAL,UNITED STATES,Recruiting,Altura,"July 1, 2020",Observational,"A Longitudinal, Long-Term, Observational Study of COVID-19 Experience and Health Effects",COVID
2877,TYPE 1 DIABETES,"February 08, 2021",3000,NCT04477928,SERA AND WHOLE BLOOD SAMPLING,UNITED STATES,Recruiting,Sanford Health,"July 17, 2020",Observational,Sanford Population Level Estimation of Type 1 Diabetes Risk GEnes in Children,Unrelated
2878,COVID,"February 08, 2021",40,NCT04477954,HYPERBARIC OXYGEN,ARGENTINA,Terminated,Asociación Argentina de Medicina Hiperbárica e Investigación,"July 6, 2020",Interventional,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia,COVID
2879,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",200,NCT04477993,JANUS KINASE INHIBITOR (RUXOLITINIB),BRAZIL,Recruiting,Vanderson Geraldo Rocha,"July 17, 2020",Interventional,"Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection",COVID
2880,COVID,"February 08, 2021",94,NCT04478019,10% POVIDONE-IODINE NASAL DECOLONIZATION SWAB PLUS 0.12% CHG ORAL RINSE,UNITED STATES,Recruiting,"University of Wisconsin, Madison","July 7, 2020",Interventional,Role of NaSo-oropHaryngeal Antiseptic dEcolonizaiton to Reduce Covid-19 Viral Shedding and Disease Transmission: SHIELD Study,COVID
2881,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",300,NCT04478071,VADADUSTAT,UNITED STATES,Recruiting,"The University of Texas Health Science Center, Houston","August 22, 2020",Interventional,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),Respiratory
2882,COVID,"February 08, 2021",35,NCT04478539,EXTRACORPOREAL BLOOD PURIFICATION USING THE OXIRIS® (AN69ST) HEMOFILTER,NORTH MACEDONIA,Recruiting,Zan Mitrev Clinic,"June 1, 2020",Interventional,Clinical Efficacy and Safety of Extracorporeal Blood Purification to Control Hyperinflammation and Hypercoagulability in COVID-19 Patients,COVID
2883,CANCER,"February 08, 2021",1500,NCT04478851,GROUP EXERCISE CLASSES,CANADA,Recruiting,University of Calgary,"September 2, 2020",Interventional,"Project EXCEL: Dissemination, Implementation, and Effectiveness of the Exercise Oncology Survivorship Partnership Model - Reaching Rural Cancer Survivors to Enhance Quality of Life",Unrelated
2884,TRAUMA,"February 08, 2021",2000,NCT04479124,COVID-19 PCR,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 10, 2020",Observational,The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul,Unrelated
2885,COVID,"February 08, 2021",5000,NCT04479137,PCR FOR COVID-19,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 10, 2020",Observational,Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul,COVID
2886,COVID,"February 08, 2021",3000,NCT04479150,,SPAIN,Recruiting,Hospital Universitari de Bellvitge,"March 1, 2020",Observational [Patient Registry],Postoperative Complications and Mortality of Patients Submited to Emergency Digestive Surgery During the COVID-19 Pandemic (COVIDCIR Study): a Multicenter Cohorts' Study Protocol,COVID
2887,COVID,"February 08, 2021",165,NCT04479163,CONVALESCENT PLASMA,ARGENTINA,Completed,Fundacion Infant,"June 4, 2020",Interventional,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2.,COVID
2888,BERBERINE,"February 08, 2021",76,NCT04479202,BERBERINE,CHINA,Completed,Chinese Medical Association,"February 8, 2020",Interventional,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,Unrelated
2889,COAGULATION DISORDER,"February 08, 2021",70,NCT04479280,"SONCLOT COAGULATION AND PLATELET FUNCTION ANALYZER SCP1, SIENCO, USA",EGYPT,Completed,Assiut University,"July 20, 2020",Observational,Evaluation of the Role of Sonoclot Signature in Assessment of Coagulopathy in Critically Ill COVID 19 Patients,Unrelated
2890,COVID,"February 08, 2021",400,NCT04479293,POST COVID-19 FUNCTIONAL SATUS SCALE,EGYPT,Recruiting,Assiut University,"July 1, 2020",Observational,Assessment of Functional Recovery From COVID-19 Using the Proposed Post- COVID-19 Functional Status Score,COVID
2891,COVID,"February 08, 2021",10000,NCT04479319,THORAX CT,TURKEY,Recruiting,Ankara University,"December 31, 2020",Observational,Developing Hybrid Decision Support System Algorithm for COVID-19 Diagnosis Between RT-PCR Graphics and Thorax CT Images Using Deep Learning,COVID
2892,CORONAVIRUS INFECTION,"February 08, 2021",334,NCT04479332,TRACHEAL INTUBATION AND CARDIOPULMONARY RESUSCITATION,,Not yet recruiting,National Taiwan University Hospital,"August 1, 2020",Interventional,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),COVID
2893,"KNOWLEDGE, ATTITUDES, PRACTICE","February 08, 2021",100,NCT04479345,QUESTIONNAIRE,,Not yet recruiting,Assiut University,July 2020,Observational,"Knowledge, Attitude and Practice of Gastrointestinal Endoscopists Toward PPE in COVID-19 Era",Unrelated
2894,COVID,"February 08, 2021",332,NCT04479358,TOCILIZUMAB,UNITED STATES,Recruiting,University of Chicago,"September 10, 2020",Interventional,"COVIDOSE-2: A Multi-center, Randomized, Controlled Phase 2 Trial Comparing Early Administration of Low-dose Tocilizumab to Standard of Care in Hospitalized Patients With COVID-19 Pneumonitis Not Requiring Invasive Ventilation",COVID
2895,COVID,"February 08, 2021",2000,NCT04479488,HOSPITAL ADMISSION,BRAZIL,Recruiting,Hospital Israelita Albert Einstein,"July 27, 2020",Observational [Patient Registry],"Brazilian COVID-19 Registry for Clinical Presentation of Individuals With COVID-19: a National, Multicentre, Prospective Observational Study (SARS-Brazil)",COVID
2896,"PNEUMONIA, VIRAL","February 08, 2021",120,NCT04479540,ANGIOGRAPHY SCANNER,FRANCE,Recruiting,Hopital Foch,"May 26, 2020",Interventional,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With SARS Coronavirus (COV-2) Lung Disease,Respiratory
2897,COVID,"February 08, 2021",16,NCT04479631,BRII-196,CHINA,"Active, not recruiting",Brii Biosciences Limited,"July 12, 2020",Interventional,"A Phase 1 Randomized, Single-blind, Placebo-controlled, Single Ascending Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Human Monoclonal Antibody, BRII-196 Administered Intravenously to Healthy Adult Volunteers",COVID
2898,COVID,"February 08, 2021",17,NCT04479644,BRII-198,CHINA,"Active, not recruiting",Brii Biosciences Limited,"July 13, 2020",Interventional,"A Phase 1 Randomized, Single-blind, Placebo-controlled, Single Ascending Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Human Monoclonal Antibody, BRII-198 Administered Intravenously to Healthy Adult Volunteers",COVID
2899,COVID,"February 08, 2021",70,NCT04479982,,EGYPT,Recruiting,Assiut University,"September 24, 2020",Observational,Microbial Infections and Antimicrobial Resistance (AMR) Patterns Associated With Hospitalized Patients With 2019 Novel Coronavirus Disease (COVID 19),COVID
2900,BARIATRIC SURGERY CANDIDATE,"February 08, 2021",1600,NCT04480034,BARIATRIC PROCEDURES,ITALY,Recruiting,University of Roma La Sapienza,"July 15, 2020",Observational,"Laparoscopic Bariatric Surgery During Phase 2-3 Covid-19 Pandemic in Italy: a Multicenter, Prospective, Observational Study.",Unrelated
2901,COVID,"February 08, 2021",100000,NCT04480060,COVID-19 DIAGNOSTIC PCR,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 10, 2020",Observational,Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic: Retrospective Cohort Study,COVID
2902,MEMORY DISORDERS,"February 08, 2021",150,NCT04480112,TECHNOLOGY BASED SOCIAL INTERACTIONS,UNITED STATES,Enrolling by invitation,Boston University,"June 2, 2020",Interventional,Impact of Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults With and Without Cognitive Impairment,Unrelated
2903,COVID,"February 08, 2021",40,NCT04480138,PEGYLATED INTERFERON-Α2B,MEXICO,Recruiting,Cadila Healthcare Limited,"August 11, 2020",Interventional,"A Phase II, Multicenter, Open-label, Randomized, Comparator Controlled Study to Evaluate the Efficacy and Safety of Pegylated Interferon - α2b in the Treatment of Adult Patients Diagnosed With SARS-CoV2 (COVID-19)",COVID
2904,PREMATURE BIRTH,"February 08, 2021",600,NCT04480255,GROUP 1: STANDARD OF CARE,UNITED STATES,Recruiting,Craig Garfield,"August 3, 2020",Interventional,NICU2HOME+: Supporting Illinois Families of Premature Infants With Smartphone Technology,Unrelated
2905,COVID,"February 08, 2021",45,NCT04480333,DRUG: NA-831 - 0.10 MG/KG,UNITED STATES,Recruiting,"NeuroActiva, Inc.","September 15, 2020",Interventional,"A Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and in Combination With NA-831 in Healthy Volunteers",COVID
2906,COVID,"February 08, 2021",91,NCT04480398,GUDUCHI GHAN VATI,INDIA,Completed,Aarogyam UK,"May 12, 2020",Observational,A Retrospective Study on Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients,COVID
2907,DIAGNOSES DISEASE,"February 08, 2021",50,NCT04480411,DOCTORGRAM PATIENT KIT,UNITED STATES,Not yet recruiting,Stanford University,February 2021,Interventional,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,Unrelated
2908,COVID,"February 08, 2021",100,NCT04480424,GAMUNEX-C,UNITED STATES,Recruiting,Grifols Therapeutics LLC,"September 17, 2020",Interventional,"A Multicenter, Randomized, Open-label Parallel Group Pilot Study to Evaluate Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Subjects With COVID-19 Requiring Admission to the Intensive Care Unit",COVID
2909,COVID,"February 08, 2021",5000,NCT04480515,IN-HOSPITAL MORTALITY RATE,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"March 11, 2020",Observational,Does COVID-19 Pandemic Reduce In-hospital Mortality?,COVID
2910,COVID,"February 08, 2021",100,NCT04480580,SARS-COV-2 AB,ITALY,Completed,University of Cagliari,"March 30, 2020",Observational,Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery,COVID
2911,COVID,"February 08, 2021",120,NCT04480593,BRAZILIAN GREEN PROPOLIS EXTRACT (EPP-AF),BRAZIL,Completed,D'Or Institute for Research and Education,"June 2, 2020",Interventional,"The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19: a Randomized, Open and Pilot Clinical Study.",COVID
2912,EXERCISE PROGRAM,"February 08, 2021",88,NCT04480606,HOME EXERCISE PROGRAM,,Not yet recruiting,Istinye University,"August 1, 2020",Interventional,"Effects of Home Exercise Program Applied to the Socially Isolated Elderly Due to COVID-19 on Physical Activity Level, Functional Capacity and Quality of Life",Unrelated
2913,COVID,"February 08, 2021",44,NCT04480632,CONVALESCENT PLASMA,COLOMBIA,Not yet recruiting,Fundación Cardiovascular de Colombia,"August 1, 2020",Interventional,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis / Plasmaféresis terapéutica en Pacientes Adultos críticamente Enfermos Con diagnóstico Confirmado de COVID-19,COVID
2914,SARS-CoV2,"February 08, 2021",92,NCT04480957,ARCT-021 DOSE 1,SINGAPORE,Recruiting,"Arcturus Therapeutics, Inc.","August 4, 2020",Interventional,"A Phase 1/2 Randomised, Double Blinded, Placebo Controlled, Ascending Dose Study to Assess the Safety, Tolerability, and Immunogenicity of ARCT-021 in Healthy Adult Subjects",COVID
2915,CORONAVIRUS,"February 08, 2021",100,NCT04481360,CT OF THE CHEST,,Not yet recruiting,Assiut University,August 2020,Observational,Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut,COVID
2916,COVID,"February 08, 2021",450,NCT04481477,"NURSING CARE TO REDUCE ANXIETY, FEAR AND LONELINESS",SPAIN,Not yet recruiting,Corporacion Parc Tauli,September 2020,Observational,Impact on Patients of Nurses' Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19,COVID
2917,STRESS,"February 08, 2021",30,NCT04481516,YOGA,UNITED KINGDOM,Recruiting,Doncaster And Bassetlaw Hospitals NHS Foundation Trust,"July 1, 2020",Observational,Effect of Breathing-based Meditation (Sudarshan Kriya Yoga) in NHS Health Care Workers With Possible COVID-19 Related Stress and Anxiety Disorder,Unrelated
2918,INFECTION VIRAL,"February 08, 2021",1576,NCT04481529,HEALTH QUESTIONNAIRE,FRANCE,"Active, not recruiting","University Hospital, Limoges","July 29, 2020",Observational,Study of the COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector in 3 French Regions Facing the COVID-19 Epidemic With Varying Degrees of Intensity,Unrelated
2919,COVID,"February 08, 2021",1315,NCT04481620,,FRANCE,Recruiting,"University Hospital, Bordeaux","August 31, 2020",Observational,"Evelopment and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT",COVID
2920,COVID,"February 08, 2021",800,NCT04481633,COVID 19 SEROLOGY,FRANCE,Recruiting,"University Hospital, Toulouse","September 9, 2020",Interventional,Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease,COVID
2921,COVID,"February 08, 2021",630,NCT04481646,FACE MASK SAMPLING,UNITED KINGDOM,Recruiting,University of Leicester,"June 12, 2020",Observational [Patient Registry],The Efficacy and Feasibility of Face Mask Sampling for Hospitalised Adult Patients and Healthcare Workers With Suspected COVID-19,COVID
2922,COVID,"February 08, 2021",36,NCT04481685,ATI-450,UNITED STATES,Recruiting,University of Kansas Medical Center,"July 20, 2020",Interventional,"A Double-blind, Randomized, Controlled Trial of ATI-450 in Patients With Moderate-severe COVID-19",COVID
2923,COVID,"February 08, 2021",150,NCT04482023,"TRAINING VIDEO ON ANXIETY, FEAR AND LONELINESS IN THE COVID-19 ENVIRONMENT.",SPAIN,Not yet recruiting,Corporacion Parc Tauli,September 2020,Observational,Emotional Support and Stress Management Activities Offered by Nurses to Patients Diagnosed With COVID-19 During Hospital Admission,COVID
2924,ECONOMIC BURDEN,"February 08, 2021",840,NCT04482205,,PAKISTAN,Completed,Aga Khan University,"March 16, 2020",Observational,Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures in Musculoskeletal Service Line of a Tertiary Care Hospital,Unrelated
2925,COVID,"February 08, 2021",5900,NCT04482361,PRESENCE OF SPECIFIC ANTI-SARS-COV-2 ANTIBODIES,ARGENTINA,Completed,Ministerio de Salud de Ciudad Autónoma de Buenos Aires,"August 6, 2020",Observational [Patient Registry],SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES,COVID
2926,VISUAL IMPAIRMENT,"February 08, 2021",250,NCT04482387,DIGIVIS VISUAL ACUITY APP,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"July 24, 2020",Interventional,DigiVis: Validation of Self-testing Visual Acuity Web-based App to Aid Ophthalmic Telephone Consultations During Covid19 Lockdown and Subsequent Social Distancing Crisis,Unrelated
2927,PULMONARY FIBROSIS,"February 08, 2021",66,NCT04482595,BIO 300 ORAL SUSPENSION,UNITED STATES,Recruiting,Humanetics Corporation,"November 11, 2020",Interventional,A Phase 2 Study of BIO 300 Oral Suspension in Discharged COVID-19 Patients,Unrelated
2928,COVID,"February 08, 2021",40,NCT04482621,DECITABINE,UNITED STATES,Recruiting,Johns Hopkins University,"September 14, 2020",Interventional,Decitabine for COVID-19 Pneumonia-ARDS Treatment: DART Trial,COVID
2929,PULMONARY REHABILITATION,"February 08, 2021",122,NCT04482634,REMOTE CONTROLLED EXERCISE,TURKEY,Recruiting,Koç University,"September 1, 2020",Interventional,Is Tele-rehabilitation Superior to Home Exercise Program in the Pulmonary Rehabilitation of the Patients With COVID-19 With Post-intensive Care Syndrome? A Randomized Controlled Trial,Unrelated
2930,COVID INFECTION,"February 08, 2021",50,NCT04482647,MEDIA INTERVENTION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"June 17, 2020",Interventional,Breathing Techniques and Meditation for Health Care Workers During COVID-19,COVID
2931,COVID,"February 08, 2021",140,NCT04482673,DAILY VITAMIN D3,UNITED STATES,Recruiting,Medical University of South Carolina,"July 31, 2020",Interventional,The Role of Vitamin D in Mitigating COVID-19 Infection Severity: Focusing on Reducing Health Disparities in South Carolina,COVID
2932,COVID,"February 08, 2021",30,NCT04482686,IVERMECTIN,UNITED STATES,Recruiting,ProgenaBiome,"December 9, 2020",Interventional,A Phase II Double-Blind Randomized Placebo-Controlled Trial of Combination Therapy to Treat COVID-19 Infection,COVID
2933,SEVERE COVID DISEASE,"February 08, 2021",88,NCT04482699,RAPA-501-ALLO OFF-THE-SHELF THERAPY OF COVID-19,UNITED STATES,Recruiting,Rapa Therapeutics LLC,"December 30, 2020",Interventional,"Phase I/Phase II Trial of Off-the-Shelf Allogeneic Hybrid TREG/Th2 Cell (RAPA-501-ALLO) Therapy for Severe, Post-Intubation Stage 3 COVID-19 Disease",COVID
2934,ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS),"February 08, 2021",20,NCT04482712,RAPAMYCIN,UNITED STATES,Not yet recruiting,The University of Texas Health Science Center at San Antonio,January 2021,Interventional,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of Acute Respiratory Distress Syndrome (RAPA-CARDS),Respiratory
2935,CYTOKINE STORM,"February 08, 2021",100,NCT04483271,300 MG OF OMEGA3-FA,JORDAN,Enrolling by invitation,Applied Science Private University,"October 2, 2020",Interventional,The Effect of Omega-3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm of Covid-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,Unrelated
2936,CORONAVIRUS DISEASE 2019(COVID),"February 08, 2021",33,NCT04483375,SCTA01,CHINA,Completed,Sinocelltech Ltd.,"July 24, 2020",Interventional,"A Randomized, Double-blinded, Placebo-controlled, Single Ascending Dose, Phase I Study to Evaluate the Tolerability, Safety, Pharmacokinetics of SCTA01 in Healthy Subjects",COVID
2937,COVID,"February 08, 2021",30,NCT04483622,,EGYPT,Recruiting,Sohag University,"June 12, 2020",Observational,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients,COVID
2938,COVID,"February 08, 2021",2414,NCT04483635,PLACEBO,CANADA,Not yet recruiting,St. Justine's Hospital,"November 30, 2020",Interventional,PROTECT RCT (PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams,COVID
2939,COV2 SARS PNEUMONIA,"February 08, 2021",100,NCT04483752,CHEST CT SCAN,FRANCE,Recruiting,Centre Chirurgical Marie Lannelongue,"June 8, 2020",Interventional,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,Respiratory
2940,COVID,"February 08, 2021",243,NCT04483830,SULODEXIDE,MEXICO,Completed,Clinedem,"June 5, 2020",Interventional,Sulodexide in the Treatment of Early Stages of COVID-19,COVID
2941,COVID INFECTION,"February 08, 2021",550,NCT04483908,BLOOD DRAW,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","April 10, 2020",Observational,COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses (SERO-BL-COVID-19),COVID
2942,SARS-CoV2 INFECTION (COVID),"February 08, 2021",2400,NCT04483960,NAFAMOSTAT MESILATE,AUSTRALIA,Recruiting,University of Melbourne,"July 28, 2020",Interventional,"A Multi-centre Randomised Adaptive Platform Clinical Trial to Assess Clinical, Virological and Immunological Outcomes in Patients With SARS-CoV-2 Infection (COVID-19)",COVID
2943,COVID,"February 08, 2021",60,NCT04483973,EBSELEN,,Not yet recruiting,"Sound Pharmaceuticals, Incorporated",December 2020,Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Severe COVID-19 Patients",COVID
2944,COVID,"February 08, 2021",60,NCT04484025,EBSELEN,,Not yet recruiting,"Sound Pharmaceuticals, Incorporated",December 2020,Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Moderate COVID-19 Patients",COVID
2945,BRIEF VIDEO-BASED INTERVENTION,"February 08, 2021",200,NCT04484207,A SHORT VIDEO INTERVENTION,UNITED STATES,Recruiting,"Research Foundation for Mental Hygiene, Inc.","July 6, 2020",Interventional,Addressing COVID-19 Mental Health Problems Among US Veterans,Unrelated
2946,COVID,"February 08, 2021",100,NCT04484493,MOMETASONE FUROATE NASAL SPRAY,EGYPT,Completed,Benha University,"August 8, 2020",Interventional,Role of Corticosteroid Nasal Spray in Recovery of Smell Sensation in COVID-19 Patients,COVID
2947,COVID,"February 08, 2021",250,NCT04484545,PROGNOSTIC SCORE,UNITED KINGDOM,"Active, not recruiting",Glasgow Royal Infirmary,"April 1, 2020",Observational,Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection,COVID
2948,POSITIVE COVID BY PCR,"February 08, 2021",100,NCT04484597,RT PCR,EGYPT,Recruiting,Port Said University,"March 15, 2020",Observational,Predictors of COVID-19 Infection and Disease Progression,COVID
2949,POSTPARTUM DEPRESSION,"February 08, 2021",388,NCT04485000,ONLINE 1-DAY COGNITIVE BEHAVIOURAL THERAPY (CBT)-BASED WORKSHOP,CANADA,Recruiting,McMaster University,"April 20, 2020",Interventional,Online 1-Day CBT-Based Workshops for Postpartum Depression,Unrelated
2950,COVID,"February 08, 2021",60,NCT04485130,DISULFIRAM,UNITED STATES,Not yet recruiting,"University of California, San Francisco","February 1, 2021",Interventional,"DISulfiram for COvid-19 (DISCO) Trial: A Phase 2 Double-Blind, Randomized Placebo-Controlled Trial of Disulfiram Compared to Standard Care in Patients With Symptomatic COVID-19",COVID
2951,COVID,"February 08, 2021",280,NCT04485169,THERAPEUTIC PLASMA EXCHANGE,PAKISTAN,Completed,UNICEF,"April 1, 2020",Interventional,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; a Retrospective Propensity Matched Control Study,COVID
2952,COVID,"February 08, 2021",200,NCT04485338,,NETHERLANDS,Recruiting,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"August 1, 2020",Observational,Radiographic Assessment of Lung Edema in Invasively Ventilated COVID-19 Patients (RALE-COVID) - Protocol for an International Multicenter Retrospective Study,COVID
2953,DIABETES MELLITUS,"February 08, 2021",700,NCT04485351,NO INTERVENTION,FRANCE,Recruiting,"Central Hospital, Nancy, France",July 2020,Observational,Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes: a Monocentric Cross-sectional Study,Unrelated
2954,CORONAVIRUS,"February 08, 2021",100,NCT04485364,,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"April 14, 2020",Observational,Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia: BioCovid Study,COVID
2955,HOUSEHOLDS,"February 08, 2021",530,NCT04485377,,UNITED STATES,Recruiting,"University of California, Berkeley","August 1, 2020",Observational,Assessing Californians Communities' Experiences With Safety Net Supports Survey,Unrelated
2956,COVID,"February 08, 2021",268,NCT04485429,METHYLPREDNISOLONE,BRAZIL,Recruiting,D'Or Institute for Research and Education,"July 20, 2020",Interventional,"Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia: A Randomized, Controlled, 2x2 Factorial Study",COVID
2957,COVID,"February 08, 2021",20,NCT04486001,PSC-04,UNITED STATES,Recruiting,"Sorrento Therapeutics, Inc.","December 15, 2020",Interventional,COVID-19 Stem Cell Therapy: A Phase I Study of Intravenous Administration of Allogeneic Adipose Stem Cells,COVID
2958,COVID POSITIVE PATIENT,"February 08, 2021",100,NCT04486144,PROPRIETARY EXTRACT OF NERIUM OLEANDER,UNITED STATES,Enrolling by invitation,HealthQuilt,"May 20, 2020",Interventional,Impact of a Proprietary Extract of Nerium Oleander on Symptoms and Mortality :A Feasibility Study,COVID
2959,COVID,"February 08, 2021",1092,NCT04486313,NITAZOXANIDE,UNITED STATES,"Active, not recruiting",Romark Laboratories L.C.,"August 13, 2020",Interventional,"Phase 3, Randomized, Double-Blind, Placebo-Controlled, Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19",COVID
2960,ACUTE STRESS DISORDER,"February 08, 2021",2500,NCT04486404,ONLINE SURVEY,ARGENTINA,Enrolling by invitation,Universidad Miguel Hernandez de Elche,"April 1, 2020",Observational,"Personal Protective Equipmente Needs, Perceptions and Acute Stress Among Healthcare Workers Caring for COVID-19 Patients in South America",Unrelated
2961,OBESITY,"February 08, 2021",20,NCT04486417,,ITALY,Recruiting,University of Roma La Sapienza,"June 1, 2020",Observational,Feasibility of a Telematics Pre-operative Assessment in a Bariatric Center of Excellence During Covid-19 Phase 2: a Prospective Observational Study,Unrelated
2962,MILD-TO-MODERATE COVID,"February 08, 2021",50,NCT04486482,KB109 + SELF SUPPORTIVE CARE (SSC),UNITED STATES,Recruiting,Kaleido Biosciences,July 2020,Interventional,"An Exploratory, Open Label, Clinical Study to Evaluate the Physiologic Effects of KB109 in Adult Patients With Mild-to-Moderate COVID-19 on Gut Microbiota Structure and Function in the Outpatient Setting",COVID
2963,COVID,"February 08, 2021",600,NCT04486508,INTERMEDIATE DOSE ENOXAPARIN/ UNFRACTIONATED HEPARIN,"IRAN, ISLAMIC REPUBLIC OF",Recruiting,Rajaie Cardiovascular Medical and Research Center,"July 30, 2020",Interventional,Intermediate-dose Versus Standard Prophylactic Anticoagulation In cRitically-ill pATIents With COVID-19: An opeN Label Randomized Controlled Trial---A Randomized Trial of Atorvastatin vs. Placebo In Critically-ill Patients With COVID-19,COVID
2964,CRITICAL ILLNESS,"February 08, 2021",11000,NCT04486521,INTERLEUKIN 6 (IL6) ANTAGONIST,SAUDI ARABIA,Recruiting,King Faisal Specialist Hospital & Research Center,"July 22, 2020",Observational,Clinical Outcome of Anti-IL6 vs Anti-IL6 Corticosteroid Combination in Patients With SARS-CoV-2 Cytokine Release Syndrome,Unrelated
2965,COVID,"February 08, 2021",15,NCT04486729,HIGH PEEP WITH END INSPIRATORY PAUSE,ARGENTINA,Recruiting,Sanatorio Anchorena San Martin,"July 1, 2020",Observational,Respiratory System Mechanics and Gas Exchange Characteristics Applying Different Ventilatory Strategies in Patients With SARS-CoV-2,COVID
2966,COVID,"February 08, 2021",29,NCT04487119,,EGYPT,Completed,Benha University,"August 12, 2020",Observational,Pediatric COVID-19 Infection; Do Clinical Features and Hematological Parameters Predict the Need for ICU Admission?,COVID
2967,POSTPARTUM DEPRESSION,"February 08, 2021",248,NCT04487171,QUESTIONNAIRE,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","July 21, 2020",Interventional,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,Unrelated
2968,KIDNEY TRANSPLANT,"February 08, 2021",300,NCT04487197,BLOOD SAMPLE FOR SEROEPIDEMIOLOGICAL INVESTIGATION,ITALY,Recruiting,Antonio Secchi,"July 15, 2020",Observational,"SARS-CoV2 (COVID-19) Seroepidemiological Investigation in Transplanted Population Subjects of Kidney, Kidney-pancreas, Isolated Pancreas, Langerhans Islets",Unrelated
2969,COVID,"February 08, 2021",45,NCT04487210,MVC-COV1901,TAIWAN,"Active, not recruiting",Medigen Vaccine Biologics Corp.,"October 7, 2020",Interventional,"A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901",COVID
2970,COVID,"February 08, 2021",80,NCT04487444,THYMALFASIN,UNITED STATES,Recruiting,Rhode Island Hospital,"September 10, 2020",Interventional,A Pilot Trial of Thymalfasin (Ta1) to Treat COVID-19 Infection in Patients With Lymphocytopenia,COVID
2971,SLEEP,"February 08, 2021",101,NCT04487483,SLEEP APP,UNITED KINGDOM,"Active, not recruiting","University College, London","February 13, 2020",Interventional,Exploring the Impact of a Sleep App on Sleep Quality: a Randomised Controlled Pilot Study,Unrelated
2972,SARS-CoV2 INFECTION,"February 08, 2021",118,NCT04487574,XC221,RUSSIAN FEDERATION,Completed,RSV Therapeutics LLC,"July 25, 2020",Interventional,"A Multicenter, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of XC221, Tablets, 100 mg in Patients With COVID-19",COVID
2973,SPERM PRESERVATION IN ONCOLOGICAL PATIENTS,"February 08, 2021",250,NCT04487639,"SARS-COV-2 RESEARCH IN NASOPHARYNGEAL SWAB, SPERM AND SEROLOGICS",FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","July 10, 2020",Interventional,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients During the COVID-19 Pandemic ?,Unrelated
2974,COVID,"February 08, 2021",50,NCT04487665,,,Not yet recruiting,Cairo University,"September 15, 2020",Observational,Oral Manifestations of COVID-19: a Multicentre Observational Study,COVID
2975,COVID,"February 08, 2021",40,NCT04487691,NEBULIZED PLATELET LYSATE,UNITED STATES,Recruiting,"Regenexx, LLC","December 8, 2020",Interventional,Autologous Nebulized Platelet Lysate for Post COVID-19 Syndrome,COVID
2976,COVID,"February 08, 2021",30,NCT04487769,,NETHERLANDS,Recruiting,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"June 1, 2020",Observational,Early Lung Ultrasound Score Predicts Duration of Ventilation and ICU Mortality in COVID-19 Invasively Ventilated Patients,COVID
2977,COVID,"February 08, 2021",28,NCT04487873,,TURKEY,Recruiting,Hacettepe University,"July 23, 2020",Observational,COVID-19 Phobia and Quality of Life in Patients With Bronchiectasis During Covid-19 Pandemic,COVID
2978,COVID,"February 08, 2021",80,NCT04487886,DUVELISIB,UNITED STATES,Recruiting,Emory University,"November 18, 2020",Interventional,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection,COVID
2979,COVID PNEUMONIA,"February 08, 2021",100,NCT04487951,"PRO BNP , VITAMIN D",EGYPT,Recruiting,Cairo University,"July 1, 2020",Observational,N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia,COVID
2980,COVID,"February 08, 2021",70,NCT04487964,LICORICE EXTRACT,EGYPT,Recruiting,Egyptian Biomedical Research Network,"January 1, 2020",Interventional,Evaluation of The Potential Therapeutic Effects of Licorice and Boswellia Serrata Gum in Egyptian Patients With COVID-19 as a Complementary Medicine,COVID
2981,AIRWAY MANAGEMENT,"February 08, 2021",5000,NCT04487977,SURVEY,SPAIN,Recruiting,Spanish Society of Anesthesia and Critical Care (SEDAR),"April 22, 2020",Observational,International Survey on Airway Management in COVID-19 Patients (ISAM-COVID),Unrelated
2982,ACUTE KIDNEY INJURY,"February 08, 2021",90,NCT04487990,UNFRACTIONATED HEPARIN,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"June 29, 2020",Interventional,CoV-Hep Study: Randomized and Paired Clinical Trial Comparing Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,Unrelated
2983,COVID,"February 08, 2021",1500,NCT04488081,REMDESIVIR,UNITED STATES,Recruiting,QuantumLeap Healthcare Collaborative,"July 31, 2020",Interventional,I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients,COVID
2984,INFLAMMATORY BOWEL DISEASES,"February 08, 2021",232,NCT04488471,,UNITED KINGDOM,Recruiting,Sheffield Teaching Hospitals NHS Foundation Trust,"June 30, 2020",Observational,Impact of Isolation in Patients With IBD During the 2020 COVID-19 Crisis: a Mixed Methods Study,Unrelated
2985,COVID,"February 08, 2021",450,NCT04488484,SEROLOGY TEST FOLLOW-UP,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"July 1, 2020",Interventional,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group,COVID
2986,COVID,"February 08, 2021",150,NCT04488510,,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"May 6, 2020",Observational,Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia: COVAP Study,COVID
2987,COLO-RECTAL CANCER,"February 08, 2021",1051,NCT04488549,SURVEY,ITALY,Completed,Treviso Regional Hospital,"May 20, 2020",Observational,DElayed COloRectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19),Unrelated
2988,COVID,"February 08, 2021",150,NCT04488562,,NETHERLANDS,Recruiting,Erasmus Medical Center,"May 8, 2020",Observational [Patient Registry],Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands,COVID
2989,COVID,"February 08, 2021",60,NCT04488575,EDP1815,UNITED STATES,Recruiting,"Evelo Biosciences, Inc.","August 26, 2020",Interventional,A Phase 2 Double-blind Placebo-controlled Study Investigating the Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With SARS-CoV-2 Infection,COVID
2990,COVID,"February 08, 2021",1064,NCT04488588,KAPLAN MEIER ANALYSIS,EGYPT,Completed,Assiut University,"March 15, 2020",Observational,Survival and 30-days Hospital Outcome in Hospitalized COVID-19 Patients in Upper Egypt: Multi-center Study,COVID
2991,HEALTH BEHAVIOUR CHANGE,"February 08, 2021",145,NCT04488796,ASSIGNED STRATEGIES: OPT-IN,CANADA,Recruiting,"Western University, Canada","September 7, 2020",Interventional,"STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers, a Pilot Randomized Controlled Trial",Unrelated
2992,CORONAVIRUS,"February 08, 2021",350,NCT04489407,REMOTE PHOTOPLETHYSMOGRAPHY (RPPG) VITAL SIGN ACQUISITION,,Not yet recruiting,Lady Davis Institute,"August 1, 2020",Interventional,Can Remote Photoplethysmography Be Used for Contactless Vital Sign Acquisition in a Healthcare Setting? A Prospective Comparative Study.,COVID
2993,COVID,"February 08, 2021",40,NCT04489446,SILDENAFIL,CHILE,Recruiting,Universidad Nacional Andres Bello,"August 19, 2020",Interventional,Sildenafil for Treating Patients With COVID-19 and Perfusion Mismatch: A Pilot Randomised Trial,COVID
2994,SARS-COV INFECTION,"February 08, 2021",110,NCT04489628,VITAMIN D3 OR PLACEBO,UNITED STATES,Not yet recruiting,University Hospitals Cleveland Medical Center,"August 1, 2020",Interventional,Tele-health Enabled Clinical Trial for COVID-19: Vitamin D as an Immunomodulator to Prevent Complications and Reduce Resource Utilization in Outpatients,Respiratory
2995,COVID,"February 08, 2021",2500,NCT04490174,,UNITED STATES,Recruiting,National Institute of Environmental Health Sciences (NIEHS),"January 8, 2020",Observational,Serological Surveillance for COVID-19 in Central North Carolina,COVID
2996,COVID,"February 08, 2021",1000,NCT04490200,VESTA RESPIRATOR,,Not yet recruiting,University of Brasilia,"November 30, 2020",Interventional,Effectiveness of a Novel Respirator With Chitosan Nanoparticles to Reduce the Incidence of SARS-CoV-2 Infection in Healthcare Professionals: Randomized Controlled Trial (VESTA Trial),COVID
2997,COVID,"February 08, 2021",6,NCT04490239,INTRANASAL HEPARIN SODIUM (PORCINE),UNITED STATES,"Active, not recruiting",Joshua Sharp,"October 9, 2020",Interventional,Intranasal Heparin Tolerability Study,COVID
2998,POST ICU SYNDROME,"February 08, 2021",80,NCT04490278,MEDICAL RECORD REVIEW - INPATIENT TREATMENT,UNITED STATES,Recruiting,Washington University School of Medicine,"September 29, 2020",Interventional,"COVID-19 Virtual Post Intensive Care Syndrome (CoV-PICS) Clinic: Modern, Convenient and Practical Recovery Care",Unrelated
2999,ANXIETY,"February 08, 2021",300,NCT04490473,SURVEY WORK,TURKEY,Recruiting,DILEK SAYIK,"July 24, 2020",Interventional,Turkish Validity And Reliability of the SARS-CoV-2 Anxiety Scale,Unrelated
3000,COVID,"February 08, 2021",21,NCT04490486,UCMSCS,UNITED STATES,Not yet recruiting,Joshua M Hare,"September 1, 2021",Interventional,"Phase I, Randomized, Double Blinded, Placebo Control Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 With Moderate to Severe Symptoms",COVID
3001,INFECTIOUS,"February 08, 2021",200,NCT04490772,LABORATORY TESTS,,Not yet recruiting,Assiut University,July 2020,Observational,Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19,Unrelated
3002,COVID,"February 08, 2021",800,NCT04490811,NO INTERVENTION. OBSERVATIONAL COHORT STUDY,FRANCE,Recruiting,Hôpital Necker-Enfants Malades,"April 9, 2020",Observational,Seroprevalence and Immunoprotection Against SARS-CoV2 in Children Hospitalized in Paris,COVID
3003,COVID,"February 08, 2021",100,NCT04490824,KELEA EXCELLERATED WATER,UNITED STATES,Recruiting,Institute of Progressive Medicine,"October 1, 2020",Interventional,Can Inhalation of KELEA Excellerated Water Reduce the Time Required for Covid-19 Infected Individuals to Become Symptom-Free and to Test Negative Using Either the PCR or Antigen Assay,COVID
3004,COVID,"February 08, 2021",3500,NCT04490837,ELISA AND RAPID TEST TO DETECT ANTIBODIES AGAINST COVID-19,SPAIN,"Active, not recruiting",Corporacion Parc Tauli,"June 22, 2020",Observational [Patient Registry],Rapid Diagnostic Test for COVID-19 Based on Antibody Detection,COVID
3005,CORONAVIRUS INFECTION,"February 08, 2021",1500,NCT04490850,BLOOD SAMPLE,FRENCH GUIANA,Recruiting,Institut Pasteur,"July 15, 2020",Interventional,COVID-19 Seroprevalence Study in French Guiana,COVID
3006,STRESS DISORDER,"February 08, 2021",405,NCT04491071,GENERALIZED ANXIETY DISORDER-7 (GAD 7),FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Saint Etienne,September 2020,Observational,Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.,Unrelated
3007,COVID PANDEMICS,"February 08, 2021",6000,NCT04491201,CUSTOMIZED QUESTIONNAIRE,CHINA,Recruiting,Lei Li,"July 27, 2020",Observational,National Survey of the Impact of COVID-19 Pandemics on Chinese Physicians of Obstetrics and Gynecology,COVID
3008,COVID,"February 08, 2021",131,NCT04491214,QUALITY OF LIVE ASSESSMENT,FRANCE,Recruiting,"University Hospital, Strasbourg, France","July 24, 2020",Observational,Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19),COVID
3009,COVID,"February 08, 2021",2000,NCT04491227,,BOLIVIA,Enrolling by invitation,"University of California, San Diego","May 5, 2020",Observational,Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection,COVID
3010,COVID,"February 08, 2021",30,NCT04491240,EXO 1 INHALATION,RUSSIAN FEDERATION,Completed,"State-Financed Health Facility ""Samara Regional Medical Center Dinasty""","July 20, 2020",Interventional,The Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Two-Sided Pneumonia,COVID
3011,COVID INFECTION,"February 08, 2021",20000,NCT04491292,QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"May 18, 2020",Observational,Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce,COVID
3012,HEMOPHILIA ARTHROPATHY,"February 08, 2021",27,NCT04491318,OBSERVATIONAL,SPAIN,Recruiting,Investigación en Hemofilia y Fisioterapia,"July 1, 2020",Observational,Effects of COVID-19 Quarantine on the Musculoskeletal Status of Adult Hemophilia Patients. An Observational Study,Unrelated
3013,COVID,"February 08, 2021",540,NCT04491994,HCQ,PAKISTAN,Completed,UNICEF,"April 10, 2020",Interventional,Clearing the Fog: Is HCQ Effective in Reducing COVID-19 progression-a Randomized Controlled Trial,COVID
3014,EATING DISORDERS,"February 08, 2021",40,NCT04492189,,FRANCE,Completed,"University Hospital, Montpellier","April 1, 2020",Observational,Impact of Containment Measures in People With Eating Disorders: a Descriptive Study,Unrelated
3015,COVID,"February 08, 2021",200,NCT04492202,SURVEY,,Not yet recruiting,Istinye University,"August 1, 2020",Observational,"Comparison of the Knowledge, Attitudes, and Practices Towards COVID-19 Between Different Healthcare Professionals",COVID
3016,COVID,"February 08, 2021",100,NCT04492228,KETOGENIC DIET,ITALY,Recruiting,Ospedale Policlinico San Martino,"September 1, 2020",Interventional,Randomized Open Controlled Clinical Trial to Evaluate the Effectiveness of a Eucaloric Ketogenic Nutrition in Comparison With a Standard Nutrition in Covid-19 Disease in Reducing Cytokine Storm Syndrome and ARDS,COVID
3017,COVID,"February 08, 2021",1370,NCT04492254,ENOXAPARIN,,Not yet recruiting,Thrombosis Research Institute,July 2020,Interventional,"Early Thromboprophylaxis in COVID-19 (ETHIC Trial): an Open Label, Randomized Phase IIIb Trial of Community-based (LMWH) Versus Standard of Care in COVID-19 Positive Patients",COVID
3018,INFLAMMATORY BOWEL DISEASE,"February 08, 2021",700,NCT04492267,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","July 7, 2020",Observational,"SARS-CoV-2 Infection in Patients From Two Tertiary Inflammatory Bowel Disease (IBD) Centres: Frequency of Suspected and Confirmed Infections, Severity and Outcome Management",Unrelated
3019,COVID,"February 08, 2021",144,NCT04492358,COLCHICINE,SPAIN,Recruiting,Maria Joyera Rodríguez,"October 22, 2020",Interventional,"Phase 2/3, Randomized, Open Study to Compare the Efficacy and Safety of Colchicine and Glucocorticoids Compared With the Standard of Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",COVID
3020,MULTIPLE MYELOMA,"February 08, 2021",500,NCT04492371,,AUSTRIA,Recruiting,European Myeloma Network,"July 1, 2020",Observational,COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS: AN EUROPEAN OBSERVATIONAL STUDY,Unrelated
3021,COVID,"February 08, 2021",3500,NCT04492384,NON-INTERVENTIONAL,RUSSIAN FEDERATION,Completed,Eurasian Association of Therapists,"June 11, 2020",Observational,Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients,COVID
3022,CANCER,"February 08, 2021",500,NCT04492410,RAPID SEROLOGICAL TEST,FRANCE,Recruiting,Centre Antoine Lacassagne,"July 21, 2020",Interventional,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),Unrelated
3023,EXPOSURE DURING PREGNANCY,"February 08, 2021",260,NCT04492449,CONGENITAL MALFORMATION,,Not yet recruiting,University of Sao Paulo,January 2021,Observational,"Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to Coronavirus SARS-CoV-2",Unrelated
3024,COVID,"February 08, 2021",969,NCT04492475,INTERFERON BETA-1A,JAPAN,"Active, not recruiting",National Institute of Allergy and Infectious Diseases (NIAID),"August 4, 2020",Interventional,"A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-3)",COVID
3025,COVID,"February 08, 2021",600,NCT04492501,THERAPEUTIC PLASMA EXCHANGE,PAKISTAN,Completed,UNICEF,"April 1, 2020",Interventional,"Role of Investigational Therapies Alone or in Combination to Treat Moderate, Severe and Critical COVID-19",COVID
3026,COVID,"February 08, 2021",60,NCT04492514,MAVRILIMUMAB,UNITED STATES,Recruiting,Kristin Hudock,"May 20, 2020",Interventional,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,COVID
3027,CHRONIC DISEASE,"February 08, 2021",75,NCT04492527,TELEHEALTH COACHING SESSIONS,CANADA,Recruiting,University of British Columbia,"July 28, 2020",Interventional,A Student-delivered Community Outreach teleheAlth Program for Covid Education and Health Promotion (COACH),Unrelated
3028,COVID,"February 08, 2021",150,NCT04492865,MSCT,EGYPT,Not yet recruiting,Assiut University,"July 30, 2020",Observational,MSCT Chest in Suspected COVID-19 Patients in Correlation With Symptomology and Laboratory Findings,COVID
3029,SARS (DISEASE),"February 08, 2021",75,NCT04492891,CYCLOSPORINE,UNITED STATES,Recruiting,"Bryan Burt, MD","November 23, 2020",Interventional,Randomized Phase IIa Clinical Trial Of Cyclosporine For The Treatment Of COVID-19(+) Non-ICU Hospital Inpatients,Respiratory
3030,COVID,"February 08, 2021",5000,NCT04492904,HOME-USE TEST AND FOLLOW-UP QUESTIONNAIRE,SINGAPORE,Recruiting,"Clinical Nutrition Research Centre, Singapore","July 23, 2020",Observational,Singapore COVID-19 Chemosensory Tracking (SCCT) Study,COVID
3031,COVID,"February 08, 2021",35,NCT04492943,,UNITED STATES,Completed,Massachusetts General Hospital,"April 20, 2020",Observational,To Observe Whether Isoflurane Can Treat COVID-19 Patients,COVID
3032,COVID,"February 08, 2021",60,NCT04493242,DB-001,,Not yet recruiting,"Direct Biologics, LLC","September 1, 2020",Interventional,Extracellular Vesicle Infusion Treatment for Severe COVID-19,COVID
3033,HYPONATREMIA,"February 08, 2021",250,NCT04493268,,ARGENTINA,Completed,Hospital Nacional Profesor Alejandro Posadas,"March 7, 2020",Observational,HYPONATREMIA AND INFLAMMATION AND CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS,Unrelated
3034,COVID PNEUMONITIS,"February 08, 2021",500,NCT04493294,LOW DOSE WHOLE LUNG RADIOTHERAPY FOR OLDER PATIENTS WITH COVID-19 PNEUMONITIS,,Not yet recruiting,International Geriatric Radiotherapy Group,November 2020,Interventional,Low Dose Whole Lung Radiotherapy for Older Patients With Coronavirus 19 Disease (COVID-19) Pneumonitis: Practical Protocol by the International Geriatric Radiotherapy Group,COVID
3035,COVID,"February 08, 2021",100,NCT04493307,PHLEBOTOMY,UNITED STATES,Recruiting,LifeBridge Health,"June 30, 2020",Observational,"The Evaluation of Hemostasis by Thromboelastography, Platelet Function Testing, and Biomarker Analysis in Hospitalized COVID-19 Patients",COVID
3036,COVID,"February 08, 2021",240,NCT04493359,RENIN-ANGIOTENSIN SYSTEM INHIBITORS,BRAZIL,Recruiting,University of Sao Paulo,"July 25, 2020",Interventional,Switch or Maintenance of Renin-Angiotensin System Inhibitors in Patients With Covid-19: A Randomized Proof of Concept Trial,COVID
3037,TREATMENT OF COVID VIRUS INFECTION,"February 08, 2021",100,NCT04494204,IMMUNOFREE TABLETS AND REGINMUNE CAPSULE,INDIA,Completed,PUNEET MITTAL,"August 7, 2020",Interventional,"An Open Label, Multicenter, Randomized, Controlled, Clinical Study to Evaluate the Efficacy and Safety of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets Compared With Standard Treatment Protocol in the Treatment of Mild to Moderate COVID-19 Patients.",COVID
3038,COVID,"February 08, 2021",60,NCT04494386,UMBILICAL CORD LINING STEM CELLS (ULSC),UNITED STATES,Recruiting,"Restem, LLC.","July 23, 2020",Interventional,Phase 1/2a Study of Umbilical Cord Lining Stem Cells (ULSC) in Patients With ARDS Due to COVID-19,COVID
3039,COVID,"February 08, 2021",96,NCT04494399,INTERFERON BETA-1B,HONG KONG,Recruiting,The University of Hong Kong,"July 29, 2020",Interventional,"An Open-label Randomised Controlled Trial on IFN Beta-1b and Ribavirin Combination, as Treatment for Covid-19 Infection",COVID
3040,COVID,"February 08, 2021",440,NCT04494646,BARDOXOLONE METHYL,UNITED STATES,Recruiting,NYU Langone Health,"September 8, 2020",Interventional,"BARCONA: A Phase II/III, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)",COVID
3041,COVID INFECTION,"February 08, 2021",60,NCT04494724,CLAZAKIZUMAB,UNITED STATES,Recruiting,The Methodist Hospital System,"July 13, 2020",Interventional,A Phase 2 Trial to Evaluate the Safety and Tolerability of Clazakizumab® [Anti-Interleukin (IL)-6 Monoclonal] Compared to Placebo for the Treatment of COVID-19 Infection,COVID
3042,SARS-CoV2 INFECTION,"February 08, 2021",500,NCT04494776,,BRAZIL,Recruiting,Helio Tedesco Silva Junior,"May 21, 2020",Observational,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Infection (COVID-19) in Kidney Transplant Recipients: a Brazilian Multicenter Study,COVID
3043,COVID,"February 08, 2021",20,NCT04494867,CORE WARMING,UNITED STATES,Recruiting,Sharp HealthCare,"August 19, 2020",Interventional,"Core Warming of COVID-19 Patients Undergoing Mechanical Ventilation: a Randomized, Single Center Pilot Study",COVID
3044,COVID,"February 08, 2021",1000,NCT04494893,,UNITED STATES,Recruiting,Adaptive Biotechnologies,"April 24, 2020",Observational,ImmuneRACE - Immune Response Action to COVID-19 Events,COVID
3045,COVID,"February 08, 2021",242,NCT04494984,INM005,ARGENTINA,"Active, not recruiting",Inmunova S.A.,"July 27, 2020",Interventional,"A Stage 2/3, Adaptive, Randomized, Controlled, Double-blind Study to Investigate the Pharmacokinetics, Efficacy and Safety of the Hyperimmune Equine Serum (INM005) in Adult Patients With Moderate to Severe Confirmed SARS-CoV2 Disease.",COVID
3046,COVID,"February 08, 2021",100,NCT04495101,PROLASTIN,SPAIN,Recruiting,"Instituto Grifols, S.A.","July 29, 2020",Interventional,"A Multicenter, Randomized, Open-label, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of Prolastin Plus Standard Medical Treatment (SMT) Versus SMT Alone in Hospitalized Subjects With COVID-19",COVID
3047,COLON CANCER,"February 08, 2021",100,NCT04495387,CHEMOTHERAPY,,Not yet recruiting,University of Florence,January 2021,Observational,Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy,Unrelated
3048,SUICIDAL IDEATION,"February 08, 2021",75,NCT04495543,BRIEF SKILLS FOR SAFER LIVING,CANADA,Recruiting,Unity Health Toronto,"December 1, 2020",Interventional,"Mitigating Suicide Risk During the COVID-19 Pandemic Via Telehealth Using an Intensive Single Session of ""Brief Skills for Safer Living""",Unrelated
3049,SARS-CoV2 INFECTION,"February 08, 2021",2504,NCT04495764,,UNITED STATES,"Active, not recruiting",Davita Clinical Research,"July 20, 2020",Observational,Registry of Sustained Immunity to COVID-19 Among ESKD Patients,COVID
3050,PERINATAL ANXIETY,"February 08, 2021",120,NCT04495803,COGNITIVE BEHAVIOURAL GROUP THERAPY FOR PERINATAL ANXIETY,,Not yet recruiting,St. Joseph's Healthcare Hamilton,"August 10, 2020",Interventional,Augmented Cognitive Behavioural Group Therapy for Perinatal Anxiety During a Global Pandemic (COVID-19),Unrelated
3051,ANOSMIA,"February 08, 2021",126,NCT04495816,OMEGA-3 FATTY ACID SUPPLEMENT,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,"July 15, 2020",Interventional,COVID-19 Anosmia Study,Unrelated
3052,STRESS,"February 08, 2021",65,NCT04495842,ESSENTIAL OIL BLEND,UNITED STATES,Recruiting,Franklin School of Integrative Health Sciences,"October 1, 2020",Interventional,The Effect of Aromatherapy on COVID-19-induced Anxiety,Unrelated
3053,SARS-CoV2 INFECTION (ASYMPTOMATIC),"February 08, 2021",1000,NCT04495907,,UNITED STATES,Recruiting,Davita Clinical Research,"August 6, 2020",Observational,COVID-19 Progression in End-Stage Kidney Disease,COVID
3054,SARS-CoV2,"February 08, 2021",216,NCT04495933,MF59 ADJUVANTED SARS-COV-2 SCLAMP VACCINE 5MCG,AUSTRALIA,Recruiting,The University of Queensland,"July 13, 2020",Interventional,"A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Dosage-Escalation, Single Centre Study to Evaluate the Safety and Immunogenicity of an Adjuvanted SARS-CoV-2 Sclamp Protein Subunit Vaccine in Healthy Adults Aged 18 to 55 Years Old and Healthy Older Adults, Aged 56 Years and Over",COVID
3055,SARS-CoV2,"February 08, 2021",300,NCT04496076,,UNITED STATES,Enrolling by invitation,University of Pittsburgh,"April 2, 2020",Observational,Severe Neurologic Injury Outcomes During COVID-19 Crisis,COVID
3056,SARS-CoV2,"February 08, 2021",300,NCT04496128,,UNITED STATES,Enrolling by invitation,University of Pittsburgh,"April 13, 2020",Observational,Neurological Complications of COVID-19,COVID
3057,COVID,"February 08, 2021",70,NCT04496141,SARS-COV-2 ANTIBODY IMMUNOASSAYS,HONG KONG,"Active, not recruiting",Hong Kong Sanatorium & Hospital,"July 27, 2020",Observational,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19,COVID
3058,RESPIRATORY VIRAL INFECTION,"February 08, 2021",1000,NCT04496245,BRONCHO-VAXOM®,AUSTRALIA,Recruiting,The University of Queensland,"August 24, 2020",Interventional,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,Respiratory
3059,CORONAVIRUS,"February 08, 2021",500,NCT04496466,,UNITED STATES,Enrolling by invitation,Johns Hopkins University,"April 9, 2020",Observational,Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI),COVID
3060,TELEMEDICINE,"February 08, 2021",200,NCT04496713,INTERNET-CONNECTED COMPUTER TABLET,,Not yet recruiting,Johns Hopkins University,"January 24, 2021",Interventional,Pilot Study - Randomized Controlled Trial of Video and Telephone Primary Care Visits,Unrelated
3061,INFERTILITY TREATMENT,"February 08, 2021",600,NCT04496869,ONLINE QUESTIONNAIRE,FRANCE,Not yet recruiting,Hospices Civils de Lyon,July 2020,Observational,"Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment, a French Cohort",Unrelated
3062,CORONAVIRUS DISEASE 2019,"February 08, 2021",500,NCT04497194,NOT APPLICABLE (OBSERVATIONAL STUDY),ITALY,Recruiting,Azienda Ospedaliera Universitaria Integrata Verona,"March 1, 2020",Observational [Patient Registry],"Registry of Biological Samples, Clinical Information and Epidemiological Data of COVID-19 Patients Admitted at the University Hospital of Verona (AOUI Verona)",COVID
3063,COVID,"February 08, 2021",5000,NCT04497246,QUESTIONNAIRE,BELGIUM,Recruiting,Murielle Surquin,"May 29, 2020",Observational,"Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)",COVID
3064,COVID,"February 08, 2021",150,NCT04497272,COVID-19 PATIENTS,FRANCE,Recruiting,Centre Hospitalier Universitaire de Nice,"August 7, 2020",Interventional,Assesment of the Metabolomic Signature in COVID-19 Patients (SignCov Study),COVID
3065,COVID,"February 08, 2021",90,NCT04497298,TWO COVID-19 VACCINE CANDIDATE (TMV-083) ADMINISTRATIONS - LOW DOSE,BELGIUM,Recruiting,Institut Pasteur,"August 10, 2020",Interventional,"A Randomized, Placebo-controlled Trial, to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine, a Measles Vector-based Vaccine Candidate Against COVID-19 in Healthy Volunteers Consisting of an Unblinded Dose Escalation and a Blinded Treatment Phase",COVID
3066,SARS-CoV2,"February 08, 2021",100,NCT04497311,THORAXIC COMPUTED TOMOGRAPHY,MEXICO,Recruiting,Universidad de Guanajuato,"June 15, 2020",Observational,Pulmonary Tomographic Findings in COVID-19 and Influenza H1N1 Patients,COVID
3067,COVID,"February 08, 2021",100,NCT04497324,CONVALESCENT PLASMA,PERU,Not yet recruiting,Universidad Peruana Cayetano Heredia,"August 20, 2020",Interventional,PERUCONPLASMA: Randomized Clinical Trial to Evaluate Safety and Efficacy of the Use of Convalescent Plasma in Hospitalized Patients With COVID-19,COVID
3068,SARS COV-2,"February 08, 2021",60,NCT04497389,HUMAN AMNIOTIC FLUID,UNITED STATES,Recruiting,University of Utah,"October 28, 2020",Interventional,A Phase I/II Randomized Double-blinded Placebo-controlled Clinical Trial to Determine Safety and Feasibility of Using an Acellular Sterile Filtered Amniotic Fluid as a Treatment for COVID-19 Patients,Respiratory
3069,COVID,"February 08, 2021",88,NCT04497402,,ITALY,Recruiting,University of Roma La Sapienza,"September 1, 2020",Observational [Patient Registry],Sex-Informed Data in the COVID-19 Pandemic.,COVID
3070,BRIEF VIDEO-BASED INTERVENTION,"February 08, 2021",1200,NCT04497415,VIDEO-BASED INTERVENTION,UNITED STATES,Recruiting,"Research Foundation for Mental Hygiene, Inc.","October 21, 2020",Interventional,The COVID-19 and Healthcare Workers: An Active Intervention,Unrelated
3071,COVID,"February 08, 2021",385,NCT04497441,ELECTRONIC SURVEY QUESTIONNAIRE,SAUDI ARABIA,Recruiting,Qassim University,"June 10, 2020",Observational,Perceptions of Netizens Regarding COVID-19 Information & Information Sources: A Cross Sectional Study,COVID
3072,RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",128,NCT04497454,EIT-GROUP,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"May 8, 2020",Interventional,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) - COVEN Study,Respiratory
3073,PATIENT PREFERENCE,"February 08, 2021",1200000,NCT04497467,,TAIWAN,Recruiting,National Taiwan University Hospital,"August 1, 2020",Observational,An Analysis of Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic,Unrelated
3074,COVID,"February 08, 2021",12,NCT04497519,INHALED HYDROXYCHLOROQUINE,NETHERLANDS,Completed,University Medical Center Groningen,"September 15, 2020",Interventional,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers; a Pilot Study,COVID
3075,COVID,"February 08, 2021",1000,NCT04497610,BREATH SAMPLE,COSTA RICA,Not yet recruiting,Instituto Costarricense de Investigaciones Clínicas ICIC,"August 4, 2020",Observational [Patient Registry],SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem,COVID
3076,COVID,"February 08, 2021",5,NCT04497623,INVASIVE MECHANICAL VENTILATION USING THE UNISABANA-HERONS VENTILATOR DURING 24 HOURS,COLOMBIA,Completed,Fundación Neumologica Colombiana,"July 28, 2020",Interventional,"Clinical Evaluation of Ventilator Innovation Product in Colombia in the SARS Pandemic Covid 19, Unisabana Herons - A Cohort Study - Phase 1",COVID
3077,ANXIETY,"February 08, 2021",1092,NCT04497636,,CHILE,Recruiting,Pontificia Universidad Catolica de Chile,"July 3, 2020",Observational,"Mental Health Impact of the COVID-19 Pandemic Among Immigrants in Santiago, Chile (STRING-COVID)",Unrelated
3078,COVID,"February 08, 2021",100,NCT04497649,SOFOSBUVIR,EGYPT,Recruiting,Tanta University,"July 1, 2020",Interventional,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients: A Randomized Controlled Trial.,COVID
3079,RESPIRATORY INFECTIOUS DISEASES,"February 08, 2021",6000,NCT04497675,,CHINA,Completed,Fuwai Yunnan Cardiovascular Hospital,"June 19, 2020",Observational,An Epidemiological Investigation on Correct Wearing of Mask by Direct Spray Test,Respiratory
3080,RESPIRATORY INFECTIOUS DISEASES,"February 08, 2021",6000,NCT04497753,,CHINA,Completed,Fuwai Yunnan Cardiovascular Hospital,"June 19, 2020",Observational,An Epidemiological Investigation on Correct Wearing of Mask by Hood Test,Respiratory
3081,ASYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",800,NCT04497779,BIOSPECIMEN COLLECTION,UNITED STATES,Recruiting,City of Hope Medical Center,"July 13, 2020",Observational,Evaluation of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,COVID
3082,COVID,"February 08, 2021",385,NCT04497818,CROSS SECTIONAL STUDY USING SCIENTIFICALLY VALIDATED PSYCHOMETRIC SCALES,SAUDI ARABIA,Completed,Qassim University,"June 16, 2020",Observational,Correlation of Fear of COVID-19 Infection and Dental Treatment Anxiety Among Netizens: A Cross-sectional Study.,COVID
3083,"SATISFACTION, PATIENT","February 08, 2021",100,NCT04497922,E-INK SCREEN,UNITED STATES,Recruiting,Brigham and Women's Hospital,"January 25, 2021",Interventional,Improving Patient Satisfaction Through Information Display Using Virtual White Boards,Unrelated
3084,COVID,"February 08, 2021",8,NCT04497948,ACALABRUTINIB,BRAZIL,Terminated,Acerta Pharma BV,"September 21, 2020",Interventional,"An Open-label, Multiple-dose Study of Acalabrutinib, Co Administered With a Proton-pump Inhibitor, in Participants Hospitalized With COVID-19",COVID
3085,COVID,"February 08, 2021",5000,NCT04497987,LY3819253,UNITED STATES,Recruiting,Eli Lilly and Company,"August 2, 2020",Interventional,"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of LY3819253 Alone and in Combination With LY3832479 in Preventing SARS-CoV-2 Infection and COVID-19 in Skilled Nursing and Assisted Living Facility Residents and Staff; a NIAID and Lilly Collaborative Study",COVID
3086,COVID,"February 08, 2021",200,NCT04498065,BIOLOGICAL DATA,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire Dijon,"March 1, 2020",Observational,MYocardial DOmmages Related to COVID-19,COVID
3087,ACUTE MYOCARDIAL INFARCTION,"February 08, 2021",35,NCT04498091,BIOLOGICAL DATA,FRANCE,"Active, not recruiting",Centre Hospitalier Universitaire Dijon,"March 15, 2020",Observational,EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19,Unrelated
3088,CORONAVIRUS DISEASE (COVID),"February 08, 2021",260,NCT04498247,V591,AUSTRIA,"Active, not recruiting",Merck Sharp & Dohme Corp.,"August 27, 2020",Interventional,"A Phase 1/Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety, Tolerability and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Younger and Older Participants",COVID
3089,COVID,"February 08, 2021",7000,NCT04498273,APIXABAN 2.5 MG,UNITED STATES,Recruiting,Frank C Sciurba,"September 7, 2020",Interventional,COVID-19 Outpatient Thrombosis Prevention Trial: A Multi-center Adaptive Randomized Placebo-controlled Platform Trial Evaluating the Efficacy and Safety of Anti-thrombotic Strategies in COVID-19 Adults Not Requiring Hospitalization at Time of Diagnosis,COVID
3090,MULTIPLE SCLEROSIS,"February 08, 2021",800,NCT04498286,TESTING OF SARS-COV-2 ANTIBODIES,NETHERLANDS,Recruiting,Zoé van Kempen,"August 6, 2020",Observational,COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients: a Large Study in the Amsterdam MS Cohort,Unrelated
3091,"ECHOCARDIOGRAPHY, STRESS","February 08, 2021",30,NCT04498299,ECHOCARDIOGRAM 2D,MEXICO,Recruiting,Miguel Ayala León,"September 1, 2020",Observational,Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness,Unrelated
3092,COVID,"February 08, 2021",42,NCT04498325,NT-I7,UNITED STATES,Not yet recruiting,Washington University School of Medicine,"February 28, 2021",Interventional,"A Phase I and Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2",COVID
3093,COVID,"February 08, 2021",38,NCT04498377,F-652,UNITED STATES,Recruiting,Generon (Shanghai) Corporation Ltd.,"January 26, 2021",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Multicenter Study to Evaluate the Efficacy and Safety of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19",COVID
3094,MENTAL HEALTH DISORDER,"February 08, 2021",70,NCT04498416,QUANTITATIVE AND QUALITATIVE ASSESSMENTS OF MENTAL HEALTH,FRANCE,Recruiting,Fondation Lenval,"April 27, 2020",Observational,"Methodology of "" CoCo 20 "": a Longitudinal Follow-up Study of the Paediatric Population and Their Families During and After the Coronavirus Pandemic and the Confinement",Unrelated
3095,COVID,"February 08, 2021",8519,NCT04498442,SIMHA KRIYA,UNITED STATES,Completed,Beth Israel Deaconess Medical Center,"May 22, 2020",Interventional,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",COVID
3096,CRITICAL ILLNESS,"February 08, 2021",39,NCT04498507,HADS QUESTIONNAIRE,BELGIUM,Completed,University of Liege,"April 16, 2020",Observational,Psychosocial Outcomes in Families of Patients Admitted in ICU for COVID-19 During the Pandemic in Belgium,Unrelated
3097,EXERCISE TEST,"February 08, 2021",60,NCT04498546,,TURKEY,Recruiting,KTO Karatay University,"July 20, 2020",Observational [Patient Registry],The Effects of Mask Usage on Exercise Capacity and Related Parameters During the COVİD-19 Pandemic,Unrelated
3098,TYPE 2 DIABETES,"February 08, 2021",20,NCT04498819,"WEARABLE ACTIVITY TRACKERS, EXERCISE PRESCRIPTION AND VIRTUAL CARE",CANADA,Recruiting,"Western University, Canada","November 9, 2020",Interventional,Virtually Delivered Lifestyle Program Integrating Wearable Technology and Exercise Prescriptions in Patients With Type 2 Diabetes (STAND-VAT): A Feasibility Study,Unrelated
3099,COVID,"February 08, 2021",240,NCT04498936,SOFOSBUVIR AND LEDIPASVIR,EGYPT,Completed,Assiut University,"July 15, 2020",Interventional,"Efficacy of Adding Sofosbuvir/Ledipasvir Combination, or Nitazoxanide to the Standard of Care in Treatment of COVID-19: A Randomized Controlled Trial",COVID
3100,COVID,"February 08, 2021",50,NCT04499300,DATA COLLECTION FROM MEDICAL FILES,BELGIUM,Recruiting,Murielle Surquin,"June 9, 2020",Observational,Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age,COVID
3101,COVID,"February 08, 2021",60,NCT04499313,DEXAMETHASONE,BANGLADESH,Recruiting,Chattogram General Hospital,"August 2, 2020",Interventional,The Outcome of Dexamethasone and Methylprednisolone Treatment for Patients With ARDS Caused by COVID-19,COVID
3102,COVID,"February 08, 2021",200,NCT04499378,LUNG CT,,Not yet recruiting,Universidad de Guanajuato,"August 15, 2020",Observational,Pulmonary Tomographic Findings in COVID-19 and Influenza H1N1 Patients at IMSS Guanajuato,COVID
3103,COVID,"February 08, 2021",100,NCT04499391,PROJECT ECHO,UNITED STATES,Recruiting,Milton S. Hershey Medical Center,"December 4, 2020",Interventional,"COVID-19 Project ECHO for Nursing Homes: A Patient-centered, Randomized-controlled Trial to Implement Infection Control and Quality of Life Best Practice",COVID
3104,COVID,"February 08, 2021",240,NCT04499677,FAVIPIRAVIR,UNITED KINGDOM,Recruiting,"University College, London","September 24, 2020",Interventional,"Favipiravir, Lopinavir/Ritonavir or Combination Therapy: a Randomised, Double Blind, 2x2 Factorial Placebo-controlled Trial of Early Antiviral Therapy in COVID-19",COVID
3105,COVID,"February 08, 2021",76,NCT04500067,IVIG,UKRAINE,Completed,Biopharma Plasma LLC,"May 7, 2020",Interventional,"An Open-label Multicenter Randomized Trial to Evaluate the Efficacy of Bioven, Manufactured by Biopharma Plasma, LLC, in Complex Therapy of Patients With Pneumonia Induced by COVID-19 / SARS-CoV-2",COVID
3106,COVID,"February 08, 2021",60,NCT04500132,EC-18,"KOREA, REPUBLIC OF",Recruiting,Enzychem Lifesciences Corporation,"May 28, 2020",Interventional,"Phase 2, Multi-center, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia",COVID
3107,FRAILTY,"February 08, 2021",70,NCT04500366,SOCIALIZATION,CANADA,Recruiting,McMaster University,"August 26, 2020",Interventional,GERAS Frailty Rehabilitation at Home: Virtual Bundled Care for Seniors Who Are Frail to Build Strength and Resilience During COVID-19,Unrelated
3108,COVID,"February 08, 2021",183,NCT04500418,CENICRIVIROC (CVC),GERMANY,Recruiting,"Charite University, Berlin, Germany","August 25, 2020",Interventional,Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,COVID
3109,COVID INFECTION,"February 08, 2021",50000,NCT04500600,QUALITY-OF-LIFE ASSESSMENT,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"June 11, 2020",Observational,Well-Being and Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic,COVID
3110,COVID,"February 08, 2021",234,NCT04500626,OXYGEN,CANADA,Not yet recruiting,Ottawa Hospital Research Institute,October 2020,Interventional,Multicentre Randomized Controlled Trial of Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,COVID
3111,SARS-CoV2 INFECTION,"February 08, 2021",14000,NCT04500639,,CANADA,Recruiting,University of Alberta,"July 23, 2020",Observational,Do Common Medications Alter the Course of COVID-19?,COVID
3112,ANXIETY,"February 08, 2021",310,NCT04500652,,TURKEY,Recruiting,Dokuz Eylul University,"June 27, 2020",Observational,Evaluation of Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians During the Covid-19 Pandemic,Unrelated
3113,COVID,"February 08, 2021",1214,NCT04501172,QUESTIONNAIRE COMPLETION,GREECE,Completed,Democritus University of Thrace,"June 25, 2020",Observational,Impact of Spectacles on Compliance to Mask-wearing Directives in Greece,COVID
3114,CARDIAC REHABILITATION,"February 08, 2021",27,NCT04501432,NO INTERVENTION,AUSTRIA,Completed,Ludwig Boltzmann Institute for Digital Health and Prevention,"July 14, 2020",Observational,Cardiac Rehabilitation and Ongoing Physical Activity During the Coronavirus Disease (COVID-19) Pandemic: An Exploratory Mixed-Methods Study,Unrelated
3115,FAMILY MEMBERS,"February 08, 2021",100,NCT04501445,WRITTEN SUMMARY OF ROUNDS,UNITED STATES,Recruiting,Rush University Medical Center,"September 14, 2020",Interventional,Relieving the Burden of Psychological Symptoms Among Families of Critically Ill Patients With COVID-19,Unrelated
3116,COVID,"February 08, 2021",200000,NCT04501458,"TRAINING OF YOUTH, COMMUNITY HEALTH ASSISTANTS AND COMMUNITY HEALTH WORKERS.",KENYA,Recruiting,Surgical Systems Research Group,"May 18, 2020",Interventional,"Western Kenya Integrated COVID-19 Response Leveraging the Community Health Strategy, Youth, and Technology to Flatten the COVID-19 Curve and Improve COVID-19 Case Detection, Isolation and Management in Western Kenya",COVID
3117,AUTISM SPECTRUM DISORDER,"February 08, 2021",40,NCT04501588,RESPONSIVE TRAINING WITH NO VIDEO FEEDBACK,UNITED STATES,Recruiting,Northwestern University,"March 6, 2020",Interventional,Parent Language Intervention for Autism,Unrelated
3118,COVID,"February 08, 2021",168,NCT04501783,FAVIPIRAVIR,RUSSIAN FEDERATION,"Active, not recruiting",R-Pharm,"May 20, 2020",Interventional,Randomized Open-label Multicenter Parallel-group Study of Efficacy and Safety of TL-FVP-t vs. Standard of Care Therapy in Patients With Mild to Moderate Coronavirus Disease (SARS-CoV-2/COVID-19),COVID
3119,COVID,"February 08, 2021",30,NCT04501796,DOUBLE-BLIND NT-I7,UNITED STATES,Recruiting,NeoImmuneTech,August 2020,Interventional,"A Double-blind, Randomized, Placebo-controlled, Phase 1, Single-dose, Dose-escalating Trial of Long-acting Recombinant Human IL-7 (NT-I7) for COVID-19",COVID
3120,COVID,"February 08, 2021",380,NCT04501822,"EVALUATION OF CLINICAL, INSTRUMENTAL AND LABORATORY DIAGNOSTICS TESTS",RUSSIAN FEDERATION,Recruiting,Tomsk National Research Medical Center of the Russian Academy of Sciences,"July 19, 2020",Observational,One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia,COVID
3121,COVID,"February 08, 2021",1264,NCT04501952,RDV,DENMARK,Recruiting,Gilead Sciences,"September 18, 2020",Interventional,"A Phase 3 Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of COVID-19 in an Outpatient Setting",COVID
3122,COVID,"February 08, 2021",231,NCT04501965,HYDROXYCHLOROQUINE/AZITHROMYCINE,GUINEA,Enrolling by invitation,Institute for Research and Development of Medicinal and Food Plants of Guinea,"June 1, 2020",Interventional,"Evaluation de l'efficacité et de la tolérance de Quinquina et d'un phytomédicament "" ACAR "" en Comparaison Avec l'Hydroxychloroquine Chez Des Adultes Malades de Covid-19 Sans symptômes",COVID
3123,COVID,"February 08, 2021",10000,NCT04501978,LY3819253,DENMARK,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"August 4, 2020",Interventional,"A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19",COVID
3124,TYPE 2 DIABETES,"February 08, 2021",114,NCT04501991,ANTIDIABETIC TREATMENT,ITALY,Completed,University of Pisa,"March 11, 2020",Observational,Determining the Impact of COVID-19 Lockdown on Metabolic Control in Individuals With Type 2 Diabetes,Unrelated
3125,COVID,"February 08, 2021",20000,NCT04502056,ACKNOWLEDGEMENT RACIAL INJUSTICE AMA,UNITED STATES,"Active, not recruiting","National Bureau of Economic Research, Inc.","July 31, 2020",Interventional,Covid-19 Messaging to Underserved Communities - 2nd Experiment,COVID
3126,COVID,"February 08, 2021",0,NCT04502069,OPAGANIB,ISRAEL,Withdrawn,RedHill Biopharma Limited,August 2020,Interventional,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen But Not Mechanical Ventilation,COVID
3127,EXERCISE,"February 08, 2021",1000,NCT04502108,COVID19,SWITZERLAND,Recruiting,Slavko Rogan,"April 1, 2020",Observational,Online Survey About Physical Activity and Nutrition During and After Coronavirus Pandemic,Unrelated
3128,COVID,"February 08, 2021",30,NCT04502342,HYDROXYCLOROQUINE AND AZYTHROMYCINE,GUINEA,Enrolling by invitation,Institute for Research and Development of Medicinal and Food Plants of Guinea,"June 1, 2020",Interventional,Évaluationefficacité et tolérance d'Une médication à Base de Cosphérunate et d'un phytomédicament Antiviral Par Voie Orale en Comparaison Avec un Traitement à Base d'Hydroxychloroquine Chez Des Adultes Malades Covid-19 Sans Complications,COVID
3129,FIBEROPTIC BRONCHOSCOPY (FOB),"February 08, 2021",15,NCT04502368,FIBEROPTIC BRONCHOSCOPY (FOB),BELGIUM,Recruiting,Erasme University Hospital,"September 1, 2020",Observational,Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients: Impact on Respiratory Mechanics and Gas Exchange,Unrelated
3130,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",85,NCT04502433,CUROSURF® (PORACTANT ALFA),UNITED KINGDOM,Recruiting,Chiesi Farmaceutici S.p.A.,"January 6, 2021",Interventional,"Multicenter, Open-label, Randomised Trial to Assess the Efficacy and Tolerability of Poractant Alfa(Porcine Surfactant, Curosurf®) in Hospitalized Patients With SARS-COV-19 Acute Respiratory Distress Syndrome (ARDS)",Respiratory
3131,COVID,"February 08, 2021",200,NCT04502472,CONVALESCENT PLASMA TRANSFUSION,UNITED STATES,Recruiting,Inova Health Care Services,"June 6, 2020",Interventional,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma Collected From Individuals With Documented Infection and Recovery From COVID-19 (SARS-CoV-2),COVID
3132,COVID,"February 08, 2021",40,NCT04502667,CHOLECALCIFEROL,MEXICO,Recruiting,"Coordinación de Investigación en Salud, Mexico","July 15, 2020",Interventional,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19: Open Controlled Clinical Trial,COVID
3133,COVID,"February 08, 2021",300,NCT04503057,,SWEDEN,Recruiting,Lund University Hospital,"May 1, 2020",Observational [Patient Registry],Exhaled Breath Particles as a Clinical Indicator for Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrom (ARDS) in COVID-19 Positive and Negative Patients,COVID
3134,PATIENT PREFERENCE,"February 08, 2021",517,NCT04503434,,SPAIN,Completed,Hospital Clinic of Barcelona,"May 15, 2020",Observational [Patient Registry],Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support,Unrelated
3135,COVID,"February 08, 2021",330,NCT04503447,,BELGIUM,Completed,"Institute of Tropical Medicine, Belgium","August 1, 2020",Observational,Severe Acute Respiratory Syndrome Coronavirus (CoV) 2 (SARS-CoV-2) Seroprevalence Study in Institute of Tropical Medicine (ITM) Staff,COVID
3136,SARS-COV,"February 08, 2021",50,NCT04503525,NUTRITIONAL ASSESSMENT,FRANCE,Recruiting,Lille Catholic University,"May 25, 2020",Observational,Nutritional Assessment of French Hospitalized Patients Infected With COVID-19,Respiratory
3137,COVID,"February 08, 2021",600,NCT04504032,RIVAROXABAN,UNITED KINGDOM,Recruiting,Bill & Melinda Gates Medical Research Institute,"September 2, 2020",Interventional,"A Randomized, Controlled, Phase 2b Study to Evaluate Safety and Efficacy of Rivaroxaban (Xarelto®) for High Risk People With Mild COVID-19",COVID
3138,COVID,"February 08, 2021",200,NCT04504240,FAMOTIDINE 20 MG,BANGLADESH,Recruiting,Chattogram General Hospital,"August 1, 2020",Interventional,Role of Famotidine in the Symptomatic Improvement of Moderate to Severe COVID-19 Patients,COVID
3139,COVID,"February 08, 2021",1000,NCT04504734,BUCILLAMINE,UNITED STATES,Enrolling by invitation,"Revive Therapeutics, Ltd.","November 27, 2020",Interventional,"Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Bucillamine in Patients With Mild-Moderate COVID-19",COVID
3140,COVID,"February 08, 2021",120,NCT04504877,CANNABIDIOL,BRAZIL,"Active, not recruiting",University of Sao Paulo,"June 16, 2020",Interventional,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling (Bonsai Study) wIth COVID-19: a Randomised Controlled Trial,COVID
3141,COVID,"February 08, 2021",16500,NCT04505098,ICOSAPENT ETHYL,UNITED STATES,Recruiting,Kaiser Permanente,"August 7, 2020",Interventional,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults (MITIGATE),COVID
3142,COVID,"February 08, 2021",60,NCT04505592,TENECTEPLASE,UNITED STATES,Recruiting,Hooman Poor,"September 25, 2020",Interventional,Tenecteplase With Concomitant Anticoagulation for Severe Acute Respiratory Failure in Patients With COVID-19,COVID
3143,COMMUNITY-ACQUIRED PNEUMONIA,"February 08, 2021",200,NCT04505605,BLOOD SAMPLES,FRANCE,"Active, not recruiting",Groupe Hospitalier Paris Saint Joseph,"May 14, 2020",Observational,Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia: the LPSARS2 Study,Respiratory
3144,COVID,"February 08, 2021",100,NCT04505631,,FRANCE,Recruiting,Groupe Hospitalier de la Region de Mulhouse et Sud Alsace,"June 10, 2020",Observational,Follow-up of Respiratory Sequelae of Patients Hospitalized With SARS-CoV-2: a Prospective Multicenter Observational Study,COVID
3145,COVID,"February 08, 2021",1000,NCT04505709,,SPAIN,Enrolling by invitation,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,"August 1, 2020",Observational [Patient Registry],"STOP-Coronavirus: Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19",COVID
3146,PARTICIPANTS WITH OR WITHOUT STABLE CO-MORBIDITIES ASSOCIATED WITH PROGRESSION TO SEVERE COVID AT DIFFERENT STAGES OF THE PROTOCOL,"February 08, 2021",44325,NCT04505722,AD26.COV2.S,ARGENTINA,"Active, not recruiting",Janssen Vaccines & Prevention B.V.,"September 7, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older",COVID
3147,CORONAVIRUS,"February 08, 2021",40,NCT04505761,VIRTUAL REALITY,NETHERLANDS,Recruiting,Radboud University,"August 1, 2020",Interventional,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19: An Explorative Study",COVID
3148,COVID,"February 08, 2021",2000,NCT04505774,THERAPUTIC HEPARIN,SPAIN,Recruiting,Matthew Neal MD,"September 4, 2020",Interventional,"A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults With COVID-19",COVID
3149,COVID,"February 08, 2021",60,NCT04506229,WHOLE EXOME SEQUENCING,UNITED STATES,Recruiting,Texas Cardiac Arrhythmia Research Foundation,"August 20, 2020",Observational,Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function,COVID
3150,COVID,"February 08, 2021",1200,NCT04506268,OPT-OUT RECRUITMENT EMAIL,UNITED STATES,"Active, not recruiting",University of Pennsylvania,"September 9, 2020",Interventional,Opt-In Versus Opt-Out for COVID Screening Assessment for Exposure,COVID
3151,COVID,"February 08, 2021",3000,NCT04506515,PSYCHOLOGICAL STRESS AND ADAPTATION AT WORK SCORE (PSAS),SPAIN,Completed,Hospital General Universitario de Valencia,"April 9, 2020",Observational,Psychological Impact of COVID-19 Pandemic in Healthcare Workers in Spain: A Cross-sectional Study. PSIMCOV Group,COVID
3152,COVID,"February 08, 2021",170000,NCT04506528,,UNITED STATES,Recruiting,"University of Wisconsin, Madison","August 10, 2020",Observational [Patient Registry],Investigating the Association Between Smoking Status and COVID-19 Outcomes: Collecting Data From Health Systems Affiliated With the National Cancer Institute's Cancer Center Cessation Initiative (C3I),COVID
3153,COVID,"February 08, 2021",100,NCT04506632,,UNITED KINGDOM,Recruiting,Sheffield Teaching Hospitals NHS Foundation Trust,"June 2, 2020",Observational,COST-NHS: COvid Burden in STaff Working in the NHS: A Study to Assess the Mental Health Burden of the COVID-19 Pandemic on NHS Healthcare Staff,COVID
3154,COAGULOPATHY,"February 08, 2021",150,NCT04507230,,EGYPT,Recruiting,Assiut University,"August 7, 2020",Observational,Assessment of COVID-19 Associated Coagulopathy and Hypercoagulable State in Upper Egypt,Unrelated
3155,COVID,"February 08, 2021",60,NCT04507256,AZD7442,UNITED KINGDOM,"Active, not recruiting",AstraZeneca,"August 18, 2020",Interventional,"A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD7442 in Healthy Adults",COVID
3156,COVID,"February 08, 2021",80,NCT04507282,LMWH,TURKEY,Completed,Bursa Postgraduate Hospital,"May 15, 2020",Observational,Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi,COVID
3157,COVID,"February 08, 2021",240,NCT04507867,NUTRITIONAL SUPPORT SYSTEM (NSS),,Not yet recruiting,Anahuac University,August 2020,Interventional,Effect of a Nutritional Support System to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,COVID
3158,COVID,"February 08, 2021",80,NCT04507893,"CLINICAL, LABORATORY AND IMAGING CHARACTERISTICS OF PNEUMONIA",ITALY,Recruiting,University of Palermo,"March 15, 2020",Observational,"Clinical, Laboratory and Imaging Comparison Between COVID-19 Pneumonia Confirmed by PCR Detection on Nasopharyngeal Swab and Negative Swab Pneumonia",COVID
3159,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",4000,NCT04508023,RIVAROXABAN,UNITED STATES,Recruiting,"Janssen Research & Development, LLC","August 13, 2020",Interventional,"A Multicenter, Randomized, Placebo-Controlled, Pragmatic Phase 3 Study Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic COVID-19 Infection",COVID
3160,SARS-CoV2 INFECTION,"February 08, 2021",1620,NCT04508075,SARS-COV-2 VACCINE (INACTIVATED),INDONESIA,Recruiting,PT Bio Farma,"August 10, 2020",Interventional,"A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years in Indonesia",COVID
3161,HAND HYGIENE,"February 08, 2021",120,NCT04508114,TECHNOLOGY-ASSISTED INDEX,TAIWAN,Recruiting,National Taiwan University Hospital,"August 10, 2020",Interventional,The Effectiveness of Technology-assisted Index on Improving Hand Hygiene of Registered Nurses - An Experimental Research,Unrelated
3162,COVID,"February 08, 2021",130,NCT04508439,ENOXAPARIN,MEXICO,Recruiting,Hospital Regional de Alta especialidad de Ixtapaluca,"June 20, 2020",Interventional,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,COVID
3163,COVID,"February 08, 2021",500,NCT04508556,BREATH BIOPSY FACE MASKS WITH REMOVABLE FILTERS AND FITTED PVA STRIP,,Not yet recruiting,Owlstone Ltd,September 2020,Observational,Performance Assessment of SARS-CoV-2 Detection Through Analysis of Exhaled Breath Aerosols,COVID
3164,COVID,"February 08, 2021",900,NCT04508712,,CHINA,Recruiting,RenJi Hospital,"August 10, 2020",Observational [Patient Registry],Long-term Outcomes in Patients With COVID-19,COVID
3165,COVID,"February 08, 2021",600,NCT04508777,SALIVA-BASED TESTING,UNITED STATES,Enrolling by invitation,University of Pennsylvania,"September 9, 2020",Observational,COVID SAFE: COVID-19 Screening Assessment for Exposure,COVID
3166,DEPRESSION,"February 08, 2021",41,NCT04508868,BRIEF BEHAVIORAL ACTIVATION WITH MENTAL IMAGERY,SWEDEN,Terminated,Uppsala University,"August 31, 2020",Interventional,Behavioral Activation and Mental Imagery Delivered Via Telephone for the Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19: A Randomized Clinical Trial,Unrelated
3167,CARDIOVASCULAR DISEASES,"February 08, 2021",76,NCT04508920,"SYMPTOMATOLOGY, TREATMENT. DAILY ACTIVITIES AND ANXIETY FOR CARDIOVASCULAR PATIENTS SURVEY (STRATA)",MEXICO,Recruiting,"Centro en Insuficiencia Cardiaca, Mexico","May 15, 2019",Observational [Patient Registry],"A Survey to Assess Effects of the Covid-19 Pandemic on Symptomatology, Treatment and Medical Care for Cardiovascular Patients",Unrelated
3168,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",10,NCT04508933,EXTRAVASCULAR LUNG WATER INDEX,TURKEY,Not yet recruiting,Istanbul University-Cerrahpasa,"September 1, 2020",Observational,"Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and ""Typical""ARDS Patients",Respiratory
3169,CORONAVIRUS INFECTION,"February 08, 2021",1500,NCT04508959,,CANADA,Recruiting,McMaster University,"April 15, 2020",Observational [Patient Registry],A Rapid Research Platform to Inform Prevention & Improve the Clinical Management of COVID-19 Illness for Priority Older Adult Groups: The McMaster Multi-regional Hospital Coronavirus Registry,COVID
3170,COVID,"February 08, 2021",200,NCT04508972,ALEXA AMAZON,CANADA,Recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,"July 1, 2020",Observational,Voice-based Identification of Clinical Features Requiring Emergent Action in Patients With Suspected COVID-19 Infection (VOICE-COVID) Study,COVID
3171,COVID,"February 08, 2021",40,NCT04508985,TEMPORARILY HOLDING THE RAAS INHIBITOR [INTERVENTION],,Not yet recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,"September 1, 2020",Interventional,Management of Renin-Angiotensin-Aldosterone System Blockade in Patients Admitted in Hospital With Confirmed Coronavirus Disease (COVID-19) Infection: The McGill RAAS-COVID-19 Randomized Controlled Trial,COVID
3172,CARDIAC HEALTH,"February 08, 2021",25,NCT04509206,NUTRITIONAL EDUCATION,UNITED STATES,Enrolling by invitation,Boston University,"September 28, 2020",Interventional,A Virtual Nutritional Education Delivered Through a Hospital Teaching Kitchen : a Proof-of-concept Study,Unrelated
3173,COVID,"February 08, 2021",16250,NCT04509713,COLLECTION OF ODOUR SAMPLES,UNITED KINGDOM,Recruiting,ARCTEC,"July 2, 2020",Observational,Using Medical-detection Dogs to Identify People With SARS-CoV-: Phase I: Proof-of-concept Studies,COVID
3174,DYSPHAGIA,"February 08, 2021",50,NCT04509752,SURVEY,TURKEY,Recruiting,Hacettepe University,"October 8, 2020",Observational,Experiences in Dysphagia Management During COVID-19 Pandemic,Unrelated
3175,HEALTHY,"February 08, 2021",250,NCT04509947,AD26.COV2.S,JAPAN,"Active, not recruiting",Janssen Pharmaceutical K.K.,"August 11, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26.COV2.S in Adults",Unrelated
3176,COVID,"February 08, 2021",1000,NCT04509973,DEXAMETHASONE,DENMARK,Recruiting,Scandinavian Critical Care Trials Group,"August 27, 2020",Interventional,Higher vs. Lower Doses of Dexamethasone in Patients With COVID-19 and Severe Hypoxia,COVID
3177,SURGERY,"February 08, 2021",1000,NCT04509986,,,Not yet recruiting,University of Birmingham,"October 1, 2020",Observational,GlobalSurg-CovidSurg Week: Determining the Optimal Timing for Surgery Following SARS-CoV-2 Infection,Unrelated
3178,COVID,"February 08, 2021",100,NCT04509999,BICALUTAMIDE 150 MG ORAL TABLET,UNITED STATES,Recruiting,University of Florida,"October 26, 2020",Interventional,Randomized Trial of Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection,COVID
3179,SARS-COV INFECTION,"February 08, 2021",150,NCT04510012,"ANALYSIS OF CYTOKINE RESPONSE, INNATE AND ADAPTIVE IMMUNE RESPONSE, COMPLEMENT ACTIVATION, AND SERUM NEUROFILAMENTS AS A MARKER OF NEUROLOGICAL DAMAGE.",SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","March 5, 2020",Observational,Characterizing the Immune Response and Neuronal Damage in SARS-CoV-2 Infected Individuals,Respiratory
3180,CORONAVIRUS INFECTION,"February 08, 2021",616,NCT04510025,MAGNETIC RESONANCE IMAGING,UNITED KINGDOM,Recruiting,University of Oxford,"May 13, 2020",Observational,"Assessing the Effects of Coronavirus Disease (COVID-19) on Multiple Organ Systems and Impact on Quality of Life, Functional Capacity and Mental Health",COVID
3181,COVID,"February 08, 2021",75,NCT04510038,COLCHICINE,,Not yet recruiting,Miami Cardiac and Vascular Institute,"September 1, 2020",Interventional,Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19),COVID
3182,COVID,"February 08, 2021",70,NCT04510194,METFORMIN,UNITED STATES,Recruiting,University of Minnesota,"January 1, 2021",Interventional,MET-COVID Trial - Metformin for Outpatient Treatment and Post-exposure Prophylaxis (PEP) of COVID-19,COVID
3183,COVID,"February 08, 2021",45000,NCT04510207,INACTIVATED SARS-COV-2 VACCINE (VERO CELL),BAHRAIN,Recruiting,China National Biotec Group Company Limited,"July 16, 2020",Interventional,"Multicenter, Randomized, Double Blind, Parallel Placebo Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",COVID
3184,COVID,"February 08, 2021",60,NCT04510233,IVERMECTIN NASAL,,Not yet recruiting,Tanta University,September 2020,Interventional,Ivermectin Inhalation Forms in the Management of COVID-19 Egyptian Patients,COVID
3185,COVID,"February 08, 2021",50,NCT04510402,POVIDINE IODINE NASAL SWABS,,Not yet recruiting,Brigham and Women's Hospital,August 2020,Interventional,Phase I/II Trial (Safety and Dosing) of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,COVID
3186,CORONAVIRUS,"February 08, 2021",2000,NCT04510441,NIL INTERVENTION,UNITED KINGDOM,Recruiting,Imperial College London,"May 26, 2020",Observational,Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms and Imaging,COVID
3187,CANCER,"February 08, 2021",200,NCT04510454,NASOPHARYNGEAL AND THROAT/OROPHARYNGEAL SWABS ANALYSES BY RT-PCR AND DDPCR,,Not yet recruiting,Centre Leon Berard,September 2020,Interventional,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,Unrelated
3188,COVID,"February 08, 2021",1313,NCT04510467,,,Not yet recruiting,"University Hospital, Lille",January 2021,Observational,Mental Health Consequences of COVID19 Infection in the French Rheumatic Musculoskeletal Diseases (RMD) Cohort,COVID
3189,CORONAVIRUS INFECTION,"February 08, 2021",116,NCT04510493,CANAKINUMAB,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","October 23, 2020",Interventional,Canakinumab in Patients With COVID-19 and Type 2 Diabetes - CanCovDia Trial,COVID
3190,MAJOR DEPRESSIVE DISORDER,"February 08, 2021",50,NCT04510519,,,Not yet recruiting,"Kintsugi Mindful Wellness, Inc.","September 1, 2020",Observational,Scaling Mental Healthcare in COVID-19 With Voice Biomarkers: An Observational Study,Unrelated
3191,COVID,"February 08, 2021",500,NCT04510623,ARBS AND/OR ACE INHIBITORS,CANADA,Recruiting,University of British Columbia,"March 17, 2020",Observational,Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Angiotensin II Type 1 Receptor Blockers (ARBs) on Outcomes of Coronavirus Infection?,COVID
3192,COVID,"February 08, 2021",60,NCT04510662,TELMISARTAN,MEXICO,Recruiting,Abraham Edgar Gracia-Ramos,August 2020,Interventional,Effectiveness and Safety of Telmisartan in Acute Respiratory Failure Due to COVID-19,COVID
3193,PERSONAL PROTECTIVE EQUIPMENT,"February 08, 2021",100,NCT04511390,"TRANSPARENT, REUSABLE RESPIRATOR",UNITED STATES,Recruiting,Brigham and Women's Hospital,"July 25, 2020",Interventional,Transparent Elastomeric Respirator to Protect Against Aerosol Transmission of Infectious Agents,Unrelated
3194,"INFECTIONS, CORONAVIRUS","February 08, 2021",200,NCT04511429,,BRAZIL,Recruiting,D'Or Institute for Research and Education,"June 30, 2020",Observational [Patient Registry],COVID-19 in Immunosuppressed Children,COVID
3195,COVID,"February 08, 2021",180,NCT04511650,RAZUPROTAFIB SUBCUTANEOUS SOLUTION,UNITED STATES,Recruiting,Aerpio Therapeutics,"October 21, 2020",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose Escalation and Proof-of-Concept Study to Evaluate the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) (RESCUE Study)",COVID
3196,CRITICAL ILLNESS,"February 08, 2021",5000,NCT04511780,QUESTIONNAIRE FILLING,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Nīmes,January 2021,Observational,"Psychological Impact of COVID-19 Outbreak on Caregivers Involved in Intensive Care Unit Patient Management: Impact on the Occurrence of Post-traumatic Stress Disorder, Anxiety, Depression and Burn Out Syndrome",Unrelated
3197,COVID,"February 08, 2021",410,NCT04511819,LOSMAPIMOD ORAL TABLET,BRAZIL,Recruiting,Fulcrum Therapeutics,"August 28, 2020",Interventional,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Losmapimod in Adult Subjects With COVID-19 (LOSVID STUDY)",COVID
3198,COVID,"February 08, 2021",40,NCT04511923,NEBULISED HEPARIN,IRELAND,Recruiting,University College Hospital Galway,"December 23, 2020",Interventional,Can Nebulised HepArin Reduce acuTE Lung Injury in Patients With SARS-CoV-2 Requiring Respiratory Support in Ireland,COVID
3199,CORONAVIRUS INFECTION,"February 08, 2021",500,NCT04511949,"COVID-19 IGG / IGM RAPID TEST (WHOLE BLOOD, SERUM, PLASMA)",FRANCE,Completed,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,"July 12, 2020",Interventional,Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,COVID
3200,PULMONARY DISEASE,"February 08, 2021",40,NCT04511962,TELE-PULMONARY REHABILITATION,UNITED KINGDOM,Not yet recruiting,Hull University Teaching Hospitals NHS Trust,"August 12, 2020",Observational,"A Feasibility, Randomised Controlled Trial of Tele-rehabilitation Following COVID-19",Unrelated
3201,COVID,"February 08, 2021",10,NCT04512027,PROLECTIN-M; A (1-6)-ALPHA-D-MANNOPYRANOSE CLASS,INDIA,Completed,Composite Interceptive Med Science,"September 15, 2020",Interventional,"Effect of Prolectin-M; a (1-6)-Alpha-D-Mannopyranose on SarsCoV2 Viral Copy Numbers: A Proof of Concept, Open Label Randomized Controlled Trial",COVID
3202,COVID,"February 08, 2021",3600,NCT04512079,ENOXAPARIN,UNITED STATES,Recruiting,Valentin Fuster,"September 8, 2020",Interventional,FREEDOM COVID Anticoagulation Strategy Randomized Trial,COVID
3203,PRESENCE OF COVID COMPATIBLE CT ABNORMALITIES,"February 08, 2021",22,NCT04512118,PET-CT OF 18F-FDG,FRANCE,Completed,"Central Hospital, Nancy, France","March 15, 2020",Observational,CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients,COVID
3204,DENTAL TREATMENT DURING COVID -19,"February 08, 2021",267,NCT04512300,,EGYPT,Completed,Cairo University,"June 15, 2020",Observational,Parental Attitude Toward Children Dental Treatment and Care During COVID-19 Pandemic (Cross -Sectional Study),COVID
3205,GENERALIZED ANXIETY DISORDER,"February 08, 2021",20,NCT04512378,BEHAVIOURAL EXPERIMENTS FOR INTOLERANCE OF UNCERTAINTY,CANADA,Recruiting,University of Manitoba,"February 1, 2021",Interventional,Facing the Unknown Together: Piloting a Group-based CBT Protocol for Intolerance of Uncertainty,Unrelated
3206,COVID,"February 08, 2021",100,NCT04513158,CONVALESCENT PLASMA,UNITED STATES,Recruiting,"Joseph M. Flynn, D.O., MPH","August 14, 2020",Interventional,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,COVID
3207,COVID,"February 08, 2021",60,NCT04513184,IV DEXAMETHASONE,MEXICO,Recruiting,Edda Sciutto Conde,"July 14, 2020",Interventional,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,COVID
3208,COVID,"February 08, 2021",300,NCT04513210,,POLAND,Enrolling by invitation,Jagiellonian University,"October 10, 2020",Observational,"Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity, Length of Hospitalization and Long-term Complications and of Covid-19 Infection",COVID
3209,COVID,"February 08, 2021",20,NCT04513314,VALPROATE,UNITED STATES,Not yet recruiting,University of Miami,"November 1, 2021",Interventional,"A Practical, Pilot, Randomized, Controlled Trial of Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium",COVID
3210,COVID,"February 08, 2021",5,NCT04513470,ALLOCETRA-OTS,ISRAEL,"Active, not recruiting",Hadassah Medical Organization,"August 1, 2020",Interventional,"A Multi-Center, Open-Label Study, Evaluating Safety of Allocetra-OTS for the Prevention of Organ-Failure Deterioration in Severe Patients With COVID-19 and Respiratory Dysfunction",COVID
3211,TELEMEDICINE,"February 08, 2021",4000,NCT04513496,,,Not yet recruiting,Fundacion Ibis,"September 1, 2020",Observational,"Delivery of HIV Care Through Telemedicine in Public Hospitals in Buenos Aires, Argentina During COVID-19 Pandemic: Implementation Research",Unrelated
3212,INFLAMMATORY DISEASE,"February 08, 2021",4500,NCT04513561,,,Not yet recruiting,"University Hospital, Lille",December 2020,Observational,"Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU (Rheumatology, Dermatology, Internal Medicine, Pneumology, Gastroenterology, Neurology).",Unrelated
3213,PSORIASIS,"February 08, 2021",661,NCT04513847,,CANADA,Completed,Dermatrials Research,"August 13, 2020",Observational,PsoVac: A Psoriatic Patient-based Survey on the Understanding of the Use of Vaccines While on Biologics During the Covid-19 Pandemic,Unrelated
3214,HEART FAILURE,"February 08, 2021",60,NCT04513964,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"November 1, 2020",Observational,Impact of COVID-19 on the Benefit of Cardiac Rehabilitation,Unrelated
3215,COVID INFECTION,"February 08, 2021",1500,NCT04513990,BIOSPECIMEN COLLECTION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"April 9, 2020",Interventional,Evaluation of a Novel Point-of-Care Diagnostic Test for SARS-CoV-2,COVID
3216,COVID,"February 08, 2021",5000,NCT04514003,,NORWAY,Recruiting,Sykehuset Telemark,"July 1, 2020",Observational,The Corona and COVID-19 Study in Telemark and Agder - COVITA,COVID
3217,SARS-COV INFECTION,"February 08, 2021",100,NCT04514016,,UNITED STATES,Recruiting,University of Miami,"August 12, 2020",Observational,"Cross Sectional Survey Of Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (COV-2) Infection And Seroprevalence In A Cohort Of HIV-Infected Children, Youth, And Adolescents Receiving Care At A Single Tertiary Care Medical Center In Miami-Dade County, Florida",Respiratory
3218,COVID,"February 08, 2021",51,NCT04514302,PLACEBO,MEXICO,Not yet recruiting,Hospital San Jose Tec de Monterrey,"October 20, 2020",Interventional,Pilot Study to Evaluate Safety and Efficacy of Anti-SARS-CoV-2 Equine Immunoglobulin F(ab')2 Fragments (INOSARS) in Hospitalized Patients With COVID-19,COVID
3219,COVID,"February 08, 2021",100,NCT04514627,AURICULAR PERCUTANEOUS NEUROSTIMULATION,UNITED STATES,Recruiting,Olive View-UCLA Education & Research Institute,"July 13, 2020",Interventional,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,COVID
3220,CORONAVIRUS INFECTION,"February 08, 2021",20,NCT04514705,EXERCISE,BRAZIL,Recruiting,Universidade Metodista de Piracicaba,"August 11, 2020",Interventional,Clinical Respiratory Investigation in Post Covid-19 Patients,COVID
3221,COVID,"February 08, 2021",500,NCT04514874,QUESTIONNAIRE,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 1, 2020",Observational,Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020,COVID
3222,OBESITY,"February 08, 2021",120,NCT04514900,VIDEO CHAT +PERSONALIZED FEEDBACK,UNITED STATES,"Active, not recruiting",University of South Carolina,"September 23, 2020",Interventional,Exploring the Optimal Treatment Components for a Contactless Online Group-based Behavioral Weight Loss Program for the COVID 19 Pandemic,Unrelated
3223,"PREGNANCY, INFECTIONS IN","February 08, 2021",108,NCT04515108,CLINICAL ASSESSMENT,TURKEY,Completed,Ankara City Hospital Bilkent,"March 10, 2020",Observational,Comparison of Hematological Parameters and Perinatal Outcomes in COVID-19 Pregnancies and Healthy Pregnancy Cohort,Unrelated
3224,CORONAVIRUS,"February 08, 2021",674,NCT04515147,CVNCOV 6 ΜG,PANAMA,"Active, not recruiting",CureVac AG,"September 28, 2020",Interventional,"COVID-19: A Phase 2a, Partially Observer-blind, Multicenter, Controlled, Dose-confirmation Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults >60 Years of Age and 18 to 60 Years of Age",COVID
3225,COVID,"February 08, 2021",400,NCT04515199,,EGYPT,Recruiting,Cairo University,"July 1, 2020",Observational [Patient Registry],Effectiveness of Telemedicine Use in Home Management of Adult Egyptian Mild COVID-19 Cases,COVID
3226,HIV INFECTIONS,"February 08, 2021",500,NCT04515225,BLOOD SAMPLE,,Not yet recruiting,"University Hospital, Strasbourg, France","September 15, 2020",Observational,Seroprevalence of SARS-CoV-2 Antibodies Among Adult Patients Living With HIV,Unrelated
3227,HEALTHCARE DISPARITIES,"February 08, 2021",50,NCT04515771,PARTNER-MH,UNITED STATES,Recruiting,VA Office of Research and Development,"August 17, 2020",Interventional,Improving Patient-provider Communication to Reduce Mental Health Disparities (CDA 16-153),Unrelated
3228,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",180,NCT04516486,RETROSPECTIVE METAGENOMICS ON CLINICAL SAMPLES COLLECTED DURING HOSPITALIZATION,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 9, 2020",Observational,Characterization and Prognostic Impact of Inflammatory Responses by Host Transcriptomics and Co-infection by Metagenomics in Patients With ARDS COVID-19 in Intensive Care,Respiratory
3229,COVID,"February 08, 2021",2500,NCT04516512,BLOOD DRAW,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"September 1, 2020",Interventional,SARS-CoV-2 Seroprevalence Among Adults People Living in Jail,COVID
3230,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",32,NCT04516564,AK119,NEW ZEALAND,Recruiting,Akesobio Australia Pty Ltd,September 2020,Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, First-In-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AK119 in Healthy Subjects",COVID
3231,POST PARTUM DEPRESSION,"February 08, 2021",250,NCT04516668,,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,November 2020,Observational,Survey About Anxious and Depressive Symptoms During COVID-19 in Women Who Have Medical History of Post-partum Depression: Interest of Tele-consultation,Unrelated
3232,COVID,"February 08, 2021",30000,NCT04516746,AZD1222,ARGENTINA,Recruiting,AstraZeneca,"August 28, 2020",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19",COVID
3233,COVID,"February 08, 2021",150,NCT04516759,AZD1656,CZECHIA,Recruiting,St George Street Capital,"August 12, 2020",Interventional,"A Phase II, Randomised, Double-blind, Placebo-controlled Clinical Trial to Assess the Safety and Efficacy of AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19",COVID
3234,COVID,"February 08, 2021",600,NCT04516811,COVID-19 CONVALESCENT PLASMA (CCP) PLUS STANDARD OF CARE (SOC),SOUTH AFRICA,Recruiting,South African National Blood Service,"September 21, 2020",Interventional,"A Prospective, Randomized, Placebo-controlled, Double-blinded, Phase III Clinical Trial of the Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19",COVID
3235,ORTHOPAEDIC DISORDERS,"February 08, 2021",2160,NCT04516824,ORTHOPAEDIC SURGICAL PROCEDURES,PAKISTAN,Completed,Ghurki Trust and Teaching Hospital,"March 19, 2020",Observational,Experience of Workforce From Orthopaedic and Spine Center Ghurki Trust Hospital Pakistan During COVID-19,Unrelated
3236,IMMUNE THROMBOCYTOPENIA,"February 08, 2021",120,NCT04516837,ELTROMBOPAG,CHINA,Recruiting,Peking University People's Hospital,"August 31, 2020",Interventional,The Combination of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) Versus Eltrombopag Monotherapy as Subsequent Treatment for Immune Thrombocytopenia During the COVID-19 Pandemic,Unrelated
3237,COVID,"February 08, 2021",500,NCT04516850,EXPRESSION OF RECEPTORS AND ACTIVATING PROTEASES,SWITZERLAND,Not yet recruiting,Ricardo Pereira Mestre,"September 1, 2020",Observational,An Exploratory Analysis of the Expression of Receptors and Activating Proteases Mediating SARS-CoV-2 Entry and the Association Between HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients,COVID
3238,COVID,"February 08, 2021",120,NCT04516915,IMU-838,UNITED KINGDOM,Recruiting,University Hospitals Coventry and Warwickshire NHS Trust,"June 15, 2020",Interventional,"Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination With Oseltamivir, in Adults With COVID-19",COVID
3239,SARS-COV INFECTION,"February 08, 2021",950,NCT04516928,ANTI-SARS-COV2 SEROLOGY,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 21, 2020",Observational,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel,Respiratory
3240,SARS-COV INFECTION,"February 08, 2021",420,NCT04516941,EDOXABAN TABLETS,SWITZERLAND,Not yet recruiting,"University Hospital Inselspital, Berne","October 1, 2020",Interventional,Efficacy and Safety of Edoxaban and or Colchicine for Patients With SARS-CoV-2 Infection Managed in the Out of Hospital Setting,Respiratory
3241,COVID,"February 08, 2021",10,NCT04516954,CONVALESCENT COVID 19 PLASMA,VIETNAM,Enrolling by invitation,Vinmec Research Institute of Stem Cell and Gene Technology,"August 1, 2020",Interventional,Assessment of the Safety of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above Illness,COVID
3242,HAPPINESS,"February 08, 2021",1542,NCT04517006,SELF-FOCUSED ACTS,,Not yet recruiting,University of Toronto,January 2021,Interventional,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic: A Randomized Clinical Trial,Unrelated
3243,CANCER,"February 08, 2021",1680,NCT04517097,BLOOD SAMPLE,FRANCE,Completed,Centre Georges Francois Leclerc,"May 12, 2020",Observational,Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic,Unrelated
3244,COVID,"February 08, 2021",100,NCT04517123,PRONE POSITIONING,UNITED STATES,Recruiting,Johns Hopkins University,"September 1, 2020",Interventional,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study",COVID
3245,COVID,"February 08, 2021",60,NCT04517136,ASSESSMENT OF WORK-RELATED STRESS,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 14, 2020",Observational,Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions,COVID
3246,COVID,"February 08, 2021",90,NCT04517162,COLLAGEN-POLYVINYLPYRROLIDONE,MEXICO,Recruiting,Janette Furuzawa Carballeda,"August 19, 2020",Interventional,Effect of Collagen-Polyvinylpyrrolidone for the Treatment of Hyperinflammation and the Pulmonary Fibrosis in COVID-19 Patients. Double Blind Placebo-controlled Pilot Trial,COVID
3247,SARS-CoV2 INFECTION,"February 08, 2021",40,NCT04517188,POVIDONE-IODINE SOLUTION 1.25% W/W [0.125% AVAILABLE IODINE] USP,,Not yet recruiting,Halodine LLC,"October 15, 2020",Interventional,A Phase 4 Study to Evaluate Nasopharyngeal SARS-CoV-2 Viral Shedding After Halodine Nasal Antiseptic in Patients With COVID-19,COVID
3248,COVID,"February 08, 2021",700,NCT04517396,FENOFIBRATE/FENOFIBRIC ACID,UNITED STATES,Enrolling by invitation,University of Pennsylvania,"August 18, 2020",Interventional,FEnofibRate as a Metabolic INtervention for Coronavirus Disease 2019,COVID
3249,SARS-COV INFECTION,"February 08, 2021",300,NCT04517422,PROBIOTICS,MEXICO,"Active, not recruiting","AB Biotics, SA","August 19, 2020",Interventional,Efficacy and Safety of Lactobacillus Plantarum and Pediococcus Acidilactici as Co-adjuvant Therapy for Reducing the Risk of Severe Disease in Adults With SARS-CoV-2 and Its Modulation of the Fecal Microbiota: A Randomized Clinical Trial,Respiratory
3250,CORONAVIRUS INFECTION,"February 08, 2021",90,NCT04517630,"URINARY NGAL, TIMP-2, IGFBP7, IL-6, VIRAL LOAD AND METABOLOMIC",MEXICO,Recruiting,Instituto Nacional de Enfermedades Respiratorias,"June 1, 2020",Observational [Patient Registry],Acute Kidney Injury In Subjects With Severe Acute Respiratory Syndrome Due to SARS-CoV2 Infection,COVID
3251,RNA VIRUS INFECTIONS,"February 08, 2021",300,NCT04517682,RT-PCR,UNITED STATES,Enrolling by invitation,Ambry Genetics,"May 21, 2020",Observational,SARS -CoV-2 Detection in Saliva Samples: A Test Validation Protocol,Unrelated
3252,COVID,"February 08, 2021",30,NCT04517695,BVA-100,UNITED STATES,Recruiting,NYU Langone Health,"August 1, 2020",Observational,"Blood Volume, Components and Capillary Leak in SARS-CoV-2 Infections",COVID
3253,CORONAVIRUS,"February 08, 2021",2000,NCT04518410,LY3819253,PUERTO RICO,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"August 19, 2020",Interventional,Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID),COVID
3254,PATIENTS UNDERGOING ELECTIVE SURGERY WITH ANESTHESIA,"February 08, 2021",100,NCT04518514,TAPE-SOFTWARE,GERMANY,Recruiting,RWTH Aachen University,"April 20, 2020",Interventional,Telemedical Risk Assessment and Preoperative Evaluation for Anesthesia During the COVID-19 Pandemic,Unrelated
3255,COVID,"February 08, 2021",1707,NCT04518735,ANTITHROMBOTIC THERAPY (ANTICOAGULANT AND/OR ANTIPLATELET) BEFORE ADMISSION FOR COVID19,SPAIN,Completed,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,"April 1, 2020",Observational,Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients,COVID
3256,IMMUNE THROMBOCYTOPENIA,"February 08, 2021",30,NCT04518878,ELTROMBOPAG,CHINA,Recruiting,Peking University People's Hospital,"August 31, 2020",Interventional,Combination of Fixed Low-dose Eltrombopag and rhTPO for Treatment of Immune Thrombocytopenia,Unrelated
3257,COVID,"February 08, 2021",24,NCT04518969,CYTOSORB,BELGIUM,Recruiting,Dr David DE BELS,"May 3, 2020",Interventional,"Comparing the Cytokine Clearances of Pro-, and Anti-inflammatory Mediators, Chemokines and Complement in the COVID-19 Patients Treated With CytoSorb as Compared to the Same Patient Population Who do Not Receive Blood Purification Treatment",COVID
3258,COVID,"February 08, 2021",27000,NCT04519034,NO INTERVENTION,UNITED KINGDOM,Not yet recruiting,Guy's and St Thomas' NHS Foundation Trust,"September 1, 2020",Observational,Retrospective Pilot Study of Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection,COVID
3259,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",950,NCT04519125,TENOFOVIR/ EMTRICITABINE ( 300 MG / 200 MG DAILY DURING 60 DAYS) + PERSONAL PROTECTIVE EQUIPMENT (PPE),,Not yet recruiting,Hospital Universitario San Ignacio,"August 30, 2020",Interventional,Effectiveness of the Use of Personal Protective Equipment in Addition to Tenofovir/Emtricitabine for the Prevention of the Transmission of SARS-COV-2 to Health Care Personnel. Randomized Clinical Trial,COVID
3260,BREASTFEEDING,"February 08, 2021",39,NCT04519216,TELESIMULATION,UNITED STATES,Recruiting,"University of California, Davis","July 31, 2020",Interventional,"Breastfeeding Education in the Time of COVID-19. Hybrid Telesimulation With Standardized Patients for Pediatric and Family Medicine Trainees, a Randomized Trial",Unrelated
3261,PET/CT,"February 08, 2021",60,NCT04519255,,CHINA,"Active, not recruiting","Fifth Affiliated Hospital, Sun Yat-Sen University","July 1, 2020",Observational,"Single-center, Open, Prospective, Randomized Pilot Study for Quantitative Analysis of Whole Body Inflammatory Lesions in Recovered COVID-19 Patients by 18F-FDG-PET/CT",Unrelated
3262,VIRAL INFECTION,"February 08, 2021",72,NCT04519307,,TURKEY,"Active, not recruiting",Dr. Behcet Uz Children's Hospital,"March 1, 2020",Observational,Evaluation of Newborns Presenting With Suspected COVID 19: A Single Center Experience,Unrelated
3263,SARS-CoV2,"February 08, 2021",140,NCT04519320,PULMONARY FUNCTION TESTING,FRANCE,Recruiting,Centre Hospitalier Universitaire de Besancon,"May 18, 2020",Interventional,Medium and Long Term Follow-up of SARS-COV-2 Infected Patients Treated at Besançon and Dijon Hospitals: Research and Characterization of Pulmonary Sequelae,COVID
3264,COVID,"February 08, 2021",4099,NCT04519372,TESTING FOR SARS-COV-2,SWITZERLAND,"Active, not recruiting","University Hospital, Basel, Switzerland","April 1, 2020",Observational,SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting (Covid-Screen Quality Control Study),COVID
3265,"PNEUMONIA, VIRAL","February 08, 2021",69,NCT04519385,TOCILIZUMAB,EGYPT,Completed,South Valley University,"March 1, 2020",Interventional,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,Respiratory
3266,COVID,"February 08, 2021",60,NCT04519398,COMPLETE THROMBOPHILIC PROFILE TESTING BY MULTIPLEX PCR,ROMANIA,Recruiting,Grigore T. Popa University of Medicine and Pharmacy,"August 18, 2020",Observational,Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events,COVID
3267,COVID,"February 08, 2021",10,NCT04519411,TRANSPULMONARY PRESSURE MEASUREMENTS,UNITED STATES,Recruiting,Mayo Clinic,"May 21, 2020",Interventional,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,COVID
3268,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",0,NCT04519424,CSL324,,Withdrawn,CSL Behring,September 2020,Interventional,"A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate CSL324 in Coronavirus Disease 2019 (COVID-19)",COVID
3269,HEALTHY,"February 08, 2021",974,NCT04519437,REGN10933+REGN10987,UNITED STATES,"Active, not recruiting",Regeneron Pharmaceuticals,"July 26, 2020",Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers",Unrelated
3270,COVID,"February 08, 2021",26400,NCT04519502,,UNITED STATES,Recruiting,The George Washington University Biostatistics Center,"June 23, 2020",Observational,Maternal Morbidity and Mortality During the COVID-19 Pandemic,COVID
3271,COVID REALTED DISRUPTION IN PATIENT WITH DIABETES AND CKD,"February 08, 2021",529,NCT04520191,,,Not yet recruiting,University of New Mexico,"September 1, 2020",Observational,Home-based Kidney Care in Native Americans of New Mexico (HBKC) -COVID-19 Related Disruption in Health and Health Care,COVID
3272,SARS-CoV2,"February 08, 2021",0,NCT04520620,LOVENOX 40 MG IN 0.4 ML PREFILLED SYRINGE,FRANCE,Withdrawn,Centre Hospitalier Universitaire de Saint Etienne,"May 2, 2020",Interventional,Evaluation of the Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention in COVID-19 Intensive Unit Care Patients.,COVID
3273,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",200,NCT04520815,,FRANCE,Recruiting,Centre Hospitalier Universitaire de la Réunion,"June 24, 2020",Observational,Assessment of the Prevalence and Kinetics of Diaphragmatic Dysfunction in Elderly Patients With Acute Respiratory Distress,Respiratory
3274,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2 INFECTION),"February 08, 2021",158,NCT04520880,TESTING PROCEDURE FOR BINDING ANTIBODIES,SAUDI ARABIA,Not yet recruiting,Dammam University,August 2020,Observational,Antibodies Responses to SARS-CoV 2 Infection (COVID-19) in Hospitalized Patients. A Prospective Observational Study,COVID
3275,COVID PANDEMIC,"February 08, 2021",700,NCT04521010,COVID-19 PANDEMIC,POLAND,Completed,Poznan University of Medical Sciences,"January 1, 2020",Observational,Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic at Wiktor Dega Orthopedic and Rehabilitation Clinical Hospital in Poznań,COVID
3276,COVID,"February 08, 2021",44,NCT04521036,CONVALESCENT PLASMA AS THERAPY FOR COVID-19 PATIENTS,VIETNAM,Not yet recruiting,Vinmec Research Institute of Stem Cell and Gene Technology,"December 1, 2020",Interventional,Assessment of the Safety and Efficacy of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above Illness,COVID
3277,COVID,"February 08, 2021",1000,NCT04521088,,GERMANY,Recruiting,Wissenschaftliches Institut Bethanien e.V,"July 2, 2020",Observational [Patient Registry],Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic,COVID
3278,MILD TO MODERATE COVID,"February 08, 2021",90,NCT04521296,DWJ1248,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,August 2020,Interventional,"A Double-blind, Randomized, Placebo-controlled, Multi-center, Phase II Study to Evaluate the Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19",COVID
3279,COVID,"February 08, 2021",50,NCT04521309,SARS-COV-2 ANTIBODY BASED IVIG THERAPY,PAKISTAN,Recruiting,Dow University of Health Sciences,"June 19, 2020",Interventional,Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Antibodies Based Intravenous Immunoglobulin (IVIG) Therapy for Severe and Critically Ill COVID-19 Patients,COVID
3280,COVID,"February 08, 2021",400,NCT04521322,IOTA-CARRAGEENAN,ARGENTINA,Recruiting,Ariel Dogliotti,"July 24, 2020",Interventional,"Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19. Multicenter, Randomized, Double-blind, Placebo-controlled Trial (CARR-COV-02)",COVID
3281,COVID,"February 08, 2021",100,NCT04521400,HIGH DOSE INTERFERON-BETA 1A,,Not yet recruiting,Shahid Beheshti University of Medical Sciences,"August 20, 2020",Interventional,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",COVID
3282,OPIOID USE,"February 08, 2021",20,NCT04521920,SUBOXONE,UNITED STATES,Recruiting,Duke University,"November 9, 2020",Interventional,Providing Comprehensive Harm Reduction Via Telemedicine for PWID Using Syringe Services Programs: a Feasibility Study,Unrelated
3283,PATIENTS HOSPITALIZED IN THE HOSPICES CIVILS OF LYON,"February 08, 2021",200,NCT04522037,NO INTERVENTION / COMPARE THE DIFFERENCE IN RESPIRATORY RATE BETWEEN H0 AND H12 OF THE INITIATION OF MORPHINE BETWEEN THE CONTROL AND INTERVENTIONAL GROUPS,FRANCE,Recruiting,Hospices Civils de Lyon,"June 1, 2020",Observational,Retrospective Study of the Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients With Moderate to Severe Impairment Without Objective of Resuscitation Management (Level of Care 3 and 4) at the Hospices Civils of Lyon,Unrelated
3284,COVID,"February 08, 2021",1124,NCT04522076,,RUSSIAN FEDERATION,"Active, not recruiting",National Research Center for Preventive Medicine,"April 6, 2020",Observational,Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia,COVID
3285,COVID,"February 08, 2021",70,NCT04522089,ADIMRSC-2F,TAIWAN,Recruiting,Adimmune Corporation,"August 24, 2020",Interventional,"A Randomized, Single Center, Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of Pandemic Virus Vaccine, AdimrSC-2f (SARS-CoV-2), in Healthy Volunteers",COVID
3286,COVID,"February 08, 2021",969,NCT04522128,BEHAVIOUR CHANGE TECHNIQUE INTERVENTION TO IMPROVE QUALITY OF LIFE,UNITED KINGDOM,Recruiting,University of Manchester,"May 22, 2020",Interventional,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,COVID
3287,COVID,"February 08, 2021",183,NCT04522310,MR-PRO-ADM,FRANCE,Recruiting,Centre Hospitalier de Lens,"May 20, 2020",Observational,ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis,COVID
3288,SARS-CoV2,"February 08, 2021",7,NCT04522466,HYDROXYCHLOROQUINE (HCQ),FRANCE,Terminated,Centre Hospitalier Universitaire de Saint Etienne,"April 3, 2020",Interventional,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients,COVID
3289,SKIN PICKING,"February 08, 2021",18,NCT04522492,INTERNET-BASED COGNITIVE BEHAVIORAL THERAPY,BRAZIL,"Active, not recruiting",Hospital de Clinicas de Porto Alegre,"August 11, 2020",Interventional,Impact of COVID-19 Pandemia on the Mental Health of Patients With Skin Picking Disorder and Their Treatment With Remote Cognitive Behavioral Therapy: Controlled Clinical Trial,Unrelated
3290,DEPRESSION,"February 08, 2021",68,NCT04522713,"BEHAVIORAL ACTIVATION, EVIDENCE-BASED SLEEP STRATEGIES INCLUDING SLEEP RESTRICTION, EXPOSURE-BASED STRATEGIES, PROMOTION OF PHYSICAL ACTIVITY AND RECUPERATING ACTIVITIES, PSYCHOEDUCATIONAL MATERIAL",SWEDEN,Recruiting,Karolinska Institutet,"August 24, 2020",Interventional,Single-Arm Feasibility Study of a Transdiagnostic Course for Common Mental Health Problems in Primary Care,Unrelated
3291,COVID,"February 08, 2021",0,NCT04522817,CLBS119,UNITED STATES,Withdrawn,"Caladrius Biosciences, Inc.","October 5, 2020",Interventional,CLBS119 (Autologous Peripheral Blood Derived CD34+ Cells) for Repair of COVID-19 Induced Pulmonary Damage,COVID
3292,SARS-CoV2 INFECTION,"February 08, 2021",40,NCT04522830,BTL-TML-COVID,UNITED STATES,Recruiting,"Beech Tree Labs, Inc.","July 30, 2020",Interventional,"A Double-blind, Placebo-controlled, Phase 2 Trial of Sublingual Low-Dose Thimerosal in Adults With Symptomatic SARS-CoV-2 Infection",COVID
3293,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",6,NCT04522986,MESENCHYMAL STEM CELL,JAPAN,Not yet recruiting,"Rohto Pharmaceutical Co., Ltd.",September 2020,Interventional,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,COVID
3294,COVID,"February 08, 2021",2200,NCT04523012,SEROPREVALENCE OF SARS-COV-2 INFECTION IN PATIENTS WITH HIV INFECTION,FRANCE,Recruiting,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,"July 1, 2020",Observational,Seroprevalence of SARS-CoV-2 Infection in Patients With HIV Infection,COVID
3295,COVID,"February 08, 2021",40,NCT04523051,,FRANCE,Recruiting,Centre Hospitalier Régional Metz-Thionville,"April 1, 2020",Observational,Rehabilitation After Admission in Intensive Care Unit for COVID-19: an Observational Study,COVID
3296,COVID,"February 08, 2021",960,NCT04523090,NITAZOXANIDE,SOUTH AFRICA,Recruiting,University of Cape Town,"August 27, 2020",Interventional,"The C3 Nitazoxanide for Mild to Moderate COVID-19 in HIV-infected and HIV-uninfected Adults With Enhanced Risk: a Double-blind, Randomised, Placebo-controlled Trial in a Resource-poor Setting",COVID
3297,COVID,"February 08, 2021",174,NCT04523181,ANTROQUINONOL,ARGENTINA,Recruiting,Golden Biotechnology Corporation,"October 8, 2020",Interventional,"A Phase 2 Randomized, Double-blind, Placebo-controlled, Proof of Concept Study to Evaluate the Safety and Efficacy of Antroquinonol in Hospitalized Patients With Mild to Moderate Pneumonia Due to COVID-19",COVID
3298,HERPES ZOSTER,"February 08, 2021",250,NCT04523246,"SHINGRIX (ZOSTER VACCINE RECOMBINANT, ADJUVANTED)",UNITED STATES,Recruiting,Barbara Carlson,"September 1, 2020",Interventional,"Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents: A Randomized, Doubled-Blinded, Comparative Group Observational Study",Unrelated
3299,SARS-CoV2,"February 08, 2021",144,NCT04523571,BNT162B1,CHINA,"Active, not recruiting",BioNTech RNA Pharmaceuticals GmbH,"July 28, 2020",Interventional,"Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects: A Phase I, Randomized, Placebo-controlled, Observer-blind Study",COVID
3300,"DEPRESSION, ANXIETY","February 08, 2021",258,NCT04523610,TELEHEALTH PHONE CALLS,,Not yet recruiting,Lady Davis Institute,October 2020,Interventional,Telehealth Intervention Program for Older Adults (TIP-OA) Struggling With Mental Health/Cognitive Issues,Unrelated
3301,COVID,"February 08, 2021",400,NCT04523831,IVERMECTIN AND DOXYCYCLINE,BANGLADESH,Completed,Dhaka Medical College,"June 1, 2020",Interventional,A Phase III Trial to Promote Recovery From Covid 19 With Combined Doxycycline and Ivermectin Along Standard Care,COVID
3302,HEALTHY,"February 08, 2021",32,NCT04524052,DWRX2003,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,August 2020,Interventional,"Phase I Study to Evaluate the Safety, Tolerability, Pharmacodynamics (PD) and Pharmacokinetics (PK) of DWRX2003 (Niclosamide IM Depot) Injection Following Intramuscular Administration in Healthy Volunteers",Unrelated
3303,COVID,"February 08, 2021",100,NCT04524156,PHYSIOLOGY,BELGIUM,Not yet recruiting,Erasme University Hospital,"October 4, 2020",Interventional,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,COVID
3304,COVID,"February 08, 2021",132,NCT04524234,ECHOCARDIOGRAPHY,SWEDEN,Completed,"Sahlgrenska University Hospital, Sweden","April 20, 2020",Observational,Cardiac Dysfunction in Critically Ill Patients With COVID-19,COVID
3305,"HEALTH KNOWLEDGE, ATTITUDES, PRACTICE","February 08, 2021",60,NCT04524286,INTERVIEWS ONLY.,UNITED KINGDOM,Recruiting,Bournemouth University,"November 6, 2020",Observational,The Role of a Midwifery Continuity of CARE Model in Reducing Health Inequalities in Childbearing Women and Babies Living on a Low-income: The Mi-CARE Study,Unrelated
3306,COVID,"February 08, 2021",56,NCT04524507,HIGH-TITER CONVALESCENT COVID-19 PLASMA (CCP1),UNITED STATES,Recruiting,"University of North Carolina, Chapel Hill","August 27, 2020",Interventional,"IGHID 12021 - A Randomized, Phase II Study Comparing the Efficacy and Safety of Standard Versus High-Titer Anti-SARS-CoV2 Neutralizing Antibody Plasma in Hospitalized Patients With COVID-19",COVID
3307,EXPLORING RISK ASSESSMENT AND RECOVERY FROM COVID INFECTION IN HOSPITALISED PATIENTS,"February 08, 2021",30,NCT04524520,,UNITED KINGDOM,Recruiting,Western Sussex Hospitals NHS Trust,"May 5, 2020",Observational,"COVID19-OR (SARS-CoV-2):Observation, Risk & Recovery. An Observational Study Exploring Risk Assessment and Recovery From COVID-19 (SARS-CoV-2) Infection in Hospitalised Patients",COVID
3308,DEPRESSION,"February 08, 2021",410,NCT04524598,LIMBIX SPARK,UNITED STATES,Recruiting,"Limbix Health, Inc.","July 20, 2020",Interventional,Limbix Spark: A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,Unrelated
3309,COVID,"February 08, 2021",120,NCT04524663,CAMOSTAT MESILATE,UNITED STATES,Recruiting,Stanford University,"December 19, 2020",Interventional,"A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Camostat Mesilate Compared to Standard of Care in Subjects With Mild-Moderate COVID-19",COVID
3310,COVID,"February 08, 2021",64,NCT04524715,NON-INVASIVE RED LLLT TREATMENT TO CHEST OF PATIENT.,UNITED STATES,Not yet recruiting,Ward Photonics LLC,"March 31, 2021",Interventional,Low-Level Laser Therapy Treatment of Lung Inflammation in COVID-19 Patients,COVID
3311,ANOSMIA,"February 08, 2021",218,NCT04524754,,EGYPT,Recruiting,Ain Shams University,"July 11, 2020",Observational,Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19,Unrelated
3312,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",30,NCT04524962,DESCARTES 30,UNITED STATES,Recruiting,Cartesian Therapeutics,"September 15, 2020",Interventional,Phase I/IIA Study of Descartes-30 in Acute Respiratory Distress Syndrome,Respiratory
3313,SARS-CoV2 INFECTION,"February 08, 2021",32,NCT04525079,CT-P59,"KOREA, REPUBLIC OF",Recruiting,Celltrion,"July 18, 2020",Interventional,"A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel Group, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects",COVID
3314,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04525287,,CHINA,Recruiting,"Second Affiliated Hospital, School of Medicine, Zhejiang University","February 20, 2020",Observational,Prediction Models for Diagnosis and Prognosis of Severe COVID-19,COVID
3315,COVID,"February 08, 2021",20,NCT04525378,MESENCHYMAL STROMAL CELL-BASED THERAPY,BRAZIL,Recruiting,D'Or Institute for Research and Education,"July 1, 2020",Interventional,Mesenchymal Stromal Cell-based Therapy for COVID-19-associated Acute Respiratory Distress Syndrome: a Pilot Clinical Study,COVID
3316,COVID,"February 08, 2021",228,NCT04525404,"MRI (HEART, BRAIN, LUNGS, LIVER)",CANADA,Recruiting,University of Alberta,"November 12, 2020",Observational,MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients,COVID
3317,COVID IMMUNE STATUS OF HEALTHCARE WORKERS,"February 08, 2021",75,NCT04525417,AAZ COVID-19 RAPID TEST,FRANCE,Completed,Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux,"April 25, 2020",Interventional,Use of Rapid Covid-19 Antibody Test Marketed by AAZ Laboratories in Healthcare Workers Presumably Being Infected by SARS-CoV-2,COVID
3318,COVID,"February 08, 2021",100,NCT04525443,,SPAIN,Recruiting,"Hospital San Carlos, Madrid","June 3, 2020",Observational,Assessment of Endothelial Vasodilator Function in COVID-19 Patients,COVID
3319,DERMATITIS HAND,"February 08, 2021",40,NCT04525521,HAND SANITIZER AND HAND WASHING,UNITED STATES,Recruiting,National Jewish Health,"September 8, 2020",Observational,Hand Sanitizer Effects on the Skin Barrier,Unrelated
3320,COVID,"February 08, 2021",2000,NCT04525716,COVID-19 INFECTION STATUS,SWEDEN,Recruiting,Karolinska Institutet,"March 1, 2020",Observational,"How Does Covid-19 Affect Patient Outcome Following Surgery? A Hospital Based Cohort in Stockholm, Sweden",COVID
3321,COVID,"February 08, 2021",309,NCT04525742,DIFFICULTIES LIVED BY DISABLED CHILDREN'S PARENTS IN THE PERIOD OF COVID-19 PANDEMIC,TURKEY,Completed,Gaziosmanpasa Taksim Research and Education Hospital,"July 5, 2020",Interventional,COVID-19 Pandemic From the Perspective of Parents of Disabled Children,COVID
3322,COVID,"February 08, 2021",80,NCT04525820,SINGLE HIGH DOSE VITAMIN D,SWITZERLAND,Recruiting,Prof. Dr. Jörg Leuppi,"December 15, 2020",Interventional,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study",COVID
3323,COVID,"February 08, 2021",258,NCT04525911,DIAGNOSTIC TEST: SEROLOGY TEST FOR COVID-19,FRANCE,Recruiting,Hôpital Européen Marseille,"August 26, 2020",Observational,Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital,COVID
3324,OLFACTION DISORDERS,"February 08, 2021",30,NCT04526054,ENT EXAM,FRANCE,Recruiting,Hopital Foch,"September 3, 2020",Interventional,Longitudinal and Comparative Study of Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,Unrelated
3325,"STRESS, PSYCHOLOGICAL","February 08, 2021",30,NCT04526145,STRESS AND EMOTION MANAGEMENT,,Not yet recruiting,Ohio State University,"January 31, 2021",Interventional,Operating Under Resilience (OUR) Project: Stress and Emotion Management for Black/African American Women With Hypertension In a Covid--19 Social Distancing Society,Unrelated
3326,THALASSEMIA MAJOR,"February 08, 2021",63,NCT04526405,SARS-COV-2 S1/S2 IGG,ITALY,Completed,University of Milano Bicocca,"July 14, 2020",Observational,Study on the Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases Subject to Chronic Transfusion Support.,Unrelated
3327,COVID,"February 08, 2021",15,NCT04526717,MPT0B640,,Not yet recruiting,Joseah Bio,December 2020,Interventional,"Phase 1, Open Label, Single Arm Study to Evaluate the Safety, Tolerability and Efficacy of MPT0B640 in Patients With COVID-19 Infection",COVID
3328,COVID,"February 08, 2021",30,NCT04526769,TEAR COLLECTION,UNITED STATES,Not yet recruiting,University of Minnesota,September 2020,Observational,Detecting SARS-CoV-2 Virus in Tears From Patients With COVID-19,COVID
3329,SARS-CoV2,"February 08, 2021",336,NCT04526821,BOVINE LACTOFERRIN,PERU,Not yet recruiting,Universidad Peruana Cayetano Heredia,"September 1, 2020",Interventional,"Bovine Lactoferrin for the Prevention of COVID-19 Infection in Physicians and Nurses in Hospitals in Lima, Peru: a Double Blinded Randomized Clinical Trial (LF-COVID)",COVID
3330,ACUTE LUNG INJURY,"February 08, 2021",48,NCT04526912,VIB7734,UNITED STATES,Recruiting,Viela Bio,"August 28, 2020",Interventional,A Proof of Concept Study of the Safety and Efficacy of VIB7734 for the Treatment and Prevention of Acute Lung Injury (ALI) in Patients With SARS-CoV-2 Infection,Unrelated
3331,"TRANSMISSION, PATIENT-PROFESSIONAL","February 08, 2021",10,NCT04526925,RESPIRATORY FILTER IN-LINE PLACED WITH THE STANDARD MOUTHPIECE,UNITED STATES,Completed,Rush University Medical Center,"August 29, 2020",Interventional,A Physiologic Research to Assess the Effect of an Inline Filter During Cardiopulmonary Exercise Testing (CPET): A Healthy Volunteer Study,Unrelated
3332,COVID,"February 08, 2021",90,NCT04526977,IMMUNE RESPONSE STUDY,SPAIN,Recruiting,Asociacion para el Estudio de las Enfermedades Infecciosas,"January 10, 2021",Observational,"Differences in Susceptibility and Cytokine Profile, Specific CD4/CD8 T Cell Response, Toll Like Receptors (TLRs) and Killer Immunoglobulin-like Receptors (KIRs) Among HIV-1-infected Individuals With Previous or Current COVID-19",COVID
3333,COVID,"February 08, 2021",40000,NCT04526990,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR),ARGENTINA,Recruiting,CanSino Biologics Inc.,"September 15, 2020",Interventional,"A Global Multicenter, Randomized, Double-blind, Placebo -Controlled, Adaptive Designed Phase Ⅲ Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of Ad5-nCoV in Adults 18 Years of Age and Older",COVID
3334,COVID,"February 08, 2021",30,NCT04527081,AG0302-COVID19,JAPAN,"Active, not recruiting","AnGes, Inc.","August 31, 2020",Interventional,"A Randomized, Open-label, Non-controlled Phase I/II Study to Assess Safety and Immunogenicity of Twice or Three Times Dosing of Intramuscular AG0302-COVID19 (2mg) in Healthy Adults",COVID
3335,COVID,"February 08, 2021",30,NCT04527133,APROTININ,RUSSIAN FEDERATION,"Active, not recruiting",Aviron LLC,"June 11, 2020",Interventional,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,COVID
3336,COVID,"February 08, 2021",40,NCT04527198,BRAINSTEM RESPONSES ASSESSMENT SEDATION SCORE (BRASS),FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,September 2020,Interventional,Brainstem Dysfunction in Ventilated and Deeply Sedated COVID-19 Critically Ill Patients: a Prospective Observational Study,COVID
3337,COVID,"February 08, 2021",550,NCT04527211,IVERMECTIN,COLOMBIA,Not yet recruiting,Javeriana University,"September 7, 2020",Interventional,"Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel at All Levels of Care, During the 2020 Pandemic: A Randomized Clinical Controled Trial",COVID
3338,COVID,"February 08, 2021",10,NCT04527224,ASTROSTEM-V,,Not yet recruiting,Nature Cell Co. Ltd.,"December 1, 2020",Interventional,A Phase I/Ⅱa Trial to Explore the Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stem Cell (AstroStem-V) Therapy in Patients With COVID-19 Pneumonia,COVID
3339,COVID,"February 08, 2021",350,NCT04527315,QUESTIONNAIRES,UNITED STATES,Recruiting,NYU Langone Health,"July 17, 2020",Observational [Patient Registry],Assessment of ICU and Non-ICU Survivors: A Creation of a COVID Survivorship Database,COVID
3340,SARS-CoV2 INFECTION,"February 08, 2021",60,NCT04527354,TREAMID,RUSSIAN FEDERATION,"Active, not recruiting",PHARMENTERPRISES LLC,"September 8, 2020",Interventional,"Multicenter, Randomized, Double-blind, Placebo-controlled Pilot Study of Treamid Efficacy and Safety in the Rehabilitation of Patients After COVID-19 Pneumonia",COVID
3341,CORONAVIRUS INFECTION,"February 08, 2021",3000,NCT04527432,SURVEY,UNITED KINGDOM,Recruiting,The Royal Wolverhampton Hospitals NHS Trust,"December 16, 2020",Interventional,"A Pilot Assessment of the COVID-19 Antibody Status and Associated Factors, in Individuals Employed by a Large Acute NHS Trust During the Coronavirus Pandemic",COVID
3342,COVID,"February 08, 2021",70000,NCT04527458,PATIENT CHARACTERISTICS,UNITED KINGDOM,Completed,University of Edinburgh,"February 24, 2020",Observational,Case Fatalities in Hospitalised COVID-19 Patients in the UK: An ISARIC Study,COVID
3343,CORONAVIRUS INFECTION,"February 08, 2021",45,NCT04527471,ENSIFENTRINE DOSE 1,UNITED STATES,"Active, not recruiting",Verona Pharma Inc,"September 4, 2020",Interventional,"A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients With COVID-19",COVID
3344,COVID,"February 08, 2021",50,NCT04527497,,GERMANY,Recruiting,Wissenschaftliches Institut Bethanien e.V,"August 1, 2020",Observational,Clinical Course and Treatment of COVID-19 Inpatients in Hospital,COVID
3345,COVID,"February 08, 2021",299,NCT04527562,COLCHICINE,BANGLADESH,Completed,Dhaka Medical College,"July 14, 2020",Interventional,"Colchicine in Moderate Symptomatic COVID-19 Patients: Double Blind, Randomized, Placebo Controlled Trial to Observe the Efficacy",COVID
3346,COVID,"February 08, 2021",100,NCT04527575,EPIVACCORONA (EPIVACCORONA VACCINE BASED ON PEPTIDE ANTIGENS FOR THE PREVENTION OF COVID-19),RUSSIAN FEDERATION,"Active, not recruiting","Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ""Vector""","July 27, 2020",Interventional,"Simple, Blind, Placebo-controlled, Randomized Study of the Safety, Reactogenicity and Immunogenicity of Vaccine Based on Peptide Antigens for the Prevention of COVID-19 (EpiVacCorona), in Volunteers Aged 18-60 Years (I-II Phase)",COVID
3347,EXTREME PREMATURITY,"February 08, 2021",885,NCT04527601,,DENMARK,Completed,"Rigshospitalet, Denmark","August 21, 2020",Observational,Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments,Unrelated
3348,"INFLUENZA, HUMAN","February 08, 2021",2000,NCT04527614,QRT-PCR AND SEROLOGY,BELGIUM,Enrolling by invitation,Sciensano,"September 24, 2020",Interventional,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection (PICOV) A Multicentre Academic Prospective Cohort Study in Nursing Home During the Winter Season 2020-2021,Respiratory
3349,VIRAL MYOCARDITIS,"February 08, 2021",18,NCT04527835,"ELIZA, EXTRACTION OF NUCLEIC ACID ,DETERMINATION OF VIRAL GENOME BY USING PCR, QUANTITATIVE REAL-TIME PCR TO ASSESS VIRAL LOAD ,IMMUNOHISTOCHEMISTRY ANALYSIS OF EMB.",EGYPT,Recruiting,Assiut University,"October 1, 2020",Observational,"Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis",Unrelated
3350,COVID,"February 08, 2021",300,NCT04528329,EARLY-DEXAMETHASONE,EGYPT,Recruiting,ClinAmygate,"August 30, 2020",Interventional,Time to Recover of Anosmia and / or Ageusia and Early Corticosteroid Use,COVID
3351,COVID,"February 08, 2021",60,NCT04528368,CONVALESCENT PLASMA,BRAZIL,Recruiting,D'Or Institute for Research and Education,"December 11, 2020",Interventional,Efficacy and Safety of Using Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,COVID
3352,COVID,"February 08, 2021",90,NCT04528641,GRAD-COV2,ITALY,Recruiting,ReiThera Srl,"August 10, 2020",Interventional,"A Phase 1, Dosage-Escalation Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine GRAd-COV2 in Healthy Adults and Elderly Subjects",COVID
3353,COVID,"February 08, 2021",400,NCT04528667,STI-5656,BRAZIL,Recruiting,"Sorrento Therapeutics, Inc.","January 6, 2021",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-controlled Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19",COVID
3354,SARS-CoV2 INFECTION,"February 08, 2021",21,NCT04528771,SNO,UNITED STATES,Not yet recruiting,Robert Schilz,"October 31, 2020",Interventional,Phase 1b Safety Trial for S-Nitrosylation Therapy to Treat COVID-19 Induced Respiratory Distress,COVID
3355,COVID,"February 08, 2021",210,NCT04528888,ENOXAPARIN,,Not yet recruiting,Massimo Girardis,"September 1, 2020",Interventional,"Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection. A Multicenter, Interventional, Randomized, Three Arms Study Design",COVID
3356,COVID,"February 08, 2021",1080,NCT04528901,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","September 4, 2020",Observational,Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital),COVID
3357,COVID,"February 08, 2021",0,NCT04528927,HCQ,TUNISIA,Withdrawn,Abderrahmane Mami Hospital,"May 15, 2020",Interventional,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia Multicentric Randomized Comparative Study",COVID
3358,COVID,"February 08, 2021",60,NCT04529408,EARSATS PULSE OXIMETER PROBE,UNITED KINGDOM,Recruiting,Imperial College London,"August 26, 2020",Observational,EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up,COVID
3359,INFECTION,"February 08, 2021",70000,NCT04529421,ONLINE INSTRUCTION,NORWAY,Not yet recruiting,Oslo Metropolitan University,September 2020,Observational,Relationship Between In-person Instruction and COVID-19 Incidence Among University Students: A Prospective Cohort Study,Unrelated
3360,COVID,"February 08, 2021",485,NCT04529447,SURVEY,"KOREA, REPUBLIC OF",Completed,Jaseng Hospital of Korean Medicine,"June 10, 2020",Observational,Hospital Operational Response Strategy and Experience During the COVID-19 Pandemic in a Spine-specialty Korean Medicine Training Hospital,COVID
3361,COVID,"February 08, 2021",200,NCT04529460,COVID-19 ANTIBODY POINT OF CARE TEST KIT,,Not yet recruiting,Royal Free Hospital NHS Foundation Trust,"September 1, 2020",Observational,Post Market Clinical Study of a Point of Care COVID-19 IgG-IgM Rapid Test in Healthy Volunteers,COVID
3362,COVID,"February 08, 2021",780,NCT04529499,AVIGAN,KUWAIT,"Active, not recruiting",Dr. Reddy's Laboratories Limited,"August 20, 2020",Interventional,"A Multi-center, Randomized, Double Blind, Placebo Controlled Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients",COVID
3363,COVID,"February 08, 2021",500,NCT04529525,IVERMECTIN,ARGENTINA,Recruiting,Instituto de Cardiología de Corrientes,"August 19, 2020",Interventional,"Ivermectin to Prevent Hospitalizations in COVID-19: Randomized, Double-blind, Placebo-controlled",COVID
3364,CONFIRMED CORONAVIRUS DISEASE,"February 08, 2021",120,NCT04530136,RUCONEST,UNITED STATES,Recruiting,Pharming Technologies B.V.,"November 30, 2020",Interventional,"Recombinant Human C1 Esterase Inhibitor (Ruconest®) in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19: a Randomized, Parallel-group, Open-label, Multi-center Pilot Trial in the United States (PROTECT-COVID-19-US)",COVID
3365,ARDS,"February 08, 2021",68,NCT04530188,SEVOFLURANE,,Not yet recruiting,Bicetre Hospital,November 2020,Interventional,Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With Acute Respiratory Distress Syndrome,Unrelated
3366,COVID,"February 08, 2021",244,NCT04530357,QAZCOVID-IN® - COVID-19 INACTIVATED VACCINE,KAZAKHSTAN,Completed,Research Institute for Biological Safety Problems,"September 19, 2020",Interventional,"Randomized, Blind, Placebo-controlled Phase- i Study and Randomized, Open Phase Phase-ii Study of QAZCOVID-IN®- COVID-19 Inactivated Vaccine in Healthy Adult Volunteers From 18 Years Old and Elder",COVID
3367,COVID,"February 08, 2021",30,NCT04530370,RECOVERED COVID 19 PATIENTS PLASMA,EGYPT,Recruiting,South Valley University,"May 29, 2020",Interventional,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,COVID
3368,COVID PREVENTION,"February 08, 2021",33758,NCT04530396,GAM-COVID-VAC,RUSSIAN FEDERATION,"Active, not recruiting","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","September 7, 2020",Interventional,"Randomized Double-blind Placebo-controlled Multi-center Clinical Trial in Parallel Assignment of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine in SARS-СoV-2 Infection Prophylactic Treatment",COVID
3369,COVID,"February 08, 2021",450,NCT04530409,EARLY-DEXAMETHASONE,EGYPT,Recruiting,ClinAmygate,"August 26, 2020",Interventional,Timing of Corticosteroids in COVID-19,COVID
3370,COVID,"February 08, 2021",250,NCT04530422,SOFOSBUVIR PLUS LEDIPASVIR,EGYPT,Completed,Almaza Military Fever Hospital,"April 15, 2020",Interventional,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,COVID
3371,COVID,"February 08, 2021",400,NCT04530435,PEP FLUTE,DENMARK,Recruiting,Bispebjerg Hospital,"October 6, 2020",Interventional,PEP Flute-selfcare to Prevent Respiratory Deterioration and Hospitalization Among COVID-19 Patients: a Randomized Trial,COVID
3372,COVID,"February 08, 2021",40,NCT04530448,SODIUM BICARBONATE,UNITED STATES,Recruiting,West Virginia University,"October 5, 2020",Interventional,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,COVID
3373,SARS-COV INFECTION,"February 08, 2021",200,NCT04530461,SEROLOGICAL TEST,TUNISIA,Recruiting,faida agili,"June 1, 2020",Observational,Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases,Respiratory
3374,COVID,"February 08, 2021",200,NCT04530474,IVERMECTIN PILL,UNITED STATES,Not yet recruiting,Temple University,"October 1, 2020",Interventional,Outpatient Use of Ivermectin in COVID-19,COVID
3375,COVID,"February 08, 2021",200,NCT04530500,COVID-19 ANDROGEN SENSITIVITY TEST (COVAST),UNITED STATES,Enrolling by invitation,"University of California, Irvine","August 13, 2020",Observational,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,COVID
3376,COVID,"February 08, 2021",150,NCT04530539,VITAMIN C,UNITED STATES,Not yet recruiting,Lancaster General Hospital,"September 18, 2020",Interventional,The Effect of Melatonin and Vitamin C on COVID-19,COVID
3377,COVID,"February 08, 2021",200,NCT04530578,HEPARIN SODIUM,ARGENTINA,Recruiting,"Clinica San Camilo, Argentina","June 1, 2020",Interventional,Efficacy and Safety Study to Evaluate the Use of Nebulized Heparin in Patients With Severe Acute Respiratory Syndrome Covid-19 (SARS-CoV-2),COVID
3378,COVID,"February 08, 2021",12,NCT04530604,DEFIBROTIDE,UNITED STATES,Recruiting,Gregory Yanik,"October 1, 2020",Interventional,Defibrotide Therapy for SARS-CoV2 Acute Respiratory Distress Syndrome (ARDS),COVID
3379,COVID,"February 08, 2021",360,NCT04530617,CAMOSTAT MESILATE,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"October 5, 2020",Interventional,"Randomized, Double-blind, Placebo-controlled, Multicenter, Multi-arm, Phase II Trial of Novel Agents for the Treatment of Mild to Moderate COVID-19 Positive Outpatients",COVID
3380,COVID,"February 08, 2021",168,NCT04530656,"TWO DOSES OF MIDDLE-DOSE RECOMBINANT SARS-COV-2 VACCINE (SF9 CELL) AT THE SCHEDULE OF DAY 0, 28",CHINA,Not yet recruiting,Jiangsu Province Centers for Disease Control and Prevention,"August 28, 2020",Interventional,"Safety, Tolerability and Immunogenicity of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) in Chinese Healthy Population Aged 18 Years and Older: A Phase I, Single-center, Randomized, Placebo-controlled, Double-blind Study",COVID
3381,RHEUMATOID ARTHRITIS,"February 08, 2021",5000,NCT04530682,,FRANCE,Not yet recruiting,"University Hospital, Montpellier","February 1, 2021",Observational,Seroprevalence and Clinical Expression of SARS-CoV-2 Infection in Patients With Chronic Inflammatory Rheumatisms and Impact of Immuno-suppressive Drugs on the Persistence of Anti-SARS-CoV2 Antibodies During Two Years of Follow-up,Unrelated
3382,TYPE 1 DIABETES,"February 08, 2021",150,NCT04531111,,EGYPT,Recruiting,Ain Shams University,"July 7, 2020",Observational,Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt: A Pilot Study,Unrelated
3383,CORONAVIRUS INFECTION (COVID),"February 08, 2021",2000,NCT04531202,,BRAZIL,Recruiting,D'Or Institute for Research and Education,"March 2, 2020",Observational [Patient Registry],Clinical Characterization Protocol for Severe Emerging Infections: Coronavirus,COVID
3384,COVID,"February 08, 2021",240,NCT04531254,PERSONAL BEHAVIOURS,CANADA,"Active, not recruiting",The Hospital for Sick Children,"August 10, 2020",Observational,Understanding the Impact of Public Health Measures Planned for School Reopening During COVID-19 Using Simulation Exercises,COVID
3385,COVID,"February 08, 2021",50,NCT04531319,FLOW CYTOMETRIC ANALYSIS,TURKEY,Completed,Istanbul Training and Research Hospital,"August 15, 2020",Observational,Evaluation of Immune Cell Subgroups in Covid 19 Patients,COVID
3386,COVID,"February 08, 2021",60,NCT04531345,FLOW CYTOMETRIC ANALYSIS,TURKEY,Completed,Istanbul Training and Research Hospital,"October 1, 2020",Observational,The Cytokine Status of Covid-19 Patients,COVID
3387,COVID,"February 08, 2021",400,NCT04531501,SALIVA AND NPS TEST,UNITED KINGDOM,Recruiting,Chronomics Limited,"June 29, 2020",Observational,COVID-19 Saliva Test Research Study - Evaluation of High Throughput COVID-19 Testing Via Saliva Based Sampling and Alternative RNA Extraction Methods.,COVID
3388,CHILD DEVELOPMENT,"February 08, 2021",280,NCT04531618,FAMILY NURTURE INTERVENTION (FNI),UNITED STATES,Recruiting,Columbia University,"August 13, 2020",Interventional,Promoting Mother-Infant Emotional Connection During the COVID-19 Pandemic: an Randomized Controlled Trial (RCT) of Virtual Family Nurture Intervention,Unrelated
3389,RSV INFECTION,"February 08, 2021",28,NCT04531735,,TURKEY,"Active, not recruiting",Dr. Behcet Uz Children's Hospital,"March 1, 2020",Observational,Is Respiratory Syncytial Virus Infection More Dangerous Than Covid 19 in the Neonatal Period?,Unrelated
3390,COVID,"February 08, 2021",390,NCT04531748,TOREMIFENE,,Not yet recruiting,"Reena Mehra, MD",March 2021,Interventional,Selective Estrogen Modulation and Melatonin in Early COVID-19,COVID
3391,STRESS,"February 08, 2021",160,NCT04531774,RECHARGE,SWITZERLAND,Recruiting,Naser Morina,"August 28, 2020",Interventional,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,Unrelated
3392,PROTECTIVE DEVICE (PHYSICAL OBJECT),"February 08, 2021",150,NCT04532112,BIOCONTAINMENT DEVICE FOR AEROSOL GENERATING PROCEDURES (BIOBOX),UNITED STATES,Recruiting,University of Pennsylvania,"December 7, 2020",Interventional,Biocontainment Device With Aerosol Clearance for Aerosol Generating Procedures,Unrelated
3393,COVID,"February 08, 2021",30,NCT04532294,BGB DXP593,AUSTRALIA,Recruiting,BeiGene,"September 8, 2020",Interventional,"A First-in-Human, Randomized, Double-Blind, Placebo Controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of SARS-CoV-2 Neutralizing Antibody BGB-DXP593 in Healthy Subjects",COVID
3394,HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM,"February 08, 2021",30,NCT04532372,BEST PRACTICE,UNITED STATES,Recruiting,City of Hope Medical Center,"January 7, 2021",Interventional,A Phase 1/2 Trial of Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,Unrelated
3395,SARS-COV INFECTION,"February 08, 2021",25000,NCT04532411,PERSONAL PROTECTIVE TESTING BOOTH,UNITED STATES,"Active, not recruiting",Massachusetts General Hospital,"March 1, 2020",Observational,Evaluation of SARS-CoV-2 Sample Acquisition Efficiency and PPE Usage With and Without the Hexapod Personal Protective Booth,Respiratory
3396,COVID,"February 08, 2021",0,NCT04532554,GROWTH HORMONE,EGYPT,Withdrawn,ClinAmygate,"October 26, 2020",Interventional,The Impact of Growth Hormone in Obese Cases With Covid-19,COVID
3397,SMELL DISORDER,"February 08, 2021",40,NCT04532632,,TURKEY,Completed,Pinar Ay Sayin,"September 1, 2020",Observational [Patient Registry],Taste and Smell Impairment in Critically Ill COVID-19 Patients,Unrelated
3398,COPD,"February 08, 2021",1176,NCT04532853,,AUSTRALIA,Recruiting,General Practitioners Research Institute,"October 21, 2020",Observational,"Optimizing Maintenance Therapy in COPD Patients: Real-world Observational Study of Peak Inspiratory Flow Rate, Inhalation Technique, and Medication Adherence",Unrelated
3399,COVID,"February 08, 2021",250,NCT04532931,STANDARD OF CARE (PARACETAMOL),SOUTH AFRICA,Recruiting,Shin Poong Pharmaceutical Co. Ltd.,"September 3, 2020",Interventional,"Phase 2, Exploratory, Single Center, Randomized, Open Label, Adaptive Clinical Trial to Compare Safety and Efficacy of Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19",COVID
3400,COVID,"February 08, 2021",42,NCT04533048,MW33 INJECTION,CHINA,"Active, not recruiting","Mabwell (Shanghai) Bioscience Co., Ltd.","August 7, 2020",Interventional,"A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Immunogenicity of a Single Dose of MW33 Injection in Healthy Subjects",COVID
3401,COVID DISEASE,"February 08, 2021",275,NCT04533347,TAFENOQUINE ORAL TABLET,,Not yet recruiting,60 Degrees Pharmaceuticals LLC,October 2020,Interventional,A Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Oral Tafenoquine Versus Placebo in Patients With Mild to Moderate COVID-19 Disease,COVID
3402,COVID,"February 08, 2021",3000,NCT04533360,VITROS ANTI-SARS-COV-2 IGG TEST,UNITED STATES,Enrolling by invitation,Kingman Regional Medical Center,"September 28, 2020",Observational [Patient Registry],Seroprevalence of SARS CoV2 Antibodies Among Adults in Kingman AZ,COVID
3403,SARS-CoV2 INFECTION,"February 08, 2021",4400,NCT04533399,SARS-COV-2 RS/MATRIX-M1 ADJUVANT,SOUTH AFRICA,Recruiting,Novavax,"August 17, 2020",Interventional,"A Phase 2A/B, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity, and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in South African Adult Subjects Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV",COVID
3404,SARS-CoV2 INFECTION,"February 08, 2021",1000,NCT04534400,THORACIC CT-SCAN,FRANCE,Recruiting,"University Hospital, Strasbourg, France","September 1, 2020",Observational,Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic,COVID
3405,COVID PNEUMONIA,"February 08, 2021",120,NCT04534478,PREDNISONE,,Not yet recruiting,Hospital Universitari Vall d'Hebron Research Institute,"September 7, 2020",Interventional,"Randomized, Open, Parallel, Single-center, Non-inferiority Clinical Trial, With an Active Control Group, Comparing Two Oral Prednisone Regimens With the Aim of Optimizing the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19 Infection",COVID
3406,COVID,"February 08, 2021",40,NCT04534569,EXPERTS CONSENSUS,UNITED ARAB EMIRATES,Completed,NMC Specialty Hospital,"September 4, 2020",Observational,Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF) Using Modified Delphi Methodology,COVID
3407,COVID EXPERIENCE,"February 08, 2021",1500,NCT04534595,COVID-19,CANADA,Recruiting,Unity Health Toronto,"April 30, 2019",Observational,Data Collection on the Model Schools Pediatric Health Initiative at 5 School Based Health Clinic (SBHC) Sites: COVID-19 Questionnaire,COVID
3408,SARS-CoV2,"February 08, 2021",6000,NCT04534608,,GERMANY,"Active, not recruiting",Universitätsklinikum Hamburg-Eppendorf,"May 11, 2020",Observational,Prevalence of Infection and Seroconversion and the Clinical Course of the Novel Coronavirus SARS-CoV-2 Infection in Children Between 0 to 18 Years of Age in Hamburg and Surroundings,COVID
3409,COVID,"February 08, 2021",948,NCT04534621,ELECTRONIC SURVEY,,Not yet recruiting,Trate - Tratamentos Especializados,"August 26, 2020",Observational,How Brazilian Chiropractors Are Being Affected and What Strategies They Have Developed for Facing the COVID-19 Pandemic,COVID
3410,COVID,"February 08, 2021",40,NCT04534673,LAMBDA 180 MCG S.C,ISRAEL,Recruiting,Soroka University Medical Center,"August 5, 2020",Interventional,Pegylated Interferon Lambda for Treatment of COVID-19 Infection- A Randomized Open Label Pilot Trial,COVID
3411,COVID,"February 08, 2021",100,NCT04534712,LYMPHOCYTE MONOCYTE RATIO,INDIA,Not yet recruiting,Postgraduate Institute of Medical Education and Research,"September 1, 2020",Observational,Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19,COVID
3412,CANCER,"February 08, 2021",2282,NCT04534725,INTERFERON ALFA,AUSTRALIA,Recruiting,"Peter MacCallum Cancer Centre, Australia","December 17, 2020",Interventional,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.,Unrelated
3413,COVID PNEUMONIA,"February 08, 2021",30,NCT04534790,LOW DOSE RADIOTHERAPY,MEXICO,Recruiting,Instituto Mexicano del Seguro Social,"July 24, 2020",Interventional,"Randomized Trial, Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia",COVID
3414,COVID,"February 08, 2021",2100,NCT04534803,BCG VACCINE,,Not yet recruiting,Harvard Medical School,September 2020,Interventional,Bacillus Calmette-Guerin Against Covid-19 for Prevention and Amelioration of Severity Trial,COVID
3415,COVID PNEUMONIA,"February 08, 2021",200,NCT04535063,COVID19 CONVALESCENT PLASMA INFUSION,ARGENTINA,Recruiting,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,"April 18, 2020",Interventional,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,COVID
3416,COVID,"February 08, 2021",10000,NCT04535128,NO INTERVENTION,UNITED STATES,Recruiting,Brigham and Women's Hospital,"March 24, 2020",Observational [Patient Registry],"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications (CORONA-VTE NETWORK)",COVID
3417,COVID,"February 08, 2021",264,NCT04535154,NO INTERVENTIONS,NORWAY,"Active, not recruiting","University Hospital, Akershus","March 31, 2020",Observational,Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19,COVID
3418,VIRAL DISEASE,"February 08, 2021",72,NCT04535167,PF-07304814,UNITED STATES,Recruiting,Pfizer,"September 9, 2020",Interventional,"A PHASE 1B, 2-PART, DOUBLE-BLIND, PLACEBO-CONTROLLED, SPONSOR-OPEN STUDY, TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING (24-HOUR, PART 1) AND EXTENDED (120-HOUR, PART 2) INTRAVENOUS INFUSIONS OF PF-07304814 IN HOSPITALIZED PARTICIPANTS WITH COVID-19",Unrelated
3419,PARKINSON DISEASE,"February 08, 2021",198,NCT04535297,EXPOSURE,ISRAEL,Completed,University of Haifa,"May 10, 2020",Observational,Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke,Unrelated
3420,HEALTHY,"February 08, 2021",1210,NCT04535453,AD26.COV2.S,CANADA,Recruiting,Janssen Vaccines & Prevention B.V.,"August 28, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 2a Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults Aged 18 to 55 Years Inclusive and Adults Aged 65 Years and Older and to Evaluate 2 Dose Levels of Ad26.COV2.S in Healthy Adolescents Aged 12 to 17 Years Inclusive",Unrelated
3421,COVID INDUCED PNEUMONIA,"February 08, 2021",400,NCT04535674,ASUNERCEPT,RUSSIAN FEDERATION,Recruiting,Apogenix AG,"October 9, 2020",Interventional,"A Multicenter, Randomised, Controlled, Open Label Trial on the Efficacy and Safety of Asunercept for Patients With Severe COVID-19 Disease",COVID
3422,TYPE 2 DIABETES,"February 08, 2021",76,NCT04535700,PIOGLITAZONE 30 MG,SPAIN,Recruiting,Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal,"September 18, 2020",Interventional,"Non-blinded, Randomized and Controlled Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19",Unrelated
3423,TREATMENT OF ILLNESS-RELATED DISTRESS IN PHYSICAL LTCS,"February 08, 2021",200,NCT04535778,COMPASS,UNITED KINGDOM,Not yet recruiting,King's College London,"September 28, 2020",Interventional,Pilot RCT for COMPASS: an Online CBT Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic.,Unrelated
3424,COVID,"February 08, 2021",400,NCT04535791,CHOLECALCIFEROL,MEXICO,Recruiting,"Coordinación de Investigación en Salud, Mexico","July 15, 2020",Interventional,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring or Evolving Into the Severe Form of COVID-19 in Healthcare Workers Caring for Patients With the Disease. Blinded Randomized Clinical Trial,COVID
3425,COVID,"February 08, 2021",9,NCT04535856,ALLOGENEIC MESENCHYMAL STEM CELL,INDONESIA,Completed,Ina-Respond,"November 14, 2020",Interventional,"Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients: Randomized, Double-blind, and Placebo-controlled",COVID
3426,COVID,"February 08, 2021",50,NCT04535869,SOFOSBUVIR 400 MG PLUS DACLATASVIR 200MG,EGYPT,Recruiting,Mansoura University,"December 30, 2020",Interventional,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),COVID
3427,CORONAVIRUS,"February 08, 2021",10300,NCT04536051,CHADOX1 NCOV-19 SINGLE DOSE + PARACETAMOL,BRAZIL,Recruiting,University of Oxford,"June 2, 2020",Interventional,"A Randomized, Controlled, Phase III Study to Determine the Safety, Efficacy, and Immunogenicity of the Non-Replicating ChAdOx1 nCoV-19 Vaccine",COVID
3428,COVID,"February 08, 2021",150,NCT04536090,ISOQUERCETIN (IQC-950AN),,Not yet recruiting,Institut de Recherches Cliniques de Montreal,November 2020,Interventional,An Open-Label Randomized Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of 2019 Novel Coronavirus Disease (COVID-19),COVID
3429,HOSPITAL OUTPATIENT CLINICS,"February 08, 2021",1481,NCT04536259,VIDEO DEFAULT,UNITED KINGDOM,Completed,University of Warwick,"September 11, 2020",Interventional,Assessing People's Hospital Outpatient Appointment Preferences in the United Kingdom,Unrelated
3430,TYPE 1 DIABETES,"February 08, 2021",36,NCT04536285,,EGYPT,Completed,Ain Shams University,"May 1, 2020",Observational,Clinical Characteristics and Outcome of Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic: Data From a Single Center Surveillance Study in Egypt,Unrelated
3431,COVID,"February 08, 2021",2700,NCT04536298,VITAMIN D,UNITED STATES,Recruiting,Brigham and Women's Hospital,"December 28, 2020",Interventional,"A Cluster-Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vitamin D3 Supplementation to Reduce Disease Severity in Persons With Newly Diagnosed COVID-19 Infection and to Prevent Infection in Household Members",COVID
3432,COVID,"February 08, 2021",80,NCT04536350,AVIPTADIL 67ΜG,SWITZERLAND,Not yet recruiting,Prof. Dr. Jörg Leuppi,January 2021,Interventional,"Inhaled Aviptadil for the Prevention of COVID-19 Related ARDS: a Randomized, Placebo Controlled, Multicenter Trial",COVID
3433,COVID,"February 08, 2021",284,NCT04536363,"ANALOGS, PROSTAGLANDIN E1",,Not yet recruiting,Alonso Vera Torres,"October 1, 2020",Interventional,Effectiveness and Safety of the Administration of Intravenous Prostaglandin E1 Analog in the Reduction of Mortality and Complications of Patients With COVID-19,COVID
3434,RESILIENCE,"February 08, 2021",10,NCT04536376,RESILIENCE PROGRAM,UNITED STATES,Recruiting,Mayo Clinic,"January 15, 2021",Interventional,First Responder Resiliency Program for Health Care Professionals During a Pandemic,Unrelated
3435,MENTAL HEALTH WELLNESS,"February 08, 2021",161,NCT04536441,ULTRA BRIEF ONLINE MINDFULNESS-BASED INTERVENTION,MALAYSIA,Completed,Universiti Tunku Abdul Rahman,"April 1, 2020",Interventional,Effects of an Ultra-brief Online Mindfulness-based Intervention on Mental Health During the Coronavirus Disease (COVID-19) Outbreak in Malaysia: A Randomised Controlled Trial,Unrelated
3436,DEPRESSION,"February 08, 2021",2000,NCT04536935,MOBILE MENTAL HEALTH APP - 1,UNITED STATES,Enrolling by invitation,University of Washington,January 2021,Interventional,"Acceptability, Usability and Effectiveness of Mental Health Apps for Suicide Prevention in Essential Workers and the Unemployed During SARS-CoV-2",Unrelated
3437,COVID,"February 08, 2021",202,NCT04537117,QUESTIONAIRE,EGYPT,Completed,Fayoum University,"April 20, 2020",Observational,"Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19",COVID
3438,PULMONARY FIBROSIS,"February 08, 2021",40,NCT04537130,IN01 VACCINE,SPAIN,Not yet recruiting,Instituto Oncológico Dr Rosell,"December 1, 2020",Interventional,Phase Ib Controlled Exploratory Trial for Treatment of Fibrosing Interstitial Lung Disease Patients Secondary to SARS-CoV-2 Infection With IN01 Vaccine (COVINVAC),Unrelated
3439,COVID (HEALTHY VOLUNTEERS),"February 08, 2021",440,NCT04537208,SARS-COV-2 VACCINE FORMULATION 1 WITH ADJUVANT 1,UNITED STATES,"Active, not recruiting","Sanofi Pasteur, a Sanofi Company","September 3, 2020",Interventional,Immunogenicity and Safety of SARS-CoV-2 Recombinant Protein Vaccine Formulations (With or Without Adjuvant) in Healthy Adults 18 Years of Age and Older,COVID
3440,COVID,"February 08, 2021",150,NCT04537299,FISETIN,UNITED STATES,Not yet recruiting,Mayo Clinic,December 2020,Interventional,COVID-FIS: A Phase 2 Placebo-Controlled Pilot Study in COVID-19 of Fisetin to Alleviate Dysfunction and Excessive Inflammatory Response in Older Adults in Nursing Homes,COVID
3441,COVID,"February 08, 2021",2000,NCT04537338,1. CHARACTERIZE THE IMMUNE RESPONSE AFTER INFECTION WITH SARS-COV-2,,Not yet recruiting,Agencia Costarricense de Investigaciones Biomedicas,"September 14, 2020",Observational,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica,COVID
3442,COVID,"February 08, 2021",24,NCT04537351,CYP-001,AUSTRALIA,Recruiting,Cynata Therapeutics Limited,"August 24, 2020",Interventional,"A Pilot, Open-label, Randomised Controlled Clinical Trial to Investigate Early Efficacy of CYP-001 in Adults Admitted to Intensive Care With COVID-19",COVID
3443,COVID,"February 08, 2021",40000,NCT04537559,,SWITZERLAND,Enrolling by invitation,"University Hospital, Geneva","March 1, 2020",Observational,Impact of the COVID-19 Pandemic on the Morbidity and Mortality of Non-COVID-19 Patients Hospitalized Around the Epidemic Peak in the Geneva Area (Switzerland) (No COVID Impact),COVID
3444,COVID,"February 08, 2021",300,NCT04537572,COMPARISON OF SAMPLE COLLECTION METHODS,,Not yet recruiting,Salveo Diagnostics,September 2020,Interventional,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,COVID
3445,COVID,"February 08, 2021",2000,NCT04537585,TOMEKA®,"CONGO, THE DEMOCRATIC REPUBLIC OF THE",Not yet recruiting,"Guyguy K Tshima, MD",November 2020,Interventional,"A Multi-center, Investigator-blinded, Randomized Clinical Trial, 18-months, Parallel-group to Compare the Efficacy of Tomeka® Foods Versus Vernonia Amygdalina in the Prevention and Maintenance of Remission of COVID-19 in DRC",COVID
3446,COVID,"February 08, 2021",75,NCT04537650,VIDEOFLUOROSCOPIC SWALLOWING STUDY (VFSS),CANADA,Enrolling by invitation,"University Health Network, Toronto","January 1, 2021",Observational,The Pathophysiology of Swallowing Impairment in People Recovering From COVID-19,COVID
3447,RESPIRATORY TRACT INFECTIONS,"February 08, 2021",5200,NCT04537663,BACILLE CALMETTE-GUÉRIN (BCG),NETHERLANDS,Recruiting,UMC Utrecht,"August 25, 2020",Interventional,Bacillus Calmette-Guérin Vaccination To Prevent Serious Respiratory Tract Infection And Covid-19 In Vulnerable Elderly - An Adaptive Randomized Controlled Trial,Respiratory
3448,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",100,NCT04537806,BREXANOLONE,UNITED STATES,Recruiting,Sage Therapeutics,"December 18, 2020",Interventional,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,Respiratory
3449,COVID,"February 08, 2021",50,NCT04537858,VIRTUAL REALITY THERAPY FIRST,BRAZIL,"Active, not recruiting",University of Sao Paulo,"June 18, 2020",Interventional,Analysis of the Influence of Rehabilitation With Virtual Reality on the Heart Rate Variability of Individuals Under Treatment of COVID-19 in a Hospital Unit.,COVID
3450,COVID,"February 08, 2021",120,NCT04537949,BNT162B3,GERMANY,Recruiting,BioNTech SE,"September 9, 2020",Interventional,"A Multi-site, Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of a Prophylactic SARS-CoV-2 RNA Vaccine (BNT162b3) Against COVID-19 Using Different Dosing Regimens in Healthy Adults",COVID
3451,CORONAVIRUS INFECTION,"February 08, 2021",70,NCT04537962,COLGATE PERIOGARD MOUTHWASH,BRAZIL,Enrolling by invitation,Hospital Israelita Albert Einstein,"June 11, 2020",Interventional,"Avaliação do Covid-19 na Cavidade Oral, Orofaringe e Saliva após desinfecção Com soluções Antimicrobianas Orais: Estudo Piloto.",COVID
3452,CONTINUOUS RENAL REPLACEMENT THERAPY,"February 08, 2021",0,NCT04537975,C2RX,,Withdrawn,SeaStar Medical,"September 15, 2020",Interventional,A Randomized Clinical Trial of CLR2.0 Hemofiltration Treatment (C2Rx) in Severe or Critically Ill Adults With COVID-19 Infection,Unrelated
3453,LUNG CANCER,"February 08, 2021",800,NCT04538456,QUESTIONNAIRE AND OPTIONAL INTERVIEW,UNITED KINGDOM,Recruiting,The Christie NHS Foundation Trust,"October 15, 2020",Observational,"Understanding the Physical, Social and Psychological Impact of COVID-19 on Frail and Shielded Lung Cancer Patients",Unrelated
3454,CARDIOVASCULAR DISEASES,"February 08, 2021",1000,NCT04538469,COVID VISITATION RESTRICTIONS,,Not yet recruiting,University of Glasgow,September 2020,Observational,"Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff",Unrelated
3455,KAWASAKI DISEASE,"February 08, 2021",100,NCT04538495,,UNITED STATES,Recruiting,"University of California, San Diego","August 1, 2020",Observational,Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease,Unrelated
3456,COVID SCREENING,"February 08, 2021",1000,NCT04538586,,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","May 1, 2020",Observational,"Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures",COVID
3457,COVID,"February 08, 2021",152,NCT04539262,REMDESIVIR (RDV),UNITED STATES,Recruiting,Gilead Sciences,"September 14, 2020",Interventional,"A Phase 1b/2a Study in Participants With Early Stage COVID-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation",COVID
3458,COVID,"February 08, 2021",702,NCT04539275,CONVALESCENT PLASMA,UNITED STATES,Recruiting,VA Office of Research and Development,"November 16, 2020",Interventional,VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1),COVID
3459,COVID,"February 08, 2021",60,NCT04539626,ESTROGEN THERAPY,,Not yet recruiting,"CMN ""20 de Noviembre""","October 1, 2020",Interventional,Estrogen Therapy in Non-severe COVID-19 Patients: Proposed Treatment Scheme in a Tertiary Hospital,COVID
3460,HEALTHY,"February 08, 2021",250,NCT04539756,POSITIVE PSYCHOLOGICAL INTERVENTION,UNITED STATES,Recruiting,University of Pittsburgh,"September 8, 2020",Interventional,Does an Online Two-week Positive Psychological Intervention Improve Positive Affect in Young Adults?,Unrelated
3461,COVID,"February 08, 2021",15,NCT04539795,ALVELESTAT,UNITED STATES,Recruiting,University of Alabama at Birmingham,"November 1, 2020",Interventional,"A Phase Ib/II, Single Center, Placebo-Controlled, Randomized, Blinded Study in Adult Patients (> 18 Years) With COVID-19 Respiratory Disease, to Evaluate, Safety, Tolerability and Mechanistic Effect of Alvelestat on Top of Standard of Care (COSTA)",COVID
3462,CHRONIC PAIN,"February 08, 2021",60,NCT04539821,VCPM,UNITED STATES,Recruiting,VA Office of Research and Development,"October 1, 2020",Interventional,Virtual Pain Care for High Risk Veterans on Opioids During COVID19 (and Beyond),Unrelated
3463,ELECTROLYTE IMBALANCE,"February 08, 2021",52,NCT04539834,ELECTROLYTES,EGYPT,"Active, not recruiting",Zagazig University,"May 1, 2020",Observational,Electrolyte State in Patients With COVID-19,Unrelated
3464,CORONAVIRUS INFECTION,"February 08, 2021",128,NCT04539873,COLCHICINE 0.5 MG,COLOMBIA,Not yet recruiting,Fundación Universitaria de Ciencias de la Salud,"November 30, 2020",Interventional,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,COVID
3465,PRENATAL STRESS,"February 08, 2021",600,NCT04540029,MATERNAL STRESS,ITALY,Recruiting,"IRCCS National Neurological Institute ""C. Mondino"" Foundation","May 6, 2020",Observational,Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure,Unrelated
3466,COVID,"February 08, 2021",80,NCT04540120,DAPANSUTRILE CAPSULES,SWITZERLAND,Recruiting,Olatec Therapeutics LLC,"September 25, 2020",Interventional,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Orally Administered Dapansutrile Capsules for the Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome",COVID
3467,COVID,"February 08, 2021",3600,NCT04540185,BIOLOGICAL: ORAL POLIO VACCINE,NEW ZEALAND,Enrolling by invitation,"NeuroActiva, Inc.","November 1, 2020",Interventional,"A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Polio Vaccine and NA-831 for Prophylaxis and Treatment of Early Onset of Covid-19",COVID
3468,COVID,"February 08, 2021",100,NCT04540393,AZD1222,RUSSIAN FEDERATION,Suspended,AstraZeneca,"September 2, 2020",Interventional,"A Phase III Open-label Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19",COVID
3469,SUSPECTED OR CONFIRMED COVID,"February 08, 2021",100,NCT04540406,NBT-NM108,UNITED STATES,Not yet recruiting,Notitia Biotechnologies Company,"January 29, 2021",Interventional,Modulation of Gut Microbiota With NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes Mellitus,COVID
3470,COVID,"February 08, 2021",500,NCT04540419,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR),RUSSIAN FEDERATION,"Active, not recruiting",NPO Petrovax,"September 11, 2020",Interventional,"Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group Study Evaluating Efficacy, Reactogenicity and Safety of Recombinant Vaccine Ad5-nCoV Against Novel Coronavirus Infection in Adult Volunteers",COVID
3471,COVID,"February 08, 2021",900,NCT04540484,,UNITED STATES,Recruiting,Advocate Health Care,"August 26, 2020",Observational,The Prevalence of SARS-CoV-2 IgG Antibody Formation in Physicians at Advocate Lutheran General Hospital and Their Household Members,COVID
3472,SPINAL CORD INJURIES,"February 08, 2021",60,NCT04540679,VIP4SCI,,Not yet recruiting,Lawson Health Research Institute,"September 1, 2020",Interventional,An Integrated Self-Management Service Delivery Model for Persons With SCI Across the Care Continuum,Unrelated
3473,COVID PNEUMONIA,"February 08, 2021",200,NCT04540926,CYCLOSPORIN A,MEXICO,Not yet recruiting,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,September 2020,Interventional,"Utility of Low Doses of Corticosteroids and Cyclosporine Combined With Enoxaparin, in Patients With COVID-19 Pneumonia at the ISSSTE Regional Hospital, Puebla, During the Contingency Period Due to the SARS-Cov2 Pandemic",COVID
3474,TRAUMA,"February 08, 2021",60,NCT04540939,MINDFULNESS-BASED COGNITIVE THERAPY,UNITED STATES,Recruiting,University of Michigan,"October 19, 2020",Interventional,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,Unrelated
3475,DENTAL SURGEON,"February 08, 2021",1000,NCT04541472,,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","May 1, 2020",Observational,Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons,Unrelated
3476,COVID PATIENTS,"February 08, 2021",40,NCT04541485,DWRX2003,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,"October 6, 2020",Interventional,"Phase I Study to Evaluate the Safety, Tolerability, and Pharmacodynamics (PD) of DWRX2003 (Niclosamide IM Depot) Injection Following Intramuscular Administration in COVID-19 Patients",COVID
3477,SARS-CoV2 INDUCED PULMONARY FIBROSIS,"February 08, 2021",250,NCT04541680,NINTEDANIB 150 MG [OFEV],FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 29, 2020",Interventional,"""Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis""",COVID
3478,COVID,"February 08, 2021",100,NCT04541979,AEROSOLIZED DNASE,SWEDEN,Recruiting,Region Skane,"June 4, 2020",Interventional,"Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19 - a Phase 2, Single-blinded, Randomized Study",COVID
3479,COVID,"February 08, 2021",7911,NCT04542031,QUESTIONNAIRE,UNITED KINGDOM,Not yet recruiting,The Royal Wolverhampton Hospitals NHS Trust,October 2020,Interventional,COVID-19 Prevalence in a Single Large UK Rheumatology Centre and the Impact on Quality of Life From Stringent Social Distancing,COVID
3480,COVID,"February 08, 2021",40,NCT04542044,MANAGEMENT STRATEGY OF OUTPATIENT WITH MILD TO MODERATE SARS-COV-2 PNEUMONIA,SWITZERLAND,Completed,"University Hospital, Geneva","April 2, 2020",Observational,Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia (PneumoCoV-Ambu),COVID
3481,COVID,"February 08, 2021",4000,NCT04542083,,FRANCE,Not yet recruiting,"University Hospital, Montpellier","January 20, 2021",Observational,Impact of COVID-19 on Unplanned Admissions for Acute Cardiovascular and Neurovascular Conditions in France,COVID
3482,MORALS,"February 08, 2021",500,NCT04542122,CHOICES AND JUDGEMENTS,,Not yet recruiting,"University Hospital, Caen","September 3, 2020",Interventional,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic: a Randomized Experimental Study,Unrelated
3483,COVID,"February 08, 2021",70812,NCT04542200,ANTIBODY TESTING,UNITED STATES,Enrolling by invitation,Northwell Health,"January 1, 2021",Observational,Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment,COVID
3484,HYPERGLYCEMIA,"February 08, 2021",28,NCT04542213,LINAGLIPTIN TABLET,MEXICO,Recruiting,Hospital Regional de Alta Especialidad del Bajio,"August 1, 2020",Interventional,Effect of the Combination of Dipeptidyl Peptidase-4 Inhibitor (DPP4i) and Insulin in Comparison to Insulin on Metabolic Control and Prognosis in Hospitalized Patients With COVID-19,Unrelated
3485,"INFECTIONS, CORONAVIRUS","February 08, 2021",81,NCT04542226,POLYOXIDONIUM,BELARUS,Completed,NPO Petrovax,"March 31, 2020",Observational,Open Observational Study of Efficacy and Safety of Polyoxidonium in Complex Therapy of Hospitalized Patients With COVID-19,COVID
3486,COVID,"February 08, 2021",1900,NCT04542330,BCG-DENMARK,DENMARK,Recruiting,Bandim Health Project,"September 15, 2020",Interventional,Using BCG Vaccine to Enhance Non-specific Protection of Senior Citizens During the COVID-19 Pandemic. A Randomized Clinical Trial.,COVID
3487,CORONAVIRUS,"February 08, 2021",265,NCT04542343,"CHANGE IN KNOWLEDGE, MOTIVATION, SKILLS, RESOURCES",UNITED STATES,Recruiting,Charles Drew University of Medicine and Science,"November 1, 2020",Interventional,"Multilevel, Multidisciplinary, Faith-Based Participatory Interventions to Reduce COVID-19 Related-Risks Among Underserved African Americans",COVID
3488,CORONAVIRUS,"February 08, 2021",310,NCT04542395,INCREASING WILLINGNESS AND UPTAKE OF COVID-19 TESTING AND VACCINATION,,Not yet recruiting,Charles Drew University of Medicine and Science,"June 1, 2021",Interventional,Multilevel Participatory Intervention to Reduce Barriers and Promote Social and Behavioral Facilitators of COVID-19 Testing Among African Americans and Latinx Public Housing Residents,COVID
3489,COVID,"February 08, 2021",172,NCT04542408,ANTICOAGULATION AGENTS (EDOXABAN AND/OR HIGH DOSE LMWH),GERMANY,Recruiting,Universitätsklinikum Hamburg-Eppendorf,"November 12, 2020",Interventional,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,COVID
3490,COVID,"February 08, 2021",90,NCT04542421,LUNG ULTRASOUND USE IN PATIENTS HOSPITALIZED WITH COVID,UNITED STATES,Recruiting,"University of Colorado, Denver","July 1, 2020",Interventional,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,COVID
3491,COVID,"February 08, 2021",148,NCT04542434,NICLOSAMIDE ORAL TABLET,,Not yet recruiting,"First Wave Bio, Inc.","November 1, 2020",Interventional,"A Phase 2 Randomized Double Blind, Placebo-controlled Study on the Safety and Efficacy of Niclosamide in Patients With COVID-19",COVID
3492,COVID,"February 08, 2021",10,NCT04542447,NUVASTATIC,INDIA,Recruiting,Natureceuticals Sdn Bhd,"September 1, 2020",Interventional,An Open Label Proof of Concept Study to Assess Aspects of Safety and Efficacy of Nuvastatic™ (C5OSEW5050ESA) as an Immunomodulator Adjuvant Therapy to the Standard Care of Treatment in Covid 19 Patients.,COVID
3493,"CHOLECYSTITIS, ACUTE","February 08, 2021",800,NCT04542512,,FRANCE,Recruiting,Poissy-Saint Germain Hospital,"October 1, 2020",Observational [Patient Registry],Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic: the ChoCO-WSES Prospective Multicenter Observational Study.,Unrelated
3494,SEPSIS,"February 08, 2021",15000,NCT04542538,"NO INTERVENTION, OBSERVATIONAL STUDY",SWEDEN,"Active, not recruiting",Uppsala University,"April 11, 2018",Observational,The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome,Unrelated
3495,OPIOID-USE DISORDER,"February 08, 2021",130,NCT04542642,RESET-O,UNITED STATES,Recruiting,"Pear Therapeutics, Inc.",February 2021,Interventional,"A Randomized, Controlled, Open-Label, Decentralized Study, to Evaluate Patient Engagement With PEAR-008, a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder",Unrelated
3496,COVID,"February 08, 2021",200,NCT04542694,FAVIPIRAVIR,RUSSIAN FEDERATION,Completed,"Promomed, LLC","May 21, 2020",Interventional,"Open-label Randomized Multicenter Comparative Study on the Efficacy and Safety of Areplivir Film-coated Tablets (PROMOMED RUS LLC, Russia) in Patients Hospitalized With COVID-19",COVID
3497,SARS-CoV2,"February 08, 2021",40,NCT04542850,5-ALA-PHOSPHATE + SFC (5-ALA + SFC),BAHRAIN,Recruiting,Royal College of Surgeons in Ireland - Medical University of Bahrain,"November 15, 2020",Interventional,"An Open-Label, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-Aminolevulinic Acid Phosphate and Sodium Ferrous Citrate (5-ALA-Phosphate + SFC) in Subjects With SARS-CoV-2 Infection (COVID-19)",COVID
3498,SOLID TUMOR,"February 08, 2021",100,NCT04542863,18F-DX600 PET/CT,CHINA,Recruiting,Beijing Cancer Hospital,"September 11, 2020",Interventional,The Molecular Imaging Research of F-18 Labeled DX600 PET Probe,Unrelated
3499,COVID,"February 08, 2021",46,NCT04542876,GUDUCHI GHAN VATI,INDIA,Completed,Aarogyam UK,"May 1, 2020",Interventional,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection: An Open Label Feasibility Study,COVID
3500,SARS-COV INFECTION,"February 08, 2021",4776,NCT04542915,NO INTERVENTION,UNITED STATES,"Active, not recruiting",American Dental Association,"September 29, 2020",Observational,COVID-19-Related Health and Practices Among Dental Hygienists,Respiratory
3501,COVID,"February 08, 2021",136,NCT04542941,COVID CONVALESCENT PLASMA,UGANDA,Completed,Makerere University,"June 16, 2020",Interventional,Assessment of Safety and Efficacy of COVID-19 Convalescent Plasma for Treatment of COVID-19 in Adults in Uganda; A Randomised Controlled Trial,COVID
3502,COVID,"February 08, 2021",104,NCT04542954,OPTIMIZED MANAGEMENT OF COVID-19 POSITIVE KIDNEY TRANSPLANT RECIPIENTS: SINGLE CENTER EXPERIENCE FROM THE MIDDLE EAST,KUWAIT,Completed,Hamid Al-Essa Organ Transplant Center,"March 1, 2020",Observational [Patient Registry],Renal Dysfunction Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (Covid-19) Patients: Kuwait Experience,COVID
3503,SEVERE COVID DISEASE,"February 08, 2021",150,NCT04542967,BIOLOGICAL,MEXICO,Recruiting,Hospital Central Militar,"June 23, 2020",Interventional,Convalescent Plasma as a Treatment for Patients With Severe COVID-19 Disease,COVID
3504,SARS-CoV2 INFECTION,"February 08, 2021",200,NCT04542980,SARS-COV2 AUTOANTIBODY DETECTION,,Not yet recruiting,Namida Lab,"September 15, 2020",Observational,"Qualitative Evaluation of Tear Fluid and Blood for IgM and IgG Produced in Response to SARS-CoV2, the Virus Responsible for COVID-19.",COVID
3505,COVID,"February 08, 2021",60,NCT04542993,ZINC PICOLINATE,UNITED STATES,Recruiting,Swedish Medical Center,"September 8, 2020",Interventional,"Can SARS-CoV-2 Viral Shedding in COVID-19 Disease be Reduced by Resveratrol-assisted Zinc Ingestion, a Direct Inhibitor of SARS-CoV-2-RNA Polymerase? A Single Blinded Phase II Protocol (Reszinate Trial)",COVID
3506,COVID,"February 08, 2021",170,NCT04543006,SEROLOGY,,Not yet recruiting,"University Hospital, Grenoble","September 8, 2020",Interventional,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,COVID
3507,COVID,"February 08, 2021",18,NCT04543760,PRONE POSITION,FRANCE,Recruiting,"Hospital St. Joseph, Marseille, France","October 1, 2020",Interventional,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to Sars-covid-2: a Randomized Crossover Trial.,COVID
3508,COVID,"February 08, 2021",120,NCT04544033,INTERLEUKEN 6 LEVEL MEASURMENT,EGYPT,Recruiting,Tanta University,"September 15, 2020",Observational,IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients,COVID
3509,SARS-COV INFECTION,"February 08, 2021",400,NCT04544072,,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"May 1, 2020",Observational,A Prospective Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards of a Tertiary University Hospital During the COVID-19 Pandemic,Respiratory
3510,COVID,"February 08, 2021",220,NCT04544150,,EGYPT,Completed,Assiut University,"June 1, 2020",Observational,Gastrointestinal Manifestations in COVID-19: Symptoms and Signs and Its Impact on the Outcome,COVID
3511,COVID,"February 08, 2021",34000,NCT04544176,OBSERVATIONAL,UNITED KINGDOM,"Active, not recruiting",Nottingham University Hospitals NHS Trust,"January 1, 2020",Observational,Determining the Risk of Developing Symptomatic COVID-19 After Attending Hospital Outpatient Clinics,COVID
3512,POST COVID,"February 08, 2021",150,NCT04544605,INDIVIDUALIZED-CHINESE HERBAL MEDICINE,CHINA,Recruiting,Hong Kong Baptist University,"September 7, 2020",Observational,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients: An Observational Study,COVID
3513,COVID,"February 08, 2021",100,NCT04544878,,FRANCE,Recruiting,Bicetre Hospital,"March 26, 2020",Observational [Patient Registry],Clinical and Biological Characteristics of Critically Ill Patients With COVID-19 Admitted to Pediatric Intensive Care Unit,COVID
3514,COVID,"February 08, 2021",1000,NCT04544891,BLOOD SAMPLING,FRANCE,Not yet recruiting,"Central Hospital, Nancy, France","October 1, 2020",Observational [Patient Registry],Prognostic Significance of the TREM-1 Pathway Activation in COVID-19,COVID
3515,COVID,"February 08, 2021",42,NCT04545008,FAMOTIDINE,,Not yet recruiting,Prisma Health-Upstate,September 2020,Interventional,A Phase I Clinical Trial of the Combination of Famotidine (FAM) and Oral N-Acetyl Cysteine (NAC) Open Label for Outpatient Treatment of Subjects With Newly Diagnosed SARS-CoV-2 Infection,COVID
3516,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",10000,NCT04545047,COVID-19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",VA Office of Research and Development,"May 1, 2020",Observational,CSP #2030 - Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19,COVID
3517,COVID,"February 08, 2021",1360,NCT04545060,VIR-7831,AUSTRIA,Recruiting,"Vir Biotechnology, Inc.","August 27, 2020",Interventional,"A Randomized, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Monoclonal Antibody VIR-7831 for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Non-hospitalized Patients",COVID
3518,ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",980,NCT04545242,DEXAMETHASONE,SPAIN,Not yet recruiting,Dr. Negrin University Hospital,"February 8, 2021",Interventional,Efficacy of Higher vs. Lower Doses of Dexamethasone in Patients With Acute Hypoxemic Respiratory Failure (Including ARDS) Caused by Infections (Including COVID-19),Respiratory
3519,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",340,NCT04545424,HYPOTHERMIA,UNITED STATES,Not yet recruiting,"University of Maryland, Baltimore","January 31, 2021",Interventional,Cooling to Help Injured Lungs (CHILL) Phase IIB Randomized Control Trial of Therapeutic Hypothermia in Patients With ARDS,Respiratory
3520,COVID,"February 08, 2021",300,NCT04545541,NEBULISED UNFRACTIONATED HEPARIN (UFH),UNITED STATES,Recruiting,Australian National University,"November 1, 2020",Interventional,Can Nebulised HepArin Reduce morTality and Time to Extubation in Patients With COVID-19 Requiring Mechanical Ventilation Meta-Trial (CHARTER-MT): Protocol for an Investigator-initiated International Meta-trial of Randomised Studies,COVID
3521,DEPRESSION,"February 08, 2021",450,NCT04545593,POSITIVE MINDS STRONG BODIES ENHANCED,UNITED STATES,Recruiting,Massachusetts General Hospital,"January 15, 2021",Interventional,Building Community Capacity for Disability Prevention for Minority Elders - Renewal,Unrelated
3522,COVID,"February 08, 2021",60,NCT04545749,UB-612,TAIWAN,Recruiting,"United Biomedical Inc., Asia","September 25, 2020",Interventional,"A Phase I, Open-label Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 Vaccine in Healthy Adult Volunteers",COVID
3523,COVID,"February 08, 2021",1580,NCT04546191,,ICELAND,Completed,Landspitali University Hospital,"July 1, 2020",Observational [Patient Registry],Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland,COVID
3524,COVID,"February 08, 2021",500,NCT04546581,HYPERIMMUNE IMMUNOGLOBULIN TO SARS-COV-2 (HIVIG),DENMARK,Recruiting,University of Minnesota,"October 8, 2020",Interventional,"An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19",COVID
3525,COVID,"February 08, 2021",20,NCT04546737,MAGNETIC RESONANCE SPECTROSCOPY (MRS).,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","September 8, 2020",Interventional,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",COVID
3526,SARS-COV INFECTION,"February 08, 2021",200,NCT04546776,,UNITED KINGDOM,Enrolling by invitation,Quadram Institute Bioscience,"September 8, 2020",Observational,Prevalence and Persistence of SARS-CoV-2 in Stool of COVID-19 Positive Subjects,Respiratory
3527,COVID VACCINE,"February 08, 2021",36,NCT04546841,MULTIPEPTIDE COCKTAIL,GERMANY,Recruiting,University Hospital Tuebingen,"November 27, 2020",Interventional,P-pVAC-SARS-CoV-2: Phase I Single-center Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,COVID
3528,INFLUENZA VACCINE,"February 08, 2021",200,NCT04546854,APPEALS,UNITED KINGDOM,Completed,University of Warwick,"September 21, 2020",Interventional,Influenza 2020/2021. A Survey to Assess How People's Political Attitudes and Messages Influence Their Behavioral Intentions in the United Kingdom.,Respiratory
3529,SARS-CoV2 INFECTION,"February 08, 2021",200,NCT04547114,MULTICAPILLARY COLUMN COUPLED ION MOBILITY SPECTROMETRY,GERMANY,Recruiting,Klinikum Bayreuth GmbH,"September 14, 2020",Observational,Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects,COVID
3530,COVID,"February 08, 2021",200,NCT04547127,CONVALESCENT ANTI-SARS-COV-2 MBT PLASMA,SPAIN,Recruiting,"Instituto Grifols, S.A.","April 29, 2020",Interventional,"A Multicenter, Randomized, Open-label, Parallel Group Pilot Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) With Standard Medical Treatment (SMT) Versus SMT Alone in Subjects With COVID-19 Requiring Admission to the Intensive Care Unit (ICU)",COVID
3531,COVID,"February 08, 2021",100,NCT04547140,LIQUID ALPHA1-PROTEINASE INHIBITOR (HUMAN),BRAZIL,Recruiting,Grifols Therapeutics LLC,January 2021,Interventional,"A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) Plus Standard Medical Treatment (SMT) Versus Placebo Plus SMT in Hospitalized Subjects With COVID-19",COVID
3532,AGE PROBLEM,"February 08, 2021",150,NCT04547218,,MALAYSIA,Completed,University of Malaya,"June 22, 2020",Observational,Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population,Unrelated
3533,COVID,"February 08, 2021",42,NCT04547257,SERAPH 100,NETHERLANDS,Not yet recruiting,ExThera Medical Europe BV,"February 1, 2021",Interventional,Safety and Performance Evaluation of Seraph 100 Filter in the Treatment of Patients With COVID-19,COVID
3534,COVID,"February 08, 2021",40,NCT04547283,USUAL CARE,UNITED STATES,Recruiting,Atrium Health,"June 14, 2020",Interventional,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19: A Pilot Randomized Controlled Trial,COVID
3535,CANCER METASTATIC,"February 08, 2021",30,NCT04547634,THERAPEUTIC EXERCISE AND EDUCATION,SPAIN,Enrolling by invitation,University of Malaga,"July 1, 2020",Interventional,Effect of a Telerehabilitation-exercise Intervention in Oncology Patients in the Covid-19 Pandemic,Unrelated
3536,COVID,"February 08, 2021",160,NCT04547660,CONVALESCENT PLASMA,BRAZIL,Recruiting,Hospital de Clinicas de Porto Alegre,"July 16, 2020",Interventional,"Convalescent Plasma for Severe COVID-19 Patients: a Randomized, Open-label, Phase 3 Trial",COVID
3537,THE USE OF MODERN TECHNOLOGY APPLICATIONS IN HOME ISOLATION,"February 08, 2021",175,NCT04548492,SURVEY,,Not yet recruiting,Ain Shams University,"September 14, 2020",Observational,The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Randomized Survey for Health Care Professionals,Unrelated
3538,SARS-COV INFECTION,"February 08, 2021",100,NCT04548505,,FRANCE,Not yet recruiting,Direction Centrale du Service de Santé des Armées,October 2020,Observational,Recovery of Exertion Ability Following COVID-19 Infection in Military Staff,Respiratory
3539,COLON CANCER,"February 08, 2021",800,NCT04548531,SHARED DECISION MAKING,UNITED STATES,Enrolling by invitation,Massachusetts General Hospital,"September 10, 2020",Interventional,Engaging Patients in Colon Cancer Screening Decisions During COVID-19,Unrelated
3540,HEALTHY,"February 08, 2021",21,NCT04548544,"TRAINING FOR AWARENESS, RESILIENCE, AND ACTION (TARA)",UNITED STATES,Completed,"University of California, San Francisco","October 18, 2019",Interventional,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During the COVID-19 Pandemic,Unrelated
3541,COVID,"February 08, 2021",60,NCT04548557,INTRAVENOUS IMMUNOGLOBULIN THERAPY,PAKISTAN,Not yet recruiting,University of Health Sciences Lahore,"September 15, 2020",Interventional,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,COVID
3542,COVID,"February 08, 2021",30,NCT04548895,OBSERVATIONAL MEASUREMENT OF BIOMETRIC DATA. NO CHANGE TO HEALTH CARE PROVIDED.,UNITED STATES,Recruiting,"Health Stream Analytics, LLC","December 30, 2020",Observational,Non-invasive Biometric Monitoring for the Prevention of COVID-19 Transmission and Deaths in Nursing Homes,COVID
3543,COVID,"February 08, 2021",1300,NCT04548908,"SERELOGY TESTING, RT PCR",FRANCE,Recruiting,Centre Hospitalier Sud Essonne,"August 3, 2020",Observational,Prevalence Of COVID-19 Among Health-workers in a French General Hospital,COVID
3544,CARDIOPULMONARY RESUSCITATION,"February 08, 2021",34,NCT04548934,PERSONAL PROTECTIVE EQUIPMENT (PPE),ITALY,Completed,Institute of Mountain Emergency Medicine,"September 13, 2020",Interventional,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,Unrelated
3545,COVID,"February 08, 2021",10,NCT04549337,EXERCISE TRAINING,DENMARK,Recruiting,"Rigshospitalet, Denmark","September 25, 2020",Interventional,Investigator-blinded Randomized Controlled Trial Examining the Safety and Feasibility of Different Exercise Training Programs in Patients Who Have Survived COVID-19,COVID
3546,SLEEP QUALITY,"February 08, 2021",217,NCT04549350,PSQI,EGYPT,Completed,Zagazig University,"May 19, 2020",Observational,Sleep Quality Among Health Care Workers During COVID-19 Pandemic: Kuwait Experience,Unrelated
3547,COVID,"February 08, 2021",200,NCT04549376,POVIDONE-IODINE 0.4% NI,BANGLADESH,Recruiting,"Pi Research Consultancy Center, Bangladesh","July 1, 2020",Interventional,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo: an Open Label Randomized Clinical Trial,COVID
3548,COVID,"February 08, 2021",92,NCT04549636,V/Q SPECT-CT,CANADA,Recruiting,McMaster University,"September 18, 2020",Observational,Prospective Longitudinal Study to Characterize and Understand the Clinical Relevance of SARS-CoV2 Related Ventilation and Perfusion Injury Evaluated by V/Q SPECT-CT in an Asthmatic and Healthy Population,COVID
3549,COVID,"February 08, 2021",2000,NCT04549831,MASSIVE PARALLEL SEQUENCING OF HOST GENOME,ITALY,Recruiting,University of Siena,"April 8, 2020",Observational,Identification of the Genetic Bases Determining COVID-19 Clinical Variability in the Italian Population,COVID
3550,COVID,"February 08, 2021",111,NCT04549922,ISIS 721744,BRAZIL,"Active, not recruiting",Hospital do Coracao,"October 22, 2020",Interventional,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19: A Phase II Randomized Controlled Trial,COVID
3551,LIFESTYLE ALTERATION,"February 08, 2021",80000,NCT04550312,,CHINA,Recruiting,The First Affiliated Hospital with Nanjing Medical University,September 2020,Observational,The Impact of Lifestyle Alteration by Strict Prevention Measures on Non-COVID Deaths in the Region With Low COVID-19 Transmission Rate,Unrelated
3552,COVID,"February 08, 2021",12,NCT04550325,KAMADA ANTI-SARS-COV-2,ISRAEL,Completed,"Kamada, Ltd.","August 5, 2020",Interventional,"A Phase 1/2 Open Label, Multicenter, Single Arm Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose Kamada Anti-SARS-CoV-2 in COVID-19 Hospitalized Patients With Pneumonia",COVID
3553,COVID,"February 08, 2021",100,NCT04550338,TRANEXAMIC ACID,,Not yet recruiting,University of Alabama at Birmingham,"December 1, 2020",Interventional,Antiviral Effects of Tranexamic Acid (TXA) as a Preventative Treatment Following COVID-19 Exposure,COVID
3554,CORONAVIRUS,"February 08, 2021",50,NCT04550351,BIOLOGICAL/VACCINE: RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) LOW-DOSE GROUP,CHINA,"Active, not recruiting","Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","August 19, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Tolerability of Recombinant New Coronavirus Vaccines (CHO Cells) in Healthy People Aged 60 Years and Above",COVID
3555,SARS-COV INFECTION,"February 08, 2021",2400,NCT04550390,SALIVA COLLECTION,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"September 15, 2020",Observational,Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19.,Respiratory
3556,DIABETES MELLITUS,"February 08, 2021",700,NCT04550403,,ITALY,Recruiting,Azienda Ospedaliero-Universitaria di Parma,"July 30, 2020",Observational,Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes,Unrelated
3557,MOOD,"February 08, 2021",20,NCT04551274,MUSIC THERAPY,CANADA,Not yet recruiting,Simon Fraser University,"October 1, 2020",Interventional,Investigating the Use of Virtual Music Therapy in Frontline Healthcare Workers During COVID-19,Unrelated
3558,HEALTHY,"February 08, 2021",4500,NCT04551339,PRESERVISION AREDS FORMULATION SOFT GELS OR TABLETS,UNITED STATES,Enrolling by invitation,Mayo Clinic,"September 28, 2020",Interventional,Zinc Versus Multivitamin Micronutrient Supplementation to Support Immune Health in the Setting of COVID-19 Pandemic: A Randomized Study,Unrelated
3559,COVID INFECTION,"February 08, 2021",600,NCT04551378,QUALITY-OF-LIFE ASSESSMENT,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"July 13, 2020",Observational,Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Adolescent and Young Adult (AYA) Cancer Patients and Survivors,COVID
3560,COVID,"February 08, 2021",552,NCT04551547,"TWO DOSES OF LOW DOSAGE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,28",CHINA,Recruiting,"Sinovac Research and Development Co., Ltd.","October 31, 2020",Interventional,"A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) in Healthy Population Aged 3-17 Years",COVID
3561,PREGNANCY,"February 08, 2021",720,NCT04551690,,CHILE,Completed,"Hospital San Juan de Dios, Santiago","April 15, 2020",Observational,"Analysis of Prevalence, Pregnancy Outcomes and Sociodemographic Conditions in Women at Labour With and Without Coronavirus 19 Disease COVID-19 in a Public Hospital in Chile",Unrelated
3562,COVID,"February 08, 2021",188,NCT04551755,IVERMECTIN AND DOXYCYCLINE,,Not yet recruiting,Bangladesh Medical Research Council (BMRC),September 2020,Interventional,The Safety and Efficacy Outcome of Ivermectin Plus Doxycycline in Treatment of RT-PCR Positive Adult Mild Covid-19 Cases: a Randomized Double Blind Placebo Controlled Trial,COVID
3563,COVID,"February 08, 2021",50,NCT04551768,50 MG/ML VIRAZOLE,,Not yet recruiting,"Bausch Health Americas, Inc.",February 2021,Interventional,"An Open-Label Study to Evaluate the Safety and Efficacy of VIRAZOLE® (RIBAVIRIN FOR INHALATION SOLUTION, USP) in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19",COVID
3564,COVID,"February 08, 2021",450,NCT04551781,20 MG PREDNISONE FOR 14 DAYS,EGYPT,Completed,South Valley University,"April 1, 2020",Interventional,Short Term Low Dose Corticosteroids for Management of Post Covid-19 Pulmonary Fibrosis,COVID
3565,COVID,"February 08, 2021",180,NCT04551898,BGB-DXP593,,Not yet recruiting,BeiGene,"October 30, 2020",Interventional,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody BGB-DXP593 in Patients WithMild-to-Moderate COVID-19",COVID
3566,COVID,"February 08, 2021",160,NCT04551911,RAYALDEE 30MCG EXTENDED-RELEASE (ER) CAPSULE,UNITED STATES,Recruiting,"OPKO Health, Inc.","October 26, 2020",Interventional,"A Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of Rayaldee (Calcifediol) Extended-release Capsules to Treat Symptomatic Patients Infected With SARS-CoV-2 (REsCue)",COVID
3567,COVID,"February 08, 2021",1500,NCT04552340,PATIENT WITH SAR-COV-2 INFECTION,ITALY,Recruiting,Istituto Clinico Humanitas,"March 16, 2020",Observational,"Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV: A Retrospective-Prospective Cohort Study.",COVID
3568,COVID,"February 08, 2021",149,NCT04552366,AD5-NCOV,CHINA,"Active, not recruiting","Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China","September 29, 2020",Interventional,A Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults Aged 18 Years and Older,COVID
3569,SARS-COV INFECTION,"February 08, 2021",1240,NCT04552379,PEGINTERFERON BETA-1A,CHILE,Recruiting,Pontificia Universidad Catolica de Chile,"December 1, 2020",Interventional,A Cluster Randomised Trial of Interferon Versus Standard of Care in the Reduction of Transmission of SARS-Cov-2. The Containing Coronavirus Disease 19 Trial (ConCorD-19),Respiratory
3570,QUARANTINE,"February 08, 2021",100,NCT04552392,NO INTERVENTION,INDIA,Not yet recruiting,Dr. Ram Manohar Lohia Hospital,"September 20, 2020",Observational,Psychological Impact of Institutional Quarantine - A Cross-Sectional Observational Study,Unrelated
3571,COVID,"February 08, 2021",392,NCT04552483,NITAZOXANIDE,BRAZIL,Completed,Universidade Federal do Rio de Janeiro,"June 8, 2020",Interventional,Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19,COVID
3572,COVID,"February 08, 2021",80,NCT04552951,CHOLECALCIFEROL,SPAIN,Recruiting,Fundación para la Investigación Biosanitaria del Principado de Asturias,"April 4, 2020",Interventional,Estudio Destinado a Valorar la Utilidad de Vitamina D Sobre Morbilidad y Mortalidad de la infección Por Virus SARS-COV-2 (COVID-19) en el Hospital Universitario Central de Asturias,COVID
3573,COVID,"February 08, 2021",413,NCT04553055,ONLINE QUESTIONNAIRES,EGYPT,Completed,Beni-Suef University,"July 20, 2020",Observational [Patient Registry],Assessment of Community Pharmacies Related Antibiotic Misuse and Application of Infection Control Measures During COVID-19 Pandemic,COVID
3574,CORONAVIRUS INFECTION,"February 08, 2021",499,NCT04553575,SEROLOGY,FRANCE,Recruiting,CHU de Reims,"September 25, 2020",Observational [Patient Registry],Follow-up CoViD-19 Patients Hospitalized in Reims University Hospital Between the 01/03/2020 and 30/04/2020,COVID
3575,COVID,"February 08, 2021",200,NCT04553705,OMEGA 3/NIGELLA SATIVA OIL,SAUDI ARABIA,Recruiting,Beni-Suef University,"September 20, 2020",Interventional,Impact of Different Treatment Modalities on Immunity Against COVID-19,COVID
3576,COVID,"February 08, 2021",100,NCT04554251,SURVEY,EGYPT,Enrolling by invitation,Assiut University,"September 1, 2020",Observational,"Global Impact of COVID-19 on Pulmonology Special Units (Bronchoscopy, Thoracoscopy, Ultrasonography and Sleep Lab)",COVID
3577,COMPLICATED GRIEF,"February 08, 2021",160,NCT04554264,QUESTIONNAIRE,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","September 1, 2020",Interventional,Complicated Grief in ICU in the Aftermath of COVID-19,Unrelated
3578,COVID,"February 08, 2021",80,NCT04554433,ETHANOL WITH ASPRIN,,Not yet recruiting,Mansoura University,"December 1, 2020",Interventional,Disinfection of SARS-COV-2 ( COVID-19 ) in Human Respiratory Tract by Controlled Ethanol Vapor Inhalation Combined With Oral Asprin .,COVID
3579,COVID,"February 08, 2021",199,NCT04554979,HYDROXYCHLOROQUINE PILL,EGYPT,Completed,Cairo University,"June 1, 2020",Observational,Corona Virus (COVID-19) Disease Duration and Gastrointestinal Tract (GIT) Manifestations; Can be New Disease Severity Classification. A Pilot Egyptian Single National Center Experience,COVID
3580,COVID,"February 08, 2021",350,NCT04554992,COVID 19 CONVALESCENT PLASMA,UNITED STATES,"Active, not recruiting",The Methodist Hospital System,"March 20, 2020",Interventional,Convalescent Plasma for the Treatment of Coronavirus Disease 2019,COVID
3581,MINDFULNESS,"February 08, 2021",1000,NCT04555005,MINDFULNESS BASED INTERVENTION,SPAIN,Completed,Instituto de Investigación Hospital Universitario La Paz,"March 10, 2020",Interventional,"Implementation of a Mindfulness-based Crisis Intervention for Frontline Healthcare Workers During the COVID-19 Outbreak in a Public General Hospital in Madrid, Spain",Unrelated
3582,COVID,"February 08, 2021",50,NCT04555096,GC4419,UNITED STATES,Recruiting,"Galera Therapeutics, Inc.","September 9, 2020",Interventional,"A Pilot, Randomized, Placebo-Controlled Trial of GC4419 (Avasopasem Manganese) in Patients With Critical Illness Due to SARS-CoV-2 Infection (COVID-19)",COVID
3583,COVID,"February 08, 2021",1000,NCT04555109,,CANADA,Recruiting,The Hospital for Sick Children,"June 30, 2020",Observational,Convalescent Plasma for COVID-19 Research (CONCOR) Donor Study,COVID
3584,SOCIAL DISTANCE,"February 08, 2021",52500,NCT04555122,SOCIAL DISTANCING ADVERTISEMENTS,UNITED STATES,Not yet recruiting,"University of California, Irvine","September 29, 2020",Interventional,COVID-19 Ad Intervention for Social Distancing,Unrelated
3585,COVID,"February 08, 2021",60,NCT04555148,GC5131,"KOREA, REPUBLIC OF",Recruiting,Green Cross Corporation,"September 20, 2020",Interventional,"A Prospective, Open-label, Randomized, Multi-center, Phase 2a Study to Evaluation the Dose Response, Efficacy and Safety of Hyper-Ig (Hyper-immunoglobulin) GC5131 in Patients With COVID-19",COVID
3586,COVID,"February 08, 2021",60000,NCT04555187,,UNITED STATES,"Active, not recruiting",Oregon Health and Science University,"June 8, 2020",Observational,Cardiovascular Risk Stratification in Covid-19,COVID
3587,COVID,"February 08, 2021",40,NCT04555213,NOX66,"MOLDOVA, REPUBLIC OF",Recruiting,Noxopharm Limited,"September 30, 2020",Interventional,A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 Infection (NOXCOVID),COVID
3588,"HEALTH, SUBJECTIVE","February 08, 2021",205,NCT04555954,SURVEYS AND QUESTIONNAIRES,TURKEY,Completed,Pamukkale University,"April 11, 2020",Observational,"Determining the Physical Activity Level of Healthy Adults During Novel Coronavirus (COVID-19) (SARS-CoV-2 Infection) Pandemic: a Descriptive, Cross-sectional Study",Unrelated
3589,CORONAVIRUS INFECTION,"February 08, 2021",34,NCT04556149,IMPULSE™ UNA E-STETHOSCOPE,UNITED STATES,Completed,"Level 42 AI, Inc.","October 1, 2020",Observational,SARS-CoV-2/COVID-19 Study of the Audible and Inaudible Vibroacoustic E-stethoscope - imPulse™ Una,COVID
3590,COVID,"February 08, 2021",392,NCT04556318,ION MOBILITY SPECTROMETRY (IMS),GERMANY,Recruiting,B. Braun Melsungen AG,"September 23, 2020",Observational,Study to Identify Differences of Exhaled Breath Components Using Ion Mobility Spectrometry (IMS) in Patients Tested Positive or Negative on SARS-CoV-2,COVID
3591,COVID,"February 08, 2021",500,NCT04556513,PARACLINICAL EXAMINATION,FRANCE,Recruiting,Centre Hospitalier Universitaire Dijon,"September 18, 2020",Observational,Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status,COVID
3592,COVID,"February 08, 2021",16000,NCT04556565,,SPAIN,Recruiting,Jordi Alonso,"May 8, 2020",Observational,MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain,COVID
3593,CONSENT,"February 08, 2021",45,NCT04556604,EDUCATIONAL MEETINGS AND VISUAL PROMPTS,UNITED KINGDOM,Completed,Medway Primary Care Trust,"April 10, 2020",Observational,Consent for Surgery During the COVID-19 Pandemic,Unrelated
3594,ASSISTED REPRODUCTION,"February 08, 2021",360,NCT04556630,,,Not yet recruiting,"University Hospital, Lille",October 2020,Observational,Evaluation of the Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood of the Couples Followed in Assisted Reproduction,Unrelated
3595,COVID,"February 08, 2021",67,NCT04556864,,SPAIN,Not yet recruiting,Juan Victor Lorente,"October 1, 2020",Observational,Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to SARS-CoV-2 Infection,COVID
3596,COVID,"February 08, 2021",400,NCT04557046,NASAL SWAB,UNITED STATES,Recruiting,LumiraDx UK Limited,"June 26, 2020",Interventional,A Multicenter COVID-19 Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 Ag Test at Point of Care Testing Sites,COVID
3597,COVID BEHAVIORAL PROPHYLAXIS,"February 08, 2021",1000,NCT04557241,BRIEF INFORMATIONAL INFOGRAPHIC,,Not yet recruiting,Indiana University,October 2020,Interventional,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,COVID
3598,RHEUMATOID ARTHRITIS,"February 08, 2021",346,NCT04557358,COVID-19 SURVEY,MEXICO,Recruiting,"National Institute of Medical Sciences and Nutrition, Salvador Zubiran","July 1, 2020",Observational,Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic,Unrelated
3599,HYPOXEMIA,"February 08, 2021",14,NCT04557605,PROGRESSIVE CYCLING EXERCISE TEST TO EXHAUSTION,CANADA,Completed,University of Saskatchewan,"September 14, 2020",Interventional,The Effects of Wearing a Face Mask During COVID-19 on Blood and Muscle Oxygenation While Performing Exercise,Unrelated
3600,COVID,"February 08, 2021",200,NCT04558021,NICLOSAMIDE SUSPENSION,TURKEY,Recruiting,Imuneks Farma ilac San. Tic. A.S.,"October 8, 2020",Interventional,"A Phase III, Randomized, Placebo-controlled, Clinical Trial to Evaluate the Efficacy and Safety of Co-administered Niclosamide in Patients Treated With an Established Regimen for Novel Coronavirus Infectious Disease (COVID-19)",COVID
3601,BODY DISSATISFACTION,"February 08, 2021",90,NCT04558073,BODY PROJECT (BP),,Not yet recruiting,School of Health Sciences Geneva,"December 1, 2020",Interventional,Prevention of Eating Disorders in At-Risk Female Students: Adaptation and Evaluation of Two Interventions in French-Speaking Switzerland,Unrelated
3602,PULMONARY EMBOLISM,"February 08, 2021",45,NCT04558125,TNKASE,UNITED STATES,"Active, not recruiting",Cedars-Sinai Medical Center,"September 8, 2020",Interventional,"Low-Dose Tenecteplase in Covid-19 Patients With Acture Pulmonary Embolism: A Randomized, Double-Blind, Placebo-Controlled Trial",Unrelated
3603,COVID,"February 08, 2021",450,NCT04558203,,EGYPT,Recruiting,ClinAmygate,"September 22, 2020",Observational [Patient Registry],"The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice",COVID
3604,CORONAVIRUS DISEASE (COVID),"February 08, 2021",1000,NCT04558307,PILOT A RAPID SARS-COV-2 TESTING STRATEGY,UNITED STATES,Enrolling by invitation,Mayo Clinic,"June 3, 2020",Observational,Enhancing Rapid Health Response in National Crises: Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations Through Community-Academic Partnerships,COVID
3605,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04558320,,UNITED STATES,Recruiting,University of Rochester,"July 2, 2020",Observational,COVID-19 and Lactating Mothers,COVID
3606,COVID,"February 08, 2021",1999,NCT04558372,EXHALED BREATH SAMPLING,INDONESIA,Completed,Gadjah Mada University,"April 1, 2020",Interventional,Genosvid Diagnostic Test for Early Detection of COVID-19: UGM Electronic-Nose Innovation for Indonesia,COVID
3607,COVID,"February 08, 2021",275,NCT04558385,IGG SARS COV2,PAKISTAN,"Active, not recruiting",Lahore General Hospital,"July 1, 2020",Observational,Seroconversion in COVID-19 Recovered Population: an Observational Study,COVID
3608,EMOTIONAL REGULATION,"February 08, 2021",150,NCT04558411,DIALECTICAL BEHAVIORAL THERAPY (DBT) SKILLS,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","September 12, 2020",Interventional,"Pilot Study of a Brief, Scaleable Intervention for COVID-19 Mental Health Sequelae in College Students",Unrelated
3609,COVID,"February 08, 2021",50,NCT04558424,ZINC GLUCONATE AND ASCORBIC ACID,BANGLADESH,Not yet recruiting,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","October 1, 2020",Interventional,"Randomized, Double -Blind, Placebo Controlled, Trial to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU",COVID
3610,POST TRAUMATIC STRESS DISORDER (PTSD),"February 08, 2021",20000,NCT04558437,QUESTIONNAIRE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 12, 2020",Observational,Prevalence and Development of Post-traumatic Stress Disorder and Anxiety and Depressive Symptoms Among AP-HP Staff During the Covid-19 Epidemic,Unrelated
3611,COVID,"February 08, 2021",360,NCT04558450,CAROTID-FEMORAL PULSE-WAVE VELOCITY,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,September 2020,Interventional,Covid-19 Effects on ARTErial StIffness and Vascular AgiNg,COVID
3612,COVID,"February 08, 2021",100,NCT04558463,FAVIPIRAVIR,INDONESIA,Recruiting,Indonesia University,"April 16, 2020",Interventional,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19: An Open Label Trial,COVID
3613,COVID,"February 08, 2021",500,NCT04558476,CONVALESCENT PLASMA,BELGIUM,Recruiting,University of Liege,"September 1, 2020",Interventional,A Multicenter Randomized Trial to Assess the Efficacy of CONvalescent Plasma Therapy in Patients With Invasive COVID-19 and Acute Respiratory Failure Treated With Mechanical Ventilation: the CONFIDENT Trial,COVID
3614,TYPE 1 DIABETES MELLITUS,"February 08, 2021",118,NCT04558645,ONLINE SURVEY,TURKEY,Completed,Gazi University,"September 18, 2020",Observational,"Evaluation of Quality of Life, Physical Activity and Depression in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic",Unrelated
3615,COVID,"February 08, 2021",150,NCT04558749,STATE-TRAIT ANXIETY INVENTORY SCALE,EGYPT,Recruiting,Assiut University,"October 1, 2020",Observational,Assessment of Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic,COVID
3616,RHEUMATOID ARTHRITIS,"February 08, 2021",156,NCT04558905,FACE-TO-FACE MEDICAL VISITS,MEXICO,Not yet recruiting,"National Institute of Medical Sciences and Nutrition, Salvador Zubiran","October 1, 2020",Interventional,Impact of a Hybrid Medical Care Model (Face-to-face Medical Visits Alternating With Video Medical Consultations) in the Rheumatoid Arthritis Patient-reported-outcomes Measures: A Non-inferiority Study,Unrelated
3617,COVID,"February 08, 2021",3000,NCT04558996,,SPAIN,Recruiting,Puerta de Hierro University Hospital,"March 1, 2020",Observational [Patient Registry],REGISTRO EPIDEMIOLOGICO DE COVID 19 EN GESTANTES,COVID
3618,COVID,"February 08, 2021",100,NCT04559009,,UNITED STATES,Recruiting,Atrium Health,"October 15, 2020",Observational [Patient Registry],COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry,COVID
3619,COVID,"February 08, 2021",200,NCT04559035,NASAL LAVAGE,UNITED STATES,Enrolling by invitation,Augusta University,"September 24, 2020",Interventional,Nasal Irrigation to Reduce COVID-19 Morbidity,COVID
3620,HYPERTENSION,"February 08, 2021",1000,NCT04559074,AMLODIPINE,UNITED KINGDOM,Recruiting,Queen Mary University of London,"October 23, 2020",Interventional,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,Unrelated
3621,COVID,"February 08, 2021",112,NCT04559100,CHEST RADIOGRAPHY,,Not yet recruiting,Fundacion Clinica Valle del Lili,"November 21, 2020",Observational,"Clinical, Radiological, Lung Function, and Quality of Life Characterization of Patients With Severe/Critical Infection by SARS-COV-2 (COVID-19) Virus, After 6 and 12 Months of Hospital Discharge",COVID
3622,SARS-COV INFECTION,"February 08, 2021",200,NCT04559113,METHYLPREDNISOLONE INJECTABLE PRODUCT,PAKISTAN,Recruiting,Lahore General Hospital,"May 1, 2020",Interventional,Perks of Methylprednisolone for Hospitalized COVID-19 Patients: A Clinical Trial,Respiratory
3623,BODY WEIGHT CHANGES,"February 08, 2021",200,NCT04559542,,NORWAY,Recruiting,Norwegian School of Sport Sciences,"September 10, 2020",Observational,"Management of Body Weight Regulation, Symptoms of Low Energy Availability, Body Acceptance, Eating Disorders, and Sexual Harassment Among Female Martial Art Athletes, and Impact of COVID-19 on Training and Sport Participation",Unrelated
3624,SARS-COV INFECTION,"February 08, 2021",50,NCT04560205,TOCILIZUMAB,PAKISTAN,Recruiting,Lahore General Hospital,"May 1, 2020",Interventional,Tocilizumab: A Therapeutic Cache Against the Treatment of Severe Cases of COVID-19,Respiratory
3625,SARS-COV INFECTION,"February 08, 2021",30,NCT04560231,REMDESIVIR,PAKISTAN,Recruiting,Lahore General Hospital,"June 1, 2020",Interventional,Is Remdesivir a Possible Therapeutic Option for SARS-CoV-2 : An Interventional Study,Respiratory
3626,SARS-COV INFECTION,"February 08, 2021",30,NCT04560257,HIGH FLOW NASAL CANNULA HFNC,PAKISTAN,Recruiting,Lahore General Hospital,"May 1, 2020",Interventional,Prone Positioning and High Flow Nasal Canula (HFNC) Therapy: A Game Changer in COVID-19 Outcome,Respiratory
3627,SARS-CoV2,"February 08, 2021",77,NCT04560413,,TURKEY,Completed,Fatih Sultan Mehmet Training and Research Hospital,"June 1, 2020",Observational,"Depression, Anxiety and SARS-CoV-2 Phobia in Post-stroke Patients During SARS-CoV-2 Pandemic",COVID
3628,COVID,"February 08, 2021",76,NCT04560530,NON-ENHANCED CT SCAN OF THE CHEST,SAUDI ARABIA,Completed,Tanta University,"March 1, 2020",Observational,The Use of Preoperative CT Chest Scan in the Pre-anesthetic Assessment of COVID-19,COVID
3629,COVID,"February 08, 2021",255,NCT04560608,,FRANCE,Recruiting,"University Hospital, Angers","March 15, 2020",Observational [Patient Registry],"Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19",COVID
3630,COVID,"February 08, 2021",400,NCT04560855,CONNECTED DEVICES MEASUREMENTS,FRANCE,Recruiting,Withings,"September 14, 2020",Observational,Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home,COVID
3631,COVID VIRUS INFECTION,"February 08, 2021",3000,NCT04560881,INACTIVATED SARS-COV-2 VACCINE (VERO CELL),ARGENTINA,"Active, not recruiting",Laboratorio Elea Phoenix S.A.,"September 16, 2020",Interventional,"Randomized, Double Blind, Placebo Parallel-controlled Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (Vero Cell) in Argentine Healthy Population Aged Between 18 and 85 Years",COVID
3632,COVID,"February 08, 2021",4000,NCT04561024,AI MODEL,HONG KONG,"Active, not recruiting","Ensemble Group Holdings, LLC","March 1, 2020",Observational,Evaluation of a Chest X-Ray AI Neural Network (RadGen SARS-CoV2 Detection System) for the Detection of RT-PCR Confirmed SARS-Cov2 Covid-19 Pneumonia,COVID
3633,COVID,"February 08, 2021",1950,NCT04561063,NITAZOXANIDE,SOUTH AFRICA,Recruiting,"University of Witwatersrand, South Africa","December 8, 2020",Interventional,"A Multi-center, Randomised, Open Label Study of Nitazoxanide (NTZ), or Sofosbuvir and Daclatasvir (SOF/DCV), Compared to no Pharmacological Intervention for the Prevention of COVID-19 Disease in Healthcare Workers at High Risk of Exposure to SARS-CoV-2",COVID
3634,COVID,"February 08, 2021",24,NCT04561076,HLX70,,Not yet recruiting,Hengenix Biotech Inc,"December 9, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Phase I Clinical Study to Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers",COVID
3635,SARS-CoV2,"February 08, 2021",2000,NCT04561089,COVIDSEQ TEST,UNITED STATES,Enrolling by invitation,"Illumina, Inc.","July 13, 2020",Observational,Evaluation of the COVIDSeq Test in Saliva Specimens From Illumina Personnel,COVID
3636,SARS-CoV2,"February 08, 2021",2500,NCT04561102,DIAGNOSTIC TEST FOR DETECTION OF SARS-COV-2,UNITED STATES,Enrolling by invitation,"Illumina, Inc.","September 11, 2020",Observational,Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population,COVID
3637,COVID,"February 08, 2021",85,NCT04561141,,,Not yet recruiting,Assiut University,"December 1, 2020",Observational,Post Covid Syndrome: Clinical Pattern and Functional Assessment,COVID
3638,SARS-CoV2,"February 08, 2021",134,NCT04561154,QUESTIONNAIRE,FRANCE,Recruiting,Centre Hospitalier le Mans,"June 11, 2020",Interventional,Identifying Functional and Psycho-social Complaints After Hospitalization for Severe SARS-CoV-2 Infection (COVID19)- REPERCOV,COVID
3639,PNEUMONIA AS ONE OF THE LUNG COMPLICATIONS CAUSED BY SARS-CoV2 INFECTION,"February 08, 2021",96,NCT04561180,EG-HPCP-03A,,Not yet recruiting,"Evergreen Therapeutics, Inc.",December 2020,Interventional,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to Dexamethasone in Patients With Moderate/Severe (Non-intubated, Non-mechanical Ventilation) COVID-19 Pneumonia",COVID
3640,COVID,"February 08, 2021",200,NCT04561193,OBSERVATIONAL,UNITED STATES,Recruiting,Methodist Health System,"May 30, 2020",Observational,Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19),COVID
3641,COVID,"February 08, 2021",500,NCT04561219,NITAZOXANIDE,BRAZIL,Completed,Universidade Federal do Rio de Janeiro,"April 19, 2020",Interventional,"Nitazoxanide for Moderate to Severe COVID-19 Pneumonia: a Multicenter, Randomized, Placebo-controlled, Double-Blind Clinical Trial",COVID
3642,COVID,"February 08, 2021",500,NCT04562246,SEROLOGIC ASSAYS FOR ANTIBODIES TO SARS-COV-2,UNITED STATES,Recruiting,Henry Ford Health System,"August 14, 2020",Observational,Laboratory Validation of SARS-CoV-2 IgG and IgM Serologic Assays on an Automated Immunoassay System,COVID
3643,COVID,"February 08, 2021",500,NCT04562285,SEROLOGIC IMMUNOASSAYS TO SARS-COV-2 ANTIBODIES,UNITED STATES,Recruiting,Henry Ford Health System,"June 23, 2020",Observational,Initial and Sustained Immunity to SARS-CoV-2 Measured by Serologic Assays on an Automated Immunoassay System,COVID
3644,HEALTHY,"February 08, 2021",500,NCT04562350,XATJOVE ANOIA APLICATION,SPAIN,Recruiting,Jordi Gol i Gurina Foundation,"October 1, 2020",Interventional,"XatJove Anoia, as a Tool to Bring Health Services Closer to Teenagers",Unrelated
3645,ANXIETY,"February 08, 2021",250,NCT04562948,,CANADA,Recruiting,University of Windsor,"November 11, 2020",Observational,Community Applications of the MindShift App,Unrelated
3646,PREGNANCY COMPLICATIONS,"February 08, 2021",280,NCT04563065,EXERCISE PROGRAM,SPAIN,Recruiting,Universidad Politecnica de Madrid,"August 1, 2020",Interventional,"Active Pregnancy, Prevention Against the Effects of COVID-19",Unrelated
3647,COVID,"February 08, 2021",100,NCT04563156,LUNG FUNCTION TEST,BRAZIL,Enrolling by invitation,University of Sao Paulo General Hospital,"June 23, 2020",Observational,Follow-up and Rehabilitation of Survivors of Severe Covid-19 Infection,COVID
3648,COVID,"February 08, 2021",40,NCT04563208,PLACEBO,SOUTH AFRICA,Recruiting,"University of Witwatersrand, South Africa","December 9, 2020",Interventional,"A Randomized, Double-Blind, Study Comparing the Efficacy, Safety, and Tolerability of Oral Administration of Ribavirin (RBV) and Nitazoxamide (NTZ)Versus Placebo in SARS-CoV-2 Virus Infected Participants (DuACT)",COVID
3649,COVID,"February 08, 2021",700,NCT04563247,IGG SARS COV 2 ANTIBODIES,PAKISTAN,"Active, not recruiting",Lahore General Hospital,"July 1, 2020",Observational,Seroprevalence of SARS-CoV 2 Among Asymptomatic Frontline Healthcare Workers During COVID 19: A Cross Sectional Study,COVID
3650,COVID,"February 08, 2021",200,NCT04563442,COMPLICATION,,Not yet recruiting,Assiut University,"October 15, 2020",Observational [Patient Registry],Comorbidities And Complications Associated With Covid-19 Infection,COVID
3651,"NAUSEA AND VOMITING, POSTOPERATIVE","February 08, 2021",126,NCT04563494,DEXAMETHASONE,,Not yet recruiting,"University of Colorado, Denver","October 1, 2020",Interventional,"The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, Pain, and Drug Cost in Children Undergoing Tonsillectomy: A Randomized Controlled Prospective Non-inferiority Study",Unrelated
3652,COVID,"February 08, 2021",330,NCT04563650,BLOOD SAMPLE,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","September 18, 2020",Interventional,Kinetics of COVID-19-neutralising Antibodies in Patients Residing in EHPAD / USLD: Influence of Immunosenescence,COVID
3653,COVID,"February 08, 2021",400,NCT04563676,BLOOD TEST,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","September 22, 2020",Interventional,Physiopathology and Sequelae of COVID-19 Infection,COVID
3654,COVID,"February 08, 2021",23,NCT04563689,CHX0.12+CPC0.05 ORAL RINSE (PERIOAIDACTIVE CONTROL),COLOMBIA,Completed,Dentaid SL,"June 18, 2020",Interventional,Efecto de un Enjuague Bucal Con Clorhexidina al 0.12% y Cloruro de Cetil Piridinio al 0.05% en la Carga Viral en Saliva en Pacientes COVID-19 + Hospitalizados o Que Esten Recibiendo Cuidado médico en Casa en Cali - 2020.,COVID
3655,COVID,"February 08, 2021",35,NCT04563702,VXA-COV2-1,UNITED STATES,"Active, not recruiting",Vaxart,"September 21, 2020",Interventional,"A Phase 1 Open-Label, Dose-Ranging Trial to Determine the Safety and Immunogenicity of an Adenoviral-Vector Based Vaccine (VXA-CoV2-1) Expressing a SARS-CoV-2 Antigen and dsRNA Adjuvant Administered Orally to Healthy Adult Volunteers",COVID
3656,MANTLE CELL LYMPHOMA,"February 08, 2021",20,NCT04564040,ACALABRUTINIB TREATMENT A,GERMANY,Completed,AstraZeneca,"October 12, 2020",Interventional,"A 2-Part, Phase I, Open-label, Single-dose, Sequential, Randomized, Crossover Study of Acalabrutinib Tablet Suspension Delivered Via Nasogastric Tube in Healthy Subjects to Evaluate Relative Bioavailability and Proton-pump Inhibitor (Rabeprazole) Effect",Unrelated
3657,IPF,"February 08, 2021",1000,NCT04564183,SAMPLE COLLECTION,,Not yet recruiting,"University of Colorado, Denver","December 1, 2020",Observational,Advancing Prevention of Pulmonary Fibrosis - A Cohort Study of Preclinical Pulmonary Fibrosis,Unrelated
3658,CHRONIC HEALTH CONDITIONS,"February 08, 2021",5000,NCT04564274,,UNITED STATES,Recruiting,"National Heart, Lung, and Blood Institute (NHLBI)","February 11, 2021",Observational,Natural History Study: COV2Base-a Rare Disease by COVID Study,Unrelated
3659,COVID,"February 08, 2021",100,NCT04564287,,UNITED STATES,Enrolling by invitation,National Institute of Neurological Disorders and Stroke (NINDS),"October 28, 2020",Observational,An Observational Study of Neurologic Function After COVID-19 Infection,COVID
3660,PREDIABETES,"February 08, 2021",32,NCT04564586,DPPFIT,UNITED STATES,"Active, not recruiting",Augusta University,"January 1, 2020",Interventional,Developing and Testing a Technology-Based Translation of the Diabetes Prevention Program for Adult Primary Care Patients At-Risk of Developing Type 2 Diabetes Mellitus,Unrelated
3661,COVID,"February 08, 2021",100,NCT04564716,GAM-COVID-VAC,BELARUS,"Active, not recruiting","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","September 28, 2020",Interventional,"Сlinical Trial of Efficacy, Safety and Immunogenicity of Combined Vector Vaccine Gam-COVID-Vac in SARS-СoV-2 Infection Prophylactic Treatment in Republic of Belarus",COVID
3662,COVID,"February 08, 2021",120,NCT04565067,,UNITED STATES,Recruiting,National Institute on Aging (NIA),"February 11, 2021",Observational,Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans a Clinical Observation Trial,COVID
3663,PARKINSON'S DISEASE,"February 08, 2021",150,NCT04565080,,UNITED STATES,Recruiting,National Institute of Neurological Disorders and Stroke (NINDS),"February 11, 2021",Observational,Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD),Unrelated
3664,COVID,"February 08, 2021",16,NCT04565106,CLOSED-LOOP CONTROL OF OXYGEN SUPPLEMENTATION BY O2MATIC,DENMARK,Completed,Hvidovre University Hospital,"April 15, 2020",Observational,Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure,COVID
3665,SARS-COV INFECTION,"February 08, 2021",20,NCT04565197,CONVALESCENT PLASMA,PAKISTAN,"Active, not recruiting",Lahore General Hospital,"May 1, 2020",Interventional,Convalescent Plasma for Passive Immunization in COVID-19 ICU Patients: An Interventional Study,Respiratory
3666,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",36,NCT04565249,PLN-74809,UNITED STATES,Recruiting,"Pliant Therapeutics, Inc.","October 22, 2020",Interventional,"A Randomized, Double-blind, Dose-ranging, Placebo Controlled, Phase 2a Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 (INTEGRIS-ARDS)",Respiratory
3667,"INFLUENZA, HUMAN","February 08, 2021",80000,NCT04565353,FLU SHOT TEXT MESSAGES,UNITED STATES,Recruiting,University of Pennsylvania,"September 20, 2020",Interventional,Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates,Respiratory
3668,COVID PNEUMONIA,"February 08, 2021",60,NCT04565379,NUSEPIN® 0.1 MG,ROMANIA,Recruiting,Shaperon,"September 25, 2020",Interventional,"A Randomized, Double Blind, Placebo-controlled, Phase 2 Clinical Trial to Investigate the Efficacy and Safety of 2 Doses of NuSepin® Intravenous Infusion in COVID-19 Pneumonia Patients",COVID
3669,COVID,"February 08, 2021",150,NCT04565392,FAMOTIDINE 20 MILLIGRAM TABLET,UNITED STATES,Not yet recruiting,drpykessupplements.com,"May 1, 2021",Interventional,Proof-of-concept Randomized Placebo-controlled Trial of Famotidine for Outpatients With COVID-19,COVID
3670,COVID,"February 08, 2021",2500,NCT04565509,GENERAL COMMUNICATION MESSAGE,UNITED STATES,Recruiting,Washington University School of Medicine,"November 20, 2020",Interventional,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,COVID
3671,COVID,"February 08, 2021",5000,NCT04565522,PROSPECTIVE OBSERVATION,ITALY,Not yet recruiting,"Simeone Andrulli, MD","September 21, 2020",Observational,Transmission of COVID-19 Among Patients and Health Personnel in Dialysis Centers: a Cohort Prospective Study (DIAL-COVID-19),COVID
3672,COVID INFECTION,"February 08, 2021",70,NCT04565665,BEST PRACTICE,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"July 29, 2020",Interventional,Emergency Use Pilot Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,COVID
3673,SARS-COV INFECTION,"February 08, 2021",150,NCT04565782,,EGYPT,Recruiting,Assiut University,"September 15, 2020",Observational,Corona Virus Infection Among Liver Transplant Recipients: A Multicenter Study,Respiratory
3674,COVID VACCINE,"February 08, 2021",96,NCT04566276,CHULACOV19 MRNA VACCINE,THAILAND,Not yet recruiting,Chulalongkorn University,January 2021,Interventional,"A Phase 1/2, Dose-finding Study to Evaluate Safety, Tolerability, and Immunogenicity of the ChulaCov19 mRNA Vaccine in Healthy Adults",COVID
3675,MALARIA,"February 08, 2021",200000,NCT04566510,"LONG LASTING INSECTICIDAL NETS WITH ALPHA-CYPERMETHRIN + PYRIPROXYFEN (PPF LLIN, ROYAL GUARD))",UGANDA,Recruiting,"University of California, San Francisco","October 17, 2020",Interventional,Impact of Long-lasting Insecticidal Nets (LLINs) Treated With Pyrethroid Plus Pyriproxyfen vs LLINs Treated With Pyrethroid Plus Piperonyl Butoxide on Malaria Incidence in Uganda: a Cluster-randomised Trial,Unrelated
3676,"NEOPLASM, COLORECTAL","February 08, 2021",112,NCT04566614,CTDNA BLOOD SAMPLING,UNITED KINGDOM,Recruiting,Royal Marsden NHS Foundation Trust,"June 18, 2020",Observational,Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies,Unrelated
3677,COVID,"February 08, 2021",481,NCT04566770,RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR),CHINA,Recruiting,CanSino Biologics Inc.,"September 24, 2020",Interventional,"A Randomized, Double-blind, Placebo -Controlled Phase IIb Clinical Trial to Evaluate the Safety and Immunogenicity of Ad5-nCoV in Person 6 Years of Age and Older and Those Who Have Previously Been Vaccinated With Ad5-EBOV",COVID
3678,COVID,"February 08, 2021",230,NCT04566965,SARS-COV-2,UNITED STATES,Recruiting,"Children's Hospital Medical Center, Cincinnati","August 18, 2020",Observational,Serology to Covid for Recording Exposures and Evaluating Needs (SCREEN),COVID
3679,COVID,"February 08, 2021",136,NCT04567173,ANTI-SARS-COV-2 CONVALESCENT PLASMA,PHILIPPINES,Recruiting,University of the Philippines,"September 21, 2020",Interventional,"A Randomized, Open-Label, Single Center Clinical Trial to Assess the Efficacy and Safety of Convalescent Plasma to Hospitalized Adult COVID-19 Patients as Adjunctive Therapy to Reduce the Need for ICU Admission: Co-CLARITY Trial",COVID
3680,RHEUMATIC DISEASES,"February 08, 2021",150,NCT04567576,DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS),,Not yet recruiting,Fundación Santa Fe de Bogota,October 2020,Observational,Predictive Factors for COVID-19 in Rheumatology Study Based on Information Collected in The COVID-19 Global Rheumatology Alliance,Unrelated
3681,COVID,"February 08, 2021",48,NCT04567810,ANTI-SARS-COV-2 IGY,AUSTRALIA,Completed,Stanford University,"September 18, 2020",Interventional,"A Phase 1 Study in Healthy Participants to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single -Ascending and Multiple Doses of an Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY)",COVID
3682,COVID,"February 08, 2021",3000,NCT04567836,INVESTIGATION OF THE PREVALENCE OF TEST POSITIVITY,ITALY,Recruiting,University of Milano Bicocca,"June 1, 2020",Observational,Screening of Health-care Workers in an University Hospital: an Observational Prospective Study on the Screening of Hospital Workers for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),COVID
3683,SARS VIRUS,"February 08, 2021",80,NCT04567927,ULTRASONOGRAPHY,SWITZERLAND,Completed,Chiesa Alessandro Felice,"March 3, 2020",Observational,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With SARS-CoV-2 Infection,Respiratory
3684,COVID,"February 08, 2021",2000,NCT04567953,SALIVA COLLECTION,UNITED STATES,"Active, not recruiting",Paradigm Laboratories LLC,"July 28, 2020",Interventional,COVID-19 Tests With Saliva Specimens,COVID
3685,COVID,"February 08, 2021",149,NCT04567979,,MEXICO,"Active, not recruiting",Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"June 11, 2020",Observational,Prospective Determination of COVID-19 Infection Rate in Patients With Solid Tumors and Healthcare Workers of the Chemotherapy and Radiotherapy Unit at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador.,COVID
3686,LYMPHEDEMA,"February 08, 2021",60,NCT04568005,,TURKEY,Completed,Fatih Sultan Mehmet Training and Research Hospital,"June 1, 2020",Observational [Patient Registry],"Evaluation of Lymphedema Patients Treatment Processes, Health Status, Coronavirus Phobia, Quality of Life, Anxiety and Depression During Covid-19 Pandemic",Unrelated
3687,ARDS DUE TO COVID,"February 08, 2021",120,NCT04568018,SURFACTANT,RUSSIAN FEDERATION,Recruiting,Biosurf LLC.,"July 3, 2020",Observational,"Open-label Trial to Assess the Efficacy and Safety of Inhalation Use of the Approved Drug Surfactant-BL (Biosurf LLC, Russia) as a Part of Complex Therapy of Acute Respiratory Distress Syndrome (ARDS) in Patients With SARS-CoV-2 Coronavirus Infection (COVID-19)",COVID
3688,COVID,"February 08, 2021",256,NCT04568031,AZD1222,JAPAN,"Active, not recruiting",AstraZeneca,"August 23, 2020",Interventional,"A Phase I/II Randomized, Double-blind, Placebo-controlled Multicentre Study in Participants Aged 18 Years or Older to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19",COVID
3689,COVID,"February 08, 2021",96,NCT04568044,BLOOD SAMPLE,UNITED KINGDOM,Recruiting,Imperial College London,"September 16, 2020",Observational,Evaluation of Cell-mediated and Humoral Immunity Following COVID-19 in Pregnancy,COVID
3690,THE LUNG COMPLICATION OF COVID,"February 08, 2021",160,NCT04568096,AEROSOLIZED ALL-TRANS RETINOIC ACID PLUS ORAL TAMOXIFEN,,Not yet recruiting,Kafrelsheikh University,November 2020,Interventional,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,COVID
3691,COVID,"February 08, 2021",3015,NCT04568122,SALIVA TEST KIT,UNITED STATES,Recruiting,Stanford University,"November 20, 2020",Interventional,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",COVID
3692,COVID,"February 08, 2021",1000,NCT04568135,SURVEY,,Not yet recruiting,Siyan Clinical Corporation,"October 31, 2020",Observational,A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis,COVID
3693,COVID,"February 08, 2021",50,NCT04568148,,UNITED STATES,Recruiting,University of Kansas Medical Center,"April 15, 2020",Observational,COVID-19 Biorepository,COVID
3694,SARS COV-2,"February 08, 2021",200,NCT04568356,DIRECT ANTIGEN TESTS FOR COVID-19,UNITED STATES,Completed,"E25Bio, Inc.","April 24, 2020",Interventional,"A Clinical Performance Evaluation of the SARS-COV-2 Direct Antigen Rapid Test ""DART""",Respiratory
3695,RHEUMATIC DISEASES,"February 08, 2021",3000,NCT04568421,IMMUNOSUPPRESSIVE AGENTS,ARGENTINA,Recruiting,Sociedad Argentina de Reumatologia,"August 18, 2020",Observational [Patient Registry],Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection,Unrelated
3696,COVID,"February 08, 2021",1000,NCT04568499,,,Not yet recruiting,Johns Hopkins Bloomberg School of Public Health,October 2020,Observational,"Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings: a Prospective Cohort Study in South Sudan and DRC",COVID
3697,COVID,"February 08, 2021",195,NCT04568525,PASSIVE MICROWAVE RADIOMETRY,KYRGYZSTAN,Completed,Kyrgyz State Medical Academy,"July 1, 2020",Interventional,Microwave Radiation for Early Diagnostics of Pneumonia in Patients With COVID-19,COVID
3698,ANXIETY STATE,"February 08, 2021",300,NCT04568551,,GERMANY,Recruiting,Martin-Luther-Universität Halle-Wittenberg,"October 1, 2020",Observational,"COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor - CAASPtrial",Unrelated
3699,LUNG CANCER,"February 08, 2021",40,NCT04568564,"BREATHING EXERCISE, INTENSIVE SPIROMETRY USE, SUPPORTED COUGH, PROGRESSIVE MOBILISATION AND AMBULATION",TURKEY,Recruiting,Istanbul Medipol University Hospital,"October 1, 2020",Interventional,Telerehabilitation of Reduced Physiotherapy Service in SARS-CoV-2 Pandemic Process in Lung Surgery Patients,Unrelated
3700,NONINVAVIE VENTILATION TO PATIENTS WITH COVID,"February 08, 2021",23,NCT04568655,NONINVASIVE VENTILATION,CHINA,Completed,The First Affiliated Hospital of Guangzhou Medical University,"February 1, 2020",Observational,The Noninvasive Ventilation to COVID-19 Patients With Respiratory Failure,COVID
3701,COVID,"February 08, 2021",200,NCT04568707,BLOOD SAMPLE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"October 15, 2020",Interventional,Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19,COVID
3702,ADENOVIRUS TYPE-5 VECTORED COVID VACCINE,"February 08, 2021",89,NCT04568811,ADENOVIRUS TYPE-5 VECTORED COVID-19 VACCINE,CHINA,"Active, not recruiting",Jiangsu Province Centers for Disease Control and Prevention,"September 26, 2020",Interventional,"The Single-center, Open-label Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine in Healthy Adults Aged 18-60 Years",COVID
3703,COVID,"February 08, 2021",50,NCT04568850,PLASMA IGG LEVELS,PAKISTAN,"Active, not recruiting",Lahore General Hospital,"July 1, 2020",Observational,Waxing and Waning of Serum SARS CoV 2 IgG Level: A Prospective Study,COVID
3704,COVID,"February 08, 2021",18,NCT04568863,MELATONIN INTRAVENOUS,SPAIN,Recruiting,Pharmamel S.L.,"June 20, 2020",Interventional,"A Phase II, Single-center, Double-blind, Randomized Placebo-controlled Trial to Explore the Efficacy and Safety of Intravenous Melatonin in Patients With COVID-19 Admitted to the Intensive Care Unit (MelCOVID Study)",COVID
3705,COVID,"February 08, 2021",40,NCT04568876,"MICRONIZED AND ULTRA-MICRONIZED PALMITOYLETHANOLAMIDE (MPEA AND UMPEA, 300MG + 600MG) ORAL SUSPENSION",ITALY,Recruiting,Epitech Group SpA,"October 23, 2020",Interventional,"Efficacy of Palmitoylethanolamide, in add-on to Standard Therapy, on Inflammatory Markers of Patients With Interstitial Pneumonia Due to COVID-19. A Pilot Controlled, Randomized, Open Lable Clinical Study",COVID
3706,COVID,"February 08, 2021",1000,NCT04568889,A $10 SURVEY INCENTIVE,,Not yet recruiting,Harvard University,"September 28, 2020",Interventional,Minnesota COVID-19 Testing Project,COVID
3707,VACCNATION IN HCW,"February 08, 2021",1000,NCT04569019,VACCIANTION STATUS IN HEALTH CARE WORKERS,POLAND,Recruiting,Medical University of Warsaw,"September 1, 2020",Observational,Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of the University Clinical Center of the Medical University of Warsaw,Unrelated
3708,COVID,"February 08, 2021",21,NCT04569188,CONVALESCENT PLASMA,ITALY,Completed,Azienda Socio Sanitaria Territoriale di Mantova,"May 15, 2020",Interventional,Real-time Evaluation of Safety and Efficacy of Convalescent Plasma Units Transfused to Elderly Patients With COVID-19,COVID
3709,COVID PNEUMONIA,"February 08, 2021",60,NCT04569227,EC-18,,Not yet recruiting,Enzychem Lifesciences Corporation,"November 16, 2020",Interventional,"Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EC-18 in Preventing the Progression of COVID-19 Infection to Severe Pneumonia or ARDS",COVID
3710,DYSPNEA,"February 08, 2021",200,NCT04569266,SPECIFIC EXERCISE REHABILITATION TREATMENT,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"August 7, 2020",Interventional,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,Unrelated
3711,COVID,"February 08, 2021",150,NCT04569292,NO INTERVENTION ON PATIENTS,ITALY,Recruiting,Ospedale Andrea Tortora di Pagani,"January 1, 2020",Observational,Clinical Course of Cancer Patients Who Contracted COVID 19 Infection: An Observational Study,COVID
3712,VENOUS THROMBOEMBOLISM,"February 08, 2021",40000,NCT04569344,LABORATORY TEST POSITIVE FOR SARS-COV-2 VIRUS,UNITED STATES,Enrolling by invitation,"University of California, San Francisco","January 1, 2020",Observational,COVID-19 and Venous Thromboembolism Risk,Unrelated
3713,COVID,"February 08, 2021",30,NCT04569383,MVA-SARS-2-S VACCINATIONS (DAYS 0 & 28),GERMANY,Recruiting,Universitätsklinikum Hamburg-Eppendorf,"October 5, 2020",Interventional,"An Open, Single-center Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of Two Ascending Doses of the Candidate Vaccine MVA-SARS-2-S",COVID
3714,CORONAVIRUS DISEASE (COVID),"February 08, 2021",252,NCT04569786,V590,UNITED STATES,"Active, not recruiting",Merck Sharp & Dohme Corp.,"October 29, 2020",Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety and Immunogenicity of V590 in Healthy Adults",COVID
3715,CLINICAL TRIAL,"February 08, 2021",250,NCT04569825,OPHTAMESONE,IRAQ,Recruiting,University Of Anbar,"August 1, 2020",Interventional,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,Unrelated
3716,COVID INFECTION,"February 08, 2021",100000,NCT04569851,,SPAIN,Enrolling by invitation,Medsavana,"January 1, 2020",Observational,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 Using Big Data and Artificial Intelligence Techniques (BigCoviData),COVID
3717,SEVERE ACUTE RESPIRATORY SYNDROME (SARS) PNEUMONIA,"February 08, 2021",238,NCT04569877,MOLGRAMOSTIM NEBULISER SOLUTION,GERMANY,Recruiting,University of Giessen,"September 24, 2020",Interventional,Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to Prevent ARDS in COVID-19 Pneumonia (GI-COVID),Respiratory
3718,COVID,"February 08, 2021",40,NCT04570189,AUSCUL-X,CANADA,Recruiting,AusculSciences Canada Inc.,"October 1, 2020",Observational,"Evaluating Auscul-X, a Touch Free Digital Stethoscope, for Physical Distancing to Protect Patients and Health Care Professionals From COVID-19 (The Auscul-X Study)",COVID
3719,DEPRESSION,"February 08, 2021",900,NCT04570202,EMDR,FRANCE,Recruiting,"University Hospital, Tours","November 20, 2020",Interventional,"Symptoms of Depression, Stress and Burnout, and Long-term Psychological Impact in Health Care Professionals Exposed to the Novel Coronavirus Disease 2019 Outbreak (HARD-COVID-19 - Health cAre woRkers exposeD to covID-19)",Unrelated
3720,"PNEUMONIA, VIRAL","February 08, 2021",11,NCT04570254,VITAMIN C,MEXICO,"Active, not recruiting",Unidad Temporal COVID-19 en Centro Citibanamex,"August 19, 2020",Interventional,Open Clinical Trial of the Use of Antioxidants and Pentoxifylline as Adjuvant Therapy to Standard Therapy in Patients With and Without Septic Shock Secondary to COVID-19 Severe Pneumonia,Respiratory
3721,ACUTE HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",60,NCT04570384,L-CITRULLINE,UNITED STATES,Recruiting,"Asklepion Pharmaceuticals, LLC","October 15, 2020",Interventional,"Prospective, Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Intravenous L-Citrulline (Turnobi) to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness",Respiratory
3722,COVID,"February 08, 2021",32,NCT04570397,RAVULIZUMAB,UNITED STATES,Recruiting,Brigham and Women's Hospital,"December 18, 2020",Interventional,C5 Complement Inhbition Using Ravulizumab for the Treatment of COVID-19 Induced Thrombotic Microangiopathy,COVID
3723,COVID,"February 08, 2021",0,NCT04570449,FLUOXETINE,UNITED STATES,Withdrawn,Milton S. Hershey Medical Center,November 2020,Interventional,Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19),COVID
3724,COVID ARDS,"February 08, 2021",20,NCT04570462,HYPOTHERMIA VIA COOLING MACHINE- ARCTIC SUN 5000,UNITED STATES,Recruiting,Northwell Health,"May 18, 2020",Interventional,Application of Mild Hypothermia for COVID-19 Acute Respiratory Distress,COVID
3725,COVID,"February 08, 2021",1200,NCT04570488,EPIC RISK SCORE DISPLAY,UNITED STATES,Recruiting,NYU Langone Health,"May 15, 2020",Interventional,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,COVID
3726,COVID,"February 08, 2021",160,NCT04570501,ANGIOTENSIN-(1-7),UNITED STATES,Not yet recruiting,Stanford University,February 2021,Interventional,"A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Safety and Efficacy of Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients",COVID
3727,AGEISM,"February 08, 2021",121,NCT04570917,ONLINE EDUCATIONAL INTERVENTION TO REDUCE AGEISM,,Not yet recruiting,"University of Mississippi, Oxford","September 28, 2020",Interventional,Effectiveness of an Online Educational Intervention to Reduce Ageism in Undergraduate Students in an Entry-level Nutrition Class,Unrelated
3728,COVID,"February 08, 2021",200,NCT04570982,CONVALESCENT PLASMA,NEPAL,Recruiting,"Dr. Pradip Gyanwali,MD","July 30, 2020",Observational,Compassionate Use of Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Prospective Observational Study (Amended Protocol),COVID
3729,INSOMNIA DUE TO ANXIETY AND FEAR,"February 08, 2021",74,NCT04571593,YOGA NIDRA,UNITED STATES,Completed,National University of Natural Medicine,"April 15, 2020",Interventional,Digital Delivery of Yoga Nidra for Anxiety and Sleep: A Feasibility Study,Unrelated
3730,FIBROMYALGIA,"February 08, 2021",300,NCT04571853,PNE-EXPLAINED GROUP,SPAIN,Recruiting,Hospital Universitari Vall d'Hebron Research Institute,"September 21, 2020",Interventional,Usefulness of a New Educational Tool for Understanding Pain for Fibromyalgia Patients,Unrelated
3731,CORONAVIRUS DISEASE (COVID),"February 08, 2021",172,NCT04572360,CARDIORESPIRATORY EXERCISE,HONG KONG,Not yet recruiting,Hong Kong Baptist University,"October 1, 2020",Interventional,Would Cardiorespiratory Exercise and Chinese Herbal Medicine Facilitate Rehabilitation From Pulmonary Fibrosis Among Post-discharge Patients With COVID-19? Clinical Efficacy and Mechanisms,COVID
3732,CORONAVIRUS,"February 08, 2021",5,NCT04572399,UV LIGHT TREATMENT,UNITED STATES,Completed,Cedars-Sinai Medical Center,"October 30, 2020",Interventional,Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Pilot Study,COVID
3733,COVID,"February 08, 2021",13,NCT04572412,LOW DOSE RADIOTHERAPY,UNITED KINGDOM,Recruiting,Lancashire Teaching Hospitals NHS Foundation Trust,"November 25, 2020",Interventional,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia (a Phase I Feasibility Trial),COVID
3734,TRACHEOSTOMY COMPLICATION,"February 08, 2021",2500,NCT04572438,TRACHEOSTOMY,UNITED KINGDOM,Recruiting,"University College, London","August 1, 2020",Observational,COVIDTrach; a UK National Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy,Unrelated
3735,POST-CORONAVIRUS DISEASE 19,"February 08, 2021",1200,NCT04573062,,UNITED STATES,Recruiting,National Institute of Neurological Disorders and Stroke (NINDS),"February 11, 2021",Observational,Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health,COVID
3736,COVID,"February 08, 2021",400,NCT04573153,HYDROXYCHLOROQUINE + METABOLIC COFACTOR SUPPLEMENTATION,TURKEY,Recruiting,ScandiBio Therapeutics AB,"September 21, 2020",Interventional,"A Multi Centre, Randomised, Controlled, Open-Label Phase 2/3 Study to Evaluate The Efficacy, Tolerability and Safety of Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients",COVID
3737,COVID,"February 08, 2021",40,NCT04573270,PRIMEPRO,UNITED STATES,Completed,Thomas Advanced Medical LLC,"April 24, 2020",Interventional,A Pilot Phase Study Evaluating the Effects of a Single Mesenchymal Stem Cell Injection in Patients With Suspected or Confirmed COVID-19 Infection and Healthcare Providers Exposed to Coronavirus Patients,COVID
3738,SARS-CoV2 (COVID),"February 08, 2021",224,NCT04573322,TRANS SODIUM CROCETINATE,ROMANIA,Recruiting,Diffusion Pharmaceuticals Inc,"September 10, 2020",Interventional,"Open-label, Pharmacokinetic, Pharmacodynamic, Ascending Dose Safety lead-in Followed by a Single-center, Placebo-controlled, Double-blind, Adaptive, Safety and Efficacy, Pilot Study of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 Infected Subjects",COVID
3739,DIABETES,"February 08, 2021",1282,NCT04573335,,PAKISTAN,Completed,"Services Institute of Medical Sciences, Pakistan","June 1, 2020",Observational,Health-related Outcomes and Behaviour Changes in a Cohort of Diabetic Population During COVID-19 Pandemic: Results of a Telephonic Survey,Unrelated
3740,COVID,"February 08, 2021",400,NCT04573348,SAVICELL'S IMMUNOBIOPSY™,ISRAEL,Recruiting,Savicell Diagnostics Ltd,"October 14, 2020",Observational,"Prospective, One Center, Four Groups, Open, Comparative, Controlled Study to Explore T Cells Response to SARS COV 2 Peptides by Metabolic Activity Method in Convalesce and Healthy Individuals Versus Antibody Response",COVID
3741,MUSCULOSKELETAL PAIN,"February 08, 2021",723,NCT04573361,CHIROPRACTIC CARE (ONE VISIT),SPAIN,Completed,Real Centro Universitario Maria Cristina,"May 2, 2020",Interventional,Access to Chiropractic Care During the State of Emergency Generated by the COVID-19 Pandemic in Spain: a Pragmatic Controlled Trial,Unrelated
3742,COVID,"February 08, 2021",960,NCT04573634,,UNITED STATES,Recruiting,Jill M Kolesar,"May 15, 2020",Observational,A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition (START) - Assessment of COVID19 Penetrance in HCW and Non HCW in Kentucky,COVID
3743,COVID,"February 08, 2021",12,NCT04573764,"D-BETA-HYDROXYBUTYRATE-(R)-1,3 BUTANEDIOL MONOESTER",,Not yet recruiting,Steno Diabetes Center Copenhagen,"October 1, 2020",Interventional,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,COVID
3744,COVID,"February 08, 2021",41,NCT04573855,ANTI-SARS-COV-2 IMMUNOGLOBULIN,,Not yet recruiting,D'Or Institute for Research and Education,"December 1, 2020",Interventional,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19: A PHASE I / II STUDY,COVID
3745,MORTALITY,"February 08, 2021",1000,NCT04573868,,SPAIN,Recruiting,Hospitales Universitarios Virgen del Rocío,"March 1, 2020",Observational [Patient Registry],"National Study ""AEC COVID-19"" on Patients Undergoing Surgical Intervention During the SARS-CoV-2 Pandemic.",Unrelated
3746,CANCER,"February 08, 2021",40,NCT04574050,SELF-BREATHE,,Not yet recruiting,King's College Hospital NHS Trust,"December 3, 2020",Interventional,"A Self - Guided, Internet - Based Intervention for Patients With Chronic Breathlessness (SELF-BREATHE): Feasibility Randomised Controlled Trial",Unrelated
3747,ANXIETY,"February 08, 2021",184,NCT04574219,USE OF FACETIME WITH CHILD AND PARENTS DURING INDUCTION,CANADA,Recruiting,"Children's Hospital Medical Center, Cincinnati","November 3, 2020",Interventional,Feasibility and Acceptability of Virtual Parental Presence on Induction of Anesthesia - Modernizing Solutions for Pediatric Anesthesia in Response to COVID-19,Unrelated
3748,DISTRESS,"February 08, 2021",380,NCT04574466,PROBLEM MANAGEMENT PLUS,SWITZERLAND,Recruiting,University of Zurich,"August 25, 2020",Interventional,Scaling-up Psychological Interventions With Syrian Refugees in Switzerland: RCT,Unrelated
3749,HEALTHCARE WORKER,"February 08, 2021",100000,NCT04574765,NASOPHARYNGEAL SWAB,CANADA,Recruiting,"University Health Network, Toronto","April 16, 2020",Observational,"A Research Platform to Screen and Protect Individuals That Work Within a Food Production, Healthcare, Research or Clinical Organization - RESPECT",Unrelated
3750,ACUTE LUNG INJURY,"February 08, 2021",42,NCT04574869,RLS-0071,UNITED STATES,Not yet recruiting,"ReAlta Life Sciences, Inc.",October 2020,Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study to Evaluate the Safety, Tolerability, Preliminary Efficacy, PK, & PD of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure",Unrelated
3751,COVID INFECTION,"February 08, 2021",100,NCT04575038,BREQUINAR,UNITED STATES,Recruiting,"Clear Creek Bio, Inc.","November 19, 2020",Interventional,"The CRISIS2 Study: A Phase 2, Randomized, Double Blind, Placebo-controlled, Multi-center Study Assessing the Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Out-patient Adults With SARS-CoV-2",COVID
3752,SARS-CoV2 INFECTION,"February 08, 2021",400,NCT04575064,STANDARD OF CARE (SOC),GERMANY,"Active, not recruiting",Professor Dr. Bernd Mühlbauer,"June 29, 2020",Interventional,An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY,COVID
3753,COVID,"February 08, 2021",100,NCT04575168,SPARTAN COVID-19 TEST,UNITED STATES,Recruiting,Spartan Bioscience Inc.,"October 30, 2020",Observational,Assess the Performance of Spartan COVID-19 V2 System in a Clinical Setting in Comparison to a Laboratory (Standard of Care (SOC)) PCR Method,COVID
3754,COVID,"February 08, 2021",400,NCT04575532,"USE OF THE PINPOINTIQ SOLUTION (PHYSIQ, INC.)",UNITED STATES,Enrolling by invitation,"physIQ, Inc.","October 5, 2020",Observational,Personalized Analytics and Wearable Biosensor Platform for Early Detection of COVID-19 Decompensation,COVID
3755,COVID,"February 08, 2021",600,NCT04575545,SEROLOGY TEST FOR COVID-19,FRANCE,Not yet recruiting,Hôpital Européen Marseille,October 2020,Observational,Prevalence of COVID-19 Infection in a Cohort of Patient Infected by the HIV and Patients Taking PrEP Pre-exposure Prophylaxis,COVID
3756,SARS-CoV2,"February 08, 2021",0,NCT04575558,HYDROXYCHLOROQUINE AND AZITHROMYCIN,BRAZIL,Withdrawn,Latin American Cooperative Oncology Group,"June 30, 2020",Interventional,"A Randomized, Multi-institutional, Phase 2 Study of Hydroxichloroquine Plus Azithromycin for High Risk SARS-CoV-2 Positive Patients (COVID-19)",COVID
3757,PSYCHOSOCIAL IMPACTS OF THE COVID PANDEMIC,"February 08, 2021",5000,NCT04575571,"NO INTERVENTION, THIS IS AN OBSERVATIONAL STUDY THAT USES VALIDATED QUESTIONNAIRES AND QUALITATIVE INTERVIEWS..",CANADA,Recruiting,Laval University,"April 29, 2020",Observational,The MAVIPAN Protocol: For a Structured Response to the Psychosocial Consequences of the Restrictive Measures Imposed by the Global Health COVID-19 Pandemic,COVID
3758,CORONAVIRUS DISEASE (COVID),"February 08, 2021",1300,NCT04575584,MOLNUPIRAVIR,BRAZIL,Recruiting,Merck Sharp & Dohme Corp.,"October 19, 2020",Interventional,"A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults With COVID-19",COVID
3759,CORONAVIRUS DISEASE (COVID),"February 08, 2021",1450,NCT04575597,MOLNUPIRAVIR,BRAZIL,Recruiting,Merck Sharp & Dohme Corp.,"October 19, 2020",Interventional,"A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults With COVID-19.",COVID
3760,COVID,"February 08, 2021",68,NCT04575610,PF-06650833,UNITED STATES,Recruiting,Yale University,"November 30, 2020",Interventional,Investigation of IRAK4 Inhibition to Mitigate the Impact of COVID-19 in Severe SARS-CoV-2 (I-RAMIC),COVID
3761,SLEEP,"February 08, 2021",40,NCT04576260,COGNITIVE BEHAVIOURAL THERAPY FOR INSOMNIA,UNITED KINGDOM,Recruiting,University of Glasgow,"October 16, 2020",Interventional,"Effect of a Cognitive Behavioural Therapy Intervention to Improve Sleep on Wellbeing, Dietary Intake and Food Preference: a Feasibility Study.",Unrelated
3762,PATIENT SAFETY,"February 08, 2021",800,NCT04576299,GROUP 1,CHILE,"Active, not recruiting",Universidad Miguel Hernandez de Elche,"September 1, 2020",Observational,Health Care Workers' Perception of Patient Safety During the COVID-19 Pandemic: Opportunities and Challenges,Unrelated
3763,COVID,"February 08, 2021",64,NCT04576312,UNI911 INHALATION,DENMARK,"Active, not recruiting",UNION therapeutics,"June 29, 2020",Interventional,"Phase 1 Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19",COVID
3764,COVID,"February 08, 2021",150,NCT04576351,OBSERVATION,NORWAY,Recruiting,Oslo University Hospital,"September 1, 2020",Observational,The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19,COVID
3765,"INFLUENZA, HUMAN","February 08, 2021",820,NCT04576377,FLUBLOK,HONG KONG,Recruiting,The University of Hong Kong,"October 5, 2020",Interventional,The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE) Study - a Randomized Controlled Trial,Respiratory
3766,COVID,"February 08, 2021",164,NCT04576728,TRIMODULIN,BRAZIL,Recruiting,Biotest,"October 6, 2020",Interventional,"A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase II Trial Investigating the Efficacy and Safety of Trimodulin (BT588) as add-on Therapy to Standard of Care in Adult Subjects With Severe COVID-19",COVID
3767,COVID,"February 08, 2021",233,NCT04577105,SIMPLE CHEST TOMOGRAPHY,MEXICO,Completed,Instituto Nacional de Cardiologia Ignacio Chavez,"April 1, 2020",Observational,"Risk Factors, Prognosis and Findings by Computed Tomography in Patients Infected by COVID-19 and Its Association With Severity.",COVID
3768,COVID,"February 08, 2021",29,NCT04577235,SEVERITY OF LUNG INVOLVEMENT WITH COVID-19.,TURKEY,Completed,Gaziosmanpasa Taksim Research and Education Hospital,"June 5, 2020",Interventional,Evaluation of the Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores of Patients With Severe COVID 19 Pneumonia in Intensive Care.,COVID
3769,COVID,"February 08, 2021",45,NCT04577378,DRUG: ISOTRETINOIN(AEROSOLIZED 13 CIS RETINOIC ACID) PLUS AEROSOLIZED ITRACONAZOLE,EGYPT,Not yet recruiting,Kafrelsheikh University,"October 20, 2020",Interventional,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach,COVID
3770,COVID,"February 08, 2021",90,NCT04577534,IV TOCILLIZUMAB (TCZ),FINLAND,Recruiting,Jarmo Oksi,"August 14, 2020",Interventional,COVID-19: Salvage TOcilizumab as a Rescue Measure. Use of Tocilizumab in the Inflammatory Phase of COVID-19 / New Coronavirus Disease,COVID
3771,COVID,"February 08, 2021",250,NCT04578132,,SPAIN,Recruiting,Spanish Oncology Genito-Urinary Group,"November 24, 2020",Observational,Observational Retrospective-prospective Study in Patients With Genitourinary Tumors Presenting COVID-19 Infection (SOGUG-COVID-19),COVID
3772,COVID,"February 08, 2021",200,NCT04578158,STANDARD COVID-19 CARE,PAKISTAN,Recruiting,Liaquat University of Medical & Health Sciences,"September 29, 2020",Interventional,"A Prospective, Randomized, Open-labelled, Controlled Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With Diagnosis of COVID-19.",COVID
3773,COVID,"February 08, 2021",100,NCT04578197,,SWEDEN,Recruiting,Karolinska University Hospital,"August 18, 2020",Observational,"NeuroCOVID - A Study of Activation and Inhibition of the Immune and Coagulation Systems, the Presence of Biochemical (Blood / CSF) and Structural Brain Changes and Their Association With Long-term Cognitive Dysfunction in Intensive Care-requiring Covid-19 Patients",COVID
3774,CORONAVIRUS INFECTION,"February 08, 2021",58,NCT04578210,T MEMORY CELLS AND NK CELLS,SPAIN,Recruiting,Instituto de Investigación Hospital Universitario La Paz,"September 4, 2020",Interventional,A Phase I/II Dose-escalation Multi Center Study to Evaluate the Safety of Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in coronaviruS pnEumonia and/or Lymphopenia,COVID
3775,COVID,"February 08, 2021",360,NCT04578236,AEROSOLIZED 13 CIS RETINOIC ACID PLUS INHALATION ADMINISTRATION BY NEBULIZATION CAPTOPRIL 25MG,,Not yet recruiting,Kafrelsheikh University,November 2020,Interventional,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",COVID
3776,SARS-CoV2 INFECTION,"February 08, 2021",2750,NCT04578509,NASOPHARYNGEAL SWAB,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 19, 2020",Observational,Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva (COVID-19),COVID
3777,COVID,"February 08, 2021",230,NCT04579289,QUESTIONNAIRE,FRANCE,Completed,Rennes University Hospital,"June 15, 2020",Observational,Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions_COVID-19,COVID
3778,CORONAVIRUS DISEASE 2019,"February 08, 2021",80,NCT04579393,PLACEBO,UNITED STATES,Recruiting,"National Heart, Lung, and Blood Institute (NHLBI)","January 27, 2020",Interventional,A Phase II Study Evaluating Fostamatinib for Hospitalized Adults With COVID-19,COVID
3779,COVID,"February 08, 2021",0,NCT04579458,COLLECTION OF TEARS AND SALIVA.,UNITED STATES,Withdrawn,Vanderbilt University Medical Center,"December 28, 2020",Observational,Assessment of COVID (Coronavirus Disease)-19 in Tearfilm,COVID
3780,COVID,"February 08, 2021",2000,NCT04579471,SARS-COV-2 IGG,BELGIUM,Recruiting,Universitaire Ziekenhuizen Leuven,"July 1, 2020",Observational,Prevalence and Outcome of SARS-CoV-2 Infection in Solid Organ and Hematopoietic Cell Transplant Recipients: The COVITRA Study,COVID
3781,COVID,"February 08, 2021",10000,NCT04579549,SALIVA ASSAY,UNITED STATES,Enrolling by invitation,"University of Wisconsin, Madison","September 29, 2020",Interventional,Repeat Saliva Testing for SARS-CoV-2 Using RT-LAMP Assay,COVID
3782,ACUTE KIDNEY INJURY,"February 08, 2021",5000,NCT04579562,NO INTERVENTION,,Not yet recruiting,University Hospitals of Derby and Burton NHS Foundation Trust,"November 1, 2020",Observational,Regional Epidemiology of COVID-19 and Acute Kidney Injury in England,Unrelated
3783,CORONAVIRUS INFECTION,"February 08, 2021",100,NCT04579588,FLU SHOT,UNITED STATES,Enrolling by invitation,Stanford University,"October 29, 2020",Observational,Understanding Immunity to the Flu Vaccine in COVID-19 Patients,COVID
3784,COVID,"February 08, 2021",358,NCT04579627,QUESTIONNAIRE,UNITED KINGDOM,Completed,Royal Cornwall Hospitals Trust,"May 14, 2020",Observational,How Has the Increased Use of FFP3 Style Respirators During the COVID-19 Pandemic Affected Hospital Doctor's Facial Hair? Implications for Staff Safety and Welfare.,COVID
3785,COVID,"February 08, 2021",6200,NCT04579640,VITAMIN D,UNITED KINGDOM,"Active, not recruiting",Queen Mary University of London,"October 27, 2020",Interventional,Phase 3 Randomised Controlled Trial of Vitamin D Supplementation to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections in the UK Population,COVID
3786,COVID,"February 08, 2021",50,NCT04581018,HEALTH SUPPLEMENTS,HONG KONG,Recruiting,Siew Chien NG,"August 13, 2020",Interventional,An Evaluation of a Synbiotic Formula for Symptom Improvement in Hospitalised Patients With COVID-19 Infection,COVID
3787,COVID,"February 08, 2021",60,NCT04581031,CONTINUOUS VITAL SIGN MONITORING - ISANSYS PATIENT STATUS ENGINE,UNITED KINGDOM,Recruiting,The Christie NHS Foundation Trust,"July 11, 2020",Interventional,COntinuous Signs Monitoring In Covid-19 Patients,COVID
3788,PSORIASIS,"February 08, 2021",197,NCT04581044,,EGYPT,Completed,Cairo University,"September 17, 2020",Observational,Impact of COVID-19 on Psoriasis Practice: A Cross Sectional Study,Unrelated
3789,CANCER,"February 08, 2021",4,NCT04581070,,IRELAND,Terminated,Cancer Trials Ireland,"April 29, 2020",Observational,"COVID-IYON Study. Prospective, Multisite, Descriptive, Observational Clinical/Epidemiological Study Examining Data Pertaining to Clinical Outcomes and Organizational Responses to the 2020 SARS-Coronavirus-2 (SARS-CoV-2) Pandemic",Unrelated
3790,COVID,"February 08, 2021",30,NCT04581083,RT-PCR,BOLIVIA,Completed,Hunter College of City University of New York,"October 8, 2020",Observational,"Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic, Tarija-Bolivia",COVID
3791,COVID,"February 08, 2021",3000,NCT04581096,NO INTERVENTION,SPAIN,Recruiting,Hospital General Universitario de Valencia,"October 2, 2020",Observational [Patient Registry],Evaluation of the Response of COVID-19 Spread With a Spatiotemporal Analysis in a Tertiary Hospital,COVID
3792,COVID,"February 08, 2021",500,NCT04581135,COVID-19,SWITZERLAND,Recruiting,"University Hospital Inselspital, Berne","May 1, 2020",Observational [Patient Registry],Prospective Observational Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19,COVID
3793,SARS-CoV2,"February 08, 2021",2000,NCT04581148,BLOOD TEST FOR IGG ANTIBODIES AGAINST SARS-COV-2,,Not yet recruiting,University of Erlangen-Nürnberg Medical School,"October 5, 2020",Observational,Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients,COVID
3794,ACUTE RESPIRATORY FAILURE,"February 08, 2021",10,NCT04581161,LIFE2000® VENTILATOR,UNITED STATES,Recruiting,Hill-Rom,"August 28, 2020",Interventional,A Novel Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,Respiratory
3795,HEMATOLOGIC MALIGNANCIES,"February 08, 2021",400,NCT04581187,QUALITY OF LIFE ASSESSMENT,,Not yet recruiting,Gruppo Italiano Malattie EMatologiche dell'Adulto,October 2020,Observational [Patient Registry],An onLine-pLatform to Improve Patient-centered Care During the COVID-19 pAndemic: a GIMEMA surveillaNce Program in hematologiC malignanciEs,Unrelated
3796,COVID,"February 08, 2021",300,NCT04581200,LIFT,UNITED STATES,Recruiting,Duke University,"January 25, 2021",Interventional,"Addressing Psychological Distress Symptoms Among Serious Illness Survivors of a Viral Pandemic With a Completely Self-directed, Symptom-responsive Mobile Mindfulness Intervention: a Randomized Controlled Trial",COVID
3797,COVID,"February 08, 2021",30,NCT04581291,MODERATE INTENSITY AEROBIC EXERCISES,TURKEY,Completed,Istanbul Gelisim University,"January 1, 2020",Interventional,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,COVID
3798,NEUROMUSCULAR DISEASES,"February 08, 2021",75,NCT04581577,SEMI-STRUCTURED TELEPHONE QUESTIONNAIRE,UNITED KINGDOM,Recruiting,Royal Brompton & Harefield NHS Foundation Trust,"September 11, 2020",Observational,Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders,Unrelated
3799,PERINATAL ANXIETY,"February 08, 2021",50,NCT04581681,GROUP COGNITIVE BEHAVIOUR THERAPY FOR PERINATAL ANXIETY (CBT-PA),CANADA,Recruiting,University of Manitoba,"December 2, 2020",Interventional,Group Cognitive Behaviour Therapy for Perinatal Anxiety: A Randomized Controlled Trial,Unrelated
3800,VIRUS-HIV,"February 08, 2021",1800,NCT04581746,QUESTIONNAIRE,FRANCE,Recruiting,Tourcoing Hospital,"November 25, 2020",Interventional,Evaluation of the Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),Unrelated
3801,ARDS,"February 08, 2021",52,NCT04581811,PROLONGED PRONED POSITIONING,UNITED STATES,Recruiting,University of Alabama at Birmingham,"November 10, 2020",Interventional,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS): A Pilot Study,Unrelated
3802,COVID,"February 08, 2021",850,NCT04581863,PULSE OXIMETER,UNITED STATES,Recruiting,University of Pennsylvania,"November 30, 2020",Interventional,Randomized Trial of Adding Pulse Oximetry to an Automated Text-messaging Program for Remotely Monitoring Patients at Home With COVID-19,COVID
3803,SEVERE ACUTE RESPIRATORY SYNDROME,"February 08, 2021",2380,NCT04581889,DIAGNOSTIC TEST,GERMANY,Recruiting,University Hospital Tuebingen,"July 2, 2020",Observational,"Prospective, Seroepidemiological, Non-invasive Cohort Study in Tübingen Children Age-stratified by Nursery and School Attendance",Respiratory
3804,COVID,"February 08, 2021",420,NCT04581915,TRIAZAVIRIN (RIAMILOVIR),SOUTH AFRICA,Recruiting,Fatima Mayat,"September 8, 2020",Interventional,"A Pragmatic, Individually Randomised, Double-blind, Placebo-controlled Trial of Triazavirin (TZV) for the Treatment of Mild-moderate SARS-CoV-2 Infection A Phase II and III Clinical Trial",COVID
3805,COVID,"February 08, 2021",300,NCT04581928,,EGYPT,Recruiting,ClinAmygate,"October 10, 2020",Observational,Patients Reactions Towards Their Diagnosis as Having COVID-19: A Cohort Study,COVID
3806,CORONAVIRUS,"February 08, 2021",456,NCT04581954,RUXOLITINIB,UNITED KINGDOM,Recruiting,Imperial College London,"October 2, 2020",Interventional,Randomised Multi-arm Trial of Ruxolitinib (RUX) and Fostamatinib (FOS) for COVID-19 Pneumonia,COVID
3807,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",55,NCT04582201,AGENT-797,UNITED STATES,Recruiting,"AgenTus Therapeutics, Inc.","September 21, 2020",Interventional,A Phase 1 Study of agenT-797 to Treat Moderate to Severe Acute Respiratory Syndrome in COVID-19 Patients,Respiratory
3808,COVID,"February 08, 2021",30,NCT04582214,METANEB® SYSTEM,UNITED STATES,Recruiting,Hill-Rom,"September 28, 2020",Interventional,A Pilot Study of the Use of Oscillation and Lung Expansion (OLE) Therapy in Patients Hospitalized With COVID-19,COVID
3809,COVID,"February 08, 2021",40,NCT04582266,REMDESIVIR,PUERTO RICO,Not yet recruiting,International Maternal Pediatric Adolescent AIDS Clinical Trials Group,"October 15, 2020",Observational,Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States,COVID
3810,SARS-CoV2 INFECTION,"February 08, 2021",48,NCT04582318,NGM621,AUSTRALIA,Recruiting,"NGM Biopharmaceuticals, Inc","November 8, 2020",Interventional,"A Randomized, Double Blind, Placebo Controlled, Combined Phase 1/2 Single Dose and Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of NGM621 in Healthy Volunteers and the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy in Subjects With Confirmed SARS-CoV-2 Infection",COVID
3811,COVID,"February 08, 2021",300,NCT04582331,SMARTPHONE-BASED VOICE AND SELF-REPORTED SYMPTOM COLLECTION,INDIA,Recruiting,Sonde Health,"September 10, 2020",Observational,Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis,COVID
3812,COVID,"February 08, 2021",13000,NCT04582344,CORONAVAC,TURKEY,Recruiting,Health Institutes of Turkey,"September 14, 2020",Interventional,"Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated",COVID
3813,RESPIRATORY FAILURE,"February 08, 2021",60,NCT04582838,PULSE OXIMETER,ROMANIA,Recruiting,Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu,"October 1, 2020",Observational,Photoplethysmographic Signal Analysis as a Proxy for Excessive Effort and Impending Respiratory Failure,Respiratory
3814,COVID INFECTION,"February 08, 2021",500,NCT04582903,,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"February 11, 2021",Observational,Send-in Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence,COVID
3815,COVID,"February 08, 2021",500,NCT04583189,PERFORMANCE OF THE TEST ANTIGENIC AND TEST RT-PCR,FRANCE,Completed,Centre Hospitalier Intercommunal Creteil,"October 1, 2020",Interventional,Evaluation Des Performances du Test Rapide antigénique Covid-19 Ag BSS Chez l'Enfant Symptomatique Dans un Service d'Urgences pédiatriques,COVID
3816,COVID,"February 08, 2021",40,NCT04583228,HLX71,,Not yet recruiting,Hengenix Biotech Inc,"November 30, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 in Healthy Adult Subjects",COVID
3817,ACUTE KIDNEY INJURY,"February 08, 2021",220,NCT04583293,NO INTERVENTION,UNITED KINGDOM,Recruiting,University Hospitals of Derby and Burton NHS Foundation Trust,"December 8, 2020",Observational,Long-term Outcomes After Acute Kidney Injury in Coronavirus Disease (COVID-19),Unrelated
3818,COVID,"February 08, 2021",120,NCT04583306,"RAMAN ANALYSIS OF SALIVA, CHARACTERIZATION OF THE RAMAN DATABASE AND BUILDING OF THE CLASSIFICATION MODEL",ITALY,Recruiting,Fondazione Don Carlo Gnocchi Onlus,"June 1, 2020",Observational [Patient Registry],Characterization of the COVID-19 Raman Signature of Saliva as a Potential Tool for the Fast Discrimination of SARS-CoV-2 Infection and Severity,COVID
3819,SARS-COV,"February 08, 2021",160,NCT04583319,EASYCOV POC,TURKEY,Recruiting,Firalis SA,October 2020,Observational,"A Prospective, Non-interventional Study for Validation of a Rapid, Non-invasive IVD as a Point-of-care Test for Diagnosis of SARS-COV-2 Infection",Respiratory
3820,HYPERTENSION,"February 08, 2021",32,NCT04583345,QUESTIONNAIRES,TURKEY,Recruiting,Ebru Calik Kutukcu,"June 1, 2020",Observational,Comparison of Physical Activity Levels and Disease Attitudes of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic,Unrelated
3821,COVID,"February 08, 2021",1633,NCT04583410,NICOTINE PATCH,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 22, 2020",Interventional,Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers,COVID
3822,VIRAL INFECTION,"February 08, 2021",250,NCT04583449,MENTAL IMAGERY,UNITED KINGDOM,Recruiting,University of East London,"August 19, 2020",Interventional,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,Unrelated
3823,CORONAVIRUS INFECTION,"February 08, 2021",40,NCT04583566,COVID-19 DIAGNOSTIC AND ASSESSMENT TESTS,EGYPT,Recruiting,Tanta University,"October 4, 2020",Observational [Patient Registry],"Studies on the Differential Expression of Cytokines, Transcriptome and miRNA in the Context of COVID-19 Infection in Egyptian Community",COVID
3824,COVID,"February 08, 2021",300,NCT04583592,CAMOSTAT MESILATE,UNITED STATES,Recruiting,Sagent Pharmaceuticals Inc.,"November 9, 2020",Interventional,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Camostat Mesilate for Treatment of COVID-19 in Outpatients",COVID
3825,COVID,"February 08, 2021",700,NCT04583761,QUESTIONNAIRE,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"October 12, 2020",Observational,Tobacco and Nicotine Consumption and the Risk of Acquisition of COVID-19: A Case Control Study Among Healthcare Workers,COVID
3826,ANESTHESIA,"February 08, 2021",400,NCT04583865,TELECONSULTATION,FRANCE,"Active, not recruiting","University Hospital, Toulouse","October 7, 2020",Observational,Assessment of the Feasibility and Quality of the Consultation by TeleConsultation in Pediatric Anesthesia in the Context of the Covid 19 Pandemic,Unrelated
3827,COVID,"February 08, 2021",200,NCT04583956,PLACEBO,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"October 14, 2020",Interventional,A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults,COVID
3828,COVID,"February 08, 2021",200,NCT04583969,LENZILUMAB,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"October 19, 2020",Interventional,A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults,COVID
3829,CORONAVIRUS DISEASE (COVID),"February 08, 2021",180,NCT04583982,T-DETECT™ SARS-COV-2 ASSAY,UNITED STATES,Completed,Adaptive Biotechnologies,"October 9, 2020",Observational,ImmuneSense™ COVID-19 Study,COVID
3830,SARS-CoV2 INFECTION,"February 08, 2021",15000,NCT04583995,SARS-COV-2 RS/MATRIX M1-ADJUVANT,UNITED KINGDOM,Recruiting,Novavax,"September 28, 2020",Interventional,"A Phase 3, Randomised, Observer-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants 18-84 Years of Age in the United Kingdom",COVID
3831,COVID,"February 08, 2021",50,NCT04584411,CARDIAC MAGNETIC RESONANCE IMAGING,,Not yet recruiting,Assiut University,"November 1, 2020",Observational,Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance,COVID
3832,EPIDEMIOLOGY,"February 08, 2021",6390,NCT04584424,THE STUDY DOES NOT REQUIRED,ETHIOPIA,Not yet recruiting,Ethiopian Public Health Institute,"October 30, 2020",Observational,Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia: Multi-Site Cohort Study,Unrelated
3833,COVID,"February 08, 2021",400,NCT04584437,INFRARED ENERGY AND DIETARY SUPPLEMENT,CANADA,Not yet recruiting,GAAD Medical Research Institute Inc.,"January 31, 2021",Interventional,The Treatment and Prevention of Covid-19 Pandemic Using Infrared and /or Vitamin C.,COVID
3834,COVID,"February 08, 2021",100,NCT04584450,QUESTIONNAIRE,TURKEY,Completed,Hacettepe University,"September 2, 2020",Observational,Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale,COVID
3835,SPONDYLOARTHRITIS,"February 08, 2021",150,NCT04584541,BLOOD TESTS,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 11, 2020",Interventional,Study of the Viral Load and Humoral and Cellular B and T Responses in Patients With Rheumatoid Arthritis and Spondyloarthritis Under Immunosuppressive Treatments,Unrelated
3836,COVID,"February 08, 2021",1100,NCT04584567,DOXYCYCLIN,TUNISIA,Recruiting,Hedi Gharsallah,"November 20, 2020",Interventional,Covid-19 Infection Prophylaxis With Low Dose of Doxycycline and Zinc in Health Care Workers,COVID
3837,CORONAVIRUS DISEASE (COVID)19,"February 08, 2021",50,NCT04584580,LOW-MOLECULAR-WEIGHT HEPARIN,EGYPT,Recruiting,Ain Shams University,"August 1, 2020",Interventional,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,COVID
3838,COVID,"February 08, 2021",50,NCT04584593,SAMPLE,FRANCE,Recruiting,"University Hospital, Toulouse","October 2, 2020",Interventional,Pilot Study to Detect SARS-CoV-2 Virus in Sperm : a COVID-19 Study.,COVID
3839,CORONAVIRUS DISEASE (COVID),"February 08, 2021",100,NCT04584606,LAB WORKUP (ON ADMISSION AND REGULARLY DURING FOLLOW UP).,EGYPT,Recruiting,Ain Shams University,"June 27, 2020",Observational,Ain Shams University Experience: Clinical Characteristics and Outcome Determinants of Hospitalized Covid-19 Patients at Ain Shams University Obour Hospital,COVID
3840,DYSPHAGIA,"February 08, 2021",36,NCT04584658,FIBREOPTIC ENDOSCOPIC EVALUATION OF SWALLOWING (FEES),UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"September 15, 2020",Observational,Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19): A Prospective Observational Cohort Study.,Unrelated
3841,COVID,"February 08, 2021",200,NCT04584671,HYPERPOLARIZED XENON-129 MRI OF THE LUNGS,CANADA,Not yet recruiting,"Western University, Canada","December 1, 2020",Observational,Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI and CT For Rapid Evaluations and NExt-wave Healthcare Planning,COVID
3842,COVID,"February 08, 2021",480,NCT04584684,1.5-2% W/V HYDROGEN PEROXIDE,UNITED STATES,Recruiting,"University of North Carolina, Chapel Hill","December 18, 2020",Interventional,Antiviral Efficacy and Acceptability of Therapeutic Antiseptic Mouth Rinses for Inactivation of COVID SARS-2 Virus,COVID
3843,COVID,"February 08, 2021",50,NCT04584697,COVI-AMG,,Not yet recruiting,"Sorrento Therapeutics, Inc.",December 2020,Interventional,"A Randomized, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Outpatients With COVID-19 Who Are Asymptomatic or Have Mild Symptoms",COVID
3844,COVID,"February 08, 2021",60,NCT04584710,RTB101,UNITED STATES,Recruiting,Restorbio Inc.,"October 13, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Adults Age ≥65 Years",COVID
3845,COVID,"February 08, 2021",100,NCT04585945,POSITIVE FOR SARS-COV-2 INFECTION,UNITED STATES,Recruiting,Prisma Health-Upstate,"August 4, 2020",Observational,Pregnancy Outcomes During the Pandemic: Using Placental Pathology and Gene Expression to Understand Fetal Risk,COVID
3846,ACUTE RESPIRATORY DISTRESS SYNDROME SECONDARY TO COVID,"February 08, 2021",200,NCT04586114,CORTICOSTEROIDS AND DERIVATIVES,FRANCE,"Active, not recruiting","Central Hospital, Nancy, France","March 1, 2020",Observational,Effect of Early Corticosteroid Therapy on Mortality in Patient With Acute Respiratory Distress Syndrome Secondary to Covid-19,COVID
3847,COVID,"February 08, 2021",30,NCT04586140,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"November 9, 2020",Observational,Operation of the Groupe Hospitalier Paris Saint-Joseph Clinical Ethical Reflection Assistance Group During the COVID-19,COVID
3848,COVID,"February 08, 2021",456,NCT04586153,MEPLAZUMAB FOR INJECTION,,Not yet recruiting,Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd,"December 30, 2020",Interventional,"A Multicenter, Seamless, Randomized, Third-Party-Blind, Clinical Trial to Evaluate the Safety and Efficacy of Meplazumab in Addition to Standard of Care for the Treatment of COVID-19 in Hospitalized Adults",COVID
3849,DEPRESSIVE SYMPTOMS,"February 08, 2021",2500,NCT04586192,COMMON ELEMENTS TOOLBOX- ADULT VERSION (COMET-A),UNITED STATES,Recruiting,University of Pennsylvania,"January 31, 2021",Interventional,Developing and Assessing a Digital Mental Health and Wellness Intervention for Adults: Randomized Control Trial of the Common Elements Toolbox (COMET),Unrelated
3850,"BURNOUT, PROFESSIONAL","February 08, 2021",50,NCT04586309,TRANSCENDENTAL MEDITATION,,Not yet recruiting,University of Arizona,November 2020,Interventional,Improving the Mental Health of Resident Physicians and Fellows : Reducing Burnout & Enhancing Resilience Through Transcendental Meditation,Unrelated
3851,COVID,"February 08, 2021",100,NCT04586413,NO INTERVENTION - QUALITY OF LIFE MEASURE,UNITED KINGDOM,Recruiting,Medialis Ltd.,"October 7, 2020",Observational,Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg),COVID
3852,CORONAVIRUS INFECTION,"February 08, 2021",110,NCT04587219,GAM-COVID-VAC,RUSSIAN FEDERATION,"Active, not recruiting","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","October 22, 2020",Interventional,"An Open Study of the Safety, Tolerability and Immunogenicity of the ""Gam-COVID-Vac""Vaccine Against COVID-19 (Solution for Intramuscular Injection) With the Participation of Volunteers in the Age Group Over 60 Years",COVID
3853,COVID,"February 08, 2021",100,NCT04587245,ONLINE QUESTIONNAIRE AND INTERVIEWS,UNITED STATES,Recruiting,"ND Sciences, LLC","October 1, 2020",Observational,The Provider Insurance Revenue Study,COVID
3854,BREAST CANCER,"February 08, 2021",100,NCT04587258,INFORMATIONAL VIDEOS AND SOCIAL MEDIA CAMPAIGNS ENCOURAGING CANCER SCREENING.,UNITED STATES,Recruiting,Rhode Island Hospital,"August 28, 2020",Observational,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island: A Community Based Quality Improvement Project of the Lifespan Cancer Institute,Unrelated
3855,COVID DISEASE,"February 08, 2021",100,NCT04587323,,UNITED STATES,Recruiting,University of Alabama at Birmingham,"May 22, 2020",Observational,COVID-19 RELATED SUBMISSION: VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease,COVID
3856,COVID,"February 08, 2021",50,NCT04587375,,FRANCE,Completed,"University Hospital, Montpellier","March 1, 2020",Observational,Diagnosis of Endocrine Dysfunctions in Covid-19 : Explorations of the Plasma Renin and Aldosterone Levels in Patients With Covid-19 Infection.,COVID
3857,TYPE2 DIABETES,"February 08, 2021",122,NCT04587414,EHEALTH +COUNSELLING CONTACTS,FINLAND,"Active, not recruiting",UKK Institute,"March 6, 2019",Interventional,Personalized eHealth Intervention in Patients With Type 2 Diabetes to Promote Daily Physical Activity Utilizing 24h Self-monitoring - Implementation Frustrated by COVID-19 Epidemic,Unrelated
3858,OXIMETRY,"February 08, 2021",90,NCT04587921,DIGITAL OXIMETER MONITORING,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"June 22, 2020",Interventional,Feasibility and Impact of Remote Oximetry and Cardiac Frequency Monitoring in Patients Hospitalized and Isolated With Covid-19,Unrelated
3859,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2),"February 08, 2021",250,NCT04588363,SARS-COV-2 AND/OR MIS-C EXPOSURE,UNITED STATES,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"November 19, 2020",Observational,An Observational Cohort Study to Determine Late Outcomes and Immunological Responses After Infection With SARS-CoV-2 in Children With and Without Multisystem Inflammatory Syndrome (MIS-C),COVID
3860,BEREAVEMENT,"February 08, 2021",200,NCT04588415,BEREAVEMENT VIRTUAL SUPPORT GROUP,,Not yet recruiting,Ottawa Hospital Research Institute,"November 1, 2020",Interventional,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic,Unrelated
3861,ACUTE RESPIRATORY DISTRESS,"February 08, 2021",30,NCT04588441,ADENOSINE,,Not yet recruiting,University of Florida,March 2021,Interventional,Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19 (The ARCTIC Trial),Respiratory
3862,SARS-CoV2 INFECTION,"February 08, 2021",160,NCT04588480,BNT162B2,JAPAN,"Active, not recruiting",BioNTech SE,"October 21, 2020",Interventional,"A PHASE 1/2, PLACEBO-CONTROLLED, RANDOMIZED, AND OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTHY JAPANESE ADULTS",COVID
3863,COVID,"February 08, 2021",640,NCT04588792,NEBULIZED FUROSEMIDE,CANADA,Recruiting,Queen's University,"February 1, 2021",Interventional,Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19 - A Phase 2/3 Study,COVID
3864,COLO-RECTAL CANCER,"February 08, 2021",100,NCT04588909,COLORECTAL RESECTIONS,INDIA,"Active, not recruiting",Sheri Kashmir Institute of Medical Sciences,"March 23, 2020",Observational,Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy,Unrelated
3865,DISTRESS DUE TO COVID,"February 08, 2021",63,NCT04589104,EXPRESSIVE WRITING,UNITED STATES,Completed,Duke University,"May 26, 2020",Interventional,Expressive Writing for COVID-19 Resilience,COVID
3866,PARENTS DURING COVID,"February 08, 2021",11,NCT04589117,EXPRESSIVE WRITING,UNITED STATES,Completed,Duke University,"May 27, 2020",Interventional,Expressive Writing for COVID-19 Resilience for Parents,COVID
3867,STRESS,"February 08, 2021",150,NCT04589377,MINDFULNESS TRAINING,UNITED STATES,Recruiting,University of Pittsburgh,"October 26, 2020",Interventional,Mobile Mindfulness Training and Physics Learning,Unrelated
3868,HYPERTENSION,"February 08, 2021",200,NCT04589923,LIFELIGHT® DATA COLLECT BLOOD PRESSURE GROUP,UNITED KINGDOM,Not yet recruiting,Xim Limited,October 2020,Observational,The Measurement of VItal SIgns by Lifelight® Data Collect Software in comparisON to the Standard of Care in Acutely Unwell Patients - The VISION-Acute Study,Unrelated
3869,PNEUMONIA,"February 08, 2021",56,NCT04589936,PRONE POSITIONING,UNITED KINGDOM,Recruiting,Cambridge University Hospitals NHS Foundation Trust,"September 3, 2020",Interventional,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care (PRONE-COVID Study),Respiratory
3870,COVID,"February 08, 2021",690,NCT04589949,CONVP,NETHERLANDS,Recruiting,Erasmus Medical Center,"October 12, 2020",Interventional,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),COVID
3871,COVID,"February 08, 2021",24,NCT04590053,ALLOCETRA-OTS,ISRAEL,Recruiting,Hadassah Medical Organization,"October 20, 2020",Interventional,"A Multi-Center Open-Label Study, Evaluating Safety and Preliminary Efficacy of Allocetra-OTS for the Treatment and Prevention of Organ-Failure Deterioration in Severe and Critical Patients With COVID-19 and Respiratory Dysfunction",COVID
3872,"INFLUENZA, HUMAN","February 08, 2021",734383,NCT04590066,FLU SHOT TEXT MESSAGES,UNITED STATES,Completed,University of Pennsylvania,"September 25, 2020",Interventional,Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy,Respiratory
3873,COVID,"February 08, 2021",100,NCT04590170,POST-INTENSIVE CARE UNIT SYNDROME,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"October 30, 2020",Observational,French Cohort of covid19 Patients With Post-intensive Care Syndrome : Rehabilitation From Intensive Care Unit to Home Return,COVID
3874,ADULT PATIENTS WITH LESIONS ON FINGERS OR TOES,"February 08, 2021",25,NCT04590209,BLOOD SAMPLING,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,October 2020,Interventional,Clinical and Mechanistic Study of Patients With a Recent Acrosyndrome,Unrelated
3875,SARS-CoV2 INFECTION,"February 08, 2021",80,NCT04590222,BLOOD SAMPLE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,November 2020,Observational,Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19,COVID
3876,COVID; SARS-CoV2,"February 08, 2021",120,NCT04590261,BLOOD SAMPLING,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"November 1, 2020",Interventional,Myeloid Cells in Patients With Covid-19 Pneumonia,COVID
3877,COVID,"February 08, 2021",5000,NCT04590274,HYDROXYCHLOROQUINE,,Not yet recruiting,International Brain Research Foundation,November 2020,Interventional,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),COVID
3878,SARS-CoV2 INFECTION,"February 08, 2021",187,NCT04590352,NASOPHARYNGEAL AND THROAT SWAB,NETHERLANDS,Completed,Radboud University,"March 26, 2020",Observational,Mucosal Immunity in Patients Diagnosed With SARS-CoV-2 Infection and Their Household Contacts,COVID
3879,COVID,"February 08, 2021",480,NCT04590365,CARRAGEENAN NASAL AND THROAT SPRAY,,Not yet recruiting,Swansea University,"January 30, 2021",Interventional,Efficacy of Iota-carrageenan Nasal Spray Prophylaxis for Healthcare Professionals Treating Patients During the COVID-19 Pandemic - A Double Blind Randomised Placebo-controlled Trial,COVID
3880,COVID,"February 08, 2021",600,NCT04590378,INTENSIVE CARE UNIT ADMISSION RATIO,TURKEY,Recruiting,Uşak University,"March 1, 2020",Observational,Evaluation of the Patients With COVID-19 in Terms of Pulmonary Embolism,COVID
3881,HEALTHY,"February 08, 2021",24,NCT04590430,HFB30132A,UNITED STATES,"Active, not recruiting",HiFiBiO Therapeutics,"October 20, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose First-in-Human Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenously Administered HFB30132A, a Monoclonal Antibody Directed Against SARS-CoV-2, in Healthy Adult Subjects",Unrelated
3882,DEMENTIA,"February 08, 2021",2880,NCT04590469,COVID WHELD,,Not yet recruiting,University of Exeter,"November 20, 2020",Interventional,Evidence-Based Supported Digital Intervention for Improving Wellbeing and Health of People Living in Care Homes and Care Home Staff (WHELD) During COVID-19: An RCT to Evaluate COVID-19 Adapted E-WHELD: Benefits and Cost-Effectiveness,Unrelated
3883,PNEUMONITIS,"February 08, 2021",132,NCT04590547,GLS-1027,,Not yet recruiting,"GeneOne Life Science, Inc.",February 2021,Interventional,"Safety, Tolerability and Efficacy of GLS-1027 in the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection",Unrelated
3884,COVID,"February 08, 2021",1400,NCT04590586,STANDARD OF CARE,SOUTH AFRICA,Recruiting,Amgen,"November 24, 2020",Interventional,Industry Alliance Platform Trial to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,COVID
3885,COVID,"February 08, 2021",500,NCT04590794,SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR,GREECE,"Active, not recruiting",University of Thessaly,"October 11, 2020",Observational,A Prospective Observational Study on Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Adult Patients With Covid-19,COVID
3886,"DIABETES MELLITUS, TYPE 2","February 08, 2021",172,NCT04591015,HOSPITAL: DD-CA,,Not yet recruiting,Scripps Whittier Diabetes Institute,"February 1, 2021",Interventional,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,Unrelated
3887,COVID,"February 08, 2021",100,NCT04591158,BUTTERFLY IQ,CANADA,Recruiting,Bridge to Health Medical and Dental USA,"September 15, 2020",Interventional,The Utility of Self-administered Lung Ultrasound in Patients With COVID-19,COVID
3888,SARS-CoV2,"February 08, 2021",72,NCT04591184,COVIGENIX VAX-001 PLACEBO,,Not yet recruiting,Entos Pharmaceuticals Inc.,February 2021,Interventional,"Phase I/II Trial to Evaluate Safety, Tolerability, Immunogenicity of a Prophylactic Plasmid DNA Vaccine for SARS CoV-2 [Covigenix VAX-001] in Healthy Adults From 18 to <85 Years of Age",COVID
3889,COVID,"February 08, 2021",1155,NCT04591210,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,CANADA,Not yet recruiting,Ottawa Heart Institute Research Corporation,"October 30, 2020",Interventional,"Evaluation of the Potential Benefit of Renin-angiotensin System Inhibitors (RASi, ACEi/ARB) in High-risk Patients With COVID-19. The COVID-RASi Trial",COVID
3890,COVID,"February 08, 2021",140,NCT04591600,IVERMECTIN AND DOXYCYLINE,IRAQ,Completed,Alkarkh Health Directorate-Baghdad,"July 1, 2020",Interventional,"Controlled Randomized Clinical Trial on Using Ivermectin With Doxycycline for Treating COVID-19 Patients in Baghdad, Iraq",COVID
3891,COVID,"February 08, 2021",1000,NCT04591613,QUESTIONNAIRE,FRANCE,Recruiting,Tourcoing Hospital,"December 31, 2020",Interventional,Late Clinical Events Associated With COVID-19 Infection: Multicenter Cohort,COVID
3892,COVID,"February 08, 2021",2000,NCT04591704,"HOSPITALISATION, NECESSITY OF ICU, MORTALITY RATE, LUNG INVOLVEMENT",TURKEY,Recruiting,Uşak University,"March 20, 2020",Observational,The Effect of Diabetes Mellitus on the Morbidity and Mortality Rates in Patients With COVID-19,COVID
3893,COVID,"February 08, 2021",35,NCT04591717,HAD5-S-FUSION+N-ETSD VACCINE,UNITED STATES,Recruiting,"ImmunityBio, Inc.","October 19, 2020",Interventional,"Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of Prophylactic Vaccination With 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers",COVID
3894,CRITICAL ILLNESS,"February 08, 2021",100,NCT04591873,TELEMEDICINE,TAIWAN,Not yet recruiting,National Taiwan University Hospital,"October 10, 2020",Observational,Application of Telemedicine to Optimize Teamwork and Infection Control of Critical Patients in Isolation Rooms in the Emergency Department During Novel Coronavirus Disease 2019 Outbreak,Unrelated
3895,EATING DISORDERS IN ADOLESCENCE,"February 08, 2021",140,NCT04591912,MIND. BODY. VOICE,UNITED STATES,Recruiting,"University of Colorado, Boulder","October 9, 2020",Interventional,"Randomized Controlled Trial of the Peer-Delivered ""Mind. Body. Voice."" Eating Disorder Prevention Program Among High School Women - Remote",Unrelated
3896,DIABETES MELLITUS,"February 08, 2021",500,NCT04592055,,TURKEY,Recruiting,Uşak University,"March 20, 2020",Observational,The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus,Unrelated
3897,CANCER,"February 08, 2021",40,NCT04592224,,UNITED KINGDOM,Recruiting,University of Southampton,"November 12, 2020",Observational,Cancer Information Your Way: Get What You Need to Make Your Decisions - a Qualitative Study of Decision Making by Patients With Lower Health Literacy Receiving Care for Incurable Cancer,Unrelated
3898,TREATMENT OF FATIGUE AFTER RESOLUTION OF COVID INFECTION,"February 08, 2021",40,NCT04592354,OXALOACETATE MEDICAL FOOD/DIETARY SUPPLEMENT,UNITED STATES,Recruiting,Terra Biological LLC,"October 15, 2020",Interventional,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,COVID
3899,SARS-CoV2,"February 08, 2021",345,NCT04592510,,,Not yet recruiting,Cairo University,February 2021,Observational,Impact of COVID-19 on Pediatric Dental Practice During First and Second Wave In Egypt : A Cross -Sectional Study Among Egyptian Pediatric Dentists,COVID
3900,SARS-CoV2,"February 08, 2021",40,NCT04592549,ADM03820,UNITED STATES,Recruiting,Ology Bioservices,"December 4, 2020",Interventional,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820 in Adults",COVID
3901,DEPRESSIVE SYMPTOMS,"February 08, 2021",500,NCT04592588,COMMON ELEMENTS TOOLBOX,INDIA,Recruiting,University of Pennsylvania,"October 19, 2020",Interventional,Online Wellness Activities for Indian College Students,Unrelated
3902,COVID,"February 08, 2021",10,NCT04592705,THERAPEUTIC PLASMA EXCHANGE,UNITED STATES,Recruiting,Larkin Community Hospital,"September 11, 2020",Interventional,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,COVID
3903,COVID PATIENTS,"February 08, 2021",24,NCT04592835,DWRX2003,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,"October 19, 2020",Interventional,"A Double-blind, Randomized, Placebo-controlled, Single-ascending Dose Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Following Intramuscular Administration in Healthy Volunteers",COVID
3904,COVID,"February 08, 2021",60,NCT04593069,NEUROCOGNITIVE ASSESSMENT,BELGIUM,Recruiting,Ziekenhuis Oost-Limburg,"October 7, 2020",Interventional,"Long-term Cognitive Impairment in ICU Patients, Admitted for COVID-19 Pneumonia: a Single Centre, Prospective Cohort Study",COVID
3905,SOCIAL ISOLATION,"February 08, 2021",40,NCT04593433,MUSEUM VIRTUAL GUIDED TOURS,CANADA,Not yet recruiting,Jewish General Hospital,"January 4, 2021",Interventional,"A 3-month Cycle of Virtual Weekly Montreal Museum of Fine Arts Tours to Promote Social Inclusion, Well-being, Quality of Life and Health in Older Community Members : a Pilot Study",Unrelated
3906,SARS-CoV2 INFECTION,"February 08, 2021",18,NCT04593641,CT-P59,"KOREA, REPUBLIC OF","Active, not recruiting",Celltrion,"September 4, 2020",Interventional,"A Pilot Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel Group, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Virology of CT-P59 in Patient With Mild Symptoms of SARS-CoV-2 Infection",COVID
3907,COVID,"February 08, 2021",257,NCT04593654,DOSE OF TINZAPARIN OR DALTEPARIN,SWEDEN,Completed,Karolinska Institutet,"March 1, 2020",Observational,Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients - More Patients Included and 90-day Follow up,COVID
3908,COVID,"February 08, 2021",2160,NCT04593940,INFLIXIMAB,UNITED STATES,Recruiting,Daniel Benjamin,"October 15, 2020",Interventional,Randomized Master Protocol for Immune Modulators for Treating COVID-19,COVID
3909,STRESS,"February 08, 2021",100,NCT04594278,MINDFULNESS BASED INTERVENTION,,Not yet recruiting,"University Health Network, Toronto","November 1, 2020",Interventional,Remote Delivery of a Mindfulness-based Intervention to Decrease Anxiety Levels and Burnout Among Health-care Professionals During the Covid-19 Pandemic,Unrelated
3910,ACUTE KIDNEY INJURY,"February 08, 2021",60,NCT04594291,MRI SCANS,UNITED KINGDOM,Recruiting,University Hospitals of Derby and Burton NHS Foundation Trust,"October 7, 2020",Observational,Long-term Outcomes After Acute Kidney Injury in Coronavirus Disease (COVID-19) as Determined by Multiparametric Magnetic Resonance Imaging (MRI),Unrelated
3911,CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04594330,VIRGIN COCONUT OIL (VCO),INDONESIA,Recruiting,Gadjah Mada University,"June 1, 2020",Interventional,Pilot Trial for the Benefit of Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,COVID
3912,COVID,"February 08, 2021",200,NCT04594343,DISULFIRAM,BRAZIL,Recruiting,ETICA,"November 20, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Safety and Clinical Outcomes Study of Disulfiram in Subjects With Moderate COVID-19",COVID
3913,COVID,"February 08, 2021",126,NCT04594356,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"November 19, 2020",Observational,"Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist",COVID
3914,HEALTHY VOLUNTEERS,"February 08, 2021",2700,NCT04594395,,CAMBODIA,Not yet recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"February 11, 2021",Observational,Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in Healthy Volunteers,Unrelated
3915,COVID,"February 08, 2021",198,NCT04594460,"HYDROGEN-OXYGEN GENERATOR WITH NEBULIZER, AMS-H-03",CHINA,Not yet recruiting,Guangzhou Institute of Respiratory Disease,"October 31, 2020",Interventional,A Clinical Trial to Evaluate the Efficacy and Safety of Hydrogen-oxygen Mixed Gas Inhalation in Convalescent Severe/Critically Ill Patients With Novel Coronavirus Pneumonia (COVID-19),COVID
3916,PERINATAL DEPRESSION,"February 08, 2021",58,NCT04594525,LOW-INTENSITY PSYCHOSOCIAL INTERVENTIONS THROUGH TELEMENTAL HEALTH,,Not yet recruiting,Hamad Medical Corporation,November 2020,Interventional,Low-intensity Psychosocial Interventions in Pregnant Women in Response to COVID-19: Maternal Mental Health Matters An Interventional Study,Unrelated
3917,"ARDS, HUMAN","February 08, 2021",46,NCT04594668,SENICAPOC,DENMARK,Recruiting,University of Aarhus,"April 24, 2020",Interventional,"Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency - A Randomized, Open-Label, Phase II Trial",Unrelated
3918,STREPTOCOCCUS PNEUMONIA,"February 08, 2021",150,NCT04594785,,FRANCE,Recruiting,"University Hospital, Montpellier","October 1, 2020",Observational,"Evaluation of Post Infectious Inflammatory Reaction (PIIR) in a Retrospective Study Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection",Respiratory
3919,DEPRESSION,"February 08, 2021",240,NCT04595084,MINDFULNESS BASED COGNITIVE THERAPY FOR RESILIENCE DURING COVID-19 PLUS CHAMINDWELL,,Not yet recruiting,Cambridge Health Alliance,"February 15, 2021",Interventional,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,Unrelated
3920,COVID,"February 08, 2021",120,NCT04595097,INSPIRATORY MUSCLE TRAIING,BRAZIL,Not yet recruiting,Escola Superior de Ciencias da Saude,"February 1, 2021",Interventional,Adjunctive Inspiratory Muscle Training for Patients With COVID-19,COVID
3921,COVID,"February 08, 2021",400,NCT04595110,OBSERVATIONAL STUDY,ITALY,Recruiting,ANNA FALANGA,"March 25, 2020",Observational,Extensive Investigation of the Hemostatic Profile in a Prospective Cohort of Patients Affected by COVID-19,COVID
3922,POST TRAUMATIC STRESS DISORDER,"February 08, 2021",3900,NCT04595123,,ALBANIA,Recruiting,University of Minho,"June 15, 2020",Observational,Impact of COVID-19 Pandemic in Perinatal Mental Health,Unrelated
3923,SARS-CoV2 INFECTION,"February 08, 2021",60,NCT04595136,DRUG COVID19-0001-USR,COLOMBIA,Not yet recruiting,United Medical Specialties,"November 2, 2020",Interventional,A Two-arm Randomized Double-blind Study With COVID19-0001-USR Administered Via Nebulization to Patients With Mild and/or Moderate Severe Acute Respiratory Syndrome (SARS-COV-2) Infection to Decrease Viral Load,COVID
3924,COVID INFECTION,"February 08, 2021",2000,NCT04595175,,UNITED STATES,Recruiting,"Brian Tiffany, MD","June 10, 2020",Observational [Patient Registry],Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW),COVID
3925,COVID,"February 08, 2021",100,NCT04595240,SEMEN ANALYSIS,EGYPT,Completed,Assiut University,"May 1, 2020",Observational,Semen Analysis Changes in Covid-19 Positive Patients,COVID
3926,COMMUNICATION,"February 08, 2021",200,NCT04595695,TRANSPARENT MASK,UNITED STATES,Completed,"University of North Carolina, Chapel Hill","September 3, 2020",Interventional,The Effect of Clear Masks in Improving Patient Relationships,Unrelated
3927,COVID,"February 08, 2021",90,NCT04595773,AEROBIC EXERCISE TRAINING,UNITED STATES,Recruiting,National Institutes of Health Clinical Center (CC),"January 22, 2021",Interventional,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): A Randomized Controlled Trial",COVID
3928,SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",40,NCT04595903,HEMOPURIFIER,UNITED STATES,Not yet recruiting,Aethlon Medical Inc.,January 2021,Interventional,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device,Respiratory
3929,COVID,"February 08, 2021",124,NCT04596085,INVESTIGATIONAL PRODUCT - VIRACIDE,INDIA,Recruiting,"The Herb, Inc","September 16, 2020",Interventional,"A Double Blind, Randomized, Placebo Controlled Study to Evaluate Efficacy and Safety of ""VIRACIDE"" in the Management of Corona Virus Disease 2019 (COVID-19)",COVID
3930,SARS-CoV2,"February 08, 2021",100,NCT04596098,BLOOD SAMPLING,FRANCE,Recruiting,"University Hospital, Grenoble","April 30, 2020",Observational,Immune Responses to COVID-19 (SARS-CoV-2 Related Infection); Isolation of Human Neutralizing Monoclonal Antibodies for Therapeutics and Vaccine Design Approaches: a Prospective Monocentric Trial With Collaborative Sample Collection.,COVID
3931,CORONAVIRUS INFECTION,"February 08, 2021",1200,NCT04596579,SARS-COV-2 ANTIBODY ANALYSIS,UNITED STATES,Enrolling by invitation,H. Lee Moffitt Cancer Center and Research Institute,"October 9, 2020",Observational,SARS-CoV-2 Immune Surveillance Among a Population Based Sample of Adults in Florida,COVID
3932,RESPIRATORY TRACT INFECTIONS,"February 08, 2021",2099,NCT04596657,VITAMIN D SUPPLEMENTATION,UNITED STATES,Recruiting,The Cooper Health System,"October 27, 2020",Interventional,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections in Hospital Workers: a Pragmatic Study,Respiratory
3933,COVID,"February 08, 2021",60,NCT04596839,REMDESIVIR,BANGLADESH,Recruiting,Dr. Md. Alimur Reza,"September 4, 2020",Interventional,"Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19): An Open Label, Multi-Center, Randomized Controlled Trial",COVID
3934,COVID,"February 08, 2021",10,NCT04596943,[68GA]GA-DOTA-(RGD)2 PET/CT,NETHERLANDS,Recruiting,Radboud University,"October 15, 2020",Observational,[68Ga]Ga-DOTA-(RGD)2 PET/CT Imaging of Activated Endothelium in Lung Parenchyma of COVID-19 Patients,COVID
3935,COVID,"February 08, 2021",35,NCT04597034,AN69-OXIRIS,MEXICO,Recruiting,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,"October 2, 2020",Interventional,"A Randomized, Controlled Trial to Evaluate Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) in Comparison With a Semi Selective Semipermeable Membrane (Standard AN-69) in COVID-19 Associated Acute Kidney Injury: oXAKI-COV Study.",COVID
3936,COVID,"February 08, 2021",200,NCT04597047,CAPILLARY COLLECTION & TESTING,UNITED STATES,Recruiting,LumiraDx UK Limited,"August 20, 2020",Interventional,"A Multicenter Covid-19 Study Conducted to Evaluate the Agreement Between Fingerstick Whole Blood, Venous Whole Blood, Plasma & Serum as Determined on the LumiraDx POC SARS-CoV-2 Ab Test & to Evaluate the Ease of Use at Point of Care Sites",COVID
3937,COVID,"February 08, 2021",200,NCT04597216,SAMPLE OF BLOOD AND SALIVA,FRANCE,Recruiting,"University Hospital, Grenoble","October 15, 2020",Interventional,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix,COVID
3938,MRSA BLOODSTREAM INFECTION,"February 08, 2021",,NCT04597242,EXEBACASE,UNITED STATES,Available,ContraFect,,Expanded Access,Expanded Access Study of a Single Dose of Exebacase in Addition to Antistaphylococcal Antibiotics for the Treatment of Persistent Methicillin-Resistant Staphylococcus Aureus (MRSA) Bloodstream Infections (Including Right Sided Endocarditis) in Patients Who Are Hospitalized With Coronavirus Disease 2019 (COVID-19),Unrelated
3939,COVID,"February 08, 2021",100,NCT04597736,"BIOLOGICAL COLLECTION WITH NASOPHARYNGEAL SAMPLES, SALIVA, BLOOD, STOOL AND URINE",FRANCE,Not yet recruiting,"University Hospital, Clermont-Ferrand",November 2020,Interventional,Biological Collection for the Study of the Relationship Between the Biological Profiles Observed and the Clinical Evolutions Within the Same Cluster of Transmission of the Coronavirus SARS-CoV-2,COVID
3940,SARS-COV INFECTION,"February 08, 2021",93,NCT04597775,HYDROXYCHLOROQUINE,,Not yet recruiting,"Regional Center for Disease Control and Prevention, Jordan","October 27, 2020",Interventional,"A Prospective, Randomized, Adaptive Phase II/III Clinical Trial, Controlled, Open-label, 3-arms, Parallel, Multi-centred, Chemoprevention of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis For COVID-19",Respiratory
3941,COVID,"February 08, 2021",25,NCT04597853,ASSESSMENT OF LUNG MECHANICS AND HEART-LUNG INTERACTIONS,,Not yet recruiting,University of Zurich,"October 20, 2020",Observational,"Assessment of Lung Mechanics in SARS-CoV-2/ COVID-19 Acute Respiratory Distress Syndrome: A Holistic, Longitudinal Analysis of the Lung-heart-ventilator Interaction",COVID
3942,COVID,"February 08, 2021",77,NCT04598256,ENDOSCOPIC PROCEDURE,TURKEY,Completed,Tepecik Training and Research Hospital,"June 1, 2020",Observational [Patient Registry],Evaluation of Children Who Were Underwent Endoscopic Procedures in the Normalization Process of Covid-19 Pandemic,COVID
3943,"CYTOKINE STORM, COVID","February 08, 2021",75,NCT04598334,,BANGLADESH,Not yet recruiting,"International Centre for Diarrhoeal Disease Research, Bangladesh","February 15, 2021",Observational,"Investigating the Inflammatory Cytokines and Cytokine Storm Among Bangladeshi Patients With COVID-19: a Prospective, Observational Study",COVID
3944,COVID,"February 08, 2021",225,NCT04598347,,SPAIN,Recruiting,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,"August 8, 2020",Observational [Patient Registry],Valuation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19,COVID
3945,SEVERE-ACUTE-RESPIRATORY-SYNDROME-CORONAVIRUS-2 (SARS-CoV2),"February 08, 2021",22,NCT04598581,LOW DOSE RADIATION THERAPY (LD-RT),SWITZERLAND,"Active, not recruiting","University Hospital, Basel, Switzerland","November 2, 2020",Interventional,Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2),COVID
3946,COVID,"February 08, 2021",220,NCT04598594,"PATCH, NICOTINE",FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"November 6, 2020",Interventional,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,COVID
3947,COVID,"February 08, 2021",50,NCT04598620,,DENMARK,Recruiting,Inger Lise Gade,"September 19, 2020",Observational,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate,COVID
3948,OLFACTION DISORDERS,"February 08, 2021",80,NCT04598763,SMELL THE ODORS OF THE OLFACTORY REHABILITATION KIT ACCORDING TO THE CLASSIC OR INTENSIVE METHOD,FRANCE,Recruiting,"Central Hospital, Nancy, France","July 1, 2020",Interventional,Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive,Unrelated
3949,COVID,"February 08, 2021",144,NCT04599959,SAMPLING OF SARS-COV-2 RNA FROM NASOPHARYNGEAL SWAB SPECIMEN OR SALIVA COLLECTED VIA SALIVETTE CORTISOL,MEXICO,Completed,Boehringer Ingelheim,"October 26, 2020",Interventional,"COVID-19 Tests: a Systematic Comparison of Viral RNA Test Sample Taking for RT-qPCR, in This Case With a Nasopharyngeal Swab or Saliva Collected With Salivette® Cortisol, to Diagnose SARS-CoV-2 Virus Infection",COVID
3950,COVID,"February 08, 2021",37,NCT04599998,"SPIROMETRY, THORACIC CT, CPET, 6 MINUTE WALKING TEST, SF-36 QUESTIONNAIRE",TURKEY,Enrolling by invitation,Koc University Hospital,"October 15, 2020",Observational,"Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia Related to Lung Functions, Radiology and Exercise Capacity",COVID
3951,COVID,"February 08, 2021",308,NCT04600141,TOCILIZUMAB,,Not yet recruiting,University of Sao Paulo,"October 20, 2020",Interventional,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection: a Randomized Clinical Trial,COVID
3952,COVID,"February 08, 2021",100,NCT04600440,CONVALESCENT PLASMA,SWEDEN,Recruiting,Skane University Hospital,"April 25, 2020",Interventional,Convalescent Plasma in the Treatment of Covid-19,COVID
3953,ATRIAL FIBRILLATION PAROXYSMAL,"February 08, 2021",180,NCT04600713,PT-X AND IMT,,Not yet recruiting,Vastra Gotaland Region,January 2021,Interventional,Physiotherapist Led Exercise Within Cardiac Rehabilitation and Inspiratory Muscle Training and Patients With Paroxysmal Atrial Fibrillation - a Randomized Controlled Trial,Unrelated
3954,COVID,"February 08, 2021",826,NCT04600895,FAVIPIRAVIR,UNITED STATES,Recruiting,Appili Therapeutics Inc.,"November 30, 2020",Interventional,Favipiravir for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19),COVID
3955,SARS-CoV2 INFECTION,"February 08, 2021",150,NCT04600999,FAVIPIRAVIR,HUNGARY,Recruiting,University of Pecs,"October 7, 2020",Interventional,An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients With Mild Pneumonia - An Open-label Randomized Controlled Study -,COVID
3956,COVID,"February 08, 2021",40,NCT04601012,OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY,ITALY,Completed,Federico II University,"September 20, 2020",Observational,Optical Coherence Tomography Angiography in Patients Affected by SARS-CoV-2 Infection: a Pilot Study,COVID
3957,COVID,"February 08, 2021",100,NCT04601077,"NITRIC OXIDE LOZENGES, 30 MG",UNITED STATES,Recruiting,Nitric Oxide Innovations LLC,"November 1, 2020",Interventional,Pilot Study: The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American Origin,COVID
3958,COVID,"February 08, 2021",250,NCT04601090,ICU TREATMENT,NORWAY,Recruiting,Oslo University Hospital,"September 16, 2020",Observational [Patient Registry],Survival Rates and Long-term Outcomes for Patients With COVID-19 Admitted to Norwegian ICUs,COVID
3959,HEART FAILURE,"February 08, 2021",1500,NCT04601415,ECG FROM HANDHELD DEVICE,,Not yet recruiting,Imperial College London,"February 1, 2021",Observational,"Diagnosis of Heart Failure in the Post-COVID-19 Clinic, Primary Care and Hospital Setting Using a Digital Stethoscope With Artificial Intelligence (AI) Electrocardiogram (ECG)",Unrelated
3960,SARS-CoV2 INFECTION,"February 08, 2021",1020,NCT04602000,CT-P59/PLACEBO,"KOREA, REPUBLIC OF",Recruiting,Celltrion,"September 25, 2020",Interventional,"A Phase 2/3, Randomized, Parallel-group, Placebo-controlled, Double-Blind Study to Evaluate the Efficacy and Safety of CT-P59 in Combination With Standard of Care in Outpatients With Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) Infection",COVID
3961,COVID,"February 08, 2021",211,NCT04602260,,CANADA,Recruiting,McMaster University,"June 9, 2020",Observational,Functional Recovery of Older Hospitalised Patients With COVID-19: a Prospective and Retrospective Cohort Study Extension to the Coronavirus Registry (COREG),COVID
3962,"PAIN, INTRACTABLE","February 08, 2021",292,NCT04602286,MEDITATION (1 X 20-MINUTE GUIDED AUDIO TRAINING),AUSTRALIA,Recruiting,The University of Queensland,"October 28, 2020",Interventional,"An Online Randomized Controlled Trial Comparing the Effects of Mindfulness, Sham Mindfulness and Book Listening Control on Pain Experience in Adults With Recurrent and Chronic Pain",Unrelated
3963,CATASTROPHIZING CORONAVIRUS (COVID),"February 08, 2021",624,NCT04602312,MEDITATION (1 X 20-MINUTE GUIDED AUDIO TRAINING),AUSTRALIA,Recruiting,The University of Queensland,"October 28, 2020",Interventional,"Online RCT Comparing the Effects of Mindfulness, Sham Mindfulness and Book Listening Control on Coronavirus-related Catastrophizing in Adults",COVID
3964,COVID,"February 08, 2021",200,NCT04602351,COMMUNICATION,UNITED ARAB EMIRATES,Not yet recruiting,NMC Specialty Hospital,"January 15, 2021",Observational,"Communication in ICU During COVID-19: Multinational, Multicentric Cross-sectional Survey (ComICU)",COVID
3965,COVID,"February 08, 2021",90,NCT04602442,EXO 1 INHALATION,RUSSIAN FEDERATION,Enrolling by invitation,Olga Tyumina,"October 1, 2020",Interventional,The Extended Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Two-Sided Pneumonia,COVID
3966,PRIMARY CILIARY DYSKINESIA,"February 08, 2021",1000,NCT04602481,,SWITZERLAND,Recruiting,University of Bern,"May 31, 2020",Observational,COVID-19 in People With Primary Ciliary Dyskinesia,Unrelated
3967,COVID,"February 08, 2021",100,NCT04602507,IVERMECTIN,COLOMBIA,Recruiting,CES University,"December 7, 2020",Interventional,Ivermectin in Adults With Severe COVID-19. Double-blind Randomized Clinical Trial,COVID
3968,DEATH,"February 08, 2021",135,NCT04602520,3 WISHES PROJECT,CANADA,Recruiting,McMaster University,"March 16, 2020",Observational,Dying During the Pandemic: Preserving Compassionate End-of-Life Care,Unrelated
3969,MONITOR TRAINING LOAD,"February 08, 2021",3,NCT04602637,TRAINING LOAD,ARGENTINA,"Active, not recruiting",Kine Kinesiologia Deportiva y Funcional,"December 15, 2019",Observational,Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study,Unrelated
3970,WELL-BEING,"February 08, 2021",350,NCT04602832,ENDURING HAPPINESS AND CONTINUED SELF-ENHANCEMENT (ENHANCE) FOR COVID-19,CANADA,Enrolling by invitation,University of British Columbia,"October 14, 2020",Interventional,A Randomized Controlled Trial of an Online Well-Being Intervention (The ENHANCE Program) for Improving Individuals Health and Well-Being During the COVID-19 Pandemic,Unrelated
3971,COVID,"February 08, 2021",108,NCT04602871,BREATH BIOPSY,ISRAEL,Recruiting,Scentech Medical Technologies Ltd,"July 3, 2020",Interventional,Early Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Feasibility Study,COVID
3972,COVID,"February 08, 2021",50,NCT04602884,BREATH BIOPSY SAMPLING USING THE RECIVA BREATH SAMPLER,ISRAEL,Suspended,Scentech Medical Technologies Ltd,"September 22, 2020",Interventional,Early Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis: First Cross-Sectional Study,COVID
3973,COVID,"February 08, 2021",4000,NCT04602949,BREATH BIOPSY ANALYSIS,ISRAEL,Not yet recruiting,Scentech Medical Technologies Ltd,"November 12, 2020",Interventional,Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Validation Study,COVID
3974,NURSE'S ROLE,"February 08, 2021",200,NCT04603079,INTERVENTION FOR COVID-19 PREVENTIVE PROTOCOLS,,Not yet recruiting,"Forman Christian College, Pakistan","April 1, 2021",Interventional,A Randomized Control Trial to Change Nurse Leadership in Maintaining Minimum Service Delivery Standards for Hospital Infection Control in the Era of COVID-19,Unrelated
3975,HEALTH LITERACY,"February 08, 2021",1000,NCT04603092,DIGITAL HEALTH LITERACY INTERVENTION,,Not yet recruiting,"Forman Christian College, Pakistan","April 1, 2021",Interventional,Digital Health Literacy Intervention by Community Health Workers for Corona Preventive Behaviors for Disadvantaged Women at Primary Level,Unrelated
3976,CANCER,"February 08, 2021",9000,NCT04603105,,,Not yet recruiting,The Clatterbridge Cancer Centre NHS Foundation Trust,"February 28, 2021",Observational,Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK) - a Prospective Companion Study for Patients With Cancer and COVID-19,Unrelated
3977,COVID,"February 08, 2021",,NCT04603651,BAMLANIVIMAB,,No longer available,Eli Lilly and Company,,Expanded Access,Expanded Access Information for Physicians for Bamlanivimab (LY3819253) Emergency Investigational New Drug [EIND],COVID
3978,"BIOCHEMICAL MARKERS ,NGAL,CYSTATIN C, ACUTE KIDNEYINJURY, COVID","February 08, 2021",88,NCT04603664,SERUM NGAL AND CYSTATIN C,EGYPT,Recruiting,Ain Shams University,"October 30, 2020",Observational,Role of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C in Prediction of Acute Kidney Injury in Patients With Covid-19 Infection,COVID
3979,COVID,"February 08, 2021",200,NCT04603677,,UNITED STATES,Enrolling by invitation,Colorado State University,"July 8, 2020",Observational,Northern Colorado Coronavirus Biobank: A Biorepository for Acute and Convalescent Patient Samples From Coloradoans Infected With SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2),COVID
3980,COVID,"February 08, 2021",0,NCT04603690,COLCHICINE,,Withdrawn,Liaquat University of Medical & Health Sciences,"December 15, 2020",Interventional,"A Randomized, Open-labeled, and Controlled Trial to Study the Benefits of Colchicine in Patients With COVID-19",COVID
3981,COVID DISEASE,"February 08, 2021",100,NCT04603729,DEXAMETHASONE 2 MG/ML,PAKISTAN,Completed,Fatima Memorial Hospital,"May 30, 2020",Interventional,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,COVID
3982,COVID,"February 08, 2021",100,NCT04603742,ANAKINRA,UNITED STATES,Not yet recruiting,Weill Medical College of Cornell University,November 2020,Interventional,"Anakinra in Adults With Severe COVID-19 and Features of Cytokine Storm Syndrome: A Randomized, Double-blind, Placebo-controlled Trial",COVID
3983,SARS-COV INFECTION,"February 08, 2021",15,NCT04603755,ELECTRICAL IMPEDANCE TOMOGRAPHY,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"October 26, 2020",Observational,Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome,Respiratory
3984,ANXIETY DEPRESSION,"February 08, 2021",120,NCT04603781,CBD ISOLATE,UNITED STATES,Recruiting,University of Texas at Austin,"December 4, 2020",Interventional,Use of CBD Oil for Reducing the Negative Emotional Impact of COVID-19: A Randomized Placebo-Controlled Clinical Trial,Unrelated
3985,COVID,"February 08, 2021",60,NCT04603794,0.5% POVIDONE IODINE,UNITED STATES,Recruiting,Ohio State University,"October 1, 2020",Interventional,"Comparison of Normal Saline, Hydrogen Peroxide, Chlorhexidine and Povidone-Iodine Mouth Rinses in COVID-19 Patients",COVID
3986,COVID,"February 08, 2021",436,NCT04603924,NICLOSAMIDE,UNITED STATES,Recruiting,ANA Therapeutics,"October 7, 2020",Interventional,A Phase 2/3 Randomized and Placebo-Controlled Study of ANA001 in Moderate and Severe COVID-19 Patients,COVID
3987,COVID,"February 08, 2021",55,NCT04603963,POWER BREATHE,BRAZIL,Terminated,Elaine Cristina Pereira <elaine.cpereira@einstein.br>,"June 1, 2020",Interventional,Efects of Inspiratory Muscle Training in Patients With COVID-19 After Acute Phase. Prospective Study,COVID
3988,"DEPRESSION, ANXIETY","February 08, 2021",390,NCT04604080,SERVICE OF QUESTIONNAIRE,PAKISTAN,Completed,Islamia University of Bahawalpur,"November 1, 2020",Observational,Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan,Unrelated
3989,SARS-CoV2,"February 08, 2021",104,NCT04604119,,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"May 1, 2020",Observational [Patient Registry],Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic,COVID
3990,SARS-COV INFECTION,"February 08, 2021",600,NCT04604145,SARS-COV-2 TESTING ON THE EPPENDORF THERMAL CYCLER PCR SYSTEM USING SELF-COLLECTED SALIVA AS THE SPECIMEN,,Not yet recruiting,David Grant U.S. Air Force Medical Center,October 2020,Interventional,Evaluation of Self-Collected Saliva Samples Without Viral Transport Media for SARS-CoV-2 Testing Via RT-PCR,Respiratory
3991,COVID,"February 08, 2021",130,NCT04604184,BI 764198,BRAZIL,Recruiting,Boehringer Ingelheim,"November 3, 2020",Interventional,BI 764198 Efficacy and Safety in Prevention/Progression of ARDS and ARDS-related Complications Secondary to COVID-19 (ACTION ON COVID-19),COVID
3992,COVID,"February 08, 2021",1506,NCT04604223,PIOGLITAZONE 45 MG,,Not yet recruiting,Dasman Diabetes Institute,"November 15, 2020",Interventional,Effect of Pioglitazone on Inflammatory Response and Clinical Outcome in T2DM Patients With COVID-19,COVID
3993,COVID,"February 08, 2021",200,NCT04604249,"SARS-COV-2 RAPID DIAGNOSTIC TEST (COVID-PRESTO® IGM/IGG, AAZ, BOULOGNE-BILLANCOURT, FRANCE)",PERU,"Active, not recruiting",Centre d'Expertise sur l'Altitude EXALT,"October 26, 2020",Observational,"Prevalence of COVID-19 and Risk Factors Associated With Seroconversion in La Rinconada, the Highest City of the World - 5,100 m",COVID
3994,COVID,"February 08, 2021",164,NCT04604327,BEMIPARIN SODIUM,SPAIN,Recruiting,"Clinica Universidad de Navarra, Universidad de Navarra","October 26, 2020",Interventional,"Ensayo clínico Aleatorizado, Abierto, Para Evaluar el Efecto de Dosis profilácticas o terapéuticas de Bemiparina en Pacientes Con COVID-19",COVID
3995,COVID,"February 08, 2021",80,NCT04604678,METFORMIN,UNITED STATES,Not yet recruiting,AgelessRx,February 2021,Interventional,Pilot Study Into the Use of Metformin and Low Dose Naltrexone (LDN) for Patients With Coronavirus Disease 2019 (COVID-19) - Assessment of Short and Long Term Effects,COVID
3996,COVID,"February 08, 2021",60,NCT04604704,NALTREXONE,UNITED STATES,Recruiting,AgelessRx,"January 28, 2021",Interventional,Pilot Study Into Low Dose Naltrexone (LDN) and Nicotinamide Adenine Dinucleotide (NAD+) for Treatment of Patients With Post-COVID-19 Syndrome (Long-COVID19),COVID
3997,VACCINE REFUSAL,"February 08, 2021",4,NCT04604743,"INTERVENTION, TBN",UNITED STATES,Not yet recruiting,University of Alabama at Birmingham,"January 1, 2021",Interventional,Exploratory Sequential Mixed Methods Cluster Randomized Controlled Implementation Science Trial to Develop a Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for African American Older Adolescents in Rural Alabama,Unrelated
3998,CORONAVIRUS,"February 08, 2021",60,NCT04604769,,BELGIUM,Completed,University of Liege,"June 26, 2019",Observational,Perceived Stress and Needs Among Medical Staff in ICU During COVID-19 Crisis,COVID
3999,LANGUAGE IMPAIRMENT,"February 08, 2021",28,NCT04604821,ENHANCED MILIEU TEACHING,,Not yet recruiting,Oregon Health and Science University,"October 20, 2020",Interventional,Delivering Enhanced Milieu Teaching (EM-Teach) Via Telehealth to Children and Families in Rural Communities,Unrelated
4000,HEADACHES CHRONIC,"February 08, 2021",25,NCT04604977,MINDFULNESS,ITALY,Recruiting,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"September 15, 2020",Interventional,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Chronic Migraine and High Frequency Migraine Without Aura After the Covid-19 Emergency,Unrelated
4001,PREMATURE BIRTH,"February 08, 2021",1000,NCT04605172,HOSPITALIZATION FOR PREMATURE BIRTH,FRANCE,Enrolling by invitation,"Central Hospital, Nancy, France","November 2, 2020",Observational,The Impact of the SARS CoV-2 Lockdown Policy on Spontaneous Premature Birth at the Regional University Maternity Hospital of Nancy,Unrelated
4002,SARS-COV INFECTION,"February 08, 2021",70,NCT04605588,NITAZOXANIDE,UNITED STATES,Recruiting,"Rutgers, The State University of New Jersey","December 2, 2020",Interventional,"A Triple Combination Antiviral Coronavirus Therapy (TriACT) RCT Comparing Nitazoxanide, Ribavirin and Hydroxychloroquine vs. Placebo",Respiratory
4003,BURNOUT,"February 08, 2021",706,NCT04605692,,TURKEY,Completed,Akdeniz University,"March 9, 2020",Observational,Attitudes and Predictive Factors of Psychological Distress and Occupational Burnout Among Dentists During COVID-19 Pandemic in Turkey,Unrelated
4004,SARS-CoV2 PNEUMONIA,"February 08, 2021",100,NCT04605757,"CLINICAL, FUNCTIONAL AND RADIOLOGICAL LUNG INVOLVEMENT EVOLUTION",ITALY,Recruiting,Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi,"July 30, 2020",Observational,Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Long-term Impact and Predictors of Possible Lasting Damage: Follow the Covid Study,COVID
4005,COVID,"February 08, 2021",120,NCT04605887,ANGIOTENSIN 1-7,ISRAEL,Recruiting,Rambam Health Care Campus,"January 18, 2021",Interventional,Angiotensin 1-7 as a Therapy for Pneumonia Caused by Coronavirus 2(SARS-CoV-2),COVID
4006,CORONAVIRUS,"February 08, 2021",0,NCT04605926,EQ001,COLOMBIA,Withdrawn,Equillium,November 2020,Interventional,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Itolizumab in Subjects Hospitalized With COVID-19",COVID
4007,COVID,"February 08, 2021",201,NCT04605952,REPEAT SARS-COV-2 IGG ANTIBODIES AT 45-65 DAYS,INDIA,Completed,Tata Main Hospital,"July 1, 2020",Observational,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive,COVID
4008,COVID,"February 08, 2021",100,NCT04605965,,UNITED STATES,Recruiting,Tulane University,"June 9, 2020",Observational [Patient Registry],Wearable Health Data to Investigate Long-term Cardiovascular and Behavioral Health Outcomes in COVID-19 Patients After Discharge: The WEAICOR Study,COVID
4009,COVID,"February 08, 2021",40,NCT04606069,REGADENOSON,UNITED STATES,Not yet recruiting,"University of Maryland, Baltimore","November 1, 2020",Interventional,Clinical Trial on the Safety and Efficacy of Regadenoson for Moderate to Severe COVID-19 Adult Patients,COVID
4010,VIRAL PNEUMONIA,"February 08, 2021",90,NCT04606407,LUNGFIT™,ISRAEL,Recruiting,Beyond Air Inc.,"November 25, 2020",Interventional,"Prospective, Open-label, Randomized, Multi-Center Study for Safety and Efficacy Evaluation of Inhaled Nitric Oxide (NO) Given Intermittently to Adults With Viral Pneumonia",Respiratory
4011,COVID,"February 08, 2021",200,NCT04606498,OBSERVATIONAL,UNITED STATES,Recruiting,Henry M. Jackson Foundation for the Advancement of Military Medicine,"December 18, 2020",Observational,Blood Purification With Seraph® 100 Microbind® Affinity Blood Filter for the Treatment of Severe COVID-19: An Observational Study (PURIFY-OBS-1),COVID
4012,COVID,"February 08, 2021",1372,NCT04606563,LOSARTAN,BELGIUM,Recruiting,University of British Columbia,"October 9, 2020",Interventional,Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,COVID
4013,COVID,"February 08, 2021",2000,NCT04606732,,ITALY,Recruiting,University of Bologna,"September 20, 2020",Observational [Patient Registry],"Cardiovascular Clinical Features and Cardiovascular Therapies in the Development, Progression and Outcome of Patients With SARS-Cov-2 Related Pneumonia",COVID
4014,COVID,"February 08, 2021",40,NCT04606784,AMPION,UNITED STATES,Recruiting,Ampio Pharmaceuticals. Inc.,"October 28, 2020",Interventional,A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Nebulized Ampion In Adults With Respiratory Distress Secondary to COVID-19 Infection,COVID
4015,DEPRESSION,"February 08, 2021",216,NCT04607902,SUPPORTIVE THERAPY SSI,UNITED STATES,Not yet recruiting,Stony Brook University,February 2021,Interventional,Harnessing Network Science to Personalize Scalable Interventions for Adolescent Depression: Do Idiographic Symptom Structures Predict Response to Single Session Interventions?,Unrelated
4016,TYPE 2 DIABETES,"February 08, 2021",30,NCT04607915,INTERVENTION FOR TECC MODEL,,Not yet recruiting,Centre for Addiction and Mental Health,"February 5, 2021",Interventional,Technology-enabled Collaborative Care for Diabetes (TECC-Diabetes) Management During COVID: A Feasibility Study,Unrelated
4017,FIBROTIC PULMONARY SEQUELAE POST-COVID INFECTION,"February 08, 2021",148,NCT04607928,PIRFENIDONE,SPAIN,Recruiting,Institut d'Investigació Biomèdica de Bellvitge,"August 1, 2020",Interventional,Phase-II Randomized Clinical Trial to Evaluate the Effect of Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis,COVID
4018,COVID,"February 08, 2021",57720,NCT04607941,QUESTIONNAIRES,FRANCE,Recruiting,Institut Pasteur,"October 27, 2020",Observational,"Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2",COVID
4019,HEALTHY PARTICIPANTS,"February 08, 2021",66,NCT04608097,SIMPLE COGNITIVE TASK INTERVENTION,SWEDEN,Recruiting,Uppsala University,"October 28, 2020",Interventional,Understanding Reactions to Emotional Material in the Media During COVID-19 and the Connections to Cognitive Activities,Unrelated
4020,SARS-CoV2,"February 08, 2021",220,NCT04608201,NICOTINE 7 MG/ 24H TRANSDERMAL PATCH - 24 HOUR,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"December 9, 2020",Interventional,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,COVID
4021,SARS-CoV2,"February 08, 2021",100,NCT04608214,ALISPORIVIR,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"November 1, 2020",Interventional,"Evaluation of the Efficacy, Safety and Tolerability of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19). A Randomised, Open-label, Proof of Concept, Phase 2 Study",COVID
4022,COVID,"February 08, 2021",596,NCT04608266,CAMOSTAT MESYLATE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"December 3, 2020",Interventional,A Multicenter Randomized Trial to Evaluate the Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients (CAMOVID),COVID
4023,COVID,"February 08, 2021",1040,NCT04608305,"IIBR-100, LOW DOSE (PRIME)",ISRAEL,Recruiting,Israel Institute for Biological Research (IIBR),"October 28, 2020",Interventional,"A Phase I/II Randomized, Multi-Center, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine (IIBR-100) in Adults",COVID
4024,COVID,"February 08, 2021",20,NCT04608383,ADDITIONAL AND MINIMAL COLLECTION OF PRODUCTS OF THE HUMAN BODY CARRIED OUT DURING A SAMPLE FOR STANDARD OF CARE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"November 1, 2020",Observational,Laparoscopy and COVID-19 Contamination,COVID
4025,POST INTENSIVE CARE UNIT SYNDROME,"February 08, 2021",160,NCT04608994,,ITALY,Recruiting,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,"June 1, 2020",Observational,Long-term Follow-up in Survivors of Critical Illness: An Longitudinal Assessment of Critically Ill Patients Discharged Alive From the Intensive Care Unit,Unrelated
4026,SARS-CoV2 VIRUS,"February 08, 2021",5000,NCT04609085,,UNITED STATES,Enrolling by invitation,National Institute of Allergy and Infectious Diseases (NIAID),"February 11, 2021",Observational,SARS-COV2 Pandemic Serosurvey in a Rare Disease Population,COVID
4027,COVID,"February 08, 2021",40,NCT04609332,ENDOTHELIAL DAMAGE AND ANGIOGENIC BIOMARKERS,CHILE,Recruiting,University of Chile,"November 10, 2020",Observational [Patient Registry],Association of Endothelial Damage and Angiogenesis Biomarkers With Morbidity and Mortality in SARS-CoV-2 Infection,COVID
4028,MENTAL HEALTH WELLNESS 1,"February 08, 2021",176,NCT04609371,SELF-CARE TOOLS,CANADA,Enrolling by invitation,"St. Mary's Research Center, Canada","October 21, 2020",Interventional,Assisting Family Physicians With Gaps in Mental Health Care Generated by the COVID-19 Pandemic: A Randomized Controlled Trial,Unrelated
4029,COVID,"February 08, 2021",80000,NCT04609423,COD LIVER OIL,NORWAY,Recruiting,Oslo University Hospital,"November 10, 2020",Interventional,"A Randomized, Parallel-group Treatment, Quadruple Masked, Two-arm Study, to Assess the Effectiveness of Cod Liver Oil Compared to Placebo in the Prevention of Covid-19 and Airway Infections in Healthy Adults",COVID
4030,COVID,"February 08, 2021",196,NCT04609462,CONVENTIONAL OXYGEN THERAPY,COLOMBIA,Recruiting,Fundacion Clinica Valle del Lili,"August 11, 2020",Interventional,A Trial of High-Flow Nasal Cannula vs. Conventional Oxygen Therapy in Patients With SARS-CoV-2-Related Acute Respiratory Failure: the HiFlo-COVID Trial.,COVID
4031,TO ASSESS SURFACTANT LEVELS IN LUNG FLUID,"February 08, 2021",30,NCT04609488,SURFACTANT ASSESSMENT,,Not yet recruiting,Zealand University Hospital,"November 1, 2020",Observational,An Exploratory Study to Assess Surfactant Levels in COVID-19 Patients Who Will be on Ventilatory Support Due to Severe Respiratory Failure,Respiratory
4032,DELIVERY; TRAUMA,"February 08, 2021",440,NCT04609501,,ISRAEL,"Active, not recruiting",Hillel Yaffe Medical Center,"June 1, 2020",Observational [Patient Registry],"Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship in the Shadow of a Socioeconomic Crisis",Unrelated
4033,ANXIETY,"February 08, 2021",60,NCT04609722,SOLUTION-FOCUSED SUPPORT PROGRAM,TURKEY,Recruiting,Adiyaman University Research Hospital,"July 1, 2020",Interventional,Effect of Solution-Focused Support Program on Anxiety Levels of Parents With Children Aged 3-6 Years During the COVID-19 Pandemic,Unrelated
4034,CORONAVIRUS DISEASE (COVID),"February 08, 2021",8,NCT04609774,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 DETECTION,ARGENTINA,Completed,Hospital Italiano de Buenos Aires,"October 8, 2020",Observational,Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus: a Dilemma,COVID
4035,PATIENT ADMITTED TO INTENSIVE CARE UNIT FOR COVID,"February 08, 2021",200,NCT04609839,FOLLOW-UP OF PATIENTS WITH COVID-19,FRANCE,Recruiting,"University Hospital, Strasbourg, France","October 27, 2020",Observational,TeleRea'nCo : FOLLOW-UP OF PATIENTS WITH COVID-19.,COVID
4036,ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS),"February 08, 2021",100,NCT04609865,LIDOCAINE 2%,FRANCE,Recruiting,"University Hospital, Strasbourg, France","November 4, 2020",Interventional,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,Respiratory
4037,COVID,"February 08, 2021",200,NCT04609969,RT-QPCR TEST,FRANCE,Completed,Centre Hospitalier Régional d'Orléans,"October 13, 2020",Interventional,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test on Nasopharyngeal Specimens i,COVID
4038,COVID,"February 08, 2021",276,NCT04610138,CNM-ZNAG,,Not yet recruiting,Clene Nanomedicine,February 2021,Interventional,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ZnAg Liquid Solution to Treat COVID-19 in Acutely Symptomatic Non-Hospitalized Participants",COVID
4039,COVID,"February 08, 2021",800,NCT04610489,QUIDEL SOFIA SARS ANTIGEN FIA,,Not yet recruiting,Carilion Clinic,"November 1, 2020",Interventional,Diagnostic Performance of an Antigen Test for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),COVID
4040,COVID,"February 08, 2021",26,NCT04610502,ADMINISTRATION OF EQUINE IMMUNOGLOBULIN ANTI SARS-COV-2,COSTA RICA,"Active, not recruiting",Caja Costarricense de Seguro Social,"September 6, 2020",Interventional,"Randomized, Controlled, Double-blind, Multicenter Clinical Study to Compare the Efficacy and Safety of the Administration of Two Hyperimmune Equine Anti-Sars-CoV-2 (""S"" and ""M"") Serum Formulations in Hospitalized Patients With COVID-19",COVID
4041,COVID,"February 08, 2021",4800,NCT04610515,,UNITED STATES,Recruiting,Rush University Medical Center,"December 15, 2020",Observational [Patient Registry],Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE),COVID
4042,SARS-CoV2 INFECTION,"February 08, 2021",2000,NCT04610541,REMDESIVIR-HU,HUNGARY,"Active, not recruiting",University of Pecs,"October 12, 2020",Interventional,Open-label Study to Assess the Safety of REMdesivir-HU as Eligible Novel therapY for Moderate and Severe Covid-19 Patients,COVID
4043,COVID PNEUMONIA,"February 08, 2021",74,NCT04610554,,ITALY,Completed,"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy","May 14, 2020",Observational,Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19,COVID
4044,CORONAVIRUS,"February 08, 2021",100,NCT04610567,METHOTREXATE-LDE PHASE 1,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"October 27, 2020",Interventional,Two Phases Clinical Trial to Evaluate Safety and Efficacy of Methotrexate Associated to LDL Like Nanoparticles (LDE-MTX) in the Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease.,COVID
4045,COVID,"February 08, 2021",200,NCT04610801,NASAL SPRAY,UNITED STATES,Recruiting,Larkin Community Hospital,"August 8, 2020",Interventional,A Randomized Placebo Control Trial to Evaluate the Efficacy of Xylitol Nasal Spray vs. Placebo for Acute COVID-19 Infection,COVID
4046,SEVERE ACUTE RESPIRATORY SYNDROME - CORONAVIRUS 2 (SARS-CoV2),"February 08, 2021",1250,NCT04611230,,UNITED STATES,Recruiting,AbbVie,"November 5, 2020",Observational,"EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois: CONTACT",COVID
4047,LUNG FUNCTION,"February 08, 2021",80,NCT04611243,KALETRA AND BETA INTERFERON,HONG KONG,Recruiting,Chinese University of Hong Kong,"May 22, 2020",Observational,"Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19",Unrelated
4048,COVID,"February 08, 2021",20,NCT04611256,MSC,MEXICO,Recruiting,Hospital Reg. Lic. Adolfo Lopez Mateos,"August 1, 2020",Interventional,Adjuvant Therapy With Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 in Critical Condition,COVID
4049,RESPIRATORY FAILURE,"February 08, 2021",950,NCT04611269,,ARGENTINA,Completed,Argentinian Intensive Care Society,"March 20, 2020",Observational [Patient Registry],"Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina: a Prospective, Multicenter Cohort Study",Respiratory
4050,STRESS RELATED DISORDER,"February 08, 2021",90,NCT04611399,VR FOR PSYCHOEDUCATION AND RELAXATION,ITALY,Recruiting,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"February 3, 2021",Interventional,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,Unrelated
4051,ACUTE RESPIRATORY FAILURE,"February 08, 2021",30,NCT04611425,REMIMAZOLAM,FRANCE,Not yet recruiting,Nantes University Hospital,"November 1, 2020",Interventional,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19. The Non-randomized, Non-controlled, Pilot, Open, Mono-centric REHSCU Study",Respiratory
4052,SARS-COV INFECTION,"February 08, 2021",30000,NCT04611802,SARS-COV-2 RS/MATRIX-M1 ADJUVANT,MEXICO,Recruiting,Novavax,"December 27, 2020",Interventional,"A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years",Respiratory
4053,COVID,"February 08, 2021",250,NCT04611841,,RUSSIAN FEDERATION,Enrolling by invitation,Federal Research and Clinical Center of Physical-Chemical Medicine,"July 21, 2020",Observational,Medical-biological Research of the Pathogenesis of Disease Caused by SARS-CoV-2,COVID
4054,COVID,"February 08, 2021",6000,NCT04612972,INACTIVATED SARS COV 2 VACCINE (VERO CELL). WUHAN,PERU,Recruiting,Universidad Peruana Cayetano Heredia,"September 10, 2020",Interventional,"Ensayo Clínico de Fase III, Aleatorio, Doble Ciego y Controlado Con Placebo Paralelo, Para Evaluar la Seguridad y la Eficacia Protectora de la Vacuna Inactivada Contra el SARS-CoV-2 en la Población Sana de 18 años o más, en Perú",COVID
4055,COVID INFECTION,"February 08, 2021",80,NCT04613050,RESPIRATORY TRAINING,EGYPT,Recruiting,Cairo University,"July 2, 2020",Interventional,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,COVID
4056,ASTHMA CHRONIC,"February 08, 2021",400,NCT04613245,,EGYPT,Recruiting,Cairo University,"May 1, 2020",Observational [Patient Registry],Health-Related Quality of Life of Patients With Asthma and Its Associated Factors During the Pandemic of COVID-19,Unrelated
4057,INFECTIOUS DISEASE,"February 08, 2021",210,NCT04613271,FAVIPIRAVIR,INDONESIA,Suspended,Ina-Respond,"October 15, 2020",Interventional,"Phase III, Random-Open, Clinical Trials on the Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia",Unrelated
4058,COVID,"February 08, 2021",120,NCT04613297,BASELINE AND DURING HOSPITALIZATION BLOOD SAMPLES,FRANCE,Recruiting,Hopital Foch,"October 19, 2020",Interventional,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,COVID
4059,COVID,"February 08, 2021",1250,NCT04613310,RAPID DIAGNOSTIC TEST VS PCR,SWITZERLAND,Recruiting,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland","September 25, 2020",Interventional,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2: a Comparative Clinical Trial,COVID
4060,ASTHMA,"February 08, 2021",430,NCT04613739,INSURANCE NAVIGATION,UNITED STATES,Recruiting,Harvard Pilgrim Health Care,"December 8, 2020",Interventional,Comparing Patient-Centered Outcomes for Adults and Children With Asthma in High-Deductible Health Plans With and Without Preventive Drug Lists: COVID Enhancement,Unrelated
4061,SARS-CoV2,"February 08, 2021",1640,NCT04613817,,BELGIUM,Recruiting,Sciensano,"December 3, 2020",Observational [Patient Registry],Prevalence and Incidence of Antibodies Against SARS-CoV-2 in Children Measured for One Year in Belgium: a Sero-epidemiological Prospective Cohort Study,COVID
4062,SEVERE COVID,"February 08, 2021",20,NCT04613986,THERAPEUTIC PLASMAEXCHNAGE,,Not yet recruiting,University of Zurich,December 2020,Interventional,"Randomized, Prospective, Open-label, Controlled Parallel-group Trial Investigating the Efficacy of Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat the Systemic Inflammatory Response Against SARS-CoV2 and the Associated Coagulopathy",COVID
4063,COVID,"February 08, 2021",100,NCT04614012,TREATED WITH HYPERIMMUNE PLASMA,ITALY,Recruiting,ANNA FALANGA,"July 2, 2020",Interventional,The Use of Hyperimmune Plasma for the Treatment of COVID-19 Infection,COVID
4064,COVID,"February 08, 2021",40,NCT04614025,PLX-PAD,GERMANY,Recruiting,Pluristem Ltd.,November 2020,Interventional,"A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19",COVID
4065,PHYSICIAN STRESS LEVELS,"February 08, 2021",84,NCT04614844,SIMULATION INTERVENTION,UNITED STATES,Not yet recruiting,Yale University,"December 15, 2020",Interventional,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS) Randomized Control Trial,Unrelated
4066,COVID,"February 08, 2021",100,NCT04614883,VOLATILE ORGANIC COMPOUNDS ANALYSIS,FRANCE,Recruiting,Hopital Foch,"October 21, 2020",Interventional,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in Patients Referred to the Emergency Reception Service for Suspected COVID-19 Infection: Diagnostic Value and for Rapid Screening,COVID
4067,PARTICIPANTS WITH OR WITHOUT STABLE CO-MORBIDITIES ASSOCIATED WITH PROGRESSION TO SEVERE COVID,"February 08, 2021",30000,NCT04614948,AD26.COV2.S,BELGIUM,Recruiting,Janssen Vaccines & Prevention B.V.,"November 12, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older",COVID
4068,COVID,"February 08, 2021",1000,NCT04615000,SARS-COV-2 SEROLOGICAL ASSESSMENT (IGG),BELGIUM,Recruiting,"University Hospital, Ghent","October 29, 2020",Observational [Patient Registry],SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort,COVID
4069,COVID,"February 08, 2021",400,NCT04615026,DUPLEX SONOGRAPHY,GERMANY,Recruiting,University Hospital Augsburg,"November 4, 2020",Observational [Patient Registry],Prevalence of Thrombosis in COVID-Patients in Correlation to Humoral and Cellular Immunity,COVID
4070,COVID,"February 08, 2021",60,NCT04615052,EXERCISE TRAINING,BRAZIL,Recruiting,University of Sao Paulo,"September 26, 2020",Interventional,Home-based Exercise Training in COVID-19 Survivors: a Randomized Controlled Trial,COVID
4071,POST TRAUMATIC STRESS DISORDER,"February 08, 2021",1000,NCT04615195,CRIES 13 QUESTIONNAIRE,FRANCE,Recruiting,"University Hospital, Toulouse","June 10, 2020",Observational,Effect of COVID19-related COntainment in ChildreN,Unrelated
4072,BEING SUSPECTED OF COVID INFECTION,"February 08, 2021",200,NCT04615208,SUSPECTED OF COVID-19 INFECTION,,Not yet recruiting,University of Manitoba,"November 15, 2020",Observational,A Touchless Tool to Screen for COVID-19 for Reopening Industries,COVID
4073,COVID_REHABILITATION,"February 08, 2021",200,NCT04615390,EARLY REHABILITATION,ITALY,Recruiting,University Hospital of Ferrara,"March 30, 2020",Observational,Recovery Profiles in Patients With COVID 19 Outcomes Undergoing Rehabilitation,COVID
4074,"DISTRESS, EMOTIONAL","February 08, 2021",100,NCT04615416,EMOTION REGULATION TRAINING VIA TELEHEALTH,UNITED STATES,Recruiting,"Teachers College, Columbia University","May 1, 2020",Interventional,Open Trial of Emotion Regulation Training Via Telehealth for Distressed Adults During the COVID-19 Pandemic,Unrelated
4075,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",20,NCT04615429,MESENCHYMAL STROMAL CELLS,SPAIN,"Active, not recruiting",Cristina Avendaño Solá,"September 15, 2020",Interventional,"Double-blind, Randomized, Controlled, Clinical Trial to Assess the Efficacy of Allogenic Mesenchymal Stromal Cells in Patients With Acute Respiratory Distress Syndrome Due to COVID-19",Respiratory
4076,SARS-CoV2,"February 08, 2021",4734,NCT04615676,FOLLOW-UP PHONE CALL,FRANCE,Completed,"University Hospital, Toulouse","April 27, 2020",Observational [Patient Registry],Prospective Evaluation of the Predictive Criteria of Severity Related to Patient Calling Emergency Centre for Low or High Respiratory Infection With or Without Fever and Suspected to be COVID-19.,COVID
4077,ACUTE APPENDICITIS,"February 08, 2021",207,NCT04615728,LAPAROSCOPIC OR OPEN APPENDICECTOMY,UNITED KINGDOM,Completed,Cambridge University Hospitals NHS Foundation Trust,"November 1, 2019",Observational,"APPENDICITIS DURING THE COVID-19 PANDEMIC: TO OPERATE OR NOT TO OPERATE, THAT IS THE QUESTION: COHORT STUDY FROM A TERTIARY CENTRE",Unrelated
4078,MENTAL HEALTH WELLNESS 1,"February 08, 2021",200,NCT04615741,TRAUMA INFORMED YOGA,CANADA,Recruiting,University of Lethbridge,"November 1, 2020",Interventional,Improving Health and Wellness During COVID-19,Unrelated
4079,COVID,"February 08, 2021",400,NCT04615871,SEMAGLUTIDE,BRAZIL,Not yet recruiting,Vladimír Džavík,"November 30, 2020",Interventional,Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19 Randomized Controlled Trial,COVID
4080,COVID,"February 08, 2021",100,NCT04615936,METHYLENE-BLUE PHOTODISINFECTION,CANADA,Recruiting,Sunnybrook Health Sciences Centre,"July 10, 2020",Interventional,Methylene Blue-mediated Photodisinfection for SARS-CoV-2 in the Upper Respiratory Tract,COVID
4081,COVID,"February 08, 2021",422,NCT04615949,"CANNABIDIOL, PHARMACEUTICALLY PRODUCED WITH < 5 PPM THC",,Not yet recruiting,Cardiol Therapeutics Inc.,December 2020,Interventional,"Study to Evaluate the Efficacy and Safety of CardiolRx™ in Patients With COVID-19 and Cardiovascular Disease or Risk Factors A Double-blind, Placebo-controlled Trial",COVID
4082,COVID,"February 08, 2021",28,NCT04615975,KETOGENIC DIET WITH PHYTOEXTRACTS,ITALY,Recruiting,University of Padova,"November 1, 2020",Interventional,Pilot Study: Ketogenic Diet as Protective Factor During SARS-CoV-2 Infection,COVID
4083,COVID,"February 08, 2021",10,NCT04616001,IVIG,UNITED STATES,Not yet recruiting,Sharp HealthCare,"November 1, 2020",Interventional,Pilot Study of the Use of IVIG in Patients With Severe COVID-19 Infections Requiring Mechanical Ventilation and to Assess Their Biological Responses to IVIG Therapy,COVID
4084,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",555,NCT04616586,SILTUXIMAB,UNITED STATES,Recruiting,EusaPharma (UK) Limited,"November 13, 2020",Interventional,A Study Comparing the Efficacy and Safety of Standard of Care With or Without Siltuximab in Selected Hospitalized Patients With Viral Acute Respiratory Distress Syndrome (SILVAR),Respiratory
4085,CANCER,"February 08, 2021",125,NCT04616768,PRO QUESTIONNAIRE,UNITED STATES,Recruiting,University of Pennsylvania,"November 19, 2020",Interventional,"A Feasibility Trial Using Remote Patient-reported Outcomes and Wearable Technology-reported Step Data to Compare Engagement, Utilization, and Functional Status in Patients With Incurable Lung and Gastrointestinal Cancers",Unrelated
4086,NEOPLASMS MALIGNANT,"February 08, 2021",120,NCT04616846,PERIPHERAL VENOUS ULTRASOUND,FRANCE,Recruiting,Centre Antoine Lacassagne,"August 4, 2020",Interventional,Thromboembolic Risk Screening in Patients With Cancer and COVID-19,Unrelated
4087,COVID,"February 08, 2021",800,NCT04616950,,FRANCE,Recruiting,Groupe Hospitalier Paris Saint Joseph,"December 1, 2020",Observational,Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System: Description of Typical Pathways and Simulation Model,COVID
4088,COVID CONVALESCENT PLASMA TREATMENT,"February 08, 2021",78,NCT04616976,CONVALESCENT PLASMA,CHINA,Completed,"Southeast University, China","January 1, 2020",Observational,Efficiency of Convalescent Plasma Therapy in Management of Critically Ill Patients With COVID-19: a Matched Case-control Study,COVID
4089,COMMUNITY MENTAL HEALTH,"February 08, 2021",840,NCT04616989,PSYCHO-EDUCATION,,Not yet recruiting,Makerere University,"January 1, 2021",Interventional,Integration of Mental Health Care in Communities Affected by the COVID-19 Pandemic in Central Uganda,Unrelated
4090,COVID,"February 08, 2021",38,NCT04617119,THRESHOLD IMT DEVICE,KUWAIT,Not yet recruiting,DR. JASSIM ALGHAITH,"November 1, 2020",Interventional,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU: A Pilot Study,COVID
4091,POSTPARTUM DEPRESSION,"February 08, 2021",40,NCT04617132,MBCT/MBSR,CANADA,"Active, not recruiting",British Columbia Children's Hospital,"October 20, 2020",Observational,Online Mindfulness Groups for Families Affected by Postpartum Depression and Anxiety: Study Protocol,Unrelated
4092,DEPRESSION,"February 08, 2021",100,NCT04617262,REMOTE PROBLEM MANAGEMENT PLUS,,Not yet recruiting,The New School,November 2020,Interventional,Pilot Feasibility Study of Remote Problem Management Plus to Improve Well-being and Functioning of Adults Affected by COVID-,Unrelated
4093,COVID,"February 08, 2021",1040,NCT04617483,"TWO DOSES OF COMMERCIAL SCALE INACTIVATED SARS-COV-2 VACCINE AT THE SCHEDULE OF DAY 0,14",CHINA,Recruiting,"Sinovac Research and Development Co., Ltd.","October 31, 2020",Interventional,"A Randomized, Double-Blinded Clinical Trial, to Evaluate the Non-inferiority of the Commercial Scale Inactivated SARS-CoV-2 Vaccine Against That of the Pilot Scale Among Adults Aged 26-45 Years, and the Open-labelled, Bridging Non-inferiority of the Vaccine Induced Immunogenicity in Elderly Against That in Adults",COVID
4094,COVID,"February 08, 2021",,NCT04617535,REGN10933+REGN10987 COMBINATION THERAPY,,Available,Regeneron Pharmaceuticals,,Expanded Access,Compassionate Use of REGN-COV2 for the Treatment of COVID-19,COVID
4095,ARDS,"February 08, 2021",50,NCT04618042,FX06,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"November 13, 2020",Interventional,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,Unrelated
4096,ANXIETY,"February 08, 2021",32,NCT04618341,,UNITED KINGDOM,Completed,Revival Active,"March 30, 2020",Observational,A Clinical Study of Online Active Play Program With Adolescents During COVID-19 Lockdown,Unrelated
4097,VACCINE REFUSAL,"February 08, 2021",100,NCT04618796,VACCINE,,Not yet recruiting,Assiut University,"April 1, 2021",Observational,Effect of COVID-19 Pandemic on Vaccination Compliance Among Children Attending Assiut University Children Hospital,Unrelated
4098,COVID,"February 08, 2021",1000,NCT04618835,40-STEPS-TEST,UNITED KINGDOM,Recruiting,Betsi Cadwaladr University Health Board,"November 3, 2020",Observational,Exertional Desaturation as a Marker of Risk - Validation Study for the 40-steps-test; A Multi-centre Prospective Observational Cohort Study,COVID
4099,COVID,"February 08, 2021",127,NCT04618861,,TURKEY,Completed,Kafkas University,"October 13, 2020",Observational,Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study,COVID
4100,DIFFICULT AIRWAY,"February 08, 2021",80,NCT04618926,DEVICE INTUBATING LARYNGEAL TUBE SUCTION DISPOSABLE,,Not yet recruiting,Bnai Zion Medical Center,"November 1, 2020",Observational,A Prospective Randomized Study Comparing Fiberoptic Bronchoscope Endotracheal Intubation Between the Intubating Laryngeal Tube Suction and the LMA Protector,Unrelated
4101,SARS COV 2,"February 08, 2021",46,NCT04619290,SUBLINGUAL METHYLENE BLUE,MEXICO,Recruiting,Hospital Reg. Lic. Adolfo Lopez Mateos,"October 12, 2020",Interventional,Treatment in Outpatient Patients With Covid-19 With Methylene Blue and Photodynamic,Respiratory
4102,HUMAN ARDS,"February 08, 2021",100,NCT04619368,FOLLOW UP CALLS,FRANCE,Recruiting,"University Hospital, Toulouse","July 27, 2020",Observational [Patient Registry],Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-CoV-2 (COVID-19),Unrelated
4103,SARS-CoV2,"February 08, 2021",300,NCT04619407,NASOPHARYNGEAL SWAB,GERMANY,Recruiting,University Medicine Greifswald,"November 4, 2020",Observational,"Screening for SARS-CoV-2-Infections in Teachers, Childcare Educators, Pupils and Preschoolers in the State of Mecklenburg-Vorpommern",COVID
4104,OCCUPATIONAL HEALTH,"February 08, 2021",1000,NCT04619576,OCCUPATIONAL HEALTH WORKERS,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 1, 2020",Observational,Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers,Unrelated
4105,COVID,"February 08, 2021",48,NCT04619628,COVI-VAC,UNITED KINGDOM,Recruiting,"Codagenix, Inc","December 11, 2020",Interventional,"First-in-human, Randomised, Double-blind, Placebo-controlled, Dose-escalation Study in Healthy Young Adults Evaluating the Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Candidate for Prevention of COVID-19",COVID
4106,PULMONARY FIBROSIS,"February 08, 2021",120,NCT04619680,NINTEDANIB,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,"November 18, 2020",Interventional,Early Nintedanib Deployment in COVID-19 Interstitial Fibrosis,Unrelated
4107,"PNEUMONIA, VIRAL","February 08, 2021",100,NCT04619693,,FRANCE,Recruiting,"University Hospital, Montpellier","November 18, 2020",Observational,Determination of Biomarkers for the Prediction of Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia,Respiratory
4108,COVID,"February 08, 2021",350,NCT04619706,FSD201,UNITED STATES,Recruiting,"FSD Pharma, Inc.","December 14, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIA Study of FSD201 (Ultramicronized PEA) + Standard of Care (SOC) Vs SOC in the Treatment of Hospitalized Patients With COVID-19",COVID
4109,COVID,"February 08, 2021",600,NCT04619719,HYPERBARIC OXYGEN THERAPY (HBOT),UNITED STATES,Not yet recruiting,NYU Langone Health,"February 15, 2021",Interventional,"Multi-Center, Randomized Control Trial to Study the Effectiveness of Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Respiratory Distress",COVID
4110,SARS-CoV2,"February 08, 2021",1700,NCT04620798,IMMEDIATE VS. DELAYED PROVISION OF ANTIBODY TEST RESULTS,UNITED STATES,"Active, not recruiting",Indiana University,"September 14, 2020",Interventional,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,COVID
4111,SAR,"February 08, 2021",108,NCT04621058,VITAMIN D,SPAIN,Recruiting,Bioaraba Health Research Institute,"November 9, 2020",Interventional,Efficacy of Treatment With Vitamin D in Patients Diagnosed With COVID-19 Who Presenting Vitamin D Deficiency and Pneumonia.,Unrelated
4112,COVID,"February 08, 2021",84,NCT04621071,PROBIOTICS (2 STRAINS 10X10^9 UFC),CANADA,Recruiting,Centre de recherche du Centre hospitalier universitaire de Sherbrooke,"January 5, 2021",Interventional,"Evaluation of the Efficacy of Probiotics to Reduce the Duration and Symptoms of COVID-19 (PROVID-19 Study): a Randomized, Double-blind, Controlled Trial",COVID
4113,NUTRITION,"February 08, 2021",1000,NCT04621084,EATING HABITS,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","April 1, 2020",Observational,Influence of the COVId-19 Pandemic on STRESS and Eating Habits,Unrelated
4114,SARS-CoV2 INFECTION,"February 08, 2021",474,NCT04621123,CONVALESCENT ANTI-SARS-COV-2 MBT PLASMA,SPAIN,Recruiting,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","October 30, 2020",Interventional,Convalescent Methylene Blue Treated (MBT) Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients: a Randomized Double Blind Study (COnV-ert),COVID
4115,COVID,"February 08, 2021",120,NCT04621149,CHLORINE DIOXIDE,UNITED STATES,Recruiting,"Profact, Inc.","November 15, 2020",Interventional,"A Phase 2 Screening Study of Candidate Non-prescription Treatments for COVID-19: A Patient-driven, Randomized, Factorial Study Evaluating Patient-reported Outcomes (PROFACT-01)",COVID
4116,AUDIO-VISUAL TRIAGE SYSTEM,"February 08, 2021",60,NCT04621214,AUDIO-VISUAL TRIAGE SYSTEM (AVT),PAKISTAN,Completed,University of Lahore,"March 21, 2020",Observational,Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy,Unrelated
4117,CORONAVIRUS INFECTION,"February 08, 2021",750,NCT04621461,ZINC SULFATE 220 MG,UNITED STATES,Not yet recruiting,"St. Francis Hospital, New York","December 20, 2020",Interventional,"A Randomized, Placebo-Controlled Study Evaluating the Efficacy of Zinc for the Treatment of COVID-19 in the Outpatient Setting",COVID
4118,ANEURYSM,"February 08, 2021",186,NCT04621552,WEB EMBOLIZATION,FRANCE,Completed,"University Hospital, Montpellier","January 1, 2015",Observational,Comparison of Woven EndoBridge Device Sizing With Conventional Measurements and Virtual Simulation Using the Sim&Size Software: A Multi-Center Experience,Unrelated
4119,COVID,"February 08, 2021",26,NCT04621903,SHANSHAMANI VATI PLUS,UNITED KINGDOM,Completed,Aarogyam UK,"October 8, 2020",Interventional,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19: Community Based Participatory Research,COVID
4120,CORONAVIRUS INFECTION,"February 08, 2021",60,NCT04622332,SIR1-365,,Not yet recruiting,"Sironax USA, Inc.","December 15, 2020",Interventional,"A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19",COVID
4121,COGNITION,"February 08, 2021",160,NCT04622748,TRIER SOCIAL STRESS TEST,CHINA,Recruiting,"National Institute on Drug Dependence, China","July 10, 2020",Observational,An Investigation of Neurocognitive Functions and the Influencing Factors in Recovered Patients With COVID-19,Unrelated
4122,COVID PNEUMONIA,"February 08, 2021",50,NCT04622826,IMMUNE PLASMA,ITALY,Recruiting,Azienda USL Toscana Nord Ovest,"May 15, 2020",Interventional,"Studio in Aperto Sulla Somministrazione di Plasma di Paziente Convalescente da COVID- 19 a Paziente Con Polmonite COVID-19 Ospedalizzato, Non in Terapia Intensiva",COVID
4123,SARS-CoV2,"February 08, 2021",200,NCT04622865,MASITINIB,FRANCE,Recruiting,AB Science,"June 1, 2020",Interventional,"Randomized, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Masitinib Combined With Isoquercetin, and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19",COVID
4124,COVID,"February 08, 2021",300,NCT04622891,CLARITHROMYCIN 500MG,EGYPT,Completed,South Valley University,"April 1, 2020",Interventional,"Efficacy of Clarithromycin in Comparison to Azithromycin in Treatment of Mild COVID-19 Infection, Randomized Controlled Trial",COVID
4125,COVID,"February 08, 2021",104,NCT04623021,NAFAMOSTAT MESILATE,RUSSIAN FEDERATION,Completed,Chong Kun Dang Pharmaceutical,"September 25, 2020",Interventional,"An Open-label, Randomized, Multicenter, Controlled Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia",COVID
4126,COVID,"February 08, 2021",100000,NCT04623047,,UNITED STATES,Recruiting,Duke University,"April 2, 2020",Observational,Using Smart Watches to Detect and Monitor COVID-19,COVID
4127,COVID,"February 08, 2021",950,NCT04623138,,,Not yet recruiting,Evidation Health,November 2020,Observational,"A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and SARS-CoV-2 Infection",COVID
4128,COVID,"February 08, 2021",950,NCT04623177,,SPAIN,"Active, not recruiting",Instituto de Investigacion Sanitaria La Fe,"March 1, 2020",Observational,"Effectiveness of Thromboprophylaxis With Low Molecular Weight Heparin in Critically Ill Patients With COVID-19. A Prospective, Cohort, Multicenter Study.",COVID
4129,COVID,"February 08, 2021",20,NCT04623255,OCTAPLAS,UNITED KINGDOM,Recruiting,"University College, London","October 16, 2020",Interventional,A Randomised Controlled Trial of Plasma Exchange With Standard of Care Compared to Standard of Care Alone in the Treatment of Severe COVID-19 Infection (COVIPLEX),COVID
4130,ANKLE FRACTURES,"February 08, 2021",262,NCT04623346,OBSERVATION FOR STUDY GROUP,TURKEY,"Active, not recruiting",Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization,"March 11, 2020",Observational,Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic,Unrelated
4131,COVID,"February 08, 2021",1000,NCT04623385,AEROSOLIZED 13 CIS RETINOIC ACID PLUS INHALATION INHALED TESTOSTERONE,,Not yet recruiting,Kafrelsheikh University,November 2020,Interventional,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,COVID
4132,COVID,"February 08, 2021",100,NCT04623619,ACETYL L-CARNITINE,,Not yet recruiting,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,"December 15, 2020",Interventional,Use of Acetyl L-Carnitine in Patients With Covid-19 Pneumonia,COVID
4133,COVID,"February 08, 2021",60,NCT04623671,CAP-1002,UNITED STATES,Recruiting,Capricor Inc.,"November 15, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Intravenous Infusion of CAP-1002 in Patients With COVID-19 (INSPIRE)",COVID
4134,COVID,"February 08, 2021",600,NCT04623697,,DENMARK,Recruiting,Hospital of South West Jutland,"November 1, 2020",Observational [Patient Registry],Covid-19 and Type 1 Diabetes - a Multicenter Study,COVID
4135,INFECTION VIRAL,"February 08, 2021",30000,NCT04624048,COVID-19 SURVEY,,Not yet recruiting,University of Salamanca,"December 4, 2020",Observational,"""Influence of Physical Exercise on the Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19""",Unrelated
4136,OVERWEIGHT AND OBESITY,"February 08, 2021",100,NCT04624087,FOOD-SPECIFIC GO/NO-GO COMPUTERIZED TRAINING,UNITED STATES,Recruiting,University of Minnesota,"October 19, 2020",Interventional,"The Effect of Go/No-Go Training Dosage on Weight Loss, Food Evaluation, and Disinhibition in Overweight and Obese Individuals: A Randomized Controlled Trial",Unrelated
4137,COVID,"February 08, 2021",500,NCT04624503,,ITALY,Recruiting,"Humanitas Hospital, Italy","October 1, 2020",Observational,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19 (Rilevanza Clinica e Prognostica Del Coinvolgimento Cardiovascolare Nei Pazienti Affetti da COVID-19),COVID
4138,COVID,"February 08, 2021",1000,NCT04624997,BIOLOGICAL SAMPLE,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 8, 2020",Observational,Evaluation de la COagulopathie et de la Dysfonction enDOthéliale Comme Facteur prédictif de la gravité de l'Infection Par SARS-CoV-2 / COVID-19,COVID
4139,COVID PNEUMONIA,"February 08, 2021",30,NCT04625036,SINGLE PASSIVE LEG MOVEMENT,ITALY,Recruiting,Istituti Clinici Scientifici Maugeri SpA,"May 30, 2020",Observational [Patient Registry],Pilot Study on Peripheral Vascular Function in Covid-19 Patient,COVID
4140,COVID,"February 08, 2021",40,NCT04625075,CARDIAC MRI,UNITED KINGDOM,Recruiting,University of Edinburgh,"June 10, 2020",Observational,Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (MEMORY- COVID),COVID
4141,COVID,"February 08, 2021",150,NCT04625114,CAMOSTAT,BELGIUM,Recruiting,"University Hospital, Ghent","November 4, 2020",Interventional,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,COVID
4142,COVID PNEUMONIA,"February 08, 2021",40,NCT04625218,,,Not yet recruiting,"University Hospital, Toulouse",January 2021,Observational,Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) in the Critically Ill Patient: Pharmacokinetic Study. (CHLORO-VID),COVID
4143,CORONAVIRUS INFECTIOUS DISEASE 2019 (COVID),"February 08, 2021",3000,NCT04625257,SALIVA BASED ASSAY: CRUDE RNA EXTRACTION,SWITZERLAND,Recruiting,"University Hospital, Basel, Switzerland","October 24, 2020",Observational,"COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)",COVID
4144,HEALTHCARE WORKER FACING COVID,"February 08, 2021",75,NCT04625296,SEMI-DIRECTIVE INTERVIEW,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"September 17, 2020",Observational,Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 Epidemic,COVID
4145,ALCOHOL CONSUMPTION,"February 08, 2021",480,NCT04625465,CBT TEXT MESSAGING,UNITED STATES,Recruiting,Georgia State University,"November 12, 2020",Interventional,Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence,Unrelated
4146,COVID,"February 08, 2021",5000,NCT04625725,AZD7442,BELGIUM,Recruiting,AstraZeneca,"November 21, 2020",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19.",COVID
4147,COVID ARDS,"February 08, 2021",30,NCT04625738,EX VIVO EXPANDED WHARTON'S JELLY MESENCHYMAL STEM CELLS,,Not yet recruiting,"Central Hospital, Nancy, France","November 6, 2020",Interventional,Efficacy of Infusions of Mesenchymal Stem Cells From Wharton Jelly in the Moderate to Severe SARS-Cov-2 Related Acute Respiratory Distress Syndrome (COVID-19): A Phase IIa Double-blind Randomized Controlled Trial,COVID
4148,COVID,"February 08, 2021",1125,NCT04625972,AZD7442,UNITED KINGDOM,Recruiting,AstraZeneca,"December 2, 2020",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Post-exposure Prophylaxis of COVID-19",COVID
4149,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",20,NCT04625985,METFORMIN GLYCINATE,MEXICO,Recruiting,Laboratorios Silanes S.A. de C.V.,"July 14, 2020",Interventional,"Adaptive Study to Demonstrate Efficacy and Safety of Metformin Glycinate for the Treatment of Hospitalized Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb",COVID
4150,POST-TRAUMATIC STRESS DISORDER,"February 08, 2021",120,NCT04626050,MEDICAL MUSIC,UNITED STATES,Not yet recruiting,Weill Medical College of Cornell University,January 2021,Interventional,"A Brief Phased Two-Step Intervention for Treating General Psychological Distress, PTSD and Co-Morbidities in Healthcare Workers Consequent to the COVID-19 Pandemic",Unrelated
4151,SARS-COV INFECTION,"February 08, 2021",10000,NCT04626076,COMPARATIVE OBSERVATIONAL COHORT STUDY,PAKISTAN,Recruiting,Certara,"August 13, 2020",Observational [Patient Registry],International Registry of Healthcare Workers Exposed to COVID-19 Patients,Respiratory
4152,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",20,NCT04626089,METFORMIN GLYCINATE,MEXICO,Not yet recruiting,Laboratorios Silanes S.A. de C.V.,"November 30, 2020",Interventional,"Adaptive Study for Efficacy and Safety of Metformin Glycinate for the Treatment of Patients With MS and DM2, Hospitalized With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb.",COVID
4153,COVID,"February 08, 2021",1000,NCT04627194,,KAZAKHSTAN,"Active, not recruiting",Semey State Medical University,"February 20, 2020",Observational,"Epidemiological and Clinical Characteristics of COVID-19 Patients in Kazakhstan in Early 2020: a Retrospective, Observational Cohort Study",COVID
4154,COVID,"February 08, 2021",20,NCT04627233,HUMAN EZRIN PEPTIDE 1 (HEP1),"IRAN, ISLAMIC REPUBLIC OF",Not yet recruiting,Shahid Beheshti University of Medical Sciences,"December 20, 2020",Interventional,The Clinical Trial of Application of Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,COVID
4155,COVID,"February 08, 2021",3217,NCT04627467,CHLOROQUINE,COLOMBIA,"Active, not recruiting",Fundacion Clinica Valle del Lili,"March 28, 2020",Interventional,Prophylaxis With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19),COVID
4156,AGING,"February 08, 2021",32,NCT04627493,ONLINE EXERCISE,CANADA,Recruiting,McMaster University,November 2020,Interventional,"Improving Physical Activity and Mobility, During a Pandemic, Via Live Online Exercise Sessions for Older Persons: a Pilot RCT",Unrelated
4157,COVID,"February 08, 2021",69,NCT04627519,RHEA HEALTH TONE®,,Not yet recruiting,Universitas Padjadjaran,"December 1, 2020",Interventional,"A Multicenter, Randomized, Open-label, Controlled Trial to Assess Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia",COVID
4158,COVID,"February 08, 2021",150,NCT04627584,MW33 INJECTION,,Not yet recruiting,"Mabwell (Shanghai) Bioscience Co., Ltd.",January 2021,Interventional,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of MW33 Injection to Evaluate the Efficacy and Safety in Patients With Mild or Moderate COVID-19",COVID
4159,COVID,"February 08, 2021",6000,NCT04627623,IGM AND IGG ANTIBODIES ASSAY,POLAND,Recruiting,Medical University of Silesia,"June 22, 2020",Observational,Prevalence and Risk Factors of COVID-19 Infection in the Upper Silesian Agglomeration Population in 2020,COVID
4160,SARS-CoV2,"February 08, 2021",36,NCT04627675,CORVAX,UNITED STATES,Recruiting,Providence Health & Services,"December 30, 2020",Interventional,"CORVax12 - a Phase I Trial of SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine (CORVax) +/- pIL-12 (Tavokinogene Telseplasmid) in Healthy Volunteers, With Immunodynamic Biomarker Monitoring of Coordinated Cellular/Humoral Response",COVID
4161,VITAMIN D DEFICIENCY,"February 08, 2021",50,NCT04628000,VITAMIN D,UNITED STATES,Recruiting,Parkview Medical Center,"October 27, 2020",Observational,Baseline Vitamin D Deficiency and COVID-19 Disease Severity/Need for Escalation of Care,Unrelated
4162,COVID,"February 08, 2021",506,NCT04628039,REHABILITATION-FOCUSED PROGRAM,UNITED STATES,Not yet recruiting,VA Office of Research and Development,"March 1, 2021",Interventional,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)",COVID
4163,MYOCARDIAL INFARCTION,"February 08, 2021",60,NCT04628104,CARDIAC MAGNETIC RESONANCE,,Not yet recruiting,Assiut University,"January 1, 2021",Observational [Patient Registry],CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction,Unrelated
4164,CHRONIC PAIN,"February 08, 2021",42,NCT04628130,YOGA THERAPY,UNITED KINGDOM,Completed,Aarogyam UK,"September 17, 2020",Observational,Efficacy of Yoga Based Self-Management Program for Chronic Pain: Community Based Clinical Efficacy Study,Unrelated
4165,COVID,"February 08, 2021",100,NCT04628143,NAFAMOSTAT MESILATE,,Not yet recruiting,Chong Kun Dang Pharmaceutical,"November 20, 2020",Interventional,"Open-label, Multi-center, Randomized Controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19",COVID
4166,COVID,"February 08, 2021",100,NCT04628195,,CHILE,Completed,Pontificia Universidad Catolica de Chile,"April 1, 2020",Observational,Cardiac Performance in Mechanically Ventilated Patients With Severe Pneumonia by SARS-CoV-2: Echo-COVID Study,COVID
4167,COVID,"February 08, 2021",60,NCT04628208,SPARTAN COVID-19 V2 SYSTEM,CANADA,Recruiting,Spartan Bioscience Inc.,"November 17, 2020",Observational,Assess the Performance of Spartan COVID-19 V2 System in a Clinical Setting in Comparison to a Laboratory (Standard of Care (SOC)) PCR Method (Canada Alternate),COVID
4168,COVID,"February 08, 2021",144,NCT04628637,SERUM PROTEIN LEVEL ANALYSIS,TURKEY,Completed,Kafkas University,"April 16, 2020",Observational,High GRP78 Levels in Covid-19 Infection: A Case-Control Study,COVID
4169,PREGNANCY WITHOUT COMPLICATIONS EXCEPT GETTING COVID INFECTION,"February 08, 2021",1000,NCT04629001,"COVID-19 PCR , IGM",EGYPT,"Active, not recruiting",Assiut University,"September 1, 2020",Observational [Patient Registry],Effect of Covid-19 on Outcomes of Pregnancy,COVID
4170,"ARDS, HUMAN","February 08, 2021",70,NCT04629105,LONGEVERON MESENCHYMAL STEM CELLS (LMSCS),UNITED STATES,Recruiting,Longeveron LLC,"July 24, 2020",Interventional,"A Phase 1 Double-blinded, Randomized, Placebo-controlled Study for COVID-19 and Influenza Virus-Elicited Acute Respiratory Distress Syndrome (ARDS) Using Longeveron Mesenchymal Stem Cells (LMSCs)",Unrelated
4171,THIS IS A PILOT STUDY WHICH AIMS TO ASSESS THE VALIDITY AND APPLICABILITY OF LATERAL FLOW ASSAYS (LFAS) WHICH CAN BE USED AS A POINT OF CARE TEST FOR COVID,"February 08, 2021",400,NCT04629157,INNOVA LATERAL FLOW DEVICE,UNITED KINGDOM,Recruiting,Alder Hey Children's NHS Foundation Trust,"November 5, 2020",Interventional,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,COVID
4172,COVID,"February 08, 2021",400,NCT04629183,INTEGRATED CLINICAL EVALUATION,ITALY,Recruiting,Azienda Ospedaliera Città della Salute e della Scienza di Torino,"November 1, 2020",Observational,Risk Stratification of COVID-19 Patients Discharged From the Emergency Department,COVID
4173,VENTILATION LUNG SCINTIGRAPHY DURING COVID INFECTION,"February 08, 2021",10,NCT04629222,,FRANCE,Completed,Pierre Yves MARIE,"March 11, 2020",Observational,Tracheobronchitis May Constitute the Main Sign of Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients,COVID
4174,COVID,"February 08, 2021",500,NCT04629638,"MATERNAL ATTACHMENT, EDINBURGH DEPRESSION SCORING AND POSTPARTUM ANXIETY SCALE SCORES",TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"August 1, 2020",Observational,Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women,COVID
4175,COVID,"February 08, 2021",308,NCT04629703,FOSTAMATINIB,,Not yet recruiting,Rigel Pharmaceuticals,December 2020,Interventional,"Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects",COVID
4176,DEPRESSION,"February 08, 2021",1765,NCT04629755,INTERVENTION,UNITED STATES,Completed,University of Washington,"April 4, 2020",Interventional,A Smartphone Intervention for Relational and Mental Well Being,Unrelated
4177,COVID,"February 08, 2021",27,NCT04629989,STANDARD OXYGEN DELIVERY SYSTEM,BELGIUM,Recruiting,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"November 13, 2020",Interventional,The Effects of Two Systems Above Low-flow Nasal Cannula on Arterial Oxygen Tension in Patients With COVID-19 : Surgical Face Mask Versus Double-trunk Mask,COVID
4178,COVID INFECTION,"February 08, 2021",250,NCT04630015,SURVEY ADMINISTRATION,UNITED STATES,Recruiting,"University of California, San Francisco","August 31, 2020",Observational,Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth,COVID
4179,COVID,"February 08, 2021",450000,NCT04630054,FACE MASK,BANGLADESH,Recruiting,Yale University,"November 15, 2020",Interventional,Can Face Masks Reduce Transmission of SARS-CoV-2 in Bangladesh? A Cluster Randomized Controlled Trial,COVID
4180,SARS-CoV2,"February 08, 2021",150,NCT04631172,"CORONAVIRUS ANXIETY SCALE , COVID-19 PHOBIA SCALE",TURKEY,Completed,Selcuk University,"May 1, 2020",Observational [Patient Registry],Evaluation of Covid-19 Anxiety and Phobia Levels of the Parents of Pediatric Patients,COVID
4181,"KNOWLEDGE, ATTITUDES, PRACTICE","February 08, 2021",404,NCT04631367,KUKAA SALAMA: MHEALTH INTERVENTION,,Not yet recruiting,University of Toronto,"February 1, 2021",Interventional,"Kukaa Salama (Staying Safe): A Pre-Post Trial of a mHealth Social Group for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Kampala, Uganda",Unrelated
4182,COVID,"February 08, 2021",200,NCT04631380,PRAYER,BRAZIL,Recruiting,Hospital do Coracao,"August 1, 2020",Interventional,"A Double Blind, Controlled, Randomized, Prospective Study That Will Evaluate the Impact of Remote Intercession Prayer on the Clinical Evolution of Patients Diagnosed With COVID -19 in HCOR.",COVID
4183,DEPRESSION,"February 08, 2021",100,NCT04631497,TEST,POLAND,Recruiting,Jagiellonian University,"July 1, 2020",Observational,"Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19",Unrelated
4184,COVID,"February 08, 2021",80,NCT04631536,ATORVASTATIN + L-ARGININE + FOLIC ACID + NICORANDIL + NEBIVOLOL,,Not yet recruiting,Lebanese American University Medical Center,"January 10, 2021",Interventional,Managing Endothelial Dysfunction in Moderate COVID-19 : A Randomized Controlled Trial at the Lebanese American University Medical Center- Rizk Hospital,COVID
4185,SARS-COV INFECTION,"February 08, 2021",69,NCT04631666,HUMAN MONOCLONAL ANTIBODY DZIF-10C (GROUP 1A-2D),,Not yet recruiting,University of Cologne,"November 23, 2020",Interventional,A Phase 1/2a Trial of the Intravenous Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c in SARS-CoV-2-Infected and -Uninfected Individuals,Respiratory
4186,SARS-COV INFECTION,"February 08, 2021",69,NCT04631705,HUMAN MONOCLONAL ANTIBODY DZIF-10C (GROUP 1A-2D),,Not yet recruiting,University of Cologne,"November 23, 2020",Interventional,A Phase 1/2a Trial of the Inhaled Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c in SARS-CoV-2-Infected and -Uninfected Individuals,Respiratory
4187,COVID,"February 08, 2021",132069,NCT04631861,,,Completed,Wonju Severance Christian Hospital,"January 1, 2014",Observational,Physical Activity and the Risk of COVID-19 Infection and Mortality,COVID
4188,DRY MOUTH,"February 08, 2021",3000,NCT04632004,INVITATION TO PARTICIPATE,GERMANY,Enrolling by invitation,University of Göttingen,"November 20, 2020",Interventional,Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health,Unrelated
4189,COVID,"February 08, 2021",80,NCT04632043,ENDOTRACHEAL INTUBATION,GREECE,Not yet recruiting,Evangelismos Hospital,"November 18, 2020",Interventional,Effect of Early versUs Delayed intubatiOn on Clinical Outcomes of Patients With COVID-19 (EUDOCO): a Feasibility Randomized Controlled Trial,COVID
4190,MENTAL HEALTH WELLNESS 1,"February 08, 2021",2200,NCT04632082,TELEPSYCHOEDUCATION WITH PERSONALIZED VIDEOS,BRAZIL,Enrolling by invitation,Hospital de Clinicas de Porto Alegre,"November 5, 2020",Interventional,A Pragmatic Superiority Randomized Controlled Trial Comparing Telepsychoeducation Plus Personalized Videos vs. Telepsychoeducation Without Personalized Videos for the Prevention of Future Emotional Distress in Professionals From Essential Services With Low to Moderate Levels of Emotional Distress in Brazil in the Context of COVID-19,Unrelated
4191,HEAD AND NECK CANCER,"February 08, 2021",750,NCT04632173,NON INTERVENTIONAL STUDY,,Not yet recruiting,Hellenic Cooperative Oncology Group,"December 1, 2020",Observational,HERODOTUS: Head and Neck cancERs International cOviD-19 collabOraTion,Unrelated
4192,COVID,"February 08, 2021",100,NCT04632355,INTERVIEW,ITALY,Not yet recruiting,Fondazione Don Carlo Gnocchi Onlus,"December 1, 2020",Observational,After the First and Second Wave in Italy: What Effects of Musculoskeletal Pain Did the Covid-19 in Patients Who Have Hospital Care?,COVID
4193,"BURNOUT, PROFESSIONAL","February 08, 2021",80,NCT04632368,TRANSCENDENTAL MEDITATION,UNITED STATES,Recruiting,Duke University,"November 20, 2020",Interventional,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,Unrelated
4194,CORONAVIRUS INFECTION,"February 08, 2021",36,NCT04632381,ZOTATIFIN,,Not yet recruiting,Effector Therapeutics,"November 16, 2020",Interventional,"A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial of Intravenous Zotatifin in Adults With Mild or Moderate Coronavirus Disease 2019 (COVID-19)",COVID
4195,COVID,"February 08, 2021",550,NCT04632537,TICE® BCG (FOR INTRAVESICAL USE) BCG LIVE STRAIN OF THE BCG (MERCK) VACCINE,UNITED STATES,Recruiting,Henry M. Jackson Foundation for the Advancement of Military Medicine,"December 7, 2020",Interventional,Novel Use of an Existing Vaccine (BCG) Alliance: The NUEVA Trial,COVID
4196,RESPIRATORY FAILURE,"February 08, 2021",20,NCT04632602,PHYSIOLOGICAL EFFECTS OF AWAKE PRONE POSITION IN COVID 19 PATIENTS,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"April 4, 2020",Interventional,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure: a Randomized Cross Over Electrical Impedance Tomography Study,Respiratory
4197,SLEEP,"February 08, 2021",230,NCT04632615,,ITALY,Recruiting,Istituto Ortopedico Galeazzi,"May 22, 2020",Observational,Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak,Unrelated
4198,COVID,"February 08, 2021",24,NCT04632706,IVERMECTIN,UNITED KINGDOM,Recruiting,MedinCell S.A,"September 22, 2020",Interventional,"A Randomised, Double-Blind, Placebo-Controlled, Exploratory Phase I Trial Assessing the Pharmacokinetic Profile, Safety and Tolerability of a Continuous Daily Dosing Regimen of Active IMP in Healthy Volunteers",COVID
4199,COGNITIVE IMPAIRMENT,"February 08, 2021",200,NCT04632719,THE USE OF THE MENTALPLUS® DIGITAL GAME FOR ASSESSMENT AND REHABILITATION OF COGNITIVE FUNCTION AFTER REMISSION OF THE SYMPTOMS OF COVID-19,BRAZIL,Recruiting,University of Sao Paulo,"November 8, 2020",Interventional,MentalPlus® for Assessment and Rehabilitation of Cognitive Functions After Remission of Symptoms of COVID-19,Unrelated
4200,COVID,"February 08, 2021",140,NCT04632732,COVID-19 TEST,CANADA,Recruiting,Centre de recherche du Centre hospitalier universitaire de Sherbrooke,"October 26, 2020",Observational [Patient Registry],Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).,COVID
4201,MEDITATION,"February 08, 2021",68,NCT04632875,LOVING-KINDNESS MEDITATION,UNITED STATES,Recruiting,Georgetown University,"December 4, 2020",Interventional,Identifying Neural Correlates of Altruism,Unrelated
4202,"INFECTION, CORONAVIRUS","February 08, 2021",130,NCT04633772,ANGIOTENSIN-(1-7),BRAZIL,Recruiting,Erasme University Hospital,"August 5, 2020",Interventional,Randomized Clinical Trial Phase I/II for the Use of Angiotensin-(1-7) in the Treatment of Severe Infection by Sars-CoV-2,COVID
4203,DIALYSIS,"February 08, 2021",40,NCT04633915,,RUSSIAN FEDERATION,Recruiting,"Saint Petersburg State University, Russia","November 26, 2020",Observational,A Comparison of Antibody Response Against SARS-CoV-2 in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.,Unrelated
4204,"DIABETES MELLITUS, TYPE 2","February 08, 2021",272,NCT04633941,STANDARD CARE,SINGAPORE,Completed,Singapore General Hospital,"June 1, 2020",Observational,Comparing the Impact of Social Distancing and Lockdown on Bariatric Patients Versus Non-Surgical Obese Patients During COVID-19 Pandemic - Cross Sectional Study,Unrelated
4205,COVID,"February 08, 2021",10,NCT04633980,"MIXTURE 3,6% H2 IN N2 (96.4%)",,Not yet recruiting,"University Hospital, Grenoble","December 1, 2020",Interventional,Hydrogen Inhalation Therapy in Patients With Moderate Covid-19: Phase-1 Clinical Trial,COVID
4206,COVID,"February 08, 2021",1050,NCT04634214,,INDIA,Not yet recruiting,India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals,"November 16, 2020",Observational,Study on Characteristics and Prognosis of Diabetes and Non Diabetes Patients With COVID 19 Among Southern Indian Population,COVID
4207,COVID,"February 08, 2021",118,NCT04634318,RESPIRATORY REHABILITATION PROGRAM (RR).,FRANCE,Recruiting,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"December 10, 2020",Interventional,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae. Assessment and Therapeutic Indication of Tele-rehabilitation Versus Conventional Rehabilitation,COVID
4208,COVID,"February 08, 2021",24,NCT04634370,NATURAL KILLER CELLS INFUSION,BRAZIL,Not yet recruiting,Hospital de Clinicas de Porto Alegre,"January 2, 2021",Interventional,Fase I Clinical Trial on Natural Killer Cells for COVID-19,COVID
4209,COVID,"February 08, 2021",700,NCT04634409,LY3819253,PUERTO RICO,Recruiting,Eli Lilly and Company,"October 29, 2020",Interventional,"A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)",COVID
4210,RESPIRATORY FAILURE,"February 08, 2021",220,NCT04634422,PLASMA EXCHANGE AND CONVALESCENT PLASMA,DENMARK,Recruiting,Wladimir Szpirt,"November 16, 2020",Interventional,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure - the COVID PLEX+CCP Trial,Respiratory
4211,COVID,"February 08, 2021",80,NCT04634799,TM5614,UNITED STATES,Recruiting,Northwestern University,"January 8, 2021",Interventional,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 (STOP Severe COVID-19),COVID
4212,TECHNOLOGY,"February 08, 2021",100,NCT04634851,VIRTUAL HOME VISITS,,Not yet recruiting,"University of California, San Francisco","January 1, 2021",Interventional,Optimizing Dietary Habits for Kidney Stone Formers Using Telehealth Directed Individualized Nutritional Counseling,Unrelated
4213,DEPRESSION,"February 08, 2021",2409,NCT04634903,SUPPORTIVE THERAPY SSI,UNITED STATES,"Active, not recruiting",Stony Brook University,"November 19, 2020",Interventional,Comparing Two Online Single-Session Interventions for Adolescent Depression: Outcomes of a Randomized Trial,Unrelated
4214,COVID,"February 08, 2021",712,NCT04635241,UNFRACTIONATED HEPARIN,ARGENTINA,Recruiting,Australian National University,"June 1, 2020",Interventional,INHALEd Unfractionated HEParin for the Treatment of Hospitalised Patients With COVID-19 Meta-trial,COVID
4215,SARS-COV INFECTION,"February 08, 2021",300,NCT04635592,SARS-COV2 NASAL SWAB,SLOVENIA,Not yet recruiting,University Medical Centre Ljubljana,November 2020,Observational,Serological Diagnostics of COVID-19 and Risk Factors for Infection Among Different Groups of Health Care Workers at Surgical Division at Tertiary Hospital,Respiratory
4216,SARS-CoV2,"February 08, 2021",64,NCT04635605,METHYLENE BLUE,SWITZERLAND,Recruiting,Fondazione Epatocentro Ticino,"November 5, 2020",Interventional,"Evaluation of the Efficacy of Methylene Blue Administration in SARS-CoV2- Affected Patients: a Phase 2, Randomized, Placebo- Controlled, Single Blind Clinical Trial",COVID
4217,MENTAL DISORDER,"February 08, 2021",999,NCT04635618,COGNITIVE BEHAVIORAL BRIEF-TELEPSYCHOTHERAPY,BRAZIL,Enrolling by invitation,Hospital de Clinicas de Porto Alegre,"November 5, 2020",Interventional,"A Pragmatic Superiority Randomized Controlled Trial Comparing Brief Cognitive Behavioral Telepsychotherapy, Brief Interpersonal Telepsychotherapy and Telepsychoeducation for the Reduction of Emotional Distress During COVID-19 Outbreak in Professionals and Students From Essential Services With a High Level of Emotional Distress in Brazil in the Context of COVID-19",Unrelated
4218,COVID,"February 08, 2021",300,NCT04635787,ANNE ONE,UNITED STATES,Enrolling by invitation,Northwestern University,"November 5, 2020",Observational,ICU-Grade Wearable Sensors With Novel Respiratory Biomarkers to Diagnose and Detect Pre- and Very Early Symptomatic COVID-19 Infection Using Predictive Machine Learning Algorithms,COVID
4219,THYROID DISEASE,"February 08, 2021",3800,NCT04635813,THYROIDECTOMY,ITALY,Completed,University of Cagliari,"March 10, 2020",Observational,The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study,Unrelated
4220,COVID,"February 08, 2021",68,NCT04635943,IVERMECTIN,PERU,Recruiting,Universidad Peruana Cayetano Heredia,"August 28, 2020",Interventional,Randomized Phase IIA Clinical Trial to Compare the Efficacy of Ivermectin Versus Placebo to Obtain Negative PCR Results in Patients With Early Phase COVID-19,COVID
4221,CORONAVIRUS INFECTION,"February 08, 2021",1000,NCT04636021,COVID-19 TESTING,UNITED STATES,Recruiting,Pinnacle Health Cardiovascular Institute,"August 1, 2020",Observational [Patient Registry],Restoring Non-Emergent Cardiovascular Care in the Peri-COVID 19 Era,COVID
4222,HEADACHE,"February 08, 2021",60,NCT04636034,SPHENOPALATINE GANGLION BLOCK WITH LOCAL ANESTHETIC,DENMARK,Recruiting,University Hospital Bispebjerg and Frederiksberg,"January 12, 2021",Interventional,"The Effect of Ganglion Sphenopalatine Block (SPG-block) Versus Placebo on Persistent Headache Following COVID-19 Infection: a Randomised, Blinded, Clinical Trial",Unrelated
4223,COVID,"February 08, 2021",100,NCT04636086,CHOLECALCIFEROL,BELGIUM,Recruiting,University of Liege,"November 12, 2020",Interventional,"Vitamin D Supplementation and Covid-19: a Randomised, Double- Blind, Controlled Study",COVID
4224,SARS-CoV2 INFECTION,"February 08, 2021",3500,NCT04636203,,,Not yet recruiting,Neuromed IRCCS,"December 15, 2020",Observational,Burden of SARS-CoV-2 Infection in Populations With High or Low Risk of Infection,COVID
4225,COVID,"February 08, 2021",30000,NCT04636294,SARS-COV-2 PCR,BELGIUM,"Active, not recruiting",Jessa Hospital,"August 1, 2020",Observational,Follow-up of Patients With a Borderline COVID-19 PCR Test Result,COVID
4226,COVID,"February 08, 2021",240,NCT04636320,CONTRAST-ENHANCED CMR,FRANCE,Recruiting,"University Hospital, Bordeaux","June 13, 2020",Interventional,Prevalence of Silent Myocardial Scars on Cardiac Magnetic Resonance Following COVID-19 Infection,COVID
4227,COVID,"February 08, 2021",216,NCT04636333,"TWO DOSES OF MIDDLE-DOSE RECOMBINANT SARS-COV-2 VACCINE (CHO CELL) AT THE SCHEDULE OF DAY 0, 14",CHINA,Recruiting,Jiangsu Province Centers for Disease Control and Prevention,"October 30, 2020",Interventional,Safety and Immunogenicity of a Recombinant COVID-19 Vaccine (CHO Cell) in Healthy Population Aged 18 Years and Older: A Phase I Study,COVID
4228,COVID,"February 08, 2021",,NCT04636554,PHAGE THERAPY,,Available,"Adaptive Phage Therapeutics, Inc.",,Expanded Access,"Expanded Access Study of Phage Treatment in Covid-19 Patients on Anti-Microbials for Pneumonia or Bacteremia/Septicemia Due to A. Baumannii, P. Aeruginosa or S. Aureus",COVID
4229,COVID,"February 08, 2021",680,NCT04636671,METHYLPREDNISOLONE,,Not yet recruiting,University of Trieste,"November 25, 2020",Interventional,Randomized Controlled Trial of Methylprednisolone Versus Dexamethasone in COVID-19 Pneumonia (MEDEAS Trial),COVID
4230,SARS-CoV2 INFECTION,"February 08, 2021",30918,NCT04636697,INTRAMUSCULAR INJECTION,CANADA,Recruiting,Medicago,"November 19, 2020",Interventional,"Randomized, Observer-Blind, Placebo-Controlled, Phase 2/3 Study to Assess the Safety, Efficacy, and Immunogenicity of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults 18 Years of Age or Older",COVID
4231,HEART FAILURE,"February 08, 2021",13,NCT04636944,WEB-BASED COMPASS INTERVENTION,UNITED KINGDOM,Recruiting,King's College London,"October 2, 2020",Observational,Learning From Heart Failure Nurses and Patients: Exploring Their Perspectives in the Management of Depression and Anxiety in Primary Care Settings,Unrelated
4232,NEOPLASMS MALIGNANT,"February 08, 2021",1000,NCT04637295,,UNITED STATES,Recruiting,University of Nebraska,"January 27, 2021",Observational,"Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19",Unrelated
4233,COVID,"February 08, 2021",178,NCT04637828,GNS561,FRANCE,Recruiting,Genoscience Pharma,"November 18, 2020",Interventional,"Cure COVID: A Prospective, Controlled, Randomized Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection",COVID
4234,INFECTION VIRAL,"February 08, 2021",200,NCT04637867,"COLLECTION OF BLOOD, SALIVARY AND NASOPHARYNGEAL SAMPLES.",FRANCE,Recruiting,Hospices Civils de Lyon,"November 23, 2020",Interventional,Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study,Unrelated
4235,COLORECTAL CANCER,"February 08, 2021",1000,NCT04637893,COLONOSCOPY,,Not yet recruiting,Istituto Clinico Humanitas,"December 16, 2020",Observational,The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study,Unrelated
4236,COVID,"February 08, 2021",290,NCT04637906,BIOARGININA®,ITALY,Recruiting,"University of Campania ""Luigi Vanvitelli""","November 18, 2020",Interventional,"Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Randomized, Parallel Group, Double-blind Placebo-controlled Clinical Trial",COVID
4237,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",24,NCT04638634,CSL760,,Not yet recruiting,CSL Behring,"January 21, 2021",Interventional,"A Single Center, Phase 1, Single-Ascending Dose, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects",COVID
4238,CORONAVIRUS,"February 08, 2021",30,NCT04638673,SOTERIX TAVNS MODEL 0125-LTE STIMULATOR - ACTIVE-ACTIVE GROUP,UNITED STATES,Recruiting,Medical University of South Carolina,"November 19, 2020",Interventional,Testing a Wearable Telemedicine-controllable taVNS Device for NeuroCovid Recovery and Rehab,COVID
4239,GRIEF,"February 08, 2021",42,NCT04638842,ONLINE INTERVENTION GRIEF COVID-19,MEXICO,Recruiting,Universidad Internacional de Valencia,"December 24, 2020",Interventional,"Effectiveness of a Self-applied Multi-component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: A Randomized Clinical Trial",Unrelated
4240,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,"February 08, 2021",40,NCT04639349,EXERCISE GROUP,EGYPT,Recruiting,Cairo University,"November 19, 2020",Interventional,Effect of Home Exercise Activity on Cortisol and Depression in COPD Patients During the Pandemic COVID-19,Unrelated
4241,SARS-CoV2,"February 08, 2021",300,NCT04639375,VACCINATED WITH POLIO VACCINE (IPV),UNITED STATES,Recruiting,E-MO Biology Inc,"November 15, 2020",Interventional,A Proof-of-concept Study of Poliovirus Vaccine (IPV) Activity to Induce an Immune Response That Cross-reacts With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2),COVID
4242,ORAL-LINGUO-FACIAL PRAXIES,"February 08, 2021",4,NCT04639427,,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,November 2020,Observational,Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases,Unrelated
4243,COVID,"February 08, 2021",60,NCT04639440,ADIPOSE TISSUE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,"November 23, 2020",Observational,Impact of Adipose Tissue in COVID-19 : From Pathophysiology to Therapeutic Perspectives,COVID
4244,COVID,"February 08, 2021",129,NCT04639466,PLACEBO ADMINISTRATION,UNITED STATES,Recruiting,City of Hope Medical Center,"December 11, 2020",Interventional,"Phase 1 Dose Escalation Study to Evaluate the Safety and Biologically Effective Dose of COH04S1, a Synthetic MVA-Based SARS-CoV-2 Vaccine, Administered as One or Two Injections to Healthy Adult Volunteers",COVID
4245,DUAL-GENERATION INTERVENTION FOR MOTHERS WITH DEPRESSION,"February 08, 2021",40,NCT04639557,BRIDGE THERAPY PROGRAM,CANADA,Enrolling by invitation,University of Manitoba,"September 1, 2020",Interventional,"Building Regulation in Dual Generations - A Telehealth Parenting Program for Depressed Mothers of Preschoolers, Matched With Dialectical Behavior Therapy Skills",Unrelated
4246,PERIODONTAL DISEASES,"February 08, 2021",200,NCT04639661,,CANADA,Enrolling by invitation,Brock University,"November 25, 2020",Observational,Predictors of Periodontal Outcomes in Patients 5 to 10 Years Post-sanative Therapy,Unrelated
4247,COVID,"February 08, 2021",30,NCT04640038,SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES,UNITED STATES,Recruiting,Children's Hospital of Philadelphia,"December 18, 2020",Interventional,Contrast Enhanced Ultrasound (CEUS) Detection of Microvascular Perfusion Impairment in COVID-19 Pediatric Patients,COVID
4248,TYPE1DIABETES,"February 08, 2021",500,NCT04640064,,ARGENTINA,Not yet recruiting,Hospital General Puyo,"November 22, 2020",Observational,Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group,Unrelated
4249,COVID,"February 08, 2021",1500,NCT04640168,BARICITINIB,JAPAN,Recruiting,National Institute of Allergy and Infectious Diseases (NIAID),"November 24, 2020",Interventional,"A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-4)",COVID
4250,COVID,"February 08, 2021",150,NCT04640181,ENOXAPARIN,,Not yet recruiting,St. David's HealthCare,"December 1, 2020",Interventional,"A Phase 2-3, Multi-Center, Randomized Trial to Study the Potential Benefit of Factor Xa Inhibitor (Rivaroxaban) Versus Standard of Care Low Molecular Weight Heparin (Lovenox) in Hospitalized Patients With COVID-19 (XACT)",COVID
4251,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",270,NCT04640194,ALTEPLASE,BELGIUM,Recruiting,Boehringer Ingelheim,"December 16, 2020",Interventional,"The TRISTARDS Trial - ThRombolysIS Therapy for ARDS A Phase IIb/III Operationally Seamless, Open-label, Randomised, Sequential, Parallel-group Adaptive Study to Evaluate the Efficacy and Safety of Daily Intravenous Alteplase Treatment Given up to 5 Days on Top of Standard of Care (SOC) Compared With SOC Alone, in Patients With Acute Respiratory Distress Syndrome (ARDS) Triggered by COVID-19",Respiratory
4252,COVID PREVENTION,"February 08, 2021",1600,NCT04640233,GAM-COVID-VAC,INDIA,Recruiting,Dr. Reddy's Laboratories Limited,"November 30, 2020",Interventional,"Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase II/III Adaptive Clinical Trial to Assess the Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for SARS-Сov-2 Infection in Indian Healthy Subjects",COVID
4253,COVID,"February 08, 2021",960,NCT04640402,LOW-DOSE RECOMBINANT COVID-19 VACCINE (SF9 CELLS) (18-59 YEARS) & TWO DOSE REGIMEN,CHINA,Recruiting,Jiangsu Province Centers for Disease Control and Prevention,"November 17, 2020",Interventional,"A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱ Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in the Subjects From Healthy Aged 18 Years and Above",COVID
4254,COVID,"February 08, 2021",1000,NCT04640428,,UNITED KINGDOM,Recruiting,King's College Hospital NHS Trust,"May 26, 2020",Observational,COVID-19 Stroke Apical Lung Examination Study - A Multi-centre Prospective Study,COVID
4255,ADENOIDECTOMY,"February 08, 2021",40,NCT04640610,STORAGE OF OPERATING WASTE,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,December 2020,Observational,"Study of the Expression of Angiotensin-converting Enzyme 2 (ACE2), a Cell Membrane Receptor for SARS-CoV-2 and the TMPRSS2 Serine Protease in Tonsils and Adenoids of Children and Adults",Unrelated
4256,COVID,"February 08, 2021",66,NCT04641182,PRONE POSITION,CHILE,Completed,Pontificia Universidad Catolica de Chile,"July 6, 2020",Observational [Patient Registry],Observational Study of Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure,COVID
4257,COVID,"February 08, 2021",700,NCT04641195,VITAMIN D3 (CHOLECALCIFEROL),INDIA,Not yet recruiting,Harvard School of Public Health,"December 7, 2020",Interventional,A Randomized Trial to Determine the Effect of Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,COVID
4258,COVID,"February 08, 2021",25800,NCT04641481,BBV152,INDIA,Recruiting,Bharat Biotech International Limited,"November 25, 2020",Interventional,"An Event-Driven, Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Efficacy, Safety, Immunogenicity, Lot-to-Lot Consistency of BBV152, a Whole-Virion Inactivated SARS-CoV-2 Vaccine in Adults≥18 Yrs of Age",COVID
4259,B-CELL LYMPHOMA,"February 08, 2021",120,NCT04641806,,,Not yet recruiting,Versailles Hospital,"December 15, 2020",Observational,Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma,Unrelated
4260,COVID,"February 08, 2021",1050,NCT04641858,BCG-DENMARK,CAPE VERDE,Recruiting,University of Southern Denmark,"December 3, 2020",Interventional,BCG Vaccine to Reduce Unplanned Absenteeism Due to Illness of Health Care Workers During the COVID-19 Pandemic. A Multi-center Randomised Controlled Trial (BCG-COVID-RCT),COVID
4261,COVID,"February 08, 2021",111,NCT04641988,,FRANCE,Completed,"University Hospital, Montpellier","February 1, 2020",Observational,Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) : COROBIOCHIC,COVID
4262,COVID CONVALESCENT PLASMA TREATMENT,"February 08, 2021",500,NCT04642014,COVID-19 CONVALESCENT PLASMA TREATMENT,POLAND,Not yet recruiting,Wroclaw Medical University,"December 1, 2020",Interventional,"A Multi-centre, 18-months, Single-group Study of Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Metabolomic and Laboratory Evaluation of Plasma Therapy Effectiveness",COVID
4263,COVID,"February 08, 2021",100,NCT04642040,PULMONARY REHABILITATION,TURKEY,Recruiting,Sisli Hamidiye Etfal Training and Research Hospital,"June 30, 2020",Interventional,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,COVID
4264,COVID,"February 08, 2021",155,NCT04642196,,SWEDEN,Completed,"University Hospital, Linkoeping","May 2, 2020",Observational,COVID-19 in Home Healthcare and Mortality,COVID
4265,COVID,"February 08, 2021",50,NCT04642326,TEST GROUP: EXPERIMENTAL - UVC THERAPY APPLIED,TURKEY,"Active, not recruiting",RD Global Araştirma Geliştirme Sağlik Ilaç Inşaat Yatirimlari A.Ş.,"June 26, 2020",Interventional,"Prospective, Parallel, Multicenter Randomized Controlled Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis",COVID
4266,COVID,"February 08, 2021",2000,NCT04642339,GAM-COVID-VAC,,Not yet recruiting,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",November 2020,Interventional,"Randomized, Double-blind, Placebo Controlled, Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Combined Vector Vaccine in Prophylactic Treatment for SARS-СoV-2 Infection",COVID
4267,CORONAVIRUS INFECTION,"February 08, 2021",6578,NCT04642638,INO-4800,UNITED STATES,Recruiting,Inovio Pharmaceuticals,"November 30, 2020",Interventional,"Phase 2/3 Randomized, Blinded, Placebo-Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of INO-4800, a Prophylactic Vaccine Against COVID-19 Disease, Administered Intradermally Followed by Electroporation in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure",COVID
4268,MECHANICAL VENTILATION,"February 08, 2021",100,NCT04642703,,CHILE,Recruiting,University of Chile,"March 3, 2020",Observational,Mortality in Patients With Severe SARS-CoV-2 Pneumonia Who Underwent Tracheostomy Due to Prolonged Mechanical Ventilation,Unrelated
4269,ELBOW FRACTURE,"February 08, 2021",52,NCT04642807,LONG ARM SOFT CAST,,Not yet recruiting,University of British Columbia,January 2021,Interventional,Management of Type 1 Supracondylar Humeral Fractures: A Multicentre Randomized Control Trial,Unrelated
4270,COVID,"February 08, 2021",60,NCT04642950,SARGRAMOSTIM,JAPAN,Recruiting,Nobelpharma,"December 17, 2020",Interventional,A Phase II/III Study of Sargramostim in Patients With Coronavirus Disease-2019 (COVID-19),COVID
4271,COVID,"February 08, 2021",100,NCT04643054,OVOTRANSFERRIN,ITALY,Not yet recruiting,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,"December 1, 2020",Interventional,Efficacy and Safety of Ovotransferrin in COVID-19 Patients With Mild-to-Moderate Disease,COVID
4272,SARS-CoV2 INFECTION,"February 08, 2021",1000,NCT04643444,BLOOD SAMPLING,SWITZERLAND,Recruiting,University of Bern,January 2021,Observational,"Police Officer COVID-19 Seroprevalence Survey in the Canton of Bern, Switzerland",COVID
4273,"SPERM COUNT, LOW","February 08, 2021",21,NCT04643522,CLINICAL ASSESSMENT,TURKEY,Completed,Ankara City Hospital Bilkent,"January 7, 2020",Observational,Does COVID-19 Worsen the Semen Parameters? Early Results of a Tertiary Health Center,Unrelated
4274,SARS-CoV2 INFECTION,"February 08, 2021",20,NCT04643548,,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","October 13, 2020",Observational,Neurological Abnormalities in SARS-CoV-2 ICU Patients. A Prospective Study. NeuroCOVID Study,COVID
4275,COVID,"February 08, 2021",5,NCT04643561,TRAVELAN OTC,ISRAEL,"Active, not recruiting",Hadassah Medical Organization,"November 1, 2020",Interventional,A Feasibility Trial Using Trevalan in Healthy Volunteers for Increasing an in Vitro Immune Response to COVID-19 Proteins,COVID
4276,COVID,"February 08, 2021",80,NCT04643678,ANAKINRA,QATAR,Recruiting,Hamad Medical Corporation,"October 30, 2020",Interventional,Efficacy of Anakinra in the Management of Patients With COVID-19 Infection in Qatar: A Randomized Clinical Trial,COVID
4277,COVID,"February 08, 2021",90,NCT04643691,LOSARTAN 50 MG AND SPIRONOLACTONE 25 MG PILLULES ORAL USE,FRANCE,Recruiting,Assistance Publique Hopitaux De Marseille,"September 11, 2020",Interventional,Benefit of Treatment With Losartan and Spironolactone on the Regulation of the Renin-angiotensin System in the Prognosis of Patients Infected With COVID-19 and Suffering From Acute Respiratory Distress Syndrome,COVID
4278,SARS-CoV2 INFECTION COVID,"February 08, 2021",1000,NCT04643860,DIFFERENTIAL LEUCOCYTE COUNT (CLDC) DEVICE AND ALGORITHM,ITALY,Not yet recruiting,Neuromed IRCCS,December 2020,Observational,"A New Point-of-care Test Based on Differential Leucocyte Count, Suitable for a Mass Screening Program to Detect SARS-CoV-2: A Diagnostic Accuracy Study",COVID
4279,DEPRESSIVE SYMPTOMS,"February 08, 2021",501,NCT04643964,ENTRÉE: COGNITIVE SKILLS,UNITED STATES,Recruiting,Ohio State University,November 2020,Interventional,Building Mental Health Resilience in the COVID-19 Pandemic.,Unrelated
4280,CORONAVIRUS DISEASE-2019 (COVID),"February 08, 2021",32,NCT04644120,ABBV-47D11,ISRAEL,Recruiting,AbbVie,"December 10, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ABBV-47D11 in Adults Hospitalized With COVID-19",COVID
4281,COVID,"February 08, 2021",40,NCT04644146,GENETIC,FRANCE,Recruiting,Hospices Civils de Lyon,"December 1, 2020",Observational,Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection) in Patients Without Comorbidities,COVID
4282,SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",2000,NCT04644159,HUMAN BIOLOGICAL SAMPLES,FRANCE,Recruiting,Institut Pasteur,"November 13, 2020",Observational,Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation in Early 2020,Respiratory
4283,COVID,"February 08, 2021",40,NCT04644172,SPEED OF PROCESSING TRAINING,UNITED STATES,Recruiting,University of Alabama at Birmingham,"November 1, 2020",Interventional,Improving Thinking in Everyday Life: Pilot Study C,COVID
4284,COVID,"February 08, 2021",795,NCT04644185,SCTA01,ARGENTINA,Not yet recruiting,Sinocelltech Ltd.,"February 10, 2021",Interventional,"A Multicenter, Adaptive, Randomized, Double-blinded, Placebo-controlled Phase II/III Trial to Evaluate the Efficacy and Safety of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in Hospitalized Patients With Severe COVID-19",COVID
4285,"COVID, CONVALESCENT PLASMA TREATMENT","February 08, 2021",30,NCT04644198,CONVALESCENT PLASMA INFUSION,JAMAICA,Recruiting,The University of The West Indies,"February 1, 2021",Interventional,Pilot Study of Convalescent COVID-19 Plasma Transfusion in Severe COVID-19 Patients at a Type A Teaching Hospital in Jamaica,COVID
4286,RESPIRATORY FAILURE,"February 08, 2021",30,NCT04644276,MASK WITH MASK ADHESIVE/ARM 1,UNITED STATES,Not yet recruiting,Philips Clinical & Medical Affairs Global,"January 18, 2021",Interventional,Feasibility Study of a Mask Adhesive in Patients Treated With NIV in an Institutional Setting,Respiratory
4287,VIRAL PNEUMONIA,"February 08, 2021",25,NCT04644302,MICROCIRCULATION RECORDING,CZECHIA,Recruiting,University Hospital Hradec Kralove,"February 1, 2020",Observational,"Circulatory and Endothelial Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis - Prospective, Observational Pilot Study",Respiratory
4288,COVID,"February 08, 2021",20000000,NCT04644328,FACEBOOK ADS ON THE IMPORTANCE OF STAYING SAFE DURING THE THANKSGIVING HOLIDAY,UNITED STATES,Not yet recruiting,"National Bureau of Economic Research, Inc.","November 14, 2020",Interventional,The Doctors for Coronavirus Prevention Project Thanksgiving Messaging Campaign,COVID
4289,COVID,"February 08, 2021",20,NCT04644341,CARDIOVASCULAR AND RESPIRATORY SYSTEMS MONITORING,,Not yet recruiting,University of Manitoba,"December 1, 2020",Observational,Post Discharge Tele-monitoring of COVID-19 Survivors for Long-Term Impacts and Point-of-Care,COVID
4290,PARKINSON DISEASE,"February 08, 2021",40,NCT04644367,TAI CHI INTERVENTION,,Not yet recruiting,University of Ottawa,January 2021,Interventional,THE EFFECTS OF A BIOMECHANICAL BASED TAI CHI INTERVENTION PROGRAM ON POSTURAL STABILITY AND GAIT IN PEOPLE WITH PARKINSON'S DISEASE,Unrelated
4291,MENISCECTOMY,"February 08, 2021",60,NCT04644640,TELEREHABILITATION THERAPY,UNITED STATES,Not yet recruiting,NYU Langone Health,"December 1, 2020",Interventional,Telerehabilitation Following Meniscectomy: A Randomized Clinical Trial,Unrelated
4292,HEALTHY VOLUNTEERS,"February 08, 2021",28,NCT04644705,NICLOSAMIDE,GERMANY,Recruiting,Charité Research Organisation GmbH,"November 2, 2020",Interventional,A 3-part Study to Investigate the Safety and Pharmacokinetics of a Novel Niclosamide Solution as a Treatment Option for COVID-19 in Combination With Camostat,Unrelated
4293,"FIBROSES, PULMONARY","February 08, 2021",160,NCT04645368,BOVHYALURONIDASE AZOXYMER,RUSSIAN FEDERATION,Recruiting,NPO Petrovax,"July 1, 2020",Observational,"Multicenter, Open-label Prospective Cohort Study of the Efficacy and Safety of the Inclusion of Longidaze in the Prevention and Treatment of Post-inflammatory Pulmonary Fibrosis and Interstitial Lung Diseases Caused by COVID-19.",Unrelated
4294,NOVEL CORONAVIRUS PNEUMONIA,"February 08, 2021",66,NCT04645407,FUZHENG HUAYU TABLET,CHINA,Completed,ShuGuang Hospital,"February 1, 2020",Interventional,Efficacy of Fuzheng Huayu Tablets for Treating Pulmonary Inflammation in Patients With COVID-19: A Case-Control Study,COVID
4295,MORTALITY,"February 08, 2021",100,NCT04645433,,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"March 15, 2020",Observational,Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit: Single Center Experience,Unrelated
4296,COVID,"February 08, 2021",77,NCT04645498,,,Not yet recruiting,"University Hospital, Lille",January 2021,Observational,Prospective Study on the Impact of COVID-19 on the Equilibrium of Hereditary Metabolic Disease (MHM) in Patients With or Who Have Contracted COVID-19,COVID
4297,COVID,"February 08, 2021",144,NCT04645563,SENDING THORAX CT VIDEO IMAGES VIA SMARTPHONE APPLICATIONS,TURKEY,Completed,Kafkas University,"March 11, 2020",Observational,Using Whatsapp for the Consultation of Covid-19 Suspected Patients in Pandemic Polyclinics; A Retrospective Case Control Study,COVID
4298,COVID,"February 08, 2021",,NCT04646031,T89 CAPSULE,UNITED STATES,Available,"Tasly Pharmaceuticals, Inc.",,Expanded Access,"Expanded Access Use of T89 in An Intermediate-size Patients Population for the Treatment of Severe ""Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)"" Infection Disease Patients (COVID-19)",COVID
4299,COVID,"February 08, 2021",30,NCT04646044,BEMPEGALDESLEUKIN,UNITED STATES,Recruiting,Nektar Therapeutics,"November 13, 2020",Interventional,"A Phase 1b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) Plus Standard of Care Versus Placebo Plus Standard of Care in Adults With Mild COVID-19",COVID
4300,COVID,"February 08, 2021",66,NCT04646109,IVERMECTIN,TURKEY,Completed,Afyonkarahisar Health Sciences University,"May 11, 2020",Interventional,The Effectiveness and Safety of Ivermectin as add-on Therapy in Severe COVID-19 Management,COVID
4301,COVID,"February 08, 2021",80,NCT04646239,HETEROLOGOUS STIMULI,UNITED STATES,Recruiting,Washington University School of Medicine,"December 17, 2020",Observational,"Determining Biomarkers of Trained Immunity in a Randomized Controlled Trial of the Measles, Mumps, and Rubella Vaccine - a Sub-study of the CROWN CORONATION Trial",COVID
4302,INFERTILITY,"February 08, 2021",350,NCT04646291,INSEMINATION WITH THE MOSIE BABY KIT,UNITED STATES,Completed,Mosie Baby,"August 5, 2020",Observational,"Retrospective Study on the Use, Efficiency, and Safety of the At-home Mosie Kit",Unrelated
4303,PROBLEM GAMBLING,"February 08, 2021",3626,NCT04646421,MOTIVATIONAL TELEPHONE INTERVENTION,SWEDEN,Recruiting,Lund University,"November 30, 2020",Observational,"Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden. Effectiveness, User Satisfaction and Acceptability of the Motivational Telephone Intervention of AB Svenska Spel.",Unrelated
4304,COVID,"February 08, 2021",300,NCT04646525,PHYSICAL EXAMINATION,TURKEY,Recruiting,Selcuk University,"October 1, 2020",Observational,The Relationship Between Mild Covid-19 Infection in Pediatric Patients and Protection of Secondary Lymphoid Organs,COVID
4305,COVID,"February 08, 2021",165,NCT04646551,,,Not yet recruiting,Assiut University,December 2020,Observational,Assessment of the Pattern and Risk Factors of Covid-19 Between Infected Healthcare Workers at Assiut University Hospitals,COVID
4306,PREVENTION OF COVID,"February 08, 2021",29000,NCT04646590,RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) GROUP,CHINA,Recruiting,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","December 16, 2020",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled Clinical Trial in 18 Years of Age and Above to Determine the Safety and Efficacy of ZF2001, a Recombinant Novel Coronavirus Vaccine (CHO Cell) for Prevention of COVID-19",COVID
4307,COVID,"February 08, 2021",18,NCT04646603,MRG-001,UNITED STATES,Recruiting,MedRegen LLC,"January 28, 2021",Interventional,"A Combined Phase I Double-Blind Randomized Placebo Controlled Study in Healthy Subjects /Phase IIa, Randomized, Double-blind, Placebo Controlled, Multi-center Study in Subjects Infected With SARS CoV-2 to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of MRG-001",COVID
4308,COVID,"February 08, 2021",800,NCT04646616,COMMUNITY POPULAR OPINION LEADER (POL) BASED INTERVENTION,UNITED STATES,Not yet recruiting,Drexel University,"January 6, 2021",Interventional,CRISOL: Building Community Resilience and Integrating Efforts to Understand and Address Syndemic Health Conditions Afflicting Young LatinoImmigrants,COVID
4309,COPING SKILLS,"February 08, 2021",160,NCT04646642,,,Not yet recruiting,David Grant U.S. Air Force Medical Center,December 2020,Observational,"Psychological Health, Coping Strategies and Preferences of David Grant USAF Medical Center COVID-19 Deployers: A Critical Needs Assessment",Unrelated
4310,COVID,"February 08, 2021",300,NCT04646655,ENOXAPARIN,ITALY,Recruiting,ASST Fatebenefratelli Sacco,"July 27, 2020",Interventional,Enoxaparin at Prophylactic or Therapeutic Doses With Monitoring of Outcomes in Subjects Infected With COVID-19: a Pilot Study on 300 Cases Enrolled at ASST-FBF-Sacco,COVID
4311,SARS-CoV2 INFECTION,"February 08, 2021",233,NCT04647305,CLOSED FACE SHIELD WITH SURGICAL FACE MASK USE,,Not yet recruiting,"University of Los Andes, Columbia",December 2020,Interventional,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission: A Randomized Controlled Trial,COVID
4312,COVID,"February 08, 2021",40,NCT04647604,OMEGAVEN®,SWEDEN,Recruiting,Karolinska University Hospital,"June 23, 2020",Interventional,"Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids - A Single-blind, Randomized, Placebo-controlled Feasibility Study",COVID
4313,COVID,"February 08, 2021",70,NCT04647656,HYPERBARIC OXYGEN,ISRAEL,Not yet recruiting,Assaf-Harofeh Medical Center,"January 1, 2021",Interventional,"Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome: a Prospective, Randomized, Double Blind Study.",COVID
4314,COVID,"February 08, 2021",100,NCT04647669,REMDESIVIR,JAMAICA,Not yet recruiting,The University of The West Indies,"February 1, 2021",Interventional,"WHO Public Health Emergency ""Solidarity"" Clinical Trial for COVID-19 Treatments",COVID
4315,COVID INFECTION,"February 08, 2021",30,NCT04647682,PHYSICAL ACTIVITY PROGRAM,FRANCE,Recruiting,"University Hospital, Toulouse","November 1, 2020",Observational,Feasibility and Effect of Implementing Physical Activity Program Implementation During Covid-19 in Hospitalized Positive Covid-19 Older Adults,COVID
4316,COVID,"February 08, 2021",100,NCT04647695,INTERFERON BETA-1B,HONG KONG,Recruiting,The University of Hong Kong,"November 20, 2020",Interventional,An Open-label Randomized Controlled Trial on Interferon β-1b and Remdesivir Combination Versus Remdesivir as Treatment for COVID-19 Infection,COVID
4317,"COVID, SARS-CoV2","February 08, 2021",40,NCT04647734,HIGH INTENSITY INTERVAL TRAINING,DENMARK,Not yet recruiting,"Rigshospitalet, Denmark","January 1, 2021",Interventional,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,COVID
4318,COVID,"February 08, 2021",40,NCT04647747,SELF MEASUREMENT WITH PULSE OXIMETER,NORWAY,Recruiting,Ostfold Hospital Trust,"November 30, 2020",Interventional,Silent Hypoxia and Awake Proning in COVID-19 Patients: Home Monitoring and Self-Reporting,COVID
4319,PEDIATRIC OBESITY,"February 08, 2021",128,NCT04647760,JOIN FOR ME,UNITED STATES,Recruiting,The Miriam Hospital,January 2021,Interventional,Packaging and Disseminating the JOIN for ME Program in Low-Income Settings,Unrelated
4320,PREGNANT WOMEN,"February 08, 2021",500,NCT04647994,SARS-COV-2 SEROLOGY,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"September 21, 2020",Observational,Exploratory Study in COVID-19 During Pregnancy,Unrelated
4321,"BLOOD PRESSURE, HEART RATE, BREATHING RATE, HEART RATE VARIABILITY (HRV: STRESS), AND OXYGEN LEVEL","February 08, 2021",200,NCT04648111,VITAL SIGN MEASUREMENT,CANADA,Not yet recruiting,"University Health Network, Toronto","December 15, 2020",Observational,Implementing Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement (MAC-VITAL): A Proof of Concept Trial,Unrelated
4322,HEMODYNAMIC MONITORING,"February 08, 2021",1000,NCT04648293,STARLING,UNITED STATES,Recruiting,Baxter Healthcare Corporation,"November 12, 2020",Observational [Patient Registry],Starling Registry Study,Unrelated
4323,SEVERE COVID,"February 08, 2021",2000,NCT04648410,QUESTIONNAIRE,CZECHIA,Not yet recruiting,Brno University Hospital,"February 1, 2021",Observational,Administration of Systemic Corticosteroids Among Critically Ill Patients With COVID-19: Electronic Survey (ASAP-C Study),COVID
4324,COVID,"February 08, 2021",100,NCT04648709,ELISPOT,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Saint Etienne,"February 1, 2021",Observational,Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19,COVID
4325,COVID,"February 08, 2021",1000,NCT04648800,BCG-10 VACCINE,POLAND,Recruiting,Hanna Czajka,"July 7, 2020",Interventional,"A Multi-centre, Randomised, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland",COVID
4326,SARS-CoV2,"February 08, 2021",960,NCT04649021,BNT162B2,CHINA,Recruiting,BioNTech SE,"December 4, 2020",Interventional,"Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population: A Phase II, Randomized, Placebo-controlled, Observer-blinded Study",COVID
4327,COVID,"February 08, 2021",120,NCT04649086,REHABILITATION BY ECCENTRIC EXERCISES,FRANCE,Recruiting,"University Hospital, Clermont-Ferrand","June 5, 2020",Interventional,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection: Research Protocol for Randomized Controlled Trial (CovExc),COVID
4328,SARS-CoV2,"February 08, 2021",3000,NCT04649151,MRNA-1273,UNITED STATES,Recruiting,"ModernaTX, Inc.","December 9, 2020",Interventional,"A Phase 2/3, Randomized, Observer-Blind, Placebo Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS CoV 2 Vaccine in Healthy Adolescents 12 to <18 Years of Age",COVID
4329,COVID,"February 08, 2021",300,NCT04649320,QUESTIONNAIRE,AUSTRIA,Recruiting,Medical University Innsbruck,"November 23, 2020",Observational,Investigation of the Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias Using Patient-reported Outcome Measures (PROMs),COVID
4330,COVID,"February 08, 2021",1336,NCT04649333,,AUSTRIA,Completed,Medical University Innsbruck,"June 15, 2020",Observational,COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures,COVID
4331,COVID,"February 08, 2021",72,NCT04649424,CANSWAB,CANADA,Not yet recruiting,Orthopaedic Innovation Centre,December 2020,Interventional,Comparative Evaluation of Nasopharyngeal Swabs for Sampling and Detection of SARS-CoV2,COVID
4332,CORONAVIRUS DISEASE-2019 (COVID),"February 08, 2021",1305,NCT04649515,TY027,SINGAPORE,Recruiting,Tychan Pte Ltd.,"December 4, 2020",Interventional,"Phase 3 Multi-Site, Randomised, Placebo Controlled, Double Blind, Single Dose Study of TY027 for Early Treatment of COVID-19",COVID
4333,COVID,"February 08, 2021",93,NCT04649658,PRONE POSITION,ITALY,Completed,University of Modena and Reggio Emilia,"March 1, 2020",Observational,Awake Prone Position in Critical and Severe COVID-19 Patients Undergoing Noninvasive Respiratory Support: a Retrospective Multicenter Cohort Study,COVID
4334,COVID,"February 08, 2021",108,NCT04649736,RESPIRATORY AND PSYCHOLOGICAL REHABILITATION,PERU,Recruiting,Universidad Peruana Cayetano Heredia,"October 26, 2020",Interventional,Prevalence of Altered Pulmonary Function Post-infection by COVID-19 and Impact of Participation in a Pilot Program of Comprehensive Rehabilitation in the Short and Medium-term,COVID
4335,CORONAVIRUS INFECTION,"February 08, 2021",50,NCT04649775,AIRFLO2,,Not yet recruiting,Duke University,"January 30, 2021",Interventional,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,COVID
4336,COVID,"February 08, 2021",3000,NCT04649827,CLINICAL OBSERVATION,BRAZIL,Recruiting,Escola de Saúde Pública do Ceará,"April 2, 2020",Observational,"SARS-CoV-2 Epidemiology Study at e Referenced Hospital in Fortaleza, Brazil: ResCOVID Study",COVID
4337,COVID,"February 08, 2021",60,NCT04649840,HUMORAL AND CELLULAR IMMUNITY,BELARUS,Enrolling by invitation,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,"October 1, 2020",Observational,Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients,COVID
4338,COVID,"February 08, 2021",920,NCT04649879,SARS-COV-2 CONVALESCENT PLASMA,SWEDEN,Not yet recruiting,Joakim Dillner,"December 3, 2020",Interventional,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,COVID
4339,COVID,"February 08, 2021",50,NCT04649918,PULMONARY REHABILITATION,GERMANY,Recruiting,Schön Klinik Berchtesgadener Land,"November 25, 2020",Observational,Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19 - an Observational Trial,COVID
4340,SARS (SEVERE ACUTE RESPIRATORY SYNDROME),"February 08, 2021",400,NCT04649931,ION MOBILITY SPECTROMETRY (IMS),GERMANY,Recruiting,B. Braun Melsungen AG,"December 14, 2020",Observational,Study to Evaluate Whether Differences in Exhaled Breath Can be Identified Using Ion Mobility Spectrometry (IMS) in Subjects Tested Positive for SARS-CoV-2 Infection and Subjects Tested Negative,Respiratory
4341,COVID,"February 08, 2021",40,NCT04649944,SEROLOGICAL TEST AND PHONE INTERVIEW,ITALY,Not yet recruiting,University of Milan,"February 5, 2021",Observational,Assessment of the Serological Profile of Children and Adolescents Between 4 and 16 Years of Age Cohabiting With at Least One Family Member Who Tested Positive to COVID-19: an Observational Study,COVID
4342,"INFECTIONS, RESPIRATORY","February 08, 2021",100,NCT04649957,,UNITED KINGDOM,Not yet recruiting,University of Derby,"January 4, 2021",Observational,Profiling the Determinants of Recovery to Establish Novel Rehabilitation Guidelines to Improve Clinically Relevant and Patient-reported Outcomes in the Post-COVID-19 Period,Respiratory
4343,ACUTE APPENDICITIS,"February 08, 2021",532,NCT04649996,APPENDECTOMY,ITALY,Completed,University of Milano Bicocca,"September 1, 2020",Observational,Variation of Incidence and Clinical Presentation of Acute Appendicitis During a Pandemic.,Unrelated
4344,COVID,"February 08, 2021",60,NCT04650035,,JORDAN,Completed,Yarmouk University,"November 1, 2020",Observational,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak : A Survey,COVID
4345,COVID,"February 08, 2021",5320,NCT04650087,APIXABAN 2.5 MG,,Not yet recruiting,"Thomas Ortel, M.D., Ph.D.",April 2021,Interventional,"COVID-19 Post-hospital Thrombosis Prevention Trial: An Adaptive, Multicenter, Prospective, Randomized Platform Trial Evaluating the Efficacy and Safety of Antithrombotic Strategies in Patients With COVID-19 Following Hospital Discharge",COVID
4346,COVID INFECTION,"February 08, 2021",274,NCT04650178,QUALITY-OF-LIFE ASSESSMENT,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"May 26, 2020",Observational,COVID-19: Well-Being in Cancer Patients With Neuropathy Who Participated in Prior Clinical Trials,COVID
4347,CORONAVIRUS INFECTION,"February 08, 2021",300,NCT04650191,IDENTIFICATION OF GENETIC VARIANTS,UNITED STATES,Recruiting,Milton S. Hershey Medical Center,"March 1, 2020",Observational [Patient Registry],Surfactant Protein Genetic Variants in COVID-19 Infection,COVID
4348,COVID,"February 08, 2021",40,NCT04651374,GEKO T3,CANADA,Not yet recruiting,Lawson Health Research Institute,December 2020,Interventional,COVID-19 And Geko Evaluation: The CAGE Study,COVID
4349,SARS-COV INFECTION,"February 08, 2021",74,NCT04651387,OZONIZED OIL (HOO,,Not yet recruiting,Neuromed IRCCS,January 2021,Interventional,Efficacy and Safety of Ozonised Oil (HOO) as Adjuvant Nutrition Supplement in COVID-19 Patients With Mild-to-Moderate Disease - HOO-COVID Project,Respiratory
4350,COVID,"February 08, 2021",300,NCT04651400,ANTITHROMBIN III,AUSTRIA,Recruiting,Octapharma,"October 19, 2020",Observational,"Multinational, Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection",COVID
4351,COVID,"February 08, 2021",800,NCT04651413,PCR VALUE,UNITED KINGDOM,Recruiting,University Hospitals of North Midlands NHS Trust,"November 24, 2020",Observational,Can Quantitative (Real-time) Polymerase Chain Reaction (PCR) Cycle Threshold (Ct) Values be Used to Predict Poor Outcomes for Patients Infected With SARS-CoV-2? A Local Exploratory Sub-study at The University Hospitals of North Midlands NHS Trust in Collaboration With the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 Trial,COVID
4352,COVID,"February 08, 2021",2300,NCT04651790,SARS-COV-2 INACTIVATED VACCINE,CHILE,Recruiting,Pontificia Universidad Catolica de Chile,"November 27, 2020",Interventional,"Multi-center, Phase 3, Double-blind, Randomized, Placebo-controlled, Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of an Inactivated Vaccine Against the SARS-CoV-2 Infection in High Risk of Infection Adults",COVID
4353,BIOEQUIVALENCE,"February 08, 2021",30,NCT04651959,AVICOD 200 MG FILM TABLET,TURKEY,"Active, not recruiting",Pharma Plant,"November 13, 2020",Interventional,"Open-label, Randomised, Single Oral Dose, Two-period, Cross-over Trial to Assess to Bioequivalence of Favira 200 mg FT in Comparison With Avigan 200 mg FT in Healthy Male Subjects Under Fasting Conditions",Unrelated
4354,COVID,"February 08, 2021",36500,NCT04652102,CVNCOV,BELGIUM,Recruiting,CureVac AG,"December 14, 2020",Interventional,"COVID-19: A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older",COVID
4355,COVID,"February 08, 2021",42,NCT04652115,DEFIBROTIDE,UNITED STATES,Not yet recruiting,Brigham and Women's Hospital,"January 1, 2021",Interventional,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19,COVID
4356,COVID INFECTION,"February 08, 2021",700,NCT04652505,QUESTIONNAIRE ADMINISTRATION,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"July 13, 2020",Observational,Coping With COVID: The Effect of the COVID-19 Public Health Crisis on Mental Well-Being in Cancer Patients Seen at the Psychiatric Oncology Clinic,COVID
4357,COVID,"February 08, 2021",168,NCT04652518,LYT-100,ROMANIA,Recruiting,PureTech,"December 11, 2020",Interventional,"A Phase 2 Randomized, Double-blind, Placebo-controlled Safety and Efficacy Trial of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease",COVID
4358,FOOD INSECURITY,"February 08, 2021",250,NCT04652596,PRODUCE PRESCRIPTION PROGRAM,UNITED STATES,Not yet recruiting,Boston Medical Center,January 2021,Interventional,Comparative Effectiveness of Two Interventions to Reduce Food Insecurity During the COVID-19 Pandemic,Unrelated
4359,COVID,"February 08, 2021",54,NCT04652648,HYDROXYCHLOROQUINE,UNITED STATES,Completed,Bryn Mawr Hospital,"May 27, 2020",Interventional,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,COVID
4360,COVID,"February 08, 2021",70,NCT04652674,TELEMEDICINE VISIT,UNITED STATES,Recruiting,Cedars-Sinai Medical Center,"September 28, 2020",Interventional,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective Randomized Trial,COVID
4361,COVID,"February 08, 2021",60,NCT04652765,CAMOSTAT MESILATE,UNITED STATES,Recruiting,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,February 2021,Interventional,COMBO Trial: Camostat With Bicalutamide for COVID-19,COVID
4362,COVID,"February 08, 2021",3000,NCT04653727,CROSS-SECTIONAL SURVEY,GERMANY,Recruiting,"Charite University, Berlin, Germany","January 6, 2021",Observational,Effects of Interventions and Lifestyle Modifications in Integrative Medicine and the Course of Infectious Respiratory Diseases Including COVID-19,COVID
4363,COVID,"February 08, 2021",100,NCT04653831,PIRFENIDONE,ISRAEL,Recruiting,Soroka University Medical Center,"November 8, 2020",Interventional,Treatment With Pirfenidone for COVID-19 Related Severe ARDS An Open Label Pilot Trial,COVID
4364,COVID,"February 08, 2021",7000000,NCT04653844,,FRANCE,"Active, not recruiting","University Hospital, Montpellier","February 1, 2020",Observational,SARS-Cov2 (COVID-19) Infection and Reinfection Through the Analysis of a RT-PCR Results Database,COVID
4365,COVID,"February 08, 2021",250,NCT04653857,,FRANCE,"Active, not recruiting","University Hospital, Montpellier","April 1, 2020",Observational,Evaluation of Cardiological Tests Before Returning to Sport in Athletes After COVID-19 Infection (CADE Study),COVID
4366,SARS-CoV2,"February 08, 2021",1280,NCT04654325,CONJUNCTIVAL SWAB,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,December 2020,Interventional,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,COVID
4367,COVID,"February 08, 2021",301,NCT04654416,CORTICOSTEROID WITH OR WITHOUT COLCHICINE,COLOMBIA,Completed,Clínica Medellín - Grupo Quirónsalud,"March 20, 2020",Observational,Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine in Colombia,COVID
4368,COVID,"February 08, 2021",60,NCT04654442,TESTNPASS,FRANCE,Not yet recruiting,"University Hospital, Grenoble","December 15, 2020",Observational,Evaluation of the Feasibility and Analytic Performance of TestNPass (In Vitro Diagnosis Medical Device) for CoViD-19 Diagnosis on Saliva Sample. : a Pilot Study,COVID
4369,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,"February 08, 2021",30,NCT04654481,HCFWO,UNITED STATES,Recruiting,Icahn School of Medicine at Mount Sinai,December 2020,Interventional,Feasibility of Using a Home-Based High Frequency Chest Wall Oscillation Device (AffloVest) in At-Risk Respiratory Patients to Decrease Acute Respiratory Care Burden During the COVID-19 Pandemic,Unrelated
4370,SMOKING,"February 08, 2021",528,NCT04654585,THE STOP INTERVENTION,FRANCE,Not yet recruiting,Société de Formation Thérapeutique du Généraliste Recherche,"December 15, 2020",Interventional,"Sevrage Tabagique à l'Aide Des Outils dédiés Selon la Préférence, un Essai randomisé contrôlé Pragmatique",Unrelated
4371,CANCER,"February 08, 2021",128,NCT04654637,NUTRITION AND EXERCISE STRATEGIES,TAIWAN,Recruiting,Tzu Chi University,"November 1, 2020",Interventional,"Department of Nursing, Tzu Chi University, Hualien, Taiwan",Unrelated
4372,PAIN,"February 08, 2021",100,NCT04655001,MORPH,UNITED STATES,Not yet recruiting,Wake Forest University,January 2021,Interventional,MORPH II: Revisiting A Mobile Intervention to Reduce Pain and Improve Health (MORPH),Unrelated
4373,COVID,"February 08, 2021",300,NCT04655521,,GERMANY,Recruiting,Universität des Saarlandes,"December 2, 2020",Observational,The Dynamics of the Immune Response to Infection by SARS Coronavirus 2,COVID
4374,COVID,"February 08, 2021",100,NCT04655586,RNAPC2,UNITED STATES,Recruiting,"ARCA Biopharma, Inc.","December 10, 2020",Interventional,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 (ASPEN-COVID-19)",COVID
4375,COVID,"February 08, 2021",5000,NCT04655612,,FRANCE,Recruiting,"University Hospital, Montpellier","December 1, 2020",Observational,Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases,COVID
4376,COVID,"February 08, 2021",500,NCT04655625,GROUP A (AG0302-COVID19),JAPAN,Recruiting,"AnGes, Inc.","November 23, 2020",Interventional,"A Randomized, Double-blind, Placebo Controlled Phase II / III Study to Assess Safety, Immunogenicity and Efficacy of Twice Dosing of Intramuscular AG0302-COVID19 (2mg) in Healthy Adults",COVID
4377,COVID,"February 08, 2021",364,NCT04655638,HIGH FLOW NASAL THERAPY,ITALY,Not yet recruiting,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,"January 10, 2021",Interventional,High-Flow Nasal Therapy Versus Conventional Oxygen Therapy in Patients With COVID-19: A Randomized Controlled Trial (The COVID-HIGH Trial),COVID
4378,COVID,"February 08, 2021",80,NCT04655716,SODIUM BICARBONATE 150MEQ/L/D5W INJ,,Not yet recruiting,Guy's and St Thomas' NHS Foundation Trust,"February 1, 2021",Interventional,Urine Alkalinisation to Prevent Acute Kidney Injury in COVID-19,COVID
4379,HEALTHY,"February 08, 2021",28,NCT04656288,BI 764198 - FORMULA A,BELGIUM,Recruiting,Boehringer Ingelheim,"January 15, 2021",Interventional,"A Two-part Phase I Trial Investigating the Relative Bioavailability and Food Effect of Different Oral Formulations of BI 764198 in Healthy Subjects (an Open-label, Single-dose, Randomised, Crossover Study)",Unrelated
4380,COVID,"February 08, 2021",250,NCT04656444,,FRANCE,Not yet recruiting,Fondation Lenval,April 2021,Observational [Patient Registry],Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID-19 Epidemic in France,COVID
4381,COVID,"February 08, 2021",1000,NCT04656613,GAM-COVID-VAC,,Not yet recruiting,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",December 2020,Interventional,"A Phase III, Randomized, Double -Blind, Placebo-controlled Trial to Evaluate Immunogenicity and Safety of the Gam-COVID-Vac Combined Vector Vaccine in Prophylactic Treatment for SARS-СoV-2 Infection in the United Arab Emirates",COVID
4382,"STRESS, PSYCHOLOGICAL","February 08, 2021",146,NCT04656626,BRIEF MINDFULNESS BASED INTERVENTION,SAUDI ARABIA,Completed,Imam Abdulrahman Bin Faisal University,"July 7, 2020",Interventional,"Brief Mindfulness Based Intervention for Front-Line Medical Staff in the COVID19 Pandemic to Improve Psychological Wellbeing, a Randomized Controlled Multicenter Trial",Unrelated
4383,COVID,"February 08, 2021",7500,NCT04656691,BAMLANIVIMAB,UNITED STATES,Enrolling by invitation,Daniel Griffin,"January 4, 2021",Interventional,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,COVID
4384,COVID,"February 08, 2021",500,NCT04657263,VACCINE COVERAGE ASSESSMENT,FRANCE,Recruiting,"University Hospital, Montpellier","November 1, 2020",Observational,Impact of the COVID-19 Pandemic on Vaccination in Patients at Risk of Infection,COVID
4385,COVID,"February 08, 2021",,NCT04657406,ZOFINTM,,Available,Organicell Regenerative Medicine,,Expanded Access,Expanded Access to ZofinTM (OrganicellTM Flow) for the Treatment of Patients With Mild to Moderate COVID-19 Due to SARS-Cov-2 for Outpatient and Inpatient Population,COVID
4386,COVID,"February 08, 2021",720,NCT04657419,SURVEY,,Not yet recruiting,"University Hospital, Bordeaux","December 5, 2020",Observational,Fatigue and Sleep in Patients With COVID-19,COVID
4387,OLFACTORY AND TASTE DYSFUNCTION IN SARS-CoV2 INFECTION,"February 08, 2021",100,NCT04657445,VISUAL ANALOGUE SCALE,GREECE,Recruiting,"University Hospital, Ioannina","November 17, 2020",Observational,"EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY",COVID
4388,COVID,"February 08, 2021",,NCT04657458,BONE MARROW MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES INFUSION TREATMENT,,Available,"Direct Biologics, LLC",,Expanded Access,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment: Expanded Access Protocol for Patients With COVID-19 Associated ARDS Who Do Not Qualify for Phase II Randomized Control Trial,COVID
4389,CORONAVIRUS INFECTION,"February 08, 2021",1300,NCT04657471,REVISED HOME-COV SCORE,FRANCE,Recruiting,"University Hospital, Angers","December 8, 2020",Interventional,Hospitalization or Outpatient ManagEment of Patients With Suspected or Confirmed SRAS-CoV-2 Infection: the Revised HOME-CoV Score Study.,COVID
4390,POST COVID DIFFUSE LUNG DISEASE,"February 08, 2021",100,NCT04657484,MEDIUM DOSE PREDNISOLONE,INDIA,Recruiting,Postgraduate Institute of Medical Education and Research,"December 8, 2020",Interventional,Comparison of the Efficacy and Safety of Two Corticosteroid Regimens in the Treatment of Diffuse Lung Disease After Coronavirus Disease 2019 (COVID-19) Pneumonia,COVID
4391,SARS-CoV2 INFECTION (COVID),"February 08, 2021",110,NCT04657497,FOY-305,JAPAN,Recruiting,Ono Pharmaceutical Co. Ltd,"November 9, 2020",Interventional,"A Placebo-controlled, Multicenter, Double-blind, Randomized, Parallel-group Comparative Study in SARS-CoV-2 Infection (COVID-19)",COVID
4392,COVID,"February 08, 2021",140,NCT04657510,COVID-19,ITALY,Recruiting,Istituto Ortopedico Galeazzi,"November 14, 2020",Observational,Femoral frACturEs and COVID-19. Retrospective Comparative Cohort Study on the Early Prognosis of Patients Affected by Proximal Femur Fractures and COVID-19.,COVID
4393,ANOSMIA,"February 08, 2021",40,NCT04657809,INSULIN FILM,EGYPT,"Active, not recruiting",Soad Ali,"December 1, 2020",Interventional,"""Insulin Fast Dissolving Film for Intranasal Delivery Via Olfactory Region, a Promising Approach for the Treatment of Anosmia in COVID 19 Patients: Design, In-vitro Characterization and Clinical Evaluation.""",Unrelated
4394,COVID,"February 08, 2021",3920,NCT04658121,,PUERTO RICO,Not yet recruiting,COVID-19 Prevention Network,"December 15, 2020",Observational,SARS-CoV-2 PREVALENCE STUDY,COVID
4395,CARDIOVASCULAR RISK FACTOR,"February 08, 2021",100,NCT04658433,300 MG OF OMEGA3-FA,JORDAN,Recruiting,Applied Science Private University,"December 5, 2020",Interventional,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the COVID-19 Uninfected Jordanian People,Unrelated
4396,OBESITY,"February 08, 2021",120,NCT04658550,REMOTE BEHAVIOUR MODIFICATION PROGRAM,CANADA,Recruiting,St. Joseph's Healthcare Hamilton,"October 16, 2020",Observational,"A Mixed Retrospective-prospective, Observational Study Evaluating the Efficacy of Counselling in a Remote Setting Compared to an In-person Setting on Weight Loss, in Obese Patients With Body Mass Index > 35 Kg/m2 and Enrolled in the Behaviour Modification Program at the Bariatric Centre of Excellence at St Joseph's Healthcare Hamilton.",Unrelated
4397,CHRONIC PULMONARY DISEASE,"February 08, 2021",30,NCT04658979,PULMONARY TELE-REHABILITATION,CANADA,Recruiting,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,December 2020,Interventional,Evaluation of the Feasibility and Safety of a Pulmonary Tele-rehabilitation Program in the Times of COVID-19,Unrelated
4398,SARS-COV INFECTION,"February 08, 2021",60,NCT04659109,GLENZOCIMAB,,Not yet recruiting,Acticor Biotech,December 2020,Interventional,"A Randomized, Double Blind, Multicenter, Placebo Controlled, Parallel Group, Exploratory Efficacy and Safety Study of Glenzocimab in SARS-Cov-2-related Acute Respiratory Distress Syndrome",Respiratory
4399,COVID,"February 08, 2021",9,NCT04659122,AT-100,,Not yet recruiting,"Airway Therapeutics, Inc.",January 2021,Interventional,"Phase 1b Open-label, Single Arm, Cohort Dose Escalation Study Evaluating the Safety, Tolerability, and Feasibility of Intervention With AT-100 (rhSP-D) in Intubated Patients Receiving Invasive Mechanical Ventilation With Severe COVID-19 Infection",COVID
4400,NEOPLASMS,"February 08, 2021",2000,NCT04659135,,UNITED STATES,Recruiting,American Society of Clinical Oncology,"April 19, 2020",Observational [Patient Registry],ASCO Survey on Coronavirus Disease 2019 (COVID-19) in Oncology (ASCO) Registry,Unrelated
4401,COVID,"February 08, 2021",4000,NCT04659187,,GERMANY,Recruiting,Asklepios proresearch,"March 26, 2020",Observational,"""CORONA Germany"" - Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany",COVID
4402,COVID INFECTION,"February 08, 2021",20,NCT04659200,VENOUS BLOOD WAS COLLECTED FOR BIOCHEMISTRY TESTING.,TURKEY,Completed,Bezmialem Vakif University,"September 1, 2020",Observational,"Thyroid Function Tests and the Status of Thyroid Autoantibodies in Hospitalized Covid-19 Patients and Their Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer",COVID
4403,COVID,"February 08, 2021",34020,NCT04659239,INACTIVATED SARS-COV-2 VACCINE (VERO CELL),BRAZIL,Enrolling by invitation,Chinese Academy of Medical Sciences,"January 28, 2021",Interventional,"A Randomized, Double-Blinded, Placebo Controlled Phase III Clinical Trial of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Adults Aged 18 Years and Above",COVID
4404,MULTIPLE MYELOMA,"February 08, 2021",70,NCT04659252,N/A - SAMPLES COLLECTED ALONG ROUTINE CARE SAMPLES ONLY,,Not yet recruiting,"Institute of Cancer Research, United Kingdom","January 15, 2021",Observational,Circulating Tumour Protein Quantification From Capillary Blood for Patient Selfsampling and Safe Remote Monitoring of Multiple Myeloma During COVID-19,Unrelated
4405,COVID,"February 08, 2021",50,NCT04659304,ALLOCETRA-OTS,,Not yet recruiting,Enlivex Therapeutics Ltd.,March 2021,Interventional,"A Multi-Center Study, Placebo-Controlled, Evaluating Safety, Tolerability and Efficacy of Different Doses and Regimens of Allocetra-OTS in Patients With COVID-19",COVID
4406,CORONAVIRUS INFECTIOUS DISEASE (COVID),"February 08, 2021",600,NCT04659356,PATIENTS ADMITTED IN INTENSIVE CARE UNITS,FRANCE,Recruiting,Nantes University Hospital,"September 1, 2020",Observational,"Evaluation of a SARS-CoV-2 Infectious Risk Management Protocol on the Transmission of Nosocomial COVID in Intensive Care Unit""",COVID
4407,COVID,"February 08, 2021",30,NCT04659460,REMOTE ISCHEMIC CONDITIONING,,Not yet recruiting,Unity Health Toronto,"December 15, 2020",Interventional,Remote Ischemic Conditioning as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,COVID
4408,COVID,"February 08, 2021",1000,NCT04659473,ONLINE SURVEY,SPAIN,Not yet recruiting,University of Salamanca,"December 9, 2020",Observational,"COVID-19, the Third Wave Update People Coping With the COVID-19. A Cross-sectional Online Spanish Survey",COVID
4409,COVID,"February 08, 2021",100,NCT04659486,HOME-BASED EXERCISE TRAINING,BRAZIL,Enrolling by invitation,University of Sao Paulo,"September 24, 2020",Interventional,Prospective Studies in School-aged Children and Adolescents With COVID-19 Treated at HCFMUSP,COVID
4410,BOWEL CANCER,"February 08, 2021",600,NCT04659590,,UNITED KINGDOM,Recruiting,Origin Sciences,"November 6, 2020",Observational,An Exploratory Study Investigating the Potential of a Rectal Mucus Sample for Development of Biomarker Assays in Subjects With Gastrointestinal Diseases,Unrelated
4411,COVID,"February 08, 2021",20,NCT04659707,HYPERPOLARIZED XE129,,Not yet recruiting,University of Kansas Medical Center,"January 1, 2021",Interventional,Evaluating Lung Structure and Function in Survivors of COVID-19 Using Hyperpolarized 129Xe MRI,COVID
4412,QUALITY OF LIFE,"February 08, 2021",96,NCT04659746,MEJORACARE,PARAGUAY,Recruiting,Universidad Autónoma de Encarnación,"December 9, 2020",Interventional,mHealth Technology to Optimize Mental Health in Chronic Patients During the COVID-19 Outbreak in Paraguay,Unrelated
4413,COVID,"February 08, 2021",300,NCT04659759,COVID-19 EXPOSURE,UNITED STATES,Recruiting,Thomas Jefferson University,"November 17, 2020",Observational,COVID-19 in Pregnancy: Utilizing Immunology Through Epidemiology to Improve Perinatal/Neonatal Outcomes,COVID
4414,COVID,"February 08, 2021",30,NCT04659772,CLAZAKIZUMAB,UNITED STATES,Enrolling by invitation,Ayan Sen,December 2020,Interventional,A Randomized Placebo-Controlled Safety And Dose-Finding Study For The Use Of The Il-6 Inhibitor Clazakizumab in Patients With Life-Threatening COVID-19 Infection,COVID
4415,COVID AND MORTALITY,"February 08, 2021",445,NCT04659876,CLINICAL FEATURES AND LABORATORY VALUES,TURKEY,Completed,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,"March 22, 2020",Observational,Clinical Characteristics and Laboratory Values Affecting Mortality in Critical COVID 19 Patients Followed in the Intensive Care Unit,COVID
4416,LONG COVID,"February 08, 2021",100,NCT04659889,BLOOD SAMPLING (VENESECTION),UNITED KINGDOM,Recruiting,HCA International Limited,December 2020,Observational,Analysis of the Relationship Between Clinical and Haematological Phenotypes in Long COVID,COVID
4417,COVID,"February 08, 2021",50,NCT04659928,HIGH VOLUME EVACUATION (HVE),UNITED STATES,Not yet recruiting,"The University of Texas Health Science Center, Houston","December 1, 2020",Interventional,Evaluation of Aerosol in a Dental Clinic,COVID
4418,COVID VACCINE,"February 08, 2021",1000,NCT04659941,BCG VACCINE,BRAZIL,Recruiting,Universidade Federal do Rio de Janeiro,"October 1, 2020",Interventional,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,COVID
4419,PNEUMONIA,"February 08, 2021",1060,NCT04660084,ULTRA-RAPID MOLECULAR POINT-OF-CARE TESTING,NORWAY,Recruiting,Haukeland University Hospital,"September 25, 2020",Interventional,"Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP in Norway: a Pragmatic Randomised Controlled Trial",Respiratory
4420,ADVANCED CARE PLANNING,"February 08, 2021",13150,NCT04660422,VITALTALK COMMUNICATION SKILLS TRAINING,UNITED STATES,Recruiting,Dana-Farber Cancer Institute,"December 15, 2020",Observational,Advance Care Planning: Communicating With Outpatients for Vital Informed Decisions,Unrelated
4421,CARDIOVASCULAR DISEASES,"February 08, 2021",118,NCT04661189,PHYSICAL EXERCISE TRAINING,CANADA,Recruiting,Montreal Heart Institute,"May 18, 2020",Interventional,The Cognitive and spOrt Virtual EPIC Training Study: Investigating the Effects of Home-based Exercise and Cognitive Training in Cardiovascular Diseases,Unrelated
4422,BULIMIA NERVOSA,"February 08, 2021",60,NCT04661410,REWARD RE-TRAINING,UNITED STATES,Recruiting,Drexel University,"December 1, 2020",Interventional,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,Unrelated
4423,POST ICU REHABILITATION,"February 08, 2021",60,NCT04661423,REMOTE AUTOMATED MONITORING SYSTEM,FRANCE,Not yet recruiting,IHU Strasbourg,January 2021,Interventional,Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era,Unrelated
4424,COVID,"February 08, 2021",1000,NCT04661462,ONLINE SURVEY,AUSTRIA,Recruiting,Medical University Innsbruck,"September 30, 2020",Observational,Health After COVID-19 in the European Region Tyrol - South Tyrol,COVID
4425,COVID DRUG TREATMENT,"February 08, 2021",60,NCT04661527,SARILUMAB,SPAIN,Recruiting,"Clinica Universidad de Navarra, Universidad de Navarra","April 22, 2020",Interventional,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,COVID
4426,PNEUMONIA,"February 08, 2021",36,NCT04661540,CM4620-IE (INJECTABLE EMULSION),UNITED STATES,Not yet recruiting,"CalciMedica, Inc.",February 2021,Interventional,A Single-Blind Dose-Ranging Pharmacodynamic Study of Auxora for the Treatment of Patients With Critical COVID-19 Pneumonia,Respiratory
4427,ULTRASONOGRAPHY,"February 08, 2021",451,NCT04661631,LUNG ULTRASOUND,COLOMBIA,Recruiting,Fundacion Clinica Valle del Lili,"May 8, 2020",Observational [Patient Registry],Lung Ultrasound in COVID-19 Infection Screening for Patients With Indication of Emergency Surgery,Unrelated
4428,COVID,"February 08, 2021",70,NCT04661657,TRANSTHORACIC ECHOCARDIOGRAM (TTE),UNITED STATES,Recruiting,Columbia University,"December 28, 2020",Observational [Patient Registry],COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae (COLUMBIA CARDS) Registry,COVID
4429,HIV-1-INFECTION,"February 08, 2021",75,NCT04661813,EXTRA-CVD VIRTUAL CARE,UNITED STATES,Not yet recruiting,Case Western Reserve University,February 2021,Interventional,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,Unrelated
4430,SARS-CoV2,"February 08, 2021",56,NCT04661839,COVID-HIGIV,UNITED STATES,Recruiting,Emergent BioSolutions,December 2020,Interventional,"A Phase 1, Double-blind, Randomized, Placebo-controlled Study to Evaluate Safety and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) Administered as a Single Dose or a Repeat Dose Regimen to Healthy Adults",COVID
4431,CORONA VIRUS DISEASE (COVID),"February 08, 2021",50,NCT04661930,TRICOR® 145MG TABLETS,ISRAEL,Recruiting,Hebrew University of Jerusalem,"December 13, 2020",Interventional,Controlled Trial of Fenofibrate for Patients With COVID-19 Requiring Hospitalization,COVID
4432,MULTIPLE SCLEROSIS,"February 08, 2021",150,NCT04662008,TELE-COACHING,,Not yet recruiting,Case Western Reserve University,"January 10, 2021",Interventional,CLOSER_MS: Communicating With Local or Distance Caregivers Offering Support and Electronic Resources,Unrelated
4433,ANXIETY DEPRESSION DISORDER,"February 08, 2021",40,NCT04662021,AEROBIC EXERCISES,EGYPT,Enrolling by invitation,Cairo University,"December 10, 2020",Interventional,"The Effect of Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety, Depression and Stress-related to Covid 19 Pandemics Among University Students: a Comparative Study",Unrelated
4434,COVID,"February 08, 2021",120,NCT04662060,ACEBILUSTAT,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Interventional,"COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19",COVID
4435,COVID,"February 08, 2021",120,NCT04662073,CAMOSTAT,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Interventional,"COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19",COVID
4436,COVID,"February 08, 2021",240,NCT04662086,ACEBILUSTAT,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Interventional,"COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19",COVID
4437,COVID INFECTION,"February 08, 2021",150,NCT04662437,VENOUS BLOOD WAS COLLECTED FOR BIOCHEMISTRY TESTING,TURKEY,Completed,Bezmialem Vakif University,"September 10, 2020",Observational,"The Status of Parathyroid Hormone Secretion and Its Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer in Hospitalized Covid-19 Patients",COVID
4438,OBESITY,"February 08, 2021",120,NCT04662593,WHOLE HEALTH PROGRAM,UNITED STATES,Not yet recruiting,"University of California, Davis",January 2021,Interventional,Koa Family Study--A Community-Based Intervention to Improve Health and Well-Being,Unrelated
4439,COVID,"February 08, 2021",60,NCT04662671,RD-X19,UNITED STATES,Recruiting,EmitBio Inc.,"November 18, 2020",Interventional,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19",COVID
4440,COVID,"February 08, 2021",320,NCT04662684,RIVAROXABAN 10 MG,BRAZIL,Recruiting,Science Valley Research Institute,"October 16, 2020",Interventional,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,COVID
4441,PHYSICAL ACTIVITY,"February 08, 2021",42,NCT04662775,HERIZON PROJECT,IRELAND,Completed,Liverpool John Moores University,"April 15, 2020",Interventional,Formative Evaluation of a Home-based Physical Activity Intervention for Adolescent Girls - The HERizon Project: A Randomised Controlled Trial,Unrelated
4442,COVID,"February 08, 2021",300,NCT04663555,DEXAMETHASONE,CZECHIA,Recruiting,Brno University Hospital,"February 2, 2021",Interventional,"Effect of Dexamethasone in Patients With ARDS and COVID-19 - Prospective, Multi-centre, Open-label, Parallel-group, Randomized Controlled Trial (REMED Trial)",COVID
4443,DEPRESSION,"February 08, 2021",400,NCT04663594,WOFB,UNITED KINGDOM,Recruiting,University of Oxford,"December 4, 2020",Interventional,An Online Cultural Experience to Support Mental Health in People Aged 16-24 During COVID-19: the O-ACEPOP (Online Active Community Engagement Proof of Principle) Study,Unrelated
4444,COVID,"February 08, 2021",150,NCT04663659,NO INTERVENTION,TURKEY,Completed,Sisli Hamidiye Etfal Training and Research Hospital,"March 15, 2020",Observational,The Effect of Diabetes Mellitus on Mortality in Patients Hospitalized in the COVID Intensive Care Unit in the COVID-19 Pandemic,COVID
4445,ARTHRITIS,"February 08, 2021",25,NCT04663685,EXERCISE PROGRAM,CANADA,Recruiting,University of Waterloo,"October 5, 2020",Interventional,"MoveStrong at Home: A Model for Remote Delivery of Strength Training and Nutrition Education for Older Adults in Canada, A Pilot Study",Unrelated
4446,COVID,"February 08, 2021",20,NCT04663737,SILMITASERTIB,UNITED STATES,Recruiting,"Chris Recknor, MD","December 3, 2020",Interventional,"A Phase II, Randomized and Controlled Investigator Initiated Trial Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Outpatient Adult Subjects With Moderate Coronavirus Disease 2019 (COVID-19)",COVID
4447,COVID,"February 08, 2021",100000,NCT04663776,,UNITED STATES,Recruiting,Boston Children's Hospital,"November 4, 2020",Observational,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform,COVID
4448,ISOTRETINOIN ADVERSE REACTION,"February 08, 2021",300,NCT04663906,,,Not yet recruiting,University of Aberdeen,"January 15, 2021",Observational,"Does Oral Isotretinoin Increase the Risk of Developing Infection With and Complications From Covid-19, Compared to an Age-matched Background Population",Unrelated
4449,COVID,"February 08, 2021",45,NCT04663945,BIOBEHAVIORAL TELE-REHABILITATION SESSIONS,UNITED STATES,Recruiting,"University of Colorado, Denver","December 11, 2020",Interventional,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID Survivors,COVID
4450,COVID,"February 08, 2021",60,NCT04664010,"ALPHA-INTERFERON ALPHA, ABIDOL, RIBAVIRIN, BUZHONG YIQI PLUS AND MINUS FORMULA, HUHUANG DETOXICITY PASTE, BAIMU QINGRE JIEDU PASTE, FUMIGATION/INHALATION OF VITAMIN C",CHINA,"Active, not recruiting",Xi'an International Medical Center Hospital,"February 6, 2020",Interventional,Efficacy and Safety of High-dose Vitamin C Combined With Traditional Chinese Medicine in the Treatment of Moderate and Severe Coronavirus Pneumonia (COVID-19),COVID
4451,COVID,"February 08, 2021",120,NCT04664023,"BLOOD COLLECTION AT DAY 8, DAY 16, DAY 24, MONTH 6 AND MONTH 12 AFTER FIRST SYMPTOMS FROM SARS-COV-2 INFECTION",FRANCE,Recruiting,Poitiers University Hospital,"December 9, 2020",Observational,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 and Its Resolution",COVID
4452,SARS-CoV2,"February 08, 2021",51000,NCT04664049,NRICM101,TAIWAN,Recruiting,"National Research Institute of Chinese Medicine, Ministry of Health and Welfare","December 23, 2020",Observational,The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection,COVID
4453,INFLUENZA,"February 08, 2021",100,NCT04664075,RESPIRATORY INFECTIONS,UNITED KINGDOM,Not yet recruiting,Imperial College London,January 2021,Observational,Predicting Severity and Disease Progression in Influenza-like Illness,Respiratory
4454,COVID,"February 08, 2021",30,NCT04664101,"REMOTELY MONITORED, MHEALTH (REMM) SUPPORTED HIGH INTENSITY INTERVAL TRAINING (HIIT)",UNITED STATES,Not yet recruiting,Duke University,"April 1, 2021",Interventional,"REmotely Monitored, Mobile Health Supported High Intensity Interval Training to Improve Functional Recovery of Survivors of Critical Illness (REMM-HIIT-ICU-COVID)",COVID
4455,INFECTION VIRAL,"February 08, 2021",75,NCT04664296,REVIEW OF MEDICAL PATIENT FILE,,Not yet recruiting,Hospices Civils de Lyon,"January 1, 2021",Observational,Epidemiology of CoV-2 SARS Infections: Dynamics of Community Contamination in Children and Adults,Unrelated
4456,COVID,"February 08, 2021",1000,NCT04664309,NO INTERVENTION,UNITED STATES,Not yet recruiting,Stanford University,March 2021,Observational,Understanding Immunity to the COVID-19 Vaccines,COVID
4457,ASYMPTOMATIC COVID INFECTION LABORATORY-CONFIRMED,"February 08, 2021",134,NCT04665115,IBRUTINIB,UNITED STATES,Not yet recruiting,Academic and Community Cancer Research United,"June 30, 2021",Interventional,A Prospective Study of Patients With B-Cell Hematologic Malignancies on Ibrutinib Therapy Who Are Infected With Coronavirus Disease 2019 (COVID-19),COVID
4458,ASYMPTOMATIC CONDITION,"February 08, 2021",900,NCT04665193,RAPID ANTIGEN TEST,CANADA,Recruiting,University of British Columbia,"November 23, 2020",Interventional,An Approach to Screening for SARS-CoV-2 at YVR: UBC-PHC-WestJet-YVR COVID-19 Screening Study,Unrelated
4459,COVID,"February 08, 2021",500,NCT04665245,,UNITED STATES,Enrolling by invitation,University of Iowa,"December 15, 2020",Observational,Contact Network Transmission Modeling of Healthcare Associated Infections: Symptom-Based Markers for COVID-19 Transmission,COVID
4460,"INFERTILITY, MALE","February 08, 2021",60,NCT04665258,,UNITED STATES,Recruiting,University of Miami,"December 14, 2020",Observational,Corona Virus Disease 19 (COVID-19) Vaccine and Impact on Fertility Study,Unrelated
4461,BODY IMAGE,"February 08, 2021",2000,NCT04665557,DOVE CONFIDENT ME INDONESIA SINGLE SESSION,UNITED KINGDOM,Not yet recruiting,University of the West of England,January 2021,Interventional,"Evaluating ""Dove Confident Me Indonesia""; A School-Based Single Session Intervention to Improve Body Image and Wellbeing Among Indonesian Adolescents",Unrelated
4462,COVID,"February 08, 2021",150,NCT04665752,,UNITED STATES,Recruiting,National Eye Institute (NEI),"February 11, 2021",Observational,"Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors, a Natural History, Observational Study",COVID
4463,COVID,"February 08, 2021",1516,NCT04665778,HOSPITAL BEDROOM BOOKING,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","December 4, 2020",Observational,Prediction of the Patient Pathway in Emergency Room in an Exceptional Sanitary Situation,COVID
4464,COVID,"February 08, 2021",40,NCT04665960,,UNITED ARAB EMIRATES,Not yet recruiting,NMC Specialty Hospital,"January 15, 2021",Observational,Expert Statements on Infection Control in Intensive Care Unit for Severe Acute Respiratory Syndrome Coronavirus 2,COVID
4465,COVID,"February 08, 2021",150,NCT04666012,ADCLD-COV19,"KOREA, REPUBLIC OF",Recruiting,"Cellid Co., Ltd.","December 29, 2020",Interventional,"A Phase 1/2a Study (Dose Escalation, Single Center, Open, Phase 1 and Multicenter, Randomized, Open, Phase 2a) to Assess the Safety and Immunogenicity of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers",COVID
4466,"ACCELERATED PHASE CML, BCR-ABL1 POSITIVE","February 08, 2021",36,NCT04666025,BIOSPECIMEN COLLECTION,UNITED STATES,Recruiting,City of Hope Medical Center,"September 23, 2020",Observational,Observational Study of SARS-CoV-2 Donor-Recipient Immunity Transfer,Unrelated
4467,COVID,"February 08, 2021",100,NCT04666064,COVID19 RT-PCR,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","December 10, 2020",Observational,Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room,COVID
4468,COVID,"February 08, 2021",96,NCT04666116,DIETARY SUPPLEMENTATION IN PATIENTS WITH COVID DISEASE ADMITTED TO HOSPITAL,SPAIN,Recruiting,Hospital de Sagunto,"April 1, 2020",Interventional,Changes in Viral Load in Patients With COVID-19 Disease After Dietary Supplementation With Probiotics: A Randomized Clinical Trial,COVID
4469,COVID,"February 08, 2021",20,NCT04666207,PCR,DENMARK,Recruiting,"Rigshospitalet, Denmark","May 25, 2020",Observational,"A Cohort Study of Non-hospitalized SARS-CoV-2 Positive Children in Denmark: Viral Shedding, Symptoms and Exposure",COVID
4470,NEONATES NEEDING RESUSCITATION AT BIRTH,"February 08, 2021",48,NCT04666233,NEONATAL RESUSCITATION WITH PPE FOR THE PREVENTION OF SARS-COV-2 INFECTION,,Not yet recruiting,University Hospital Padova,January 2021,Interventional,Does Personal Protective Equipment for the Prevention of SARS-Cov-2 Infection Impact the Timing of Ventilation in Neonates Needing Resuscitation at Birth? A Crossover Randomized Controlled Trial,Unrelated
4471,ACUTE RESPIRATORY FAILURE,"February 08, 2021",40,NCT04666246,,ITALY,Recruiting,University of Modena and Reggio Emilia,"March 1, 2020",Observational,Inspiratory Effort Assessment in Patients With COVID-19 Pneumonia Undergoing Non Invasive Respiratory Support,Respiratory
4472,MENTAL HEALTH WELLNESS 1,"February 08, 2021",1000,NCT04666285,EXPERIENCE OF PANDEMIC,UNITED KINGDOM,Not yet recruiting,University of Southampton,December 2020,Observational,A Survey of Southampton Women's Survey Women's and Offspring's Health and Wellbeing During the COVID-19 Pandemic and Lockdown.,Unrelated
4473,PULMONARY TUBERCULOSIS,"February 08, 2021",1400,NCT04666311,ACCURACY OF CAD4TB AND AFINION CRP ASSAY FOR PULMONARY TB,LESOTHO,Not yet recruiting,Klaus Reither,December 2020,Observational,"Prospective, Multicentre Evaluation of the Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for the Diagnosis of Pulmonary Tuberculosis in Presumptive Adult TB Patients (TB TRIAGE+ Accuracy)",Unrelated
4474,COVID,"February 08, 2021",1400,NCT04666441,REGN10933+REGN10987 COMBINATION THERAPY,UNITED STATES,Recruiting,Regeneron Pharmaceuticals,"December 15, 2020",Interventional,A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection,COVID
4475,AUTISM SPECTRUM DISORDER,"February 08, 2021",100,NCT04666493,"COGNITIVE BEHAVIOR THERAPY (CBT), SPECIFICALLY USING THE FACING YOUR FEARS (FYF) CURRICULUM",CANADA,Recruiting,Evdokia Anagnostou,"December 4, 2020",Interventional,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19: A Research Project to Provide and Evaluate Virtual Mental Health Care,Unrelated
4476,CANCER,"February 08, 2021",216,NCT04666558,EXERCISE & NUTRITION,CANADA,Recruiting,University of Alberta,"November 30, 2020",Interventional,Heal-Me PiONEeR (Personalized Online Nutrition and Exercise Routines) - Reconnecting Vulnerable Outpatients With Multidisciplinary Care - a Randomized Controlled Trial Assessing 3 Levels of Online Programming in the Time of COVID,Unrelated
4477,DENTAL CARIES IN CHILDREN,"February 08, 2021",420,NCT04666597,MODIFIED CARIESCARE INTERNATIONAL MANAGEMENT,ARGENTINA,Recruiting,"Universidad El Bosque, Bogotá","November 15, 2020",Observational,CariesCare International Adapted for the Pandemic in Children: Caries OUT Multicentre Single-group Interventional Study,Unrelated
4478,COVID,"February 08, 2021",40,NCT04666753,IMMUNOFORMULATION,SPAIN,Completed,Fagron Iberica S.A.U.,"July 2, 2020",Observational,Retrospective Observational Study to Describe the Evolution of SARS-CoV-2 Disease and the Profile of Patients Treated or Not With Imuno TF® and a Combination of Nutraceuticals and Who Have Tested Positive for COVID-19,COVID
4479,ACCESS TO CHIROPRACTIC CARE SERVICES,"February 08, 2021",500,NCT04666779,CHIROPRACTIC CARE,SPAIN,Not yet recruiting,Real Centro Universitario Maria Cristina,"December 14, 2020",Observational [Patient Registry],Access to Chiropractic Care During the COVID-19 Pandemic: a Prospective Comparative Cohort Trial,Unrelated
4480,COVID,"February 08, 2021",66,NCT04667247,FOTV,UNITED STATES,Recruiting,Gordon Saxe,"December 3, 2020",Interventional,"Multicenter Double Blind, Placebo Controlled RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19",COVID
4481,COVID INFECTION,"February 08, 2021",100,NCT04667286,PRONE POSITION (PP),,Not yet recruiting,Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi,"December 30, 2020",Interventional,"Pronation in Spontaneously Breathing Patients With Acute Respiratory Failure Deu to Covid-19: Multicenter, Randomised Study",COVID
4482,COVID,"February 08, 2021",60,NCT04667442,NANOMIX ELAB® COVID-19 RAPID ANTIGEN PANEL (NON-INTERVENTIONAL),UNITED STATES,Recruiting,Nanomix,"December 1, 2020",Observational,An Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects,COVID
4483,COVID,"February 08, 2021",102,NCT04667780,COLCHICINE,PAKISTAN,Recruiting,Ayub Teaching Hospital,"December 10, 2020",Interventional,Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19,COVID
4484,COVID,"February 08, 2021",50,NCT04667923,RESPIRATORY MONITORING,RUSSIAN FEDERATION,Recruiting,I.M. Sechenov First Moscow State Medical University,"October 1, 2020",Observational,Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome to Prevent Tracheal Intubation: the COVID-NIV Study,COVID
4485,PRONE POSITION,"February 08, 2021",100,NCT04667936,TREATMENT GROUP,GERMANY,Recruiting,Goethe University,"March 1, 2020",Observational,Evaluation of Impaired Sedation in Patients With Moderate to Severe COVID-19 ARDS,Unrelated
4486,"BURNOUT, CAREGIVER","February 08, 2021",302,NCT04667962,ONLINE QUESTIONNAIRE,FRANCE,Recruiting,Direction Centrale du Service de Santé des Armées,"December 23, 2020",Observational,Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain,Unrelated
4487,COVID,"February 08, 2021",340,NCT04668170,BLOOD COLLECTION ON ADMISSION AND LONGITUDINALLY,FRANCE,Recruiting,"University Hospital, Toulouse","May 5, 2020",Observational,Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management,COVID
4488,COVID,"February 08, 2021",300,NCT04668196,HIGH-FLOW NASAL CANNULA TREATMENT,SPAIN,Recruiting,Hospital Universitari Vall d'Hebron Research Institute,"May 22, 2020",Observational,Noninvasive Respiratory Support Outside the Intensive Care Unit in COVID-19 Pneumonia: a Multicentric Study (CATCOVID-AIR),COVID
4489,CORONAVIRUS,"February 08, 2021",40,NCT04668209,SILMITASERTIB,UNITED STATES,Recruiting,University of Arizona,"January 1, 2021",Interventional,"Phase II, Randomized, Investigator Initiated Trial to Evaluate Safety and to Explore Clinical Benefit of Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)",COVID
4490,COVID,"February 08, 2021",480,NCT04668222,YU-PING-FENG FORMULA,HONG KONG,Not yet recruiting,The University of Hong Kong,"December 15, 2020",Interventional,"Based on the Theory of ""Body Constitution of Chinese Medicine"" and ""Combination of Prescription and Syndrome"" to Improve COVID-19 Susceptible Body Constitution of Residents in Hong Kong",COVID
4491,COVID,"February 08, 2021",342,NCT04668235,AZVUDINE,BRAZIL,Not yet recruiting,HRH Holdngs Limited,December 2020,Interventional,"Evaluation of Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected): Phase III, Randomized, Double-blind, PLACEBO Controlled Trial",COVID
4492,RESPIRATORY FAILURE,"February 08, 2021",150,NCT04668313,,UNITED KINGDOM,Recruiting,NHS Greater Glasgow and Clyde,"September 29, 2020",Observational [Patient Registry],COVID-19 Advanced Respiratory Physiology (CARP) Study,Respiratory
4493,COVID,"February 08, 2021",600,NCT04668339,ARCT-021 SINGLE DOSE PRIMING,SINGAPORE,Recruiting,"Arcturus Therapeutics, Inc.","January 7, 2021",Interventional,"A Phase 2 Randomized, Observer-Blind, Placebo-Controlled Study to Assess the Safety, Reactogenicity, and Immunogenicity of the SARS CoV-2 Vaccine ARCT-021 in Healthy Adult Participants",COVID
4494,COVID,"February 08, 2021",50,NCT04668404,SONOCLOT,INDIA,Recruiting,Postgraduate Institute of Medical Education and Research,"August 24, 2020",Observational [Patient Registry],Study of Coagulation Profile and Role of Heparin-like Effect in Patients With COVID-19,COVID
4495,COVID,"February 08, 2021",600,NCT04668469,IVERMECTIN,EGYPT,Completed,Benha University,"June 8, 2020",Interventional,Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic,COVID
4496,COVID (SARS-CoV2),"February 08, 2021",1000,NCT04668625,PARTICIPATE IN A MASSIVE MUSICAL EVENT,SPAIN,Completed,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","November 30, 2020",Interventional,Risk of Infection of SARS-CoV-2 in a Massive Musical Show With Transmission Prevention Measures: Randomized Study,COVID
4497,MUSCULOSKELETAL ABNORMALITY,"February 08, 2021",15,NCT04668820,"VIDEO PEDIATRIC GAIT, ARMS, LEGS AND SPINE (V-PGALS)",TURKEY,Not yet recruiting,Marmara University,"February 1, 2021",Interventional,"Reliability and Acceptability of Real-time Virtual Video Pediatric Gait, Arms, Legs and Spine (V-pGALS) Assessment for Musculoskeletal Assessment of Children for Telemedicine Visits",Unrelated
4498,COVID,"February 08, 2021",150,NCT04668911,SWAB,UNITED KINGDOM,Recruiting,Eastman Dental Insitute and Hospital,"December 13, 2020",Observational,"Oral Health, Microbial Burden and COVID-19",COVID
4499,NUMBER OF PATIENTS DURING THE STUDYING PERIOD,"February 08, 2021",11000,NCT04668937,,FRANCE,Completed,"Central Hospital, Nancy, France","March 18, 2020",Observational,Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy,Unrelated
4500,COVID,"February 08, 2021",1100,NCT04668950,FLUVOXAMINE,CANADA,Recruiting,Washington University School of Medicine,"December 22, 2020",Interventional,"Fluvoxamine for Early Treatment of Covid-19: a Fully-remote, Randomized Placebo Controlled Trial",COVID
4501,COVID,"February 08, 2021",914,NCT04669015,NOVAFERON,,Not yet recruiting,Genova Inc.,January 2021,Interventional,"NOVATION-1: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon + SOC vs. Placebo + SOC in Hospitalized Adult Patients With Moderate to Severe COVID-19",COVID
4502,COVID,"February 08, 2021",102,NCT04669054,,FRANCE,"Active, not recruiting","University Hospital, Montpellier","December 1, 2020",Observational,Hospital Interns Psychological State During the COVID-19 Pandemic,COVID
4503,COVID; LIVER INJURY; MORTALITY,"February 08, 2021",532,NCT04669509,LIVER FUNCTION TESTS,TURKEY,Completed,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,"April 1, 2020",Observational,Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit,COVID
4504,TYPE 1 DIABETES,"February 08, 2021",77,NCT04669912,GLUCOSE CONTROL AND SENSOR USAGE,FRANCE,Completed,Centre Hospitalier Sud Francilien,"January 15, 2021",Observational,Observational Study of Glycemic Control and Self-management of Young People (Aged 13 to 25 Years ) With Type 1 Diabetes During COVID-19 Lockdown.,Unrelated
4505,COVID,"February 08, 2021",10000,NCT04669925,,ITALY,"Active, not recruiting",Mario Negri Institute for Pharmacological Research,"September 1, 2020",Observational,Tsunami Project - Description and Prediction of COVID-19 Impact on the Lombardy Region's Emergency System,COVID
4506,COVID,"February 08, 2021",200,NCT04669938,OROPHARYNGEAL AND INTESTINAL MICROBIOTA,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"December 4, 2020",Observational,Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease in Hospitalized Patients,COVID
4507,COVID,"February 08, 2021",2000,NCT04669990,REMDESIVIR,NEPAL,Recruiting,Nepal Health Research Council,"November 19, 2020",Observational,Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study,COVID
4508,COVID,"February 08, 2021",20000,NCT04670003,USERS,,Not yet recruiting,Weprom,January 2021,Observational [Patient Registry],Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application: an Observational Study,COVID
4509,COVID,"February 08, 2021",2500,NCT04670094,,ITALY,"Active, not recruiting",University of Milano Bicocca,"December 30, 2020",Observational,Comorbidities and Risk Score for Severity and Outcome in Patients With Infection by SARS-CoV-2.,COVID
4510,STROKE,"February 08, 2021",50,NCT04670315,TELEMATIC EVALUATION OF MOTOR FUNCTION,SPAIN,Not yet recruiting,University of Salamanca,"March 1, 2021",Observational,Validation of theTelematic Spanish Version of the Fugl-Meyer Assessment of Motor Recovery After Stroke,Unrelated
4511,COVID,"February 08, 2021",101,NCT04670328,NOT REQUIRED,PAKISTAN,Completed,FMH College of Medicine and Dentistry,"May 1, 2020",Observational,Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity,COVID
4512,HYPOXIA,"February 08, 2021",30,NCT04670484,WEARING MASK,UNITED STATES,Not yet recruiting,University of New Mexico,"January 1, 2021",Interventional,To Determine the Presence of Mask Hypoxia in Subject Wearing Masks as Personal Protective Equipment (PPE) Due to the Federal Guidelines,Unrelated
4513,SARS-CoV2 VIRUS INFECTION,"February 08, 2021",153,NCT04671017,VLA2001,UNITED KINGDOM,"Active, not recruiting",Valneva Austria GmbH,"December 16, 2020",Interventional,"A Phase I/II Randomized, Two Parts, Dose-Finding Study To Evaluate The Safety, Tolerability and Immunogenicity Of An Inactivated, Adjuvanted Sars-Cov-2 Virus Vaccine Candidate (VLA2001), Against Covid-19 In Healthy Subjects",COVID
4514,HYPERTENSION IN PREGNANCY,"February 08, 2021",500,NCT04671602,,IRELAND,Recruiting,University College Cork,"August 19, 2020",Observational,Implementing LEANBH Ambulatory Integrated Blood Pressure Monitoring in Maternity Services,Unrelated
4515,COVID - 19,"February 08, 2021",43,NCT04672291,POLY-ICLC (HILTONOL®),CANADA,Not yet recruiting,"Oncovir, Inc.","January 15, 2021",Interventional,"A Phase I-Ib, Double-blinded, Randomized Repeated Dose Multicenter, Safety and Immunogenicity Study of Nasal Poly-ICLC (Hiltonol®) for Prophylaxis of COVID-19 in Healthy Adults",COVID
4516,SARS-CoV2,"February 08, 2021",300,NCT04672343,DATA COLLECTION,FRANCE,Recruiting,Centre Hospitalier Universitaire Dijon,"October 19, 2020",Observational,IPrognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2,COVID
4517,COVID,"February 08, 2021",34000,NCT04672395,AS03-ADJUVANTED SCB-2019 VACCINE,BELGIUM,Not yet recruiting,Clover Biopharmaceuticals AUS Pty Ltd,January 2021,Interventional,"A Double-Blind, Randomized, Controlled, Phase 2/3 Study to Evaluate the Efficacy, Immunogenicity, and Safety of SCB 2019, a Recombinant SARS-CoV-2 Trimeric S Protein Subunit Vaccine for the Prevention of COVID-19 in Participants Aged 18 Years and Older",COVID
4518,MENTAL HEALTH ISSUE,"February 08, 2021",120,NCT04672486,POD ADVENTURES,,Not yet recruiting,Sangath,"December 18, 2020",Interventional,"PRIDE - Pilot Trial of an Online Digital Problem-solving Intervention for School-going Adolescents in Goa, India",Unrelated
4519,CORONAVIRUS DISEASE 2019,"February 08, 2021",300,NCT04672564,CARRIMYCIN,ARGENTINA,Not yet recruiting,"Shenyang Tonglian Group CO., Ltd","January 14, 2021",Interventional,"A Phase 3, Randomized, Multicenter, Placebo-controlled, Double-blind Clinical Study of the Safety and Efficacy of Carrimycin for Treatment of Severe COVID-19 in Hospitalized Patients",COVID
4520,DISEASES OF THE NERVOUS SYSTEM,"February 08, 2021",681,NCT04672590,PRIMARY EXPOSURE IS HYPOXIA (NO INTERVENTION),,Not yet recruiting,University of Liverpool,January 2021,Observational,"COVID-19 Neurological Disease: A Prospective Study in Brazil, India and Malawi",Unrelated
4521,SARS-CoV2,"February 08, 2021",345,NCT04673149,GLS-5310,"KOREA, REPUBLIC OF",Recruiting,"GeneOne Life Science, Inc.","December 23, 2020",Interventional,"Multicenter, Randomized, Combined Phase I Dose-escalation and Phase IIa Double-blind, Placebo-controlled Study of the Safety, Tolerability, and Immunogenicity of GLS-5310 DNA Vaccine, Administered Intradermally Against SARS-CoV-2 in Healthy Adults",COVID
4522,COVID,"February 08, 2021",260,NCT04673162,"METHYLPREDNISOLONE, PLACEBO",ITALY,Not yet recruiting,Azienda Unità Sanitaria Locale Reggio Emilia,December 2020,Interventional,"A Randomized, Multicentre, Double-blind Study to Evaluate the Efficacy of High-dose Administration of Methylprednisolone in Addition to Standard Treatment, in SARS-CoV2 (COVID-19) Pneumonia Patients",COVID
4523,COVID,"February 08, 2021",62,NCT04673214,AZITHROMYCIN / IVERMECTIN / RIBAROXABAN / PARACETAMOL,MEXICO,Recruiting,Gilberto Cruz Arteaga,"December 16, 2020",Interventional,Prognostic Modification in Patients With COVID-19 Under Early Intervention Treatment at U.M.F 13 and U.M.F 20,COVID
4524,CORONAVIRUS DISEASE 2019,"February 08, 2021",189,NCT04673279,SEROLOGY,ARGENTINA,Recruiting,Hospital Italiano de Buenos Aires,"December 2, 2020",Observational [Patient Registry],"Long-term Persistence of Immunoglobulin G Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Vulnerable Neighbourhood in Buenos Aires, Argentina",COVID
4525,CORONAVIRUS INFECTION,"February 08, 2021",3000,NCT04673292,FIXED SITE STANDARD OF CARE TESTING,,Not yet recruiting,Johns Hopkins University,February 2021,Interventional,Community Collaboration to Combat COVID-19,COVID
4526,COVID,"February 08, 2021",87,NCT04673318,HEAT THERAPY,,Not yet recruiting,"University of Massachusetts, Amherst",January 2021,Interventional,Physical Rehabilitation of COVID-19 Survivors by Heat Therapy,COVID
4527,CYSTIC FIBROSIS,"February 08, 2021",24,NCT04673331,EXERCISE CAPACITY,TURKEY,Recruiting,Hacettepe University,"November 4, 2020",Observational,"Comparison of Physical Activity, Exercise Capacity, Quality of Life, Cognitive Function and Coronavirus Phobia Levels of Adult Cystic Fibrosis Patients With Healthy Individuals With Telerehabilitation in the COVID-19 Pandemic",Unrelated
4528,DEPRESSION,"February 08, 2021",150,NCT04673513,PSYCHOTHERAPY,UNITED STATES,Recruiting,Ohio State University,"December 11, 2020",Interventional,Cognitive Behavioral Therapy for Depression: Helping Clients Learn New Skills,Unrelated
4529,SPONDYLOARTHRITIS,"February 08, 2021",200,NCT04673825,PATIENT INITIATED CARE + TELEMONITORING,NETHERLANDS,Recruiting,Maastricht University Medical Center,"December 2, 2020",Interventional,Effectiveness and Cost-effectiveness of Monitoring Spondyloarthritis With the Integrated eHealth System SpA-Net: a Randomized Controlled Trial,Unrelated
4530,CORONAVIRUS,"February 08, 2021",2520,NCT04674189,CVNCOV VACCINE,GERMANY,Recruiting,CureVac AG,"December 23, 2020",Interventional,"COVID-19: A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Clinical Study Evaluating the Safety and Immunogenicity of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adult Health Care Workers in Mainz (Germany)",COVID
4531,COVID,"February 08, 2021",100000,NCT04674410,ANTIBIOTIC,UNITED STATES,"Active, not recruiting",National Institutes of Health Clinical Center (CC),"March 1, 2020",Observational,Utility of Empiric Antibiotics on Admission for Non-intubated Patients With Novel Coronavirus Diseases 2019 (COVID-19): A Retrospective Cohort Study of Electronic Health Records,COVID
4532,OBESITY,"February 08, 2021",100,NCT04674553,,PAKISTAN,Completed,"Services Institute of Medical Sciences, Pakistan","November 10, 2020",Observational,Effect of Obesity Among COVID-19 Patients in Critical Care Settings,Unrelated
4533,COVID,"February 08, 2021",45,NCT04674566,COR-101,,Not yet recruiting,Corat Therapeutics Gmbh,"January 31, 2021",Interventional,"Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, First-in-human, Phase Ib/II Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Efficacy of COR-101 in Hospitalized Patients",COVID
4534,COVID PANDEMIC,"February 08, 2021",850,NCT04674644,THE PSYCHOSOCIAL EFFECTS OF COVID-19 PANDEMIC ON DENTAL PROFESSIONALS,TURKEY,Completed,Suleyman Demirel University,"October 16, 2020",Interventional,Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department,COVID
4535,COVID,"February 08, 2021",0,NCT04675086,ALPHA1-PROTEINASE INHIBITOR,UNITED STATES,Withdrawn,"Blessing Corporate Services, Inc",January 2021,Interventional,"A Randomized, Open-Label Study of the Efficacy and Safety of Aralast NP, an Alpha-1 Antitrypsin Infusion Therapy With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection",COVID
4536,SARS-CoV2,"February 08, 2021",100,NCT04675281,2 POST-MORTEM TRANSCUTANEOUS LUNG BIOPSIES (1 ANTERIOR ; 1 POSTERIOR) USING ANATOMICAL LANDMARKS,FRANCE,Recruiting,Nantes University Hospital,"April 24, 2020",Observational,Pathological Findings in Critically-ill Patients Who Died From SARS-CoV-2 Related Acute Respiratory Distress Syndrome,COVID
4537,HEALTHY LIFESTYLE,"February 08, 2021",515,NCT04675658,CBPA + FAMILY SUPPORT,UNITED STATES,"Active, not recruiting",Children's Mercy Hospital Kansas City,"October 5, 2020",Interventional,"Stay Active Physical Activity Program for Teachers, Students, and Families",Unrelated
4538,COVID,"February 08, 2021",208,NCT04676867,DALCETRAPIB,CANADA,Recruiting,DalCor Pharmaceuticals,"January 11, 2021",Interventional,"A Double-blind, Placebo-controlled, Phase 2a Proof-of-concept Trial of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19",COVID
4539,COVID,"February 08, 2021",105,NCT04676971,HZVSF-V13,ITALY,Recruiting,"ImmuneMed, Inc.","December 11, 2020",Interventional,"Efficacy and Safety of Intravenously Administered hzVSF-v13 in Patients With COVID-19 Pneumonia: a Phase II, Proof of Concept, Multicentre, Randomized, Parallel-group, Double-blind, Placebo-controlled Study",COVID
4540,PROBLEM SOLVING,"February 08, 2021",397,NCT04677270,DIGITAL PROBLEM SOLVING TOOL,SWEDEN,Completed,Karolinska Institutet,"August 31, 2020",Interventional,Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic,Unrelated
4541,SYMPTOMS RELATED TO COVID,"February 08, 2021",2020,NCT04677283,,FRANCE,Recruiting,Gérond'if,"April 5, 2020",Observational,"Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France.",COVID
4542,TUBERCULOSIS,"February 08, 2021",20,NCT04677478,IMPACT OF RESPIRATORY ISOLATION ON QUALITY OF LIFE,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,December 2020,Observational,Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19,Unrelated
4543,PREVENTION OF INFECTIOUS DISEASE CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV2),"February 08, 2021",200,NCT04677660,TAK-919,JAPAN,Recruiting,Takeda,"January 21, 2021",Interventional,"A Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of TAK-919 by Intramuscular Injection in Healthy Japanese Male and Female Adults Aged 20 Years and Older (COVID-19)",COVID
4544,HIV INFECTIONS,"February 08, 2021",10000,NCT04677842,ART THERAPY,,"Active, not recruiting",PENTA Foundation,"January 1, 2013",Observational [Patient Registry],European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC): Paediatric Protocol,Unrelated
4545,COVID,"February 08, 2021",410,NCT04678024,,ITALY,Enrolling by invitation,Istituto Ortopedico Galeazzi,"November 18, 2020",Observational,Multicentric Sensitivity Assessment of Antibody Diagnostic Tests Developed for Diagnosis of SARS-CoV2 Infection,COVID
4546,COVID,"February 08, 2021",27000,NCT04678193,COROMEC REGISTRY WITH ECL-19,INDIA,Enrolling by invitation,"Aventyn, Inc.","December 24, 2020",Observational [Patient Registry],COVID-19 Risk Assessment Hospitalization Outcomes Epidemiology Efficacy,COVID
4547,COVID,"February 08, 2021",10,NCT04678687,"LIVER, LUNG, HEART AND KIDNEY BIOPSY",TURKEY,"Active, not recruiting",Dokuz Eylul University,"January 1, 2021",Interventional,Evaluation of Postmortem Biopsy Specimens of COVID-19 Cases,COVID
4548,COVID- CORONAVIRUS- SARS-CoV2,"February 08, 2021",40,NCT04678700,CHEST PHYSIOTHERAPY POST-COVID19,SPAIN,Recruiting,European University of Madrid,"March 1, 2021",Interventional,Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance,COVID
4549,COVID,"February 08, 2021",150,NCT04678739,REMDESIVIR,BANGLADESH,Recruiting,M Abdur Rahim Medical College and Hospital,"August 15, 2020",Interventional,Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial,COVID
4550,HEALTHY AGING,"February 08, 2021",11,NCT04678778,PHYSICAL AND COGNITIVE ACTIVITY,UNITED STATES,Recruiting,University of Southern California,"March 19, 2019",Interventional,Targeted Physical and Cognitive Activity in a VR Environment - COVID-19 Protocol,Unrelated
4551,CORONAVIRUS DISEASE 2019,"February 08, 2021",102,NCT04678830,PLACEBOS,,Not yet recruiting,"CytoDyn, Inc.","January 21, 2021",Interventional,"A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab in Patients Experiencing Prolonged Coronavirus Disease 2019 (COVID-19) Symptoms [Long-Haulers]",COVID
4552,ANOREXIA NERVOSA,"February 08, 2021",36,NCT04678843,VIRTUAL FAMILY-BASED TREATMENT,,Not yet recruiting,Jennifer Couturier,January 2021,Interventional,Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond,Unrelated
4553,COVID,"February 08, 2021",310,NCT04679168,,"KOREA, REPUBLIC OF",Recruiting,Seoul National University Hospital,"June 1, 2020",Observational [Patient Registry],Change of Environmental Chemical Exposures and Prevalence of Chronic Kidney Disease After Epidemiological Spread of SARS-CoV-2 (COVID-19),COVID
4554,COVID,"February 08, 2021",2000,NCT04679272,,FRANCE,Enrolling by invitation,"University Hospital, Montpellier","December 1, 2020",Observational,Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients : ProCOVRA,COVID
4555,COVID,"February 08, 2021",48,NCT04679350,HZVSF-V13,"KOREA, REPUBLIC OF",Not yet recruiting,"ImmuneMed, Inc.",March 2021,Interventional,"A Multi Center, Randomized, Double-blind, Parallel Design, Phase 2 Study to Evaluate the Efficacy and Safety of hzVSFv13 Compared to Standard of Care After Intravenous(IV) Administration With Add-on Standard of Care in COVID-19 Moderate to Severe Patients",COVID
4556,COVID,"February 08, 2021",63,NCT04679415,HZVSF-V13,INDONESIA,Recruiting,"ImmuneMed, Inc.","December 17, 2020",Interventional,"A Multi Center, Randomized, Double-blind, Parallel Design, Phase 2 Study to Evaluate the Efficacy and Safety of hzVSFv13 Compared to Standard of Care After Intravenous (IV) Administration With Add-on Standard of Care in COVID-19 Moderate to Severe Patients",COVID
4557,COVID,"February 08, 2021",230,NCT04679428,,SLOVENIA,Recruiting,The University Clinic of Pulmonary and Allergic Diseases Golnik,"May 7, 2020",Observational,Immunological Characteristics of COVID-19 Patients and Determination of Neutralizing Antibodies Against SARS-CoV-2 Virus,COVID
4558,COVID,"February 08, 2021",16,NCT04679493,XC7 100 MG SINGLE,RUSSIAN FEDERATION,Not yet recruiting,NP Therapeutics,December 2020,Interventional,"Double Blind, Randomized, Placebo-controlled Study of Safety, Tolerability, and Pharmacokinetics of Ascending Doses of XC7 After Single and Multiple Oral Administration in Healthy Volunteers",COVID
4559,COVID,"February 08, 2021",2000,NCT04679584,OBSERVATION OF DIFFERENT COURSES OF SARS-COV-2 INFECTION IN DIFFERENT PHASES (ACUTE VS. POST-ACUTE) AND SETTINGS,GERMANY,Recruiting,University Hospital Schleswig-Holstein,"November 16, 2020",Observational,COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life (NAPKON-POP),COVID
4560,HEALTHY VOLUNTEERS,"February 08, 2021",180,NCT04679909,ADCOVID,,Not yet recruiting,"Altimmune, Inc.",February 2021,Interventional,"A Phase 1, Double-blind, Randomized, Placebo-controlled, First-in-Human Study of the Safety and Immunogenicity of AdCOVID Administered as One or Two Doses",Unrelated
4561,CHRONIC PAIN,"February 08, 2021",716,NCT04680000,BRIEF COGNITIVE BEHAVIORAL THERAPY FOR CHRONIC PAIN (BCBT-CP),UNITED STATES,Not yet recruiting,The University of Texas Health Science Center at San Antonio,February 2021,Interventional,"Targeting Chronic Pain in Primary Care Settings Using Behavioral Health Consultants, A Randomized Pragmatic Trial",Unrelated
4562,COVID,"February 08, 2021",50,NCT04680819,ANATOLIAN PROPOLIS,,Not yet recruiting,Ataturk University,"December 25, 2020",Observational [Patient Registry],Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals,COVID
4563,HEARING LOSS,"February 08, 2021",3000,NCT04680845,SELF-AFFIRMATION,UNITED KINGDOM,Recruiting,University of Manchester,"January 18, 2021",Interventional,INSPIRES Hearing Health Trial - INnovative Psychological Intervention to REduce Stigma in Hearing Health Trial,Unrelated
4564,ENDOSCOPY,"February 08, 2021",500,NCT04680858,DECT,GERMANY,Enrolling by invitation,University of Ulm,"July 1, 2020",Interventional,Impact of Digital Enhanced Telecommunication for Team Communication in Endoscopic Procedures During COVID-19 Pandemic,Unrelated
4565,COVID,"February 08, 2021",600,NCT04680949,ANAKINRA,GREECE,Recruiting,Hellenic Institute for the Study of Sepsis,"December 23, 2020",Interventional,"suPAR-Guided Anakinra Treatment for Validation of the Risk and Early Management of Severe Respiratory Failure by COVID-19: The SAVE-MORE Double-blind, Randomized, Phase III Confirmatory Trial",COVID
4566,RESPIRATORY VIRAL INFECTION,"February 08, 2021",300,NCT04681001,NASAL SPRAY,AUSTRIA,Recruiting,Marinomed Biotech AG,"December 20, 2020",Interventional,Clinical Trial to Evaluate the Efficacy of an Iota-Carrageenan Nasal Spray to Reduce Symptoms Caused by SARS-CoV-2 and Other Respiratory Viruses in Healthcare Workers Managing COVID-19 Patients,Respiratory
4567,COVID,"February 08, 2021",1000,NCT04681040,,BRAZIL,Recruiting,"National Center for Global Health and Medicine, Japan","December 19, 2020",Observational,Monitoring of COVID-19 Using Urine POC Kit,COVID
4568,COVID,"February 08, 2021",80,NCT04681053,IVERMECTIN POWDER,,Not yet recruiting,Mansoura University,"January 1, 2021",Interventional,Efficacy and Safety of Inhaled Ivermectin in the Treatment of SARS-COV-2 (COVID-19),COVID
4569,COVID,"February 08, 2021",10,NCT04681079,ALBUTEROL SULFATE (MDI),UNITED STATES,Not yet recruiting,Theravance Biopharma,January 2021,Observational,"A 2-Period, Crossover Study to Assess the Impact of Nebulizer With Filtered Mouthpiece vs MDI With Spacer on Viral Load in Rooms of Subjects With Mild to Moderate COVID-19",COVID
4570,COVID,"February 08, 2021",130,NCT04681092,AKS-452,NETHERLANDS,Not yet recruiting,University Medical Center Groningen,"January 18, 2021",Interventional,Anti-COVID19 AKS-452 Phase I/II VaccinaTion Study,COVID
4571,COVID,"February 08, 2021",300,NCT04681157,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 3, 2020",Observational,Retrospective Study on Anosmias and Ageusias Linked to Infection by SARS-Cov 2,COVID
4572,COVID,"February 08, 2021",699,NCT04681261,THIS STUDY IS NOT AN INTERVENTION STUDY,TURKEY,Completed,Hacettepe University,"May 4, 2020",Observational,"Evaluation of Occupational Balance, Fear and Agoraphobia in Adults",COVID
4573,COMMUNITY ACQUIRED PNEUMONIA IN CHILDREN,"February 08, 2021",200,NCT04681339,ANTIBIOTIC TREATMENT,GERMANY,Not yet recruiting,ARCIM Institute Academic Research in Complementary and Integrative Medicine,February 2021,Observational,"Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study",Respiratory
4574,COVID,"February 08, 2021",66,NCT04681365,STAFF WILL WEAR AND EVALUATE BUBBLE-PAPR (NON-CE MARKED PAPR),,Not yet recruiting,Manchester University NHS Foundation Trust,"February 1, 2021",Observational,A Phase I Study of an 'In-house' Developed Prototype Powered Air Purifying Respirator (PAPR) for Use as Personal Protective Equipment (PPE) for Healthcare Workers (Bubble PAPR),COVID
4575,CORONAVIRUS INFECTION,"February 08, 2021",1094,NCT04681430,CONVALESCENT PLASMA,GERMANY,Recruiting,"Heinrich-Heine University, Duesseldorf","January 8, 2021",Interventional,Reconvalescent Plasma / Camostat Mesylate Early in Sars-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals,COVID
4576,COVID,"February 08, 2021",55,NCT04681755,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","May 19, 2020",Observational,Rehabilitation Required Due to Functional Neurological Impairment and Respiratory Disorders After Severe SARS-CoV-2 Infection in ICU Units,COVID
4577,COVID,"February 08, 2021",40,NCT04681859,HIGH FLOW NASAL OXYGEN (HFNO) TREATMENT,BANGLADESH,Not yet recruiting,Bangladesh University of Engineering and Technology,"December 30, 2020",Interventional,Safety and Efficacy Evaluation of a Low-cost CPAP Device for Hypoxemic COVID-19 Patients: A Pilot Study,COVID
4578,SUBJECTS POSSIBLY EXPOSED TO COVID,"February 08, 2021",500,NCT04681950,,UNITED STATES,Recruiting,Biocerna LLC,"November 24, 2020",Observational,Assessment of Unsupervised Self-Collected Saliva Sample Compared to Clinician CollectedSaliva Sample and Clinician Collected Anterior Nares Sample in a COVID-19 and Influenza A/Influenza B Screening Program,COVID
4579,COVID,"February 08, 2021",420,NCT04682041,BOVINE PLASMA-DERIVED IMMUNOGLOBULIN CONCENTRATE,SPAIN,Recruiting,"Entera Health, Inc","December 22, 2020",Interventional,"Randomized Open-Label Clinical Study Evaluating the Impact of EnteraGam, a Nutritional Intervention Containing Bovine Plasma-Derived Immunoglobulin CoNcentrate, on Clinical Outcomes In People With COVID-19",COVID
4580,COVID,"February 08, 2021",8000,NCT04682093,,CROATIA,Enrolling by invitation,European Society for Emergency Medicine (EUSEM) Research Network,"March 9, 2020",Observational,Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED (EUROCOV Study),COVID
4581,COVID,"February 08, 2021",686,NCT04682132,"COVID-19 ANTIGEN AND ANTIBODY TESTS, AND INFLUENZA RAPID TEST",UNITED STATES,"Active, not recruiting",Polk County Fire Rescue,"May 26, 2020",Observational,County-wide Emergency Personnel Assessment of COVID-19 and Influenza Status,COVID
4582,HEALTH PERSONNEL,"February 08, 2021",100,NCT04682197,CERESET RESEARCH,,Not yet recruiting,Wake Forest University Health Sciences,February 2021,Interventional,Cereset Research To Reduce Stress And Anxiety In Healthcare Workers In The Time Of COVID-19,Unrelated
4583,MULTIPLE SCLEROSIS,"February 08, 2021",1000,NCT04682548,,UNITED STATES,Not yet recruiting,NYU Langone Health,January 2021,Observational,"Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients With and Without Ocrelizumab Treatment, and Comparing Immune Responses to COVID-19 in MS Patients on Ocrelizumab and Healthy Controls",Unrelated
4584,STRESS,"February 08, 2021",40,NCT04682561,SUPPORTIVE TRAUMA EXPOSURE PREPARATION PROGRAM,CANADA,Not yet recruiting,Unity Health Toronto,January 2021,Interventional,The STEP Program: Building Trauma Resilience Among Nurses and Personal Support Workers at Providence Healthcare During and Beyond the COVID-19 Pandemic,Unrelated
4585,CORONAVIRUS INFECTION,"February 08, 2021",15,NCT04682574,VITAMIN C,PAKISTAN,Recruiting,University of Lahore,"November 2, 2020",Interventional,Efficacy of Mega Dose Vitamin C in Critically Ill COVID-19 Patients,COVID
4586,COVID DISEASE,"February 08, 2021",700,NCT04682873,ENISAMIUM IODIDE,UKRAINE,Recruiting,"Joint Stock Company ""Farmak""","May 15, 2020",Interventional,"A Multi-centre, Double-blind, Randomised, Placebo-controlled, Trial to Assess the Efficacy and Safety of Amizon® Max, Manufactured by Farmak JSC, in Combination With Basic Treatment, in Subjects With Moderate Covid-19",COVID
4587,COVID INFECTION,"February 08, 2021",2000,NCT04682912,,TURKEY,Recruiting,Mersin Training and Research Hospital,"January 30, 2021",Observational,ABO-Rh Blood Types and COVID-19 Infection in Children: Is There a Link?,COVID
4588,COVID,"February 08, 2021",7320,NCT04683224,UB-612,,Not yet recruiting,COVAXX,"February 1, 2021",Interventional,"A Phase 2/3 Randomized, Multicenter, Double-Blind, Placebo Controlled, Dose-Response Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 Vaccine in Adults",COVID
4589,COVID,"February 08, 2021",560,NCT04683328,SCTA01,,Not yet recruiting,Sinocelltech Ltd.,"February 25, 2021",Interventional,"An Adaptive, Randomized, Double-blinded, Placebo-controlled, Phase II/III Trial of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in Patients With Severe COVID-19 Admitted to High Dependence or Intensive Care Unit (MASP3 Trial)",COVID
4590,COVID,"February 08, 2021",620,NCT04683484,NANOCOVAX,VIETNAM,Recruiting,Nanogen Pharmaceutical Biotechnology Joint Stock Company,"December 10, 2020",Interventional,"Clinical Trials of Phase 1, 2 of Nanocovax Manufactured by Nanogen",COVID
4591,COLORECTAL CANCER SCREENING,"February 08, 2021",100,NCT04683744,SEMI-STRUCTURED INTERVIEWS-PATIENTS,UNITED STATES,Recruiting,Indiana University,January 2021,Observational,Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation,Unrelated
4592,COVID,"February 08, 2021",707,NCT04684433,DATA EXTRACTION FROM MEDICAL FILES,BELGIUM,Recruiting,Brugmann University Hospital,"April 14, 2020",Observational,Surgery in the Time of COVID-19 Pandemic,COVID
4593,COVID,"February 08, 2021",100,NCT04684446,AZD1222,,Not yet recruiting,AstraZeneca,"March 16, 2021",Interventional,"A Phase I/II Open-label Randomized Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID 19",COVID
4594,SARS-COV INFECTION,"February 08, 2021",556,NCT04684550,STABILIZED HYPOCHLOROUS ACID,,Not yet recruiting,Hospital Universitario San Ignacio,"February 15, 2021",Interventional,Randomized Controlled Clinical Study (RCT) Phase 3 of the Safety and Efficacy of Hypochlorous Acid in the Prophylaxis of Healthcare Personnel at High Risk of Infection by SARS-CoV2 (COVID19) Versus Placebo,Respiratory
4595,AUTOIMMUNE DISEASES,"February 08, 2021",5000,NCT04684602,PRIMEPRO™/ PRIMEMSK™,UNITED STATES,Recruiting,Thomas Advanced Medical LLC,"July 9, 2020",Interventional,"Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions",Unrelated
4596,DEPRESSION,"February 08, 2021",1000,NCT04684615,,UNITED STATES,Enrolling by invitation,National Institute of Mental Health (NIMH),"February 11, 2021",Observational,Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen,Unrelated
4597,ASTHMA,"February 08, 2021",216000,NCT04684836,"EXPOSURE TO TELEMEDICINE, AFTER THE ONSET OF THE PANDEMIC",UNITED STATES,Not yet recruiting,Weill Medical College of Cornell University,February 2021,Observational,Evaluating the Comparative Effectiveness of Telemedicine in Primary Care: Learning From the COVID-19 Pandemic,Unrelated
4598,COVID,"February 08, 2021",20,NCT04685213,ELECTRICAL STIMULATION,UNITED STATES,Recruiting,Baylor College of Medicine,"August 18, 2020",Interventional,Electrical Stimulation Therapy for Preventing Hospital-acquired Weakness in Critically Ill COVID-19 Patients - A Proof of Concept Randomized Controlled Trial,COVID
4599,ULTRASOUND THERAPY; COMPLICATIONS,"February 08, 2021",200,NCT04685330,ULTRASOUND GUIDED PROCEDURE,,Not yet recruiting,Massachusetts General Hospital,"January 1, 2021",Observational,Portable Ultrasound for Interventional Procedures,Unrelated
4600,COVID,"February 08, 2021",30,NCT04685447,EXPANDED HEMODIALYSIS FOR COVID19 MAINTENANCE HEMODIALYSIS PATIENTS,ITALY,Recruiting,Universita degli Studi di Genova,"March 16, 2020",Interventional,Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients Affected by COVID-19: Effects of 2 Different Dialysis Strategies,COVID
4601,COVID,"February 08, 2021",180,NCT04685512,TENOFOVIR DISOPROXIL AND EMTRICITABINE,FRANCE,Recruiting,"University Hospital, Caen","November 18, 2020",Interventional,Effect of Tenofovir/Emtricitabine Short Course on Viral Clearance in Patients Recently Infected With SARS-COV2 (Covid-19) Not Requiring Hospitalization: a Phase IIB/III Multicenter Open-label Randomized Controlled Trial,COVID
4602,COVID,"February 08, 2021",27,NCT04685603,AV-COVID-19,INDONESIA,Recruiting,Indonesia-MoH,"December 7, 2020",Interventional,"Adaptive Phase I Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From SARS-CoV-2, in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies",COVID
4603,COVID,"February 08, 2021",50,NCT04685629,25 POST ICU-PATIENTS,BELGIUM,Recruiting,"University Hospital, Antwerp","May 7, 2020",Observational,Long-term Follow-up of Covid-19 Patients in Their Home Environment After Hospitalization in a Covid Department or Intensive Care Unit,COVID
4604,THERAPEUTIC PLASMA EXCHANGE,"February 08, 2021",228,NCT04685655,THERAPEUTIC PLASMA EXCHANGE,GERMANY,Recruiting,Heidelberg University,"January 7, 2020",Interventional,RescuE pLAsma eXchange in Severe COVID-19 (RELAX Severe COVID-19),Unrelated
4605,COVID,"February 08, 2021",50,NCT04685681,HIKING CHALLENGE,,Not yet recruiting,State University of New York at Buffalo,"January 1, 2021",Interventional,Examining Adults' Activity Choices During COVID-19: The UB GO Study,COVID
4606,CANCER OF GASTROINTESTINAL TRACT,"February 08, 2021",50,NCT04685759,IN-PERSON EXERCISE PROTOCOL,,Not yet recruiting,University of Texas Southwestern Medical Center,March 2021,Interventional,Assessing the Non-inferiority of Virtual vs. In-person Concurrent Exercise Regimens in Patients Receiving Neoadjuvant Therapy Prior to Surgical Resection of a Primary GI Tumor,Unrelated
4607,ADVERSE EVENTS IN COVID VACCINATION,"February 08, 2021",500,NCT04686409,COVID-19 VACCINES,GERMANY,Not yet recruiting,University of Ulm,"January 11, 2021",Observational,App-based Symptom Tracking After Corona Vaccination (CoCoV),COVID
4608,COVID,"February 08, 2021",50,NCT04686539,CBD,,Not yet recruiting,Sheba Medical Center,"December 20, 2020",Interventional,Synthetic CBD Oil Droplets as a Therapy for Mild to Moderate SARS-CoV-2 Infection. Assesment of Efficacy and Safety.,COVID
4609,CEREBRAL PALSY,"February 08, 2021",100,NCT04686565,,TURKEY,Recruiting,Diskapi Yildirim Beyazit Education and Research Hospital,"February 15, 2020",Observational,Evaluation The Effect of The Covid-19 Pandemic on Children With CerebralPalsy and The Caregivers' Quality of Life,Unrelated
4610,FIBROMYALGIA,"February 08, 2021",100,NCT04686578,,TURKEY,Recruiting,Diskapi Yildirim Beyazit Education and Research Hospital,"December 1, 2020",Observational,"Investigation the Effect of Covid-19 Fear, Anxiety on Daily Life, Sleep Quality, and Anxiety-depression of the Patients With Fibromyalgia",Unrelated
4611,EMERGENCIES,"February 08, 2021",750,NCT04686708,EMERGENCY GENERAL SURGICAL ADMISSIONS,TURKEY,Completed,Gulhane Training and Research Hospital,"March 11, 2019",Observational,Impact of the COVID-19 Pandemic on Emergency General Surgery Outcomes: a Single-center Cohort Study,Unrelated
4612,TRACHEAL STENOSIS,"February 08, 2021",200,NCT04686721,CHEST CT SCAN + BASELINE SPIROMETRY,ITALY,Recruiting,Istituto Clinico Humanitas,"December 20, 2020",Observational [Patient Registry],"A Retrospective and Prospective Observational, Multicentric, Case-control Clinical Study for the Evaluation of Tracheal Stenosis Among Patients With COVID-19 and Prolonged Intubation or Tracheostomy.",Unrelated
4613,COVID,"February 08, 2021",500,NCT04686734,NO ACTIVE INTERVENTION (OBSERVATIONAL ONLY),,Not yet recruiting,"University Hospital, Akershus","January 6, 2021",Observational,Long-term Effects of COVID-19 in Adolescents,COVID
4614,PANCREATIC CANCER,"February 08, 2021",2000,NCT04686747,,ITALY,Enrolling by invitation,S.M. Misericordia Hospital,January 2021,Observational,COVID - 19 and Advanced Gastro-intestinal Cancer Treatment,Unrelated
4615,CORONAVIRUS INFECTION,"February 08, 2021",30,NCT04686760,NITROGLYCERIN,PAKISTAN,Recruiting,University of Lahore,"November 15, 2020",Interventional,Efficacy of Inhaled Nitroglycerin in Moderate to Severe Cases of COVID-19 Patients,COVID
4616,COVID,"February 08, 2021",100,NCT04686773,AZD1222,AZERBAIJAN,Not yet recruiting,R-Pharm,"February 10, 2021",Interventional,"A Phase II Open-label Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID 19",COVID
4617,AEROSOL GENERATION AND DROPLET DISPERSION AND DEPOSITION DURING NASO-GASTRIC INTUBATION FOR GASTROINTESTINAL MOTILITY INVESTIGATIONS,"February 08, 2021",15,NCT04687488,FLUORESCEIN,BELGIUM,Completed,Universitaire Ziekenhuizen Leuven,"July 23, 2020",Interventional,COVID-19: The Study of Aerosol Generation and Droplet Dispersion and Deposition During Naso-gastric Intubation for Gastrointestinal Motility Investigations,Unrelated
4618,PELVIC FLOOR,"February 08, 2021",85,NCT04687852,CONSERVATIVE AND NON-CONSERVATIVE TREATMENTS,TURKEY,Recruiting,Istanbul Medipol University Hospital,"June 9, 2020",Interventional,Comparison of the Efficacy of Pharmacology and Non-pharmacological Treatment in Women With Primary Dysmenorrhea.,Unrelated
4619,VOLUME OUTCOME RELATIONSHIP AMONG COVID INPATIENTS IN US HOSPITALS,"February 08, 2021",100000,NCT04688372,SURGE INDEX,UNITED STATES,"Active, not recruiting",National Institutes of Health Clinical Center (CC),"October 1, 2020",Observational,Association Between Hospital Case Burden and Mortality Risk Among Patients Hospitalized With COVID-19: A Retrospective Cohort Study of U.S. Hospitals,COVID
4620,DYSPNEA,"February 08, 2021",24,NCT04688502,HIGH INTENSITY INTERVAL TRAINING,CANADA,Not yet recruiting,University of Saskatchewan,"January 11, 2021",Interventional,The Effects of Wearing a Face Mask During COVID-19 on Performance and Intensity Markers During CrossFit Exercise,Unrelated
4621,ANXIETY DISORDERS AND SYMPTOMS,"February 08, 2021",56,NCT04688567,PATIENT-DRIVEN ICBT,SWEDEN,"Active, not recruiting",Vastra Gotaland Region,"November 1, 2019",Interventional,Patient-driven Internet Delivered Psychological Treatment in a Primary Care Context: a Randomized Controlled Trial,Unrelated
4622,TELEMEDICINE,"February 08, 2021",167,NCT04688840,HIP ARTHROPALSTY,EGYPT,Completed,Tanta University,"January 1, 2020",Observational,Smartphone Application: A Possible Solution for Follow up of Patients With Hip Arthroplasty During COVID-19 Pandemic,Unrelated
4623,COVID,"February 08, 2021",4000,NCT04689399,"STANDARD Q COVID-19 AG - TEST, PRODUCED BY SD BIOSENSOR INC.",DENMARK,Recruiting,"Rigshospitalet, Denmark","December 26, 2020",Interventional,Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test,COVID
4624,COVID,"February 08, 2021",500,NCT04689464,,IRAQ,Recruiting,Alhasan Mujtaba Al-Mudhaffer,"December 1, 2020",Observational,COVID19 and Psychological Health: a Cross Sectional Evaluation of the Risks of Anxiety and Depression Among Patients Diagnosed With Covid 19,COVID
4625,COVID,"February 08, 2021",612,NCT04689477,VASCULAR OCCLUSION TEST,BRAZIL,Recruiting,Corporacion Parc Tauli,"May 25, 2020",Observational [Patient Registry],Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients,COVID
4626,COVID,"February 08, 2021",50,NCT04689490,CARDIOPULMONARY EXERCISE TEST,SPAIN,Recruiting,Hospital Clínico Universitario de Valladolid,"August 1, 2020",Observational,Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients,COVID
4627,COVID,"February 08, 2021",30,NCT04689542,SIT-TO-STAND TEST,BELGIUM,Recruiting,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,"January 1, 2021",Interventional,Effects of Surgical Face Mask on Submaximal Exercise Test in Patients With COVID-19,COVID
4628,COVID,"February 08, 2021",600,NCT04689672,LUNG ULTRASOUND,ITALY,Recruiting,IRCCS San Raffaele,"December 16, 2020",Observational,Predictivity of hEmoGasAnalysis Associated to Bedside Lung UltraSound in Determining COVID-19 Severity in the Emergency Departement,COVID
4629,COVID,"February 08, 2021",16,NCT04689711,,UNITED STATES,Enrolling by invitation,Tufts Medical Center,"December 7, 2020",Observational,Generalizable Prognostic Models for Patient-Centered Decisions in COVID-19,COVID
4630,COVID_AIRWAYS MANAGEMENT,"February 08, 2021",250,NCT04689724,,CANADA,Recruiting,"University Health Network, Toronto","August 10, 2020",Observational,Determining Airway Management Related Outcomes in COVID19 Patients and in Health Care Providers,COVID
4631,SARS-CoV2 INFECTION,"February 08, 2021",2000,NCT04690114,,ISRAEL,Recruiting,Shaare Zedek Medical Center,"October 1, 2020",Observational [Patient Registry],"Incidence, Prevalence. Risk Factors and Epidemiology of SARS-CoV-2 Seropositivity in the Pediatric Population",COVID
4632,COVID,"February 08, 2021",27,NCT04690387,AV-COVID-19,INDONESIA,"Active, not recruiting","Aivita Biomedical, Inc.","December 7, 2020",Interventional,"Adaptive Phase I Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From SARS-CoV-2, in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies",COVID
4633,FIBROMYALGIA,"February 08, 2021",28,NCT04690400,EXPERIMENTAL: ACTIVE CARE GROUP,,Not yet recruiting,Federal University of Pelotas,"January 18, 2021",Interventional,"Adaptations From a Telehealth Stretching Exercise Program on Painful Conditions, Depression, Sleep and Functionality of Women With Fibromyalgia During the Covid-19 Pandemic: a Randomized Clinical Trial",Unrelated
4634,COVID,"February 08, 2021",60,NCT04690413,NOWDX COVID-19 TEST,UNITED STATES,Enrolling by invitation,"NOWDiagnostics, Inc.","September 1, 2020",Interventional,NOWDx Test for the Detection of Antibodies to COVID-19,COVID
4635,CARDIOPULMONARY ARREST,"February 08, 2021",34,NCT04690517,TRACHEAL ULTRASOUND,"KOREA, REPUBLIC OF",Not yet recruiting,Samsung Medical Center,December 2020,Interventional,Comparison of Tracheal Ultrasound With Capnography for Intubation Confirmation During CPR (Cardiopulmonary Resuscitation) Wearing PPE (Personnel Protective Equipment): A Prospective Comparative Study,Unrelated
4636,SYSTEMIC AUTOIMMUNE DISEASES,"February 08, 2021",350,NCT04690816,,UNITED STATES,Recruiting,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),"February 11, 2021",Observational,The Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases; An Observational Prospective Study,Unrelated
4637,UVEITIS,"February 08, 2021",1000,NCT04690829,,UNITED STATES,Enrolling by invitation,National Eye Institute (NEI),"February 11, 2021",Observational,Biomarkers in Ocular Inflammation and Uveitis,Unrelated
4638,CORONA VIRUS DISEASE 2019 (COVID),"February 08, 2021",200,NCT04690920,TOCILIZUMAB,PAKISTAN,Completed,University of Lahore,"July 23, 2020",Interventional,Theranostic Implication of Complimentary Medicines Against IL-6/Gp-130 in COVID-19.: An in Vitro and in Silco Approach,COVID
4639,COVID,"February 08, 2021",24,NCT04691180,BRII-196 AND BRII-198,CHINA,Recruiting,Brii Biosciences Limited,"January 5, 2021",Interventional,"A Phase 1 Randomized, Single-blind, Placebo-controlled, Single Ascending Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Human Monoclonal Antibodies, Brii-196 and BRII-198, Administered Intravenously to Healthy Adult Volunteers",COVID
4640,ACS-COVID-ASSIUT,"February 08, 2021",2500,NCT04691609,,EGYPT,Recruiting,Assiut University,"March 1, 2020",Observational,Assiut University Registry for ACS Patients During COVID-19 Pandemic,COVID
4641,COVID DISEASE,"February 08, 2021",2000,NCT04691895,SARS-COV2 INFECTION,ITALY,"Active, not recruiting",University of Bologna,"May 1, 2020",Observational [Patient Registry],Gastrointestinal Symptoms of SARS-CoV-2 Infection: a Prospective Multicentre Study,COVID
4642,COVID,"February 08, 2021",3000,NCT04691908,QAZCOVID-IN®-VACCINE AGAINST COVID-19,KAZAKHSTAN,Enrolling by invitation,Research Institute for Biological Safety Problems,"December 25, 2020",Interventional,"Multicenter, Randomized, Blind, Placebo-controlled Clinical Study of III Phase on Assessment of Preventive Efficiency, Safety and Immunogenicity QazCovid-in®-Vaccine Against COVID-19 in Healthy Adult Volunteers",COVID
4643,COVID,"February 08, 2021",1000,NCT04691921,CURRENT CLINICAL PRACTICES OF PARTICIPATING PHYSICIANS,INDIA,Recruiting,NMC Specialty Hospital,"January 4, 2021",Observational,Nation-wide Cross-sectional Survey on Current Pharmacological Practices in Severe COVID-19,COVID
4644,COVID,"February 08, 2021",61,NCT04691934,ANESTHESIA MANAGEMENT,TURKEY,Completed,Turkiye Yuksek Ihtisas Education and Research Hospital,"March 11, 2020",Observational,Our Anesthesia Experiences in COVID-19 Positive Patients Undergoing Cesarean Section: A Retrospective Single-center Cohort Study,COVID
4645,COVID VACCINE,"February 08, 2021",44,NCT04691947,ERUCOV-VAC,TURKEY,Recruiting,Health Institutes of Turkey,"November 5, 2020",Interventional,"Phase 1 Study for the Determination of Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC, Given Twice Intramuscularly to Healthy Volunteers, in a Placebo Controlled Study Design.",COVID
4646,COVID,"February 08, 2021",100,NCT04692129,,BRAZIL,Recruiting,Corporacion Parc Tauli,"May 29, 2020",Observational,"Short-term Effects of Prone Positioning on Tissue Oxygen Saturation, Measured by Near-infrared Spectroscopy, in COVID-19 Patients With Acute Respiratory Distress Syndrome",COVID
4647,COVID,"February 08, 2021",60,NCT04692779,LUNG ULTRASOUND (LUS),,Not yet recruiting,Rush University Medical Center,"January 31, 2021",Observational,"A Prospective Clinical Study to Explore the Mechanism of Patients' Response to Prone Positioning in ARDS Patients, Including COVID-19",COVID
4648,COVID,"February 08, 2021",150,NCT04693026,REMDESIVIR,BANGLADESH,Recruiting,M Abdur Rahim Medical College and Hospital,"September 10, 2020",Interventional,Efficacy of Ramdicivir and Baricitinib Combination Therapy for the Treatment of COVID 19 ARDS,COVID
4649,PSYCHIATRIC DISORDER,"February 08, 2021",600,NCT04693052,NO INTERVENTIONS,UNITED STATES,Enrolling by invitation,Northwestern University,"December 10, 2020",Observational,Attitudes Towards Receiving Mental Health Care Using Telehealth During the COVID-19 Pandemic,Unrelated
4650,TRUST,"February 08, 2021",32400,NCT04693689,RNA VACCINE,,Not yet recruiting,"National University, Singapore","January 15, 2021",Interventional,"Novelty, Conformity and Trust in Vaccines",Unrelated
4651,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,"February 08, 2021",94,NCT04693975,,BRAZIL,Recruiting,Universidade Estadual de Londrina,"October 16, 2020",Observational [Patient Registry],Impact of Social Distancing During the COVID-19 Pandemic on Non-infected People With Chronic Respiratory Diseases,Unrelated
4652,EMOTIONAL INTELLIGENCE,"February 08, 2021",20,NCT04694014,EI OPEN ENDED PRE-SURVEY AND SEMI STRUCTURED INTERVIEW,KENYA,Enrolling by invitation,African Wood Inc,"October 15, 2020",Observational,Emotional Intelligence Skills Leaders and Managers Need to Engage Frontline Healthcare Professionals During Covid-19 Pandemic,Unrelated
4653,PSYCHOSIS;SCHIZOPHRENIC,"February 08, 2021",200,NCT04694482,PSYCHOMETRIC SCALE ADMINISTRATION,ITALY,Recruiting,University of Milano Bicocca,"November 12, 2020",Observational,The Psychopathological Impact of the SARS-CoV-2 Epidemic on Subjects Suffering From Mental Disorders: Data From ASST Monza,Unrelated
4654,COVID,"February 08, 2021",600,NCT04694573,,GERMANY,Recruiting,Heidelberg University,"December 28, 2020",Observational [Patient Registry],Collaborative Transplant Study (CTS) Pre- and Post-Transplantation Covid-19 Serum Studies: Antibody Development Following a SARS-CoV-2 Infection,COVID
4655,COVID,"February 08, 2021",676,NCT04694612,FAVIPIRAVIR,NEPAL,Recruiting,Nepal Health Research Council,"January 1, 2021",Interventional,"Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal: a Multi-center, Randomized, Open-labelled, Phase III Clinical Trial",COVID
4656,PRONE POSITIONING,"February 08, 2021",24,NCT04694638,BODY POSITION CHANGE,UNITED STATES,Recruiting,Mayo Clinic,"May 21, 2020",Interventional,"The Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in Acute Hypoxemic and/or Hypercapnic Respiratory Failure Secondary to COVID-19 Infection: A Feasibility, Safety Phase One, Open Label Study",Unrelated
4657,COVID,"February 08, 2021",400,NCT04694651,,EGYPT,Recruiting,Assiut University,"December 15, 2020",Observational [Patient Registry],A National Survey of Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt,COVID
4658,PREGNANCY RELATED,"February 08, 2021",18000,NCT04694664,THIS IS AN ONLINE SURVEY WITH NO INTERVENTION.,UNITED STATES,Completed,Pregistry,"October 1, 2020",Observational,Vaccine Confidence Among Pregnant Women and Mothers During the COVID-19 Pandemic,Unrelated
4659,COVID,"February 08, 2021",20,NCT04694703,COVID-19 GROUP,TURKEY,Recruiting,Izmir Bakircay University,"January 6, 2021",Observational,"Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Patients Diagnosed With COVID-19 Before and After COVID-19 Treatment",COVID
4660,COVID,"February 08, 2021",40,NCT04694716,NO INTERVENTION,TURKEY,Recruiting,Izmir Bakircay University,"January 6, 2021",Observational,Determination of Serum Trace Element and Physical Activity Levels in COVID-19 Patients,COVID
4661,ARDS,"February 08, 2021",100,NCT04694742,DATA COLLECTING,ITALY,Recruiting,ASST Fatebenefratelli Sacco,"September 1, 2020",Observational,Ventilatory Efficiency in Critically Ill COVID-19 Patients,Unrelated
4662,POST COVID SYNDROME,"February 08, 2021",100,NCT04694768,REHABILITATION,EGYPT,Recruiting,Assiut University,"July 1, 2020",Observational,The Effect of Implementing a Nursing Program Intervention on Improvement of Health Quality of Post Covid-19 Patients,COVID
4663,COVID,"February 08, 2021",60,NCT04695158,COVID-19 GROUP (GROUP I),TURKEY,Recruiting,Izmir Bakircay University,"January 6, 2021",Observational,"Determination of Hemoglobin A1c, Lipid Profiles, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Patients With Type II Diabetes and/or COVID-19",COVID
4664,COVID,"February 08, 2021",142,NCT04695197,ARTEMETHER-LUMEFANTRINE (AL),BURKINA FASO,Not yet recruiting,Liverpool School of Tropical Medicine,"January 8, 2021",Interventional,Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso,COVID
4665,COVID,"February 08, 2021",50,NCT04695301,REHABILITATION PROTOCOL THROUGH A DIGITAL PLATFORM,BRAZIL,Recruiting,Hospital Israelita Albert Einstein,"July 1, 2020",Interventional,Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation,COVID
4666,MYASTHENIA GRAVIS,"February 08, 2021",150,NCT04695379,,FRANCE,Recruiting,"University Hospital, Bordeaux","May 26, 2020",Observational,Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection: Consequences on the Severity of Myasthenic Syndrome and Reciprocal Impact of the Two Pathologies on Their Respective Treatments,Unrelated
4667,COVID,"February 08, 2021",74,NCT04695457,,FRANCE,Completed,Centre Hospitalier Annecy Genevois,"July 15, 2020",Observational,Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps,COVID
4668,COVID VACCINE,"February 08, 2021",3700,NCT04695652,MVC-COV1901(S PROTEIN WITH ADJUVANT),TAIWAN,Recruiting,Medigen Vaccine Biologics Corp.,"December 30, 2020",Interventional,"A Phase II, Prospective, Double-blinded, Multi-Center, Multi-Regional Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901",COVID
4669,COVID,"February 08, 2021",4000,NCT04695678,COVID-19 NASAL/PHARYNGEAL SWAB,GERMANY,"Active, not recruiting",Wissenschaftliches Institut Bethanien e.V,"July 1, 2020",Observational,Epidemiological Multicohort Study of Latent COVID-19 Infections in Residents and Staff of Nursing Homes in the City of Solingen,COVID
4670,COVID,"February 08, 2021",284,NCT04695704,MONTELUKAST,,Not yet recruiting,Jordi Gol i Gurina Foundation,"April 1, 2021",Interventional,"Double-blind Randomized Clinical Trial, Placebo-controlled to Assess the Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID: E-SPERANZA COVID PROJECT",COVID
4671,DEMENTIA,"February 08, 2021",50,NCT04695743,ONLINE COGNITIVE STIMULATION THERAPY,UNITED KINGDOM,Recruiting,"University College, London","September 1, 2020",Interventional,Virtual CST - A Collaborative Proof of Concept Study With FaceCog HK in Response to the Covid-19 Pandemic,Unrelated
4672,COVID,"February 08, 2021",1000,NCT04695756,COVID-19 PANDEMIC,ARGENTINA,Recruiting,Hospital Italiano de Buenos Aires,"December 15, 2020",Observational,Impact of Coronavirus Disease 2019 (COVID-19) Epidemic in Patients Requiring Liver Transplantation,COVID
4673,COVID,"February 08, 2021",10,NCT04695821,SENTI V1.0 DEVICE,UNITED KINGDOM,Not yet recruiting,Senti Tech Ltd,January 2021,Interventional,"A Small-scale Study to Capture Acoustic Pathophysiological Parameters, in the Community, Through a Wearable Device, and to Evaluate the Technical and Practical Feasibility of Utilising This Data as Part of a Medical Device System for the Monitoring and Evaluation of Covid-19 at Home",COVID
4674,CHRONIC PAIN,"February 08, 2021",144,NCT04696107,PSYCHOEDUCATIVE INTERVENTION,SPAIN,Not yet recruiting,Hospital San Juan de Dios del Aljarafe de Sevilla,"April 1, 2021",Interventional,Effectiveness of Coping Strategies on the Control of Musculoskeletal Chronic Non-Cancer Pain and Quality of Life: A Randomized Clinical Trial,Unrelated
4675,RESPIRATORY FAILURE,"February 08, 2021",250,NCT04696406,RESPINOR DXT,FRANCE,Not yet recruiting,Respinor AS,"March 1, 2021",Observational [Patient Registry],"Multicenter, Multinational, Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure",Respiratory
4676,COVID,"February 08, 2021",44,NCT04696562,DEEP BREATHING EXERCISE WITH TRIFLO,,Not yet recruiting,Ankara University,"January 1, 2021",Interventional,"The Effect of Deep Breathing Exercise Applied With Triflo on Dyspnea, Anxiety and Quality of Life in Patients Treated for COVID-19: Randomized Controlled StudyPatients Treated for COVID-19: A Randomized Controlled Study",COVID
4677,OLFACTION DISORDERS,"February 08, 2021",2000,NCT04696601,OLFACTORY TEST,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Nice,"January 10, 2021",Interventional,Rapid Screening for Olfactory Disorders in Covid-19 Infection,Unrelated
4678,VERY PRETERM CHILDREN WITH DYSEXECUTIVE DISORDERS,"February 08, 2021",170,NCT04696679,PATIENT QUALITY OF LIFE ASSESSMENT,FRANCE,Completed,Assistance Publique Hopitaux De Marseille,"June 19, 2020",Observational,Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic,Unrelated
4679,COVID,"February 08, 2021",347,NCT04696913,EXPOSURE: POSITIVE COVID-19 INFECTION,,Not yet recruiting,University of Aberdeen,"January 1, 2021",Observational,Does COVID-19 Infection Increase the Risk of Pulmonary Embolism? A Retrospective Case-control Study,COVID
4680,"BURNOUT, PSYCHOLOGICAL","February 08, 2021",443,NCT04697030,,PAKISTAN,Completed,Sialkott College of Physical Therapy,"September 15, 2020",Observational,Behavioral Outcomes Among Adolescent Population During Covid-19 Pandemic Lockdown in Pakistan: A Lower Middle Income Country Experience,Unrelated
4681,COVID,"February 08, 2021",30,NCT04697654,TLC19,AUSTRALIA,"Active, not recruiting",Taiwan Liposome Company,"October 14, 2020",Interventional,"A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers",COVID
4682,COVID INFECTIONS IN CANCER PATIENTS,"February 08, 2021",10000,NCT04697927,QUESTIONNAIRES,UNITED STATES,Recruiting,Memorial Sloan Kettering Cancer Center,"December 30, 2020",Observational,Ascertainment of Epidemiologic Risk Information to Assess Susceptibility to and Severity of SARS-CoV-2 Infection,COVID
4683,ANXIETY,"February 08, 2021",1107,NCT04698044,HOSPITAL ANXIETY DEPRESSION SCALE,TURKEY,Completed,"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey","May 8, 2020",Observational,Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period: A Population-based Comparative Study,Unrelated
4684,COVID,"February 08, 2021",160,NCT04698083,"ELECTROCARDIOGRAPHY ,TOMOGRAPHIC IMAGING",TURKEY,Completed,Ankara Education and Research Hospital,"July 22, 2020",Observational,Retrospective Evaluation of Electrocardiographic Findings of Right Ventricular Overload in Covid 19 Patients With Respiratory Distress,COVID
4685,SEPSIS,"February 08, 2021",5000,NCT04698382,,UNITED STATES,"Active, not recruiting",National Institutes of Health Clinical Center (CC),"August 1, 2020",Observational,"Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis",Unrelated
4686,CACHEXIA,"February 08, 2021",16,NCT04698798,MUSCLE BIOPSY,BELGIUM,Recruiting,Hasselt University,January 2021,Interventional,Skeletal Muscle Wasting in SARS-CoV-2 Infected ICU (Intensive Care Unit) Patients,Unrelated
4687,SARS-CoV2,"February 08, 2021",30,NCT04698837,,SWITZERLAND,Not yet recruiting,"University Hospital Inselspital, Berne",January 2021,Observational,AeroCOVID 1: Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2 Using Patient Proximity Environmental Sampling With a Highly Efficient Bioaerosol and Droplet Collection Dummy,COVID
4688,COVID,"February 08, 2021",1650,NCT04698993,DRÄGER ANTIGEN TEST SARS-COV-2,GERMANY,Not yet recruiting,Drägerwerk AG & Co. KGaA,January 2021,Interventional,Dräger Antigen Test SARS-CoV-2 Clinical Performance Study,COVID
4689,SARS-COV INFECTION,"February 08, 2021",1650,NCT04699058,COVID-ANTIBODY TEST,"CONGO, THE DEMOCRATIC REPUBLIC OF THE",Recruiting,"Institute of Tropical Medicine, Belgium","July 17, 2020",Observational,"Sero-prevalence and Sero-conversion Study of Health Care Workers and Their Households, Democratic Republic of the Congo",Respiratory
4690,AZITHROMYCIN ADVERSE REACTION,"February 08, 2021",105,NCT04699097,AZITHROMYCIN,TURKEY,Completed,Kayseri City Hospital,"July 1, 2020",Observational,Azitromycin Use in COVID-19 Positive Pediatric Patients; Effect on Ventricle Repolarization,Unrelated
4691,COVID,"February 08, 2021",20,NCT04699227,CUFF APPLICATION WITH INFLATION,UNITED KINGDOM,Recruiting,Derek Yellon,"April 23, 2020",Interventional,"CAN REMOTE ISCHAEMIC CONDITIONING REDUCE INFLAMMATORY MARKERS IN COVID-19 PATIENTS - A MULTI-SITE, RANDOMISED PILOT STUDY",COVID
4692,COVID,"February 08, 2021",230,NCT04699578,COVID-19 POSITIVE,ITALY,Recruiting,"University of Campania ""Luigi Vanvitelli""","December 28, 2020",Observational,Impact of COVID-19 Infection on the Course of Pregnancy and Fetal-neonatal Outcomes,COVID
4693,COVID,"February 08, 2021",1200,NCT04699851,TAILORED RECOMMENDATIONS,CANADA,Recruiting,Laval University,"November 18, 2020",Interventional,Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens,COVID
4694,"SARS-CoV2, COVID","February 08, 2021",215,NCT04699903,POC SARS-COV-2 IGG ANTIBODY TEST,UNITED STATES,Not yet recruiting,Rapid Pathogen Screening,"December 28, 2020",Observational,"Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood",COVID
4695,SEDATION COMPLICATION,"February 08, 2021",44,NCT04699916,EEG BASED PROTOCOL FOR DEEP SEDATION,,Not yet recruiting,University of Chile,"January 4, 2021",Interventional,EEG-based Protocol to Guide Deep Sedation Decreases the Days of Mechanical Ventilation in COVID-19 Patients: Randomized Clinical Trial,Unrelated
4696,HYPOXEMIA,"February 08, 2021",23,NCT04699942,CONVENTIONAL (LOW FLOW) OXYGEN DELIVERY VIA NASAL CANNULA,CANADA,Not yet recruiting,Dr. David Maslove,"January 4, 2021",Interventional,Pilot Study to Evaluate the Revoxa™ System in Hypoxic Patients,Unrelated
4697,COVID,"February 08, 2021",660,NCT04700137,CARING CONTACTS PLUS INTRODUCTORY PHONE CALL (CC+),UNITED STATES,Enrolling by invitation,"St. Luke's Health System, Boise, Idaho","January 18, 2021",Interventional,"Investigating the Mental Health Impact of COVID-19 and Comparing the Effectiveness of Two Caring Contact Interventions on Patients, Providers, and Staff of St. Luke's Health System",COVID
4698,COVID,"February 08, 2021",15,NCT04700163,C144-LS AND C-135-LS,UNITED STATES,Recruiting,Rockefeller University,"January 11, 2021",Interventional,"A Phase 1, Open Label, Dose-escalation Study of the Safety and Pharmacokinetics of a Combination of Two Anti-SARS-CoV-2 mAbs (C144-LS and C135-LS) in Healthy Volunteers",COVID
4699,DIABETES MELLITUS,"February 08, 2021",150,NCT04700254,DASS QUESTIONNAIRE,GREECE,Completed,"Chania General Hospital ""St. George""","December 28, 2020",Observational,"The Effect of COVID-19 National Lockdown on People With Diabetes Mellitus Regarding Their Anxiety, Depression and Eating Attitudes, in Relation to Adjusted Work and Family Conditions",Unrelated
4700,COVID,"February 08, 2021",250,NCT04700462,SM-EMA,,Not yet recruiting,Johns Hopkins University,"February 5, 2021",Interventional,Optimizing Tailored-feedback Message to Promote Adherence Behavior to Prevent COVID-19 in African Americans,COVID
4701,COVID,"February 08, 2021",30,NCT04701489,SPLENIC ULTRASOUND,UNITED STATES,Enrolling by invitation,University of Minnesota,January 2021,Interventional,Ultrasound Neural and Immunomodulation Treatment Evaluation Study (UMN-GE) for COVID-19,COVID
4702,COVID,"February 08, 2021",60,NCT04701502,VIUSID,BULGARIA,Recruiting,Catalysis SL,"November 9, 2020",Interventional,Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19,COVID
4703,COVID,"February 08, 2021",500,NCT04701515,CHART REVIEW,UNITED STATES,Recruiting,Methodist Health System,"June 10, 2020",Observational,Cardiovascular Manifestations of COVID-19,COVID
4704,COVID,"February 08, 2021",20,NCT04701528,VOCLOSPORIN,NETHERLANDS,Recruiting,Leiden University Medical Center,"November 15, 2020",Interventional,An Open-Label Study Evaluating Anti-Viral Effects of Voclosporin in SARS-CoV-2 Positive Kidney Transplant Recipients - the VOCOVID Study,COVID
4705,COVID,"February 08, 2021",402,NCT04701606,ARTECOM® (PYRONARIDINE-ARTESUNATE),PHILIPPINES,Not yet recruiting,Shin Poong Pharmaceutical Co. Ltd.,"February 15, 2021",Interventional,"A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 2/3 Clinical Trial to Evaluate the Safety and Efficacy of Pyronaridine-artesunate (Artecom®) in COVID-19 Patients",COVID
4706,COVID,"February 08, 2021",3000,NCT04701658,BAMLANIVIMAB,,Not yet recruiting,Eli Lilly and Company,"January 8, 2021",Interventional,"A Prospective Cohort Study to Evaluate the Real-world Effectiveness of Bamlanivimab in Participants With Mild-to-moderate COVID-19 at High Risk for Progressing to Severe Illness, With Matched Controls",COVID
4707,COVID,"February 08, 2021",300,NCT04701710,IVERMECTIN / IOTA-CARRAGEENAN,ARGENTINA,Completed,Maria de los Angeles Peral de Bruno,"October 15, 2020",Interventional,A Randomized Trial - Intensive Treatment Based in Ivermectin and Iota-carrageenan as Prophylaxis for Covid-19 In Healthcare Agents,COVID
4708,COVID,"February 08, 2021",200,NCT04701892,INDICATORS OF CENTRAL SENSITISATION,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"January 19, 2021",Observational,Central Sensitisation in Post Covid-19 Infection Patients: a Prospective Cohort Study,COVID
4709,COVID PANDEMIC,"February 08, 2021",450,NCT04701905,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 30, 2020",Observational,The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19,COVID
4710,COVID,"February 08, 2021",54,NCT04701944,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 21, 2020",Observational,Clinical Study of Pregnant Women With COVID-19: A Retrospective Review of Medical Records at Strasbourg University Hospitals,COVID
4711,COVID,"February 08, 2021",1600,NCT04701996,SEROLOGICAL SURVEILLANCE,"CONGO, THE DEMOCRATIC REPUBLIC OF THE",Recruiting,"Institute of Tropical Medicine, Belgium","September 23, 2020",Observational,Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo,COVID
4712,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",108,NCT04702178,COVAC-2,CANADA,Recruiting,University of Saskatchewan,January 2021,Interventional,"A Randomized, Observer-Blind, Dose-Escalation Phase 1/2 Clinical Trial of COVAC Vaccines in Healthy Adults",COVID
4713,CONNECTIVE TISSUE DISEASES,"February 08, 2021",250,NCT04702295,,,Not yet recruiting,University of Pisa,February 2021,Observational,COVID Vaccination in Rare and Complex Connective Tissue Diseases: ERN ReCONNET Multicentre Prospective Cohort Study,Unrelated
4714,COVID,"February 08, 2021",200000,NCT04702945,,CANADA,Recruiting,University of British Columbia,"March 1, 2020",Observational [Patient Registry],Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) - Population-based Registry of Suspected and Confirmed COVID-19 Cases,COVID
4715,HEART FAILURE,"February 08, 2021",750,NCT04702958,,UNITED STATES,Enrolling by invitation,Inova Health Care Services,"December 10, 2020",Observational,Mechanistic Insights From Longitudinal Changes in Blood and Urine Proteins to Explain Efficacy and Safety of Torsemide vs Furosemide After a Heart Failure Hospitalization,Unrelated
4716,COVID,"February 08, 2021",64,NCT04703036,GLYCINE,UNITED STATES,Recruiting,Baylor College of Medicine,"January 11, 2021",Interventional,Randomized Trial of Supplementing Glycine and N-acetylcysteine vs. Placebo in COVID-19,COVID
4717,COVID,"February 08, 2021",80,NCT04703114,BLOOD COUNT,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,February 2021,Interventional,Study of the Immunological and Virological Response of Patients Infected With SARS-CoV-2 and Presenting an Asymptomatic or Pauci-symptomatic Form,COVID
4718,COVID,"February 08, 2021",350,NCT04703140,RAPID DIAGNOSTIC TEST VS PCR,,Not yet recruiting,CMC Ambroise Paré,"January 15, 2021",Interventional,Evaluation of the Performance of COVIDISC Rapid Test for Diagnosis of SARS-CoV-2,COVID
4719,COVID,"February 08, 2021",240,NCT04703205,IVERMECTIN 3 MG,JAPAN,Recruiting,Kitasato University,"September 16, 2020",Interventional,"A Placebo-controlled, Randomized, Double-blind Study in COvid-19 Patients With iveRmectin; An inVEstigator iniTiaTEd Trial",COVID
4720,CORONAVIRUS INFECTION,"February 08, 2021",1200,NCT04703270,,UNITED KINGDOM,Recruiting,"St George's, University of London","January 4, 2021",Observational,Understanding COVID-19 Infection in Pregnant Women and Their Babies,COVID
4721,SURGICAL EDUCATION,"February 08, 2021",195,NCT04703400,ANONYMOUS SURVEY,ARGENTINA,Completed,"Clinica Universitaria Reina Fabiola, Universidad Catolica de Cordoba","August 15, 2020",Observational,Analysis of the Impact on Surgical Residency Programs in Times of Pandemic in Argentina: A Cross-sectional Study,Unrelated
4722,COVID,"February 08, 2021",100,NCT04703452,INDICATORS OF CENTRAL SENSITISATION,BELGIUM,Recruiting,Universitair Ziekenhuis Brussel,"January 19, 2021",Observational,Central Sensitisation in Post Covid-19 Infection Patients: a Cross-sectional Study,COVID
4723,COVID,"February 08, 2021",20,NCT04703478,BREATHING EXERCISE,SPAIN,Not yet recruiting,University of Salamanca,"January 20, 2021",Interventional,RespiraConNosotros: Creation and Implementation of a Mobile Application for the Rehabilitation of Patients With Respiratory Sequelae of the SARS-CoV-2 (COVID-19),COVID
4724,COVID,"February 08, 2021",1200,NCT04703608,IVERMECTIN,GAMBIA,Recruiting,London School of Hygiene and Tropical Medicine,January 2021,Interventional,Prevention and Treatment for COVID -19 Associated Severe Pneumonia in The Gambia: a Single-Blinded Randomised Clinical Trial (PaTS-COVID),COVID
4725,COVID,"February 08, 2021",500,NCT04703777,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 4, 2020",Observational,"Retrospective Study on the Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic in Bas-Rhin, France",COVID
4726,COVID,"February 08, 2021",1200,NCT04703790,,,Not yet recruiting,Columbia University,February 2021,Observational,Acceptability Across Two Time Periods of a SARS-CoV-2 Vaccine Among a Representative Sample of Adults Within the United States,COVID
4727,STRESS AND ANXIETY,"February 08, 2021",60,NCT04703907,AURICULAR STIMULATION,GERMANY,Recruiting,University Medicine Greifswald,"December 3, 2020",Interventional,"Auricular Stimulation (AS) vs. ""Waiting List"" for Relief of Stress and Anxiety in Health Care Workers During COVID-19 Pandemic - a Prospective Controlled Investigation",Unrelated
4728,COVID,"February 08, 2021",830,NCT04704388,,FRANCE,Recruiting,Assistance Publique - Hôpitaux de Paris,"June 1, 2020",Observational,Study Project Comparing the Sequelae of SARS-CoV-2 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care,COVID
4729,HEAD AND NECK CANCER,"February 08, 2021",150,NCT04704466,,FRANCE,Recruiting,"Centre Hospitalier Universitaire, Amiens","January 7, 2021",Observational,Observational Study Evaluating the Impact of the Covid-19 Pandemic on the Management of Patients With Head and Neck Cancer in the Maxillofacial Surgery Department,Unrelated
4730,RHEUMATIC DISEASES,"February 08, 2021",320,NCT04704544,TELE-RHEUMATOLOGY,UNITED STATES,Not yet recruiting,University of Alabama at Birmingham,"March 1, 2021",Interventional,Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis,Unrelated
4731,HEALTHY PEOPLE,"February 08, 2021",20,NCT04704570,EXERCISE,TURKEY,Not yet recruiting,Hacettepe University,"January 25, 2021",Interventional,Investigation of The Effects of Remote Exercise Programs and Preventive Training on Muscle Architecture and Functional Level in Asymptomatic Individuals,Unrelated
4732,COVID,"February 08, 2021",5000,NCT04705116,COVID-19 VACCINE,UNITED STATES,Not yet recruiting,Pregistry,"January 15, 2021",Observational [Patient Registry],COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER),COVID
4733,COVID,"February 08, 2021",132,NCT04705597,BGE-175,UNITED STATES,Not yet recruiting,"BioAge Labs, Inc.",February 2021,Interventional,"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of BGE-175 in Hospitalized Patients Over 60 Years of Age With COVID-19",COVID
4734,COVID,"February 08, 2021",20,NCT04705753,CRETAN IAMA,GREECE,Completed,University of Crete,"April 1, 2020",Interventional,"Evaluation of the Clinical Outcomes and the Quality of Life of Patients Exhibiting Symptoms Characteristic of Viral Respiratory Infection (VRI), Including Infection by SARS-CoV-2 (COVID-19), and Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in These Patients and the People Cohabiting With Them Via an Open-label, Single-arm Trial",COVID
4735,SARS-COV INFECTION,"February 08, 2021",2000,NCT04705766,URINE COLLECTION,UNITED STATES,Not yet recruiting,"University of California, San Francisco",January 2021,Observational [Patient Registry],The KIDCOV Study: ASSESSMENT of SARS-CoV-2 Without HOSPITALIZATION as a RISK FACTOR for ACUTE KIDNEY INJURY,Respiratory
4736,POST-VIRAL FATIGUE SYNDROME,"February 08, 2021",40,NCT04705831,RUCONEST,UNITED STATES,Recruiting,IMMUNOe Research Centers,"December 30, 2020",Interventional,"A Randomized, Double Blind, Placebo Controlled, Cross-Over, Proof-of-Concept Study to Evaluate the Benefit of RUCONEST (C1 Esterase Inhibitor [Recombinant]) in Improving Neurological Symptoms in Post-SARS-CoV-2 Infection",Unrelated
4737,MILD TO MODERATE COVID,"February 08, 2021",1444,NCT04705844,ADALIMUMAB,,Not yet recruiting,Ology Bioservices,February 2021,Interventional,"Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Adalimumab (Humira) or Placebo in Patients With Mild-Moderate COVID-19",COVID
4738,COVID,"February 08, 2021",3000,NCT04706039,PERFORMANCE EVALUATION (SENSITIVITY AND SPECIFICITY) FOR COVID-19 DIAGNOSIS OF THE VOCUS PTR-TOF PROCESS,FRANCE,Not yet recruiting,Hospices Civils de Lyon,January 2021,Interventional,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air,COVID
4739,COVID VACCINES,"February 08, 2021",100,NCT04706143,COVID-19 VACCINES,,Not yet recruiting,Assiut University,"January 15, 2021",Observational,"T Cell, Antibody and Cytokine Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians",COVID
4740,ORAL MANIFESTATIONS,"February 08, 2021",1540,NCT04706156,COVID-19 VACCINE,,Not yet recruiting,Masaryk University,"January 27, 2021",Observational,Oral Side Effects of COVID-19 Vaccine: A Multicenter Cross-sectional Study,Unrelated
4741,COVID,"February 08, 2021",600,NCT04706260,,FRANCE,Recruiting,"University Hospital, Strasbourg, France","April 14, 2020",Observational,Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at the University Hospitals of Strasbourg : A Retrospective Observational Study,COVID
4742,PREVENTION OF COVID,"February 08, 2021",20,NCT04706299,RESISTANCE EXERCISE,UNITED STATES,Recruiting,The Cleveland Clinic,"January 12, 2021",Interventional,"Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing",COVID
4743,ACUTE KIDNEY INJURY,"February 08, 2021",100,NCT04706325,ACUTE KIDNEY INJURY,TURKEY,Recruiting,Kocaeli Derince Education and Research Hospital,"January 1, 2021",Observational,INVESTIGATION OF RISK FACTORS RELATED TO COVID-19 RELATED KIDNEY DAMAGE: A PROSPECTIVE OBSERVATIONAL STUDY,Unrelated
4744,COVID,"February 08, 2021",2500,NCT04706390,COVID-19 VACCINE,NORWAY,Recruiting,University of Bergen,"January 12, 2021",Observational,Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination,COVID
4745,COVID,"February 08, 2021",3000,NCT04706403,HEALTHCARE PROVIDERS' COMMUNICATION ABOUT THE COVID-19 VACCINE,,Not yet recruiting,"University of Massachusetts, Worcester",January 2021,Interventional,"If We Build It, Will They Come? A Pilot Study to Develop and Test Messages to Maximize Uptake of Coronavirus Vaccine When Available",COVID
4746,CORONAVIRUS,"February 08, 2021",50,NCT04706416,N-ACETYL GLUCOSAMINE (NAG),UNITED STATES,"Active, not recruiting",Quantinosis.ai LLC,"November 14, 2020",Interventional,N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19),COVID
4747,COVID,"February 08, 2021",2000,NCT04706533,BIOMARKERS OF INFLAMMATION,UNITED STATES,Recruiting,University of Michigan,"March 23, 2020",Observational,"Prospective Observational Study Examining Clinical Characteristics, Inflammatory Markers, Treatments and Outcomes of Patients Hospitalized for COVID-19 at the University of Michigan Healthcare System in Ann Arbor",COVID
4748,APPENDICITIS ACUTE,"February 08, 2021",200,NCT04707339,APPENDICECTOMY,UNITED KINGDOM,Recruiting,Princess Alexandra Hospital NHS Trust,"January 30, 2020",Observational,Management of Acute Appendicitis at District General Hospital,Unrelated
4749,COVID,"February 08, 2021",300,NCT04707534,DEXAMETHASONE,UNITED STATES,Recruiting,University of Oklahoma,"January 21, 2021",Interventional,Effects of Higher Dose and Lower Dose of Dexamethasone for Hospitalized Patients With COVID-19,COVID
4750,COVID,"February 08, 2021",400,NCT04707664,SARGRAMOSTIM,,Not yet recruiting,"Partner Therapeutics, Inc.",February 2021,Interventional,A Randomized Phase 2b Trial Evaluating Clinical Outcomes of Inhaled Sargramostim in High-risk Patients With Mild-moderate COVID-19,COVID
4751,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",162,NCT04707703,ISAVUCONAZONIUM INJECTION [CRESEMBA],UNITED STATES,Not yet recruiting,"Jeffrey Jenks, MD, MPH",January 2021,Interventional,Isavuconazole for the Prevention of SARS-CoV-2-associated Invasive Aspergillosis in Critically-Ill Patients,COVID
4752,COVID,"February 08, 2021",84,NCT04707742,BETADINE© BUCAL 100 MG/ML,SPAIN,Completed,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,"June 15, 2020",Interventional,Clinical Evaluation of Antiseptic Mouth Rinses to Reduce Salivary Viral Load of SARS-CoV-2 in COVID-19 Patients,COVID
4753,CORONAVIRUS INFECTION,"February 08, 2021",80,NCT04707820,ELISPOT,FRANCE,Recruiting,"University Hospital, Rouen","April 16, 2020",Interventional,Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection,COVID
4754,CORONAVIRUS INFECTION,"February 08, 2021",385,NCT04707833,SEROLOGICAL TESTING FOR COVID-19 INFECTION,FRANCE,Recruiting,"University Hospital, Rouen","November 26, 2020",Interventional,Protocol for the Collection of Clinical Samples for Evaluation and Implementation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen,COVID
4755,COVID,"February 08, 2021",385,NCT04708158,NOVAFERON,,Not yet recruiting,Genova Inc.,January 2021,Interventional,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon vs. Placebo in Hospitalized Adult Patients With ModerateCOVID-19",COVID
4756,COVID,"February 08, 2021",18,NCT04708236,ORTD-1 LOW DOSE,UNITED STATES,Recruiting,"Oryn Therapeutics, LLC",January 2021,Interventional,"A Blinded, Controlled, Escalating Dose Study of ORTD-1 for Treatment of Hospitalized Patients With SARS-CoV-2 (COVID-19) Related Pneumonia.",COVID
4757,COVID,"February 08, 2021",75,NCT04708327,NALTREXONE HYDROCHLORIDE,,Not yet recruiting,"Cytocom, Inc.",April 2021,Interventional,"A Randomized, Placebo-controlled, Phase 2 Study to Evaluate Safety and Efficacy of CYTO-205 (Low-dose Naltrexone) in Adult Patients With Mild COVID-19 Infection Who Are at High Risk for Disease Progression",COVID
4758,COVID,"February 08, 2021",237,NCT04708340,REJUVEINIX (RJX) ACTIVE COMPARATOR,,Not yet recruiting,"Reven Pharmaceuticals, Inc.","February 1, 2021",Interventional,"A Two-part, Two-cohort, Double-blind, Randomized, Placebo-controlled, Multicenter Phase 1/2 Study to Evaluate the Safety, Tolerability and Efficacy of REJUVEINIX (RJX) in Patients With COVID-19",COVID
4759,MECHANICAL VENTILATION COMPLICATION,"February 08, 2021",12,NCT04708457,VV-ECMO,AUSTRALIA,Not yet recruiting,Australian and New Zealand Intensive Care Research Centre,"February 1, 2021",Interventional,"A Pilot Feasibility RCT of Early ECMO to DE-sedate, Extubate, and Mobilise in Severe Acute Respiratory Infection",Unrelated
4760,AIRWAY EXTUBATION,"February 08, 2021",72,NCT04708509,EXTUBATION ADVISOR,CANADA,Not yet recruiting,Ottawa Hospital Research Institute,March 2021,Interventional,Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool,Unrelated
4761,COVID,"February 08, 2021",100,NCT04708912,OBSERVATION,TURKEY,Recruiting,Basaksehir Cam & Sakura Şehir Hospital,"December 15, 2020",Observational,TUSEB-Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19),COVID
4762,COVID,"February 08, 2021",4504,NCT04709003,SEROLOGIC TEST,ISRAEL,Recruiting,Clalit Health Services,"December 23, 2020",Observational,Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI): A Prospective Cohort Study,COVID
4763,COVID,"February 08, 2021",2050,NCT04709068,CURRENT HEALTH,,Not yet recruiting,Current Health,"January 20, 2021",Observational,Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization,COVID
4764,COVID,"February 08, 2021",2500,NCT04709120,,RUSSIAN FEDERATION,Recruiting,Eurasian Association of Therapists,"January 11, 2021",Observational [Patient Registry],Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection,COVID
4765,COVID,"February 08, 2021",70,NCT04709146,AUDIO-VESTIBULAR EVALUATION,,Not yet recruiting,"HaEmek Medical Center, Israel","March 1, 2021",Interventional,The Influence of Covid-19 on the Audio-vestibular System,COVID
4766,COVID PNEUMONIA,"February 08, 2021",30,NCT04709172,CEFDITOREN PIVOXIL 400MG,SPAIN,Recruiting,Meiji Pharma Spain S.A.,"January 5, 2021",Interventional,"Prospective, Non-controlled Pilot Study to Evaluate the Efficacy and Safety of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia",COVID
4767,HEART FAILURE,"February 08, 2021",20000,NCT04709263,,RUSSIAN FEDERATION,Recruiting,AstraZeneca,"December 23, 2020",Observational,Heart Failure Patients Registry A Prospective Observational Multicenter Registry of Patients With Chronic Heart Failure in the Population of the Russian Federation (PRIORITY-HF),Unrelated
4768,COVID,"February 08, 2021",342,NCT04709302,COVID-19,NIGERIA,Recruiting,Medical University of Graz,February 2021,Observational [Patient Registry],"COVID-19 and Its Effects on Endothelium in HIV-Positive Patients in Sub-Saharan Africa: Cardiometabolic Risk, Thrombosis and Vascular Function",COVID
4769,COVID,"February 08, 2021",690,NCT04709328,SCTA01,,Not yet recruiting,Sinocelltech Ltd.,"March 1, 2021",Interventional,"An Adaptive, Randomized, Double-blinded, Placebo-controlled Phase II/III Trial of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in High-Risk Outpatients With COVID-19 (MAOP3 Trial)",COVID
4770,COVID,"February 08, 2021",38,NCT04709744,VITAMIN D,EGYPT,Completed,Mansoura University,"April 1, 2020",Observational,Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic,COVID
4771,COVID,"February 08, 2021",220,NCT04709835,AT-527,BULGARIA,Not yet recruiting,Hoffmann-La Roche,"January 15, 2021",Interventional,"A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Otherwise Healthy Non-Hospitalized Adult Patients With Mild or Moderate COVID-19",COVID
4772,VIRUS DISEASES,"February 08, 2021",40,NCT04710199,MARAVIROC EXPERIMENTAL GROUP,SPAIN,Not yet recruiting,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,February 2021,Interventional,Proof-of-concept Trial to Evaluate the Safety and Efficacy of Maraviroc in Severe Acute Respiratory Syndrome (SARS) Coronavirus-2 (CoV-2) Infected Patients Hospitalized for COVID-19,Unrelated
4773,COVID,"February 08, 2021",35,NCT04710303,HAD5-S-FUSION+N-ETSD VACCINE,,Not yet recruiting,"ImmunityBio, Inc.",February 2021,Interventional,"Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of a City of a Prophylactiv COVID-19 Vaccination Using a 2nd Generation (E1/E2b/E3-Deleted) Adenoviral Platform in Healthy South African Adults (ProVIVA-SA-1)",COVID
4774,COVID,"February 08, 2021",450,NCT04710316,SARS-COV-2 SCREENING BY MOLECULAR BIOLOGY,MALI,Not yet recruiting,"Institut National de la Santé Et de la Recherche Médicale, France","January 30, 2021",Interventional,"Étude de l'épidémie de SARS-CoV-2 Dans Les Services Hospitaliers de Bamako, Mali",COVID
4775,"RESPIRATORY DISTRESS SYNDROME, ADULT","February 08, 2021",78,NCT04710329,ASCORBIC ACID,TURKEY,"Active, not recruiting",Sisli Hamidiye Etfal Training and Research Hospital,"January 16, 2021",Observational,"High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients, A Retrospective Cohort Study",Respiratory
4776,COVID,"February 08, 2021",100,NCT04710381,IMUNOR,CZECHIA,Not yet recruiting,University Hospital Ostrava,"February 1, 2021",Interventional,"Pilot, Monocentre, Phase-IV Clnical Trial Assessing the Clinical Effect of Per Oral Immunomodulation Treatment Using the IMUNOR® Preparation in the Prevention of COVID-19 Disease",COVID
4777,ANOSMIA,"February 08, 2021",240,NCT04710394,SMELL TRAINING,UNITED STATES,Recruiting,Washington University School of Medicine,"January 11, 2021",Interventional,Efficacy of Bimodal Visual-Olfactory Training in Participants With COVID-19 Resultant Hyposmia or Anosmia Using Participant-Preferred Scents,Unrelated
4778,COVID,"February 08, 2021",30,NCT04710771,PRONE LYING POSITION,PAKISTAN,Recruiting,Sialkott College of Physical Therapy,"November 23, 2020",Observational,Effect of Prone Positioning and Alternate Nostril Breathing Technique in Patients With COVID-19: A Prospective Cohort Study.,COVID
4779,COVID,"February 08, 2021",500,NCT04710836,,UNITED KINGDOM,Recruiting,Nottingham University Hospitals NHS Trust,"December 3, 2020",Observational,The Nottingham Recovery From COVID-19 Research Platform Assessment Clinic,COVID
4780,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",400,NCT04711863,FLUVOXAMINE,"KOREA, REPUBLIC OF",Recruiting,Asan Medical Center,"January 16, 2021",Interventional,"Fluvoxamine for Adults With Mild to Moderate COVID-19: A Single-blind, Randomized, Placebo-controlled Trial",COVID
4781,HIV,"February 08, 2021",2000,NCT04711954,,NETHERLANDS,Recruiting,Erasmus Medical Center,"November 1, 2020",Observational [Patient Registry],COVID-19 in People Living With HIV in Light of the 90-90-90 Goals: A Netherlands/Ukraine Research Collaboration.,Unrelated
4782,COVID,"February 08, 2021",67,NCT04712045,NEW PPE,UNITED KINGDOM,Completed,University of Oxford,"August 1, 2020",Interventional,Rational Use of Personal Protective Equipment: a Randomised Trial and Quality Improvement Intervention During COVID-19 Pandemic,COVID
4783,PREVENTION OF INFECTION DISEASE CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV2),"February 08, 2021",200,NCT04712110,TAK-019,JAPAN,Not yet recruiting,Takeda,"February 20, 2021",Interventional,"A Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of TAK-019 by Intramuscular Injection in Healthy Japanese Male and Female Adults Aged 20 Years and Older (COVID-19)",COVID
4784,COVID,"February 08, 2021",250,NCT04712175,NASOPHARYNGEAL SAMPLING,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Nīmes,January 2021,Observational,Validation Diagnostique de la détection Rapide du Virus SARS-CoV-2 Dans Des échantillons Salivaires Par spectrométrie de Masse,COVID
4785,COVID,"February 08, 2021",294,NCT04712279,IVERMECTIN 0.6MG/KG/DAY,,Not yet recruiting,Corpometria Institute,"January 25, 2021",Interventional,High-Dose Ivermectin for Mild-to-Moderate COVID-19 - The (HD)IVACOV Trial,COVID
4786,COLORECTAL NEOPLASMS MALIGNANT,"February 08, 2021",2000,NCT04712292,SURGICAL PROCEDURE FOR CANCER,ITALY,Recruiting,Matteo Rottoli,"September 8, 2020",Observational,"Impact of the Healthcare Lockdown Due to COVID-19 Pandemic on the Diagnosis, Treatment and Outcomes of Patients Affected by Colorectal Cancer Requiring Surgery: Results From a Retrospective Multicentric Study in Northern Italy",Unrelated
4787,SEVERE COVID,"February 08, 2021",58,NCT04712344,COVID-19 CONVALESCENT PLASMA,GERMANY,Recruiting,University of Erlangen-Nürnberg Medical School,"January 18, 2021",Interventional,Randomized Controlled Phase 2b Clinical Study in Parallel Groups for the Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma Plus Standard Treatment vs. Standard Treatment Alone of Subjects With Severe COVID-19,COVID
4788,COVID,"February 08, 2021",219,NCT04712357,VITAMIN C 500 MG ORAL TABLET,BRAZIL,Recruiting,Universidade Federal do Ceara,"November 9, 2020",Interventional,"Clinical, Control, Double-blind, Randomized Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19",COVID
4789,HEALTHY,"February 08, 2021",3500,NCT04712448,ANTI-COVID TEST,ITALY,"Active, not recruiting",IRCCS San Raffaele,"December 30, 2020",Observational,Serum Prevalence of Antibodies Anti-SARS-2Cov in Healthy Subjects and in Patients With Chronic Diseases in Pre-pandemic Blood Samples,Unrelated
4790,COVID,"February 08, 2021",383,NCT04713111,LIFESTYLE (MEDITATION),UNITED STATES,Completed,4YouandMe,"May 4, 2020",Interventional,Stress and Recovery in Frontline Healthcare COVID-19 Workers: A Feasibility Study Using Wearable and Smartphone Devices,COVID
4791,CHILD DEVELOPMENT,"February 08, 2021",75,NCT04713150,NO INTERVENTION,UNITED STATES,Recruiting,Boston Children's Hospital,"October 5, 2020",Observational,HEALthy Brain and Child Development Study - COVID-19 Supplement,Unrelated
4792,COVID,"February 08, 2021",200,NCT04713163,COVID19 VACCINE,,Not yet recruiting,University of Manitoba,January 2021,Observational [Patient Registry],Prospective Evaluation of COVID-19 Vaccine Induced Immunity,COVID
4793,SEVERE COVID,"February 08, 2021",1120,NCT04713176,DWJ1248 WITH REMDESIVIR,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,"January 18, 2021",Interventional,"A Double-blind, Randomized, Placebo-controlled, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of DW1248 With Remdesivir in Severe COVID-19 Patients",COVID
4794,COVID PREVENTION,"February 08, 2021",110,NCT04713488,SPUTNIK LIGHT,RUSSIAN FEDERATION,"Active, not recruiting","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","January 15, 2021",Interventional,"An Open Study on the Safety, Tolerability, and Immunogenicity of ""Sputnik Light"" t Vaccine for Prevention of Coronavirus Infection Caused by the SARS-CoV-2 Viruso",COVID
4795,COVID,"February 08, 2021",58,NCT04713540,,TURKEY,Recruiting,Bakirkoy Dr. Sadi Konuk Research and Training Hospital,"January 1, 2021",Observational,The Intensive Care Rehabilitation Experiences of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients of Pandemic Hospital in Turkey,COVID
4796,SARS-CoV2 INFECTION,"February 08, 2021",1280,NCT04713553,BNT162B2,,Not yet recruiting,BioNTech SE,"January 28, 2021",Interventional,"A PHASE 3, RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE LOT CONSISTENCY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF THE VACCINE CANDIDATE BNT162b2 AGAINST COVID-19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE",COVID
4797,IMMUNE HEALTH,"February 08, 2021",140,NCT04713735,CONTROL: PLACEBO,UNITED STATES,Recruiting,Mead Johnson Nutrition,"December 28, 2020",Interventional,"A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Impact of Lactoferrin Dietary Supplementation on Respiratory Tract Infections in an Elderly Population",Unrelated
4798,C3PI STUDY TESTING GROUP,"February 08, 2021",100,NCT04713748,TASSO-SST ON DEMAND,UNITED STATES,Not yet recruiting,Duke University,January 2021,Interventional,Pilot Study to Compare Serology Results From Blood Collected Using Tasso-SST OnDemand Device Compared to Venipuncture,Unrelated
4799,COVID,"February 08, 2021",116,NCT04713852,,BELGIUM,Completed,Jessa Hospital,"March 13, 2020",Observational,Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients: a Longitudinal Single-center Study,COVID
4800,CORONAVIRUS DISEASE 2019 (COVID) PNEUMONIA,"February 08, 2021",21,NCT04713878,MESENCHYMAL STEM CELLS,TURKEY,Completed,Kanuni Sultan Suleyman Training and Research Hospital,"May 8, 2020",Interventional,A 8-Week Trial of Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,COVID
4801,GAMBLING,"February 08, 2021",180000,NCT04714008,,FRANCE,Recruiting,Nantes University Hospital,"December 1, 2020",Observational,Impact of the COVID-19 Pandemic on Online Gambling in France and Sweden,Unrelated
4802,COVID,"February 08, 2021",250,NCT04714125,,BRAZIL,Recruiting,University of Sao Paulo General Hospital,"June 19, 2020",Observational,Prognostic Value of Flow-mediated Dilation in Hospitalized Patients With SARS-CoV-2 Infection: an Observational Prospective Study,COVID
4803,COVID,"February 08, 2021",190,NCT04714138,,FRANCE,Recruiting,Groupe Hospitalier du Havre,"January 5, 2021",Observational,Remote Evaluation of Quality of Life and Functional Capacities in Patients Hospitalised for COVID-19: a Prospective Observational Study,COVID
4804,MAJOR DEPRESSIVE DISORDER,"February 08, 2021",20,NCT04714164,GROUP COGNITIVE BEHAVIORAL THERAPY,,Not yet recruiting,Nova Scotia Health Authority,February 2021,Interventional,Feasibility of Delivering Group Cognitive Behavioral Therapy for Older Adults With Depression and Anxiety by Telehealth,Unrelated
4805,SPINOCEREBELLAR ATAXIA TYPE 3,"February 08, 2021",144,NCT04714307,SCA3/MJD MOLECULAR DIAGNOSIS,BRAZIL,Recruiting,Hospital de Clinicas de Porto Alegre,"December 13, 2019",Observational,Neuropsychiatry and Cognition in the Context of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease (SCA3/MJD),Unrelated
4806,COVID,"February 08, 2021",1000,NCT04714333,,CANADA,Enrolling by invitation,British Columbia Cancer Agency,"May 6, 2020",Observational,Detection of COVID-19 by Volatile Organic Compounds in Exhaled Breath (VOCs) - a Pilot Study,COVID
4807,COVID,"February 08, 2021",150,NCT04714515,MONTELUKAST,CHINA,Completed,University of Sargodha,"February 20, 2020",Observational,Using Montelukast to Treat the Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),COVID
4808,AUTISM SPECTRUM DISORDER,"February 08, 2021",25,NCT04714606,SIBLING SUPPORT GROUP,UNITED KINGDOM,Recruiting,University of Surrey,"December 14, 2020",Interventional,Supporting Those Who Have A Relative Experiencing Autism Spectrum Disorders (SHARE-ASD): Feasibility RCT of an 8-session Group Intervention for Siblings of Children Who Have ASD,Unrelated
4809,OBESITY,"February 08, 2021",248,NCT04714892,,UNITED STATES,Not yet recruiting,National Institute on Alcohol Abuse and Alcoholism (NIAAA),"February 11, 2021",Observational,Mechanisms Underlying Individual Variations of Taste and Smell in Obesity,Unrelated
4810,ACUTE RESPIRATORY DISTRESS SYNDROME CAUSED BY COVID,"February 08, 2021",360,NCT04715243,HIGH FLOW NASAL CANNULA (HFNC),OMAN,Recruiting,Sultan Qaboos University,January 2021,Interventional,"Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients",COVID
4811,COVID,"February 08, 2021",200,NCT04715295,DOXYCYCLINE TABLETS,CAMEROON,Recruiting,Yaounde Central Hospital,"October 5, 2020",Interventional,"Open-label, Randomized Trial of the Safety and Efficacy of Doxycycline and Rivaroxaban Therapy Versus National Standard Therapy in Ambulatory Patients With Mild Symptomatic COVID-19",COVID
4812,COVID,"February 08, 2021",30,NCT04715360,AUTOLOGOUS ACTIVATED PLATELET-RICH PLASMA,INDONESIA,Recruiting,Hayandra Peduli Foundation,"December 29, 2020",Interventional,Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy,COVID
4813,CANCER,"February 08, 2021",873,NCT04715438,,NETHERLANDS,Recruiting,University Medical Center Groningen,"January 8, 2021",Observational,Vaccination Against cOvid In CancEr,Unrelated
4814,ANXIETY,"February 08, 2021",100,NCT04715477,HOSPITAL ANXIETY DEPRESSION MEASURE,TURKEY,Recruiting,Derince Training and Research Hospital,"January 17, 2021",Observational,Intensive Care Anxiety in SARS-CoV-2 (COVID 19) Patients,Unrelated
4815,SARS-COV INFECTION,"February 08, 2021",22000,NCT04715607,SEQUENCE OF TESTING.,DENMARK,Recruiting,"Rigshospitalet, Denmark","January 22, 2021",Interventional,"Comparison of Detection Rate of SARS-CoV-2 in Saliva, Oropharyngeal and Nasopharyngeal Specimens in a Public COVID-19 Test Setting",Respiratory
4816,COVID,"February 08, 2021",40,NCT04715763,TELMISARTAN ORAL PRODUCT,,Not yet recruiting,University of Hawaii,"February 1, 2021",Interventional,"Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Treatment of COVID-19 in Hospitalized Patients",COVID
4817,CHRONIC PAIN,"February 08, 2021",30,NCT04715815,NO INTERVENTION (ONLY INTERVIEW),,Not yet recruiting,Prince of Songkla University,February 2021,Observational,Effects of COVID-19 on Chronic Pain Patients in Terms of Pain and Pain Management,Unrelated
4818,HYPOXEMIC RESPIRATORY FAILURE,"February 08, 2021",15,NCT04715854,MASK,BELGIUM,Not yet recruiting,"Laboratory of Movement, Condorcet, Tournai, Belgium","January 15, 2021",Interventional,Comparison of the Addition of an Aerosol Mask Above Nasal Canula on Oxygenation in Hypoxemic Failure,Respiratory
4819,ANXIETY DISORDERS,"February 08, 2021",500,NCT04715906,UP-CAREGIVER,UNITED STATES,Not yet recruiting,University of Miami,"February 1, 2021",Interventional,Coping Options for Parent Empowerment,Unrelated
4820,COVID,"February 08, 2021",80,NCT04715919,CHEST COMPUTED TOMOGRAPHY,TURKEY,Recruiting,Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital,"January 15, 2021",Observational,"Long Term Outcomes in Patients With Coronavirus Disease-19 (COVID-19) on Pulmonary Functions, Exercise Capacity, Lung Structure and Quality of Life",COVID
4821,COVID,"February 08, 2021",216,NCT04715932,HESPERIDIN,,Not yet recruiting,Montreal Heart Institute,"January 21, 2021",Interventional,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study of Hesperidin Therapy on COVID-19 Symptoms: The Hesperidin Coronavirus Study (Hesperidin)",COVID
4822,SARS-CoV2,"February 08, 2021",170,NCT04715997,GX-19N,"KOREA, REPUBLIC OF",Recruiting,"Genexine, Inc.","December 30, 2020",Interventional,"A Phase 1/2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Subjects",COVID
4823,COPD,"February 08, 2021",42,NCT04716023,,UNITED KINGDOM,Recruiting,Imperial College London,"August 23, 2019",Observational,Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19,Unrelated
4824,SARS-CoV2 RAPID ANTIGEN TEST,"February 08, 2021",36,NCT04716088,RAPID ANTIGEN TEST FOR SARS COV2,SLOVENIA,Completed,The University Clinic of Pulmonary and Allergic Diseases Golnik,"November 18, 2020",Observational,Usefulness of Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19 in the Hospital: a Pilot Study,COVID
4825,COVID,"February 08, 2021",88,NCT04716179,SPERM TEST,RUSSIAN FEDERATION,Recruiting,I.M. Sechenov First Moscow State Medical University,"January 18, 2021",Interventional,Prospective Two-arm Study of Fertility in Men With COVID-19,COVID
4826,COVID,"February 08, 2021",100,NCT04716426,TETRACYCLINE HYDROCHLORIDE 3%,BRAZIL,Recruiting,University of Nove de Julho,"January 28, 2021",Interventional,Use of APT™ T3X to Decrease the COVID-19 Contamination Rate in Humans,COVID
4827,COVID,"February 08, 2021",200,NCT04716465,DYSAUTONOMIA,BELGIUM,Recruiting,Moens Maarten,"January 19, 2021",Observational,Dysautonomia in Patients Post COVID-19 Infection,COVID
4828,INFLUENZA -LIKE ILLNESS,"February 08, 2021",5400,NCT04716543,ILI AND COVID-19 DETECTION,,Not yet recruiting,French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS),March 2021,Observational,One-health Approach in Epidemiological Investigation of SARS-CoV-2 in Laos,Respiratory
4829,COVID,"February 08, 2021",474,NCT04716556,CONVALESCENT PLASMA,ITALY,"Active, not recruiting",Istituto Superiore di Sanità,"July 16, 2020",Interventional,TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa Due to SARS-CoV2 (TSUNAMI Study): a Multicenter Open Label Randomized Control Trial,COVID
4830,COVID,"February 08, 2021",150,NCT04716569,INTRANASAL IVERMECTIN SPRAY,EGYPT,Recruiting,South Valley University,"January 20, 2021",Interventional,"Faculty of Medicine ,South Valley University",COVID
4831,COVID,"February 08, 2021",28,NCT04716647,AYURVEDA,UNITED KINGDOM,Completed,Aarogyam UK,"October 9, 2020",Interventional,A Community-Based Participatory Research to Assess the Feasibility of Ayurveda Intervention in Patients With Mild-to-Moderate COVID-19,COVID
4832,COVID,"February 08, 2021",36,NCT04716907,SINGLE-NUCLEOTIDE POLYMORPHISMS (SNP) WITHIN THE TCRA/D REGION,FRANCE,Not yet recruiting,CMC Ambroise Paré,"February 1, 2021",Observational,Thymic Function in Patients With COVID-19,COVID
4833,COVID,"February 08, 2021",200,NCT04716972,SURVEY,,Not yet recruiting,The Royal Wolverhampton Hospitals NHS Trust,"April 1, 2021",Observational,Evaluating the Impact of COVID-19 on Research in Care Homes,COVID
4834,SARS-CoV2,"February 08, 2021",450,NCT04716985,MOLECULAR HYDROGEN,FRANCE,Recruiting,AGIR à Dom,"January 22, 2021",Interventional,"Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care. Double-blind, Randomized, Comparative Study",COVID
4835,COVID,"February 08, 2021",35,NCT04716998,MESENCURE,ISRAEL,Recruiting,BonusBio Group Ltd,January 2021,Interventional,A Controlled Study to Evaluate the Safety and Efficacy of Allogeneic MesenCure for the Treatment of Pulmonary Manifestations in Patients With COVID19,COVID
4836,SARS-CoV2,"February 08, 2021",100,NCT04717011,PCR TEST,SPAIN,Recruiting,Igenomix,January 2021,Observational,Case Series Biomedical Study to Detect the Presence of SARS-CoV-2 in Semen of Patients Diagnosed With COVID-19 Disease,COVID
4837,COVID,"February 08, 2021",100,NCT04717024,OBSERVATIONAL STUDY - NO INTERVENTION,UNITED STATES,Recruiting,Nanowear Inc.,"September 15, 2020",Observational,The Nanowear Wearable Covid-19 Observational and Analysis Trend,COVID
4838,OVERNIGHT INTENSIVE RECOVERY,"February 08, 2021",300,NCT04717089,OVERNIGHT INTENSIVE RECOVERY / EXTENDED RECOVERY,HONG KONG,Recruiting,Tuen Mun Hospital,"February 10, 2020",Observational,The Rapid Conversion of Ordinary Recovery Beds to an Overnight Intensive Recovery (OIR) to Alleviate the High Pressure on Postoperative Intensive Care Demands During COVID-19 Pandemics in a Local Tertiary Hospital: a Multi-perspective Value-based Analysis,Unrelated
4839,COVID,"February 08, 2021",420,NCT04718220,ANTIBODY TESTING FOR SARS-COV-2 IGG,,Not yet recruiting,Washington University School of Medicine,February 2021,Interventional,"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19",COVID
4840,COVID,"February 08, 2021",380,NCT04718285,MONTELUKAST ORAL TABLET,TURKEY,Not yet recruiting,Bahçeşehir University,"January 30, 2021",Interventional,"A National, Multi-Center, Open-Label, Three-Arm, Phase II Study to Investigate the Effect of Montelukast Between Emergency Room Visits and Hospitalizations in COVID-19 Pneumonia in Comparison With Standard Treatment",COVID
4841,COVID,"February 08, 2021",4000,NCT04718467,RECOMBINANT COVID-19 VACCINE (SF9 CELLS),CHINA,Not yet recruiting,Jiangsu Province Centers for Disease Control and Prevention,"February 1, 2021",Interventional,"A Single-center, Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅱb Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells), in the Subjects From Healthy Aged 18 to 85 Years Old",COVID
4842,COVID,"February 08, 2021",100,NCT04718480,PLACEBO,HUNGARY,Recruiting,SigmaDrugs Research Ltd.,"November 27, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled, Adaptive-design Study to Assess the Safety and Efficacy of Daily 200 mg Fluvoxamine as add-on Therapy to Standard of Care in Moderate Severity COVID-19 Patients",COVID
4843,COVID,"February 08, 2021",56,NCT04718506,EXERCISE,SPAIN,Recruiting,Universidad de Murcia,"January 12, 2021",Interventional,"Rehabilitation for Post-COVID-19 Syndrome Through a Multicomponent, Educational and Supervised Exercise Intervention [RECOVE]",COVID
4844,CORONAVIRUS,"February 08, 2021",1288,NCT04718519,FACTORS PROMOTING RESILIENCE,SINGAPORE,Completed,Yale-NUS College,"June 22, 2020",Observational,Individual and Institutional Resilience in Migrant Workers During the COVID-19 Pandemic,COVID
4845,YOGA,"February 08, 2021",30,NCT04719039,RESTORATIVE YOGA INTERNVENTION,HONG KONG,Not yet recruiting,Chinese University of Hong Kong,February 2021,Interventional,The Effect of Restorative Yoga Self-Practice on Sleep Disturbance: A Pilot Randomized Controlled Trial,Unrelated
4846,COVID,"February 08, 2021",1000,NCT04719182,ADJUNCTIVE THERAPIES,NETHERLANDS,"Active, not recruiting",Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"September 1, 2020",Observational,Practice of Adjunctive Treatments in Intensive Care Unit Patients With Coronavirus Disease 2019 (PRoAcT-COVID) - an Observational Study in the Netherlands,COVID
4847,COVID,"February 08, 2021",60,NCT04719208,WATER (E) MOUTH RINSE WITH THE SOLUTION PROVIDED,UNITED STATES,Recruiting,Augusta University,"October 6, 2020",Interventional,Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse,COVID
4848,LUNG ULTRASOUND,"February 08, 2021",60,NCT04719234,LUNG ULTRASONOGRAPHY,TURKEY,Completed,Bursa Yüksek İhtisas Education and Research Hospital,"June 15, 2020",Interventional,Comparison of Lung Ultrasonography Findings With Chest Computerized Tomography Results in Corona virüs (COVID-19) Pneumonia,Unrelated
4849,PARKINSON DISEASE,"February 08, 2021",160,NCT04719468,DANCE WITH BALLET ELEMENTS,UNITED KINGDOM,Not yet recruiting,King's College Hospital NHS Trust,"February 1, 2021",Interventional,Efficacy of Ballet Dancing on Motor and Non-motor Symptoms of Parkinson's Disease: a Hybrid Type 2 Effectiveness-implementation Trial,Unrelated
4850,PARKINSON DISEASE,"February 08, 2021",150,NCT04720118,NO INTERVENTION,UNITED STATES,Recruiting,Towson University,February 2021,Observational [Patient Registry],Does Locus of Control Affect Satisfaction and Quality of Life During COVID - 19?,Unrelated
4851,COVID,"February 08, 2021",500,NCT04720235,LUCIRA COVID-19 ALL-IN-ONE TEST KIT,UNITED STATES,Recruiting,Lucira Health Inc,"December 9, 2020",Interventional,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit As Compared To The Hologic Panther Fusion SARS-CoV-2 RT-PCR Assay Among Asymptomatic Subjects,COVID
4852,CYTOKINE RELEASE SYNDROME,"February 08, 2021",12,NCT04720378,ST266,,Not yet recruiting,"Noveome Biotherapeutics, formerly Stemnion",February 2021,Interventional,"A Phase 1, Multi-Center, Open-Label, Safety and Tolerability Study of Intravenous Administration of ST266 in Subjects With Confirmed COVID-19 Infection",Unrelated
4853,MINDFULNESS,"February 08, 2021",220,NCT04720404,MINDFULNESS-BASED STRESS REDUCTION,NETHERLANDS,Recruiting,Radboud University,"June 23, 2020",Interventional,Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP),Unrelated
4854,COVID,"February 08, 2021",200,NCT04720612,OMALIZUMAB,CANADA,Not yet recruiting,McGill University Health Centre/Research Institute of the McGill University Health Centre,February 2021,Interventional,COVID-19 Immunologic Antiviral Therapy With Omalizumab - An Adaptive Phase II Randomized-Controlled Clinical Trial,COVID
4855,COVID,"February 08, 2021",101,NCT04720794,LUCIRA COVID-19 ALL-IN-ONE TEST KIT,UNITED STATES,Completed,Lucira Health Inc,"September 25, 2020",Interventional,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit As Compared To The Hologic Panther Fusion SARS-CoV-2 RT-PCR Assay,COVID
4856,COVID,"February 08, 2021",300,NCT04721236,HYPERIMMUNE PLASMA,ITALY,Recruiting,Catherine Klersy,"November 19, 2020",Interventional,COVID-19 Wave II Study for Assessing the Early Use of Hyperimmune Plasma for the Treatment of COVID-19 Patients Needing Non-invasive or Invasive Mechanical Ventilation,COVID
4857,LUNG CANCER,"February 08, 2021",1500,NCT04721444,MACHINE LEARNING CLASSIFICATION OF PARENCHYMAL LUNG CHANGE CAUSE,UNITED KINGDOM,Recruiting,Royal Marsden NHS Foundation Trust,"March 1, 2021",Observational,Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence,Unrelated
4858,SARS-CoV2,"February 08, 2021",120,NCT04721457,DISTILLED WATER,SAUDI ARABIA,Recruiting,King Abdulaziz University,"January 3, 2021",Interventional,The Efficacy of Pre-procedural Mouth Rinses on SARS-CoV-2 Saliva Viral Load: A Randomized Control Clinical Trial,COVID
4859,COVID,"February 08, 2021",1012,NCT04721535,DWJ1248,,Not yet recruiting,Daewoong Pharmaceutical Co. LTD.,January 2021,Interventional,A Randomized Double-blinded Controlled Clinical Trial of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2,COVID
4860,CHILD MENTAL DISORDER,"February 08, 2021",864,NCT04721730,PLH-YC,"MOLDOVA, REPUBLIC OF",Recruiting,University of Bremen,"December 7, 2020",Interventional,"Prevention of Child Mental Health Problems in Southeastern Europe - Adapt, Optimize, Test, and Extend Parenting for Lifelong Health ' - 'RISE' - The Randomized Controlled Trial (Phase 3 of MOST)",Unrelated
4861,COVID,"February 08, 2021",4000,NCT04723290,SEROLOGICAL TESTS FOR SARS COV-2,BELGIUM,Completed,Grand Hôpital de Charleroi,"June 20, 2020",Interventional,SARS-CoV-2 Seroconversion Study Among GHdC Staff Members,COVID
4862,COVID,"February 08, 2021",1324,NCT04723394,AZD7442,UNITED KINGDOM,Not yet recruiting,AstraZeneca,"January 22, 2021",Interventional,"A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Safety and Efficacy of AZD7442 for the Treatment of COVID-19 in Non-hospitalized Adults",COVID
4863,RHEUMATISM,"February 08, 2021",950,NCT04723407,QUESTIONNAIRES,FRANCE,Not yet recruiting,"University Hospital, Limoges","February 1, 2021",Observational,Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism According to a Management Strategy in the Rheumatology Department of Limoges University Hospital,Unrelated
4864,COVID,"February 08, 2021",40,NCT04723446,CORSODYL® ALCOHOL FREE -0.2 % CHLORHEXIDINE DIGLUCONATE,,Not yet recruiting,Queen Mary University of London,"February 1, 2021",Interventional,Efficacy of Three Antimicrobial Mouthwashes in Reducing SARS-CoV-2 Viral Load in the Saliva of Patients Diagnosed With COVID-19: A Pilot Study,COVID
4865,COVID,"February 08, 2021",150,NCT04723459,IVERMECTIN IMPREGNATED MASK,EGYPT,Recruiting,South Valley University,"January 23, 2021",Interventional,Nano-Ivermectin Impregnated Masks Versus Ordinary Surgical Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff,COVID
4866,COVID,"February 08, 2021",300,NCT04723524,"JINHUA QINGGAN (JHQG) GRANULES, TRADITIONAL CHINESE MEDICINE",PAKISTAN,Recruiting,University of Karachi,"September 22, 2020",Interventional,"Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Effectiveness and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID 19 Patients",COVID
4867,COVID,"February 08, 2021",310,NCT04723537,PART A: UPAMOSTAT 200 MG,UNITED STATES,Not yet recruiting,RedHill Biopharma Limited,February 2021,Interventional,"Phase 2/3 Study of Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease",COVID
4868,TYPE 2 DIABETES MELLITUS,"February 08, 2021",120,NCT04723550,HOSPITAL TELEMEDICINE MANAGEMENT SYSTEM,CHINA,Recruiting,Wenwen Yin,"January 5, 2021",Interventional,Impact of Telemedicine on Young and Middle-aged Obese Patients With Type 2 Diabetes Mellitus During COVID-19 Pandemic,Unrelated
4869,COVID,"February 08, 2021",50,NCT04723563,HEPARIN,UNITED STATES,Not yet recruiting,Frederick Health,"February 1, 2021",Interventional,INHALEd Unfractionated HEParin for the Treatment of Hospitalized Patients With COVID-19 Pneumonia,COVID
4870,HEALTHY,"February 08, 2021",2132,NCT04723576,STRESS FIRST AID,UNITED STATES,Recruiting,RAND,"December 3, 2020",Interventional,Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19),Unrelated
4871,COVID,"February 08, 2021",40,NCT04723589,THAWED PLASMA,,Not yet recruiting,University of Alabama at Birmingham,"February 1, 2021",Interventional,Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC),COVID
4872,EBOLA VIRUS DISEASE,"February 08, 2021",32,NCT04723602,CAD3-MARBURG,UNITED STATES,Recruiting,Albert B. Sabin Vaccine Institute,"January 6, 2021",Interventional,"Phase 1b Trial to Evaluate Safety, Tolerability and Immune Responses of 2 Monovalent Chimpanzee Adenoviral Vectored Filovirus (Ebola-S and Marburg) Vaccines to Healthy Adults, Collection of Plasma/Serum for the Purposes of Assay Development",Unrelated
4873,"HEMATOLOGIC DISORDERS AND BONE MARROW FAILURE, HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR CELLULAR THERAPY (CART)","February 08, 2021",150,NCT04723706,COVID-19 SEROLOGY IGG,UNITED STATES,Not yet recruiting,Henry Ford Health System,"February 1, 2021",Observational,Immunological Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients,Unrelated
4874,COVID,"February 08, 2021",800,NCT04724395,HOSPITALIZATION,FRANCE,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,January 2021,Observational,Prospective Multicenter Cohort Study to Evaluate Disability Following Hospitalization in People of Working-age Surviving COVID-19,COVID
4875,SARS-CoV2 POSITIVE PATIENTS,"February 08, 2021",400,NCT04724434,,GERMANY,Enrolling by invitation,Hegau-Bodensee-Klinikum Singen,"December 4, 2020",Observational,Single Center Prospective Controlled Follow-up Study of COVID-19 Patients in the District Konstanz (FSC19-KN),COVID
4876,COVID,"February 08, 2021",15,NCT04724538,99MTC-PERTECHNETATE,RUSSIAN FEDERATION,Recruiting,National Medical Research Radiological Centre of the Ministry of Health of Russia,"October 15, 2020",Interventional,Inhalation Low Dose Radionuclide Therapy in Comprehensive Treatment of COVID-19 Viral Pneumonia,COVID
4877,COVID,"February 08, 2021",60,NCT04724616,EDUCATIONAL PROGRAM (CARTOON),AUSTRIA,Recruiting,Medical University of Vienna,"January 6, 2021",Interventional,CARTOON: CoronAviRus educaTional prOgram fOr childreN to Promote Knowledge and Hygiene Measures and Dispel Fear During the COVID- 19 Pandemic,COVID
4878,COVID,"February 08, 2021",60,NCT04724629,IXEKIZUMAB,BRAZIL,Recruiting,University of Sao Paulo,"January 5, 2021",Interventional,"Prospective-randomized Adaptive Study, With Active Control to Evaluate the Efficacy and Safety of Interleukin (IL)-17 Inhibitor Treatment Versus Low Doses of IL-2 Versus Indirect IL-6 Inhibitor in Hospitalized Patients With Severe Forms of COVID-19",COVID
4879,ALLOGENIC HEMATOPOIETIC CELL TRANSPLANT,"February 08, 2021",110,NCT04724642,,ISRAEL,Recruiting,Tel-Aviv Sourasky Medical Center,"December 28, 2020",Observational,"Efficacy and Safety of COVID-19 Vaccine in Patients After Allogeneic Hamatopoietic Cell Transplantation, CAR-T Therapy and With Primary Immune Deficiency - a Post Marketing Prospective Cohort Study",Unrelated
4880,CLINICAL DETERIORATION,"February 08, 2021",800,NCT04724681,WARD CSS,DENMARK,Recruiting,University Hospital Bispebjerg and Frederiksberg,"February 1, 2021",Interventional,Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection,Unrelated
4881,COVID,"February 08, 2021",900,NCT04724707,,RUSSIAN FEDERATION,Recruiting,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","September 11, 2020",Observational [Patient Registry],An Open Multicenter Observational Study (Registry) of Patients Recovered From Novel Coronavirus Infection (COVID-19) With Involvement of the Cardiovascular System or With Baseline Severe Cardiovascular Diseases,COVID
4882,COVID,"February 08, 2021",84,NCT04724720,FAMOTIDINE,UNITED STATES,Recruiting,Northwell Health,"January 19, 2021",Interventional,"A Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Famotidine vs Placebo for the Treatment of Non-Hospitalized Symptomatic Adults With COVID-19",COVID
4883,CORONAVIRUS DISEASE 2019,"February 08, 2021",5000,NCT04724850,,,Not yet recruiting,Juan Fernando Masa Jiménez,"February 1, 2021",Observational,Observational Study About the Characteristics and Evolution of Patients Diagnosed With COVID-19 in Extremadura,COVID
4884,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV2),"February 08, 2021",300,NCT04725084,USE OF HIGH FLOW NASAL CANNULA ALONE,FRANCE,Completed,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"July 1, 2020",Observational,Comparison of Non-invasive Oxygenation Strategies in ICU Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome,COVID
4885,COVID,"February 08, 2021",10000,NCT04725097,,INDIA,Recruiting,Mayo Clinic,"December 10, 2020",Observational,Rapid Throughput Screening for Human COVID-19 Infection: A ECG Study,COVID
4886,COVID,"February 08, 2021",250,NCT04725110,INSTILLED T3,,Not yet recruiting,University of Minnesota,March 2021,Interventional,"Phase II Trial of Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 ARDS - A Multi-Site, Randomized, Double-blinded, Placebo-Controlled Clinical Trial",COVID
4887,DELIRIUM CONFUSIONAL STATE,"February 08, 2021",146,NCT04725253,NICOTINAMIDE,CHILE,Not yet recruiting,University of Chile,"January 21, 2021",Interventional,"Nicotinamide, an Inhibitor of PARP-1, for Preventing Delirium in Older Adults",Unrelated
4888,COVID,"February 08, 2021",198,NCT04726098,DEXAMETHASONE HIGH DOSE,SPAIN,Recruiting,Manuel Taboada Muñiz,"January 15, 2021",Interventional,Efficacy of Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19,COVID
4889,COVID,"February 08, 2021",200,NCT04726111,SPECIMENS SPECIFIC FOR THE STUDY,FRANCE,Recruiting,Hopital Foch,"December 30, 2020",Interventional,COVID-19 and Pregnancy: Placental and Immunological Impacts,COVID
4890,SARS-CoV2 ANTIBODIES IN CHILDREN AND ADOLESCENTS LIVING WITH HIV,"February 08, 2021",1150,NCT04726137,,,Not yet recruiting,PENTA Foundation,"March 30, 2021",Observational,European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol,COVID
4891,COVID,"February 08, 2021",250,NCT04726150,ILR IMPLANTATION,,Not yet recruiting,"University Hospital, Antwerp",April 2021,Observational [Patient Registry],Effect of CoVid-19 and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias (CovidEx),COVID
4892,"DIABETIC PATIENT (TYPE 1,2, MODY, SECONDARY) OR WITH CORTICOSTEROID-INDUCED DIABETES FOLLOWING INITIATION OF CORTICOSTEROID TREATMENT","February 08, 2021",60,NCT04726163,CONTINUOUS BLIND GLUCOSE MEASUREMENT DEVICE (FREE STYLE PRO),FRANCE,Recruiting,"University Hospital, Strasbourg, France","January 29, 2021",Interventional,Tele-expertise for Glycemic Control Monitoring in Patients With Diabetes Hospitalized for Covid-19 Infection,Unrelated
4893,COVID,"February 08, 2021",40,NCT04726176,EXPOSURE TO COVID-19,BELGIUM,Recruiting,Vrije Universiteit Brussel,"January 30, 2021",Observational,COVID-19 and Brain Health,COVID
4894,INTELLECTUAL DISABILITY,"February 08, 2021",5350,NCT04726371,GENERIC BEST PRACTICES,UNITED STATES,Recruiting,Massachusetts General Hospital,"January 8, 2021",Interventional,Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings,Unrelated
4895,THE EFFECT OF COVID PANDEMIC,"February 08, 2021",415,NCT04726865,NASER AL-HUSBAN,JORDAN,Completed,University of Jordan,"October 1, 2020",Observational,Effects of COVID-19 Pandemic on Medical Students in Jordanian Universities: A Multi-center Cross-sectional Study,COVID
4896,MULTIPLE MYELOMA,"February 08, 2021",1500,NCT04727294,QUESTIONNAIRE,UNITED STATES,Recruiting,HealthTree Foundation,"January 22, 2021",Observational,"Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Myeloma (SMM), and Multiple Myeloma Patient Experience With COVID-19 Survey",Unrelated
4897,"SOCIAL ACCEPTANCE, SOCIAL ANXIETY","February 08, 2021",1000,NCT04727372,QUESTIONNAIRE,PAKISTAN,Enrolling by invitation,Islamia University of Bahawalpur,"January 23, 2021",Observational [Patient Registry],Social Acceptability of COVID-19 Vaccines in Pakistan: Fear and Social Trends,Unrelated
4898,COVID,"February 08, 2021",2724,NCT04727424,FLUVOXAMINE MALEATE 100 MG [LUVOX],BRAZIL,Recruiting,Cardresearch,"January 19, 2021",Interventional,"A Multicenter, Prospective, Adaptive, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effect of Fluvoxamine, Ivermectin and Metformin in Reducing Hospitalization of Patients With Mild COVID-19 and a High Risk of Complications",COVID
4899,FACE MASK SQUEEZE,"February 08, 2021",500,NCT04727762,,SPAIN,Recruiting,University of Valencia,"February 4, 2021",Observational,Population Impact on the Continued Use of the Mask Due to the Avoidance of COVID-19,Unrelated
4900,COMPLICATION OF MEDICAL CARE,"February 08, 2021",300,NCT04727775,FAVIPIRAVIR,KAZAKHSTAN,Recruiting,Astana Medical University,"November 25, 2020",Interventional,A Retrospective Study of the Effect of Antiviral Drugs on the Treatment of SARS-CoV-2 COVID19,Unrelated
4901,KNOWLEDGE,"February 08, 2021",216,NCT04728243,WHO QUALITYRIGHTS E-TRAINING,,Not yet recruiting,Mental Health Society of Ghana,February 2021,Interventional,WHO QualityRights Online Training for Mental Health Workers in Ghana,Unrelated
4902,SARS-CoV2,"February 08, 2021",106,NCT04728347,ARCT-021,SINGAPORE,Recruiting,"Arcturus Therapeutics, Inc.","January 4, 2021",Interventional,"A Phase 2a, Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021",COVID
4903,VACCINATION REFUSAL,"February 08, 2021",9656,NCT04728594,SOCIAL PROOF,UNITED STATES,Completed,Geisinger Clinic,"January 15, 2021",Interventional,Evaluation of an Email Intervention Promoting COVID-19 Vaccination Among Healthcare Workers,Unrelated
4904,COVID,"February 08, 2021",100,NCT04728698,COVI-MSC,UNITED STATES,Not yet recruiting,"Sorrento Therapeutics, Inc.",March 2021,Interventional,Treatment of COVID-19-Induced Acute Respiratory Distress: A Phase 2 Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells,COVID
4905,COVID,"February 08, 2021",600,NCT04728802,PROXALUTAMIDE,BRAZIL,Not yet recruiting,"Applied Biology, Inc.","February 1, 2021",Interventional,Proxalutamide Treatment for Hospitalized COVID-19 Patients,COVID
4906,COVID,"February 08, 2021",500,NCT04728828,SEROLOGICAL COVID-19 VACCINE IMMUNOGENICITY,FRANCE,Recruiting,Centre Hospitalier de Cornouaille,"January 25, 2021",Observational,Immune Response After COVID19 Vaccination in a Multicenter Cohort of In-center Haemodialysis Patients in France,COVID
4907,"PNEUMONIA, VIRAL","February 08, 2021",300,NCT04728880,REMDESIVIR,EGYPT,Recruiting,Mansoura University,"January 26, 2021",Observational,Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience,Respiratory
4908,MYOCARDIAL INFARCTION,"February 08, 2021",10,NCT04728906,HEART PATCH SEEDED WITH AUTOLOGOUS CARDIOMYOCYTES AND AMNION EPITHELIAL STEM CELLS,,Not yet recruiting,Rumah Sakit Pusat Angkatan Darat Gatot Soebroto,"March 5, 2021",Interventional,Targeted-cell Therapy Using Epithelial Stem Cells and Patients' Cardiomyocytes Loaded in Amnion Bilayer to Regenerate Myocardial Infarction Post COVID-19 Complication,Unrelated
4909,COVID,"February 08, 2021",80,NCT04728919,,FINLAND,Recruiting,Tampere University Hospital,"January 15, 2021",Observational,Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection,COVID
4910,WELLBEING,"February 08, 2021",219,NCT04728958,GRATITUDE,,Not yet recruiting,University of Sheffield,July 2021,Interventional,Studying the Effect of Written Reflective Tasks With Healthcare Staff Working During the COVID-19 Health Pandemic,Unrelated
4911,"ARDS, HUMAN","February 08, 2021",1800,NCT04729075,ARDS AND COVID19 TREATMENTS,UNITED STATES,Completed,Northwell Health,"January 19, 2021",Observational [Patient Registry],"Towards Precision Medicine for COVID-19 ARDS - An Analysis of the NorthCARDS (Northwell Health COVID-19 ARDS) Dataset to Identify Associations Between Patient-level Factors, Inpatient Treatment and Clinical Trajectories on Mechanical Ventilation Liberation and Survival",Unrelated
4912,COVID,"February 08, 2021",150,NCT04729140,IVERMECTIN TABLETS,UNITED STATES,Recruiting,"Max Health, Subsero Health","December 28, 2020",Interventional,A Randomized Double-blinded Placebo-controlled Outpatient Clinical Trial in High Risk Population Confirmed COVID-19 Patients Using Ivermectin and Doxycycline to Prevent COVID-19 Illness-related Hospitalization (COVIVER-OUT PLUS),COVID
4913,COVID,"February 08, 2021",100,NCT04729153,DAAD COMPOUND,,Not yet recruiting,Assiut University,February 2021,Observational,Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity,COVID
4914,SARS-CoV2,"February 08, 2021",200,NCT04729374,,CHINA,Recruiting,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,"January 27, 2021",Observational,"Longidutinal, Dynamic Analysis of COVID-19 Vaccine Induced Adaptive Immune Responses",COVID
4915,COVID,"February 08, 2021",200,NCT04729452,BLOOD TEST,UNITED KINGDOM,Recruiting,Lucy Jones,"June 1, 2020",Observational,Characterisation of the Immune Response to SARS-CoV-2 Infection,COVID
4916,COVID,"February 08, 2021",138,NCT04729491,DUTASTERIDE 0.5 MG,BRAZIL,Completed,Corpometria Institute,"June 30, 2020",Interventional,Early Antiandrogen Treatment (EAT) With Dutasteride for COVID-19 (EAT-DUTA AndroCoV Trial),COVID
4917,COVID,"February 08, 2021",310,NCT04729595,TEMPOL,,Not yet recruiting,Adamis Pharmaceuticals Corporation,"April 1, 2021",Interventional,"A Phase 2/3, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of Tempol (MBM-02) on Preventing COVID-19 Related Hospitalization in Subjects With COVID-19 Infection",COVID
4918,COVID,"February 08, 2021",1306,NCT04730206,CAMOSTAT,,Not yet recruiting,KU Leuven,March 2021,Interventional,The DAWN Camostat Trial: the Efficacy of Camostat for COVID-19 Infections Presenting to Ambulatory Care: a Randomized Controlled Trial,COVID
4919,CORONAVIRUS,"February 08, 2021",20,NCT04730284,HEALTH SUPPLEMENTS,HONG KONG,Recruiting,Chinese University of Hong Kong,"August 25, 2020",Interventional,Evaluation of a Synbiotic Formula in Patient With COVID-19,COVID
4920,COVID,"February 08, 2021",93,NCT04730323,TOCILIZUMAB,PAKISTAN,Completed,FMH College of Medicine and Dentistry,"May 12, 2020",Interventional,TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience,COVID
4921,COVID,"February 08, 2021",390,NCT04730401,CONVALESCENT PLASMA FROM COVID-19 DONORS,FINLAND,Recruiting,Helsinki University Central Hospital,"January 27, 2021",Interventional,"Randomized, Double-Blind, Placebo-Controlled Study of Convalescent Plasma in the Treatment of Covid-19",COVID
4922,COVID,"February 08, 2021",40,NCT04730427,GX-I7,"KOREA, REPUBLIC OF",Recruiting,"Genexine, Inc.",January 2021,Interventional,A Phase 1b Study to Investigate the Safety and Preliminary Efficacy of GX-I7 in Patients With COVID-19,COVID
4923,SARS-COV INFECTION,"February 08, 2021",146,NCT04730661,SIT TO STAND TEST,FRANCE,Recruiting,"University Hospital, Rouen","December 21, 2020",Interventional,Efficacy of the Sit to Stand Test (STST) in the Decision to Hospitalize a Patient Consulting the Emergency Department for COVID 19 (Coronavirus Infectious Disease),Respiratory
4924,COVID,"February 08, 2021",600,NCT04730856,TINZAPARIN,SPAIN,Not yet recruiting,Hospital Universitario Infanta Leonor,"January 29, 2021",Interventional,Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID),COVID
4925,COVID VACCINE,"February 08, 2021",360,NCT04730895,ORAL 13 CIS RETINOIC ACID,,Not yet recruiting,Kafrelsheikh University,February 2021,Interventional,(Isotretinoin (13- Cis-Retinoic Acid) Versus Spike Protein Based Vaccine,COVID
4926,FIBROMYALGIA,"February 08, 2021",1395,NCT04730934,PERCEIVED STRESS SCALE,TURKEY,Recruiting,Kars State Hospital,"January 1, 2021",Observational [Patient Registry],Evaluation of the Physical and Emotional Effects of the COVID-19 Pandemic on Fibromyalgia Patients,Unrelated
4927,2019 NOVEL CORONAVIRUS,"February 08, 2021",28,NCT04731051,HCQ01,JORDAN,Not yet recruiting,King Hussein Cancer Center,March 2021,Interventional,"A Pilot, Randomized, Open-label Trial to Determine the Feasibility, Safety, Efficacy, and Pharmacokinetics of Nebulized HCQ01 for the Treatment of Patients With COVID-19 and Cancer",COVID
4928,COVID,"February 08, 2021",40,NCT04731116,CANNABIDIOL,ISRAEL,Recruiting,Rabin Medical Center,"January 10, 2021",Interventional,Cannabidiol Treatment for Severe and Critical COVID-19 Pulmonary Infection,COVID
4929,HEALTHY,"February 08, 2021",42,NCT04731324,ZYIL1 CAPSULE,INDIA,Recruiting,Cadila Healthcare Limited,"January 5, 2021",Interventional,"A Phase 1, Prospective Open Label, Single Dose, Single Arm Study of ZYIL1 Administered Via Oral Route to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Adult Human Subjects",Unrelated
4930,CORONAVIRUS,"February 08, 2021",632,NCT04731870,SURVEY RESEARCH,,Not yet recruiting,East Carolina University,February 2021,Observational,Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines Among a Cross-section of US Healthcare Providers and Key At-risk Subgroups in the Rural South,COVID
4931,COVID,"February 08, 2021",65,NCT04732468,HAD5-S-FUSION+N-ETSD (SUSPENSION FOR INJECTION),UNITED STATES,Not yet recruiting,"ImmunityBio, Inc.",February 2021,Interventional,"Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of Subcutaneously and Orally Administered Prophylactic Vaccination With 2nd Generation (E1/E2B/E3-Deleted) Adenoviral COVID-19 in Normal Healthy Volunteers",COVID
4932,COVID,"February 08, 2021",300,NCT04732637,"TEST AT HOME'S PROPRIETARY ""LOLLIPOP"" BUCCAL CAVITY SWAB",INDIA,Not yet recruiting,Datar Cancer Genetics Limited,"February 1, 2021",Observational,Evaluating the Use of Flavoured Simulated Oral Fluids Collection Method for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Enzyme Linked Immunosorbent Assay (ELISA) Method : A Concordance Study Plan,COVID
4933,COVID,"February 08, 2021",225,NCT04732663,NO INTERVENTION,CANADA,Not yet recruiting,University of Alberta,February 2021,Observational,Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19,COVID
4934,MOTHER-CHILD INTERACTION,"February 08, 2021",30,NCT04732702,NO INTERVENTION,GERMANY,Recruiting,University of Cologne,"October 29, 2020",Observational,"Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents in Terms of Mother-infant Interaction, Parental Well-being, Expression and Methylation of Candidate Genes of Stress Signaling Pathways",Unrelated
4935,COVID,"February 08, 2021",50,NCT04732767,,,Not yet recruiting,Atrium Health,"January 20, 2021",Observational,Prospective Study of Maternal and Umbilical Cord Blood Collection to Evaluate for Presence of COVID-19 Antibody Response in COVID-19 Positive Women,COVID
4936,COVID VACCINES,"February 08, 2021",22500,NCT04732819,HIGH TOUCH MULTI-PRONGED BEHAVIORAL INTERVENTION,UNITED STATES,Recruiting,Brown University,"January 4, 2021",Interventional,IMPACT-C: Improving Vaccine Uptake in Skilled Nursing Facilities,COVID
4937,COVID,"February 08, 2021",50,NCT04732858,CROSS SECTIONAL E-SURVEY ON SURGEONS EXPOSED TO ANY EDUCATIONAL INTERVENTION,FRANCE,"Active, not recruiting",Assistance Publique - Hôpitaux de Paris,"March 1, 2020",Observational,"Educational Interventions to Integrate Surgical Staff Within Medical Units During the COVID-19 Pandemic: EDUCOVID Cross-sectional, E-survey",COVID
4938,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,"February 08, 2021",610,NCT04732949,SNG001,UNITED KINGDOM,Recruiting,Synairgen Research Ltd.,"January 12, 2021",Interventional,"A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Determine the Efficacy and Safety of Inhaled SNG001 for the Treatment of Patients Hospitalised Due to Moderate COVID-19",COVID
4939,ACUTE RESPIRATORY FAILURE,"February 08, 2021",530,NCT04733105,,,Not yet recruiting,Assistance Publique - Hôpitaux de Paris,February 2021,Observational,Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure: a Multicenter Observational Study,Respiratory
4940,COVID,"February 08, 2021",600,NCT04733170,KNOWNOW SARS-COV-2 RAPID ANTIGEN TEST,,Not yet recruiting,Vatic Ltd.,"February 15, 2021",Observational,Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen,COVID
4941,COVID,"February 08, 2021",56,NCT04733625,CHOLECALCIFEROL,EGYPT,Completed,Kasr El Aini Hospital,"September 15, 2020",Interventional,The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection,COVID
4942,COVID,"February 08, 2021",250,NCT04733651,HOSPITAL STANDARD OF CARE FOR COVID-19,,Not yet recruiting,Nepal Health Research Council,"February 20, 2021",Interventional,"A Randomized, Open-labelled and Controlled Clinical Trial to Investigate the Clinical Efficacy of Isoquercetin in the Treatment of Mild-to-moderate Hospitalised COVID-19 Patients",COVID
4943,COVID,"February 08, 2021",200,NCT04733677,,UNITED STATES,Not yet recruiting,Wake Forest University Health Sciences,February 2021,Observational,User Experience of the OSR M1 Reusable Elastomeric Air Purifying Respirator in Non-Clinical Settings,COVID
4944,COVID INFECTION IN HEMATOLOGICAL MALIGNANCIES PATIENTS,"February 08, 2021",3000,NCT04733729,,ITALY,Recruiting,Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne,"March 1, 2020",Observational [Patient Registry],Epidemiology of COVID-19 Infection in Patients With Hematological Malignancies: A European Haematology Association Survey,COVID
4945,COVID,"February 08, 2021",500,NCT04733807,BNT162B2 MRNA COVID-19 VACCINE,ITALY,Recruiting,University of Roma La Sapienza,"January 28, 2021",Observational,SARS-Cov-2 Antibodies Response to BNT162b2 mRNA Vaccine to Prevent Covid-19,COVID
4946,SEVERE COVID,"February 08, 2021",30,NCT04733833,VB-201 + STANDARD OF CARE,ISRAEL,Recruiting,Vascular Biogenics Ltd. operating as VBL Therapeutics,"January 26, 2021",Interventional,"A Randomized, Controlled Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19",COVID
4947,EYE TRAUMA,"February 08, 2021",9,NCT04733846,DATA COLLECTION,FRANCE,Not yet recruiting,Centre Hospitalier Universitaire de Saint Etienne,February 2021,Observational,Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy,Unrelated
4948,COVID,"February 08, 2021",1200,NCT04734171,DIGITAL SOCIAL ACTIVITY VIDEO INTERVENTION,UNITED STATES,Completed,Columbia University,"April 2, 2020",Interventional,"COVID-19 and Its Implications on Social Activity, Loneliness and Stigma",COVID
4949,NEUROIMAGING,"February 08, 2021",436,NCT04734223,NEUROIMAGING FINDINGS IN PATIENTS WITH COVID-19,TURKEY,Completed,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,"April 1, 2020",Observational,Correlation of Neuroimaging Findings With Clinical Presentation and Laboratory Data in Patients With COVID-19: A Single Center Study,Unrelated
4950,IMMUNE RESPONSE,"February 08, 2021",150,NCT04734288,"VIT.D3 5000 IU, IMMUNE ACTIVE",UNITED STATES,Enrolling by invitation,"Metagenics, Inc.","January 22, 2021",Interventional,LIFEHOUSE: a Lifestyle Intervention and Functional Evaluation- a Health OUtcome SurvEy; Description of the Tent Bucket -Immune Support,Unrelated
4951,COVID,"February 08, 2021",88,NCT04734561,INSPIRATORY MUSCLE TRAINING GROUP,,Not yet recruiting,Universidad Complutense de Madrid,"February 8, 2021",Interventional,"Effects of Respiratory Muscle Training on Quality of Life, Physical and Pulmonary Function and Psychological Status in Patients Who Have Had COVID-19 Disease",COVID
4952,COVID,"February 08, 2021",84,NCT04734678,TOCILIZUMAB,EGYPT,Recruiting,Ain Shams University,"December 1, 2020",Observational,Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome,COVID
4953,COVID,"February 08, 2021",2,NCT04734717,NEUROLOGY TEST,HUNGARY,Enrolling by invitation,Somogy Megyei Kaposi Mór Teaching Hospital,"January 12, 2021",Interventional,Coordination and Locomotor Problems in Patients With Covid-19 Virus,COVID
4954,DYSFUNCTIONAL BREATHING,"February 08, 2021",500,NCT04734795,,DENMARK,Recruiting,Kolding Sygehus,February 2021,Observational,The Prevalence of Dysfunctional Breathing in Children and Adolescents With Asthma,Unrelated
4955,COVID,"February 08, 2021",500,NCT04734860,COVI-AMG,,Not yet recruiting,"Sorrento Therapeutics, Inc.",March 2021,Interventional,"A Randomized, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms",COVID
4956,COVID,"February 08, 2021",1000,NCT04734873,CPI-006 2 MG/KG + SOC,UNITED STATES,Recruiting,"Corvus Pharmaceuticals, Inc.","February 1, 2021",Interventional,"Phase 3, Randomized, Placebo Controlled, Double-blind, Multicenter, Stratified Study of CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients",COVID
4957,COVID,"February 08, 2021",400,NCT04734886,L. REUTERI DSM 17938 + VITAMIN D,SWEDEN,Recruiting,"Örebro University, Sweden","November 27, 2020",Interventional,Exploratory Study on the Effects of Probiotic Supplementation on SARS-CoV-2 Antibody Response in Healthy Adults,COVID
4958,ENDOSCOPY,"February 08, 2021",500,NCT04734912,GASTROSCOPY IN TRANSNASAL TECHIQUE,GERMANY,Recruiting,Johannes Gutenberg University Mainz,"January 13, 2021",Interventional,Evaluation of Transnasal Endoscopy During COVID-19 Pandemic,Unrelated
4959,MULTIPLE SCLEROSIS,"February 08, 2021",10000,NCT04735406,,UNITED STATES,Not yet recruiting,"EMD Serono Research & Development Institute, Inc.","January 29, 2021",Observational,The MS Leadership and Innovation Network (MS-LINK™) Outcomes Study: A Comprehensive Prospective Longitudinal Assessment of Patient and Clinical Reported Outcomes in Multiple Sclerosis Patients Across North America,Unrelated
4960,IMMUNE THROMBOCYTOPENIA,"February 08, 2021",140,NCT04735588,,,Not yet recruiting,Gruppo Italiano Malattie EMatologiche dell'Adulto,April 2021,Observational,"IMMUNE THROMBOCYTOPENIA (ITP) AND COVID-19: National Retrospective and Prospective Observational Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP",Unrelated
4961,COVID,"February 08, 2021",1315,NCT04735744,PATIENTS RECOVERING FROM COVID19 RECEIVE USUAL CARE BY ALLIED HEALTH PROFESSIONALS,,Not yet recruiting,Radboud University,"February 15, 2021",Observational,Evaluation of Allied Healthcare in Patients Recovering From COVID-19,COVID
4962,DIAPHRAGM DISEASE,"February 08, 2021",40,NCT04735757,CONTRAST-ENHANCED MRI,,Not yet recruiting,VU University Medical Center,"February 2, 2021",Observational,"Effects of COVID-19-infection and Mechanical Ventilation on Movement and Tissue Characteristics of the Diaphragm, Visualized by Magnetic Resonance Imaging: a Proof-of-concept Study",Unrelated
4963,DIABETES,"February 08, 2021",3000,NCT04735835,DIETARY INTERVENTION,UNITED STATES,Recruiting,Zoe Global Limited,"July 20, 2020",Interventional,Personalized Responses to Dietary Composition Trial 3,Unrelated
4964,CARDIAC INVOLVEMENT WITH COVID,"February 08, 2021",500,NCT04736004,,UNITED STATES,Not yet recruiting,Duke University,"February 15, 2021",Observational,Hearts of Athletes Study: Prospective Evaluation of Athletes for Cardiac Involvement With COVID-19,COVID
4965,IGM AND IGG IN BLOOD,"February 08, 2021",500,NCT04736524,RAPID ANTIBODY TEST,UNITED STATES,Recruiting,Texas Cardiac Arrhythmia Research Foundation,"January 15, 2021",Observational,Immune Response Following COVID-19 Vaccination (IFVAC),Unrelated
4966,TELEHEALTH,"February 08, 2021",667,NCT04736680,,,Not yet recruiting,Hospital General de Niños Pedro de Elizalde,"March 1, 2021",Observational,"Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital. Missed Appointments Rates, Associated Factors, Generation and Validation of Predictive Models",Unrelated
4967,COVID,"February 08, 2021",570,NCT04736732,MEDICAL FOLLOW-UP,CANADA,Recruiting,Institut de Recherches Cliniques de Montreal,"January 1, 2021",Observational,The IRCM POST-COVID-19 (IPCO) Clinic: A Multidisciplinary Approach to Evaluate Short and Long-term Complications of COVID-19,COVID
4968,COVID,"February 08, 2021",90,NCT04736901,ENOXAPARIN,EGYPT,Recruiting,Ain Shams University,"December 1, 2020",Observational,Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19,COVID
4969,ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",20,NCT04737161,T REGULATORY CELLS,UNITED STATES,Not yet recruiting,Stanford University,February 2021,Interventional,A Phase 1 Study to Assess the Safety of Living Related Donor Derived T Regulatory Cell Therapy in Subjects With COVID 19 Induced Acute Respiratory Distress Syndrome (ARDS),Respiratory
4970,SELF-INJURIOUS THOUGHTS AND BEHAVIOURS,"February 08, 2021",40,NCT04737252,"CONNECTING, OVERCOMING AND MOVING PAST SUICIDE AND SELF-INJURY",CANADA,Recruiting,York University,"January 18, 2021",Interventional,"Development and Initial Testing of a Couple-Based Intervention to Optimize Suicide and Self-Injury Treatment: COMPASS (Connecting, Overcoming, and Moving Past Suicide and Self-Injury)",Unrelated
4971,COVID-ASSOCIATED ARDS,"February 08, 2021",48,NCT04737486,AV-001,UNITED STATES,Recruiting,"Vasomune Therapeutics, Inc.","December 16, 2020",Interventional,"A Randomized, Double-blind, Placebo-controlled Phase 1 Single and Multiple-Dose Pharmacokinetic First-in-Human Study of AV-001 in Healthy Subjects",COVID
4972,TYPE2 DIABETES,"February 08, 2021",76,NCT04738032,DIGITAL STORYTELLING INTERVENTION,UNITED STATES,Completed,Mayo Clinic,"August 26, 2020",Observational,Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic,Unrelated
4973,COVID,"February 08, 2021",90,NCT04738045,REMDESIVIR,EGYPT,"Active, not recruiting",Ahmed Essam,"November 1, 2020",Interventional,Comparative Therapeutic Efficacy and Safety of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients,COVID
4974,COVID,"February 08, 2021",30,NCT04738136,S-1226,,Not yet recruiting,SolAeroMed Inc.,"February 15, 2021",Interventional,"A Randomized, Open-Label, Controlled, Phase II Study to Evaluate the Safety, Tolerability and Efficacy Of S-1226 In Hospitalized Subjects With Moderate Severity Covid-19 Bronchiolitis/Pneumonia",COVID
4975,COVID,"February 08, 2021",209,NCT04738175,COVI-AMG,,Not yet recruiting,"Sorrento Therapeutics, Inc.",April 2021,Interventional,"A Randomized, Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19",COVID
4976,COVID,"February 08, 2021",10000000,NCT04738331,,FRANCE,Recruiting,"University Hospital, Montpellier","February 1, 2021",Observational,Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database : CovPCR,COVID
4977,COVID,"February 08, 2021",600,NCT04738435,,ARGENTINA,Recruiting,Hospital Italiano de Buenos Aires,"January 5, 2021",Observational,"Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina",COVID
4978,COVID,"February 08, 2021",3036,NCT04738695,POINT-OF-CARE RAPID ANTI-SARS-COV-2 ANTIBODY TEST (ORIENT GENE BIOTECH) AND DRY BLOOD SPOT COLLECTION (EUROIMMUN),BELGIUM,Recruiting,Sciensano,"February 1, 2021",Observational,SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents in Belgium,COVID
4979,"ASSESSMENT, SELF","February 08, 2021",87,NCT04738721,EVALUATION,TURKEY,Not yet recruiting,Medipol University,"February 5, 2021",Observational [Patient Registry],Comparison of Physical Activity and Physical Fitness Parameters of Young Adults Before and After COVID-19 Quarantine,Unrelated
4980,COVID,"February 08, 2021",150,NCT04738760,,EGYPT,Recruiting,Ain Shams University,"December 1, 2020",Observational,Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients,COVID
4981,SARS-CoV2 INFECTION,"February 08, 2021",525,NCT04739020,RESP-AER-METER,GERMANY,Recruiting,Johann Wolfgang Goethe University Hospital,"January 18, 2021",Interventional,Measurement of Respiratory Aerosols in PCR SARS-CoV-2 Positive and Negative Children and Adults,COVID
4982,COVID,"February 08, 2021",50,NCT04739345,,EGYPT,Recruiting,Ain Shams University,"December 1, 2020",Observational,New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection,COVID
4983,COVID,"February 08, 2021",50,NCT04739410,IVERMECTIN,PAKISTAN,Completed,FMH College of Medicine and Dentistry,"May 1, 2020",Interventional,Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients,COVID
4984,SARS-COV INFECTION,"February 08, 2021",100,NCT04739449,"COACHING, CLEANING, COMMUNICATION, COLLABORATION",,Not yet recruiting,University of Michigan,"February 10, 2021",Interventional,"'4C' Intervention to Reduce SARS-CoV-2 Transmission: Coaching, Cleaning, Communication and Collaboration",Respiratory
4985,PREGNANCY COMPLICATIONS,"February 08, 2021",248,NCT04739462,MHEALTH PLATFORM,UNITED STATES,Not yet recruiting,University of Minnesota,February 2021,Interventional,mHealth for Improvement of Access to Maternal Health Services in the Era of COVID-19 Pandemic (SMS Maama Project),Unrelated
4986,FOOD INSECURITY,"February 08, 2021",1000,NCT04739540,,UNITED STATES,Not yet recruiting,Baylor College of Medicine,"February 19, 2021",Observational,Food Insecurity Screening and Intervention: From Hospital to Home,Unrelated
4987,HEALTH CARE WORKERS,"February 08, 2021",368,NCT04740125,,TUNISIA,Completed,"General Administration of Military Health, Tunisia","May 1, 2020",Observational,"PSYCHOLOGICAL IMPACT, STRESS FACTORS AND BEHAVIOURS IN HEALTH CARE PROFESSIONALS DURING THE COVID-19 PANDEMIC IN TUNISIA",Unrelated
4988,STRESS,"February 08, 2021",88,NCT04740229,YOGA,UNITED STATES,Not yet recruiting,University of Illinois at Urbana-Champaign,"February 10, 2021",Interventional,"Testing the Impact of Flow-based, Moderate-intensity Yoga on Executive Functioning and Stress Among Low Active Working Adults Having Symptoms of Stress",Unrelated
4989,COVID,"February 08, 2021",250,NCT04740320,,UNITED KINGDOM,Recruiting,Imperial College London,"December 15, 2020",Observational [Patient Registry],Screening Protocol for a Dose Finding Human Experimental Infection Study in Healthy Subjects Using a GMP-produced SARS-COV-2 Wild Type Strain,COVID
4990,"COVID, PATIENT REPORTED OUTCOME MEASURES, QUALITY OF LIFE","February 08, 2021",350,NCT04740372,NO INTERVENTION. METHOD STUDY. PSYCHOMETRIC TESTING,NORWAY,Recruiting,Oslo University Hospital,"November 20, 2020",Observational,"Development of an International Questionnaire to Assess Patient-reported Quality of Life Related to COVID-19 Disease, the Oslo COVID-19 Quality of Life Questionnaire (QLQ) - ## © Phase III of Questionnaire Development",COVID
4991,DEPRESSION,"February 08, 2021",850,NCT04740411,THE COMMON ELEMENTS TOOLBOX (COMET),,Not yet recruiting,University of Pennsylvania,"February 3, 2021",Interventional,An Online Wellness Intervention for American College Students: Investigating the Efficacy of The Common Elements Toolbox,Unrelated
4992,HEART DISEASES,"February 08, 2021",30,NCT04740489,PHASE 3 CARDIAC REHABILITATION,,Not yet recruiting,Ant Shepherd,"February 1, 2021",Observational,"A Pilot Study Examining Participants Psychosocial Health, Physical Activity and Staff Experiences: Is Adapted Home-based Phase 3 Cardiac Rehabilitation Feasible and Beneficial?",Unrelated
4993,COVID,"February 08, 2021",9600,NCT04740658,NO INTERVENTION,FRANCE,Not yet recruiting,"University Hospital, Toulouse","February 1, 2021",Observational,Effect of Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents During and After the Epidemic Period,COVID
4994,COVID PREVENTION,"February 08, 2021",6000,NCT04741061,SPUTNIK LIGHT,RUSSIAN FEDERATION,Not yet recruiting,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","February 15, 2021",Interventional,"A Phase III, Randomized, Double-blind, Placebo-controlled International Multicenter Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light Vector Vaccine in the Parallel Assignment of the Subjects in Prophylactic Treatment for SARS-СoV-2 Infection",COVID
4995,COVID,"February 08, 2021",600,NCT04741178,,ITALY,Recruiting,Morgagni Pierantoni Hospital,"March 20, 2020",Observational,PAtterns and Extension in Sars-Cov-2 Related Interstitial Pneumonia: CT Analysis,COVID
4996,HEALTHY,"February 08, 2021",10,NCT04741217,NOT AN INTERVENTIONAL STUDY,,Not yet recruiting,Guy's and St Thomas' NHS Foundation Trust,"March 1, 2021",Observational,A Proof of Concept Study to Evaluate Aerosol Generation During Non-Invasive Positive Pressure Respiratory Procedures,Unrelated
4997,COVID,"February 08, 2021",52,NCT04741282,PULMONARY TELEREHABILITATION,,Not yet recruiting,Iran University of Medical Sciences,"February 15, 2021",Interventional,Effect of Pulmonary Tele-rehabilitation With and Without Progressive Muscle Relaxation Program in Covid-19 Patients After Hospital Discharge: Randomized Clinical Trial,COVID
4998,COVID,"February 08, 2021",850,NCT04741386,SARS-COV-2 VACCINATION,NETHERLANDS,Not yet recruiting,University Medical Center Groningen,"February 1, 2021",Observational [Patient Registry],"The Immune-response and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant - A Prospective, Controlled, Multicenter Cohort Study by the RECOVAC Consortium",COVID
4999,HYPOHIDROTIC ECTODERMAL DYSPLASIA,"February 08, 2021",230,NCT04741412,,GERMANY,Recruiting,University Hospital Erlangen,"June 3, 2020",Observational [Patient Registry],"SARS-CoV-2 Infections in Children and Adolescents: Course of COVID-19, Immune Responses, Complications and Long-term Consequences in Entire Households With Members Younger Than 18 Years",Unrelated
5000,CYSTIC FIBROSIS,"February 08, 2021",30,NCT04742049,TELEREHABILITATION-BASED,TURKEY,Recruiting,Hacettepe University,"December 28, 2020",Interventional,"The Effects of Telerehabilitation on Peripheral Muscle Function, Physical Activity Level and Sleep Quality in Pediatric Cystic Fibrosis Patients Having Social Isolation Due to Pandemic",Unrelated
5001,BRONCHIECTASIS ADULT,"February 08, 2021",22,NCT04742270,SIMEOX+ RESPIRATORY PHYSIOTHERAPY TELECARE,FRANCE,Not yet recruiting,Physio-Assist,February 2021,Interventional,Feasibility of Implementing SIMEOX® Using Tele-physiotherapy and Evaluation of Compliance With SIMEOX® at Home for Bronchial Drainage in Patients With Bronchiectasis Other Than Cystic Fibrosis and Who Have Difficulties in Accessing Regular Respiratory Physiotherapy Sessions.,Unrelated
5002,SAFETY ISSUES,"February 08, 2021",22,NCT04742426,WHO RECOMMENDED PPE,,Not yet recruiting,Roman Sýkora,"May 1, 2021",Interventional,Does the Choice of Personal Protective Equipment Affect Team Performance During Medical Emergencies? Simulation-Based Randomised Controlled Trial,Unrelated
5003,COVID,"February 08, 2021",2352,NCT04742569,,UNITED STATES,Recruiting,"ClinOne, Inc.","December 21, 2020",Observational,Wearable Diagnostic for Detection of COVID-19 Infection,COVID
5004,COVID-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME,"February 08, 2021",16,NCT04742595,SARS-COV-2 ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES,UNITED STATES,Recruiting,M.D. Anderson Cancer Center,"December 18, 2020",Interventional,"Administration of Expanded, Most Closely HLA Matched SARS-CoV-2-Specific T Cells for the Treatment of COVID-19 in Patients With Cancer",COVID
5005,SARS-COV INFECTION,"February 08, 2021",40,NCT04742712,CORONACHECK DEVICE,UNITED KINGDOM,Recruiting,Portsmouth Hospitals NHS Trust,"October 27, 2020",Observational,A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 - FIND SARS CoV-2 Covid-19,Respiratory
5006,CORONAVIRUS DISEASE 2019 (COVID),"February 08, 2021",200,NCT04742725,PLACEBO,,Not yet recruiting,"Prothione, LLC","February 15, 2021",Interventional,"A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)",COVID
5007,COVID (HEALTHY VOLUNTEERS),"February 08, 2021",260,NCT04742738,GBP510 ADJUVANTED WITH ALUM (RBD 10ΜG/DOSE) - STAGE 1,"KOREA, REPUBLIC OF",Recruiting,"SK Bioscience Co., Ltd.","January 20, 2021",Interventional,"A 2-Stage, Phase I/II, Placebo-controlled, Randomized, Observer-blinded, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide in Healthy Younger and Older Adults",COVID
5008,SARS-CoV2 COVID,"February 08, 2021",150,NCT04742842,COVIGEN 0.8 MG ID OR PLACEBO ID,AUSTRALIA,Not yet recruiting,University of Sydney,"February 15, 2021",Interventional,"A Phase I, Double-blind, Dose-ranging, Randomised, Placebo-controlled Trial to Study the Safety and Immunogenicity of a DNA-based Vaccine Against COVID-19 (COVIGEN) in Healthy Participants Aged 18 to 75 Years Old",COVID
5009,COVID,"February 08, 2021",237,NCT04742946,TELEREHABILITATION INTERVENTION,SPAIN,Not yet recruiting,Universidad de Granada,"February 15, 2021",Interventional,Telerehabilitation Intervention in Patients With Covid-19 After Hospital Discharge to Improve Functional Capacity and Quality of Life. Study Protocol for a Multicenter Randomized Clinical Trial,COVID
5010,COVID,"February 08, 2021",50,NCT04743011,HEPARIN SODIUM,BRAZIL,Not yet recruiting,UPECLIN HC FM Botucatu Unesp,"February 15, 2021",Interventional,Nebulized Enriched Heparin to Treat no Critical Patients With Sars-Cov-2 - Triple Blind Clinical Trial,COVID
5011,COVID,"February 08, 2021",1000,NCT04743232,DECISION TOOL FOR CLINICIANS,NETHERLANDS,Recruiting,Erasmus Medical Center,"March 1, 2021",Interventional,Corona Virus Disease Pandemic Resuscitation Plans and Decisions on Escalation and Limitation of Treatment,COVID
5012,COVID,"February 08, 2021",200,NCT04743349,STEAM INHALATIONS,ITALY,Recruiting,Meyer Children's Hospital,"January 26, 2021",Interventional,Steam Inhalations in Asymptomatic and Paucisymptomatic COVID-19 Patients,COVID
5013,COVID,"February 08, 2021",600,NCT04743388,BNT162B2,GREECE,Recruiting,National and Kapodistrian University of Athens,"January 4, 2021",Observational [Patient Registry],Study of the Kinetics of Antibodies Against SARS-CoV-2 and of Cellular Subpopulations of the Immune System in Volunteers Receiving the BNT162b2 Vaccine or Other Approved Vaccine Against SARS-CoV-2,COVID
5014,COVID,"February 08, 2021",60,NCT04743401,TELE-EXERGAMING TABLET,UNITED STATES,Not yet recruiting,VA Office of Research and Development,"April 1, 2021",Interventional,Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients,COVID
5015,RSV INFECTION,"February 08, 2021",1600,NCT04743609,NASOPHARYNGEAL SAMPLES,FRANCE,Not yet recruiting,Association Clinique Thérapeutique Infantile du val de Marne,"February 1, 2021",Observational,"Ambulatory Respiratory Tract Infection Survey, Burden of Respiratory Syncitial Virus in the Era of Covid-19",Unrelated
5016,COVID,"February 08, 2021",2400,NCT04743908,SOCIAL NETWORK STRATEGY + COVID-19 MESSAGING,,Not yet recruiting,University of Chicago,February 2021,Interventional,Community Network-driven COVID-19 Testing of Vulnerable Populations in the Central US (C3),COVID
5017,SARS-CoV2 VACCINATION IN DIALYSIS AND KIDNEY TRANSPLANT PATIENTS,"February 08, 2021",400,NCT04743947,NO INTERVAENTION; OBSERVATIONAL STUDY,GERMANY,Recruiting,"Heinrich-Heine University, Duesseldorf","December 21, 2020",Observational,Observational Study on the Effects of SARS-CoV-2 Vaccination in Dialysis and Kidney Transplant Patients,COVID
5018,"STRESS, EMOTIONAL","February 08, 2021",20,NCT04743973,MUSE S™ HEADBAND SYSTEM,UNITED STATES,Not yet recruiting,Mayo Clinic,"March 1, 2021",Interventional,A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing A Wearable Wellness Brain Sensing Device (Muse-S) in Practicing Physicians,Unrelated
5019,ASTHMA,"February 08, 2021",60,NCT04744272,MYASTHMA,UNITED KINGDOM,Not yet recruiting,my mhealth Ltd,March 2021,Interventional,A Randomised Controlled Feasibility Study to Explore the Efficacy of Digital Self-management Within Secondary Care in an Asthmatic Population,Unrelated
